data_2m52_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m52 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.6 158.26 51.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.491 2.127 . . . . 0.0 109.853 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 p -139.28 -168.61 2.49 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -86.05 -2.64 58.5 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.95 -1.093 . . . . 0.0 112.704 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -83.3 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 121.127 1.785 . . . . 0.0 109.105 175.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.86 129.6 26.24 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.227 2.211 . . . . 0.0 105.942 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -100.74 131.86 46.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mp -129.8 154.42 47.26 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.737 1.615 . . . . 0.0 109.039 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.1 mtm -136.29 161.57 35.41 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.07 21.99 1.86 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.624 1.97 . . . . 0.0 111.545 172.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -85.22 0.06 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 163.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.55 170.66 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 127.08 2.152 . . . . 0.0 110.748 -166.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.28 160.2 35.16 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.094 0.958 . . . . 0.0 109.79 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -0.24 5.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.363 2.042 . . . . 0.0 113.037 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.96 19.4 3.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.056 2.143 . . . . 0.0 112.797 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.23 -9.33 7.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.948 0.794 . . . . 0.0 112.556 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.7 mt -79.62 28.55 0.26 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.21 1.404 . . . . 0.0 111.774 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -100.0 -38.13 8.71 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.835 -1.166 . . . . 0.0 111.282 -170.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 127.04 31.27 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.976 0.91 . . . . 0.0 109.979 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.07 -30.95 58.54 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.956 1.303 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -92.47 16.09 12.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.068 1.347 . . . . 0.0 111.872 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -125.48 -50.24 1.64 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.488 1.515 . . . . 0.0 107.413 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -45.05 -50.29 10.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.059 1.344 . . . . 0.0 112.39 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.61 -27.57 61.35 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -66.42 -46.44 76.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.806 0.843 . . . . 0.0 108.848 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.2 mt -61.16 -28.86 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.739 1.216 . . . . 0.0 111.405 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.04 -47.33 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 120.641 -1.287 . . . . 0.0 109.3 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.51 -30.92 57.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.198 0.999 . . . . 0.0 111.569 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.5 -46.45 86.66 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.849 1.66 . . . . 0.0 110.503 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.5 t -77.94 -28.64 15.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -59.42 -48.69 80.67 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.54 -44.92 95.15 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.091 0.244 . . . . 0.0 110.772 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.75 -43.49 75.74 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.878 -0.514 . . . . 0.0 111.618 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 t -85.24 -21.92 28.87 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.941 -168.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.9 m -60.08 -8.49 2.42 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.858 -1.151 . . . . 0.0 113.025 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -67.84 -7.58 29.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 119.527 -1.983 . . . . 0.0 113.64 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -124.73 -0.26 8.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.53 1.132 . . . . 0.0 112.623 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.3 -137.96 5.63 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 106.914 -2.475 . . . . 0.0 106.914 -170.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.47 115.31 10.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.35 107.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 108.366 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -55.97 -60.76 3.01 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.396 2.278 . . . . 0.0 108.618 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 p -158.84 175.46 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.541 0.61 . . . . 0.0 110.881 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.14 150.21 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.334 1.453 . . . . 0.0 107.779 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.99 109.18 8.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.027 1.331 . . . . 0.0 110.987 -169.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 86.46 58.67 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 127.363 2.265 . . . . 0.0 107.372 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.9 133.27 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.946 2.431 . . . . 0.0 109.232 172.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 159.71 32.66 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 124.082 0.953 . . . . 0.0 111.535 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.458 -0.601 0 C-N-CA 123.742 2.962 . . . . 0.0 109.926 164.692 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo . . . . . 0 N--CA 1.45 -1.084 0 N-CA-C 108.271 -1.473 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.4 9.98 86.52 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.765 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.3 t -67.17 154.42 41.3 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.837 0.818 . . . . 0.0 110.614 170.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.02 -5.24 80.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 125.527 1.537 . . . . 0.0 114.058 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.2 173.02 9.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.941 1.371 . . . . 0.0 107.987 170.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 mt -131.35 145.96 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 150.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -115.46 144.72 43.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 164.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -118.96 154.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.02 136.92 47.61 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -107.86 -177.95 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.02 1.328 . . . . 0.0 109.784 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 t -112.15 7.05 19.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 110.145 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.0 p -155.97 143.42 19.34 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 120.869 -1.144 . . . . 0.0 108.368 161.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -51.39 -44.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.952 1.301 . . . . 0.0 109.207 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -71.6 -26.04 62.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.351 -167.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -76.42 -42.66 43.43 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 12.9 t -59.74 -41.01 89.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.723 0.409 . . . . 0.0 110.556 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -56.06 -27.13 52.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 113.0 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -79.88 -47.86 14.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.727 1.149 . . . . 0.0 109.456 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.86 75.97 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.682 0.793 . . . . 0.0 110.532 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -55.77 -43.51 76.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.287 0.635 . . . . 0.0 111.329 -169.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -77.41 -48.29 17.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.79 0.836 . . . . 0.0 109.461 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -19.41 63.97 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.64 1.115 . . . . 0.0 113.073 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.1 mt -124.11 14.86 9.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.798 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.4 m -60.83 118.26 6.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.48 24.23 59.16 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 120.891 -1.131 . . . . 0.0 113.45 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.49 -179.34 5.74 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.288 0.544 . . . . 0.0 110.557 154.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -129.48 99.3 5.13 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 125.164 1.386 . . . . 0.0 107.328 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -88.68 15.02 8.81 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.469 0.577 . . . . 0.0 110.639 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.23 -85.23 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.933 2.093 . . . . 0.0 106.174 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.26 -20.21 0.63 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.56 1.144 . . . . 0.0 111.983 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -90.21 -167.88 1.96 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.81 166.3 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.177 -0.952 . . . . 0.0 108.572 165.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.7 t -124.68 118.03 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 p -93.04 149.9 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -117.89 168.7 10.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.692 1.197 . . . . 0.0 109.034 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.77 156.41 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.887 2.075 . . . . 0.0 106.908 -177.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -77.71 160.72 28.25 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 162.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.43 -168.47 2.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.397 0.999 . . . . 0.0 109.063 168.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.59 144.22 34.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -93.59 -20.46 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.132 1.888 . . . . 0.0 110.833 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -40.44 80.59 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.07 0.462 . . . . 0.0 110.446 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.56 -33.26 60.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.105 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -61.6 -50.27 73.27 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.499 1.52 . . . . 0.0 111.411 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.64 -14.63 63.14 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -106.11 -169.73 1.62 Allowed 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 127.544 2.337 . . . . 0.0 107.276 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -114.18 69.68 0.71 Allowed 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.31 27.02 9.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 109.812 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 C--O 1.235 0.313 0 C-N-CA 123.683 0.793 . . . . 0.0 109.543 -172.404 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.04 126.88 16.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.401 1.401 . . . . 0.0 108.676 165.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.1 p -100.11 179.02 4.61 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.889 1.676 . . . . 0.0 108.705 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.54 8.72 13.23 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.007 0.923 . . . . 0.0 110.658 174.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.99 163.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 O-C-N 120.896 -1.127 . . . . 0.0 111.395 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -141.71 124.19 15.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -168.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.23 135.02 33.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.7 mt -128.73 131.2 47.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.5 1.52 . . . . 0.0 107.232 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mtm -125.46 163.77 21.93 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.448 -0.782 . . . . 0.0 110.177 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 74.97 16.22 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.81 2.844 . . . . 0.0 112.677 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -52.9 11.93 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.251 -0.906 . . . . 0.0 108.916 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.88 174.34 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 128.317 2.647 . . . . 0.0 108.891 -162.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.72 150.24 52.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.102 0.961 . . . . 0.0 109.319 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.62 -14.7 40.07 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.859 2.373 . . . . 0.0 113.647 -172.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -116.56 13.18 15.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.682 1.993 . . . . 0.0 110.333 -170.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -139.69 22.62 2.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.792 2.037 . . . . 0.0 109.637 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.01 65.43 0.66 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.066 2.146 . . . . 0.0 107.057 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.3 mt -135.06 -41.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -160.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.07 151.25 31.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.6 0.76 . . . . 0.0 110.149 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -95.96 -5.55 41.05 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.623 0.769 . . . . 0.0 110.675 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -113.57 -43.41 3.32 Favored 'General case' 0 C--N 1.337 0.047 0 C-N-CA 124.42 1.088 . . . . 0.0 113.049 -167.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -80.62 -37.19 31.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.734 1.214 . . . . 0.0 109.398 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.7 -35.75 61.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.218 1.007 . . . . 0.0 110.677 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.74 -37.22 70.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.491 -0.756 . . . . 0.0 111.62 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -62.32 -45.92 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.014 . . . . 0.0 109.204 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.55 -20.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.617 0.767 . . . . 0.0 111.371 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.11 -44.71 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.954 -1.092 . . . . 0.0 109.316 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.4 -35.77 63.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.908 0.776 . . . . 0.0 112.338 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.46 -51.22 60.4 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.391 1.876 . . . . 0.0 109.768 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.6 t -75.36 -29.13 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.224 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -65.54 -36.26 83.27 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.605 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.64 -40.69 40.98 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.655 0.661 . . . . 0.0 112.243 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -50.11 69.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.983 -1.073 . . . . 0.0 109.899 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.05 -25.76 61.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -167.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.91 -22.96 4.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.396 1.078 . . . . 0.0 112.969 169.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -76.24 -13.06 60.18 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.625 -1.297 . . . . 0.0 112.626 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.414 ' CE1' HD23 ' A' ' 79' ' ' LEU . 87.9 m-85 -116.98 -16.52 10.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.576 1.08 . . . . 0.0 112.898 -173.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.46 -138.75 3.24 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -140.33 123.0 16.29 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -87.04 116.32 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -66.24 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.731 1.613 . . . . 0.0 107.84 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -154.14 169.44 23.57 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.774 1.229 . . . . 0.0 110.239 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 mt -130.2 141.97 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.266 1.826 . . . . 0.0 106.179 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -126.11 120.18 29.5 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.538 1.135 . . . . 0.0 110.58 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.37 85.75 17.7 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.46 123.16 11.61 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.351 2.034 . . . . 0.0 108.257 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.99 154.07 37.5 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 123.652 0.781 . . . . 0.0 110.093 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.456 -0.698 0 C-N-CA 123.273 2.649 . . . . 0.0 111.025 167.459 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo . . . . . 0 N--CA 1.451 -1.019 0 N-CA-C 108.025 -1.567 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.71 36.56 92.48 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.3 t -74.15 163.54 27.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.189 0.518 . . . . 0.0 110.166 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -39.03 2.72 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.192 1.377 . . . . 0.0 111.594 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 168.52 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.541 1.671 . . . . 0.0 109.709 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -131.86 152.48 36.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.56 157.94 28.39 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p -139.02 161.05 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -133.19 144.9 50.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.822 1.649 . . . . 0.0 107.441 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.75 -179.16 3.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.895 1.678 . . . . 0.0 111.035 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.11 -21.47 27.61 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.854 172.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -139.83 -179.09 5.74 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.482 1.492 . . . . 0.0 110.561 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.31 -35.14 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 158.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -76.49 -28.93 56.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.574 -1.329 . . . . 0.0 113.51 -166.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -76.49 -38.89 54.57 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.375 1.07 . . . . 0.0 109.169 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.9 t -57.1 -47.6 80.67 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.56 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -56.94 -26.89 60.4 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.449 1.499 . . . . 0.0 113.179 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -76.91 -48.13 19.08 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.17 88.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 117.155 -1.403 . . . . 0.0 111.743 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -63.89 0.89 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.719 1.145 . . . . 0.0 110.659 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -81.97 -21.13 37.33 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.529 0.732 . . . . 0.0 112.021 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.74 89.43 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 39' ' ' TYR . 96.4 mt -115.01 -1.46 13.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -160.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.6 m -47.64 116.07 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.024 -1.047 . . . . 0.0 109.507 164.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.54 5.7 63.07 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.626 0.648 . . . . 0.0 114.412 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -177.85 1.26 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.853 1.327 . . . . 0.0 111.42 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -126.9 133.2 50.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.435 1.494 . . . . 0.0 107.054 163.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -108.15 15.08 24.52 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.155 0.982 . . . . 0.0 110.937 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.11 -73.31 0.06 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -150.89 -13.28 0.22 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -98.46 164.19 12.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.155 0.889 . . . . 0.0 110.017 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.41 135.99 26.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.93 139.8 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.209 1.403 . . . . 0.0 111.058 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.264 3.1 p -110.93 115.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 170.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -78.2 143.72 36.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.09 167.68 21.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.64 1.976 . . . . 0.0 106.09 162.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -71.82 164.45 25.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.91 0.777 . . . . 0.0 109.68 163.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 -164.47 1.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.469 1.108 . . . . 0.0 108.524 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -114.38 143.42 29.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.22 -25.86 5.53 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.123 2.548 . . . . 0.0 111.169 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -54.29 -59.34 4.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.036 0.922 . . . . 0.0 109.842 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -20.12 62.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.856 2.062 . . . . 0.0 110.898 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -73.14 -46.87 48.47 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 127.488 2.315 . . . . 0.0 111.006 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -60.36 -35.89 76.74 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 -97.56 -166.77 1.43 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 109.605 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -122.08 54.72 1.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.501 1.52 . . . . 0.0 107.738 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.98 38.81 3.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.713 1.244 . . . . 0.0 109.001 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--O 1.239 0.52 0 C-N-CA 126.595 1.958 . . . . 0.0 108.822 176.183 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -66.31 133.0 31.16 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.959 2.439 . . . . 0.0 108.223 168.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.8 p -137.29 169.21 18.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.537 1.935 . . . . 0.0 106.772 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -75.39 -10.86 59.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.369 0.532 . . . . 0.0 111.798 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.87 106.78 19.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 125.469 1.508 . . . . 0.0 110.006 -170.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -91.53 113.09 25.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -85.01 134.05 34.23 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.5 139.85 52.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.276 1.031 . . . . 0.0 109.52 -173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.5 mtm -125.18 161.13 27.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.896 0.878 . . . . 0.0 109.241 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 60.87 30.68 19.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.577 2.351 . . . . 0.0 112.911 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -79.66 0.11 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 164.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.47 171.02 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 125.12 1.368 . . . . 0.0 109.791 -165.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.91 159.4 40.99 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 124.096 0.958 . . . . 0.0 109.445 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.69 4.87 2.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.574 2.183 . . . . 0.0 113.584 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -128.24 14.55 6.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.555 1.942 . . . . 0.0 113.415 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -132.45 -4.21 3.36 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.45 -0.781 . . . . 0.0 111.357 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -98.63 51.59 0.99 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.443 1.497 . . . . 0.0 109.885 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.41 -54.85 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.38 100.54 0.06 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.984 2.114 . . . . 0.0 109.952 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.28 -7.34 58.58 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.941 0.896 . . . . 0.0 113.088 -165.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -76.51 -59.64 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.983 1.713 . . . . 0.0 107.961 166.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.95 -34.33 77.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.668 0.787 . . . . 0.0 111.982 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -44.99 -45.56 10.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.931 1.292 . . . . 0.0 111.514 168.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.85 -23.0 42.26 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 121.573 -0.704 . . . . 0.0 112.078 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -71.42 -50.15 34.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 124.189 0.93 . . . . 0.0 109.162 169.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.31 -40.66 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.148 0.979 . . . . 0.0 111.147 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.0 t -57.87 -40.35 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.879 0.763 . . . . 0.0 109.951 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.56 -40.74 33.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.873 0.306 . . . . 0.0 111.032 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.72 -33.62 76.03 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.08 -36.68 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 O-C-N 121.545 -0.722 . . . . 0.0 109.414 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -58.28 -38.27 76.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 117.134 -1.413 . . . . 0.0 109.627 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.09 -33.37 73.24 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.588 1.54 . . . . 0.0 112.107 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -41.44 63.43 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 120.964 -1.085 . . . . 0.0 110.975 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.265 0.8 OUTLIER -81.22 -27.97 35.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.04 -3.91 32.24 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.659 1.118 . . . . 0.0 112.259 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -56.81 -18.43 12.85 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.3 -1.5 . . . . 0.0 113.725 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -119.75 1.26 11.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.043 1.337 . . . . 0.0 113.003 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.13 -145.13 10.21 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -122.49 112.53 18.15 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 118.747 1.274 . . . . 0.0 110.023 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.81 108.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -68.71 -53.48 21.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.846 0.858 . . . . 0.0 109.884 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -161.51 163.68 30.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -135.71 108.71 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.77 119.16 31.35 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 125.91 1.684 . . . . 0.0 109.106 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mt -133.49 85.69 42.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.29 1.836 . . . . 0.0 107.838 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.72 136.4 53.5 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.682 1.588 . . . . 0.0 109.161 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -98.08 165.2 15.78 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.512 1.125 . . . . 0.0 109.616 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.239 0.531 0 C-N-CA 122.56 2.173 . . . . 0.0 109.903 166.9 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.454 -0.839 0 N-CA-C 108.256 -1.478 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.28 -15.15 15.55 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 126.735 2.112 . . . . 0.0 112.256 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.5 t -76.45 148.47 37.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.068 0.934 . . . . 0.0 111.184 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.52 -16.0 51.73 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.124 1.821 . . . . 0.0 112.622 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -92.56 157.12 16.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.761 1.781 . . . . 0.0 108.583 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.0 149.4 33.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 164.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -129.32 114.31 16.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.82 111.63 32.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 148.49 29.2 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.232 1.813 . . . . 0.0 106.362 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -129.87 179.57 5.78 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.87 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -90.07 -13.3 36.17 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -164.55 155.8 15.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.553 1.069 . . . . 0.0 110.007 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.36 -23.42 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.558 0.743 . . . . 0.0 109.142 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -84.41 -18.03 37.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.5 -1.375 . . . . 0.0 113.224 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -76.52 -45.97 28.55 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.5 p -71.51 -36.43 71.07 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.665 -0.647 . . . . 0.0 110.714 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -47.3 -36.2 8.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.928 2.091 . . . . 0.0 112.856 168.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -79.11 -48.72 13.8 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.21 73.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.67 1.188 . . . . 0.0 111.266 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.1 ttm -48.73 -70.54 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.628 1.571 . . . . 0.0 110.336 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.76 -33.29 73.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.543 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.9 -15.85 69.69 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.516 1.055 . . . . 0.0 114.027 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.54 9.05 5.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.114 1.457 . . . . 0.0 112.687 -171.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.8 m -63.77 102.11 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.16 -0.962 . . . . 0.0 110.181 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.17 1.88 51.29 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.13 1.348 . . . . 0.0 113.14 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -178.64 0.2 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.386 1.593 . . . . 0.0 111.503 173.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.35 140.08 53.29 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -117.84 13.76 14.14 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.644 0.735 . . . . 0.0 109.854 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.34 -70.77 0.08 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.52 2.328 . . . . 0.0 107.661 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -162.42 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.64 1.176 . . . . 0.0 111.821 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -78.18 175.26 10.34 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.489 1.04 . . . . 0.0 109.456 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.43 165.63 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.57 125.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.0 t -105.84 129.51 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 167.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.0 p -99.2 146.86 25.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.609 1.164 . . . . 0.0 108.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -141.52 161.22 38.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.411 1.485 . . . . 0.0 107.334 160.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -69.36 157.49 36.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 158.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -176.68 2.95 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.523 1.529 . . . . 0.0 107.417 165.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -99.1 144.98 29.22 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.41 -24.17 6.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.823 2.349 . . . . 0.0 112.925 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.47 -46.93 73.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.19 0.905 . . . . 0.0 110.725 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 p -75.71 2.94 10.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.452 1.101 . . . . 0.0 111.925 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -93.16 -48.92 6.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.551 1.141 . . . . 0.0 108.932 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -60.27 -30.41 69.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.771 0.428 . . . . 0.0 111.256 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -104.63 163.46 12.46 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.524 1.13 . . . . 0.0 109.87 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 ttm-85 -73.23 21.89 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.276 2.23 . . . . 0.0 112.794 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -88.81 64.09 7.11 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.75 -1.219 . . . . 0.0 111.133 -158.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 4.4 m-85 . . . . . 0 C--O 1.237 0.428 0 C-N-CA 123.081 0.553 . . . . 0.0 109.625 -169.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.0 142.97 48.26 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.897 2.398 . . . . 0.0 108.868 166.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 p -121.33 -179.28 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.587 1.955 . . . . 0.0 107.983 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -82.74 9.68 9.19 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.92 157.4 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 121.083 1.765 . . . . 0.0 110.332 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tp -133.4 170.72 15.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.931 0.872 . . . . 0.0 109.268 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.86 140.4 31.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.911 1.284 . . . . 0.0 109.362 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.29 122.9 27.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.593 1.557 . . . . 0.0 107.646 -167.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.1 mtm -103.94 165.98 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.213 0.605 . . . . 0.0 110.632 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 75.22 7.36 4.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 129.334 3.054 . . . . 0.0 115.12 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -65.16 0.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.148 1.34 . . . . 0.0 109.305 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.21 144.46 35.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.784 1.634 . . . . 0.0 109.077 -158.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.45 163.78 32.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 126.197 1.799 . . . . 0.0 110.762 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.84 -1.03 7.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.08 2.52 . . . . 0.0 114.606 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.83 -0.57 3.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.565 1.146 . . . . 0.0 112.598 -163.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -115.08 -12.26 11.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.636 0.774 . . . . 0.0 112.784 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.06 47.97 0.38 Allowed 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.455 1.902 . . . . 0.0 112.396 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.73 -13.6 2.88 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -165.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.94 179.42 1.48 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.664 1.12 . . . . 0.0 109.59 159.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -122.89 -4.09 8.61 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.129 -0.982 . . . . 0.0 111.382 165.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -90.19 -72.79 0.55 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.793 2.037 . . . . 0.0 108.928 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -57.52 -33.37 68.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.561 1.944 . . . . 0.0 110.607 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -47.46 -46.97 27.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.364 1.466 . . . . 0.0 112.138 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -75.74 -34.11 60.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -60.3 -44.36 95.48 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.96 -34.81 70.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -61.02 -54.27 37.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 O-C-N 120.749 -1.219 . . . . 0.0 108.753 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -70.87 -33.2 70.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.932 0.787 . . . . 0.0 112.031 -169.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.93 -35.32 79.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.239 1.019 . . . . 0.0 111.93 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.38 -25.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 108.966 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -69.18 -21.63 63.96 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.941 -1.099 . . . . 0.0 111.723 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.25 -62.24 1.52 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.849 1.204 . . . . 0.0 108.11 159.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.08 -40.29 93.14 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -158.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -77.66 -28.65 51.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.0 t -65.86 -12.95 58.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.414 1.085 . . . . 0.0 111.473 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.57 -12.38 52.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 119.644 -1.91 . . . . 0.0 111.693 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -112.13 -7.13 14.08 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.073 1.349 . . . . 0.0 113.732 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.48 -167.3 31.4 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.52 104.1 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.987 0.898 . . . . 0.0 109.874 -175.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.28 106.49 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 125.406 1.482 . . . . 0.0 107.052 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -66.51 -67.57 0.44 Allowed 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 166.63 32.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.34 0.656 . . . . 0.0 111.341 -168.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -138.98 145.36 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 126.217 1.807 . . . . 0.0 108.85 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -132.84 121.97 23.72 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.93 1.292 . . . . 0.0 109.433 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.9 mt -127.85 86.1 59.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.89 2.076 . . . . 0.0 107.414 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.63 148.8 86.04 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.721 1.614 . . . . 0.0 109.861 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.07 152.57 46.76 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.862 0.865 . . . . 0.0 110.116 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 C--O 1.236 0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 111.243 176.459 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 N--CA 1.451 -0.979 0 N-CA-C 106.706 -2.075 . . . . 0.0 106.706 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.54 -11.03 11.32 Favored Glycine 0 C--O 1.229 -0.205 0 C-N-CA 125.733 1.635 . . . . 0.0 111.451 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.4 144.88 51.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.995 0.897 . . . . 0.0 109.806 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.18 -35.85 4.6 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 127.456 2.455 . . . . 0.0 110.512 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -85.4 167.88 15.12 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.185 -1.185 . . . . 0.0 110.389 -172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 mt -136.32 128.17 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -99.59 155.17 17.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -144.71 145.15 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -121.91 146.86 46.71 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.887 1.275 . . . . 0.0 108.901 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.07 167.03 16.51 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.492 1.117 . . . . 0.0 110.529 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.0 p -74.2 -18.1 60.8 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -159.62 159.28 32.94 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.906 1.23 . . . . 0.0 111.406 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.434 HG13 HE21 ' A' ' 73' ' ' GLN . 24.3 t -53.31 -38.97 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.923 1.289 . . . . 0.0 109.134 171.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -52.02 -52.49 50.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.297 1.039 . . . . 0.0 111.986 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.14 -43.92 81.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 10.7 t -58.11 -41.84 84.46 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.003 0.521 . . . . 0.0 111.005 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.434 HE21 HG13 ' A' ' 69' ' ' VAL . 26.2 mt-30 -62.86 -20.93 65.58 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.668 1.187 . . . . 0.0 112.734 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -90.42 -46.39 8.39 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.785 1.175 . . . . 0.0 108.664 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.32 -15.99 64.0 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.593 1.157 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.4 tpp -60.37 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.906 1.682 . . . . 0.0 108.226 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -70.76 -22.71 62.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.718 -164.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.35 -27.9 71.46 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.574 0.624 . . . . 0.0 112.426 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.1 mt -113.56 -4.1 13.56 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.06 1.344 . . . . 0.0 111.732 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.0 m -57.37 106.63 0.35 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.935 -1.103 . . . . 0.0 109.025 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.69 -0.17 59.38 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.182 -0.788 . . . . 0.0 113.884 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -63.67 178.76 0.55 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.944 1.372 . . . . 0.0 110.665 167.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -133.96 84.47 2.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.373 1.469 . . . . 0.0 107.469 -167.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -78.1 37.73 0.26 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.492 1.117 . . . . 0.0 109.54 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 174.51 -69.32 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 1 C-N-CA 132.738 4.415 . . . . 0.0 105.895 167.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.14 -29.54 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.294 1.838 . . . . 0.0 111.456 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -89.52 162.63 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.942 -1.099 . . . . 0.0 109.78 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.37 139.9 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.69 133.73 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.9 122.86 65.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -85.6 155.54 21.1 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 129.182 2.993 . . . . 0.0 109.278 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -153.13 138.62 17.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.662 1.985 . . . . 0.0 108.541 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -67.22 127.53 32.99 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 162.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.67 169.7 9.51 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.823 1.249 . . . . 0.0 108.435 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -92.13 143.65 27.89 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.64 -27.51 6.1 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.507 2.804 . . . . 0.0 111.918 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -57.18 13.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.634 1.107 . . . . 0.0 111.194 -170.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 m -65.98 -33.47 75.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.187 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -65.68 -30.74 71.47 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.482 1.113 . . . . 0.0 112.588 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -64.78 -2.8 2.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.081 0.953 . . . . 0.0 112.673 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -138.46 179.49 6.43 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.974 2.11 . . . . 0.0 108.711 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.0 21.31 0.71 Allowed 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.195 -0.94 . . . . 0.0 112.324 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.73 45.41 1.07 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.44 -1.412 . . . . 0.0 112.68 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 . . . . . 0 C--O 1.233 0.222 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.44 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.65 141.13 49.1 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.054 1.836 . . . . 0.0 108.666 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -123.48 172.97 8.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.53 1.132 . . . . 0.0 110.261 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.48 -9.11 55.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.356 0.662 . . . . 0.0 112.165 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.6 m -102.16 -176.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 120.02 1.282 . . . . 0.0 111.658 -172.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 tp -145.48 155.27 43.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.122 1.369 . . . . 0.0 109.199 161.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.41 143.13 48.69 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.505 1.122 . . . . 0.0 109.645 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.25 152.8 49.28 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.604 1.962 . . . . 0.0 109.694 -170.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 39.7 mtm -132.56 165.12 25.11 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.751 1.22 . . . . 0.0 110.238 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 75.44 -8.59 1.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 130.085 3.354 . . . . 0.0 114.571 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.0 tpp -71.17 -36.9 72.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.743 1.156 . . . . 0.0 112.472 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.06 152.62 36.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 0.0 109.855 -170.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -110.12 156.13 40.61 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.49 -1.06 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.06 2.507 . . . . 0.0 113.023 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -116.61 4.52 13.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.05 1.74 . . . . 0.0 111.817 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -133.81 33.88 3.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.358 1.463 . . . . 0.0 110.817 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt -131.75 58.75 1.72 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.426 1.89 . . . . 0.0 108.57 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.25 -45.32 1.98 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.238 1.415 . . . . 0.0 110.029 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.71 105.74 7.95 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.02 -32.43 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.914 1.686 . . . . 0.0 111.778 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.33 -63.21 1.11 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.501 0.72 . . . . 0.0 109.56 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -53.83 -42.81 68.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.221 1.008 . . . . 0.0 110.143 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -53.25 -40.51 64.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.98 1.312 . . . . 0.0 111.617 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -81.98 -38.4 25.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.866 1.212 . . . . 0.0 111.029 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -59.55 -51.1 71.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -54.72 -45.57 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.558 0.743 . . . . 0.0 109.426 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.92 -26.32 39.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 118.064 -0.969 . . . . 0.0 112.708 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.41 -28.41 23.58 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.673 1.124 . . . . 0.0 112.538 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.04 -41.53 64.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.118 0.961 . . . . 0.0 110.04 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.8 t -71.96 -28.25 29.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 125.027 1.331 . . . . 0.0 109.15 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -56.42 -57.42 12.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.55 -40.77 97.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.217 0.948 . . . . 0.0 110.079 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.5 -39.94 85.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.458 -169.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.83 -27.1 49.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.2 t -64.47 -21.66 66.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.829 0.852 . . . . 0.0 110.815 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -56.59 -21.66 28.42 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.118 -1.614 . . . . 0.0 111.976 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -110.53 2.46 18.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.928 1.691 . . . . 0.0 112.224 -175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.59 -156.14 26.91 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 120.164 1.347 . . . . 0.0 112.258 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -112.2 110.08 20.14 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.09 113.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.51 -61.03 2.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.874 1.27 . . . . 0.0 109.243 167.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 175.46 12.01 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.314 -0.866 . . . . 0.0 110.903 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.4 mt -138.89 145.11 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.31 125.1 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.167 1.787 . . . . 0.0 109.541 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.6 mt -138.46 82.42 22.75 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.71 138.88 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.084 1.856 . . . . 0.0 109.752 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -90.81 155.75 45.16 Favored Pre-proline 0 N--CA 1.474 0.735 0 O-C-N 120.485 -1.384 . . . . 0.0 111.877 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 C--N 1.352 0.746 1 C-N-CA 126.094 4.529 . . . . 0.0 112.648 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo . . . . . 0 N--CA 1.451 -1.0 0 N-CA-C 107.707 -1.69 . . . . 0.0 107.707 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.32 16.74 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.438 1.971 . . . . 0.0 112.758 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.8 t -71.99 132.54 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.687 1.243 . . . . 0.0 109.352 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.44 1.51 80.97 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.734 1.635 . . . . 0.0 113.815 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -108.72 161.08 15.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -126.63 148.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.09 142.75 50.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.64 150.95 30.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 23.6 tt0 -129.08 142.49 50.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.09 169.84 8.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.114 1.766 . . . . 0.0 108.441 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 t -98.97 8.4 45.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.957 0.903 . . . . 0.0 110.419 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.1 p -155.5 147.98 23.94 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 120.261 -1.525 . . . . 0.0 111.393 156.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.446 ' CG1' HE21 ' A' ' 73' ' ' GLN . 1.9 t -49.73 -41.3 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.121 0.968 . . . . 0.0 109.032 163.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -62.92 -22.8 67.02 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.446 1.498 . . . . 0.0 114.187 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -101.34 -37.04 8.66 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -31.78 73.03 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.294 -0.879 . . . . 0.0 111.012 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.446 HE21 ' CG1' ' A' ' 69' ' ' VAL . 35.3 mt-30 -58.72 -20.35 48.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.08 1.752 . . . . 0.0 112.987 170.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -88.26 -51.84 5.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.63 1.105 . . . . 0.0 108.613 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.5 -43.52 65.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.131 0.973 . . . . 0.0 111.118 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.0 tpp -44.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.423 2.289 . . . . 0.0 110.404 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.7 -18.62 56.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.31 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.9 -25.2 72.27 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.264 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.9 mt -115.63 4.36 14.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 -173.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.1 m -55.13 107.58 0.32 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.791 1.237 . . . . 0.0 109.899 168.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.0 8.2 72.77 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.765 -0.584 . . . . 0.0 113.935 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -72.69 -174.8 1.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.901 1.351 . . . . 0.0 111.281 169.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -134.02 98.41 4.13 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.641 0.776 . . . . 0.0 109.984 -170.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -83.1 19.49 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.721 2.008 . . . . 0.0 112.534 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.2 -85.49 0.0 OUTLIER 'General case' 0 C--O 1.231 0.126 0 C-N-CA 129.469 3.107 . . . . 0.0 104.46 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.3 -24.63 2.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.021 0.928 . . . . 0.0 110.96 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 87' ' ' ARG . 18.8 mtp85 -93.12 173.59 7.65 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.736 0.698 . . . . 0.0 110.287 -166.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.93 165.5 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 71.6 t -132.84 145.39 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.49 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.4 117.23 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 168.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 154.23 27.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.476 2.31 . . . . 0.0 110.007 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.92 150.43 28.35 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.157 2.983 . . . . 0.0 106.27 173.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -69.09 160.19 31.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.638 1.108 . . . . 0.0 108.891 160.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.39 -164.47 1.3 Allowed 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.773 1.229 . . . . 0.0 109.459 168.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.85 143.88 28.47 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.08 -32.88 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.367 2.712 . . . . 0.0 110.449 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -57.33 -54.31 48.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.1 m -66.89 -29.47 69.38 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.85 1.26 . . . . 0.0 110.794 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -64.05 -40.48 96.38 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.843 1.657 . . . . 0.0 111.09 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -70.97 -9.75 58.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.264 1.026 . . . . 0.0 112.349 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 20.8 mtp85 -106.45 -168.8 1.47 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.33 1.452 . . . . 0.0 109.482 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.3 tpt180 -108.82 73.12 0.85 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.68 92.44 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 2.8 m-85 . . . . . 0 C--O 1.227 -0.106 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -170.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.15 146.49 41.03 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.608 2.872 . . . . 0.0 109.61 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -131.7 170.35 14.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -78.9 8.38 5.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -98.14 119.7 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.62 143.62 32.52 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -108.1 142.17 38.7 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt -138.59 128.37 25.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.843 1.257 . . . . 0.0 107.613 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -133.73 156.91 47.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.154 0.582 . . . . 0.0 109.764 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 65.34 72.01 0.43 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.125 2.17 . . . . 0.0 109.771 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.44 -77.14 0.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.472 1.509 . . . . 0.0 107.786 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.35 146.31 19.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.555 1.542 . . . . 0.0 109.371 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 17' ' ' GLU . 50.9 mt -109.78 151.57 42.41 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.752 0.821 . . . . 0.0 109.082 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.95 4.91 0.55 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.61 2.873 . . . . 0.0 113.515 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 15' ' ' LEU . 19.0 pt-20 -131.14 2.94 4.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.334 2.654 . . . . 0.0 112.093 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -127.17 -18.06 4.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.541 -0.725 . . . . 0.0 112.587 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.443 ' CG ' ' HD3' ' A' ' 50' ' ' PRO 0.254 0.2 OUTLIER -90.69 16.25 9.53 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.967 -1.083 . . . . 0.0 110.927 -162.482 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.43 -22.55 16.52 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.556 -1.34 . . . . 0.0 113.36 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.22 134.39 34.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -168.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.97 -18.82 64.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.443 0.697 . . . . 0.0 112.159 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.34 -68.81 0.6 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.122 1.769 . . . . 0.0 108.968 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -58.48 -36.21 73.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.573 1.549 . . . . 0.0 112.844 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -52.05 -47.89 64.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.281 1.432 . . . . 0.0 112.395 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.28 -38.93 71.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.7 0.8 . . . . 0.0 111.067 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -52.08 -48.34 64.74 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.632 1.173 . . . . 0.0 109.243 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.5 mt -63.97 -44.49 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.52 1.528 . . . . 0.0 109.899 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -58.57 -46.37 90.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -78.36 -31.48 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -170.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.22 -42.17 99.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 123.223 1.487 . . . . 0.0 109.414 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.66 -31.78 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.403 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -66.42 -24.36 66.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 120.962 -1.086 . . . . 0.0 111.395 175.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.58 -59.71 3.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 119.884 1.22 . . . . 0.0 108.309 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -62.3 -37.58 86.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -167.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.1 t -72.7 -25.89 61.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.571 0.749 . . . . 0.0 109.881 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -61.66 -23.33 66.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.54 1.136 . . . . 0.0 111.296 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -65.52 -10.75 37.45 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.454 -1.404 . . . . 0.0 112.95 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -123.47 4.11 9.03 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.856 1.263 . . . . 0.0 113.424 -170.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.11 -131.26 3.26 Favored Glycine 0 CA--C 1.504 -0.594 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.17 116.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.5 104.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.109 1.363 . . . . 0.0 108.693 166.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.06 -55.91 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.92 2.488 . . . . 0.0 110.337 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -148.37 163.43 37.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.399 1.479 . . . . 0.0 110.209 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mt -138.81 133.82 41.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.01 110.46 12.99 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.963 0.905 . . . . 0.0 109.58 -170.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.9 mt -128.16 86.62 57.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.668 1.587 . . . . 0.0 107.516 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.93 125.5 16.67 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.787 1.658 . . . . 0.0 108.232 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -90.6 151.36 43.91 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 0.0 110.117 -174.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' CG ' ' A' ' 19' ' ' LEU . 61.0 Cg_endo . . . . . 0 N--CA 1.457 -0.633 0 C-N-CA 121.83 1.687 . . . . 0.0 109.543 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.453 -0.854 0 N-CA-C 110.259 -0.708 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.03 66.1 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 126.33 1.919 . . . . 0.0 111.583 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.14 147.95 44.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 122.042 -0.681 . . . . 0.0 109.454 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.71 65.17 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.035 1.778 . . . . 0.0 112.76 -171.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -108.42 160.81 15.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -129.36 129.97 67.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 162.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -99.83 130.66 46.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 171.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -124.73 145.76 31.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.87 139.1 51.59 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -118.71 168.02 11.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.413 1.102 . . . . 0.0 111.062 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -38.06 87.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.067 1.347 . . . . 0.0 113.273 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.5 m -160.42 156.82 26.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.596 1.089 . . . . 0.0 111.367 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.459 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 10.7 t -63.83 -28.73 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.467 1.107 . . . . 0.0 110.666 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -68.85 -24.88 64.41 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 120.724 -1.235 . . . . 0.0 112.49 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.91 -52.96 5.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.34 1.456 . . . . 0.0 108.012 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 69' ' ' VAL . 8.5 p -62.53 -29.96 70.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.144 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.66 -38.58 67.1 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.451 0.7 . . . . 0.0 112.273 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -73.65 -46.9 43.79 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.281 1.032 . . . . 0.0 108.602 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.04 -41.22 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.88 0.472 . . . . 0.0 111.556 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -66.48 0.38 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.173 1.789 . . . . 0.0 110.123 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -38.57 89.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.416 1.087 . . . . 0.0 110.508 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.13 -29.68 75.41 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 118.954 0.797 . . . . 0.0 112.332 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.56 -0.99 15.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.263 1.025 . . . . 0.0 111.436 -173.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -55.45 122.86 12.17 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 166.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.56 78.15 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.708 -1.051 . . . . 0.0 112.721 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -173.03 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.767 1.284 . . . . 0.0 109.051 162.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -129.47 120.36 25.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.714 1.606 . . . . 0.0 107.537 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -101.59 28.28 5.69 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.058 . . . . 0.0 109.196 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.97 -60.81 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.485 1.514 . . . . 0.0 108.842 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t30 177.46 -28.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 127.944 2.498 . . . . 0.0 109.037 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -103.03 167.37 9.88 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.319 0.648 . . . . 0.0 111.019 -173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.43 107.59 13.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.381 -160.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.5 t -66.84 108.6 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.872 0.869 . . . . 0.0 110.294 -174.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.73 123.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 163.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.98 142.15 27.82 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 126.289 1.835 . . . . 0.0 106.892 170.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -149.05 154.96 40.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.392 1.077 . . . . 0.0 109.373 168.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -74.34 158.21 34.38 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 169.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.84 -176.74 5.1 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.078 2.551 . . . . 0.0 108.646 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -128.52 143.7 49.31 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 119.069 0.85 . . . . 0.0 109.355 -171.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.56 -30.44 12.11 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.794 2.329 . . . . 0.0 112.357 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.83 -41.73 74.7 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.287 0.948 . . . . 0.0 110.451 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -43.77 88.76 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.33 0.652 . . . . 0.0 110.167 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -70.71 -35.81 72.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.764 1.626 . . . . 0.0 112.593 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -64.35 -10.63 25.62 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.537 1.135 . . . . 0.0 112.618 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -134.8 -164.79 1.57 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.444 1.898 . . . . 0.0 107.411 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -110.02 29.26 7.8 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.687 1.195 . . . . 0.0 110.87 -178.301 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -79.54 72.48 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.533 1.159 . . . . 0.0 109.884 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 22.0 m-30 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -165.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 . . . . . 0 C--O 1.239 0.536 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.83 136.16 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 N-CA-C 107.619 -1.723 . . . . 0.0 107.619 165.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.4 p -104.81 168.06 9.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -88.31 16.81 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.637 -0.664 . . . . 0.0 112.418 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.54 150.65 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tp -122.52 162.46 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.481 1.113 . . . . 0.0 108.104 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -135.67 130.57 34.49 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.628 1.571 . . . . 0.0 108.866 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.47 132.12 46.86 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.601 1.16 . . . . 0.0 110.767 -164.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -120.15 162.91 18.53 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.142 0.977 . . . . 0.0 110.242 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 68.68 3.2 3.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.978 2.911 . . . . 0.0 114.222 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.6 ttm -72.59 -39.59 67.25 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 110.805 -170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.27 167.21 25.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 127.009 2.124 . . . . 0.0 109.129 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.85 153.95 55.0 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.894 0.878 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.78 0.79 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.536 2.157 . . . . 0.0 112.624 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.64 9.88 10.91 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.108 1.763 . . . . 0.0 111.684 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -137.42 26.57 2.86 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.48 1.112 . . . . 0.0 111.493 -169.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.83 37.15 4.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.629 1.172 . . . . 0.0 110.39 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -92.92 -59.6 2.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -68.52 112.14 5.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.841 1.256 . . . . 0.0 111.67 -170.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.52 -34.86 74.71 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.146 1.378 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.55 -64.15 0.99 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.126 1.37 . . . . 0.0 110.345 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -63.86 -37.17 86.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 0.0 110.828 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -54.37 -37.71 65.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.377 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.85 -32.44 52.05 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.381 0.672 . . . . 0.0 111.078 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.06 -54.32 35.93 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.923 1.289 . . . . 0.0 109.384 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.83 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 -171.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.16 -39.85 81.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 118.245 0.475 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -78.54 -33.3 47.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.638 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.86 -43.8 98.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.324 1.059 . . . . 0.0 109.749 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.9 t -68.1 -30.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.826 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -64.47 -35.18 80.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 116.63 -1.653 . . . . 0.0 111.084 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.88 -52.43 59.98 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 120.24 1.382 . . . . 0.0 109.39 169.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -63.44 -46.71 85.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.237 -162.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HG ' ' CD1' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -74.66 -9.9 59.01 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.656 -1.278 . . . . 0.0 111.895 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -20.38 66.17 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.879 -1.138 . . . . 0.0 110.066 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -65.93 -3.87 5.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.204 1.402 . . . . 0.0 112.858 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -132.83 -10.99 3.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.907 1.231 . . . . 0.0 113.071 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.26 -165.22 38.72 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 119.675 1.125 . . . . 0.0 110.847 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -98.19 104.53 16.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.76 110.0 2.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.11 -62.77 1.41 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -163.36 -172.02 2.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.563 0.345 . . . . 0.0 110.326 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.76 139.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 128.27 2.628 . . . . 0.0 104.597 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -133.2 113.27 12.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.509 0.724 . . . . 0.0 110.699 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mt -126.58 86.79 57.75 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.927 2.891 . . . . 0.0 109.62 -162.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 114.16 3.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.435 2.756 . . . . 0.0 108.989 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 165.4 53.63 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 172.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 C--N 1.353 0.777 0 C-N-CA 124.115 3.21 . . . . 0.0 110.218 164.484 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 0 N--CA 1.449 -1.106 0 N-CA-C 107.93 -1.604 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.81 -10.08 62.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.147 1.356 . . . . 0.0 113.011 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.08 156.68 35.83 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.434 1.117 . . . . 0.0 112.281 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 0.1 83.05 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.179 1.371 . . . . 0.0 113.075 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -117.29 167.67 11.02 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.048 1.424 . . . . 0.0 108.966 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 mp -126.7 145.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 161.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -111.79 157.77 20.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 160.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.69 153.55 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.6 146.42 49.57 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.03 0.932 . . . . 0.0 109.113 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.53 177.91 6.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.157 1.383 . . . . 0.0 110.892 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -89.71 -15.38 32.67 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 85.0 p -150.6 152.92 34.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.194 0.906 . . . . 0.0 111.163 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.08 -27.51 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.481 1.513 . . . . 0.0 110.126 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.64 -54.65 40.05 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.317 1.047 . . . . 0.0 109.446 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.58 -33.0 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.07 -51.23 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 110.075 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -53.66 -35.78 61.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.389 1.076 . . . . 0.0 111.666 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -71.82 -52.17 18.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.346 0.976 . . . . 0.0 110.395 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.46 -51.03 68.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.405 1.482 . . . . 0.0 110.222 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.4 ttt -44.78 -68.86 0.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.174 1.79 . . . . 0.0 111.598 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -66.53 -29.0 69.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.393 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.58 -24.35 65.97 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.447 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' CD1' ' HG ' ' A' ' 36' ' ' CYS . 96.3 mt -129.07 0.88 5.25 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.068 1.434 . . . . 0.0 114.187 -166.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.3 m -58.01 120.63 8.89 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.87 66.14 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.449 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.84 179.2 0.53 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.585 1.692 . . . . 0.0 111.881 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.24 137.22 53.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 159.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -110.8 14.43 22.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.639 0.776 . . . . 0.0 110.21 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.92 -85.38 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.176 2.59 . . . . 0.0 104.902 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -140.64 -10.46 1.05 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -112.73 161.58 16.71 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.024 1.738 . . . . 0.0 110.244 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.4 109.99 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.43 0.634 . . . . 0.0 109.374 -173.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.9 t -64.52 144.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.615 1.166 . . . . 0.0 108.092 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.8 150.07 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 166.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.86 144.17 47.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.294 2.237 . . . . 0.0 108.574 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.441 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 4.8 mmpt? -143.44 162.74 34.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.67 2.388 . . . . 0.0 106.727 159.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -67.21 160.7 26.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 157.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.15 -164.5 1.13 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 168.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -113.53 142.53 27.77 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.32 -24.38 2.52 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.471 2.114 . . . . 0.0 111.528 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.39 -54.18 40.43 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -69.03 -15.6 63.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.199 0.6 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -82.35 -37.84 25.08 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.051 1.34 . . . . 0.0 110.973 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -72.23 2.21 6.36 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.016 1.327 . . . . 0.0 112.325 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -134.54 -164.52 1.52 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.734 2.414 . . . . 0.0 109.341 -163.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.472 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 5.6 ttm180 -130.26 25.1 5.19 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.931 2.092 . . . . 0.0 110.834 173.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 42.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.942 -1.098 . . . . 0.0 110.344 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 6.2 m-85 . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 119.644 -0.217 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.54 149.1 79.69 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.01 2.473 . . . . 0.0 109.27 165.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 p -139.96 170.81 15.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.29 1.836 . . . . 0.0 107.01 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.56 8.1 1.22 Allowed 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.852 -1.155 . . . . 0.0 111.468 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.9 t -129.04 111.28 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.425 1.49 . . . . 0.0 108.047 -162.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -124.38 129.44 50.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -171.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.7 t -101.0 148.81 24.61 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 mt -132.62 105.52 7.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.214 1.805 . . . . 0.0 108.33 -162.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -99.56 165.52 11.59 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.411 0.624 . . . . 0.0 111.131 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.31 28.72 18.35 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 128.744 2.817 . . . . 0.0 111.423 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 ttm -84.21 -56.11 3.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.5 -0.75 . . . . 0.0 111.276 -168.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.4 157.34 27.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.128 1.771 . . . . 0.0 107.399 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -98.51 150.03 36.32 Favored Pre-proline 0 C--O 1.235 0.309 0 O-C-N 120.867 -1.146 . . . . 0.0 110.082 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -68.24 1.25 3.66 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.261 2.641 . . . . 0.0 112.912 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -127.14 12.44 7.13 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.078 1.751 . . . . 0.0 111.385 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.67 -14.58 7.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.254 0.622 . . . . 0.0 111.653 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -76.99 66.76 2.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.831 1.252 . . . . 0.0 110.707 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -130.64 -57.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.29 0.636 . . . . 0.0 109.487 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 112.48 1.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.68 1.192 . . . . 0.0 111.417 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.4 -22.24 66.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.237 1.415 . . . . 0.0 112.561 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.9 -55.62 4.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.306 1.042 . . . . 0.0 110.304 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -40.03 90.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.119 1.767 . . . . 0.0 110.473 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -49.98 -43.59 50.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.651 1.58 . . . . 0.0 112.667 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.68 -43.15 56.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.549 1.14 . . . . 0.0 109.285 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -63.74 -27.7 69.38 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.96 -0.462 . . . . 0.0 110.852 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -77.24 -24.72 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.521 1.128 . . . . 0.0 110.801 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.17 -47.32 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 120.535 -1.353 . . . . 0.0 107.718 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -72.31 -37.03 69.03 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.628 1.171 . . . . 0.0 111.988 -164.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -60.58 -42.08 95.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 111.629 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.58 -27.12 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 125.129 1.372 . . . . 0.0 110.902 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -62.0 -43.86 97.95 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.136 -0.977 . . . . 0.0 109.883 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.95 -52.52 65.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.523 0.729 . . . . 0.0 110.743 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -61.1 -35.16 76.27 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.732 0.777 . . . . 0.0 110.964 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t -76.2 -38.96 55.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.314 1.045 . . . . 0.0 109.671 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -51.9 -25.11 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.852 1.661 . . . . 0.0 111.981 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -61.28 -31.84 71.67 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.655 -1.278 . . . . 0.0 112.47 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.87 -8.29 25.94 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 112.535 -170.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.92 -178.05 19.03 Favored Glycine 0 CA--C 1.506 -0.526 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.8 tp -103.36 121.2 42.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -160.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.56 136.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.385 2.274 . . . . 0.0 108.383 172.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -98.49 -52.0 3.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.31 2.244 . . . . 0.0 109.689 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -152.01 158.4 43.02 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.118 0.567 . . . . 0.0 110.367 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.3 mt -137.33 92.21 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.73 113.11 23.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.555 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -123.79 85.64 53.54 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 125.16 1.384 . . . . 0.0 107.313 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.82 148.7 41.47 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.64 1.56 . . . . 0.0 108.323 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -137.97 160.23 65.32 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 121.004 -1.06 . . . . 0.0 110.928 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 121.964 1.776 . . . . 0.0 110.753 -178.333 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.449 -1.123 0 N-CA-C 108.451 -1.404 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.87 28.93 71.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 124.156 0.884 . . . . 0.0 111.426 169.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.5 t -69.48 153.99 42.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.153 1.781 . . . . 0.0 110.632 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.29 34.07 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.512 1.529 . . . . 0.0 114.421 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 147.74 48.49 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.567 1.683 . . . . 0.0 110.639 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.6 144.52 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -114.56 123.79 50.24 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.45 120.25 62.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -95.2 140.74 29.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.91 -168.91 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.093 1.757 . . . . 0.0 108.851 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 p -119.67 -0.65 10.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.413 1.085 . . . . 0.0 112.544 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.9 m -159.88 146.21 15.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.512 1.525 . . . . 0.0 108.873 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.31 -13.81 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.379 1.072 . . . . 0.0 111.102 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.9 -41.26 15.1 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.132 -1.605 . . . . 0.0 110.83 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.92 -37.55 87.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.969 0.907 . . . . 0.0 110.917 -173.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.5 p -68.76 -37.05 79.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.003 0.521 . . . . 0.0 110.732 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -67.02 -31.05 71.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.139 0.976 . . . . 0.0 111.232 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -62.62 -56.09 21.0 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.603 1.092 . . . . 0.0 108.773 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.17 79.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.859 0.864 . . . . 0.0 110.973 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -44.57 -58.79 2.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.849 1.66 . . . . 0.0 111.502 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -79.45 -33.25 42.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.075 0.95 . . . . 0.0 112.166 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.6 84.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.554 1.073 . . . . 0.0 112.531 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -117.53 10.57 13.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.705 1.602 . . . . 0.0 111.19 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -56.31 124.59 18.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.04 -3.63 60.79 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.289 -0.728 . . . . 0.0 112.891 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -69.48 -178.45 1.41 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.156 1.478 . . . . 0.0 109.307 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -134.11 99.64 4.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.359 1.464 . . . . 0.0 109.347 -163.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.86 13.51 4.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.118 0.967 . . . . 0.0 112.318 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.44 -73.25 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.956 2.503 . . . . 0.0 104.521 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -146.04 -30.08 0.4 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.027 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt85 -101.01 164.98 11.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.887 0.875 . . . . 0.0 111.371 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.78 111.76 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.558 1.143 . . . . 0.0 109.794 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -72.15 134.81 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 109.884 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.4 t -113.12 143.39 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 166.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 p -112.81 146.92 37.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.493 1.517 . . . . 0.0 108.224 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.1 149.74 31.56 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.649 168.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.35 118.64 17.53 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.71 -175.72 5.52 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.25 0.62 . . . . 0.0 109.727 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -101.61 144.95 29.58 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.38 -28.78 32.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.868 3.045 . . . . 0.0 111.435 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.1 -45.24 21.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.571 1.149 . . . . 0.0 110.549 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.96 14.84 27.66 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.965 0.906 . . . . 0.0 111.739 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -103.85 -39.73 6.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.86 1.264 . . . . 0.0 110.488 163.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -58.84 -15.3 11.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.698 1.599 . . . . 0.0 113.903 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -129.67 -163.85 1.34 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.616 1.967 . . . . 0.0 108.821 -168.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.73 38.7 1.84 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.661 1.585 . . . . 0.0 111.336 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -102.71 21.27 15.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.824 2.05 . . . . 0.0 114.129 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 CA--C 1.533 0.315 0 O-C-N 120.8 -1.187 . . . . 0.0 110.265 -170.78 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.97 131.45 23.93 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.956 1.77 . . . . 0.0 108.091 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 p -123.98 179.53 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -86.33 -4.85 59.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.197 -0.906 . . . . 0.0 113.388 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.8 m -83.83 179.81 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.855 1.207 . . . . 0.0 109.098 168.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tp -155.21 163.65 39.89 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 166.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.5 t -138.61 129.37 26.46 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.783 -1.198 . . . . 0.0 109.606 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.6 115.02 19.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 126.217 1.807 . . . . 0.0 107.761 -164.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mtm -87.83 162.5 16.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 75.37 23.89 1.46 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.515 1.926 . . . . 0.0 112.968 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -82.92 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.6 m -88.02 159.84 2.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 127.721 2.408 . . . . 0.0 109.069 -170.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.82 165.32 40.17 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.283 0.633 . . . . 0.0 109.425 155.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.2 -17.76 24.2 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.604 1.536 . . . . 0.0 112.993 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -96.17 -7.14 36.59 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.673 1.189 . . . . 0.0 111.443 -165.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.12 -38.9 17.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.312 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -72.03 49.44 0.19 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.516 2.326 . . . . 0.0 115.421 -155.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.43 -11.5 3.57 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 119.857 -1.777 . . . . 0.0 110.317 -167.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.85 112.69 17.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.981 0.896 . . . . 0.0 110.066 -167.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.87 -16.1 37.87 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 129.669 3.188 . . . . 0.0 113.173 -165.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.39 -51.87 7.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.45 1.5 . . . . 0.0 110.5 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.31 -44.15 72.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.527 2.331 . . . . 0.0 108.618 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.442 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 54.0 t80 -58.43 -33.63 69.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.744 0.418 . . . . 0.0 111.818 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.63 -39.9 50.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.075 . . . . 0.0 111.599 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.2 -46.11 91.81 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.33 0.652 . . . . 0.0 109.581 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.5 mt -60.49 -39.15 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.745 1.218 . . . . 0.0 110.123 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.21 -33.07 58.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 120.751 -1.218 . . . . 0.0 110.411 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.24 -42.44 25.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.192 0.597 . . . . 0.0 110.957 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.37 -40.09 93.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.577 1.18 . . . . 0.0 110.532 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.5 t -89.01 -15.41 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.209 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -72.77 -38.22 67.38 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.52 -1.363 . . . . 0.0 111.034 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.5 -52.52 64.17 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.967 0.803 . . . . 0.0 109.825 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.35 -21.15 66.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.9 t -83.15 -34.32 26.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.848 1.659 . . . . 0.0 110.592 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -17.88 19.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 113.043 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.02 -32.71 71.14 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.914 0.886 . . . . 0.0 112.627 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.3 -7.86 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.148 0.886 . . . . 0.0 112.609 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.31 -134.51 3.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -167.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.12 112.63 4.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.78 120.67 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.674 1.226 . . . . 0.0 109.209 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -60.66 3.43 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.191 2.196 . . . . 0.0 108.155 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -160.22 -178.74 7.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.779 0.718 . . . . 0.0 110.91 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.45 136.67 57.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 126.578 1.951 . . . . 0.0 106.634 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.95 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.878 1.271 . . . . 0.0 110.167 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.06 86.14 21.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.649 1.979 . . . . 0.0 106.723 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 114.82 4.14 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.537 2.825 . . . . 0.0 109.748 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.442 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 2.4 mpp_? -72.96 159.77 84.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.156 0.982 . . . . 0.0 111.696 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.352 0.741 1 C-N-CA 125.926 4.418 . . . . 0.0 112.152 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 N-CA-C 107.515 -1.764 . . . . 0.0 107.515 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.54 -8.06 6.98 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.107 1.813 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.2 t -81.94 142.68 32.23 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.226 1.513 . . . . 0.0 110.229 -164.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.84 -12.2 24.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.002 1.763 . . . . 0.0 113.477 -170.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -86.87 146.89 26.02 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.84 147.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -122.53 158.54 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.82 153.34 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 30.9 tt0 -132.58 139.25 47.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -114.47 174.91 5.72 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.245 1.418 . . . . 0.0 110.57 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -74.37 -23.2 58.97 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.934 -0.479 . . . . 0.0 112.111 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 t -154.69 161.87 41.37 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.631 1.205 . . . . 0.0 110.111 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.2 t -52.17 -39.56 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.592 1.557 . . . . 0.0 108.173 164.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -69.36 -35.09 75.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 117.027 -1.463 . . . . 0.0 113.688 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -85.19 -20.66 29.85 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.01 1.732 . . . . 0.0 111.503 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.3 t -69.68 -49.6 51.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.517 1.527 . . . . 0.0 110.243 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -54.74 -36.82 65.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.622 0.769 . . . . 0.0 112.141 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -71.54 -45.93 60.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.08 91.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 112.036 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.7 ttm -53.69 -68.33 0.19 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.381 0.991 . . . . 0.0 109.34 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -55.64 -34.95 65.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.782 0.833 . . . . 0.0 110.617 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.9 -20.87 76.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.86 -0.967 . . . . 0.0 114.355 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.59 2.33 10.12 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.085 1.354 . . . . 0.0 112.107 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -63.2 103.01 0.44 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.614 -1.304 . . . . 0.0 109.945 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.98 0.53 30.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.079 1.323 . . . . 0.0 112.897 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -74.25 -175.53 2.31 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.333 1.066 . . . . 0.0 111.958 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -138.29 115.99 11.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -107.97 24.21 13.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.55 1.54 . . . . 0.0 111.019 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.47 -64.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.318 1.847 . . . . 0.0 108.506 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.37 -17.99 0.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 171.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -113.71 166.6 11.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 109.925 -167.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.56 118.86 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.91 138.23 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.14 131.37 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.7 p -106.72 147.24 29.84 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.258 1.823 . . . . 0.0 108.826 -164.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -153.95 151.05 28.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.708 1.603 . . . . 0.0 108.065 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -77.42 152.32 34.35 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 166.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -172.14 2.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.929 1.691 . . . . 0.0 107.779 168.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -111.85 143.55 28.89 Favored Pre-proline 0 C--O 1.236 0.36 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.02 -23.5 16.01 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.814 3.009 . . . . 0.0 110.997 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -51.49 -53.31 38.65 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.76 0.824 . . . . 0.0 108.985 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.32 77.87 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.788 0.835 . . . . 0.0 111.214 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -70.46 -39.85 74.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.911 2.084 . . . . 0.0 112.54 -169.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -63.78 -42.16 97.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 109.811 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -93.38 -167.33 1.69 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.847 1.259 . . . . 0.0 110.475 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.406 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 7.0 ttm180 -100.17 39.8 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.763 -0.585 . . . . 0.0 110.55 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -99.3 88.88 4.03 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.048 -1.033 . . . . 0.0 109.42 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.406 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.238 0.499 0 C-N-CA 126.491 1.916 . . . . 0.0 107.379 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -71.53 148.09 53.16 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.743 . . . . 0.0 108.444 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.9 p -136.51 -179.84 5.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.28 5.56 5.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.305 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.56 143.97 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.698 1.199 . . . . 0.0 110.464 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 mt -131.43 159.59 37.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.209 2.204 . . . . 0.0 109.526 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 t -116.77 110.88 18.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.773 1.629 . . . . 0.0 106.974 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.02 153.54 20.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.6 mtm -134.23 176.8 8.27 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 61.62 12.89 4.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.879 1.671 . . . . 0.0 113.034 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -68.33 -59.52 3.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 153.84 38.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.074 2.15 . . . . 0.0 108.227 -172.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -82.01 164.4 48.63 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.074 1.35 . . . . 0.0 109.548 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.87 5.28 2.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 124.116 3.211 . . . . 0.0 113.734 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -129.56 26.59 5.33 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.547 1.539 . . . . 0.0 110.326 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -141.05 24.64 2.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.301 1.84 . . . . 0.0 111.838 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -128.54 75.51 1.64 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.482 2.313 . . . . 0.0 107.039 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -134.35 -49.93 0.79 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.296 1.439 . . . . 0.0 108.166 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.92 105.96 3.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.904 2.481 . . . . 0.0 108.974 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.61 -19.73 41.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.117 1.367 . . . . 0.0 112.736 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.24 -65.71 0.98 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.35 -29.0 68.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.168 1.387 . . . . 0.0 111.897 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.22 -44.17 64.64 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.82 -0.55 . . . . 0.0 111.697 172.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.16 -43.77 50.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -55.88 -43.97 77.72 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.29 1.036 . . . . 0.0 111.119 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -68.31 -42.53 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.823 0.849 . . . . 0.0 109.604 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -59.07 -40.03 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.799 1.182 . . . . 0.0 109.515 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.77 -32.56 67.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.446 0.566 . . . . 0.0 112.361 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.84 -40.75 88.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.842 0.353 . . . . 0.0 110.753 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.1 t -78.47 -38.7 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 118.264 -0.874 . . . . 0.0 109.403 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -52.39 -36.23 53.48 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.07 0.85 . . . . 0.0 109.912 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.44 -38.02 88.16 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.546 0.612 . . . . 0.0 111.124 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.59 -47.65 18.85 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -29.81 70.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 111.65 174.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.5 t -63.52 -9.38 12.79 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.633 1.173 . . . . 0.0 113.225 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -61.56 -41.89 98.03 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.138 -2.227 . . . . 0.0 111.111 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.67 -8.42 50.04 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.214 1.406 . . . . 0.0 113.146 -160.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.12 -159.07 27.82 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -157.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.64 120.53 36.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.419 1.109 . . . . 0.0 111.759 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -75.9 142.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.051 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.3 -54.67 2.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.526 1.931 . . . . 0.0 109.288 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -159.34 155.62 27.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.474 0.579 . . . . 0.0 110.621 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mt -124.34 118.57 54.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 127.143 2.177 . . . . 0.0 105.888 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 133.53 38.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.91 86.61 26.48 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -52.06 145.74 32.61 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.237 1.958 . . . . 0.0 110.128 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.67 148.14 67.19 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.33 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 C-N-CA 123.063 2.509 . . . . 0.0 111.067 178.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 N-CA-C 109.762 -0.899 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.46 -1.37 20.44 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.84 1.21 . . . . 0.0 113.383 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -66.45 137.45 56.84 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.509 1.654 . . . . 0.0 111.158 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.73 1.74 79.83 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.935 1.731 . . . . 0.0 113.608 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -108.87 123.23 48.74 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.59 106.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -170.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -91.11 141.94 28.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.8 135.69 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.99 148.82 41.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.033 1.733 . . . . 0.0 107.184 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -129.99 168.83 16.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.686 1.594 . . . . 0.0 109.999 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 p -70.01 -4.74 22.29 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.28 1.432 . . . . 0.0 114.088 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.2 t -171.51 165.42 6.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.256 1.822 . . . . 0.0 107.984 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.6 t -52.93 -47.82 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.251 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -61.83 -48.35 80.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.312 0.645 . . . . 0.0 110.262 -172.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.29 -40.24 93.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.227 1.011 . . . . 0.0 110.342 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -44.69 94.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.247 1.019 . . . . 0.0 109.423 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.5 -51.85 57.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.389 1.476 . . . . 0.0 110.774 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -61.05 -47.35 86.81 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.77 74.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.326 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -62.25 -65.52 0.68 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.099 0.863 . . . . 0.0 109.438 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -70.04 -24.4 63.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.968 -0.457 . . . . 0.0 111.301 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.06 -24.28 73.16 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.364 -0.687 . . . . 0.0 112.505 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -127.84 -6.24 5.63 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.217 1.008 . . . . 0.0 112.468 -171.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -59.83 142.05 54.19 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.871 1.214 . . . . 0.0 108.08 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.2 -1.32 81.1 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.206 1.384 . . . . 0.0 114.029 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -78.09 -174.74 3.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.373 2.086 . . . . 0.0 112.005 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -118.66 129.97 55.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -107.1 13.47 27.38 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.96 1.254 . . . . 0.0 110.787 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.73 -74.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.73 -12.14 0.45 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -122.4 160.91 24.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.187 0.903 . . . . 0.0 110.719 -165.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.82 128.91 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 123.159 0.287 . . . . 0.0 111.764 -165.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.56 87.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.77 146.37 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.0 p -102.11 164.36 11.74 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.491 0.717 . . . . 0.0 109.489 171.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -146.75 150.47 35.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.275 1.43 . . . . 0.0 107.582 154.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -67.43 156.28 36.96 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.358 1.036 . . . . 0.0 109.461 163.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.59 -172.38 2.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.902 1.281 . . . . 0.0 108.368 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -108.83 145.34 31.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 158.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.99 -22.24 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.541 2.828 . . . . 0.0 112.723 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -44.64 -42.11 7.21 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.867 2.067 . . . . 0.0 111.969 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 p -91.23 -27.57 18.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 112.28 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -72.79 -27.25 61.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.818 2.047 . . . . 0.0 110.637 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -65.21 -12.47 51.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -130.48 -164.18 1.4 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.75 2.02 . . . . 0.0 107.852 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 2.2 ttt180 -107.1 23.44 14.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.417 1.087 . . . . 0.0 111.252 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.68 97.83 6.71 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.72 -1.237 . . . . 0.0 110.155 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 5.6 m-85 . . . . . 0 C--O 1.235 0.29 0 C-N-CA 124.651 1.181 . . . . 0.0 108.416 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.83 149.14 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.829 1.686 . . . . 0.0 108.827 167.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.0 p -128.12 171.32 12.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.06 -10.49 59.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.773 1.229 . . . . 0.0 111.716 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -114.01 155.0 15.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 119.537 1.062 . . . . 0.0 110.056 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.1 124.82 21.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 108.63 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -80.22 129.77 34.74 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.0 122.88 42.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.323 1.449 . . . . 0.0 108.411 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -97.03 163.96 12.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 74.22 18.88 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.063 2.145 . . . . 0.0 113.649 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -73.41 0.31 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 165.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.62 174.23 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 126.183 1.793 . . . . 0.0 109.616 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -112.47 146.29 34.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 125.022 1.329 . . . . 0.0 107.654 172.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -61.37 7.37 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.808 1 C-N-CA 127.892 5.728 . . . . 0.0 116.055 -175.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.34 -0.33 1.81 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.258 1.823 . . . . 0.0 111.925 -154.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -117.42 -6.08 11.23 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 112.937 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.95 -4.66 17.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.355 1.462 . . . . 0.0 113.849 -169.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.31 -25.84 60.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.978 2.111 . . . . 0.0 111.564 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.32 129.3 34.99 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.381 0.991 . . . . 0.0 109.614 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.28 -17.05 43.91 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.209 1.403 . . . . 0.0 112.393 -170.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -87.88 -61.82 1.63 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.148 0.979 . . . . 0.0 109.278 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.27 -38.03 73.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.565 0.746 . . . . 0.0 111.816 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -53.22 -39.27 63.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.258 1.023 . . . . 0.0 112.517 172.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -84.29 -31.89 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.428 0.691 . . . . 0.0 111.438 -171.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -53.95 -45.41 71.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.8 mt -67.09 -15.07 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.909 0.883 . . . . 0.0 111.724 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.0 t -86.01 -44.67 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 119.913 -1.742 . . . . 0.0 108.773 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.9 -42.54 69.84 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.684 0.793 . . . . 0.0 111.153 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -60.83 -43.6 98.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.754 1.74 . . . . 0.0 109.647 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.87 -21.78 6.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.316 -167.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -61.13 -43.34 99.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.086 -1.009 . . . . 0.0 108.826 165.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.48 -43.14 91.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.14 0.882 . . . . 0.0 111.743 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.68 -46.13 76.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.811 0.732 . . . . 0.0 110.274 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -70.89 -27.82 64.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.684 0.794 . . . . 0.0 111.276 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -55.53 -16.68 4.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.006 1.723 . . . . 0.0 113.339 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.31 -11.09 38.29 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.978 -1.701 . . . . 0.0 113.692 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.67 -15.89 10.74 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.65 -168.56 27.36 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 107.181 -2.367 . . . . 0.0 107.181 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.7 tp -99.87 119.24 37.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -162.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.58 117.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 167.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -56.23 15.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 158.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 p -160.36 170.01 21.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.504 0.593 . . . . 0.0 112.357 -166.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.64 153.1 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.14 133.21 45.37 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -137.71 85.61 20.02 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.51 148.34 92.57 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.394 1.396 . . . . 0.0 109.69 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -118.18 150.33 47.37 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 108.537 -167.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.457 -0.628 0 C-N-CA 123.079 2.519 . . . . 0.0 108.641 172.599 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.454 -0.805 0 N-CA-C 108.409 -1.419 . . . . 0.0 108.409 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.75 12.83 61.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.525 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.19 154.24 42.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.531 1.666 . . . . 0.0 110.667 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.1 -32.36 4.67 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.09 1.805 . . . . 0.0 112.89 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.17 172.59 9.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.11 1.455 . . . . 0.0 109.254 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.95 151.19 35.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 164.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.84 150.26 33.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 165.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.32 159.24 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.67 121.42 10.54 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -93.63 162.93 13.75 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.507 0.67 . . . . 0.0 109.361 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -72.93 -1.55 17.41 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.029 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.3 m -158.45 155.34 28.38 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 121.135 1.789 . . . . 0.0 111.627 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.7 t -59.76 -32.29 49.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.627 1.571 . . . . 0.0 109.852 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.73 -59.53 5.24 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.479 -0.763 . . . . 0.0 110.297 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.55 -39.5 57.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.335 1.454 . . . . 0.0 109.891 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 t -64.35 -50.11 69.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.973 1.309 . . . . 0.0 110.374 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.15 -30.67 62.5 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.871 1.268 . . . . 0.0 112.206 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -78.03 -50.13 12.69 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.0 0.92 . . . . 0.0 109.498 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.27 -47.35 78.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.361 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.2 ttm -48.06 -67.55 0.26 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.027 0.831 . . . . 0.0 110.752 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.49 -25.33 66.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.796 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.33 -26.75 74.09 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.649 -1.084 . . . . 0.0 112.565 174.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.3 mt -123.39 -5.71 8.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.608 1.204 . . . . 0.0 112.727 -167.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 m -50.59 121.08 5.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.508 1.123 . . . . 0.0 108.412 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.25 8.03 86.91 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 118.499 -1.167 . . . . 0.0 114.41 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -78.26 -169.68 1.72 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.676 1.238 . . . . 0.0 109.974 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.85 132.2 53.72 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -110.57 19.96 18.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.698 1.199 . . . . 0.0 109.737 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.57 -65.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.885 1.674 . . . . 0.0 107.179 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 -29.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.076 1.351 . . . . 0.0 111.452 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -88.51 166.5 14.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.671 -0.643 . . . . 0.0 110.255 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.95 135.49 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.1 t -93.75 111.69 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.29 142.78 13.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.8 p -119.96 151.43 38.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.369 1.068 . . . . 0.0 108.128 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -150.0 144.16 25.65 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.174 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -66.48 138.17 57.34 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 120.252 1.387 . . . . 0.0 108.218 161.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 -164.37 0.94 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -116.73 143.02 30.59 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.56 -27.8 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.132 3.221 . . . . 0.0 111.991 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -46.88 72.2 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 120.902 -1.123 . . . . 0.0 111.083 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.81 55.17 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.895 1.678 . . . . 0.0 111.325 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -92.65 -51.94 4.87 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.4 1.88 . . . . 0.0 109.251 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -62.5 -30.29 71.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.858 0.463 . . . . 0.0 111.599 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -104.96 -178.25 3.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.539 1.936 . . . . 0.0 108.659 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -111.49 76.84 1.0 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.32 69.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 . . . . . 0 C--O 1.236 0.349 0 C-N-CA 123.219 0.608 . . . . 0.0 110.075 -177.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 120.379 0.133 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.76 148.37 52.36 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.775 2.317 . . . . 0.0 108.502 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.2 p -135.79 155.21 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.16 -3.02 3.32 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 4.1 m -93.64 -167.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.472 0.653 . . . . 0.0 110.354 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.11 160.33 43.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.467 2.307 . . . . 0.0 105.877 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 t -137.65 114.29 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 mp -125.05 153.93 42.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 110.618 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mtm -138.27 170.25 16.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 111.046 -172.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.03 13.24 5.52 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.334 2.254 . . . . 0.0 112.658 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 36.9 ttm -76.17 -75.71 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -97.24 155.9 3.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.748 1.219 . . . . 0.0 108.738 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.04 156.87 38.4 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.364 1.466 . . . . 0.0 107.065 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.91 -12.37 34.08 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.434 2.756 . . . . 0.0 113.835 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -105.1 8.65 34.3 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.013 1.725 . . . . 0.0 110.756 -168.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -124.46 -16.96 6.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.393 1.077 . . . . 0.0 111.596 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.73 56.14 3.42 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.395 1.478 . . . . 0.0 109.589 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.44 -49.06 1.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.026 0.93 . . . . 0.0 108.866 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.1 92.17 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.727 1.611 . . . . 0.0 110.327 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.69 -17.7 49.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.289 1.835 . . . . 0.0 113.097 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.21 -35.0 10.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 0.0 110.802 -172.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -74.61 -36.32 62.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.712 1.205 . . . . 0.0 111.082 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.89 -40.15 13.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.839 1.655 . . . . 0.0 111.782 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.08 -46.49 74.14 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 110.927 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.96 -46.83 79.92 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.954 1.302 . . . . 0.0 109.926 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.84 -45.29 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.889 0.875 . . . . 0.0 109.813 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 t -57.26 -47.16 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.96 -37.63 88.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.555 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -76.15 -27.7 57.1 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.963 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.4 t -76.73 -34.17 22.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.61 -28.74 69.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.045 -1.034 . . . . 0.0 111.644 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.21 -47.18 78.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.854 0.752 . . . . 0.0 110.803 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.7 -42.96 69.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.943 0.497 . . . . 0.0 110.479 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.295 0.8 OUTLIER -71.96 -26.12 62.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.707 173.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -11.83 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 120.543 1.52 . . . . 0.0 113.04 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -63.2 -20.19 65.19 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 119.77 -1.831 . . . . 0.0 113.986 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -117.28 3.84 12.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.369 0.668 . . . . 0.0 112.524 -165.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.36 -139.4 5.99 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -168.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -137.54 133.31 34.36 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.141 1.471 . . . . 0.0 109.664 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -84.69 122.2 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.24 1.016 . . . . 0.0 108.48 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -73.02 -61.35 1.85 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.151 0.981 . . . . 0.0 108.866 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 t -151.84 166.68 30.68 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.781 0.832 . . . . 0.0 109.358 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 mt -133.74 123.36 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 172.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -110.87 114.13 27.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.067 1.347 . . . . 0.0 109.808 -167.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.29 86.26 30.91 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.861 1.664 . . . . 0.0 107.94 -167.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.19 150.16 87.92 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 120.946 1.097 . . . . 0.0 109.821 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -105.39 165.43 13.16 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 109.505 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.534 0.513 0 C-N-CA 123.256 2.637 . . . . 0.0 110.883 173.859 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 N--CA 1.446 -1.279 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.57 9.68 85.39 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.805 -0.997 . . . . 0.0 113.258 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.14 154.6 37.66 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.294 1.047 . . . . 0.0 111.431 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.63 -4.56 50.69 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.671 1.605 . . . . 0.0 115.223 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -98.44 147.0 25.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.706 1.253 . . . . 0.0 107.833 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.91 139.65 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -123.12 139.17 54.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.11 110.23 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -169.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 37.1 tt0 -88.62 138.96 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.522 1.129 . . . . 0.0 108.012 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.76 174.54 6.53 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.403 1.481 . . . . 0.0 110.227 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -32.41 67.51 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.696 1.199 . . . . 0.0 113.601 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.3 m -168.85 167.25 11.08 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.285 1.034 . . . . 0.0 110.324 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -51.73 -40.12 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 122.901 1.334 . . . . 0.0 110.328 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.78 -2.51 20.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.605 -1.31 . . . . 0.0 114.036 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -109.01 -33.97 6.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.237 1.015 . . . . 0.0 109.373 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.2 p -75.82 -34.37 60.13 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.472 -0.768 . . . . 0.0 109.504 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -50.27 -35.43 27.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.883 2.073 . . . . 0.0 111.83 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.3 -46.13 12.11 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.002 0.921 . . . . 0.0 108.875 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.78 76.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.581 -1.2 . . . . 0.0 111.277 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 mtp -46.59 -64.28 0.8 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 108.907 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -68.2 -34.11 75.67 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.355 -173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.07 -7.06 70.07 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.76 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.8 mt -131.21 -3.08 3.92 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 111.811 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -62.83 108.64 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.831 -1.168 . . . . 0.0 109.127 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.24 67.01 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.78 1.181 . . . . 0.0 113.14 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -64.57 177.36 0.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.295 1.547 . . . . 0.0 109.429 165.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -131.92 89.97 2.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -167.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -80.45 13.38 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.905 -0.497 . . . . 0.0 112.119 -168.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.08 -84.45 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.152 3.381 . . . . 0.0 103.288 156.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -147.06 18.92 1.25 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.426 -0.796 . . . . 0.0 112.022 -168.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 -132.86 171.7 13.58 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.748 -1.22 . . . . 0.0 110.338 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 t -87.3 109.56 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -73.17 124.56 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.69 163.62 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 p -132.88 163.29 29.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.186 2.194 . . . . 0.0 108.753 -168.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -164.6 158.9 18.48 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 130.127 3.371 . . . . 0.0 105.578 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.11 145.3 31.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 157.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.61 -164.3 1.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.01 1.324 . . . . 0.0 109.67 172.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -109.92 144.83 30.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 157.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.42 -19.55 10.19 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.825 3.016 . . . . 0.0 111.708 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -57.0 -59.28 5.29 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.991 -1.068 . . . . 0.0 108.611 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.4 m -70.01 -0.78 8.14 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.254 2.222 . . . . 0.0 111.9 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -91.06 -48.32 7.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.412 1.485 . . . . 0.0 110.522 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -68.9 -45.6 70.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.102 0.961 . . . . 0.0 109.342 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -76.29 170.89 15.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.078 0.942 . . . . 0.0 109.222 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -101.49 68.11 1.17 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.56 74.89 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.93 1.348 . . . . 0.0 108.778 169.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 177.041 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.63 136.51 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.678 2.252 . . . . 0.0 108.705 166.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -140.82 171.28 14.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.49 -2.57 14.4 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.19 -0.944 . . . . 0.0 113.056 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 t -107.44 92.55 2.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.657 1.183 . . . . 0.0 108.439 -167.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.63 125.88 29.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.59 124.06 35.46 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.82 111.24 15.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.271 1.034 . . . . 0.0 109.585 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mtm -84.55 166.49 17.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.73 0.812 . . . . 0.0 109.778 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 70.1 14.69 7.72 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.718 2.007 . . . . 0.0 113.033 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -58.63 7.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.45 163.34 24.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.534 1.134 . . . . 0.0 111.709 -161.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -103.4 163.68 16.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.052 2.141 . . . . 0.0 109.35 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.03 4.88 4.36 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.892 2.394 . . . . 0.0 113.247 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.55 14.83 11.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.831 1.252 . . . . 0.0 111.506 -171.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.47 24.04 2.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.377 1.071 . . . . 0.0 111.123 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.405 ' H ' HD21 ' A' ' 20' ' ' LEU . 53.7 mt -133.2 37.43 3.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.438 1.895 . . . . 0.0 109.82 -176.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.405 HD21 ' H ' ' A' ' 19' ' ' LEU . 1.5 mm? -113.58 -5.62 13.41 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.274 1.029 . . . . 0.0 111.245 -174.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.38 127.51 53.75 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.94 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.92 -12.72 60.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.89 0.876 . . . . 0.0 111.269 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.19 -59.31 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.039 0.936 . . . . 0.0 108.728 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.67 -36.98 77.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.057 1.743 . . . . 0.0 111.136 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -52.62 -48.55 66.27 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.928 1.291 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.2 -36.47 66.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.911 0.778 . . . . 0.0 110.221 -172.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -60.39 -49.32 78.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.394 0.678 . . . . 0.0 109.415 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -63.22 -41.18 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.1 t -56.18 -48.25 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.459 1.027 . . . . 0.0 110.045 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.31 -31.39 60.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.954 1.252 . . . . 0.0 112.924 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.83 -45.52 74.44 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.603 0.716 . . . . 0.0 110.609 176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.8 t -72.55 -41.82 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -30.65 38.19 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.105 0.866 . . . . 0.0 110.349 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.67 -36.49 67.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 120.344 1.429 . . . . 0.0 113.189 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.32 -43.13 98.67 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.261 0.9 OUTLIER -79.94 -17.47 52.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -53.28 -29.57 33.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.052 1.741 . . . . 0.0 110.69 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -59.46 -20.35 54.52 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.264 -0.898 . . . . 0.0 112.44 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -125.64 51.64 1.71 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.111 1.365 . . . . 0.0 108.35 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.57 -116.12 2.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 125.269 1.414 . . . . 0.0 110.377 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -154.47 113.13 3.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.82 116.22 21.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.036 1.734 . . . . 0.0 107.433 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -69.31 -57.82 4.82 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.085 0.554 . . . . 0.0 109.685 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.46 166.36 25.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 0.0 109.639 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 111.58 27.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 125.748 1.619 . . . . 0.0 107.11 -169.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.24 124.81 30.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.599 0.76 . . . . 0.0 109.965 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.94 85.48 22.97 Favored Pre-proline 0 C--O 1.225 -0.234 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.1 -15.15 42.56 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.52 2.146 . . . . 0.0 114.784 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.347 0.0 OUTLIER 60.41 160.86 0.11 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 128.767 2.827 . . . . 0.0 116.438 172.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.354 0.868 0 C-N-CA 123.812 3.008 . . . . 0.0 110.33 172.117 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo . . . . . 0 N--CA 1.447 -1.237 0 N-CA-C 108.765 -1.283 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.01 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 127.055 2.264 . . . . 0.0 111.973 -175.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.28 130.57 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.296 1.548 . . . . 0.0 111.036 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.07 -13.66 66.43 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.768 1.651 . . . . 0.0 113.482 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.17 122.89 40.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.45 148.72 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 167.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.37 127.49 46.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.1 p -121.73 119.79 59.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.58 150.61 22.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.674 1.59 . . . . 0.0 107.645 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -132.93 162.99 30.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.405 1.082 . . . . 0.0 110.547 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.4 p -72.55 -6.5 44.4 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -154.28 157.3 38.48 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 120.203 1.365 . . . . 0.0 113.137 162.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.21 -16.79 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 112.107 167.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -94.24 -18.85 21.26 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.424 -1.423 . . . . 0.0 112.137 -175.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -85.03 -41.98 15.28 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.285 0.634 . . . . 0.0 110.271 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 p -62.65 -31.92 72.88 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.647 -0.658 . . . . 0.0 110.818 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -63.91 -13.91 49.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 113.206 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -95.73 -41.2 8.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 120.315 1.416 . . . . 0.0 108.488 172.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.11 45.69 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.024 0.929 . . . . 0.0 111.621 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -59.45 -31.69 69.54 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -162.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.86 -40.15 9.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.711 2.405 . . . . 0.0 110.327 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.92 -25.57 67.98 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 121.731 -0.606 . . . . 0.0 112.285 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -124.72 22.52 8.2 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.94 2.096 . . . . 0.0 110.29 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.2 m -56.87 127.47 31.89 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.277 -0.889 . . . . 0.0 109.092 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.65 5.8 64.96 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 118.628 -1.096 . . . . 0.0 112.975 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -173.65 0.17 Allowed 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.612 1.706 . . . . 0.0 110.17 176.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -124.19 121.21 34.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.8 14.06 22.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.181 0.991 . . . . 0.0 110.965 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.19 -66.45 0.09 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.67 -25.78 0.14 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.169 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -105.99 172.39 6.83 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.635 1.174 . . . . 0.0 110.452 -169.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.06 118.14 28.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.41 155.09 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.426 1.09 . . . . 0.0 109.628 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.69 147.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 158.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.71 144.43 42.97 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.543 1.937 . . . . 0.0 106.799 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -147.87 145.05 28.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.049 1.74 . . . . 0.0 107.936 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -64.79 138.13 58.2 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 164.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -165.83 1.05 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.543 1.937 . . . . 0.0 107.752 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.62 144.12 52.01 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.7 -21.27 10.0 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.17 2.58 . . . . 0.0 111.644 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -49.66 -55.41 13.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -42.13 96.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.949 0.9 . . . . 0.0 109.538 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -64.54 -38.81 92.29 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.277 1.031 . . . . 0.0 112.537 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -63.33 -4.38 2.58 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.339 -0.851 . . . . 0.0 112.977 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -137.9 -173.89 3.63 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 127.675 2.39 . . . . 0.0 108.43 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.43 ' HA ' ' CE1' ' A' ' 104' ' ' PHE . 7.7 mpt_? -123.35 68.72 1.01 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -125.36 27.17 6.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.716 1.206 . . . . 0.0 112.494 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.241 0.622 0 C-N-CA 123.878 0.871 . . . . 0.0 109.547 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 119.995 -0.05 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.78 143.48 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.772 1.648 . . . . 0.0 108.751 162.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -120.32 174.37 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.962 1.305 . . . . 0.0 107.738 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.22 -5.02 55.45 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.071 0.948 . . . . 0.0 113.161 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.78 -175.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 118.856 0.753 . . . . 0.0 109.985 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.41 155.15 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.312 1.845 . . . . 0.0 106.733 164.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.3 t -113.11 136.77 52.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 169.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.1 mt -129.85 95.48 3.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.152 2.181 . . . . 0.0 107.384 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.8 mtm -87.65 157.82 19.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 66.45 30.07 8.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.69 1.596 . . . . 0.0 112.751 171.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttm -81.28 -82.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 162.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.9 m -93.73 146.38 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.822 1.649 . . . . 0.0 110.437 -162.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.74 155.04 42.13 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.253 1.021 . . . . 0.0 109.371 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.64 4.26 2.24 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.334 2.69 . . . . 0.0 113.667 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.41 6.03 8.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.986 1.714 . . . . 0.0 111.863 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -124.05 -8.56 7.7 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.907 0.883 . . . . 0.0 112.82 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.96 63.73 7.2 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.089 -1.007 . . . . 0.0 109.491 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.93 -39.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.058 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -67.28 100.94 0.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.373 1.069 . . . . 0.0 109.89 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.77 -2.98 0.17 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 130.219 3.408 . . . . 0.0 114.938 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 21' ' ' ASP . 7.3 pt-20 -124.23 -54.77 1.69 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.789 2.836 . . . . 0.0 108.651 -164.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.27 -41.75 98.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.761 1.225 . . . . 0.0 111.704 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -46.98 -40.47 14.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.466 1.506 . . . . 0.0 110.854 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.91 -25.91 40.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -63.53 -52.68 60.13 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.641 1.176 . . . . 0.0 108.954 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.31 -34.97 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.405 1.082 . . . . 0.0 110.087 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.73 -47.1 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.3 0.64 . . . . 0.0 110.141 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.36 -37.69 74.64 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.688 1.131 . . . . 0.0 112.117 -172.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.18 -38.44 91.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.23 1.015 . . . . 0.0 110.505 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.36 -33.18 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 109.763 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -66.39 -32.79 74.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.95 -54.53 37.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 110.623 171.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -63.66 -37.55 87.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.812 0.815 . . . . 0.0 111.245 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.25 -22.71 57.65 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.376 1.07 . . . . 0.0 110.543 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 t -72.37 -7.51 50.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.271 1.029 . . . . 0.0 111.282 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -73.47 -9.54 58.8 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 119.351 -2.093 . . . . 0.0 112.29 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.04 1.12 9.21 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.719 1.145 . . . . 0.0 112.668 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.12 -164.93 28.61 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 106.129 -2.788 . . . . 0.0 106.129 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -108.27 108.67 19.77 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.277 1.539 . . . . 0.0 109.984 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.67 116.05 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -55.26 -74.67 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.819 2.048 . . . . 0.0 107.024 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -174.29 4.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.259 1.024 . . . . 0.0 109.123 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.86 143.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.585 1.954 . . . . 0.0 107.145 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -130.3 118.35 21.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.211 1.404 . . . . 0.0 109.301 -172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.4 mt -131.31 86.84 49.23 Favored Pre-proline 0 C--O 1.234 0.242 0 C-N-CA 125.924 1.69 . . . . 0.0 107.921 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -55.79 124.94 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 167.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.85 47.93 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.386 . . . . 0.0 108.926 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 N--CA 1.453 -0.88 0 C-N-CA 122.818 2.345 . . . . 0.0 109.792 -179.274 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 N--CA 1.448 -1.154 0 N-CA-C 107.764 -1.668 . . . . 0.0 107.764 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.6 80.09 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 121.953 -0.467 . . . . 0.0 113.168 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.25 156.99 37.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.482 0.713 . . . . 0.0 110.572 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.91 7.12 88.78 Favored Glycine 0 C--O 1.24 0.501 0 C-N-CA 123.758 0.694 . . . . 0.0 112.922 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 171.72 13.85 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 118.18 0.99 . . . . 0.0 109.589 165.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -121.83 156.03 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.99 150.1 39.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.49 155.19 28.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.89 144.97 45.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -172.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.75 168.32 10.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.941 0.877 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 -20.58 65.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.809 1.244 . . . . 0.0 112.918 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.9 t -163.19 155.82 18.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.56 1.073 . . . . 0.0 110.323 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.0 t -51.91 -40.01 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.6 1.96 . . . . 0.0 110.307 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -75.49 -12.24 60.19 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 119.435 -2.04 . . . . 0.0 114.115 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -93.16 -41.6 9.83 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.541 1.136 . . . . 0.0 109.364 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.42 -40.58 96.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -51.4 -10.48 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 130.135 3.374 . . . . 0.0 114.733 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -97.35 -41.91 8.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.966 1.257 . . . . 0.0 109.488 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.65 87.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.71 0.804 . . . . 0.0 112.625 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -43.32 63.78 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.768 2.427 . . . . 0.0 112.947 -162.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -98.66 -31.15 12.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.061 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.79 -9.18 58.78 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.921 0.782 . . . . 0.0 113.947 -170.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -123.7 3.55 8.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.203 1.401 . . . . 0.0 112.356 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -71.96 142.74 49.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.02 -3.04 82.2 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.076 -1.015 . . . . 0.0 112.731 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -63.69 175.17 1.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.284 1.542 . . . . 0.0 110.367 170.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -125.75 96.15 4.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -83.19 13.64 4.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.415 0.626 . . . . 0.0 111.631 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.0 -77.97 0.05 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.675 2.39 . . . . 0.0 104.658 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.8 -22.9 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.071 0.948 . . . . 0.0 113.368 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -92.49 166.92 12.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.548 -0.72 . . . . 0.0 110.956 -172.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.94 109.79 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.0 t -82.16 146.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.204 1.402 . . . . 0.0 110.654 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -128.93 118.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 p -72.06 159.93 33.35 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.347 1.07 . . . . 0.0 110.493 170.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -156.47 159.74 38.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.989 2.516 . . . . 0.0 105.739 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -74.67 159.39 32.14 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.504 160.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.82 -164.58 1.36 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 108.527 163.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -114.47 144.52 31.95 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.67 -27.94 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.422 2.748 . . . . 0.0 112.927 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.74 -42.05 95.48 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 120.741 -1.224 . . . . 0.0 110.688 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -72.81 -19.5 61.32 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.55 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.47 -45.53 53.65 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.004 2.122 . . . . 0.0 111.444 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -63.05 -8.12 6.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.797 0.839 . . . . 0.0 111.757 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -134.41 -163.63 1.4 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.441 2.696 . . . . 0.0 106.987 -163.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.75 39.72 3.82 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.344 1.057 . . . . 0.0 109.132 -173.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.53 42.93 2.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.005 1.322 . . . . 0.0 111.331 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 CA--C 1.537 0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 109.043 174.906 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.12 146.75 52.65 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.515 2.143 . . . . 0.0 108.708 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 p -137.25 166.74 23.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.31 2.55 21.04 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.91 88.56 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.61 117.34 7.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.803 1.241 . . . . 0.0 108.429 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -84.48 143.04 29.63 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.5 mt -135.45 156.13 49.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 109.388 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.56 165.47 26.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 107.752 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 60.4 26.97 16.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -74.22 0.17 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 157.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -92.5 172.45 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 124.402 1.081 . . . . 0.0 110.733 -163.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -125.6 157.63 67.68 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.69 0.85 4.32 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 121.884 1.723 . . . . 0.0 112.824 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -123.22 12.39 9.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.851 2.06 . . . . 0.0 112.665 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -139.44 22.38 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.998 -1.064 . . . . 0.0 112.021 -169.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -109.72 6.37 23.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.675 1.19 . . . . 0.0 113.004 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.29 -29.87 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.501 -0.749 . . . . 0.0 111.156 -166.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.11 110.14 3.84 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.14 1.376 . . . . 0.0 108.562 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.26 -36.09 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.691 0.797 . . . . 0.0 110.056 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.89 -64.69 0.81 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.871 0.868 . . . . 0.0 110.0 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.42 -35.21 71.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.886 0.474 . . . . 0.0 112.001 -172.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -52.59 -44.21 65.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.515 1.126 . . . . 0.0 111.71 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -74.8 -34.11 62.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.375 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.35 -53.92 51.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.359 1.063 . . . . 0.0 108.631 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.38 -42.63 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.368 1.067 . . . . 0.0 110.42 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.67 -32.7 52.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 124.123 0.969 . . . . 0.0 111.316 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.98 -49.49 19.77 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 123.21 0.319 . . . . 0.0 110.537 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.11 -38.57 83.41 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.477 1.132 . . . . 0.0 109.588 -175.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.36 -36.31 48.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 121.547 -0.721 . . . . 0.0 110.12 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -59.5 -44.76 93.01 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.374 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -65.9 -42.02 90.75 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.712 0.687 . . . . 0.0 111.895 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -67.87 -34.95 77.67 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.395 -172.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 t -78.11 -32.75 50.65 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.339 1.056 . . . . 0.0 110.709 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -56.73 -14.66 3.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.348 1.459 . . . . 0.0 112.039 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -61.54 -19.24 61.9 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.099 -2.25 . . . . 0.0 113.269 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.58 -6.6 13.39 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.862 1.265 . . . . 0.0 112.595 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.39 -151.81 20.8 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -167.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -129.31 108.34 10.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.6 t -72.7 115.79 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -81.8 -50.99 8.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.805 2.042 . . . . 0.0 109.39 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.0 p -153.99 169.83 22.53 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.053 0.941 . . . . 0.0 110.208 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.4 mt -141.4 116.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.57 131.6 34.33 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 110.384 170.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.93 87.02 25.38 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.932 1.693 . . . . 0.0 107.738 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.69 154.5 68.88 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.78 1.653 . . . . 0.0 109.234 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.8 155.55 62.94 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.164 0.986 . . . . 0.0 111.548 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 C-N-CA 123.967 3.112 . . . . 0.0 110.261 177.32 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.452 -0.964 0 N-CA-C 108.412 -1.418 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.82 9.19 85.78 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.767 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.54 140.66 53.89 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.036 0.918 . . . . 0.0 109.829 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.95 -32.42 6.64 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.28 1.895 . . . . 0.0 111.926 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -85.17 152.5 23.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 mp -123.52 146.65 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 169.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.08 120.68 25.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -118.72 106.94 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -79.23 142.74 35.97 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.404 1.481 . . . . 0.0 107.889 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -121.79 177.25 5.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.356 1.063 . . . . 0.0 111.596 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.0 p -72.05 -26.76 62.31 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.721 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.7 m -153.89 159.45 41.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.504 1.621 . . . . 0.0 112.964 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.26 -12.58 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 120.588 -1.32 . . . . 0.0 111.383 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -95.9 -21.12 18.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.313 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.59 -29.98 14.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.873 1.669 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.8 p -60.4 -35.28 75.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.172 0.511 . . . . 0.0 110.4 168.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -24.06 66.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.977 1.711 . . . . 0.0 112.413 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -86.98 -46.03 10.22 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.3 68.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.884 0.874 . . . . 0.0 110.448 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -57.13 -39.41 75.11 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.056 0.389 . . . . 0.0 111.818 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -74.91 -45.83 40.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.128 -0.358 . . . . 0.0 111.04 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.16 -21.46 61.75 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.921 -0.377 . . . . 0.0 112.41 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 81' ' ' GLY . 97.4 mt -131.14 18.66 4.95 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.865 1.266 . . . . 0.0 111.858 -163.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -70.44 23.79 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 O-C-N 120.073 -1.642 . . . . 0.0 114.017 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 79' ' ' LEU . . . -175.09 3.33 0.03 OUTLIER Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.967 1.746 . . . . 0.0 115.068 -166.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -173.68 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.938 1.869 . . . . 0.0 111.931 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -133.64 81.57 1.93 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.393 0.677 . . . . 0.0 109.538 -168.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -74.94 14.02 0.58 Allowed 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.334 -0.854 . . . . 0.0 113.165 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.35 -85.04 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.663 2.385 . . . . 0.0 105.415 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.72 -5.39 1.04 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.77 176.92 5.64 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.786 1.176 . . . . 0.0 108.655 -174.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -82.51 136.9 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.42 164.39 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 124.727 1.211 . . . . 0.0 108.825 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -138.48 139.37 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.7 p -96.61 165.55 12.1 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.181 0.9 . . . . 0.0 110.983 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -153.36 154.53 34.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.921 1.688 . . . . 0.0 108.247 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -80.9 141.21 34.8 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 158.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.73 -168.16 1.28 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.823 1.649 . . . . 0.0 108.847 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -121.03 145.25 41.25 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.494 1.118 . . . . 0.0 107.983 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.29 -22.41 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.626 2.884 . . . . 0.0 114.15 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.31 -47.1 76.1 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.777 1.626 . . . . 0.0 109.537 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 p -77.06 2.1 16.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.843 1.257 . . . . 0.0 111.795 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -94.11 -41.12 9.69 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.641 1.577 . . . . 0.0 109.083 165.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -64.35 -24.7 67.74 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 112.135 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -126.39 165.7 18.56 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 126.434 1.894 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -75.68 23.62 0.12 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.363 1.865 . . . . 0.0 112.566 -175.217 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -91.28 40.33 1.03 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.351 -1.468 . . . . 0.0 112.405 -160.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 7.0 m-85 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 127.213 2.205 . . . . 0.0 115.779 -165.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 93' ' ' TYR . 20.4 Cg_endo -64.29 141.17 74.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.405 2.07 . . . . 0.0 112.143 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.1 p -133.57 -178.79 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.437 1.895 . . . . 0.0 108.149 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.02 -7.3 21.53 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.374 -1.298 . . . . 0.0 113.656 171.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.33 149.57 25.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 121.036 1.743 . . . . 0.0 110.859 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.72 119.03 27.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.744 2.418 . . . . 0.0 107.24 -170.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.84 145.78 25.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.086 0.554 . . . . 0.0 109.762 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.9 mt -136.55 120.41 17.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.286 1.435 . . . . 0.0 109.676 -167.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -106.52 156.64 18.36 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 75.44 23.6 1.48 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.48 2.312 . . . . 0.0 113.693 170.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -81.84 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 163.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.0 m -87.84 172.79 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.875 1.67 . . . . 0.0 111.764 -159.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 mt -126.32 158.1 68.04 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.409 1.483 . . . . 0.0 109.762 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.11 2.59 5.94 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.141 1.894 . . . . 0.0 113.103 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -128.63 18.55 6.27 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.966 1.706 . . . . 0.0 111.297 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -137.44 33.36 2.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.568 1.147 . . . . 0.0 111.152 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.2 mt -130.22 39.28 3.68 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 127.202 2.201 . . . . 0.0 109.406 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.97 -33.4 6.51 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.677 0.791 . . . . 0.0 110.579 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 94.94 1.68 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.42 1.088 . . . . 0.0 110.176 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.85 -36.29 58.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.968 2.107 . . . . 0.0 111.25 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -72.66 -55.31 7.03 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.716 0.407 . . . . 0.0 110.114 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -63.35 -36.44 83.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.339 0.655 . . . . 0.0 109.732 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -45.95 -48.69 16.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.994 0.918 . . . . 0.0 111.153 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.7 -28.19 50.9 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.929 -0.482 . . . . 0.0 112.172 -167.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -64.39 -55.54 20.36 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.597 1.559 . . . . 0.0 109.59 167.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.86 -36.24 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.75 0.82 . . . . 0.0 110.554 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.1 t -59.07 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 118.768 0.713 . . . . 0.0 109.228 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.46 -38.54 74.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.771 0.714 . . . . 0.0 111.315 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -70.94 -33.82 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.046 -175.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.96 -37.65 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.432 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 40.9 ttp180 -57.58 -36.29 71.5 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.707 1.139 . . . . 0.0 110.24 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.31 -29.57 68.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.759 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -68.79 -45.18 71.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.468 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' A' ' 33' ' ' ARG 0.267 0.8 OUTLIER -69.33 -26.53 64.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 172.8 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.3 t -62.77 -14.82 49.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.95 1.3 . . . . 0.0 111.887 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -62.68 -11.12 15.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 119.556 -1.965 . . . . 0.0 114.456 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.57 -0.64 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.501 1.046 . . . . 0.0 112.985 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.4 -174.37 41.89 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -94.74 111.9 23.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.6 t -71.78 109.6 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -52.06 64.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.982 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -167.87 172.23 9.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.936 1.694 . . . . 0.0 110.578 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 mt -135.58 145.89 30.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.42 125.45 47.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.517 1.927 . . . . 0.0 109.443 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.15 86.92 12.62 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.098 1.759 . . . . 0.0 107.697 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.3 140.18 30.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.774 2.316 . . . . 0.0 108.839 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mtm-85 -116.06 146.28 36.75 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.326 1.05 . . . . 0.0 108.77 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.45 -1.038 0 C-N-CA 122.244 1.962 . . . . 0.0 108.555 173.597 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 N--CA 1.449 -1.106 0 N-CA-C 108.341 -1.446 . . . . 0.0 108.341 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.54 58.82 6.13 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.5 t -72.18 154.2 41.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.82 58.38 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 124.784 1.183 . . . . 0.0 112.908 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 168.2 10.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.501 1.651 . . . . 0.0 108.276 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.81 143.54 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.32 141.86 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.12 104.52 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -167.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -83.95 135.1 34.6 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.59 173.39 6.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 126.717 2.007 . . . . 0.0 108.423 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.9 t -92.57 -9.85 39.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.562 -176.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -154.53 155.88 35.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 121.261 1.846 . . . . 0.0 111.882 166.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 t -67.02 -24.93 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.078 1.351 . . . . 0.0 109.728 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -60.56 -59.32 5.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.571 1.148 . . . . 0.0 109.502 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.79 -45.84 59.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.42 1.488 . . . . 0.0 109.632 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.1 t -62.48 -50.56 70.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.369 1.067 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -56.4 -34.87 67.14 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.059 0.943 . . . . 0.0 112.33 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.48 -42.95 33.94 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.91 0.777 . . . . 0.0 109.679 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.42 79.74 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.175 0.99 . . . . 0.0 110.51 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.442 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 4.3 mmm -44.76 -66.48 0.39 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.126 1.371 . . . . 0.0 110.12 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.69 -39.31 88.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.959 0.503 . . . . 0.0 111.226 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -36.45 93.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.959 0.79 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.8 mt -104.91 3.48 30.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.417 1.087 . . . . 0.0 110.892 -168.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.2 m -61.2 110.56 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.943 0.897 . . . . 0.0 109.659 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.73 19.44 73.28 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.387 0.539 . . . . 0.0 113.05 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -66.44 -178.64 0.7 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.761 1.28 . . . . 0.0 110.701 162.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -130.43 96.15 4.06 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.07 14.01 9.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.684 0.754 . . . . 0.0 111.898 -167.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -156.42 -66.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 161.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -147.86 -16.65 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -121.72 168.13 12.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.143 0.977 . . . . 0.0 111.637 -167.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.59 114.44 5.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.658 0.783 . . . . 0.0 109.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.25 150.86 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.349 1.06 . . . . 0.0 109.866 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.7 t -121.7 139.25 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 162.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -115.69 130.49 56.88 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.707 2.003 . . . . 0.0 108.554 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -132.9 171.18 14.28 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 119.778 1.172 . . . . 0.0 110.579 161.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 4' ' ' PRO . 86.8 m-85 -82.89 147.82 28.06 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 -163.76 1.13 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.842 1.257 . . . . 0.0 109.745 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.49 143.47 29.0 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.26 -28.18 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.709 2.272 . . . . 0.0 111.793 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.35 -50.54 73.58 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.59 -1.319 . . . . 0.0 110.166 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.4 p -70.56 -7.28 42.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.075 1.75 . . . . 0.0 111.073 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.19 -45.92 9.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.161 1.784 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -64.3 -44.52 91.37 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.515 0.674 . . . . 0.0 109.863 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -77.98 172.78 12.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 109.119 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.418 ' HG3' ' CE2' ' A' ' 104' ' ' PHE . 50.2 ttp180 -103.96 72.62 1.11 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 164.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -123.37 61.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.917 0.865 . . . . 0.0 109.66 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' A' ' 102' ' ' ARG . 4.9 m-30 . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 126.254 1.821 . . . . 0.0 109.856 -171.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.39 126.33 13.43 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.072 1.848 . . . . 0.0 108.661 156.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -103.23 177.1 4.93 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -81.9 3.58 25.68 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.571 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 94' ' ' CYS . 2.4 m -124.42 156.03 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.739 1.154 . . . . 0.0 108.729 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.2 tp -136.37 122.3 20.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.985 1.714 . . . . 0.0 107.713 -168.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -81.22 139.11 35.7 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.1 mt -128.62 95.25 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.863 2.465 . . . . 0.0 107.4 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mtm -92.63 155.69 17.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 75.2 23.69 1.55 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 114.265 170.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -84.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 161.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.4 163.18 3.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 111.184 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.9 158.42 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.002 1.321 . . . . 0.0 109.841 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.82 -2.66 9.0 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.929 2.419 . . . . 0.0 113.316 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.21 2.13 11.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.572 1.949 . . . . 0.0 111.187 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -104.87 -30.34 9.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 118.669 0.668 . . . . 0.0 112.199 169.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.99 49.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.011 2.124 . . . . 0.0 113.396 -161.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 -10.56 6.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.203 1.801 . . . . 0.0 111.674 -169.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.4 122.19 38.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.006 0.923 . . . . 0.0 110.297 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.18 -15.63 63.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.254 1.422 . . . . 0.0 112.705 -168.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -78.85 -63.16 1.48 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.429 1.492 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.79 -35.65 66.52 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 109.937 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -55.97 -38.43 70.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.611 0.764 . . . . 0.0 112.166 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -80.36 -36.65 33.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.647 0.779 . . . . 0.0 110.678 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -56.72 -45.14 82.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.525 0.679 . . . . 0.0 109.9 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.89 -33.31 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.387 1.075 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.33 -44.65 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.287 -0.883 . . . . 0.0 108.718 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.06 -39.52 86.91 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.809 0.732 . . . . 0.0 110.531 -173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.7 -36.29 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.993 1.378 . . . . 0.0 111.487 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.62 -28.52 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.621 1.568 . . . . 0.0 109.944 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -44.62 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.52 -0.738 . . . . 0.0 109.343 170.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.44 -44.58 92.89 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.524 0.678 . . . . 0.0 111.354 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -43.76 50.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.856 -166.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.529 ' HG ' ' CD1' ' A' ' 79' ' ' LEU . 1.9 t -83.36 -17.98 40.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.505 -1.278 . . . . 0.0 110.331 -167.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -65.62 -15.62 62.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 110.783 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -63.24 -12.57 29.8 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.787 -1.196 . . . . 0.0 111.212 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.649 1.579 . . . . 0.0 112.935 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.33 26.34 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 120.105 1.321 . . . . 0.0 110.784 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.77 111.58 18.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.512 1.525 . . . . 0.0 107.965 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.04 114.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -53.83 -61.36 2.36 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 109.242 166.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 t -160.23 177.35 10.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.153 0.888 . . . . 0.0 111.558 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.98 135.04 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.671 2.388 . . . . 0.0 106.087 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -125.98 106.92 9.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.231 1.013 . . . . 0.0 112.995 -167.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.31 85.93 59.84 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 127.376 2.27 . . . . 0.0 108.334 -165.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.46 138.81 61.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.553 1.502 . . . . 0.0 109.8 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 162.42 19.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 126.567 1.947 . . . . 0.0 110.471 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 C--O 1.237 0.429 0 C-N-CA 124.47 3.446 . . . . 0.0 111.977 165.463 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.454 -0.849 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.45 0.36 70.14 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -71.75 155.05 40.9 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.574 1.687 . . . . 0.0 110.049 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.59 -1.12 79.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.034 0.826 . . . . 0.0 113.203 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 170.86 7.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 120.226 2.013 . . . . 0.0 109.316 168.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.0 mt -134.82 154.37 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -119.0 166.2 13.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 158.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 p -139.07 152.7 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -132.08 139.13 48.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.14 164.32 11.9 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 108.326 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 t -87.15 0.95 54.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.827 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.9 p -154.68 148.38 25.41 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.548 1.067 . . . . 0.0 109.808 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -60.13 -34.85 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.092 0.557 . . . . 0.0 109.587 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -76.96 -23.71 52.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.69 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.99 -49.61 49.81 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.922 1.237 . . . . 0.0 108.024 166.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.6 t -56.98 -47.0 81.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.219 1.008 . . . . 0.0 109.97 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -57.65 -27.13 62.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.341 1.056 . . . . 0.0 113.339 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -79.46 -54.27 6.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.14 -51.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.269 1.027 . . . . 0.0 110.837 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -59.07 -34.54 72.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.964 0.905 . . . . 0.0 112.434 -170.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.98 -34.48 18.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.62 1.168 . . . . 0.0 110.555 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 -29.83 75.86 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.117 1.341 . . . . 0.0 112.164 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.529 ' CD1' ' HG ' ' A' ' 36' ' ' CYS . 39.8 mt -113.29 7.11 17.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.664 1.185 . . . . 0.0 111.619 -168.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -48.66 131.58 17.77 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.11 -2.62 80.55 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.486 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -62.99 176.71 0.67 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.221 1.511 . . . . 0.0 112.019 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 85' ' ' ALA . 21.9 mtpt -132.17 83.14 2.06 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -174.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -78.31 14.5 1.19 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.66 -0.65 . . . . 0.0 111.461 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' H ' ' C ' ' A' ' 83' ' ' LYS . . . -156.38 -80.25 0.08 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.695 -2.706 . . . . 0.0 103.695 159.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -145.12 -16.91 0.5 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.114 0.966 . . . . 0.0 113.264 -165.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -100.26 -173.5 2.44 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.591 1.087 . . . . 0.0 109.444 -175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.72 149.9 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 164.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.67 133.83 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.314 1.846 . . . . 0.0 107.391 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.82 138.46 25.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 161.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 p -102.05 151.56 22.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.597 1.559 . . . . 0.0 108.532 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -149.15 156.98 43.0 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.373 1.469 . . . . 0.0 108.408 170.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -76.18 144.63 40.39 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.695 1.589 . . . . 0.0 107.821 160.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -104.79 -163.93 1.0 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.003 0.921 . . . . 0.0 108.683 171.111 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.78 143.59 28.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 167.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.5 -27.07 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.506 2.138 . . . . 0.0 111.243 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -53.12 60.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -77.22 -10.41 59.4 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.398 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -75.69 -43.65 46.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.175 0.898 . . . . 0.0 110.874 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -62.75 -22.03 66.26 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.634 0.373 . . . . 0.0 111.659 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.4 -177.7 3.2 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.349 1.46 . . . . 0.0 109.714 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 13.4 ttt180 -91.89 30.81 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.734 0.814 . . . . 0.0 111.348 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.82 48.62 1.61 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.99 -1.069 . . . . 0.0 111.997 -162.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 10.3 m-85 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.017 -167.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -62.61 151.64 82.32 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.84 2.36 . . . . 0.0 109.312 162.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.7 p -138.95 176.96 8.25 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -75.47 7.94 3.22 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.327 -0.858 . . . . 0.0 111.988 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 t -133.17 107.08 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.121 1.769 . . . . 0.0 111.147 -169.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -100.19 129.37 46.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.735 2.414 . . . . 0.0 106.651 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 49.8 t -81.86 138.37 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.57 122.88 30.04 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.714 2.406 . . . . 0.0 107.47 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.3 mtm -135.01 73.94 1.5 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -161.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 174.52 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -51.65 30.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.625 1.17 . . . . 0.0 109.717 -172.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 165.59 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 O-C-N 125.167 1.542 . . . . 0.0 108.914 -174.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -100.66 160.68 26.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -68.46 7.66 0.65 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 126.224 4.616 . . . . 0.0 114.341 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -135.55 3.92 3.07 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.162 1.385 . . . . 0.0 112.739 -159.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -126.07 5.68 7.19 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.846 -1.158 . . . . 0.0 112.051 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.12 10.36 3.62 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.879 2.072 . . . . 0.0 112.93 -176.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.16 -17.89 20.51 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.789 2.035 . . . . 0.0 112.698 -168.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 88.17 2.86 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 174.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.34 -26.41 12.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.281 2.632 . . . . 0.0 112.758 -165.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.2 -28.11 69.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.307 1.843 . . . . 0.0 113.406 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -85.76 -36.67 20.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.939 0.896 . . . . 0.0 109.022 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.63 -34.26 69.12 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.82 -40.16 29.16 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.199 1.4 . . . . 0.0 112.073 -173.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -60.23 -45.79 92.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.8 mt -61.06 -31.13 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 123.735 0.814 . . . . 0.0 110.938 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.31 -55.84 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.243 0.929 . . . . 0.0 110.473 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.56 -32.98 72.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.517 1.127 . . . . 0.0 112.487 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.58 -27.3 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.474 1.11 . . . . 0.0 109.776 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -67.96 -34.25 76.21 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.176 -0.952 . . . . 0.0 109.642 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.01 -37.45 55.02 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.635 0.774 . . . . 0.0 112.483 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -50.86 61.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.437 1.017 . . . . 0.0 110.559 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.1 t -70.57 -19.39 62.87 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.783 -0.573 . . . . 0.0 110.914 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.29 3.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.351 1.86 . . . . 0.0 112.955 166.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -68.39 -9.42 48.15 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.918 -1.739 . . . . 0.0 113.863 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.4 1.51 4.58 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.741 0.816 . . . . 0.0 113.139 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.9 -139.46 5.2 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -144.13 121.41 11.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.18 1.792 . . . . 0.0 106.232 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.1 t -74.13 120.66 23.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 170.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -76.48 -57.89 3.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.006 0.923 . . . . 0.0 109.35 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.32 172.24 18.52 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.056 1.342 . . . . 0.0 109.345 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mt -137.1 118.11 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -90.86 122.11 33.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.442 1.097 . . . . 0.0 108.344 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.66 86.31 34.27 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 126.848 2.059 . . . . 0.0 105.77 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.18 158.66 33.85 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.366 1.378 . . . . 0.0 110.447 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -123.32 165.12 23.99 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.924 0.889 . . . . 0.0 109.489 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.454 -0.841 0 C-N-CA 123.982 3.121 . . . . 0.0 109.011 172.536 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 N--CA 1.45 -1.03 0 N-CA-C 108.861 -1.246 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.86 2.74 88.4 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.656 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -67.75 141.76 56.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 117.753 0.776 . . . . 0.0 109.301 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.68 -25.2 27.44 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.458 1.98 . . . . 0.0 112.311 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.04 16.09 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.26 1.03 . . . . 0.0 108.981 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -123.26 145.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.15 104.53 9.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.98 153.76 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -132.34 147.02 52.38 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.22 174.67 9.37 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.529 0.604 . . . . 0.0 110.517 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.03 -22.45 55.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 177.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.8 p -152.47 161.94 41.89 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.422 1.01 . . . . 0.0 111.168 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.68 -13.99 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 110.497 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.97 -48.44 21.12 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 120.026 -1.671 . . . . 0.0 109.894 172.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.49 -41.81 86.19 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.373 0.669 . . . . 0.0 109.554 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.4 p -68.54 -40.65 80.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.327 0.651 . . . . 0.0 109.999 -175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -56.72 -31.26 64.34 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.375 1.47 . . . . 0.0 111.032 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -83.86 -46.56 12.03 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.925 0.784 . . . . 0.0 109.7 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.63 -49.12 73.7 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.375 0.67 . . . . 0.0 109.726 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.2 tpp -44.27 -73.0 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 127.86 2.464 . . . . 0.0 110.119 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -73.11 -7.56 51.87 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.08 -35.31 61.07 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.855 -1.153 . . . . 0.0 110.678 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.5 mt -127.62 -1.13 6.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.419 1.088 . . . . 0.0 112.34 -154.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 m -50.58 122.29 6.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.753 1.221 . . . . 0.0 108.405 157.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 11.5 84.27 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.115 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.5 mmt-85 -71.2 -178.43 2.03 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.604 1.702 . . . . 0.0 112.239 174.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -120.92 94.98 4.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.68 43.02 1.13 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 173.63 -86.41 0.0 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.177 2.991 . . . . 0.0 105.958 166.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -149.09 -5.12 0.4 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.276 1.83 . . . . 0.0 111.622 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -118.46 -178.85 3.62 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.942 1.697 . . . . 0.0 109.797 -175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.39 165.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.1 t -130.31 132.65 64.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 125.777 1.631 . . . . 0.0 108.729 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.63 143.26 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 p -113.48 156.68 23.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 127.638 2.375 . . . . 0.0 107.527 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 169.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -69.38 150.02 47.75 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -130.66 -167.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.232 1.813 . . . . 0.0 108.136 174.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.65 150.64 52.87 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.96 -19.97 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.508 2.805 . . . . 0.0 113.042 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.48 -49.49 61.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.127 1.331 . . . . 0.0 110.378 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.07 7.75 5.74 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.339 1.856 . . . . 0.0 111.663 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -111.79 -36.64 5.38 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -57.96 -31.7 67.13 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -123.74 168.59 12.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.251 1.42 . . . . 0.0 109.347 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -79.73 27.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.172 1.789 . . . . 0.0 111.254 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -86.74 70.59 10.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 C--O 1.235 0.33 0 C-N-CA 124.581 1.152 . . . . 0.0 108.068 -175.105 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.02 151.64 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.352 2.034 . . . . 0.0 109.331 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 p -135.33 177.04 8.12 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -78.7 -0.43 30.12 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.662 171.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -102.22 153.02 5.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 120.657 1.571 . . . . 0.0 109.86 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.65 149.76 46.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.668 1.587 . . . . 0.0 107.545 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 50.7 t -109.29 136.13 49.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.0 mt -128.43 110.03 11.95 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -170.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtm -101.66 152.96 20.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 75.11 30.41 0.89 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.691 2.797 . . . . 0.0 114.542 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -69.12 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.521 -1.362 . . . . 0.0 109.632 169.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.32 148.45 29.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.727 1.611 . . . . 0.0 109.829 -155.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -95.36 158.1 35.2 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.37 3.81 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.626 2.217 . . . . 0.0 112.978 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -128.95 15.95 6.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.159 1.784 . . . . 0.0 112.268 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -142.17 31.42 1.56 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.653 1.181 . . . . 0.0 111.066 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.18 5.12 10.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.698 1.599 . . . . 0.0 111.38 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.66 -23.53 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.189 0.996 . . . . 0.0 109.504 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.0 81.53 8.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.955 2.502 . . . . 0.0 109.704 -162.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.5 -4.66 0.26 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.819 2.847 . . . . 0.0 114.591 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.83 -33.47 4.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 127.889 2.476 . . . . 0.0 111.856 -166.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.86 -39.82 61.34 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.131 0.878 . . . . 0.0 109.279 162.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.411 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 67.3 t80 -45.49 -40.51 8.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.155 1.782 . . . . 0.0 113.107 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.75 -31.63 41.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.722 0.809 . . . . 0.0 113.171 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -66.55 -50.49 62.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.671 1.588 . . . . 0.0 109.17 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.33 -27.07 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.027 0.931 . . . . 0.0 109.556 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.01 -49.75 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.18 -39.24 86.37 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.52 -47.97 72.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.957 1.36 . . . . 0.0 110.161 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.432 HG11 ' CE2' ' A' ' 84' ' ' PHE . 24.8 t -78.23 -32.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.555 -173.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -66.62 -42.91 86.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.712 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.27 -56.37 21.88 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.451 0.7 . . . . 0.0 109.803 174.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.53 -39.97 88.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.477 0.655 . . . . 0.0 110.582 -164.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -78.3 -20.09 52.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.832 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -73.4 -9.91 59.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.125 -0.984 . . . . 0.0 111.702 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -64.11 -15.17 59.11 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.31 -1.494 . . . . 0.0 111.44 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -116.71 5.29 13.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.616 2.366 . . . . 0.0 111.101 -175.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.29 -151.71 22.82 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 120.286 1.403 . . . . 0.0 111.978 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -125.77 108.68 11.73 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -78.76 103.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -49.14 -56.02 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.342 1.057 . . . . 0.0 110.39 164.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.81 168.15 23.62 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.329 0.513 . . . . 0.0 111.292 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.73 138.76 43.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 127.038 2.135 . . . . 0.0 105.561 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -123.34 111.07 15.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.602 1.561 . . . . 0.0 110.019 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.47 86.16 56.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.19 1.396 . . . . 0.0 108.579 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.29 144.29 61.73 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.125 1.883 . . . . 0.0 108.582 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -123.97 155.27 67.53 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 108.594 -177.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 C-N-CA 122.237 1.958 . . . . 0.0 110.867 177.771 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.456 -0.706 0 N-CA-C 108.846 -1.252 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.15 27.81 47.71 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.364 0.507 . . . . 0.0 112.296 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 t -71.88 148.68 45.89 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.371 1.086 . . . . 0.0 110.474 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.07 -32.56 5.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 126.872 2.177 . . . . 0.0 111.467 -174.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -77.19 160.09 29.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mt -127.56 147.13 32.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 168.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.67 158.02 22.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.31 155.13 28.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -133.05 134.69 44.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 0.0 107.832 -173.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.89 -177.1 3.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.766 1.626 . . . . 0.0 109.288 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 t -109.19 3.2 21.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.526 0.73 . . . . 0.0 112.074 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -152.01 139.37 19.45 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.085 -1.634 . . . . 0.0 109.545 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.471 HG12 HE21 ' A' ' 73' ' ' GLN . 4.6 t -51.98 -37.38 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.565 1.546 . . . . 0.0 109.633 168.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.31 -16.56 54.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.877 1.271 . . . . 0.0 113.104 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -115.43 -35.13 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -164.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 t -53.81 -48.48 69.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.416 1.086 . . . . 0.0 109.704 160.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.471 HE21 HG12 ' A' ' 69' ' ' VAL . 41.3 mt-30 -54.49 -24.34 20.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.17 1.388 . . . . 0.0 113.935 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -82.97 -53.76 5.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.871 1.214 . . . . 0.0 108.867 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -36.47 77.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.575 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -58.07 -35.67 71.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.156 0.889 . . . . 0.0 111.767 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -98.46 -44.33 6.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.616 1.166 . . . . 0.0 110.305 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.19 50.0 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 118.847 0.749 . . . . 0.0 112.836 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.6 mt -130.93 4.91 4.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.98 1.312 . . . . 0.0 111.975 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -68.36 144.07 54.91 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.926 1.694 . . . . 0.0 107.214 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.39 86.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.825 -0.986 . . . . 0.0 113.184 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -174.24 0.51 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.804 1.802 . . . . 0.0 109.526 165.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -123.94 141.32 52.14 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.432 ' CE2' HG11 ' A' ' 32' ' ' VAL . 2.7 m-30 -109.01 14.14 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.196 0.935 . . . . 0.0 110.852 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.18 -68.85 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.839 2.856 . . . . 0.0 104.946 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -153.93 -20.95 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 mtp85 -111.77 162.85 14.8 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.427 1.012 . . . . 0.0 110.471 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 t -77.95 106.37 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.004 -163.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.3 t -72.38 140.56 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.432 1.093 . . . . 0.0 109.552 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.0 t -126.27 128.56 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 p -87.69 156.81 19.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 0.0 110.504 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.15 155.08 41.0 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.328 2.251 . . . . 0.0 105.878 169.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -73.89 153.44 39.84 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 119.891 1.223 . . . . 0.0 108.094 159.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -172.5 2.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 164.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.13 144.28 34.53 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.68 -22.68 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.171 1.914 . . . . 0.0 112.346 -167.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -59.13 -57.54 12.59 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.061 1.301 . . . . 0.0 109.222 175.058 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -71.39 12.62 0.31 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.595 1.558 . . . . 0.0 111.355 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' A' ' 97' ' ' ASP . 30.7 t80 -97.52 -55.68 2.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.69 1.196 . . . . 0.0 110.463 169.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -65.57 -36.6 84.25 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.098 0.959 . . . . 0.0 112.714 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -85.38 -164.55 1.02 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.149 0.98 . . . . 0.0 109.519 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -111.97 26.05 10.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.787 1.235 . . . . 0.0 112.591 172.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -77.37 33.47 0.16 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.449 2.3 . . . . 0.0 111.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--O 1.239 0.507 0 O-C-N 120.511 -1.368 . . . . 0.0 111.049 -179.917 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 119.459 -0.305 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.15 151.03 66.64 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.649 2.232 . . . . 0.0 108.639 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.9 p -126.26 176.4 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.797 0.839 . . . . 0.0 109.176 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 28.1 tt0 -72.14 -1.49 15.13 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.576 1.551 . . . . 0.0 112.876 167.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.96 114.04 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 120.503 -1.373 . . . . 0.0 108.956 -151.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 142.56 51.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 108.806 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.2 t -131.12 126.35 35.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.135 0.969 . . . . 0.0 111.648 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.66 107.87 15.23 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 108.262 -159.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.6 mtm -79.1 173.45 12.56 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.389 0.675 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 65.89 18.32 11.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.809 1.644 . . . . 0.0 112.208 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.95 -70.68 0.53 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -165.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -104.33 -174.33 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 129.787 3.235 . . . . 0.0 107.051 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -127.49 153.41 77.39 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 120.142 1.337 . . . . 0.0 107.718 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -3.37 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.758 2.305 . . . . 0.0 112.5 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -115.05 11.56 16.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.675 1.19 . . . . 0.0 110.085 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -130.09 -22.57 2.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.838 1.255 . . . . 0.0 112.325 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -79.5 61.33 3.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.627 1.571 . . . . 0.0 110.385 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.03 -14.11 2.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.309 -160.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -116.6 151.75 35.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.811 1.245 . . . . 0.0 108.476 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.59 -13.42 40.04 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.59 1.556 . . . . 0.0 111.756 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.27 -60.06 1.94 Allowed 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.154 1.382 . . . . 0.0 108.445 -163.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -53.01 -36.21 60.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.513 1.525 . . . . 0.0 110.307 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -61.08 -36.82 80.67 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.44 1.896 . . . . 0.0 111.592 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.03 -40.35 53.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.392 0.996 . . . . 0.0 109.877 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.32 -34.78 72.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.433 0.693 . . . . 0.0 111.236 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.92 -24.44 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.465 0.706 . . . . 0.0 110.783 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.3 t -67.21 -47.19 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.406 -1.434 . . . . 0.0 108.322 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.86 -21.69 47.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.93 -47.62 61.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.386 1.089 . . . . 0.0 110.576 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.89 -30.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.974 -170.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -64.11 -31.66 72.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.202 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.81 -53.12 23.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.568 1.076 . . . . 0.0 110.624 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -62.45 -38.26 89.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.435 0.636 . . . . 0.0 110.926 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.8 t -70.54 -35.82 73.35 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.003 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -65.55 -14.33 60.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.457 1.026 . . . . 0.0 112.005 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.1 -19.77 21.57 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 119.71 -1.869 . . . . 0.0 112.791 172.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -115.42 2.53 13.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.935 1.294 . . . . 0.0 112.509 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.75 -147.16 15.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.5 120.85 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.92 109.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 126.34 1.856 . . . . 0.0 108.849 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -68.33 -63.96 0.96 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.466 1.906 . . . . 0.0 109.988 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -147.67 158.59 44.08 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.552 0.741 . . . . 0.0 111.691 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.7 130.89 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.399 . . . . 0.0 107.36 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -108.98 123.52 49.25 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.978 2.111 . . . . 0.0 107.845 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -129.29 85.15 60.18 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.237 1.815 . . . . 0.0 106.307 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.07 101.18 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.111 1.874 . . . . 0.0 109.825 -172.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.13 80.16 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.801 -0.562 . . . . 0.0 110.896 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 C--N 1.348 0.548 0 C-N-CA 123.572 2.848 . . . . 0.0 110.055 173.203 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 N--CA 1.453 -0.882 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.4 16.25 18.76 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.266 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.5 t -72.33 148.85 44.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.59 1.695 . . . . 0.0 110.106 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.99 -11.11 40.84 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.05 134.73 35.12 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.023 1.329 . . . . 0.0 109.657 -169.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.92 137.2 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -108.83 130.5 55.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -128.96 160.14 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.418 1.487 . . . . 0.0 107.979 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.38 143.43 39.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.596 1.958 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -110.07 -169.16 1.42 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.908 1.231 . . . . 0.0 112.249 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -93.96 -15.35 25.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 113.775 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -155.6 145.57 21.49 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.121 1.369 . . . . 0.0 108.628 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.08 -32.26 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 122.261 1.029 . . . . 0.0 110.533 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.2 -36.57 71.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.3 174.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.533 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 79.4 m-20 -64.07 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.053 1.297 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 34.4 m -76.65 -36.48 57.33 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 127.695 2.398 . . . . 0.0 109.256 -166.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.65 -40.23 82.83 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.144 1.378 . . . . 0.0 110.89 170.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' CE ' ' HA ' ' A' ' 71' ' ' ASP . 40.8 mtmt -72.34 -48.32 42.84 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.452 0.701 . . . . 0.0 109.184 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.09 -35.79 81.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.046 0.938 . . . . 0.0 112.687 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 43.1 tpp -55.1 -68.63 0.17 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.427 1.491 . . . . 0.0 109.176 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -67.81 -25.1 65.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.01 -15.46 81.1 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.341 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.74 6.71 5.15 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.668 1.187 . . . . 0.0 111.898 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.1 m -56.49 113.59 1.67 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 6.1 57.9 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.76 1.171 . . . . 0.0 113.614 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.79 179.25 0.27 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.976 1.31 . . . . 0.0 113.675 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -131.04 90.54 2.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.147 1.779 . . . . 0.0 108.35 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -77.19 14.68 0.86 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.95 -1.094 . . . . 0.0 112.539 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.53 -64.45 0.06 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.002 2.521 . . . . 0.0 105.211 163.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.66 -10.43 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -109.02 148.9 30.05 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.417 -1.427 . . . . 0.0 109.949 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -64.85 131.82 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.991 -171.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -101.0 141.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.778 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 138.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 161.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -94.42 157.48 15.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.4 2.28 . . . . 0.0 108.476 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.18 157.02 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.527 1.058 . . . . 0.0 109.481 159.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 114.5 18.71 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.2 m -79.78 166.41 21.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 163.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -92.29 142.81 26.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.56 -35.73 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.427 2.752 . . . . 0.0 112.7 -172.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -54.14 -36.66 63.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.99 0.516 . . . . 0.0 111.709 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.2 p -75.41 -43.33 50.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -62.31 -30.9 71.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.373 1.469 . . . . 0.0 112.207 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -66.38 -8.48 25.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.133 0.973 . . . . 0.0 113.086 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -129.01 -174.6 3.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.495 1.918 . . . . 0.0 108.099 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -90.06 55.98 3.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -122.15 98.76 6.08 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.117 0.567 . . . . 0.0 109.785 -174.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--O 1.233 0.233 0 C-N-CA 123.553 0.741 . . . . 0.0 109.711 -172.102 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.628 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.99 -146.43 20.99 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.709 1.623 . . . . 0.0 110.154 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -58.49 150.28 56.51 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.068 0.947 . . . . 0.0 111.471 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.6 158.26 51.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.491 2.127 . . . . 0.0 109.853 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 p -139.28 -168.61 2.49 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -86.05 -2.64 58.5 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.95 -1.093 . . . . 0.0 112.704 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -83.3 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 121.127 1.785 . . . . 0.0 109.105 175.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.86 129.6 26.24 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.227 2.211 . . . . 0.0 105.942 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -100.74 131.86 46.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mp -129.8 154.42 47.26 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.737 1.615 . . . . 0.0 109.039 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.1 mtm -136.29 161.57 35.41 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.07 21.99 1.86 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.624 1.97 . . . . 0.0 111.545 172.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -85.22 0.06 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 163.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.55 170.66 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 127.08 2.152 . . . . 0.0 110.748 -166.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.28 160.2 35.16 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.094 0.958 . . . . 0.0 109.79 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -0.24 5.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.363 2.042 . . . . 0.0 113.037 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.96 19.4 3.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.056 2.143 . . . . 0.0 112.797 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.23 -9.33 7.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.948 0.794 . . . . 0.0 112.556 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.7 mt -79.62 28.55 0.26 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.21 1.404 . . . . 0.0 111.774 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -100.0 -38.13 8.71 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.835 -1.166 . . . . 0.0 111.282 -170.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 127.04 31.27 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.976 0.91 . . . . 0.0 109.979 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.07 -30.95 58.54 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.956 1.303 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -92.47 16.09 12.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.068 1.347 . . . . 0.0 111.872 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -125.48 -50.24 1.64 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.488 1.515 . . . . 0.0 107.413 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -45.05 -50.29 10.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.059 1.344 . . . . 0.0 112.39 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.61 -27.57 61.35 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -66.42 -46.44 76.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.806 0.843 . . . . 0.0 108.848 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.2 mt -61.16 -28.86 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.739 1.216 . . . . 0.0 111.405 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.04 -47.33 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 120.641 -1.287 . . . . 0.0 109.3 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.51 -30.92 57.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.198 0.999 . . . . 0.0 111.569 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.5 -46.45 86.66 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.849 1.66 . . . . 0.0 110.503 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.5 t -77.94 -28.64 15.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -59.42 -48.69 80.67 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.54 -44.92 95.15 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.091 0.244 . . . . 0.0 110.772 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.75 -43.49 75.74 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.878 -0.514 . . . . 0.0 111.618 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 t -85.24 -21.92 28.87 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.941 -168.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.9 m -60.08 -8.49 2.42 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.858 -1.151 . . . . 0.0 113.025 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -67.84 -7.58 29.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 119.527 -1.983 . . . . 0.0 113.64 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -124.73 -0.26 8.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.53 1.132 . . . . 0.0 112.623 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.3 -137.96 5.63 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 106.914 -2.475 . . . . 0.0 106.914 -170.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.47 115.31 10.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.35 107.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 108.366 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -55.97 -60.76 3.01 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.396 2.278 . . . . 0.0 108.618 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 p -158.84 175.46 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.541 0.61 . . . . 0.0 110.881 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.14 150.21 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.334 1.453 . . . . 0.0 107.779 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.99 109.18 8.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.027 1.331 . . . . 0.0 110.987 -169.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 86.46 58.67 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 127.363 2.265 . . . . 0.0 107.372 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.9 133.27 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.946 2.431 . . . . 0.0 109.232 172.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 159.71 32.66 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 124.082 0.953 . . . . 0.0 111.535 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.4 170.09 7.18 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.742 2.962 . . . . 0.0 109.926 164.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.82 91.87 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 t0 56.1 35.47 25.7 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.094 0.958 . . . . 0.0 113.033 172.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.54 -27.42 13.65 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.213 2.339 . . . . 0.0 112.095 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.82 137.63 22.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 118.791 1.296 . . . . 0.0 109.12 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.73 148.21 36.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.798 0.808 . . . . 0.0 110.591 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.9 156.71 47.8 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 126.057 1.743 . . . . 0.0 110.144 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -63.81 138.16 62.03 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.717 1.611 . . . . 0.0 108.271 168.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.4 9.98 86.52 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.765 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.3 t -67.17 154.42 41.3 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.837 0.818 . . . . 0.0 110.614 170.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.02 -5.24 80.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 125.527 1.537 . . . . 0.0 114.058 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.2 173.02 9.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.941 1.371 . . . . 0.0 107.987 170.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 mt -131.35 145.96 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 150.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -115.46 144.72 43.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 164.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -118.96 154.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.02 136.92 47.61 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -107.86 -177.95 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.02 1.328 . . . . 0.0 109.784 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 t -112.15 7.05 19.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 110.145 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.0 p -155.97 143.42 19.34 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 120.869 -1.144 . . . . 0.0 108.368 161.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -51.39 -44.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.952 1.301 . . . . 0.0 109.207 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -71.6 -26.04 62.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.351 -167.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -76.42 -42.66 43.43 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 12.9 t -59.74 -41.01 89.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.723 0.409 . . . . 0.0 110.556 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -56.06 -27.13 52.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 113.0 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -79.88 -47.86 14.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.727 1.149 . . . . 0.0 109.456 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.86 75.97 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.682 0.793 . . . . 0.0 110.532 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -55.77 -43.51 76.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.287 0.635 . . . . 0.0 111.329 -169.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -77.41 -48.29 17.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.79 0.836 . . . . 0.0 109.461 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -19.41 63.97 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.64 1.115 . . . . 0.0 113.073 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.1 mt -124.11 14.86 9.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.798 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.4 m -60.83 118.26 6.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.48 24.23 59.16 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 120.891 -1.131 . . . . 0.0 113.45 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.49 -179.34 5.74 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.288 0.544 . . . . 0.0 110.557 154.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -129.48 99.3 5.13 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 125.164 1.386 . . . . 0.0 107.328 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -88.68 15.02 8.81 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.469 0.577 . . . . 0.0 110.639 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.23 -85.23 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.933 2.093 . . . . 0.0 106.174 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.26 -20.21 0.63 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.56 1.144 . . . . 0.0 111.983 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -90.21 -167.88 1.96 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.81 166.3 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.177 -0.952 . . . . 0.0 108.572 165.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.7 t -124.68 118.03 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 p -93.04 149.9 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -117.89 168.7 10.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.692 1.197 . . . . 0.0 109.034 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.77 156.41 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.887 2.075 . . . . 0.0 106.908 -177.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -77.71 160.72 28.25 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 162.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.43 -168.47 2.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.397 0.999 . . . . 0.0 109.063 168.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.59 144.22 34.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -93.59 -20.46 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.132 1.888 . . . . 0.0 110.833 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -40.44 80.59 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.07 0.462 . . . . 0.0 110.446 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.56 -33.26 60.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.105 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -61.6 -50.27 73.27 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.499 1.52 . . . . 0.0 111.411 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.64 -14.63 63.14 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -106.11 -169.73 1.62 Allowed 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 127.544 2.337 . . . . 0.0 107.276 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -114.18 69.68 0.71 Allowed 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.31 27.02 9.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 109.812 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -74.53 154.09 38.8 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.683 0.793 . . . . 0.0 109.543 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.0 t90 . . . . . 0 C--O 1.248 0.982 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 178.123 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.441 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.61 177.77 34.01 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -67.72 152.14 96.56 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.145 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.04 126.88 16.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.401 1.401 . . . . 0.0 108.676 165.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.1 p -100.11 179.02 4.61 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.889 1.676 . . . . 0.0 108.705 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.54 8.72 13.23 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.007 0.923 . . . . 0.0 110.658 174.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.99 163.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 O-C-N 120.896 -1.127 . . . . 0.0 111.395 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -141.71 124.19 15.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -168.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.23 135.02 33.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.7 mt -128.73 131.2 47.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.5 1.52 . . . . 0.0 107.232 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mtm -125.46 163.77 21.93 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.448 -0.782 . . . . 0.0 110.177 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 74.97 16.22 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.81 2.844 . . . . 0.0 112.677 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -52.9 11.93 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.251 -0.906 . . . . 0.0 108.916 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.88 174.34 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 128.317 2.647 . . . . 0.0 108.891 -162.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.72 150.24 52.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.102 0.961 . . . . 0.0 109.319 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.62 -14.7 40.07 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.859 2.373 . . . . 0.0 113.647 -172.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -116.56 13.18 15.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.682 1.993 . . . . 0.0 110.333 -170.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -139.69 22.62 2.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.792 2.037 . . . . 0.0 109.637 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.01 65.43 0.66 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.066 2.146 . . . . 0.0 107.057 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.3 mt -135.06 -41.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -160.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.07 151.25 31.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.6 0.76 . . . . 0.0 110.149 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -95.96 -5.55 41.05 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.623 0.769 . . . . 0.0 110.675 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -113.57 -43.41 3.32 Favored 'General case' 0 C--N 1.337 0.047 0 C-N-CA 124.42 1.088 . . . . 0.0 113.049 -167.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -80.62 -37.19 31.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.734 1.214 . . . . 0.0 109.398 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.7 -35.75 61.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.218 1.007 . . . . 0.0 110.677 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.74 -37.22 70.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.491 -0.756 . . . . 0.0 111.62 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -62.32 -45.92 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.014 . . . . 0.0 109.204 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.55 -20.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.617 0.767 . . . . 0.0 111.371 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.11 -44.71 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.954 -1.092 . . . . 0.0 109.316 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.4 -35.77 63.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.908 0.776 . . . . 0.0 112.338 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.46 -51.22 60.4 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.391 1.876 . . . . 0.0 109.768 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.6 t -75.36 -29.13 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.224 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -65.54 -36.26 83.27 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.605 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.64 -40.69 40.98 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.655 0.661 . . . . 0.0 112.243 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -50.11 69.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.983 -1.073 . . . . 0.0 109.899 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.05 -25.76 61.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -167.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.91 -22.96 4.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.396 1.078 . . . . 0.0 112.969 169.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -76.24 -13.06 60.18 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.625 -1.297 . . . . 0.0 112.626 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.414 ' CE1' HD23 ' A' ' 79' ' ' LEU . 87.9 m-85 -116.98 -16.52 10.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.576 1.08 . . . . 0.0 112.898 -173.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.46 -138.75 3.24 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -140.33 123.0 16.29 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -87.04 116.32 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -66.24 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.731 1.613 . . . . 0.0 107.84 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -154.14 169.44 23.57 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.774 1.229 . . . . 0.0 110.239 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 mt -130.2 141.97 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.266 1.826 . . . . 0.0 106.179 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -126.11 120.18 29.5 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.538 1.135 . . . . 0.0 110.58 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.37 85.75 17.7 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.46 123.16 11.61 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.351 2.034 . . . . 0.0 108.257 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.99 154.07 37.5 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 123.652 0.781 . . . . 0.0 110.093 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -54.32 155.7 15.5 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.273 2.649 . . . . 0.0 111.025 167.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.86 167.32 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 128.361 2.664 . . . . 0.0 107.882 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.36 80.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.724 2.409 . . . . 0.0 109.199 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.14 -0.63 64.21 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-O 117.978 -1.457 . . . . 0.0 113.387 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.69 135.7 62.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 120.314 2.057 . . . . 0.0 108.143 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -67.45 176.9 2.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.229 1.014 . . . . 0.0 110.084 164.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.04 151.07 54.67 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 125.93 1.692 . . . . 0.0 107.443 168.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -67.85 138.08 43.53 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 N-CA-C 108.025 -1.567 . . . . 0.0 108.025 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.71 36.56 92.48 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.3 t -74.15 163.54 27.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.189 0.518 . . . . 0.0 110.166 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -39.03 2.72 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.192 1.377 . . . . 0.0 111.594 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 168.52 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.541 1.671 . . . . 0.0 109.709 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -131.86 152.48 36.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.56 157.94 28.39 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p -139.02 161.05 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -133.19 144.9 50.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.822 1.649 . . . . 0.0 107.441 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.75 -179.16 3.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.895 1.678 . . . . 0.0 111.035 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.11 -21.47 27.61 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.854 172.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -139.83 -179.09 5.74 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.482 1.492 . . . . 0.0 110.561 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.31 -35.14 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 158.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -76.49 -28.93 56.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.574 -1.329 . . . . 0.0 113.51 -166.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -76.49 -38.89 54.57 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.375 1.07 . . . . 0.0 109.169 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.9 t -57.1 -47.6 80.67 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.56 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -56.94 -26.89 60.4 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.449 1.499 . . . . 0.0 113.179 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -76.91 -48.13 19.08 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.17 88.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 117.155 -1.403 . . . . 0.0 111.743 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -63.89 0.89 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.719 1.145 . . . . 0.0 110.659 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -81.97 -21.13 37.33 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.529 0.732 . . . . 0.0 112.021 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.74 89.43 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 39' ' ' TYR . 96.4 mt -115.01 -1.46 13.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -160.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.6 m -47.64 116.07 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.024 -1.047 . . . . 0.0 109.507 164.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.54 5.7 63.07 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.626 0.648 . . . . 0.0 114.412 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -177.85 1.26 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.853 1.327 . . . . 0.0 111.42 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -126.9 133.2 50.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.435 1.494 . . . . 0.0 107.054 163.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -108.15 15.08 24.52 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.155 0.982 . . . . 0.0 110.937 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.11 -73.31 0.06 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -150.89 -13.28 0.22 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -98.46 164.19 12.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.155 0.889 . . . . 0.0 110.017 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.41 135.99 26.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.93 139.8 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.209 1.403 . . . . 0.0 111.058 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.264 3.1 p -110.93 115.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 170.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -78.2 143.72 36.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.09 167.68 21.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.64 1.976 . . . . 0.0 106.09 162.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -71.82 164.45 25.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.91 0.777 . . . . 0.0 109.68 163.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 -164.47 1.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.469 1.108 . . . . 0.0 108.524 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -114.38 143.42 29.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.22 -25.86 5.53 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.123 2.548 . . . . 0.0 111.169 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -54.29 -59.34 4.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.036 0.922 . . . . 0.0 109.842 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -20.12 62.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.856 2.062 . . . . 0.0 110.898 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -73.14 -46.87 48.47 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 127.488 2.315 . . . . 0.0 111.006 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -60.36 -35.89 76.74 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 -97.56 -166.77 1.43 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 109.605 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -122.08 54.72 1.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.501 1.52 . . . . 0.0 107.738 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.98 38.81 3.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.713 1.244 . . . . 0.0 109.001 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -60.82 142.53 56.01 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.595 1.958 . . . . 0.0 108.822 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.9 -100.75 1.37 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -141.12 158.4 64.6 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.492 1.517 . . . . 0.0 109.066 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -66.31 133.0 31.16 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.959 2.439 . . . . 0.0 108.223 168.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.8 p -137.29 169.21 18.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.537 1.935 . . . . 0.0 106.772 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -75.39 -10.86 59.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.369 0.532 . . . . 0.0 111.798 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.87 106.78 19.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 125.469 1.508 . . . . 0.0 110.006 -170.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -91.53 113.09 25.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -85.01 134.05 34.23 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.5 139.85 52.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.276 1.031 . . . . 0.0 109.52 -173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.5 mtm -125.18 161.13 27.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.896 0.878 . . . . 0.0 109.241 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 60.87 30.68 19.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.577 2.351 . . . . 0.0 112.911 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -79.66 0.11 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 164.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.47 171.02 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 125.12 1.368 . . . . 0.0 109.791 -165.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.91 159.4 40.99 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 124.096 0.958 . . . . 0.0 109.445 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.69 4.87 2.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.574 2.183 . . . . 0.0 113.584 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -128.24 14.55 6.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.555 1.942 . . . . 0.0 113.415 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -132.45 -4.21 3.36 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.45 -0.781 . . . . 0.0 111.357 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -98.63 51.59 0.99 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.443 1.497 . . . . 0.0 109.885 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.41 -54.85 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.38 100.54 0.06 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.984 2.114 . . . . 0.0 109.952 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.28 -7.34 58.58 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.941 0.896 . . . . 0.0 113.088 -165.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -76.51 -59.64 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.983 1.713 . . . . 0.0 107.961 166.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.95 -34.33 77.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.668 0.787 . . . . 0.0 111.982 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -44.99 -45.56 10.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.931 1.292 . . . . 0.0 111.514 168.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.85 -23.0 42.26 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 121.573 -0.704 . . . . 0.0 112.078 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -71.42 -50.15 34.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 124.189 0.93 . . . . 0.0 109.162 169.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.31 -40.66 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.148 0.979 . . . . 0.0 111.147 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.0 t -57.87 -40.35 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.879 0.763 . . . . 0.0 109.951 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.56 -40.74 33.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.873 0.306 . . . . 0.0 111.032 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.72 -33.62 76.03 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.08 -36.68 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 O-C-N 121.545 -0.722 . . . . 0.0 109.414 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -58.28 -38.27 76.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 117.134 -1.413 . . . . 0.0 109.627 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.09 -33.37 73.24 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.588 1.54 . . . . 0.0 112.107 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -41.44 63.43 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 120.964 -1.085 . . . . 0.0 110.975 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.265 0.8 OUTLIER -81.22 -27.97 35.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.04 -3.91 32.24 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.659 1.118 . . . . 0.0 112.259 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -56.81 -18.43 12.85 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.3 -1.5 . . . . 0.0 113.725 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -119.75 1.26 11.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.043 1.337 . . . . 0.0 113.003 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.13 -145.13 10.21 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -122.49 112.53 18.15 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 118.747 1.274 . . . . 0.0 110.023 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.81 108.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -68.71 -53.48 21.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.846 0.858 . . . . 0.0 109.884 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -161.51 163.68 30.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -135.71 108.71 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.77 119.16 31.35 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 125.91 1.684 . . . . 0.0 109.106 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mt -133.49 85.69 42.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.29 1.836 . . . . 0.0 107.838 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.72 136.4 53.5 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.682 1.588 . . . . 0.0 109.161 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -98.08 165.2 15.78 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.512 1.125 . . . . 0.0 109.616 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.37 170.96 10.0 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.56 2.173 . . . . 0.0 109.903 166.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.97 100.63 10.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t0 59.91 27.47 16.84 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.3 -15.08 36.14 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 127.188 2.328 . . . . 0.0 113.508 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -86.13 142.95 12.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.513 1.125 . . . . 0.0 110.063 -169.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -74.69 140.82 44.45 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.989 0.915 . . . . 0.0 110.044 172.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.93 153.46 78.63 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 123.651 0.78 . . . . 0.0 112.045 -175.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.56 117.32 4.64 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.225 2.617 . . . . 0.0 108.256 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.28 -15.15 15.55 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 126.735 2.112 . . . . 0.0 112.256 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.5 t -76.45 148.47 37.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.068 0.934 . . . . 0.0 111.184 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.52 -16.0 51.73 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.124 1.821 . . . . 0.0 112.622 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -92.56 157.12 16.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.761 1.781 . . . . 0.0 108.583 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.0 149.4 33.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 164.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -129.32 114.31 16.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.82 111.63 32.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 148.49 29.2 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.232 1.813 . . . . 0.0 106.362 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -129.87 179.57 5.78 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.87 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -90.07 -13.3 36.17 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -164.55 155.8 15.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.553 1.069 . . . . 0.0 110.007 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.36 -23.42 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.558 0.743 . . . . 0.0 109.142 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -84.41 -18.03 37.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.5 -1.375 . . . . 0.0 113.224 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -76.52 -45.97 28.55 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.5 p -71.51 -36.43 71.07 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.665 -0.647 . . . . 0.0 110.714 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -47.3 -36.2 8.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.928 2.091 . . . . 0.0 112.856 168.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -79.11 -48.72 13.8 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.21 73.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.67 1.188 . . . . 0.0 111.266 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.1 ttm -48.73 -70.54 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.628 1.571 . . . . 0.0 110.336 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.76 -33.29 73.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.543 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.9 -15.85 69.69 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.516 1.055 . . . . 0.0 114.027 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.54 9.05 5.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.114 1.457 . . . . 0.0 112.687 -171.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.8 m -63.77 102.11 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.16 -0.962 . . . . 0.0 110.181 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.17 1.88 51.29 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.13 1.348 . . . . 0.0 113.14 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -178.64 0.2 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.386 1.593 . . . . 0.0 111.503 173.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.35 140.08 53.29 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -117.84 13.76 14.14 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.644 0.735 . . . . 0.0 109.854 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.34 -70.77 0.08 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.52 2.328 . . . . 0.0 107.661 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -162.42 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.64 1.176 . . . . 0.0 111.821 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -78.18 175.26 10.34 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.489 1.04 . . . . 0.0 109.456 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.43 165.63 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.57 125.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.0 t -105.84 129.51 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 167.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.0 p -99.2 146.86 25.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.609 1.164 . . . . 0.0 108.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -141.52 161.22 38.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.411 1.485 . . . . 0.0 107.334 160.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -69.36 157.49 36.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 158.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -176.68 2.95 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.523 1.529 . . . . 0.0 107.417 165.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -99.1 144.98 29.22 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.41 -24.17 6.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.823 2.349 . . . . 0.0 112.925 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.47 -46.93 73.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.19 0.905 . . . . 0.0 110.725 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 p -75.71 2.94 10.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.452 1.101 . . . . 0.0 111.925 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -93.16 -48.92 6.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.551 1.141 . . . . 0.0 108.932 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -60.27 -30.41 69.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.771 0.428 . . . . 0.0 111.256 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -104.63 163.46 12.46 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.524 1.13 . . . . 0.0 109.87 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 ttm-85 -73.23 21.89 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.276 2.23 . . . . 0.0 112.794 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -88.81 64.09 7.11 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.75 -1.219 . . . . 0.0 111.133 -158.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 4.4 m-85 -95.35 166.92 11.65 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.081 0.553 . . . . 0.0 109.625 -169.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.1 t90 . . . . . 0 C--O 1.246 0.878 0 C-N-CA 126.206 1.803 . . . . 0.0 109.291 -179.593 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.48 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -167.84 -168.68 30.33 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -173.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -55.78 151.33 23.47 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.966 1.306 . . . . 0.0 111.799 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.0 142.97 48.26 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.897 2.398 . . . . 0.0 108.868 166.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 p -121.33 -179.28 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.587 1.955 . . . . 0.0 107.983 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -82.74 9.68 9.19 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.92 157.4 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 121.083 1.765 . . . . 0.0 110.332 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tp -133.4 170.72 15.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.931 0.872 . . . . 0.0 109.268 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.86 140.4 31.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.911 1.284 . . . . 0.0 109.362 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.29 122.9 27.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.593 1.557 . . . . 0.0 107.646 -167.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.1 mtm -103.94 165.98 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.213 0.605 . . . . 0.0 110.632 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 75.22 7.36 4.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 129.334 3.054 . . . . 0.0 115.12 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -65.16 0.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.148 1.34 . . . . 0.0 109.305 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.21 144.46 35.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.784 1.634 . . . . 0.0 109.077 -158.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.45 163.78 32.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 126.197 1.799 . . . . 0.0 110.762 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.84 -1.03 7.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.08 2.52 . . . . 0.0 114.606 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.83 -0.57 3.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.565 1.146 . . . . 0.0 112.598 -163.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -115.08 -12.26 11.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.636 0.774 . . . . 0.0 112.784 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.06 47.97 0.38 Allowed 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.455 1.902 . . . . 0.0 112.396 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.73 -13.6 2.88 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -165.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.94 179.42 1.48 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.664 1.12 . . . . 0.0 109.59 159.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -122.89 -4.09 8.61 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.129 -0.982 . . . . 0.0 111.382 165.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -90.19 -72.79 0.55 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.793 2.037 . . . . 0.0 108.928 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -57.52 -33.37 68.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.561 1.944 . . . . 0.0 110.607 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -47.46 -46.97 27.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.364 1.466 . . . . 0.0 112.138 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -75.74 -34.11 60.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -60.3 -44.36 95.48 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.96 -34.81 70.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -61.02 -54.27 37.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 O-C-N 120.749 -1.219 . . . . 0.0 108.753 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -70.87 -33.2 70.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.932 0.787 . . . . 0.0 112.031 -169.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.93 -35.32 79.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.239 1.019 . . . . 0.0 111.93 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.38 -25.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 108.966 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -69.18 -21.63 63.96 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.941 -1.099 . . . . 0.0 111.723 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.25 -62.24 1.52 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.849 1.204 . . . . 0.0 108.11 159.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.08 -40.29 93.14 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -158.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -77.66 -28.65 51.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.0 t -65.86 -12.95 58.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.414 1.085 . . . . 0.0 111.473 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.57 -12.38 52.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 119.644 -1.91 . . . . 0.0 111.693 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -112.13 -7.13 14.08 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.073 1.349 . . . . 0.0 113.732 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.48 -167.3 31.4 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.52 104.1 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.987 0.898 . . . . 0.0 109.874 -175.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.28 106.49 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 125.406 1.482 . . . . 0.0 107.052 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -66.51 -67.57 0.44 Allowed 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 166.63 32.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.34 0.656 . . . . 0.0 111.341 -168.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -138.98 145.36 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 126.217 1.807 . . . . 0.0 108.85 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -132.84 121.97 23.72 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.93 1.292 . . . . 0.0 109.433 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.9 mt -127.85 86.1 59.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.89 2.076 . . . . 0.0 107.414 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.63 148.8 86.04 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.721 1.614 . . . . 0.0 109.861 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.07 152.57 46.76 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.862 0.865 . . . . 0.0 110.116 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -65.58 169.95 11.95 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 111.243 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 t -130.0 118.15 43.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 t70 57.5 24.9 10.82 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.332 1.853 . . . . 0.0 115.075 174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.59 -8.78 74.33 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.217 1.389 . . . . 0.0 112.751 -174.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.7 t -93.64 138.96 19.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 126.228 1.811 . . . . 0.0 109.243 -172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -59.38 152.77 20.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.297 1.839 . . . . 0.0 111.85 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.57 149.59 42.51 Favored Pre-proline 0 C--N 1.326 -0.418 0 C-N-CA 126.664 1.986 . . . . 0.0 111.772 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -66.55 102.1 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 N-CA-C 106.706 -2.075 . . . . 0.0 106.706 164.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.54 -11.03 11.32 Favored Glycine 0 C--O 1.229 -0.205 0 C-N-CA 125.733 1.635 . . . . 0.0 111.451 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.4 144.88 51.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.995 0.897 . . . . 0.0 109.806 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.18 -35.85 4.6 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 127.456 2.455 . . . . 0.0 110.512 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -85.4 167.88 15.12 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.185 -1.185 . . . . 0.0 110.389 -172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 mt -136.32 128.17 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -99.59 155.17 17.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -144.71 145.15 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -121.91 146.86 46.71 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.887 1.275 . . . . 0.0 108.901 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.07 167.03 16.51 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.492 1.117 . . . . 0.0 110.529 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.0 p -74.2 -18.1 60.8 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -159.62 159.28 32.94 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.906 1.23 . . . . 0.0 111.406 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.434 HG13 HE21 ' A' ' 73' ' ' GLN . 24.3 t -53.31 -38.97 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.923 1.289 . . . . 0.0 109.134 171.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -52.02 -52.49 50.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.297 1.039 . . . . 0.0 111.986 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.14 -43.92 81.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 10.7 t -58.11 -41.84 84.46 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.003 0.521 . . . . 0.0 111.005 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.434 HE21 HG13 ' A' ' 69' ' ' VAL . 26.2 mt-30 -62.86 -20.93 65.58 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.668 1.187 . . . . 0.0 112.734 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -90.42 -46.39 8.39 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.785 1.175 . . . . 0.0 108.664 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.32 -15.99 64.0 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.593 1.157 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.4 tpp -60.37 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.906 1.682 . . . . 0.0 108.226 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -70.76 -22.71 62.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.718 -164.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.35 -27.9 71.46 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.574 0.624 . . . . 0.0 112.426 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.1 mt -113.56 -4.1 13.56 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.06 1.344 . . . . 0.0 111.732 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.0 m -57.37 106.63 0.35 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.935 -1.103 . . . . 0.0 109.025 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.69 -0.17 59.38 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.182 -0.788 . . . . 0.0 113.884 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -63.67 178.76 0.55 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.944 1.372 . . . . 0.0 110.665 167.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -133.96 84.47 2.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.373 1.469 . . . . 0.0 107.469 -167.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -78.1 37.73 0.26 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.492 1.117 . . . . 0.0 109.54 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 174.51 -69.32 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 1 C-N-CA 132.738 4.415 . . . . 0.0 105.895 167.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.14 -29.54 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.294 1.838 . . . . 0.0 111.456 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -89.52 162.63 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.942 -1.099 . . . . 0.0 109.78 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.37 139.9 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.69 133.73 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.9 122.86 65.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -85.6 155.54 21.1 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 129.182 2.993 . . . . 0.0 109.278 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -153.13 138.62 17.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.662 1.985 . . . . 0.0 108.541 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -67.22 127.53 32.99 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 162.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.67 169.7 9.51 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.823 1.249 . . . . 0.0 108.435 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -92.13 143.65 27.89 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.64 -27.51 6.1 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.507 2.804 . . . . 0.0 111.918 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -57.18 13.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.634 1.107 . . . . 0.0 111.194 -170.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 m -65.98 -33.47 75.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.187 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -65.68 -30.74 71.47 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.482 1.113 . . . . 0.0 112.588 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -64.78 -2.8 2.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.081 0.953 . . . . 0.0 112.673 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -138.46 179.49 6.43 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.974 2.11 . . . . 0.0 108.711 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.0 21.31 0.71 Allowed 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.195 -0.94 . . . . 0.0 112.324 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.73 45.41 1.07 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.44 -1.412 . . . . 0.0 112.68 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -79.1 134.27 36.74 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.302 1.441 . . . . 0.0 107.429 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.51 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.97 178.6 36.01 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -66.66 156.49 86.34 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.506 1.122 . . . . 0.0 109.53 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.65 141.13 49.1 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.054 1.836 . . . . 0.0 108.666 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -123.48 172.97 8.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.53 1.132 . . . . 0.0 110.261 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.48 -9.11 55.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.356 0.662 . . . . 0.0 112.165 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.6 m -102.16 -176.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 120.02 1.282 . . . . 0.0 111.658 -172.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 tp -145.48 155.27 43.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.122 1.369 . . . . 0.0 109.199 161.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.41 143.13 48.69 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.505 1.122 . . . . 0.0 109.645 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.25 152.8 49.28 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.604 1.962 . . . . 0.0 109.694 -170.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 39.7 mtm -132.56 165.12 25.11 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.751 1.22 . . . . 0.0 110.238 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 75.44 -8.59 1.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 130.085 3.354 . . . . 0.0 114.571 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.0 tpp -71.17 -36.9 72.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.743 1.156 . . . . 0.0 112.472 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.06 152.62 36.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 0.0 109.855 -170.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -110.12 156.13 40.61 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.49 -1.06 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.06 2.507 . . . . 0.0 113.023 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -116.61 4.52 13.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.05 1.74 . . . . 0.0 111.817 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -133.81 33.88 3.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.358 1.463 . . . . 0.0 110.817 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt -131.75 58.75 1.72 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.426 1.89 . . . . 0.0 108.57 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.25 -45.32 1.98 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.238 1.415 . . . . 0.0 110.029 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.71 105.74 7.95 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.02 -32.43 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.914 1.686 . . . . 0.0 111.778 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.33 -63.21 1.11 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.501 0.72 . . . . 0.0 109.56 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -53.83 -42.81 68.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.221 1.008 . . . . 0.0 110.143 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -53.25 -40.51 64.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.98 1.312 . . . . 0.0 111.617 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -81.98 -38.4 25.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.866 1.212 . . . . 0.0 111.029 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -59.55 -51.1 71.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -54.72 -45.57 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.558 0.743 . . . . 0.0 109.426 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.92 -26.32 39.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 118.064 -0.969 . . . . 0.0 112.708 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.41 -28.41 23.58 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.673 1.124 . . . . 0.0 112.538 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.04 -41.53 64.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.118 0.961 . . . . 0.0 110.04 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.8 t -71.96 -28.25 29.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 125.027 1.331 . . . . 0.0 109.15 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -56.42 -57.42 12.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.55 -40.77 97.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.217 0.948 . . . . 0.0 110.079 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.5 -39.94 85.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.458 -169.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.83 -27.1 49.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.2 t -64.47 -21.66 66.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.829 0.852 . . . . 0.0 110.815 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -56.59 -21.66 28.42 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.118 -1.614 . . . . 0.0 111.976 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -110.53 2.46 18.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.928 1.691 . . . . 0.0 112.224 -175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.59 -156.14 26.91 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 120.164 1.347 . . . . 0.0 112.258 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -112.2 110.08 20.14 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.09 113.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.51 -61.03 2.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.874 1.27 . . . . 0.0 109.243 167.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 175.46 12.01 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.314 -0.866 . . . . 0.0 110.903 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.4 mt -138.89 145.11 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.31 125.1 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.167 1.787 . . . . 0.0 109.541 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.6 mt -138.46 82.42 22.75 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.71 138.88 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.084 1.856 . . . . 0.0 109.752 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -90.81 155.75 45.16 Favored Pre-proline 0 N--CA 1.474 0.735 0 O-C-N 120.485 -1.384 . . . . 0.0 111.877 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.16 172.33 3.26 Favored 'Trans proline' 0 C--N 1.352 0.746 1 C-N-CA 126.094 4.529 . . . . 0.0 112.648 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.9 t -128.25 98.08 4.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 t70 52.28 53.7 11.97 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.905 1.682 . . . . 0.0 112.11 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.89 -10.66 59.61 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.288 -1.285 . . . . 0.0 113.356 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 t -96.24 142.36 13.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 119.801 1.801 . . . . 0.0 109.543 -172.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.91 150.91 27.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.386 -1.734 . . . . 0.0 111.249 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.41 ' H ' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -114.75 155.54 46.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 124.908 1.283 . . . . 0.0 111.381 173.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.17 99.5 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.353 2.035 . . . . 0.0 107.707 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.32 16.74 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.438 1.971 . . . . 0.0 112.758 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.41 ' HB2' ' H ' ' A' ' 56' ' ' VAL . 17.8 t -71.99 132.54 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.687 1.243 . . . . 0.0 109.352 -170.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.44 1.51 80.97 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.734 1.635 . . . . 0.0 113.815 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -108.72 161.08 15.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -126.63 148.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.09 142.75 50.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.64 150.95 30.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 23.6 tt0 -129.08 142.49 50.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.09 169.84 8.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.114 1.766 . . . . 0.0 108.441 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 t -98.97 8.4 45.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.957 0.903 . . . . 0.0 110.419 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.1 p -155.5 147.98 23.94 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 120.261 -1.525 . . . . 0.0 111.393 156.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.446 ' CG1' HE21 ' A' ' 73' ' ' GLN . 1.9 t -49.73 -41.3 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.121 0.968 . . . . 0.0 109.032 163.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -62.92 -22.8 67.02 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.446 1.498 . . . . 0.0 114.187 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -101.34 -37.04 8.66 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -31.78 73.03 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.294 -0.879 . . . . 0.0 111.012 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.446 HE21 ' CG1' ' A' ' 69' ' ' VAL . 35.3 mt-30 -58.72 -20.35 48.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.08 1.752 . . . . 0.0 112.987 170.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -88.26 -51.84 5.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.63 1.105 . . . . 0.0 108.613 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.5 -43.52 65.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.131 0.973 . . . . 0.0 111.118 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.0 tpp -44.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.423 2.289 . . . . 0.0 110.404 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.7 -18.62 56.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.31 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.9 -25.2 72.27 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.264 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.9 mt -115.63 4.36 14.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 -173.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.1 m -55.13 107.58 0.32 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.791 1.237 . . . . 0.0 109.899 168.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.0 8.2 72.77 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.765 -0.584 . . . . 0.0 113.935 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -72.69 -174.8 1.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.901 1.351 . . . . 0.0 111.281 169.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -134.02 98.41 4.13 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.641 0.776 . . . . 0.0 109.984 -170.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -83.1 19.49 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.721 2.008 . . . . 0.0 112.534 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.2 -85.49 0.0 OUTLIER 'General case' 0 C--O 1.231 0.126 0 C-N-CA 129.469 3.107 . . . . 0.0 104.46 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.3 -24.63 2.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.021 0.928 . . . . 0.0 110.96 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 87' ' ' ARG . 18.8 mtp85 -93.12 173.59 7.65 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.736 0.698 . . . . 0.0 110.287 -166.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.93 165.5 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 71.6 t -132.84 145.39 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.49 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.4 117.23 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 168.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 154.23 27.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.476 2.31 . . . . 0.0 110.007 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.92 150.43 28.35 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.157 2.983 . . . . 0.0 106.27 173.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -69.09 160.19 31.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.638 1.108 . . . . 0.0 108.891 160.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.39 -164.47 1.3 Allowed 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.773 1.229 . . . . 0.0 109.459 168.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.85 143.88 28.47 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.08 -32.88 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.367 2.712 . . . . 0.0 110.449 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -57.33 -54.31 48.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.1 m -66.89 -29.47 69.38 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.85 1.26 . . . . 0.0 110.794 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -64.05 -40.48 96.38 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.843 1.657 . . . . 0.0 111.09 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -70.97 -9.75 58.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.264 1.026 . . . . 0.0 112.349 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 20.8 mtp85 -106.45 -168.8 1.47 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.33 1.452 . . . . 0.0 109.482 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.3 tpt180 -108.82 73.12 0.85 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.68 92.44 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 2.8 m-85 -133.78 152.59 51.92 Favored 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -170.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.443 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.72 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.0 -78.29 1.24 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 172.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -137.85 160.89 62.88 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.605 1.562 . . . . 0.0 109.209 -169.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.15 146.49 41.03 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.608 2.872 . . . . 0.0 109.61 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -131.7 170.35 14.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -78.9 8.38 5.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -98.14 119.7 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.62 143.62 32.52 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -108.1 142.17 38.7 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt -138.59 128.37 25.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.843 1.257 . . . . 0.0 107.613 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -133.73 156.91 47.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.154 0.582 . . . . 0.0 109.764 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 65.34 72.01 0.43 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.125 2.17 . . . . 0.0 109.771 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.44 -77.14 0.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.472 1.509 . . . . 0.0 107.786 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.35 146.31 19.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.555 1.542 . . . . 0.0 109.371 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 17' ' ' GLU . 50.9 mt -109.78 151.57 42.41 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.752 0.821 . . . . 0.0 109.082 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.95 4.91 0.55 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.61 2.873 . . . . 0.0 113.515 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 15' ' ' LEU . 19.0 pt-20 -131.14 2.94 4.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.334 2.654 . . . . 0.0 112.093 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -127.17 -18.06 4.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.541 -0.725 . . . . 0.0 112.587 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.443 ' CG ' ' HD3' ' A' ' 50' ' ' PRO 0.254 0.2 OUTLIER -90.69 16.25 9.53 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.967 -1.083 . . . . 0.0 110.927 -162.482 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.43 -22.55 16.52 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.556 -1.34 . . . . 0.0 113.36 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.22 134.39 34.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -168.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.97 -18.82 64.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.443 0.697 . . . . 0.0 112.159 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.34 -68.81 0.6 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.122 1.769 . . . . 0.0 108.968 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -58.48 -36.21 73.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.573 1.549 . . . . 0.0 112.844 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -52.05 -47.89 64.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.281 1.432 . . . . 0.0 112.395 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.28 -38.93 71.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.7 0.8 . . . . 0.0 111.067 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -52.08 -48.34 64.74 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.632 1.173 . . . . 0.0 109.243 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.5 mt -63.97 -44.49 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.52 1.528 . . . . 0.0 109.899 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -58.57 -46.37 90.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -78.36 -31.48 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -170.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.22 -42.17 99.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 123.223 1.487 . . . . 0.0 109.414 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.66 -31.78 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.403 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -66.42 -24.36 66.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 120.962 -1.086 . . . . 0.0 111.395 175.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.58 -59.71 3.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 119.884 1.22 . . . . 0.0 108.309 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -62.3 -37.58 86.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -167.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.1 t -72.7 -25.89 61.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.571 0.749 . . . . 0.0 109.881 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -61.66 -23.33 66.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.54 1.136 . . . . 0.0 111.296 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -65.52 -10.75 37.45 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.454 -1.404 . . . . 0.0 112.95 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -123.47 4.11 9.03 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.856 1.263 . . . . 0.0 113.424 -170.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.11 -131.26 3.26 Favored Glycine 0 CA--C 1.504 -0.594 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.17 116.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.5 104.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.109 1.363 . . . . 0.0 108.693 166.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.06 -55.91 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.92 2.488 . . . . 0.0 110.337 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -148.37 163.43 37.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.399 1.479 . . . . 0.0 110.209 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mt -138.81 133.82 41.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.01 110.46 12.99 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.963 0.905 . . . . 0.0 109.58 -170.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.9 mt -128.16 86.62 57.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.668 1.587 . . . . 0.0 107.516 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.93 125.5 16.67 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.787 1.658 . . . . 0.0 108.232 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -90.6 151.36 43.91 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 0.0 110.117 -174.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' CG ' ' A' ' 19' ' ' LEU . 61.0 Cg_endo -68.6 138.62 42.27 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.83 1.687 . . . . 0.0 109.543 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.53 104.28 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 t0 52.06 39.55 26.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.537 1.535 . . . . 0.0 113.565 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.01 12.37 71.37 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.706 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.7 t -91.76 159.32 2.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 119.086 1.443 . . . . 0.0 108.772 170.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -66.24 148.78 51.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.389 1.09 . . . . 0.0 112.471 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.72 161.05 63.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.265 2.226 . . . . 0.0 110.219 170.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.96 127.7 19.12 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.648 2.899 . . . . 0.0 110.259 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.03 66.1 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 126.33 1.919 . . . . 0.0 111.583 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.14 147.95 44.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 122.042 -0.681 . . . . 0.0 109.454 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.71 65.17 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.035 1.778 . . . . 0.0 112.76 -171.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -108.42 160.81 15.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -129.36 129.97 67.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 162.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -99.83 130.66 46.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 171.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -124.73 145.76 31.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.87 139.1 51.59 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -118.71 168.02 11.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.413 1.102 . . . . 0.0 111.062 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -38.06 87.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.067 1.347 . . . . 0.0 113.273 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.5 m -160.42 156.82 26.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.596 1.089 . . . . 0.0 111.367 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.459 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 10.7 t -63.83 -28.73 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.467 1.107 . . . . 0.0 110.666 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -68.85 -24.88 64.41 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 120.724 -1.235 . . . . 0.0 112.49 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.91 -52.96 5.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.34 1.456 . . . . 0.0 108.012 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 69' ' ' VAL . 8.5 p -62.53 -29.96 70.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.144 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.66 -38.58 67.1 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.451 0.7 . . . . 0.0 112.273 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -73.65 -46.9 43.79 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.281 1.032 . . . . 0.0 108.602 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.04 -41.22 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.88 0.472 . . . . 0.0 111.556 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -66.48 0.38 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.173 1.789 . . . . 0.0 110.123 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -38.57 89.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.416 1.087 . . . . 0.0 110.508 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.13 -29.68 75.41 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 118.954 0.797 . . . . 0.0 112.332 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.56 -0.99 15.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.263 1.025 . . . . 0.0 111.436 -173.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -55.45 122.86 12.17 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 166.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.56 78.15 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.708 -1.051 . . . . 0.0 112.721 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -173.03 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.767 1.284 . . . . 0.0 109.051 162.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -129.47 120.36 25.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.714 1.606 . . . . 0.0 107.537 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -101.59 28.28 5.69 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.058 . . . . 0.0 109.196 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.97 -60.81 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.485 1.514 . . . . 0.0 108.842 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t30 177.46 -28.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 127.944 2.498 . . . . 0.0 109.037 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -103.03 167.37 9.88 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.319 0.648 . . . . 0.0 111.019 -173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.43 107.59 13.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.381 -160.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.5 t -66.84 108.6 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.872 0.869 . . . . 0.0 110.294 -174.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.73 123.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 163.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.98 142.15 27.82 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 126.289 1.835 . . . . 0.0 106.892 170.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -149.05 154.96 40.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.392 1.077 . . . . 0.0 109.373 168.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -74.34 158.21 34.38 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 169.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.84 -176.74 5.1 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.078 2.551 . . . . 0.0 108.646 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -128.52 143.7 49.31 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 119.069 0.85 . . . . 0.0 109.355 -171.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.56 -30.44 12.11 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.794 2.329 . . . . 0.0 112.357 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.83 -41.73 74.7 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.287 0.948 . . . . 0.0 110.451 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -43.77 88.76 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.33 0.652 . . . . 0.0 110.167 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -70.71 -35.81 72.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.764 1.626 . . . . 0.0 112.593 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -64.35 -10.63 25.62 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.537 1.135 . . . . 0.0 112.618 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -134.8 -164.79 1.57 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.444 1.898 . . . . 0.0 107.411 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -110.02 29.26 7.8 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.687 1.195 . . . . 0.0 110.87 -178.301 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -79.54 72.48 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.533 1.159 . . . . 0.0 109.884 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 22.0 m-30 -100.92 -5.26 26.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -165.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.34 1.456 . . . . 0.0 109.682 -177.677 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.501 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.31 -143.54 7.47 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -53.45 150.2 12.92 Favored Pre-proline 0 C--O 1.239 0.536 0 C-N-CA 123.526 0.73 . . . . 0.0 112.486 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.83 136.16 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 N-CA-C 107.619 -1.723 . . . . 0.0 107.619 165.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.4 p -104.81 168.06 9.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -88.31 16.81 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.637 -0.664 . . . . 0.0 112.418 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.54 150.65 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tp -122.52 162.46 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.481 1.113 . . . . 0.0 108.104 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -135.67 130.57 34.49 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.628 1.571 . . . . 0.0 108.866 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.47 132.12 46.86 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.601 1.16 . . . . 0.0 110.767 -164.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -120.15 162.91 18.53 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.142 0.977 . . . . 0.0 110.242 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 68.68 3.2 3.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.978 2.911 . . . . 0.0 114.222 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.6 ttm -72.59 -39.59 67.25 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 110.805 -170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.27 167.21 25.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 127.009 2.124 . . . . 0.0 109.129 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.85 153.95 55.0 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.894 0.878 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.78 0.79 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.536 2.157 . . . . 0.0 112.624 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.64 9.88 10.91 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.108 1.763 . . . . 0.0 111.684 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -137.42 26.57 2.86 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.48 1.112 . . . . 0.0 111.493 -169.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.83 37.15 4.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.629 1.172 . . . . 0.0 110.39 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -92.92 -59.6 2.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -68.52 112.14 5.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.841 1.256 . . . . 0.0 111.67 -170.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.52 -34.86 74.71 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.146 1.378 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.55 -64.15 0.99 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.126 1.37 . . . . 0.0 110.345 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -63.86 -37.17 86.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 0.0 110.828 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -54.37 -37.71 65.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.377 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.85 -32.44 52.05 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.381 0.672 . . . . 0.0 111.078 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.06 -54.32 35.93 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.923 1.289 . . . . 0.0 109.384 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.83 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 -171.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.16 -39.85 81.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 118.245 0.475 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -78.54 -33.3 47.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.638 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.86 -43.8 98.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.324 1.059 . . . . 0.0 109.749 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.9 t -68.1 -30.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.826 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -64.47 -35.18 80.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 116.63 -1.653 . . . . 0.0 111.084 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.88 -52.43 59.98 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 120.24 1.382 . . . . 0.0 109.39 169.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -63.44 -46.71 85.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.237 -162.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HG ' ' CD1' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -74.66 -9.9 59.01 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.656 -1.278 . . . . 0.0 111.895 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -20.38 66.17 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.879 -1.138 . . . . 0.0 110.066 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -65.93 -3.87 5.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.204 1.402 . . . . 0.0 112.858 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -132.83 -10.99 3.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.907 1.231 . . . . 0.0 113.071 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.26 -165.22 38.72 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 119.675 1.125 . . . . 0.0 110.847 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -98.19 104.53 16.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.76 110.0 2.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.11 -62.77 1.41 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -163.36 -172.02 2.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.563 0.345 . . . . 0.0 110.326 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.76 139.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 128.27 2.628 . . . . 0.0 104.597 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -133.2 113.27 12.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.509 0.724 . . . . 0.0 110.699 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mt -126.58 86.79 57.75 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.927 2.891 . . . . 0.0 109.62 -162.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 114.16 3.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.435 2.756 . . . . 0.0 108.989 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 165.4 53.63 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 172.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -61.99 175.81 1.71 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.115 3.21 . . . . 0.0 110.218 164.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.4 t -132.98 116.2 25.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t0 58.02 31.64 20.91 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.949 1.3 . . . . 0.0 112.811 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.88 -3.22 76.8 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.859 1.695 . . . . 0.0 113.044 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.36 143.08 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.4 154.65 5.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.95 1.3 . . . . 0.0 110.331 165.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.31 153.78 80.74 Favored Pre-proline 0 C--O 1.239 0.516 0 C-N-CA 125.445 1.498 . . . . 0.0 109.18 165.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -63.51 135.17 48.11 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.251 1.967 . . . . 0.0 107.93 165.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.81 -10.08 62.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.147 1.356 . . . . 0.0 113.011 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.08 156.68 35.83 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.434 1.117 . . . . 0.0 112.281 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 0.1 83.05 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.179 1.371 . . . . 0.0 113.075 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -117.29 167.67 11.02 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.048 1.424 . . . . 0.0 108.966 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 mp -126.7 145.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 161.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -111.79 157.77 20.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 160.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.69 153.55 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.6 146.42 49.57 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.03 0.932 . . . . 0.0 109.113 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.53 177.91 6.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.157 1.383 . . . . 0.0 110.892 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -89.71 -15.38 32.67 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 85.0 p -150.6 152.92 34.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.194 0.906 . . . . 0.0 111.163 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.08 -27.51 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.481 1.513 . . . . 0.0 110.126 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.64 -54.65 40.05 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.317 1.047 . . . . 0.0 109.446 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.58 -33.0 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.07 -51.23 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 110.075 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -53.66 -35.78 61.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.389 1.076 . . . . 0.0 111.666 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -71.82 -52.17 18.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.346 0.976 . . . . 0.0 110.395 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.46 -51.03 68.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.405 1.482 . . . . 0.0 110.222 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.4 ttt -44.78 -68.86 0.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.174 1.79 . . . . 0.0 111.598 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -66.53 -29.0 69.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.393 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.58 -24.35 65.97 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.447 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' CD1' ' HG ' ' A' ' 36' ' ' CYS . 96.3 mt -129.07 0.88 5.25 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.068 1.434 . . . . 0.0 114.187 -166.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.3 m -58.01 120.63 8.89 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.87 66.14 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.449 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.84 179.2 0.53 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.585 1.692 . . . . 0.0 111.881 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.24 137.22 53.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 159.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -110.8 14.43 22.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.639 0.776 . . . . 0.0 110.21 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.92 -85.38 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.176 2.59 . . . . 0.0 104.902 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -140.64 -10.46 1.05 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -112.73 161.58 16.71 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.024 1.738 . . . . 0.0 110.244 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.4 109.99 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.43 0.634 . . . . 0.0 109.374 -173.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.9 t -64.52 144.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.615 1.166 . . . . 0.0 108.092 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.8 150.07 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 166.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.86 144.17 47.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.294 2.237 . . . . 0.0 108.574 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.441 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 4.8 mmpt? -143.44 162.74 34.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.67 2.388 . . . . 0.0 106.727 159.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -67.21 160.7 26.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 157.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.15 -164.5 1.13 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 168.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -113.53 142.53 27.77 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.32 -24.38 2.52 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.471 2.114 . . . . 0.0 111.528 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.39 -54.18 40.43 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -69.03 -15.6 63.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.199 0.6 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -82.35 -37.84 25.08 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.051 1.34 . . . . 0.0 110.973 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -72.23 2.21 6.36 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.016 1.327 . . . . 0.0 112.325 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -134.54 -164.52 1.52 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.734 2.414 . . . . 0.0 109.341 -163.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.472 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 5.6 ttm180 -130.26 25.1 5.19 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.931 2.092 . . . . 0.0 110.834 173.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 42.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.942 -1.098 . . . . 0.0 110.344 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 6.2 m-85 -74.95 129.29 37.4 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -176.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.818 0 C-N-CA 125.22 1.408 . . . . 0.0 108.144 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.475 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.81 172.95 52.65 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.335 0.969 . . . . 0.0 111.728 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -87.49 161.13 46.36 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.773 1.629 . . . . 0.0 110.74 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.54 149.1 79.69 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.01 2.473 . . . . 0.0 109.27 165.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 p -139.96 170.81 15.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.29 1.836 . . . . 0.0 107.01 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.56 8.1 1.22 Allowed 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.852 -1.155 . . . . 0.0 111.468 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.9 t -129.04 111.28 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.425 1.49 . . . . 0.0 108.047 -162.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -124.38 129.44 50.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -171.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.7 t -101.0 148.81 24.61 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 mt -132.62 105.52 7.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.214 1.805 . . . . 0.0 108.33 -162.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -99.56 165.52 11.59 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.411 0.624 . . . . 0.0 111.131 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.31 28.72 18.35 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 128.744 2.817 . . . . 0.0 111.423 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 ttm -84.21 -56.11 3.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.5 -0.75 . . . . 0.0 111.276 -168.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.4 157.34 27.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.128 1.771 . . . . 0.0 107.399 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -98.51 150.03 36.32 Favored Pre-proline 0 C--O 1.235 0.309 0 O-C-N 120.867 -1.146 . . . . 0.0 110.082 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -68.24 1.25 3.66 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.261 2.641 . . . . 0.0 112.912 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -127.14 12.44 7.13 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.078 1.751 . . . . 0.0 111.385 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.67 -14.58 7.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.254 0.622 . . . . 0.0 111.653 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -76.99 66.76 2.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.831 1.252 . . . . 0.0 110.707 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -130.64 -57.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.29 0.636 . . . . 0.0 109.487 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 112.48 1.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.68 1.192 . . . . 0.0 111.417 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.4 -22.24 66.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.237 1.415 . . . . 0.0 112.561 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.9 -55.62 4.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.306 1.042 . . . . 0.0 110.304 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -40.03 90.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.119 1.767 . . . . 0.0 110.473 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -49.98 -43.59 50.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.651 1.58 . . . . 0.0 112.667 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.68 -43.15 56.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.549 1.14 . . . . 0.0 109.285 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -63.74 -27.7 69.38 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.96 -0.462 . . . . 0.0 110.852 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -77.24 -24.72 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.521 1.128 . . . . 0.0 110.801 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.17 -47.32 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 120.535 -1.353 . . . . 0.0 107.718 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -72.31 -37.03 69.03 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.628 1.171 . . . . 0.0 111.988 -164.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -60.58 -42.08 95.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 111.629 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.58 -27.12 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 125.129 1.372 . . . . 0.0 110.902 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -62.0 -43.86 97.95 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.136 -0.977 . . . . 0.0 109.883 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.95 -52.52 65.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.523 0.729 . . . . 0.0 110.743 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -61.1 -35.16 76.27 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.732 0.777 . . . . 0.0 110.964 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t -76.2 -38.96 55.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.314 1.045 . . . . 0.0 109.671 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -51.9 -25.11 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.852 1.661 . . . . 0.0 111.981 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -61.28 -31.84 71.67 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.655 -1.278 . . . . 0.0 112.47 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.87 -8.29 25.94 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 112.535 -170.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.92 -178.05 19.03 Favored Glycine 0 CA--C 1.506 -0.526 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.8 tp -103.36 121.2 42.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -160.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.56 136.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.385 2.274 . . . . 0.0 108.383 172.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -98.49 -52.0 3.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.31 2.244 . . . . 0.0 109.689 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -152.01 158.4 43.02 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.118 0.567 . . . . 0.0 110.367 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.3 mt -137.33 92.21 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.73 113.11 23.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.555 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -123.79 85.64 53.54 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 125.16 1.384 . . . . 0.0 107.313 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.82 148.7 41.47 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.64 1.56 . . . . 0.0 108.323 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -137.97 160.23 65.32 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 121.004 -1.06 . . . . 0.0 110.928 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.98 158.12 55.8 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.964 1.776 . . . . 0.0 110.753 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.11 166.56 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.191 1.796 . . . . 0.0 107.708 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.01 86.17 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 130.335 3.454 . . . . 0.0 106.279 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.76 32.64 74.36 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.039 -1.437 . . . . 0.0 111.663 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.14 128.24 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 119.279 1.54 . . . . 0.0 107.129 162.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.69 171.7 8.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.53 1.157 . . . . 0.0 109.351 166.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.24 143.87 49.66 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 126.139 1.776 . . . . 0.0 108.085 167.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.61 137.3 38.63 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.493 1.462 . . . . 0.0 108.451 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.87 28.93 71.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 124.156 0.884 . . . . 0.0 111.426 169.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.5 t -69.48 153.99 42.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.153 1.781 . . . . 0.0 110.632 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.29 34.07 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.512 1.529 . . . . 0.0 114.421 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 147.74 48.49 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.567 1.683 . . . . 0.0 110.639 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.6 144.52 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -114.56 123.79 50.24 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.45 120.25 62.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -95.2 140.74 29.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.91 -168.91 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.093 1.757 . . . . 0.0 108.851 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 p -119.67 -0.65 10.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.413 1.085 . . . . 0.0 112.544 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.9 m -159.88 146.21 15.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.512 1.525 . . . . 0.0 108.873 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.31 -13.81 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.379 1.072 . . . . 0.0 111.102 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.9 -41.26 15.1 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.132 -1.605 . . . . 0.0 110.83 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.92 -37.55 87.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.969 0.907 . . . . 0.0 110.917 -173.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.5 p -68.76 -37.05 79.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.003 0.521 . . . . 0.0 110.732 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -67.02 -31.05 71.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.139 0.976 . . . . 0.0 111.232 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -62.62 -56.09 21.0 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.603 1.092 . . . . 0.0 108.773 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.17 79.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.859 0.864 . . . . 0.0 110.973 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -44.57 -58.79 2.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.849 1.66 . . . . 0.0 111.502 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -79.45 -33.25 42.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.075 0.95 . . . . 0.0 112.166 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.6 84.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.554 1.073 . . . . 0.0 112.531 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -117.53 10.57 13.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.705 1.602 . . . . 0.0 111.19 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -56.31 124.59 18.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.04 -3.63 60.79 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.289 -0.728 . . . . 0.0 112.891 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -69.48 -178.45 1.41 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.156 1.478 . . . . 0.0 109.307 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -134.11 99.64 4.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.359 1.464 . . . . 0.0 109.347 -163.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.86 13.51 4.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.118 0.967 . . . . 0.0 112.318 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.44 -73.25 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.956 2.503 . . . . 0.0 104.521 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -146.04 -30.08 0.4 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.027 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt85 -101.01 164.98 11.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.887 0.875 . . . . 0.0 111.371 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.78 111.76 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.558 1.143 . . . . 0.0 109.794 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -72.15 134.81 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 109.884 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.4 t -113.12 143.39 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 166.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 p -112.81 146.92 37.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.493 1.517 . . . . 0.0 108.224 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.1 149.74 31.56 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.649 168.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.35 118.64 17.53 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.71 -175.72 5.52 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.25 0.62 . . . . 0.0 109.727 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -101.61 144.95 29.58 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.38 -28.78 32.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.868 3.045 . . . . 0.0 111.435 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.1 -45.24 21.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.571 1.149 . . . . 0.0 110.549 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.96 14.84 27.66 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.965 0.906 . . . . 0.0 111.739 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -103.85 -39.73 6.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.86 1.264 . . . . 0.0 110.488 163.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -58.84 -15.3 11.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.698 1.599 . . . . 0.0 113.903 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -129.67 -163.85 1.34 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.616 1.967 . . . . 0.0 108.821 -168.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.73 38.7 1.84 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.661 1.585 . . . . 0.0 111.336 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -102.71 21.27 15.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.824 2.05 . . . . 0.0 114.129 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -59.92 112.79 1.99 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.8 -1.187 . . . . 0.0 110.265 -170.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 3.8 m0 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 171.632 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.537 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.96 -172.23 44.61 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 128.461 2.934 . . . . 0.0 106.677 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -134.2 158.27 75.66 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 118.428 1.114 . . . . 0.0 110.284 -171.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.97 131.45 23.93 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.956 1.77 . . . . 0.0 108.091 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 p -123.98 179.53 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -86.33 -4.85 59.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.197 -0.906 . . . . 0.0 113.388 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.8 m -83.83 179.81 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.855 1.207 . . . . 0.0 109.098 168.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tp -155.21 163.65 39.89 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 166.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.5 t -138.61 129.37 26.46 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.783 -1.198 . . . . 0.0 109.606 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.6 115.02 19.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 126.217 1.807 . . . . 0.0 107.761 -164.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mtm -87.83 162.5 16.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 75.37 23.89 1.46 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.515 1.926 . . . . 0.0 112.968 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -82.92 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.6 m -88.02 159.84 2.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 127.721 2.408 . . . . 0.0 109.069 -170.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.82 165.32 40.17 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.283 0.633 . . . . 0.0 109.425 155.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.2 -17.76 24.2 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.604 1.536 . . . . 0.0 112.993 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -96.17 -7.14 36.59 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.673 1.189 . . . . 0.0 111.443 -165.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.12 -38.9 17.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.312 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -72.03 49.44 0.19 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.516 2.326 . . . . 0.0 115.421 -155.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.43 -11.5 3.57 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 119.857 -1.777 . . . . 0.0 110.317 -167.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.85 112.69 17.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.981 0.896 . . . . 0.0 110.066 -167.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.87 -16.1 37.87 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 129.669 3.188 . . . . 0.0 113.173 -165.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.39 -51.87 7.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.45 1.5 . . . . 0.0 110.5 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.31 -44.15 72.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.527 2.331 . . . . 0.0 108.618 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.442 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 54.0 t80 -58.43 -33.63 69.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.744 0.418 . . . . 0.0 111.818 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.63 -39.9 50.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.075 . . . . 0.0 111.599 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.2 -46.11 91.81 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.33 0.652 . . . . 0.0 109.581 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.5 mt -60.49 -39.15 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.745 1.218 . . . . 0.0 110.123 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.21 -33.07 58.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 120.751 -1.218 . . . . 0.0 110.411 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.24 -42.44 25.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.192 0.597 . . . . 0.0 110.957 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.37 -40.09 93.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.577 1.18 . . . . 0.0 110.532 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.5 t -89.01 -15.41 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.209 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -72.77 -38.22 67.38 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.52 -1.363 . . . . 0.0 111.034 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.5 -52.52 64.17 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.967 0.803 . . . . 0.0 109.825 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.35 -21.15 66.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.9 t -83.15 -34.32 26.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.848 1.659 . . . . 0.0 110.592 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -17.88 19.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 113.043 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.02 -32.71 71.14 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.914 0.886 . . . . 0.0 112.627 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.3 -7.86 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.148 0.886 . . . . 0.0 112.609 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.31 -134.51 3.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -167.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.12 112.63 4.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.78 120.67 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.674 1.226 . . . . 0.0 109.209 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -60.66 3.43 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.191 2.196 . . . . 0.0 108.155 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -160.22 -178.74 7.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.779 0.718 . . . . 0.0 110.91 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.45 136.67 57.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 126.578 1.951 . . . . 0.0 106.634 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.95 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.878 1.271 . . . . 0.0 110.167 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.06 86.14 21.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.649 1.979 . . . . 0.0 106.723 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 114.82 4.14 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.537 2.825 . . . . 0.0 109.748 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.442 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 2.4 mpp_? -72.96 159.77 84.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.156 0.982 . . . . 0.0 111.696 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.97 178.29 1.95 Allowed 'Trans proline' 0 C--N 1.352 0.741 1 C-N-CA 125.926 4.418 . . . . 0.0 112.152 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.15 106.21 15.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 t70 53.71 28.44 8.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.566 1.146 . . . . 0.0 113.656 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.42 -2.13 88.17 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.278 1.418 . . . . 0.0 115.398 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.0 t -78.76 139.02 19.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 126.472 1.909 . . . . 0.0 107.548 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.91 144.72 55.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.533 0.682 . . . . 0.0 111.417 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 m -107.32 147.19 34.75 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 125.043 1.337 . . . . 0.0 111.603 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.82 98.13 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.002 2.468 . . . . 0.0 107.515 163.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.54 -8.06 6.98 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.107 1.813 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.2 t -81.94 142.68 32.23 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.226 1.513 . . . . 0.0 110.229 -164.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.84 -12.2 24.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.002 1.763 . . . . 0.0 113.477 -170.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -86.87 146.89 26.02 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.84 147.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -122.53 158.54 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.82 153.34 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 30.9 tt0 -132.58 139.25 47.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -114.47 174.91 5.72 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.245 1.418 . . . . 0.0 110.57 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -74.37 -23.2 58.97 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.934 -0.479 . . . . 0.0 112.111 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 t -154.69 161.87 41.37 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.631 1.205 . . . . 0.0 110.111 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.2 t -52.17 -39.56 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.592 1.557 . . . . 0.0 108.173 164.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -69.36 -35.09 75.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 117.027 -1.463 . . . . 0.0 113.688 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -85.19 -20.66 29.85 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.01 1.732 . . . . 0.0 111.503 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.3 t -69.68 -49.6 51.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.517 1.527 . . . . 0.0 110.243 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -54.74 -36.82 65.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.622 0.769 . . . . 0.0 112.141 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -71.54 -45.93 60.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.08 91.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 112.036 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.7 ttm -53.69 -68.33 0.19 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.381 0.991 . . . . 0.0 109.34 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -55.64 -34.95 65.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.782 0.833 . . . . 0.0 110.617 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.9 -20.87 76.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.86 -0.967 . . . . 0.0 114.355 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.59 2.33 10.12 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.085 1.354 . . . . 0.0 112.107 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -63.2 103.01 0.44 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.614 -1.304 . . . . 0.0 109.945 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.98 0.53 30.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.079 1.323 . . . . 0.0 112.897 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -74.25 -175.53 2.31 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.333 1.066 . . . . 0.0 111.958 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -138.29 115.99 11.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -107.97 24.21 13.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.55 1.54 . . . . 0.0 111.019 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.47 -64.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.318 1.847 . . . . 0.0 108.506 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.37 -17.99 0.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 171.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -113.71 166.6 11.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 109.925 -167.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.56 118.86 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.91 138.23 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.14 131.37 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.7 p -106.72 147.24 29.84 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.258 1.823 . . . . 0.0 108.826 -164.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -153.95 151.05 28.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.708 1.603 . . . . 0.0 108.065 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -77.42 152.32 34.35 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 166.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -172.14 2.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.929 1.691 . . . . 0.0 107.779 168.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -111.85 143.55 28.89 Favored Pre-proline 0 C--O 1.236 0.36 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.02 -23.5 16.01 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.814 3.009 . . . . 0.0 110.997 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -51.49 -53.31 38.65 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.76 0.824 . . . . 0.0 108.985 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.32 77.87 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.788 0.835 . . . . 0.0 111.214 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -70.46 -39.85 74.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.911 2.084 . . . . 0.0 112.54 -169.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -63.78 -42.16 97.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 109.811 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -93.38 -167.33 1.69 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.847 1.259 . . . . 0.0 110.475 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.406 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 7.0 ttm180 -100.17 39.8 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.763 -0.585 . . . . 0.0 110.55 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -99.3 88.88 4.03 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.048 -1.033 . . . . 0.0 109.42 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.406 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER -136.08 165.03 26.64 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.491 1.916 . . . . 0.0 107.379 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 11.3 t90 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 126.344 1.857 . . . . 0.0 106.743 179.625 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.569 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.66 174.26 28.22 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -171.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -115.68 160.08 36.25 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 124.832 1.253 . . . . 0.0 109.644 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -71.53 148.09 53.16 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.743 . . . . 0.0 108.444 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.9 p -136.51 -179.84 5.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.28 5.56 5.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.305 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.56 143.97 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.698 1.199 . . . . 0.0 110.464 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 mt -131.43 159.59 37.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.209 2.204 . . . . 0.0 109.526 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 t -116.77 110.88 18.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.773 1.629 . . . . 0.0 106.974 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.02 153.54 20.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.6 mtm -134.23 176.8 8.27 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 61.62 12.89 4.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.879 1.671 . . . . 0.0 113.034 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -68.33 -59.52 3.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 153.84 38.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.074 2.15 . . . . 0.0 108.227 -172.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -82.01 164.4 48.63 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.074 1.35 . . . . 0.0 109.548 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.87 5.28 2.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 124.116 3.211 . . . . 0.0 113.734 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -129.56 26.59 5.33 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.547 1.539 . . . . 0.0 110.326 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -141.05 24.64 2.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.301 1.84 . . . . 0.0 111.838 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -128.54 75.51 1.64 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.482 2.313 . . . . 0.0 107.039 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -134.35 -49.93 0.79 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.296 1.439 . . . . 0.0 108.166 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.92 105.96 3.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.904 2.481 . . . . 0.0 108.974 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.61 -19.73 41.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.117 1.367 . . . . 0.0 112.736 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.24 -65.71 0.98 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.35 -29.0 68.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.168 1.387 . . . . 0.0 111.897 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.22 -44.17 64.64 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.82 -0.55 . . . . 0.0 111.697 172.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.16 -43.77 50.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -55.88 -43.97 77.72 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.29 1.036 . . . . 0.0 111.119 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -68.31 -42.53 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.823 0.849 . . . . 0.0 109.604 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -59.07 -40.03 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.799 1.182 . . . . 0.0 109.515 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.77 -32.56 67.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.446 0.566 . . . . 0.0 112.361 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.84 -40.75 88.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.842 0.353 . . . . 0.0 110.753 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.1 t -78.47 -38.7 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 118.264 -0.874 . . . . 0.0 109.403 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -52.39 -36.23 53.48 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.07 0.85 . . . . 0.0 109.912 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.44 -38.02 88.16 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.546 0.612 . . . . 0.0 111.124 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.59 -47.65 18.85 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -29.81 70.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 111.65 174.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.5 t -63.52 -9.38 12.79 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.633 1.173 . . . . 0.0 113.225 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -61.56 -41.89 98.03 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.138 -2.227 . . . . 0.0 111.111 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.67 -8.42 50.04 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.214 1.406 . . . . 0.0 113.146 -160.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.12 -159.07 27.82 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -157.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.64 120.53 36.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.419 1.109 . . . . 0.0 111.759 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -75.9 142.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.051 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.3 -54.67 2.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.526 1.931 . . . . 0.0 109.288 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -159.34 155.62 27.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.474 0.579 . . . . 0.0 110.621 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mt -124.34 118.57 54.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 127.143 2.177 . . . . 0.0 105.888 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 133.53 38.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.91 86.61 26.48 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -52.06 145.74 32.61 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.237 1.958 . . . . 0.0 110.128 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.67 148.14 67.19 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.33 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -61.56 161.65 23.65 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.063 2.509 . . . . 0.0 111.067 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.63 104.21 16.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 62.87 24.24 14.44 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.427 1.491 . . . . 0.0 114.496 169.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.7 -4.09 53.42 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.591 2.043 . . . . 0.0 112.873 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.4 t -94.65 140.15 17.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.946 1.299 . . . . 0.0 109.197 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.44 151.96 35.69 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.969 1.308 . . . . 0.0 112.125 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.83 143.87 34.53 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.676 1.99 . . . . 0.0 110.048 165.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.37 111.62 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.45 2.767 . . . . 0.0 109.762 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.46 -1.37 20.44 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.84 1.21 . . . . 0.0 113.383 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -66.45 137.45 56.84 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.509 1.654 . . . . 0.0 111.158 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.73 1.74 79.83 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.935 1.731 . . . . 0.0 113.608 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -108.87 123.23 48.74 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.59 106.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -170.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -91.11 141.94 28.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.8 135.69 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.99 148.82 41.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.033 1.733 . . . . 0.0 107.184 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -129.99 168.83 16.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.686 1.594 . . . . 0.0 109.999 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 p -70.01 -4.74 22.29 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.28 1.432 . . . . 0.0 114.088 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.2 t -171.51 165.42 6.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.256 1.822 . . . . 0.0 107.984 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.6 t -52.93 -47.82 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.251 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -61.83 -48.35 80.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.312 0.645 . . . . 0.0 110.262 -172.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.29 -40.24 93.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.227 1.011 . . . . 0.0 110.342 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -44.69 94.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.247 1.019 . . . . 0.0 109.423 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.5 -51.85 57.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.389 1.476 . . . . 0.0 110.774 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -61.05 -47.35 86.81 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.77 74.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.326 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -62.25 -65.52 0.68 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.099 0.863 . . . . 0.0 109.438 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -70.04 -24.4 63.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.968 -0.457 . . . . 0.0 111.301 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.06 -24.28 73.16 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.364 -0.687 . . . . 0.0 112.505 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -127.84 -6.24 5.63 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.217 1.008 . . . . 0.0 112.468 -171.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -59.83 142.05 54.19 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.871 1.214 . . . . 0.0 108.08 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.2 -1.32 81.1 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.206 1.384 . . . . 0.0 114.029 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -78.09 -174.74 3.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.373 2.086 . . . . 0.0 112.005 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -118.66 129.97 55.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -107.1 13.47 27.38 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.96 1.254 . . . . 0.0 110.787 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.73 -74.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.73 -12.14 0.45 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -122.4 160.91 24.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.187 0.903 . . . . 0.0 110.719 -165.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.82 128.91 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 123.159 0.287 . . . . 0.0 111.764 -165.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.56 87.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.77 146.37 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.0 p -102.11 164.36 11.74 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.491 0.717 . . . . 0.0 109.489 171.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -146.75 150.47 35.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.275 1.43 . . . . 0.0 107.582 154.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -67.43 156.28 36.96 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.358 1.036 . . . . 0.0 109.461 163.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.59 -172.38 2.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.902 1.281 . . . . 0.0 108.368 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -108.83 145.34 31.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 158.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.99 -22.24 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.541 2.828 . . . . 0.0 112.723 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -44.64 -42.11 7.21 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.867 2.067 . . . . 0.0 111.969 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 p -91.23 -27.57 18.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 112.28 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -72.79 -27.25 61.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.818 2.047 . . . . 0.0 110.637 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -65.21 -12.47 51.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -130.48 -164.18 1.4 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.75 2.02 . . . . 0.0 107.852 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 2.2 ttt180 -107.1 23.44 14.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.417 1.087 . . . . 0.0 111.252 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.68 97.83 6.71 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.72 -1.237 . . . . 0.0 110.155 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 5.6 m-85 -140.06 165.26 27.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.651 1.181 . . . . 0.0 108.416 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 14.3 t90 . . . . . 0 C--O 1.248 0.993 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.108 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 CA-C-O 118.159 -1.356 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.52 -174.04 17.51 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 118.408 1.104 . . . . 0.0 110.725 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -65.61 157.63 77.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.216 0.606 . . . . 0.0 110.558 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.83 149.14 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.829 1.686 . . . . 0.0 108.827 167.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.0 p -128.12 171.32 12.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.06 -10.49 59.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.773 1.229 . . . . 0.0 111.716 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -114.01 155.0 15.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 119.537 1.062 . . . . 0.0 110.056 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.1 124.82 21.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 108.63 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -80.22 129.77 34.74 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.0 122.88 42.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.323 1.449 . . . . 0.0 108.411 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -97.03 163.96 12.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 74.22 18.88 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.063 2.145 . . . . 0.0 113.649 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -73.41 0.31 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 165.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.62 174.23 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 126.183 1.793 . . . . 0.0 109.616 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -112.47 146.29 34.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 125.022 1.329 . . . . 0.0 107.654 172.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -61.37 7.37 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.808 1 C-N-CA 127.892 5.728 . . . . 0.0 116.055 -175.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.34 -0.33 1.81 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.258 1.823 . . . . 0.0 111.925 -154.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -117.42 -6.08 11.23 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 112.937 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.95 -4.66 17.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.355 1.462 . . . . 0.0 113.849 -169.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.31 -25.84 60.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.978 2.111 . . . . 0.0 111.564 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.32 129.3 34.99 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.381 0.991 . . . . 0.0 109.614 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.28 -17.05 43.91 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.209 1.403 . . . . 0.0 112.393 -170.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -87.88 -61.82 1.63 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.148 0.979 . . . . 0.0 109.278 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.27 -38.03 73.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.565 0.746 . . . . 0.0 111.816 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -53.22 -39.27 63.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.258 1.023 . . . . 0.0 112.517 172.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -84.29 -31.89 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.428 0.691 . . . . 0.0 111.438 -171.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -53.95 -45.41 71.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.8 mt -67.09 -15.07 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.909 0.883 . . . . 0.0 111.724 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.0 t -86.01 -44.67 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 119.913 -1.742 . . . . 0.0 108.773 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.9 -42.54 69.84 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.684 0.793 . . . . 0.0 111.153 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -60.83 -43.6 98.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.754 1.74 . . . . 0.0 109.647 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.87 -21.78 6.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.316 -167.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -61.13 -43.34 99.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.086 -1.009 . . . . 0.0 108.826 165.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.48 -43.14 91.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.14 0.882 . . . . 0.0 111.743 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.68 -46.13 76.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.811 0.732 . . . . 0.0 110.274 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -70.89 -27.82 64.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.684 0.794 . . . . 0.0 111.276 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -55.53 -16.68 4.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.006 1.723 . . . . 0.0 113.339 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.31 -11.09 38.29 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.978 -1.701 . . . . 0.0 113.692 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.67 -15.89 10.74 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.65 -168.56 27.36 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 107.181 -2.367 . . . . 0.0 107.181 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.7 tp -99.87 119.24 37.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -162.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.58 117.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 167.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -56.23 15.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 158.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 p -160.36 170.01 21.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.504 0.593 . . . . 0.0 112.357 -166.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.64 153.1 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.14 133.21 45.37 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -137.71 85.61 20.02 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.51 148.34 92.57 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.394 1.396 . . . . 0.0 109.69 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -118.18 150.33 47.37 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 108.537 -167.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.55 124.76 11.94 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.079 2.519 . . . . 0.0 108.641 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.99 105.38 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t70 55.64 24.38 7.03 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.18 5.52 70.14 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.966 2.222 . . . . 0.0 115.06 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.83 158.48 3.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 118.591 1.196 . . . . 0.0 111.862 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.14 127.76 33.94 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 123.096 1.427 . . . . 0.0 109.105 159.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.55 143.22 29.5 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 124.992 1.317 . . . . 0.0 110.453 168.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -67.7 125.03 12.65 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.504 2.802 . . . . 0.0 108.409 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.75 12.83 61.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.525 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.19 154.24 42.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.531 1.666 . . . . 0.0 110.667 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.1 -32.36 4.67 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.09 1.805 . . . . 0.0 112.89 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.17 172.59 9.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.11 1.455 . . . . 0.0 109.254 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.95 151.19 35.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 164.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.84 150.26 33.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 165.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.32 159.24 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.67 121.42 10.54 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -93.63 162.93 13.75 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.507 0.67 . . . . 0.0 109.361 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -72.93 -1.55 17.41 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.029 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.3 m -158.45 155.34 28.38 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 121.135 1.789 . . . . 0.0 111.627 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.7 t -59.76 -32.29 49.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.627 1.571 . . . . 0.0 109.852 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.73 -59.53 5.24 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.479 -0.763 . . . . 0.0 110.297 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.55 -39.5 57.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.335 1.454 . . . . 0.0 109.891 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 t -64.35 -50.11 69.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.973 1.309 . . . . 0.0 110.374 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.15 -30.67 62.5 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.871 1.268 . . . . 0.0 112.206 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -78.03 -50.13 12.69 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.0 0.92 . . . . 0.0 109.498 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.27 -47.35 78.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.361 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.2 ttm -48.06 -67.55 0.26 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.027 0.831 . . . . 0.0 110.752 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.49 -25.33 66.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.796 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.33 -26.75 74.09 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.649 -1.084 . . . . 0.0 112.565 174.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.3 mt -123.39 -5.71 8.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.608 1.204 . . . . 0.0 112.727 -167.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 m -50.59 121.08 5.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.508 1.123 . . . . 0.0 108.412 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.25 8.03 86.91 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 118.499 -1.167 . . . . 0.0 114.41 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -78.26 -169.68 1.72 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.676 1.238 . . . . 0.0 109.974 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.85 132.2 53.72 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -110.57 19.96 18.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.698 1.199 . . . . 0.0 109.737 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.57 -65.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.885 1.674 . . . . 0.0 107.179 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 -29.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.076 1.351 . . . . 0.0 111.452 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -88.51 166.5 14.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.671 -0.643 . . . . 0.0 110.255 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.95 135.49 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.1 t -93.75 111.69 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.29 142.78 13.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.8 p -119.96 151.43 38.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.369 1.068 . . . . 0.0 108.128 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -150.0 144.16 25.65 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.174 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -66.48 138.17 57.34 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 120.252 1.387 . . . . 0.0 108.218 161.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 -164.37 0.94 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -116.73 143.02 30.59 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.56 -27.8 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.132 3.221 . . . . 0.0 111.991 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -46.88 72.2 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 120.902 -1.123 . . . . 0.0 111.083 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.81 55.17 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.895 1.678 . . . . 0.0 111.325 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -92.65 -51.94 4.87 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.4 1.88 . . . . 0.0 109.251 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -62.5 -30.29 71.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.858 0.463 . . . . 0.0 111.599 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -104.96 -178.25 3.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.539 1.936 . . . . 0.0 108.659 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -111.49 76.84 1.0 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.32 69.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -97.7 153.26 18.36 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.219 0.608 . . . . 0.0 110.075 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 C-N-CA 127.35 2.26 . . . . 0.0 106.548 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.478 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.34 -143.13 4.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -59.93 156.99 32.85 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.048 0.924 . . . . 0.0 110.984 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.76 148.37 52.36 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.775 2.317 . . . . 0.0 108.502 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.2 p -135.79 155.21 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.16 -3.02 3.32 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 4.1 m -93.64 -167.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.472 0.653 . . . . 0.0 110.354 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.11 160.33 43.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.467 2.307 . . . . 0.0 105.877 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 t -137.65 114.29 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 mp -125.05 153.93 42.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 110.618 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mtm -138.27 170.25 16.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 111.046 -172.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.03 13.24 5.52 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.334 2.254 . . . . 0.0 112.658 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 36.9 ttm -76.17 -75.71 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -97.24 155.9 3.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.748 1.219 . . . . 0.0 108.738 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.04 156.87 38.4 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.364 1.466 . . . . 0.0 107.065 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.91 -12.37 34.08 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.434 2.756 . . . . 0.0 113.835 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -105.1 8.65 34.3 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.013 1.725 . . . . 0.0 110.756 -168.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -124.46 -16.96 6.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.393 1.077 . . . . 0.0 111.596 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.73 56.14 3.42 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.395 1.478 . . . . 0.0 109.589 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.44 -49.06 1.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.026 0.93 . . . . 0.0 108.866 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.1 92.17 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.727 1.611 . . . . 0.0 110.327 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.69 -17.7 49.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.289 1.835 . . . . 0.0 113.097 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.21 -35.0 10.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 0.0 110.802 -172.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -74.61 -36.32 62.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.712 1.205 . . . . 0.0 111.082 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.89 -40.15 13.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.839 1.655 . . . . 0.0 111.782 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.08 -46.49 74.14 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 110.927 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.96 -46.83 79.92 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.954 1.302 . . . . 0.0 109.926 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.84 -45.29 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.889 0.875 . . . . 0.0 109.813 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 t -57.26 -47.16 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.96 -37.63 88.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.555 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -76.15 -27.7 57.1 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.963 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.4 t -76.73 -34.17 22.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.61 -28.74 69.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.045 -1.034 . . . . 0.0 111.644 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.21 -47.18 78.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.854 0.752 . . . . 0.0 110.803 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.7 -42.96 69.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.943 0.497 . . . . 0.0 110.479 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.295 0.8 OUTLIER -71.96 -26.12 62.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.707 173.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -11.83 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 120.543 1.52 . . . . 0.0 113.04 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -63.2 -20.19 65.19 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 119.77 -1.831 . . . . 0.0 113.986 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -117.28 3.84 12.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.369 0.668 . . . . 0.0 112.524 -165.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.36 -139.4 5.99 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -168.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -137.54 133.31 34.36 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.141 1.471 . . . . 0.0 109.664 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -84.69 122.2 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.24 1.016 . . . . 0.0 108.48 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -73.02 -61.35 1.85 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.151 0.981 . . . . 0.0 108.866 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 t -151.84 166.68 30.68 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.781 0.832 . . . . 0.0 109.358 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 mt -133.74 123.36 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 172.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -110.87 114.13 27.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.067 1.347 . . . . 0.0 109.808 -167.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.29 86.26 30.91 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.861 1.664 . . . . 0.0 107.94 -167.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.19 150.16 87.92 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 120.946 1.097 . . . . 0.0 109.821 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -105.39 165.43 13.16 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 109.505 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.38 173.74 6.01 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.256 2.637 . . . . 0.0 110.883 173.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.19 91.78 2.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 170.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 53.46 33.51 16.2 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.45 1.1 . . . . 0.0 113.313 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.01 -16.64 39.0 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.563 2.03 . . . . 0.0 113.084 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.4 t -82.51 143.1 12.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 O-C-N 120.82 -1.4 . . . . 0.0 109.962 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -68.23 146.11 53.66 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.952 0.882 . . . . 0.0 111.004 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.55 156.69 79.8 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 125.877 1.671 . . . . 0.0 109.343 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -62.27 138.61 72.86 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.633 1.556 . . . . 0.0 108.796 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.57 9.68 85.39 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.805 -0.997 . . . . 0.0 113.258 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.14 154.6 37.66 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.294 1.047 . . . . 0.0 111.431 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.63 -4.56 50.69 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.671 1.605 . . . . 0.0 115.223 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -98.44 147.0 25.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.706 1.253 . . . . 0.0 107.833 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.91 139.65 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -123.12 139.17 54.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.11 110.23 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -169.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 37.1 tt0 -88.62 138.96 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.522 1.129 . . . . 0.0 108.012 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.76 174.54 6.53 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.403 1.481 . . . . 0.0 110.227 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -32.41 67.51 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.696 1.199 . . . . 0.0 113.601 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.3 m -168.85 167.25 11.08 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.285 1.034 . . . . 0.0 110.324 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -51.73 -40.12 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 122.901 1.334 . . . . 0.0 110.328 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.78 -2.51 20.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.605 -1.31 . . . . 0.0 114.036 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -109.01 -33.97 6.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.237 1.015 . . . . 0.0 109.373 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.2 p -75.82 -34.37 60.13 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.472 -0.768 . . . . 0.0 109.504 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -50.27 -35.43 27.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.883 2.073 . . . . 0.0 111.83 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.3 -46.13 12.11 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.002 0.921 . . . . 0.0 108.875 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.78 76.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.581 -1.2 . . . . 0.0 111.277 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 mtp -46.59 -64.28 0.8 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 108.907 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -68.2 -34.11 75.67 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.355 -173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.07 -7.06 70.07 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.76 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.8 mt -131.21 -3.08 3.92 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 111.811 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -62.83 108.64 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.831 -1.168 . . . . 0.0 109.127 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.24 67.01 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.78 1.181 . . . . 0.0 113.14 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -64.57 177.36 0.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.295 1.547 . . . . 0.0 109.429 165.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -131.92 89.97 2.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -167.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -80.45 13.38 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.905 -0.497 . . . . 0.0 112.119 -168.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.08 -84.45 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.152 3.381 . . . . 0.0 103.288 156.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -147.06 18.92 1.25 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.426 -0.796 . . . . 0.0 112.022 -168.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 -132.86 171.7 13.58 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.748 -1.22 . . . . 0.0 110.338 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 t -87.3 109.56 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -73.17 124.56 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.69 163.62 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 p -132.88 163.29 29.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.186 2.194 . . . . 0.0 108.753 -168.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -164.6 158.9 18.48 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 130.127 3.371 . . . . 0.0 105.578 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.11 145.3 31.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 157.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.61 -164.3 1.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.01 1.324 . . . . 0.0 109.67 172.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -109.92 144.83 30.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 157.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.42 -19.55 10.19 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.825 3.016 . . . . 0.0 111.708 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -57.0 -59.28 5.29 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.991 -1.068 . . . . 0.0 108.611 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.4 m -70.01 -0.78 8.14 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.254 2.222 . . . . 0.0 111.9 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -91.06 -48.32 7.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.412 1.485 . . . . 0.0 110.522 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -68.9 -45.6 70.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.102 0.961 . . . . 0.0 109.342 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -76.29 170.89 15.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.078 0.942 . . . . 0.0 109.222 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -101.49 68.11 1.17 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.56 74.89 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.93 1.348 . . . . 0.0 108.778 169.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -98.64 110.62 23.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.7 t90 . . . . . 0 C--O 1.257 1.457 0 C-N-CA 127.472 2.309 . . . . 0.0 105.626 174.065 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.859 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.61 -96.94 1.75 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 151.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -144.33 165.44 23.47 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.795 1.638 . . . . 0.0 109.944 -172.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.63 136.51 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.678 2.252 . . . . 0.0 108.705 166.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -140.82 171.28 14.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.49 -2.57 14.4 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.19 -0.944 . . . . 0.0 113.056 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 t -107.44 92.55 2.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.657 1.183 . . . . 0.0 108.439 -167.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.63 125.88 29.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.59 124.06 35.46 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.82 111.24 15.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.271 1.034 . . . . 0.0 109.585 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mtm -84.55 166.49 17.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.73 0.812 . . . . 0.0 109.778 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 70.1 14.69 7.72 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.718 2.007 . . . . 0.0 113.033 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -58.63 7.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.45 163.34 24.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.534 1.134 . . . . 0.0 111.709 -161.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -103.4 163.68 16.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.052 2.141 . . . . 0.0 109.35 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.03 4.88 4.36 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.892 2.394 . . . . 0.0 113.247 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.55 14.83 11.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.831 1.252 . . . . 0.0 111.506 -171.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.47 24.04 2.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.377 1.071 . . . . 0.0 111.123 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.405 ' H ' HD21 ' A' ' 20' ' ' LEU . 53.7 mt -133.2 37.43 3.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.438 1.895 . . . . 0.0 109.82 -176.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.405 HD21 ' H ' ' A' ' 19' ' ' LEU . 1.5 mm? -113.58 -5.62 13.41 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.274 1.029 . . . . 0.0 111.245 -174.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.38 127.51 53.75 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.94 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.92 -12.72 60.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.89 0.876 . . . . 0.0 111.269 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.19 -59.31 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.039 0.936 . . . . 0.0 108.728 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.67 -36.98 77.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.057 1.743 . . . . 0.0 111.136 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -52.62 -48.55 66.27 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.928 1.291 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.2 -36.47 66.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.911 0.778 . . . . 0.0 110.221 -172.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -60.39 -49.32 78.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.394 0.678 . . . . 0.0 109.415 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -63.22 -41.18 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.1 t -56.18 -48.25 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.459 1.027 . . . . 0.0 110.045 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.31 -31.39 60.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.954 1.252 . . . . 0.0 112.924 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.83 -45.52 74.44 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.603 0.716 . . . . 0.0 110.609 176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.8 t -72.55 -41.82 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -30.65 38.19 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.105 0.866 . . . . 0.0 110.349 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.67 -36.49 67.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 120.344 1.429 . . . . 0.0 113.189 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.32 -43.13 98.67 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.261 0.9 OUTLIER -79.94 -17.47 52.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -53.28 -29.57 33.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.052 1.741 . . . . 0.0 110.69 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -59.46 -20.35 54.52 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.264 -0.898 . . . . 0.0 112.44 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -125.64 51.64 1.71 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.111 1.365 . . . . 0.0 108.35 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.57 -116.12 2.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 125.269 1.414 . . . . 0.0 110.377 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -154.47 113.13 3.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.82 116.22 21.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.036 1.734 . . . . 0.0 107.433 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -69.31 -57.82 4.82 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.085 0.554 . . . . 0.0 109.685 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.46 166.36 25.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 0.0 109.639 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 111.58 27.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 125.748 1.619 . . . . 0.0 107.11 -169.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.24 124.81 30.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.599 0.76 . . . . 0.0 109.965 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.94 85.48 22.97 Favored Pre-proline 0 C--O 1.225 -0.234 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.1 -15.15 42.56 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.52 2.146 . . . . 0.0 114.784 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.347 0.0 OUTLIER 60.41 160.86 0.11 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 128.767 2.827 . . . . 0.0 116.438 172.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.14 177.8 2.3 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.812 3.008 . . . . 0.0 110.33 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 t -129.5 115.13 33.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 168.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.5 t70 54.72 28.91 10.79 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.777 2.431 . . . . 0.0 114.582 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.18 -8.45 67.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.783 1.659 . . . . 0.0 113.291 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.84 146.56 6.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 125.031 1.333 . . . . 0.0 108.949 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.9 145.79 55.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.525 1.13 . . . . 0.0 111.842 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.51 156.19 79.02 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.145 1.778 . . . . 0.0 109.801 172.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.7 128.58 17.24 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.048 1.832 . . . . 0.0 108.765 169.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.01 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 127.055 2.264 . . . . 0.0 111.973 -175.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.28 130.57 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.296 1.548 . . . . 0.0 111.036 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.07 -13.66 66.43 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.768 1.651 . . . . 0.0 113.482 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.17 122.89 40.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.45 148.72 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 167.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.37 127.49 46.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.1 p -121.73 119.79 59.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.58 150.61 22.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.674 1.59 . . . . 0.0 107.645 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -132.93 162.99 30.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.405 1.082 . . . . 0.0 110.547 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.4 p -72.55 -6.5 44.4 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -154.28 157.3 38.48 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 120.203 1.365 . . . . 0.0 113.137 162.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.21 -16.79 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 112.107 167.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -94.24 -18.85 21.26 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.424 -1.423 . . . . 0.0 112.137 -175.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -85.03 -41.98 15.28 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.285 0.634 . . . . 0.0 110.271 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 p -62.65 -31.92 72.88 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.647 -0.658 . . . . 0.0 110.818 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -63.91 -13.91 49.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 113.206 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -95.73 -41.2 8.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 120.315 1.416 . . . . 0.0 108.488 172.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.11 45.69 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.024 0.929 . . . . 0.0 111.621 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -59.45 -31.69 69.54 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -162.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.86 -40.15 9.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.711 2.405 . . . . 0.0 110.327 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.92 -25.57 67.98 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 121.731 -0.606 . . . . 0.0 112.285 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -124.72 22.52 8.2 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.94 2.096 . . . . 0.0 110.29 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.2 m -56.87 127.47 31.89 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.277 -0.889 . . . . 0.0 109.092 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.65 5.8 64.96 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 118.628 -1.096 . . . . 0.0 112.975 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -173.65 0.17 Allowed 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.612 1.706 . . . . 0.0 110.17 176.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -124.19 121.21 34.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.8 14.06 22.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.181 0.991 . . . . 0.0 110.965 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.19 -66.45 0.09 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.67 -25.78 0.14 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.169 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -105.99 172.39 6.83 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.635 1.174 . . . . 0.0 110.452 -169.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.06 118.14 28.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.41 155.09 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.426 1.09 . . . . 0.0 109.628 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.69 147.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 158.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.71 144.43 42.97 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.543 1.937 . . . . 0.0 106.799 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -147.87 145.05 28.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.049 1.74 . . . . 0.0 107.936 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -64.79 138.13 58.2 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 164.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -165.83 1.05 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.543 1.937 . . . . 0.0 107.752 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.62 144.12 52.01 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.7 -21.27 10.0 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.17 2.58 . . . . 0.0 111.644 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -49.66 -55.41 13.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -42.13 96.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.949 0.9 . . . . 0.0 109.538 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -64.54 -38.81 92.29 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.277 1.031 . . . . 0.0 112.537 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -63.33 -4.38 2.58 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.339 -0.851 . . . . 0.0 112.977 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -137.9 -173.89 3.63 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 127.675 2.39 . . . . 0.0 108.43 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.43 ' HA ' ' CE1' ' A' ' 104' ' ' PHE . 7.7 mpt_? -123.35 68.72 1.01 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -125.36 27.17 6.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.716 1.206 . . . . 0.0 112.494 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -62.38 162.47 9.99 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.878 0.871 . . . . 0.0 109.547 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.7 t90 . . . . . 0 C--O 1.249 1.041 0 C-N-CA 124.248 1.019 . . . . 0.0 109.212 172.606 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.435 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.81 -168.62 23.87 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -172.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -60.65 158.07 33.71 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.192 0.597 . . . . 0.0 111.026 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.78 143.48 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.772 1.648 . . . . 0.0 108.751 162.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -120.32 174.37 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.962 1.305 . . . . 0.0 107.738 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.22 -5.02 55.45 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.071 0.948 . . . . 0.0 113.161 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.78 -175.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 118.856 0.753 . . . . 0.0 109.985 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.41 155.15 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.312 1.845 . . . . 0.0 106.733 164.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.3 t -113.11 136.77 52.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 169.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.1 mt -129.85 95.48 3.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.152 2.181 . . . . 0.0 107.384 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.8 mtm -87.65 157.82 19.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 66.45 30.07 8.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.69 1.596 . . . . 0.0 112.751 171.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttm -81.28 -82.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 162.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.9 m -93.73 146.38 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.822 1.649 . . . . 0.0 110.437 -162.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.74 155.04 42.13 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.253 1.021 . . . . 0.0 109.371 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.64 4.26 2.24 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.334 2.69 . . . . 0.0 113.667 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.41 6.03 8.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.986 1.714 . . . . 0.0 111.863 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -124.05 -8.56 7.7 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.907 0.883 . . . . 0.0 112.82 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.96 63.73 7.2 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.089 -1.007 . . . . 0.0 109.491 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.93 -39.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.058 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -67.28 100.94 0.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.373 1.069 . . . . 0.0 109.89 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.77 -2.98 0.17 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 130.219 3.408 . . . . 0.0 114.938 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 21' ' ' ASP . 7.3 pt-20 -124.23 -54.77 1.69 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.789 2.836 . . . . 0.0 108.651 -164.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.27 -41.75 98.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.761 1.225 . . . . 0.0 111.704 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -46.98 -40.47 14.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.466 1.506 . . . . 0.0 110.854 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.91 -25.91 40.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -63.53 -52.68 60.13 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.641 1.176 . . . . 0.0 108.954 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.31 -34.97 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.405 1.082 . . . . 0.0 110.087 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.73 -47.1 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.3 0.64 . . . . 0.0 110.141 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.36 -37.69 74.64 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.688 1.131 . . . . 0.0 112.117 -172.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.18 -38.44 91.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.23 1.015 . . . . 0.0 110.505 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.36 -33.18 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 109.763 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -66.39 -32.79 74.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.95 -54.53 37.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 110.623 171.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -63.66 -37.55 87.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.812 0.815 . . . . 0.0 111.245 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.25 -22.71 57.65 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.376 1.07 . . . . 0.0 110.543 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 t -72.37 -7.51 50.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.271 1.029 . . . . 0.0 111.282 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -73.47 -9.54 58.8 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 119.351 -2.093 . . . . 0.0 112.29 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.04 1.12 9.21 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.719 1.145 . . . . 0.0 112.668 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.12 -164.93 28.61 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 106.129 -2.788 . . . . 0.0 106.129 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -108.27 108.67 19.77 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.277 1.539 . . . . 0.0 109.984 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.67 116.05 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -55.26 -74.67 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.819 2.048 . . . . 0.0 107.024 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -174.29 4.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.259 1.024 . . . . 0.0 109.123 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.86 143.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.585 1.954 . . . . 0.0 107.145 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -130.3 118.35 21.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.211 1.404 . . . . 0.0 109.301 -172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.4 mt -131.31 86.84 49.23 Favored Pre-proline 0 C--O 1.234 0.242 0 C-N-CA 125.924 1.69 . . . . 0.0 107.921 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -55.79 124.94 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 167.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.85 47.93 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.386 . . . . 0.0 108.926 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -67.58 148.18 77.91 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.818 2.345 . . . . 0.0 109.792 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.72 167.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.656 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.08 86.87 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 128.144 2.578 . . . . 0.0 106.69 171.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.4 7.24 79.78 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-O 117.478 -1.734 . . . . 0.0 113.193 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.06 132.16 70.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 120.577 2.188 . . . . 0.0 108.724 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.95 170.39 6.79 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 122.101 0.953 . . . . 0.0 108.83 170.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.06 145.99 43.09 Favored Pre-proline 0 N--CA 1.446 -0.645 0 C-N-CA 125.32 1.448 . . . . 0.0 107.76 164.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.71 143.15 50.16 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 N-CA-C 107.764 -1.668 . . . . 0.0 107.764 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.6 80.09 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 121.953 -0.467 . . . . 0.0 113.168 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.25 156.99 37.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.482 0.713 . . . . 0.0 110.572 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.91 7.12 88.78 Favored Glycine 0 C--O 1.24 0.501 0 C-N-CA 123.758 0.694 . . . . 0.0 112.922 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 171.72 13.85 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 118.18 0.99 . . . . 0.0 109.589 165.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -121.83 156.03 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.99 150.1 39.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.49 155.19 28.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.89 144.97 45.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -172.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.75 168.32 10.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.941 0.877 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 -20.58 65.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.809 1.244 . . . . 0.0 112.918 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.9 t -163.19 155.82 18.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.56 1.073 . . . . 0.0 110.323 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.0 t -51.91 -40.01 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.6 1.96 . . . . 0.0 110.307 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -75.49 -12.24 60.19 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 119.435 -2.04 . . . . 0.0 114.115 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -93.16 -41.6 9.83 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.541 1.136 . . . . 0.0 109.364 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.42 -40.58 96.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -51.4 -10.48 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 130.135 3.374 . . . . 0.0 114.733 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -97.35 -41.91 8.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.966 1.257 . . . . 0.0 109.488 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.65 87.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.71 0.804 . . . . 0.0 112.625 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -43.32 63.78 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.768 2.427 . . . . 0.0 112.947 -162.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -98.66 -31.15 12.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.061 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.79 -9.18 58.78 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.921 0.782 . . . . 0.0 113.947 -170.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -123.7 3.55 8.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.203 1.401 . . . . 0.0 112.356 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -71.96 142.74 49.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.02 -3.04 82.2 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.076 -1.015 . . . . 0.0 112.731 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -63.69 175.17 1.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.284 1.542 . . . . 0.0 110.367 170.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -125.75 96.15 4.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -83.19 13.64 4.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.415 0.626 . . . . 0.0 111.631 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.0 -77.97 0.05 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.675 2.39 . . . . 0.0 104.658 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.8 -22.9 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.071 0.948 . . . . 0.0 113.368 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -92.49 166.92 12.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.548 -0.72 . . . . 0.0 110.956 -172.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.94 109.79 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.0 t -82.16 146.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.204 1.402 . . . . 0.0 110.654 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -128.93 118.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 p -72.06 159.93 33.35 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.347 1.07 . . . . 0.0 110.493 170.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -156.47 159.74 38.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.989 2.516 . . . . 0.0 105.739 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -74.67 159.39 32.14 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.504 160.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.82 -164.58 1.36 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 108.527 163.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -114.47 144.52 31.95 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.67 -27.94 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.422 2.748 . . . . 0.0 112.927 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.74 -42.05 95.48 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 120.741 -1.224 . . . . 0.0 110.688 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -72.81 -19.5 61.32 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.55 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.47 -45.53 53.65 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.004 2.122 . . . . 0.0 111.444 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -63.05 -8.12 6.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.797 0.839 . . . . 0.0 111.757 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -134.41 -163.63 1.4 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.441 2.696 . . . . 0.0 106.987 -163.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.75 39.72 3.82 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.344 1.057 . . . . 0.0 109.132 -173.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.53 42.93 2.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.005 1.322 . . . . 0.0 111.331 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -67.84 173.06 4.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 109.043 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.3 t90 . . . . . 0 C--O 1.248 0.999 0 O-C-N 121.012 -1.055 . . . . 0.0 109.265 169.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.711 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.66 131.4 2.26 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -172.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -68.97 152.44 96.81 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 164.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.12 146.75 52.65 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.515 2.143 . . . . 0.0 108.708 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 p -137.25 166.74 23.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.31 2.55 21.04 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.91 88.56 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.61 117.34 7.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.803 1.241 . . . . 0.0 108.429 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -84.48 143.04 29.63 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.5 mt -135.45 156.13 49.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 109.388 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.56 165.47 26.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 107.752 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 60.4 26.97 16.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -74.22 0.17 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 157.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -92.5 172.45 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 124.402 1.081 . . . . 0.0 110.733 -163.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -125.6 157.63 67.68 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.69 0.85 4.32 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 121.884 1.723 . . . . 0.0 112.824 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -123.22 12.39 9.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.851 2.06 . . . . 0.0 112.665 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -139.44 22.38 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.998 -1.064 . . . . 0.0 112.021 -169.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -109.72 6.37 23.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.675 1.19 . . . . 0.0 113.004 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.29 -29.87 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.501 -0.749 . . . . 0.0 111.156 -166.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.11 110.14 3.84 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.14 1.376 . . . . 0.0 108.562 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.26 -36.09 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.691 0.797 . . . . 0.0 110.056 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.89 -64.69 0.81 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.871 0.868 . . . . 0.0 110.0 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.42 -35.21 71.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.886 0.474 . . . . 0.0 112.001 -172.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -52.59 -44.21 65.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.515 1.126 . . . . 0.0 111.71 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -74.8 -34.11 62.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.375 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.35 -53.92 51.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.359 1.063 . . . . 0.0 108.631 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.38 -42.63 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.368 1.067 . . . . 0.0 110.42 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.67 -32.7 52.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 124.123 0.969 . . . . 0.0 111.316 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.98 -49.49 19.77 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 123.21 0.319 . . . . 0.0 110.537 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.11 -38.57 83.41 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.477 1.132 . . . . 0.0 109.588 -175.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.36 -36.31 48.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 121.547 -0.721 . . . . 0.0 110.12 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -59.5 -44.76 93.01 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.374 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -65.9 -42.02 90.75 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.712 0.687 . . . . 0.0 111.895 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -67.87 -34.95 77.67 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.395 -172.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 t -78.11 -32.75 50.65 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.339 1.056 . . . . 0.0 110.709 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -56.73 -14.66 3.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.348 1.459 . . . . 0.0 112.039 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -61.54 -19.24 61.9 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.099 -2.25 . . . . 0.0 113.269 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.58 -6.6 13.39 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.862 1.265 . . . . 0.0 112.595 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.39 -151.81 20.8 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -167.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -129.31 108.34 10.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.6 t -72.7 115.79 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -81.8 -50.99 8.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.805 2.042 . . . . 0.0 109.39 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.0 p -153.99 169.83 22.53 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.053 0.941 . . . . 0.0 110.208 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.4 mt -141.4 116.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.57 131.6 34.33 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 110.384 170.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.93 87.02 25.38 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.932 1.693 . . . . 0.0 107.738 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.69 154.5 68.88 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.78 1.653 . . . . 0.0 109.234 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.8 155.55 62.94 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.164 0.986 . . . . 0.0 111.548 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.43 132.24 37.43 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.967 3.112 . . . . 0.0 110.261 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.3 t -81.34 104.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t0 57.97 24.28 10.86 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 170.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.04 60.97 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 128.18 2.8 . . . . 0.0 115.306 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 p -66.77 158.64 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.056 1.428 . . . . 0.0 111.601 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -71.78 132.58 44.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.143 159.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.15 161.26 32.09 Favored Pre-proline 0 C--O 1.241 0.637 0 C-N-CA 124.947 1.299 . . . . 0.0 111.305 167.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.14 137.68 34.9 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.635 2.224 . . . . 0.0 108.412 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.82 9.19 85.78 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.767 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.54 140.66 53.89 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.036 0.918 . . . . 0.0 109.829 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.95 -32.42 6.64 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.28 1.895 . . . . 0.0 111.926 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -85.17 152.5 23.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 mp -123.52 146.65 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 169.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.08 120.68 25.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -118.72 106.94 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -79.23 142.74 35.97 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.404 1.481 . . . . 0.0 107.889 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -121.79 177.25 5.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.356 1.063 . . . . 0.0 111.596 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.0 p -72.05 -26.76 62.31 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.721 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.7 m -153.89 159.45 41.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.504 1.621 . . . . 0.0 112.964 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.26 -12.58 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 120.588 -1.32 . . . . 0.0 111.383 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -95.9 -21.12 18.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.313 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.59 -29.98 14.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.873 1.669 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.8 p -60.4 -35.28 75.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.172 0.511 . . . . 0.0 110.4 168.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -24.06 66.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.977 1.711 . . . . 0.0 112.413 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -86.98 -46.03 10.22 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.3 68.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.884 0.874 . . . . 0.0 110.448 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -57.13 -39.41 75.11 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.056 0.389 . . . . 0.0 111.818 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -74.91 -45.83 40.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.128 -0.358 . . . . 0.0 111.04 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.16 -21.46 61.75 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.921 -0.377 . . . . 0.0 112.41 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 81' ' ' GLY . 97.4 mt -131.14 18.66 4.95 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.865 1.266 . . . . 0.0 111.858 -163.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -70.44 23.79 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 O-C-N 120.073 -1.642 . . . . 0.0 114.017 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 79' ' ' LEU . . . -175.09 3.33 0.03 OUTLIER Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.967 1.746 . . . . 0.0 115.068 -166.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -173.68 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.938 1.869 . . . . 0.0 111.931 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -133.64 81.57 1.93 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.393 0.677 . . . . 0.0 109.538 -168.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -74.94 14.02 0.58 Allowed 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.334 -0.854 . . . . 0.0 113.165 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.35 -85.04 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.663 2.385 . . . . 0.0 105.415 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.72 -5.39 1.04 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.77 176.92 5.64 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.786 1.176 . . . . 0.0 108.655 -174.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -82.51 136.9 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.42 164.39 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 124.727 1.211 . . . . 0.0 108.825 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -138.48 139.37 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.7 p -96.61 165.55 12.1 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.181 0.9 . . . . 0.0 110.983 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -153.36 154.53 34.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.921 1.688 . . . . 0.0 108.247 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -80.9 141.21 34.8 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 158.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.73 -168.16 1.28 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.823 1.649 . . . . 0.0 108.847 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -121.03 145.25 41.25 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.494 1.118 . . . . 0.0 107.983 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.29 -22.41 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.626 2.884 . . . . 0.0 114.15 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.31 -47.1 76.1 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.777 1.626 . . . . 0.0 109.537 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 p -77.06 2.1 16.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.843 1.257 . . . . 0.0 111.795 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -94.11 -41.12 9.69 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.641 1.577 . . . . 0.0 109.083 165.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -64.35 -24.7 67.74 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 112.135 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -126.39 165.7 18.56 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 126.434 1.894 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -75.68 23.62 0.12 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.363 1.865 . . . . 0.0 112.566 -175.217 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -91.28 40.33 1.03 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.351 -1.468 . . . . 0.0 112.405 -160.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 7.0 m-85 -73.53 12.3 0.65 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.213 2.205 . . . . 0.0 115.779 -165.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 . . . . . 0 C--O 1.241 0.652 0 C-N-CA 126.044 1.737 . . . . 0.0 110.983 -166.895 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.573 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.97 -177.86 44.36 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 122.089 0.827 . . . . 0.0 112.945 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -159.08 161.12 28.55 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 129.379 3.071 . . . . 0.0 107.08 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 93' ' ' TYR . 20.4 Cg_endo -64.29 141.17 74.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.405 2.07 . . . . 0.0 112.143 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.1 p -133.57 -178.79 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.437 1.895 . . . . 0.0 108.149 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.02 -7.3 21.53 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.374 -1.298 . . . . 0.0 113.656 171.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.33 149.57 25.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 121.036 1.743 . . . . 0.0 110.859 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.72 119.03 27.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.744 2.418 . . . . 0.0 107.24 -170.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.84 145.78 25.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.086 0.554 . . . . 0.0 109.762 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.9 mt -136.55 120.41 17.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.286 1.435 . . . . 0.0 109.676 -167.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -106.52 156.64 18.36 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 75.44 23.6 1.48 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.48 2.312 . . . . 0.0 113.693 170.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -81.84 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 163.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.0 m -87.84 172.79 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.875 1.67 . . . . 0.0 111.764 -159.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 mt -126.32 158.1 68.04 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.409 1.483 . . . . 0.0 109.762 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.11 2.59 5.94 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.141 1.894 . . . . 0.0 113.103 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -128.63 18.55 6.27 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.966 1.706 . . . . 0.0 111.297 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -137.44 33.36 2.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.568 1.147 . . . . 0.0 111.152 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.2 mt -130.22 39.28 3.68 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 127.202 2.201 . . . . 0.0 109.406 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.97 -33.4 6.51 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.677 0.791 . . . . 0.0 110.579 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 94.94 1.68 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.42 1.088 . . . . 0.0 110.176 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.85 -36.29 58.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.968 2.107 . . . . 0.0 111.25 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -72.66 -55.31 7.03 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.716 0.407 . . . . 0.0 110.114 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -63.35 -36.44 83.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.339 0.655 . . . . 0.0 109.732 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -45.95 -48.69 16.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.994 0.918 . . . . 0.0 111.153 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.7 -28.19 50.9 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.929 -0.482 . . . . 0.0 112.172 -167.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -64.39 -55.54 20.36 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.597 1.559 . . . . 0.0 109.59 167.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.86 -36.24 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.75 0.82 . . . . 0.0 110.554 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.1 t -59.07 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 118.768 0.713 . . . . 0.0 109.228 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.46 -38.54 74.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.771 0.714 . . . . 0.0 111.315 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -70.94 -33.82 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.046 -175.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.96 -37.65 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.432 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 40.9 ttp180 -57.58 -36.29 71.5 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.707 1.139 . . . . 0.0 110.24 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.31 -29.57 68.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.759 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -68.79 -45.18 71.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.468 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' A' ' 33' ' ' ARG 0.267 0.8 OUTLIER -69.33 -26.53 64.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 172.8 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.3 t -62.77 -14.82 49.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.95 1.3 . . . . 0.0 111.887 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -62.68 -11.12 15.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 119.556 -1.965 . . . . 0.0 114.456 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.57 -0.64 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.501 1.046 . . . . 0.0 112.985 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.4 -174.37 41.89 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -94.74 111.9 23.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.6 t -71.78 109.6 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -52.06 64.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.982 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -167.87 172.23 9.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.936 1.694 . . . . 0.0 110.578 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 mt -135.58 145.89 30.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.42 125.45 47.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.517 1.927 . . . . 0.0 109.443 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.15 86.92 12.62 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.098 1.759 . . . . 0.0 107.697 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.3 140.18 30.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.774 2.316 . . . . 0.0 108.839 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mtm-85 -116.06 146.28 36.75 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.326 1.05 . . . . 0.0 108.77 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.38 131.48 23.36 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.244 1.962 . . . . 0.0 108.555 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.64 167.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 85.05 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 128.933 2.893 . . . . 0.0 108.138 173.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.22 -16.33 22.47 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 126.514 2.007 . . . . 0.0 112.74 173.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.88 129.6 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.81 1.305 . . . . 0.0 111.276 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -66.02 169.42 6.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.095 0.95 . . . . 0.0 110.832 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.18 154.37 42.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 126.22 1.808 . . . . 0.0 110.013 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.94 111.28 3.23 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.845 2.363 . . . . 0.0 108.341 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.54 58.82 6.13 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.5 t -72.18 154.2 41.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.82 58.38 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 124.784 1.183 . . . . 0.0 112.908 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 168.2 10.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.501 1.651 . . . . 0.0 108.276 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.81 143.54 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.32 141.86 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.12 104.52 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -167.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -83.95 135.1 34.6 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.59 173.39 6.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 126.717 2.007 . . . . 0.0 108.423 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.9 t -92.57 -9.85 39.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.562 -176.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -154.53 155.88 35.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 121.261 1.846 . . . . 0.0 111.882 166.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 t -67.02 -24.93 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.078 1.351 . . . . 0.0 109.728 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -60.56 -59.32 5.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.571 1.148 . . . . 0.0 109.502 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.79 -45.84 59.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.42 1.488 . . . . 0.0 109.632 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.1 t -62.48 -50.56 70.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.369 1.067 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -56.4 -34.87 67.14 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.059 0.943 . . . . 0.0 112.33 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.48 -42.95 33.94 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.91 0.777 . . . . 0.0 109.679 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.42 79.74 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.175 0.99 . . . . 0.0 110.51 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.442 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 4.3 mmm -44.76 -66.48 0.39 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.126 1.371 . . . . 0.0 110.12 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.69 -39.31 88.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.959 0.503 . . . . 0.0 111.226 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -36.45 93.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.959 0.79 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.8 mt -104.91 3.48 30.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.417 1.087 . . . . 0.0 110.892 -168.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.2 m -61.2 110.56 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.943 0.897 . . . . 0.0 109.659 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.73 19.44 73.28 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.387 0.539 . . . . 0.0 113.05 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -66.44 -178.64 0.7 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.761 1.28 . . . . 0.0 110.701 162.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -130.43 96.15 4.06 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.07 14.01 9.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.684 0.754 . . . . 0.0 111.898 -167.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -156.42 -66.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 161.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -147.86 -16.65 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -121.72 168.13 12.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.143 0.977 . . . . 0.0 111.637 -167.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.59 114.44 5.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.658 0.783 . . . . 0.0 109.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.25 150.86 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.349 1.06 . . . . 0.0 109.866 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.7 t -121.7 139.25 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 162.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -115.69 130.49 56.88 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.707 2.003 . . . . 0.0 108.554 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -132.9 171.18 14.28 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 119.778 1.172 . . . . 0.0 110.579 161.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 4' ' ' PRO . 86.8 m-85 -82.89 147.82 28.06 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 -163.76 1.13 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.842 1.257 . . . . 0.0 109.745 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.49 143.47 29.0 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.26 -28.18 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.709 2.272 . . . . 0.0 111.793 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.35 -50.54 73.58 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.59 -1.319 . . . . 0.0 110.166 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.4 p -70.56 -7.28 42.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.075 1.75 . . . . 0.0 111.073 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.19 -45.92 9.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.161 1.784 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -64.3 -44.52 91.37 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.515 0.674 . . . . 0.0 109.863 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -77.98 172.78 12.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 109.119 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.418 ' HG3' ' CE2' ' A' ' 104' ' ' PHE . 50.2 ttp180 -103.96 72.62 1.11 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 164.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -123.37 61.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.917 0.865 . . . . 0.0 109.66 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' A' ' 102' ' ' ARG . 4.9 m-30 -86.84 -162.28 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.254 1.821 . . . . 0.0 109.856 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 130.191 3.396 . . . . 0.0 109.112 -171.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.512 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -82.49 -123.16 0.75 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 171.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -63.2 165.04 11.73 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.277 1.431 . . . . 0.0 112.19 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.39 126.33 13.43 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.072 1.848 . . . . 0.0 108.661 156.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -103.23 177.1 4.93 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -81.9 3.58 25.68 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.571 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 94' ' ' CYS . 2.4 m -124.42 156.03 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.739 1.154 . . . . 0.0 108.729 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.2 tp -136.37 122.3 20.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.985 1.714 . . . . 0.0 107.713 -168.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -81.22 139.11 35.7 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.1 mt -128.62 95.25 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.863 2.465 . . . . 0.0 107.4 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mtm -92.63 155.69 17.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 75.2 23.69 1.55 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 114.265 170.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -84.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 161.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.4 163.18 3.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 111.184 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.9 158.42 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.002 1.321 . . . . 0.0 109.841 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.82 -2.66 9.0 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.929 2.419 . . . . 0.0 113.316 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.21 2.13 11.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.572 1.949 . . . . 0.0 111.187 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -104.87 -30.34 9.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 118.669 0.668 . . . . 0.0 112.199 169.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.99 49.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.011 2.124 . . . . 0.0 113.396 -161.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 -10.56 6.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.203 1.801 . . . . 0.0 111.674 -169.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.4 122.19 38.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.006 0.923 . . . . 0.0 110.297 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.18 -15.63 63.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.254 1.422 . . . . 0.0 112.705 -168.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -78.85 -63.16 1.48 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.429 1.492 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.79 -35.65 66.52 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 109.937 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -55.97 -38.43 70.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.611 0.764 . . . . 0.0 112.166 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -80.36 -36.65 33.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.647 0.779 . . . . 0.0 110.678 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -56.72 -45.14 82.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.525 0.679 . . . . 0.0 109.9 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.89 -33.31 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.387 1.075 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.33 -44.65 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.287 -0.883 . . . . 0.0 108.718 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.06 -39.52 86.91 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.809 0.732 . . . . 0.0 110.531 -173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.7 -36.29 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.993 1.378 . . . . 0.0 111.487 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.62 -28.52 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.621 1.568 . . . . 0.0 109.944 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -44.62 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.52 -0.738 . . . . 0.0 109.343 170.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.44 -44.58 92.89 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.524 0.678 . . . . 0.0 111.354 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -43.76 50.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.856 -166.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.529 ' HG ' ' CD1' ' A' ' 79' ' ' LEU . 1.9 t -83.36 -17.98 40.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.505 -1.278 . . . . 0.0 110.331 -167.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -65.62 -15.62 62.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 110.783 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -63.24 -12.57 29.8 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.787 -1.196 . . . . 0.0 111.212 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.649 1.579 . . . . 0.0 112.935 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.33 26.34 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 120.105 1.321 . . . . 0.0 110.784 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.77 111.58 18.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.512 1.525 . . . . 0.0 107.965 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.04 114.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -53.83 -61.36 2.36 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 109.242 166.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 t -160.23 177.35 10.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.153 0.888 . . . . 0.0 111.558 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.98 135.04 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.671 2.388 . . . . 0.0 106.087 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -125.98 106.92 9.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.231 1.013 . . . . 0.0 112.995 -167.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.31 85.93 59.84 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 127.376 2.27 . . . . 0.0 108.334 -165.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.46 138.81 61.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.553 1.502 . . . . 0.0 109.8 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 162.42 19.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 126.567 1.947 . . . . 0.0 110.471 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.05 169.77 1.83 Allowed 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 124.47 3.446 . . . . 0.0 111.977 165.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.422 ' H ' HG12 ' A' ' 54' ' ' VAL . 26.2 t -133.17 107.04 10.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t0 52.46 33.03 12.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.284 1.034 . . . . 0.0 112.232 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.49 6.78 88.87 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.987 2.232 . . . . 0.0 115.585 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 51' ' ' VAL . 1.4 p -58.15 157.47 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 118.402 1.101 . . . . 0.0 111.353 174.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.29 113.05 20.43 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 156.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.81 145.64 29.95 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.529 1.132 . . . . 0.0 110.011 167.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.06 133.36 33.01 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.972 2.448 . . . . 0.0 108.593 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.45 0.36 70.14 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -71.75 155.05 40.9 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.574 1.687 . . . . 0.0 110.049 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.59 -1.12 79.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.034 0.826 . . . . 0.0 113.203 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 170.86 7.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 120.226 2.013 . . . . 0.0 109.316 168.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.0 mt -134.82 154.37 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -119.0 166.2 13.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 158.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 p -139.07 152.7 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -132.08 139.13 48.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.14 164.32 11.9 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 108.326 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 t -87.15 0.95 54.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.827 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.9 p -154.68 148.38 25.41 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.548 1.067 . . . . 0.0 109.808 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -60.13 -34.85 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.092 0.557 . . . . 0.0 109.587 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -76.96 -23.71 52.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.69 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.99 -49.61 49.81 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.922 1.237 . . . . 0.0 108.024 166.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.6 t -56.98 -47.0 81.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.219 1.008 . . . . 0.0 109.97 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -57.65 -27.13 62.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.341 1.056 . . . . 0.0 113.339 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -79.46 -54.27 6.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.14 -51.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.269 1.027 . . . . 0.0 110.837 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -59.07 -34.54 72.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.964 0.905 . . . . 0.0 112.434 -170.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.98 -34.48 18.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.62 1.168 . . . . 0.0 110.555 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 -29.83 75.86 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.117 1.341 . . . . 0.0 112.164 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.529 ' CD1' ' HG ' ' A' ' 36' ' ' CYS . 39.8 mt -113.29 7.11 17.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.664 1.185 . . . . 0.0 111.619 -168.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -48.66 131.58 17.77 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.11 -2.62 80.55 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.486 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -62.99 176.71 0.67 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.221 1.511 . . . . 0.0 112.019 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 85' ' ' ALA . 21.9 mtpt -132.17 83.14 2.06 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -174.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -78.31 14.5 1.19 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.66 -0.65 . . . . 0.0 111.461 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' H ' ' C ' ' A' ' 83' ' ' LYS . . . -156.38 -80.25 0.08 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.695 -2.706 . . . . 0.0 103.695 159.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -145.12 -16.91 0.5 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.114 0.966 . . . . 0.0 113.264 -165.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -100.26 -173.5 2.44 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.591 1.087 . . . . 0.0 109.444 -175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.72 149.9 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 164.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.67 133.83 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.314 1.846 . . . . 0.0 107.391 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.82 138.46 25.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 161.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 p -102.05 151.56 22.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.597 1.559 . . . . 0.0 108.532 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -149.15 156.98 43.0 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.373 1.469 . . . . 0.0 108.408 170.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -76.18 144.63 40.39 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.695 1.589 . . . . 0.0 107.821 160.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -104.79 -163.93 1.0 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.003 0.921 . . . . 0.0 108.683 171.111 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.78 143.59 28.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 167.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.5 -27.07 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.506 2.138 . . . . 0.0 111.243 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -53.12 60.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -77.22 -10.41 59.4 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.398 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -75.69 -43.65 46.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.175 0.898 . . . . 0.0 110.874 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -62.75 -22.03 66.26 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.634 0.373 . . . . 0.0 111.659 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.4 -177.7 3.2 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.349 1.46 . . . . 0.0 109.714 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 13.4 ttt180 -91.89 30.81 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.734 0.814 . . . . 0.0 111.348 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.82 48.62 1.61 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.99 -1.069 . . . . 0.0 111.997 -162.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 10.3 m-85 -84.82 135.31 34.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.017 -167.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 164.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.625 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.22 -164.42 13.28 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 166.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -58.56 153.85 37.77 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.902 0.881 . . . . 0.0 113.251 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -62.61 151.64 82.32 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.84 2.36 . . . . 0.0 109.312 162.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.7 p -138.95 176.96 8.25 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -75.47 7.94 3.22 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.327 -0.858 . . . . 0.0 111.988 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 t -133.17 107.08 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.121 1.769 . . . . 0.0 111.147 -169.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -100.19 129.37 46.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.735 2.414 . . . . 0.0 106.651 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 49.8 t -81.86 138.37 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.57 122.88 30.04 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.714 2.406 . . . . 0.0 107.47 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.3 mtm -135.01 73.94 1.5 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -161.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 174.52 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -51.65 30.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.625 1.17 . . . . 0.0 109.717 -172.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 165.59 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 O-C-N 125.167 1.542 . . . . 0.0 108.914 -174.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -100.66 160.68 26.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -68.46 7.66 0.65 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 126.224 4.616 . . . . 0.0 114.341 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -135.55 3.92 3.07 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.162 1.385 . . . . 0.0 112.739 -159.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -126.07 5.68 7.19 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.846 -1.158 . . . . 0.0 112.051 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.12 10.36 3.62 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.879 2.072 . . . . 0.0 112.93 -176.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.16 -17.89 20.51 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.789 2.035 . . . . 0.0 112.698 -168.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 88.17 2.86 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 174.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.34 -26.41 12.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.281 2.632 . . . . 0.0 112.758 -165.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.2 -28.11 69.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.307 1.843 . . . . 0.0 113.406 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -85.76 -36.67 20.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.939 0.896 . . . . 0.0 109.022 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.63 -34.26 69.12 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.82 -40.16 29.16 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.199 1.4 . . . . 0.0 112.073 -173.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -60.23 -45.79 92.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.8 mt -61.06 -31.13 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 123.735 0.814 . . . . 0.0 110.938 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.31 -55.84 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.243 0.929 . . . . 0.0 110.473 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.56 -32.98 72.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.517 1.127 . . . . 0.0 112.487 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.58 -27.3 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.474 1.11 . . . . 0.0 109.776 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -67.96 -34.25 76.21 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.176 -0.952 . . . . 0.0 109.642 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.01 -37.45 55.02 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.635 0.774 . . . . 0.0 112.483 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -50.86 61.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.437 1.017 . . . . 0.0 110.559 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.1 t -70.57 -19.39 62.87 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.783 -0.573 . . . . 0.0 110.914 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.29 3.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.351 1.86 . . . . 0.0 112.955 166.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -68.39 -9.42 48.15 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.918 -1.739 . . . . 0.0 113.863 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.4 1.51 4.58 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.741 0.816 . . . . 0.0 113.139 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.9 -139.46 5.2 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -144.13 121.41 11.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.18 1.792 . . . . 0.0 106.232 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.1 t -74.13 120.66 23.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 170.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -76.48 -57.89 3.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.006 0.923 . . . . 0.0 109.35 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.32 172.24 18.52 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.056 1.342 . . . . 0.0 109.345 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mt -137.1 118.11 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -90.86 122.11 33.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.442 1.097 . . . . 0.0 108.344 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.66 86.31 34.27 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 126.848 2.059 . . . . 0.0 105.77 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.18 158.66 33.85 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.366 1.378 . . . . 0.0 110.447 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -123.32 165.12 23.99 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.924 0.889 . . . . 0.0 109.489 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.67 124.72 6.43 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.982 3.121 . . . . 0.0 109.011 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.4 106.86 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 t70 53.96 24.95 4.98 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.83 13.15 70.2 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.214 1.387 . . . . 0.0 114.291 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.89 161.07 4.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 118.579 1.189 . . . . 0.0 111.094 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -81.05 129.33 34.5 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.892 0.853 . . . . 0.0 109.701 157.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.49 156.41 53.32 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 125.629 1.571 . . . . 0.0 109.668 171.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.2 136.83 35.55 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.023 1.815 . . . . 0.0 108.861 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.86 2.74 88.4 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.656 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -67.75 141.76 56.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 117.753 0.776 . . . . 0.0 109.301 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.68 -25.2 27.44 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.458 1.98 . . . . 0.0 112.311 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.04 16.09 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.26 1.03 . . . . 0.0 108.981 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -123.26 145.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.15 104.53 9.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.98 153.76 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -132.34 147.02 52.38 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.22 174.67 9.37 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.529 0.604 . . . . 0.0 110.517 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.03 -22.45 55.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 177.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.8 p -152.47 161.94 41.89 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.422 1.01 . . . . 0.0 111.168 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.68 -13.99 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 110.497 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.97 -48.44 21.12 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 120.026 -1.671 . . . . 0.0 109.894 172.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.49 -41.81 86.19 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.373 0.669 . . . . 0.0 109.554 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.4 p -68.54 -40.65 80.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.327 0.651 . . . . 0.0 109.999 -175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -56.72 -31.26 64.34 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.375 1.47 . . . . 0.0 111.032 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -83.86 -46.56 12.03 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.925 0.784 . . . . 0.0 109.7 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.63 -49.12 73.7 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.375 0.67 . . . . 0.0 109.726 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.2 tpp -44.27 -73.0 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 127.86 2.464 . . . . 0.0 110.119 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -73.11 -7.56 51.87 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.08 -35.31 61.07 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.855 -1.153 . . . . 0.0 110.678 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.5 mt -127.62 -1.13 6.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.419 1.088 . . . . 0.0 112.34 -154.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 m -50.58 122.29 6.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.753 1.221 . . . . 0.0 108.405 157.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 11.5 84.27 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.115 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.5 mmt-85 -71.2 -178.43 2.03 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.604 1.702 . . . . 0.0 112.239 174.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -120.92 94.98 4.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.68 43.02 1.13 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 173.63 -86.41 0.0 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.177 2.991 . . . . 0.0 105.958 166.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -149.09 -5.12 0.4 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.276 1.83 . . . . 0.0 111.622 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -118.46 -178.85 3.62 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.942 1.697 . . . . 0.0 109.797 -175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.39 165.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.1 t -130.31 132.65 64.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 125.777 1.631 . . . . 0.0 108.729 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.63 143.26 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 p -113.48 156.68 23.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 127.638 2.375 . . . . 0.0 107.527 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 169.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -69.38 150.02 47.75 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -130.66 -167.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.232 1.813 . . . . 0.0 108.136 174.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.65 150.64 52.87 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.96 -19.97 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.508 2.805 . . . . 0.0 113.042 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.48 -49.49 61.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.127 1.331 . . . . 0.0 110.378 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.07 7.75 5.74 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.339 1.856 . . . . 0.0 111.663 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -111.79 -36.64 5.38 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -57.96 -31.7 67.13 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -123.74 168.59 12.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.251 1.42 . . . . 0.0 109.347 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -79.73 27.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.172 1.789 . . . . 0.0 111.254 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -86.74 70.59 10.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -101.31 149.88 23.57 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.581 1.152 . . . . 0.0 108.068 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.403 -1.284 . . . . 0.0 110.095 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.974 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.04 -110.78 0.42 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -140.73 157.12 68.46 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.099 1.759 . . . . 0.0 108.831 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.02 151.64 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.352 2.034 . . . . 0.0 109.331 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 p -135.33 177.04 8.12 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -78.7 -0.43 30.12 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.662 171.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -102.22 153.02 5.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 120.657 1.571 . . . . 0.0 109.86 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.65 149.76 46.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.668 1.587 . . . . 0.0 107.545 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 50.7 t -109.29 136.13 49.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.0 mt -128.43 110.03 11.95 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -170.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtm -101.66 152.96 20.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 75.11 30.41 0.89 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.691 2.797 . . . . 0.0 114.542 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -69.12 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.521 -1.362 . . . . 0.0 109.632 169.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.32 148.45 29.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.727 1.611 . . . . 0.0 109.829 -155.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -95.36 158.1 35.2 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.37 3.81 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.626 2.217 . . . . 0.0 112.978 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -128.95 15.95 6.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.159 1.784 . . . . 0.0 112.268 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -142.17 31.42 1.56 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.653 1.181 . . . . 0.0 111.066 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.18 5.12 10.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.698 1.599 . . . . 0.0 111.38 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.66 -23.53 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.189 0.996 . . . . 0.0 109.504 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.0 81.53 8.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.955 2.502 . . . . 0.0 109.704 -162.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.5 -4.66 0.26 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.819 2.847 . . . . 0.0 114.591 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.83 -33.47 4.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 127.889 2.476 . . . . 0.0 111.856 -166.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.86 -39.82 61.34 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.131 0.878 . . . . 0.0 109.279 162.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.411 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 67.3 t80 -45.49 -40.51 8.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.155 1.782 . . . . 0.0 113.107 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.75 -31.63 41.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.722 0.809 . . . . 0.0 113.171 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -66.55 -50.49 62.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.671 1.588 . . . . 0.0 109.17 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.33 -27.07 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.027 0.931 . . . . 0.0 109.556 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.01 -49.75 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.18 -39.24 86.37 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.52 -47.97 72.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.957 1.36 . . . . 0.0 110.161 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.432 HG11 ' CE2' ' A' ' 84' ' ' PHE . 24.8 t -78.23 -32.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.555 -173.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -66.62 -42.91 86.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.712 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.27 -56.37 21.88 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.451 0.7 . . . . 0.0 109.803 174.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.53 -39.97 88.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.477 0.655 . . . . 0.0 110.582 -164.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -78.3 -20.09 52.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.832 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -73.4 -9.91 59.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.125 -0.984 . . . . 0.0 111.702 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -64.11 -15.17 59.11 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.31 -1.494 . . . . 0.0 111.44 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -116.71 5.29 13.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.616 2.366 . . . . 0.0 111.101 -175.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.29 -151.71 22.82 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 120.286 1.403 . . . . 0.0 111.978 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -125.77 108.68 11.73 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -78.76 103.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -49.14 -56.02 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.342 1.057 . . . . 0.0 110.39 164.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.81 168.15 23.62 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.329 0.513 . . . . 0.0 111.292 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.73 138.76 43.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 127.038 2.135 . . . . 0.0 105.561 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -123.34 111.07 15.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.602 1.561 . . . . 0.0 110.019 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.47 86.16 56.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.19 1.396 . . . . 0.0 108.579 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.29 144.29 61.73 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.125 1.883 . . . . 0.0 108.582 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -123.97 155.27 67.53 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 108.594 -177.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.73 147.98 89.98 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.237 1.958 . . . . 0.0 110.867 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.56 166.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 127.469 2.308 . . . . 0.0 107.677 171.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -64.27 78.01 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 128.117 2.567 . . . . 0.0 109.138 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.44 2.61 57.68 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 117.889 -1.506 . . . . 0.0 113.612 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 t -129.89 144.83 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 120.262 2.031 . . . . 0.0 108.877 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -82.14 172.96 12.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.161 0.981 . . . . 0.0 112.415 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.07 142.38 36.44 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.311 1.845 . . . . 0.0 108.372 174.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.22 130.4 21.24 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.586 2.191 . . . . 0.0 108.846 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.15 27.81 47.71 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.364 0.507 . . . . 0.0 112.296 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 t -71.88 148.68 45.89 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.371 1.086 . . . . 0.0 110.474 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.07 -32.56 5.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 126.872 2.177 . . . . 0.0 111.467 -174.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -77.19 160.09 29.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mt -127.56 147.13 32.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 168.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.67 158.02 22.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.31 155.13 28.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -133.05 134.69 44.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 0.0 107.832 -173.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.89 -177.1 3.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.766 1.626 . . . . 0.0 109.288 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 t -109.19 3.2 21.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.526 0.73 . . . . 0.0 112.074 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -152.01 139.37 19.45 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.085 -1.634 . . . . 0.0 109.545 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.471 HG12 HE21 ' A' ' 73' ' ' GLN . 4.6 t -51.98 -37.38 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.565 1.546 . . . . 0.0 109.633 168.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.31 -16.56 54.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.877 1.271 . . . . 0.0 113.104 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -115.43 -35.13 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -164.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 t -53.81 -48.48 69.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.416 1.086 . . . . 0.0 109.704 160.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.471 HE21 HG12 ' A' ' 69' ' ' VAL . 41.3 mt-30 -54.49 -24.34 20.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.17 1.388 . . . . 0.0 113.935 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -82.97 -53.76 5.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.871 1.214 . . . . 0.0 108.867 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -36.47 77.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.575 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -58.07 -35.67 71.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.156 0.889 . . . . 0.0 111.767 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -98.46 -44.33 6.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.616 1.166 . . . . 0.0 110.305 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.19 50.0 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 118.847 0.749 . . . . 0.0 112.836 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.6 mt -130.93 4.91 4.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.98 1.312 . . . . 0.0 111.975 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -68.36 144.07 54.91 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.926 1.694 . . . . 0.0 107.214 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.39 86.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.825 -0.986 . . . . 0.0 113.184 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -174.24 0.51 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.804 1.802 . . . . 0.0 109.526 165.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -123.94 141.32 52.14 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.432 ' CE2' HG11 ' A' ' 32' ' ' VAL . 2.7 m-30 -109.01 14.14 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.196 0.935 . . . . 0.0 110.852 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.18 -68.85 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.839 2.856 . . . . 0.0 104.946 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -153.93 -20.95 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 mtp85 -111.77 162.85 14.8 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.427 1.012 . . . . 0.0 110.471 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 t -77.95 106.37 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.004 -163.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.3 t -72.38 140.56 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.432 1.093 . . . . 0.0 109.552 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.0 t -126.27 128.56 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 p -87.69 156.81 19.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 0.0 110.504 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.15 155.08 41.0 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.328 2.251 . . . . 0.0 105.878 169.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -73.89 153.44 39.84 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 119.891 1.223 . . . . 0.0 108.094 159.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -172.5 2.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 164.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.13 144.28 34.53 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.68 -22.68 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.171 1.914 . . . . 0.0 112.346 -167.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -59.13 -57.54 12.59 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.061 1.301 . . . . 0.0 109.222 175.058 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -71.39 12.62 0.31 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.595 1.558 . . . . 0.0 111.355 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' A' ' 97' ' ' ASP . 30.7 t80 -97.52 -55.68 2.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.69 1.196 . . . . 0.0 110.463 169.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -65.57 -36.6 84.25 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.098 0.959 . . . . 0.0 112.714 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -85.38 -164.55 1.02 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.149 0.98 . . . . 0.0 109.519 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -111.97 26.05 10.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.787 1.235 . . . . 0.0 112.591 172.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -77.37 33.47 0.16 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.449 2.3 . . . . 0.0 111.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.03 166.13 22.02 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 120.511 -1.368 . . . . 0.0 111.049 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.035 0 C-N-CA 125.321 1.449 . . . . 0.0 108.926 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.364 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.44 -175.9 23.47 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.69 1.138 . . . . 0.0 112.775 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 -67.36 156.11 89.19 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.556 1.142 . . . . 0.0 111.509 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.15 151.03 66.64 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.649 2.232 . . . . 0.0 108.639 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.9 p -126.26 176.4 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.797 0.839 . . . . 0.0 109.176 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 28.1 tt0 -72.14 -1.49 15.13 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.576 1.551 . . . . 0.0 112.876 167.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.96 114.04 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 120.503 -1.373 . . . . 0.0 108.956 -151.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 142.56 51.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 108.806 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.2 t -131.12 126.35 35.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.135 0.969 . . . . 0.0 111.648 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.66 107.87 15.23 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 108.262 -159.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.6 mtm -79.1 173.45 12.56 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.389 0.675 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 65.89 18.32 11.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.809 1.644 . . . . 0.0 112.208 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.95 -70.68 0.53 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -165.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -104.33 -174.33 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 129.787 3.235 . . . . 0.0 107.051 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -127.49 153.41 77.39 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 120.142 1.337 . . . . 0.0 107.718 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -3.37 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.758 2.305 . . . . 0.0 112.5 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -115.05 11.56 16.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.675 1.19 . . . . 0.0 110.085 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -130.09 -22.57 2.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.838 1.255 . . . . 0.0 112.325 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -79.5 61.33 3.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.627 1.571 . . . . 0.0 110.385 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.03 -14.11 2.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.309 -160.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -116.6 151.75 35.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.811 1.245 . . . . 0.0 108.476 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.59 -13.42 40.04 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.59 1.556 . . . . 0.0 111.756 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.27 -60.06 1.94 Allowed 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.154 1.382 . . . . 0.0 108.445 -163.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -53.01 -36.21 60.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.513 1.525 . . . . 0.0 110.307 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -61.08 -36.82 80.67 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.44 1.896 . . . . 0.0 111.592 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.03 -40.35 53.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.392 0.996 . . . . 0.0 109.877 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.32 -34.78 72.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.433 0.693 . . . . 0.0 111.236 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.92 -24.44 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.465 0.706 . . . . 0.0 110.783 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.3 t -67.21 -47.19 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.406 -1.434 . . . . 0.0 108.322 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.86 -21.69 47.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.93 -47.62 61.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.386 1.089 . . . . 0.0 110.576 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.89 -30.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.974 -170.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -64.11 -31.66 72.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.202 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.81 -53.12 23.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.568 1.076 . . . . 0.0 110.624 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -62.45 -38.26 89.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.435 0.636 . . . . 0.0 110.926 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.8 t -70.54 -35.82 73.35 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.003 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -65.55 -14.33 60.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.457 1.026 . . . . 0.0 112.005 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.1 -19.77 21.57 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 119.71 -1.869 . . . . 0.0 112.791 172.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -115.42 2.53 13.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.935 1.294 . . . . 0.0 112.509 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.75 -147.16 15.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.5 120.85 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.92 109.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 126.34 1.856 . . . . 0.0 108.849 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -68.33 -63.96 0.96 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.466 1.906 . . . . 0.0 109.988 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -147.67 158.59 44.08 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.552 0.741 . . . . 0.0 111.691 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.7 130.89 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.399 . . . . 0.0 107.36 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -108.98 123.52 49.25 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.978 2.111 . . . . 0.0 107.845 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -129.29 85.15 60.18 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.237 1.815 . . . . 0.0 106.307 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.07 101.18 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.111 1.874 . . . . 0.0 109.825 -172.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.13 80.16 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.801 -0.562 . . . . 0.0 110.896 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -62.87 170.44 7.33 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.572 2.848 . . . . 0.0 110.055 173.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t -126.7 100.88 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 t0 48.67 43.66 20.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.115 1.766 . . . . 0.0 112.209 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.83 -11.43 71.02 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.96 1.743 . . . . 0.0 114.132 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.09 140.88 15.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 120.428 2.114 . . . . 0.0 109.841 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -71.0 129.03 37.94 Favored 'General case' 0 N--CA 1.416 -2.128 0 C-N-CA 128.855 2.862 . . . . 0.0 109.59 171.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.68 145.21 94.68 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.566 164.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -61.77 99.21 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 165.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.4 16.25 18.76 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.266 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.5 t -72.33 148.85 44.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.59 1.695 . . . . 0.0 110.106 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.99 -11.11 40.84 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.05 134.73 35.12 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.023 1.329 . . . . 0.0 109.657 -169.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.92 137.2 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -108.83 130.5 55.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -128.96 160.14 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.418 1.487 . . . . 0.0 107.979 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.38 143.43 39.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.596 1.958 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -110.07 -169.16 1.42 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.908 1.231 . . . . 0.0 112.249 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -93.96 -15.35 25.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 113.775 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -155.6 145.57 21.49 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.121 1.369 . . . . 0.0 108.628 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.08 -32.26 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 122.261 1.029 . . . . 0.0 110.533 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.2 -36.57 71.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.3 174.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.533 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 79.4 m-20 -64.07 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.053 1.297 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 34.4 m -76.65 -36.48 57.33 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 127.695 2.398 . . . . 0.0 109.256 -166.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.65 -40.23 82.83 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.144 1.378 . . . . 0.0 110.89 170.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' CE ' ' HA ' ' A' ' 71' ' ' ASP . 40.8 mtmt -72.34 -48.32 42.84 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.452 0.701 . . . . 0.0 109.184 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.09 -35.79 81.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.046 0.938 . . . . 0.0 112.687 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 43.1 tpp -55.1 -68.63 0.17 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.427 1.491 . . . . 0.0 109.176 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -67.81 -25.1 65.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.01 -15.46 81.1 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.341 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.74 6.71 5.15 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.668 1.187 . . . . 0.0 111.898 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.1 m -56.49 113.59 1.67 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 6.1 57.9 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.76 1.171 . . . . 0.0 113.614 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.79 179.25 0.27 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.976 1.31 . . . . 0.0 113.675 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -131.04 90.54 2.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.147 1.779 . . . . 0.0 108.35 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -77.19 14.68 0.86 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.95 -1.094 . . . . 0.0 112.539 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.53 -64.45 0.06 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.002 2.521 . . . . 0.0 105.211 163.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.66 -10.43 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -109.02 148.9 30.05 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.417 -1.427 . . . . 0.0 109.949 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -64.85 131.82 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.991 -171.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -101.0 141.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.778 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 138.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 161.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -94.42 157.48 15.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.4 2.28 . . . . 0.0 108.476 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.18 157.02 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.527 1.058 . . . . 0.0 109.481 159.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 114.5 18.71 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.2 m -79.78 166.41 21.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 163.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -92.29 142.81 26.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.56 -35.73 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.427 2.752 . . . . 0.0 112.7 -172.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -54.14 -36.66 63.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.99 0.516 . . . . 0.0 111.709 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.2 p -75.41 -43.33 50.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -62.31 -30.9 71.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.373 1.469 . . . . 0.0 112.207 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -66.38 -8.48 25.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.133 0.973 . . . . 0.0 113.086 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -129.01 -174.6 3.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.495 1.918 . . . . 0.0 108.099 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -90.06 55.98 3.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -122.15 98.76 6.08 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.117 0.567 . . . . 0.0 109.785 -174.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.56 163.91 31.31 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.553 0.741 . . . . 0.0 109.711 -172.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.322 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.6 158.26 51.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.491 2.127 . . . . 0.0 109.853 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 p -139.28 -168.61 2.49 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -86.05 -2.64 58.5 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.95 -1.093 . . . . 0.0 112.704 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 94' ' ' CYS . 2.8 m -83.3 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 121.127 1.785 . . . . 0.0 109.105 175.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.86 129.6 26.24 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.227 2.211 . . . . 0.0 105.942 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -100.74 131.86 46.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mp -129.8 154.42 47.26 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.737 1.615 . . . . 0.0 109.039 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.1 mtm -136.29 161.57 35.41 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.07 21.99 1.86 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.624 1.97 . . . . 0.0 111.545 172.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.414 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -76.45 -85.22 0.06 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 163.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.435 HG22 ' H ' ' A' ' 14' ' ' VAL . 22.2 m -82.55 170.66 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 127.08 2.152 . . . . 0.0 110.748 -166.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.28 160.2 35.16 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.094 0.958 . . . . 0.0 109.79 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -0.24 5.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.363 2.042 . . . . 0.0 113.037 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.96 19.4 3.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.056 2.143 . . . . 0.0 112.797 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.23 -9.33 7.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.948 0.794 . . . . 0.0 112.556 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.7 mt -79.62 28.55 0.26 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.21 1.404 . . . . 0.0 111.774 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -100.0 -38.13 8.71 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.835 -1.166 . . . . 0.0 111.282 -170.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 127.04 31.27 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.976 0.91 . . . . 0.0 109.979 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.07 -30.95 58.54 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.956 1.303 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -92.47 16.09 12.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.068 1.347 . . . . 0.0 111.872 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -125.48 -50.24 1.64 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.488 1.515 . . . . 0.0 107.413 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -45.05 -50.29 10.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.059 1.344 . . . . 0.0 112.39 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.61 -27.57 61.35 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -66.42 -46.44 76.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.806 0.843 . . . . 0.0 108.848 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.2 mt -61.16 -28.86 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.739 1.216 . . . . 0.0 111.405 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.04 -47.33 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 120.641 -1.287 . . . . 0.0 109.3 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.51 -30.92 57.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.198 0.999 . . . . 0.0 111.569 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.5 -46.45 86.66 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.849 1.66 . . . . 0.0 110.503 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.5 t -77.94 -28.64 15.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -59.42 -48.69 80.67 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.54 -44.92 95.15 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.091 0.244 . . . . 0.0 110.772 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.75 -43.49 75.74 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.878 -0.514 . . . . 0.0 111.618 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.435 ' HG ' ' HZ ' ' A' ' 66' ' ' PHE . 1.4 t -85.24 -21.92 28.87 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.941 -168.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.9 m -60.08 -8.49 2.42 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.858 -1.151 . . . . 0.0 113.025 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -67.84 -7.58 29.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 119.527 -1.983 . . . . 0.0 113.64 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -124.73 -0.26 8.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.53 1.132 . . . . 0.0 112.623 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.3 -137.96 5.63 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 106.914 -2.475 . . . . 0.0 106.914 -170.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.47 115.31 10.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.35 107.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 108.366 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -55.97 -60.76 3.01 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.396 2.278 . . . . 0.0 108.618 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 p -158.84 175.46 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.541 0.61 . . . . 0.0 110.881 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.14 150.21 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.334 1.453 . . . . 0.0 107.779 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.99 109.18 8.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.027 1.331 . . . . 0.0 110.987 -169.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 86.46 58.67 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 127.363 2.265 . . . . 0.0 107.372 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.9 133.27 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.946 2.431 . . . . 0.0 109.232 172.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 159.71 32.66 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 124.082 0.953 . . . . 0.0 111.535 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.458 -0.601 0 C-N-CA 123.742 2.962 . . . . 0.0 109.926 164.692 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo . . . . . 0 N--CA 1.45 -1.084 0 N-CA-C 108.271 -1.473 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.4 9.98 86.52 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.765 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.3 t -67.17 154.42 41.3 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.837 0.818 . . . . 0.0 110.614 170.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.02 -5.24 80.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 125.527 1.537 . . . . 0.0 114.058 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.2 173.02 9.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.941 1.371 . . . . 0.0 107.987 170.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 mt -131.35 145.96 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 150.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -115.46 144.72 43.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 164.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -118.96 154.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.02 136.92 47.61 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HZ ' ' HG ' ' A' ' 36' ' ' CYS . 28.1 m-85 -107.86 -177.95 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.02 1.328 . . . . 0.0 109.784 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 t -112.15 7.05 19.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 110.145 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.0 p -155.97 143.42 19.34 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 120.869 -1.144 . . . . 0.0 108.368 161.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -51.39 -44.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.952 1.301 . . . . 0.0 109.207 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -71.6 -26.04 62.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.351 -167.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -76.42 -42.66 43.43 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 12.9 t -59.74 -41.01 89.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.723 0.409 . . . . 0.0 110.556 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -56.06 -27.13 52.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 113.0 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -79.88 -47.86 14.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.727 1.149 . . . . 0.0 109.456 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.86 75.97 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.682 0.793 . . . . 0.0 110.532 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -55.77 -43.51 76.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.287 0.635 . . . . 0.0 111.329 -169.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -77.41 -48.29 17.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.79 0.836 . . . . 0.0 109.461 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -19.41 63.97 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.64 1.115 . . . . 0.0 113.073 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.1 mt -124.11 14.86 9.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.798 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.4 m -60.83 118.26 6.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.48 24.23 59.16 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 120.891 -1.131 . . . . 0.0 113.45 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.49 -179.34 5.74 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.288 0.544 . . . . 0.0 110.557 154.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -129.48 99.3 5.13 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 125.164 1.386 . . . . 0.0 107.328 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -88.68 15.02 8.81 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.469 0.577 . . . . 0.0 110.639 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.23 -85.23 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.933 2.093 . . . . 0.0 106.174 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.26 -20.21 0.63 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.56 1.144 . . . . 0.0 111.983 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -90.21 -167.88 1.96 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.81 166.3 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.177 -0.952 . . . . 0.0 108.572 165.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.414 HG13 ' HE1' ' A' ' 13' ' ' MET . 55.7 t -124.68 118.03 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 p -93.04 149.9 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -117.89 168.7 10.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.692 1.197 . . . . 0.0 109.034 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.77 156.41 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.887 2.075 . . . . 0.0 106.908 -177.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -77.71 160.72 28.25 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 162.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.422 ' HB3' HG21 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -137.43 -168.47 2.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.397 0.999 . . . . 0.0 109.063 168.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.59 144.22 34.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -93.59 -20.46 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.132 1.888 . . . . 0.0 110.833 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -40.44 80.59 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.07 0.462 . . . . 0.0 110.446 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.56 -33.26 60.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.105 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -61.6 -50.27 73.27 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.499 1.52 . . . . 0.0 111.411 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.64 -14.63 63.14 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -106.11 -169.73 1.62 Allowed 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 127.544 2.337 . . . . 0.0 107.276 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -114.18 69.68 0.71 Allowed 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.31 27.02 9.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 109.812 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 C--O 1.235 0.313 0 C-N-CA 123.683 0.793 . . . . 0.0 109.543 -172.404 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.04 126.88 16.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.401 1.401 . . . . 0.0 108.676 165.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.1 p -100.11 179.02 4.61 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.889 1.676 . . . . 0.0 108.705 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.54 8.72 13.23 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.007 0.923 . . . . 0.0 110.658 174.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.99 163.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 O-C-N 120.896 -1.127 . . . . 0.0 111.395 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -141.71 124.19 15.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -168.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.23 135.02 33.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.7 mt -128.73 131.2 47.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.5 1.52 . . . . 0.0 107.232 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mtm -125.46 163.77 21.93 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.448 -0.782 . . . . 0.0 110.177 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 74.97 16.22 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.81 2.844 . . . . 0.0 112.677 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -52.9 11.93 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.251 -0.906 . . . . 0.0 108.916 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.88 174.34 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 128.317 2.647 . . . . 0.0 108.891 -162.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.72 150.24 52.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.102 0.961 . . . . 0.0 109.319 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.62 -14.7 40.07 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.859 2.373 . . . . 0.0 113.647 -172.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -116.56 13.18 15.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.682 1.993 . . . . 0.0 110.333 -170.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -139.69 22.62 2.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.792 2.037 . . . . 0.0 109.637 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.01 65.43 0.66 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.066 2.146 . . . . 0.0 107.057 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.3 mt -135.06 -41.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -160.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.07 151.25 31.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.6 0.76 . . . . 0.0 110.149 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -95.96 -5.55 41.05 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.623 0.769 . . . . 0.0 110.675 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -113.57 -43.41 3.32 Favored 'General case' 0 C--N 1.337 0.047 0 C-N-CA 124.42 1.088 . . . . 0.0 113.049 -167.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -80.62 -37.19 31.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.734 1.214 . . . . 0.0 109.398 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.7 -35.75 61.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.218 1.007 . . . . 0.0 110.677 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.74 -37.22 70.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.491 -0.756 . . . . 0.0 111.62 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -62.32 -45.92 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.014 . . . . 0.0 109.204 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.55 -20.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.617 0.767 . . . . 0.0 111.371 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.11 -44.71 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.954 -1.092 . . . . 0.0 109.316 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.4 -35.77 63.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.908 0.776 . . . . 0.0 112.338 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.46 -51.22 60.4 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.391 1.876 . . . . 0.0 109.768 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.6 t -75.36 -29.13 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.224 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -65.54 -36.26 83.27 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.605 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.64 -40.69 40.98 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.655 0.661 . . . . 0.0 112.243 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -50.11 69.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.983 -1.073 . . . . 0.0 109.899 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.05 -25.76 61.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -167.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.91 -22.96 4.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.396 1.078 . . . . 0.0 112.969 169.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -76.24 -13.06 60.18 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.625 -1.297 . . . . 0.0 112.626 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CE1' HD21 ' A' ' 79' ' ' LEU . 87.9 m-85 -116.98 -16.52 10.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.576 1.08 . . . . 0.0 112.898 -173.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.46 -138.75 3.24 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD13 ' C ' ' A' ' 41' ' ' LEU . 2.4 tm? -140.33 123.0 16.29 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -87.04 116.32 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -66.24 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.731 1.613 . . . . 0.0 107.84 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -154.14 169.44 23.57 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.774 1.229 . . . . 0.0 110.239 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 mt -130.2 141.97 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.266 1.826 . . . . 0.0 106.179 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -126.11 120.18 29.5 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.538 1.135 . . . . 0.0 110.58 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.37 85.75 17.7 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.46 123.16 11.61 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.351 2.034 . . . . 0.0 108.257 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.99 154.07 37.5 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 123.652 0.781 . . . . 0.0 110.093 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.456 -0.698 0 C-N-CA 123.273 2.649 . . . . 0.0 111.025 167.459 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo . . . . . 0 N--CA 1.451 -1.019 0 N-CA-C 108.025 -1.567 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.71 36.56 92.48 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.3 t -74.15 163.54 27.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.189 0.518 . . . . 0.0 110.166 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -39.03 2.72 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.192 1.377 . . . . 0.0 111.594 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 168.52 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.541 1.671 . . . . 0.0 109.709 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -131.86 152.48 36.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.56 157.94 28.39 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p -139.02 161.05 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -133.19 144.9 50.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.822 1.649 . . . . 0.0 107.441 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.75 -179.16 3.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.895 1.678 . . . . 0.0 111.035 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.441 ' CG2' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -86.11 -21.47 27.61 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.854 172.155 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -139.83 -179.09 5.74 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.482 1.492 . . . . 0.0 110.561 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.31 -35.14 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 158.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -76.49 -28.93 56.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.574 -1.329 . . . . 0.0 113.51 -166.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -76.49 -38.89 54.57 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.375 1.07 . . . . 0.0 109.169 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.9 t -57.1 -47.6 80.67 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.56 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -56.94 -26.89 60.4 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.449 1.499 . . . . 0.0 113.179 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -76.91 -48.13 19.08 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.17 88.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 117.155 -1.403 . . . . 0.0 111.743 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -63.89 0.89 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.719 1.145 . . . . 0.0 110.659 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -81.97 -21.13 37.33 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.529 0.732 . . . . 0.0 112.021 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.74 89.43 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.484 HD21 ' CE1' ' A' ' 39' ' ' TYR . 96.4 mt -115.01 -1.46 13.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -160.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.6 m -47.64 116.07 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.024 -1.047 . . . . 0.0 109.507 164.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.54 5.7 63.07 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.626 0.648 . . . . 0.0 114.412 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -177.85 1.26 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.853 1.327 . . . . 0.0 111.42 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -126.9 133.2 50.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.435 1.494 . . . . 0.0 107.054 163.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -108.15 15.08 24.52 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.155 0.982 . . . . 0.0 110.937 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.11 -73.31 0.06 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -150.89 -13.28 0.22 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -98.46 164.19 12.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.155 0.889 . . . . 0.0 110.017 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.41 135.99 26.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.93 139.8 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.209 1.403 . . . . 0.0 111.058 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.264 3.1 p -110.93 115.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 170.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -78.2 143.72 36.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.09 167.68 21.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.64 1.976 . . . . 0.0 106.09 162.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -71.82 164.45 25.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.91 0.777 . . . . 0.0 109.68 163.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 -164.47 1.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.469 1.108 . . . . 0.0 108.524 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -114.38 143.42 29.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.22 -25.86 5.53 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.123 2.548 . . . . 0.0 111.169 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -54.29 -59.34 4.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.036 0.922 . . . . 0.0 109.842 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -20.12 62.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.856 2.062 . . . . 0.0 110.898 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -73.14 -46.87 48.47 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 127.488 2.315 . . . . 0.0 111.006 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -60.36 -35.89 76.74 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 -97.56 -166.77 1.43 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 109.605 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -122.08 54.72 1.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.501 1.52 . . . . 0.0 107.738 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.98 38.81 3.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.713 1.244 . . . . 0.0 109.001 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--O 1.239 0.52 0 C-N-CA 126.595 1.958 . . . . 0.0 108.822 176.183 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -66.31 133.0 31.16 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.959 2.439 . . . . 0.0 108.223 168.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.8 p -137.29 169.21 18.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.537 1.935 . . . . 0.0 106.772 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -75.39 -10.86 59.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.369 0.532 . . . . 0.0 111.798 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.87 106.78 19.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 125.469 1.508 . . . . 0.0 110.006 -170.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -91.53 113.09 25.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -85.01 134.05 34.23 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.5 139.85 52.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.276 1.031 . . . . 0.0 109.52 -173.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.5 mtm -125.18 161.13 27.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.896 0.878 . . . . 0.0 109.241 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 m120 60.87 30.68 19.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.577 2.351 . . . . 0.0 112.911 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.624 ' CE ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -77.65 -79.66 0.11 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 164.179 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.47 171.02 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 125.12 1.368 . . . . 0.0 109.791 -165.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.91 159.4 40.99 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 124.096 0.958 . . . . 0.0 109.445 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.69 4.87 2.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.574 2.183 . . . . 0.0 113.584 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -128.24 14.55 6.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.555 1.942 . . . . 0.0 113.415 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -132.45 -4.21 3.36 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.45 -0.781 . . . . 0.0 111.357 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -98.63 51.59 0.99 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.443 1.497 . . . . 0.0 109.885 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.41 -54.85 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.38 100.54 0.06 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.984 2.114 . . . . 0.0 109.952 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.28 -7.34 58.58 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.941 0.896 . . . . 0.0 113.088 -165.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -76.51 -59.64 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.983 1.713 . . . . 0.0 107.961 166.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.95 -34.33 77.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.668 0.787 . . . . 0.0 111.982 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -44.99 -45.56 10.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.931 1.292 . . . . 0.0 111.514 168.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.85 -23.0 42.26 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 121.573 -0.704 . . . . 0.0 112.078 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -71.42 -50.15 34.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 124.189 0.93 . . . . 0.0 109.162 169.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.31 -40.66 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.148 0.979 . . . . 0.0 111.147 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.0 t -57.87 -40.35 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.879 0.763 . . . . 0.0 109.951 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.56 -40.74 33.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.873 0.306 . . . . 0.0 111.032 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.72 -33.62 76.03 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.08 -36.68 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 O-C-N 121.545 -0.722 . . . . 0.0 109.414 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -58.28 -38.27 76.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 117.134 -1.413 . . . . 0.0 109.627 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.09 -33.37 73.24 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.588 1.54 . . . . 0.0 112.107 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -41.44 63.43 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 120.964 -1.085 . . . . 0.0 110.975 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.483 ' SG ' HG21 ' A' ' 42' ' ' VAL 0.265 0.8 OUTLIER -81.22 -27.97 35.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.287 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.04 -3.91 32.24 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.659 1.118 . . . . 0.0 112.259 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -56.81 -18.43 12.85 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.3 -1.5 . . . . 0.0 113.725 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -119.75 1.26 11.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.043 1.337 . . . . 0.0 113.003 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.13 -145.13 10.21 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -122.49 112.53 18.15 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 118.747 1.274 . . . . 0.0 110.023 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.483 HG21 ' SG ' ' A' ' 36' ' ' CYS . 75.6 t -69.81 108.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -68.71 -53.48 21.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.846 0.858 . . . . 0.0 109.884 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -161.51 163.68 30.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -135.71 108.71 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.77 119.16 31.35 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 125.91 1.684 . . . . 0.0 109.106 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mt -133.49 85.69 42.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.29 1.836 . . . . 0.0 107.838 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.72 136.4 53.5 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.682 1.588 . . . . 0.0 109.161 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -98.08 165.2 15.78 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.512 1.125 . . . . 0.0 109.616 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.239 0.531 0 C-N-CA 122.56 2.173 . . . . 0.0 109.903 166.9 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.454 -0.839 0 N-CA-C 108.256 -1.478 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.28 -15.15 15.55 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 126.735 2.112 . . . . 0.0 112.256 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.5 t -76.45 148.47 37.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.068 0.934 . . . . 0.0 111.184 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.52 -16.0 51.73 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.124 1.821 . . . . 0.0 112.622 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -92.56 157.12 16.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.761 1.781 . . . . 0.0 108.583 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.0 149.4 33.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 164.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -129.32 114.31 16.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 42' ' ' VAL . 98.5 t -101.82 111.63 32.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 148.49 29.2 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.232 1.813 . . . . 0.0 106.362 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -129.87 179.57 5.78 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.87 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -90.07 -13.3 36.17 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -164.55 155.8 15.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.553 1.069 . . . . 0.0 110.007 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.429 HG12 HE21 ' A' ' 73' ' ' GLN . 40.8 t -65.36 -23.42 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.558 0.743 . . . . 0.0 109.142 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -84.41 -18.03 37.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.5 -1.375 . . . . 0.0 113.224 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -76.52 -45.97 28.55 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.5 p -71.51 -36.43 71.07 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.665 -0.647 . . . . 0.0 110.714 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.429 HE21 HG12 ' A' ' 69' ' ' VAL . 2.0 mp0 -47.3 -36.2 8.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.928 2.091 . . . . 0.0 112.856 168.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -79.11 -48.72 13.8 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.21 73.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.67 1.188 . . . . 0.0 111.266 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.1 ttm -48.73 -70.54 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.628 1.571 . . . . 0.0 110.336 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.76 -33.29 73.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.543 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.9 -15.85 69.69 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.516 1.055 . . . . 0.0 114.027 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.54 9.05 5.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.114 1.457 . . . . 0.0 112.687 -171.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.8 m -63.77 102.11 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.16 -0.962 . . . . 0.0 110.181 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.17 1.88 51.29 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.13 1.348 . . . . 0.0 113.14 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -178.64 0.2 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.386 1.593 . . . . 0.0 111.503 173.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.35 140.08 53.29 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' A' ' 89' ' ' VAL . 3.1 m-85 -117.84 13.76 14.14 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.644 0.735 . . . . 0.0 109.854 176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.34 -70.77 0.08 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.52 2.328 . . . . 0.0 107.661 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -162.42 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.64 1.176 . . . . 0.0 111.821 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -78.18 175.26 10.34 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.489 1.04 . . . . 0.0 109.456 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.43 165.63 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.624 HG22 ' CE ' ' A' ' 13' ' ' MET . 25.6 t -114.57 125.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.0 t -105.84 129.51 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 167.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.0 p -99.2 146.86 25.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.609 1.164 . . . . 0.0 108.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -141.52 161.22 38.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.411 1.485 . . . . 0.0 107.334 160.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -69.36 157.49 36.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 158.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -176.68 2.95 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.523 1.529 . . . . 0.0 107.417 165.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -99.1 144.98 29.22 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.41 -24.17 6.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.823 2.349 . . . . 0.0 112.925 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.47 -46.93 73.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.19 0.905 . . . . 0.0 110.725 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 p -75.71 2.94 10.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.452 1.101 . . . . 0.0 111.925 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -93.16 -48.92 6.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.551 1.141 . . . . 0.0 108.932 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -60.27 -30.41 69.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.771 0.428 . . . . 0.0 111.256 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -104.63 163.46 12.46 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.524 1.13 . . . . 0.0 109.87 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 ttm-85 -73.23 21.89 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.276 2.23 . . . . 0.0 112.794 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -88.81 64.09 7.11 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.75 -1.219 . . . . 0.0 111.133 -158.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 4.4 m-85 . . . . . 0 C--O 1.237 0.428 0 C-N-CA 123.081 0.553 . . . . 0.0 109.625 -169.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.0 142.97 48.26 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.897 2.398 . . . . 0.0 108.868 166.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 p -121.33 -179.28 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.587 1.955 . . . . 0.0 107.983 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -82.74 9.68 9.19 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.437 HG12 ' HG3' ' A' ' 65' ' ' GLU . 2.9 m -130.92 157.4 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 121.083 1.765 . . . . 0.0 110.332 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 93' ' ' TYR . 5.6 tp -133.4 170.72 15.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.931 0.872 . . . . 0.0 109.268 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.86 140.4 31.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.911 1.284 . . . . 0.0 109.362 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.29 122.9 27.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.593 1.557 . . . . 0.0 107.646 -167.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.1 mtm -103.94 165.98 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.213 0.605 . . . . 0.0 110.632 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 75.22 7.36 4.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 129.334 3.054 . . . . 0.0 115.12 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -65.16 0.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.148 1.34 . . . . 0.0 109.305 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.21 144.46 35.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.784 1.634 . . . . 0.0 109.077 -158.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.45 163.78 32.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 126.197 1.799 . . . . 0.0 110.762 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.84 -1.03 7.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.08 2.52 . . . . 0.0 114.606 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.83 -0.57 3.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.565 1.146 . . . . 0.0 112.598 -163.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -115.08 -12.26 11.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.636 0.774 . . . . 0.0 112.784 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.442 ' C ' HD22 ' A' ' 20' ' ' LEU . 91.8 mt -75.06 47.97 0.38 Allowed 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.455 1.902 . . . . 0.0 112.396 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD22 ' C ' ' A' ' 19' ' ' LEU . 3.6 mm? -132.73 -13.6 2.88 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -165.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.94 179.42 1.48 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.664 1.12 . . . . 0.0 109.59 159.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -122.89 -4.09 8.61 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.129 -0.982 . . . . 0.0 111.382 165.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -90.19 -72.79 0.55 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.793 2.037 . . . . 0.0 108.928 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -57.52 -33.37 68.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.561 1.944 . . . . 0.0 110.607 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -47.46 -46.97 27.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.364 1.466 . . . . 0.0 112.138 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -75.74 -34.11 60.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -60.3 -44.36 95.48 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.96 -34.81 70.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -61.02 -54.27 37.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 O-C-N 120.749 -1.219 . . . . 0.0 108.753 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -70.87 -33.2 70.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.932 0.787 . . . . 0.0 112.031 -169.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.93 -35.32 79.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.239 1.019 . . . . 0.0 111.93 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.38 -25.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 108.966 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -69.18 -21.63 63.96 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.941 -1.099 . . . . 0.0 111.723 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.25 -62.24 1.52 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.849 1.204 . . . . 0.0 108.11 159.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HB2' HH21 ' A' ' 82' ' ' ARG . 5.0 pt-20 -61.08 -40.29 93.14 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -158.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -77.66 -28.65 51.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.0 t -65.86 -12.95 58.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.414 1.085 . . . . 0.0 111.473 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.57 -12.38 52.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 119.644 -1.91 . . . . 0.0 111.693 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -112.13 -7.13 14.08 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.073 1.349 . . . . 0.0 113.732 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.48 -167.3 31.4 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.52 104.1 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.987 0.898 . . . . 0.0 109.874 -175.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.28 106.49 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 125.406 1.482 . . . . 0.0 107.052 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -66.51 -67.57 0.44 Allowed 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 166.63 32.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.34 0.656 . . . . 0.0 111.341 -168.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -138.98 145.36 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 126.217 1.807 . . . . 0.0 108.85 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -132.84 121.97 23.72 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.93 1.292 . . . . 0.0 109.433 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.9 mt -127.85 86.1 59.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.89 2.076 . . . . 0.0 107.414 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.63 148.8 86.04 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.721 1.614 . . . . 0.0 109.861 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.07 152.57 46.76 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.862 0.865 . . . . 0.0 110.116 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 C--O 1.236 0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 111.243 176.459 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 N--CA 1.451 -0.979 0 N-CA-C 106.706 -2.075 . . . . 0.0 106.706 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.54 -11.03 11.32 Favored Glycine 0 C--O 1.229 -0.205 0 C-N-CA 125.733 1.635 . . . . 0.0 111.451 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.4 144.88 51.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.995 0.897 . . . . 0.0 109.806 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.18 -35.85 4.6 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 127.456 2.455 . . . . 0.0 110.512 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -85.4 167.88 15.12 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.185 -1.185 . . . . 0.0 110.389 -172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 mt -136.32 128.17 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -99.59 155.17 17.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -144.71 145.15 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 7' ' ' VAL . 10.9 tt0 -121.91 146.86 46.71 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.887 1.275 . . . . 0.0 108.901 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.07 167.03 16.51 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.492 1.117 . . . . 0.0 110.529 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.0 p -74.2 -18.1 60.8 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -159.62 159.28 32.94 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.906 1.23 . . . . 0.0 111.406 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.31 -38.97 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.923 1.289 . . . . 0.0 109.134 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -52.02 -52.49 50.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.297 1.039 . . . . 0.0 111.986 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.14 -43.92 81.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 10.7 t -58.11 -41.84 84.46 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.003 0.521 . . . . 0.0 111.005 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.86 -20.93 65.58 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.668 1.187 . . . . 0.0 112.734 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -90.42 -46.39 8.39 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.785 1.175 . . . . 0.0 108.664 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.32 -15.99 64.0 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.593 1.157 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.436 ' CE ' HD11 ' A' ' 8' ' ' LEU . 25.4 tpp -60.37 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.906 1.682 . . . . 0.0 108.226 168.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -70.76 -22.71 62.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.718 -164.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.35 -27.9 71.46 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.574 0.624 . . . . 0.0 112.426 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.442 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 96.1 mt -113.56 -4.1 13.56 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.06 1.344 . . . . 0.0 111.732 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.0 m -57.37 106.63 0.35 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.935 -1.103 . . . . 0.0 109.025 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.69 -0.17 59.38 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.182 -0.788 . . . . 0.0 113.884 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.444 HH21 ' HB2' ' A' ' 35' ' ' GLU . 9.2 mmm180 -63.67 178.76 0.55 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.944 1.372 . . . . 0.0 110.665 167.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 85' ' ' ALA . 89.6 mttt -133.96 84.47 2.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.373 1.469 . . . . 0.0 107.469 -167.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 3.0 m-30 -78.1 37.73 0.26 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.492 1.117 . . . . 0.0 109.54 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' LYS . . . 174.51 -69.32 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 1 C-N-CA 132.738 4.415 . . . . 0.0 105.895 167.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.14 -29.54 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.294 1.838 . . . . 0.0 111.456 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -89.52 162.63 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.942 -1.099 . . . . 0.0 109.78 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.37 139.9 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.69 133.73 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.9 122.86 65.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -85.6 155.54 21.1 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 129.182 2.993 . . . . 0.0 109.278 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -153.13 138.62 17.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.662 1.985 . . . . 0.0 108.541 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HA ' HD12 ' A' ' 8' ' ' LEU . 56.0 m-85 -67.22 127.53 32.99 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 162.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.67 169.7 9.51 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.823 1.249 . . . . 0.0 108.435 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -92.13 143.65 27.89 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.64 -27.51 6.1 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.507 2.804 . . . . 0.0 111.918 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -57.18 13.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.634 1.107 . . . . 0.0 111.194 -170.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 m -65.98 -33.47 75.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.187 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -65.68 -30.74 71.47 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.482 1.113 . . . . 0.0 112.588 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -64.78 -2.8 2.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.081 0.953 . . . . 0.0 112.673 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -138.46 179.49 6.43 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.974 2.11 . . . . 0.0 108.711 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.442 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -81.0 21.31 0.71 Allowed 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.195 -0.94 . . . . 0.0 112.324 174.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.73 45.41 1.07 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.44 -1.412 . . . . 0.0 112.68 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 102' ' ' ARG . 10.8 m-85 . . . . . 0 C--O 1.233 0.222 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.65 141.13 49.1 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.054 1.836 . . . . 0.0 108.666 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -123.48 172.97 8.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.53 1.132 . . . . 0.0 110.261 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.48 -9.11 55.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.356 0.662 . . . . 0.0 112.165 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.6 m -102.16 -176.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 120.02 1.282 . . . . 0.0 111.658 -172.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 tp -145.48 155.27 43.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.122 1.369 . . . . 0.0 109.199 161.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.41 143.13 48.69 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.505 1.122 . . . . 0.0 109.645 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.25 152.8 49.28 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.604 1.962 . . . . 0.0 109.694 -170.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 39.7 mtm -132.56 165.12 25.11 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.751 1.22 . . . . 0.0 110.238 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 75.44 -8.59 1.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 130.085 3.354 . . . . 0.0 114.571 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.439 ' HE3' HG22 ' A' ' 89' ' ' VAL . 10.0 tpp -71.17 -36.9 72.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.743 1.156 . . . . 0.0 112.472 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.06 152.62 36.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 0.0 109.855 -170.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -110.12 156.13 40.61 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.49 -1.06 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.06 2.507 . . . . 0.0 113.023 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -116.61 4.52 13.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.05 1.74 . . . . 0.0 111.817 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -133.81 33.88 3.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.358 1.463 . . . . 0.0 110.817 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt -131.75 58.75 1.72 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.426 1.89 . . . . 0.0 108.57 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.25 -45.32 1.98 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.238 1.415 . . . . 0.0 110.029 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.71 105.74 7.95 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.02 -32.43 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.914 1.686 . . . . 0.0 111.778 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.33 -63.21 1.11 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.501 0.72 . . . . 0.0 109.56 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -53.83 -42.81 68.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.221 1.008 . . . . 0.0 110.143 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -53.25 -40.51 64.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.98 1.312 . . . . 0.0 111.617 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -81.98 -38.4 25.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.866 1.212 . . . . 0.0 111.029 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -59.55 -51.1 71.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -54.72 -45.57 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.558 0.743 . . . . 0.0 109.426 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.92 -26.32 39.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 118.064 -0.969 . . . . 0.0 112.708 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.41 -28.41 23.58 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.673 1.124 . . . . 0.0 112.538 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.04 -41.53 64.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.118 0.961 . . . . 0.0 110.04 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG13 ' CE2' ' A' ' 84' ' ' PHE . 42.8 t -71.96 -28.25 29.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 125.027 1.331 . . . . 0.0 109.15 -177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -56.42 -57.42 12.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.55 -40.77 97.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.217 0.948 . . . . 0.0 110.079 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.5 -39.94 85.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.458 -169.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.83 -27.1 49.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.2 t -64.47 -21.66 66.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.829 0.852 . . . . 0.0 110.815 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -56.59 -21.66 28.42 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.118 -1.614 . . . . 0.0 111.976 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.469 ' CE1' HD21 ' A' ' 79' ' ' LEU . 42.2 m-85 -110.53 2.46 18.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.928 1.691 . . . . 0.0 112.224 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.59 -156.14 26.91 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 120.164 1.347 . . . . 0.0 112.258 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.1 tm? -112.2 110.08 20.14 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.09 113.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -61.51 -61.03 2.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.874 1.27 . . . . 0.0 109.243 167.066 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 175.46 12.01 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.314 -0.866 . . . . 0.0 110.903 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 64' ' ' VAL . 57.4 mt -138.89 145.11 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.31 125.1 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.167 1.787 . . . . 0.0 109.541 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.6 mt -138.46 82.42 22.75 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.71 138.88 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.084 1.856 . . . . 0.0 109.752 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -90.81 155.75 45.16 Favored Pre-proline 0 N--CA 1.474 0.735 0 O-C-N 120.485 -1.384 . . . . 0.0 111.877 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 C--N 1.352 0.746 1 C-N-CA 126.094 4.529 . . . . 0.0 112.648 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo . . . . . 0 N--CA 1.451 -1.0 0 N-CA-C 107.707 -1.69 . . . . 0.0 107.707 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.32 16.74 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.438 1.971 . . . . 0.0 112.758 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.8 t -71.99 132.54 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.687 1.243 . . . . 0.0 109.352 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.44 1.51 80.97 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.734 1.635 . . . . 0.0 113.815 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -108.72 161.08 15.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -126.63 148.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.09 142.75 50.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 45' ' ' ILE . 53.7 t -134.64 150.95 30.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 23.6 tt0 -129.08 142.49 50.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.09 169.84 8.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.114 1.766 . . . . 0.0 108.441 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.3 t -98.97 8.4 45.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.957 0.903 . . . . 0.0 110.419 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.1 p -155.5 147.98 23.94 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 120.261 -1.525 . . . . 0.0 111.393 156.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -49.73 -41.3 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.121 0.968 . . . . 0.0 109.032 163.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -62.92 -22.8 67.02 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.446 1.498 . . . . 0.0 114.187 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -101.34 -37.04 8.66 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -31.78 73.03 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.294 -0.879 . . . . 0.0 111.012 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -58.72 -20.35 48.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.08 1.752 . . . . 0.0 112.987 170.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -88.26 -51.84 5.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.63 1.105 . . . . 0.0 108.613 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.5 -43.52 65.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.131 0.973 . . . . 0.0 111.118 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.0 tpp -44.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.423 2.289 . . . . 0.0 110.404 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.7 -18.62 56.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.31 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.9 -25.2 72.27 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.264 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.524 HD23 ' HG3' ' A' ' 82' ' ' ARG . 90.9 mt -115.63 4.36 14.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.1 m -55.13 107.58 0.32 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.791 1.237 . . . . 0.0 109.899 168.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.0 8.2 72.77 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.765 -0.584 . . . . 0.0 113.935 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.524 ' HG3' HD23 ' A' ' 79' ' ' LEU . 64.3 mmt-85 -72.69 -174.8 1.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.901 1.351 . . . . 0.0 111.281 169.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -134.02 98.41 4.13 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.641 0.776 . . . . 0.0 109.984 -170.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.458 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.0 m-85 -83.1 19.49 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.721 2.008 . . . . 0.0 112.534 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.2 -85.49 0.0 OUTLIER 'General case' 0 C--O 1.231 0.126 0 C-N-CA 129.469 3.107 . . . . 0.0 104.46 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.3 -24.63 2.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.021 0.928 . . . . 0.0 110.96 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 87' ' ' ARG . 18.8 mtp85 -93.12 173.59 7.65 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.736 0.698 . . . . 0.0 110.287 -166.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.93 165.5 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG22 ' HE3' ' A' ' 13' ' ' MET . 71.6 t -132.84 145.39 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.49 -173.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.4 117.23 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 168.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 154.23 27.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.476 2.31 . . . . 0.0 110.007 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.92 150.43 28.35 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.157 2.983 . . . . 0.0 106.27 173.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -69.09 160.19 31.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.638 1.108 . . . . 0.0 108.891 160.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.39 -164.47 1.3 Allowed 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.773 1.229 . . . . 0.0 109.459 168.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.85 143.88 28.47 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.08 -32.88 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.367 2.712 . . . . 0.0 110.449 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -57.33 -54.31 48.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.1 m -66.89 -29.47 69.38 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.85 1.26 . . . . 0.0 110.794 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -64.05 -40.48 96.38 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.843 1.657 . . . . 0.0 111.09 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -70.97 -9.75 58.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.264 1.026 . . . . 0.0 112.349 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 20.8 mtp85 -106.45 -168.8 1.47 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.33 1.452 . . . . 0.0 109.482 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.3 tpt180 -108.82 73.12 0.85 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.68 92.44 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 2.8 m-85 . . . . . 0 C--O 1.227 -0.106 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -170.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.15 146.49 41.03 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.608 2.872 . . . . 0.0 109.61 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -131.7 170.35 14.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -78.9 8.38 5.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -98.14 119.7 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.62 143.62 32.52 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -108.1 142.17 38.7 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt -138.59 128.37 25.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.843 1.257 . . . . 0.0 107.613 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -133.73 156.91 47.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.154 0.582 . . . . 0.0 109.764 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 65.34 72.01 0.43 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.125 2.17 . . . . 0.0 109.771 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.439 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -132.44 -77.14 0.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.472 1.509 . . . . 0.0 107.786 -177.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.35 146.31 19.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.555 1.542 . . . . 0.0 109.371 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 17' ' ' GLU . 50.9 mt -109.78 151.57 42.41 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.752 0.821 . . . . 0.0 109.082 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.95 4.91 0.55 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.61 2.873 . . . . 0.0 113.515 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 15' ' ' LEU . 19.0 pt-20 -131.14 2.94 4.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.334 2.654 . . . . 0.0 112.093 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -127.17 -18.06 4.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.541 -0.725 . . . . 0.0 112.587 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.843 HD11 ' HA ' ' A' ' 49' ' ' ARG 0.254 0.2 OUTLIER -90.69 16.25 9.53 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.967 -1.083 . . . . 0.0 110.927 -162.482 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.43 -22.55 16.52 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.556 -1.34 . . . . 0.0 113.36 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.22 134.39 34.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -168.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.97 -18.82 64.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.443 0.697 . . . . 0.0 112.159 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.34 -68.81 0.6 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.122 1.769 . . . . 0.0 108.968 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -58.48 -36.21 73.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.573 1.549 . . . . 0.0 112.844 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' VAL . 71.4 t80 -52.05 -47.89 64.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.281 1.432 . . . . 0.0 112.395 170.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.28 -38.93 71.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.7 0.8 . . . . 0.0 111.067 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -52.08 -48.34 64.74 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.632 1.173 . . . . 0.0 109.243 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.5 mt -63.97 -44.49 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.52 1.528 . . . . 0.0 109.899 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 25' ' ' TYR . 57.2 t -58.57 -46.37 90.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -78.36 -31.48 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -170.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.22 -42.17 99.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 123.223 1.487 . . . . 0.0 109.414 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.66 -31.78 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.403 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -66.42 -24.36 66.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 120.962 -1.086 . . . . 0.0 111.395 175.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.58 -59.71 3.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 119.884 1.22 . . . . 0.0 108.309 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -62.3 -37.58 86.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -167.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.1 t -72.7 -25.89 61.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.571 0.749 . . . . 0.0 109.881 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -61.66 -23.33 66.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.54 1.136 . . . . 0.0 111.296 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 84.3 mttt -65.52 -10.75 37.45 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.454 -1.404 . . . . 0.0 112.95 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CE1' HD21 ' A' ' 79' ' ' LEU . 71.6 m-85 -123.47 4.11 9.03 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.856 1.263 . . . . 0.0 113.424 -170.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.11 -131.26 3.26 Favored Glycine 0 CA--C 1.504 -0.594 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.17 116.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.5 104.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.109 1.363 . . . . 0.0 108.693 166.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.06 -55.91 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.92 2.488 . . . . 0.0 110.337 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -148.37 163.43 37.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.399 1.479 . . . . 0.0 110.209 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mt -138.81 133.82 41.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.01 110.46 12.99 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.963 0.905 . . . . 0.0 109.58 -170.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.493 HD12 HG22 ' A' ' 29' ' ' VAL . 13.9 mt -128.16 86.62 57.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.668 1.587 . . . . 0.0 107.516 -170.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.93 125.5 16.67 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.787 1.658 . . . . 0.0 108.232 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.843 ' HA ' HD11 ' A' ' 19' ' ' LEU . 17.7 mtp180 -90.6 151.36 43.91 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 0.0 110.117 -174.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' CD ' ' HG ' ' A' ' 19' ' ' LEU . 61.0 Cg_endo . . . . . 0 N--CA 1.457 -0.633 0 C-N-CA 121.83 1.687 . . . . 0.0 109.543 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.453 -0.854 0 N-CA-C 110.259 -0.708 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.03 66.1 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 126.33 1.919 . . . . 0.0 111.583 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.14 147.95 44.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 122.042 -0.681 . . . . 0.0 109.454 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.71 65.17 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.035 1.778 . . . . 0.0 112.76 -171.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -108.42 160.81 15.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -129.36 129.97 67.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 162.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -99.83 130.66 46.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 171.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -124.73 145.76 31.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.87 139.1 51.59 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -118.71 168.02 11.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.413 1.102 . . . . 0.0 111.062 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -38.06 87.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.067 1.347 . . . . 0.0 113.273 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.5 m -160.42 156.82 26.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.596 1.089 . . . . 0.0 111.367 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.479 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 10.7 t -63.83 -28.73 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.467 1.107 . . . . 0.0 110.666 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -68.85 -24.88 64.41 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 120.724 -1.235 . . . . 0.0 112.49 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.91 -52.96 5.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.34 1.456 . . . . 0.0 108.012 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.479 ' SG ' ' HA ' ' A' ' 69' ' ' VAL . 8.5 p -62.53 -29.96 70.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.144 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.66 -38.58 67.1 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.451 0.7 . . . . 0.0 112.273 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -73.65 -46.9 43.79 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.281 1.032 . . . . 0.0 108.602 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.04 -41.22 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.88 0.472 . . . . 0.0 111.556 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -66.48 0.38 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.173 1.789 . . . . 0.0 110.123 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -38.57 89.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.416 1.087 . . . . 0.0 110.508 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.13 -29.68 75.41 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 118.954 0.797 . . . . 0.0 112.332 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.558 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 96.1 mt -112.56 -0.99 15.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.263 1.025 . . . . 0.0 111.436 -173.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -55.45 122.86 12.17 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 166.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.56 78.15 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.708 -1.051 . . . . 0.0 112.721 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -173.03 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.767 1.284 . . . . 0.0 109.051 162.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -129.47 120.36 25.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.714 1.606 . . . . 0.0 107.537 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.558 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 4.2 m-30 -101.59 28.28 5.69 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.058 . . . . 0.0 109.196 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.97 -60.81 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.485 1.514 . . . . 0.0 108.842 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t30 177.46 -28.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 127.944 2.498 . . . . 0.0 109.037 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -103.03 167.37 9.88 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.319 0.648 . . . . 0.0 111.019 -173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.43 107.59 13.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.381 -160.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 13' ' ' MET . 64.5 t -66.84 108.6 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.872 0.869 . . . . 0.0 110.294 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.73 123.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 163.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.98 142.15 27.82 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 126.289 1.835 . . . . 0.0 106.892 170.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -149.05 154.96 40.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.392 1.077 . . . . 0.0 109.373 168.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -74.34 158.21 34.38 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 169.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.84 -176.74 5.1 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.078 2.551 . . . . 0.0 108.646 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -128.52 143.7 49.31 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 119.069 0.85 . . . . 0.0 109.355 -171.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.56 -30.44 12.11 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.794 2.329 . . . . 0.0 112.357 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.83 -41.73 74.7 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.287 0.948 . . . . 0.0 110.451 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -43.77 88.76 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.33 0.652 . . . . 0.0 110.167 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -70.71 -35.81 72.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.764 1.626 . . . . 0.0 112.593 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -64.35 -10.63 25.62 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.537 1.135 . . . . 0.0 112.618 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -134.8 -164.79 1.57 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.444 1.898 . . . . 0.0 107.411 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -110.02 29.26 7.8 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.687 1.195 . . . . 0.0 110.87 -178.301 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -79.54 72.48 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.533 1.159 . . . . 0.0 109.884 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 22.0 m-30 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -165.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 . . . . . 0 C--O 1.239 0.536 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.83 136.16 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 N-CA-C 107.619 -1.723 . . . . 0.0 107.619 165.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.4 p -104.81 168.06 9.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -88.31 16.81 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.637 -0.664 . . . . 0.0 112.418 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.54 150.65 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tp -122.52 162.46 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.481 1.113 . . . . 0.0 108.104 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -135.67 130.57 34.49 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.628 1.571 . . . . 0.0 108.866 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.47 132.12 46.86 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.601 1.16 . . . . 0.0 110.767 -164.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -120.15 162.91 18.53 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.142 0.977 . . . . 0.0 110.242 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 68.68 3.2 3.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.978 2.911 . . . . 0.0 114.222 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.501 ' HB3' HD13 ' A' ' 62' ' ' ILE . 32.6 ttm -72.59 -39.59 67.25 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 110.805 -170.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.27 167.21 25.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 127.009 2.124 . . . . 0.0 109.129 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.85 153.95 55.0 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.894 0.878 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.78 0.79 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.536 2.157 . . . . 0.0 112.624 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.64 9.88 10.91 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.108 1.763 . . . . 0.0 111.684 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -137.42 26.57 2.86 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.48 1.112 . . . . 0.0 111.493 -169.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.83 37.15 4.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.629 1.172 . . . . 0.0 110.39 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -92.92 -59.6 2.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -68.52 112.14 5.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.841 1.256 . . . . 0.0 111.67 -170.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.52 -34.86 74.71 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.146 1.378 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.55 -64.15 0.99 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.126 1.37 . . . . 0.0 110.345 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -63.86 -37.17 86.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 0.0 110.828 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -54.37 -37.71 65.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.377 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.85 -32.44 52.05 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.381 0.672 . . . . 0.0 111.078 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.06 -54.32 35.93 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.923 1.289 . . . . 0.0 109.384 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.83 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 -171.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.16 -39.85 81.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 118.245 0.475 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -78.54 -33.3 47.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.638 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.86 -43.8 98.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.324 1.059 . . . . 0.0 109.749 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 50.9 t -68.1 -30.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.826 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -64.47 -35.18 80.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 116.63 -1.653 . . . . 0.0 111.084 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.88 -52.43 59.98 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 120.24 1.382 . . . . 0.0 109.39 169.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 32' ' ' VAL . 6.3 pt-20 -63.44 -46.71 85.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.237 -162.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.66 -9.9 59.01 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.656 -1.278 . . . . 0.0 111.895 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -20.38 66.17 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.879 -1.138 . . . . 0.0 110.066 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -65.93 -3.87 5.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.204 1.402 . . . . 0.0 112.858 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -132.83 -10.99 3.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.907 1.231 . . . . 0.0 113.071 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.26 -165.22 38.72 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 119.675 1.125 . . . . 0.0 110.847 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -98.19 104.53 16.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.76 110.0 2.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.11 -62.77 1.41 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -163.36 -172.02 2.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.563 0.345 . . . . 0.0 110.326 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.76 139.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 128.27 2.628 . . . . 0.0 104.597 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -133.2 113.27 12.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.509 0.724 . . . . 0.0 110.699 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mt -126.58 86.79 57.75 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.927 2.891 . . . . 0.0 109.62 -162.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 114.16 3.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.435 2.756 . . . . 0.0 108.989 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 165.4 53.63 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 172.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 C--N 1.353 0.777 0 C-N-CA 124.115 3.21 . . . . 0.0 110.218 164.484 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 0 N--CA 1.449 -1.106 0 N-CA-C 107.93 -1.604 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.81 -10.08 62.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.147 1.356 . . . . 0.0 113.011 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.08 156.68 35.83 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.434 1.117 . . . . 0.0 112.281 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 0.1 83.05 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.179 1.371 . . . . 0.0 113.075 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' C ' HD12 ' A' ' 62' ' ' ILE . 1.7 mppt? -117.29 167.67 11.02 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.048 1.424 . . . . 0.0 108.966 -174.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.501 HD13 ' HB3' ' A' ' 13' ' ' MET . 3.0 mp -126.7 145.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 161.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -111.79 157.77 20.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 160.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.69 153.55 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.6 146.42 49.57 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.03 0.932 . . . . 0.0 109.113 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.53 177.91 6.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.157 1.383 . . . . 0.0 110.892 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -89.71 -15.38 32.67 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 85.0 p -150.6 152.92 34.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.194 0.906 . . . . 0.0 111.163 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.08 -27.51 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.481 1.513 . . . . 0.0 110.126 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.64 -54.65 40.05 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.317 1.047 . . . . 0.0 109.446 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.58 -33.0 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.07 -51.23 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 110.075 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -53.66 -35.78 61.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.389 1.076 . . . . 0.0 111.666 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -71.82 -52.17 18.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.346 0.976 . . . . 0.0 110.395 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.46 -51.03 68.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.405 1.482 . . . . 0.0 110.222 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.4 ttt -44.78 -68.86 0.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.174 1.79 . . . . 0.0 111.598 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -66.53 -29.0 69.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.393 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.58 -24.35 65.97 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.447 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.3 mt -129.07 0.88 5.25 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.068 1.434 . . . . 0.0 114.187 -166.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.3 m -58.01 120.63 8.89 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.87 66.14 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.449 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.84 179.2 0.53 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.585 1.692 . . . . 0.0 111.881 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.24 137.22 53.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 159.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.414 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.2 m-30 -110.8 14.43 22.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.639 0.776 . . . . 0.0 110.21 173.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.92 -85.38 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.176 2.59 . . . . 0.0 104.902 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -140.64 -10.46 1.05 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -112.73 161.58 16.71 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.024 1.738 . . . . 0.0 110.244 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.4 109.99 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.43 0.634 . . . . 0.0 109.374 -173.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.9 t -64.52 144.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.615 1.166 . . . . 0.0 108.092 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.8 150.07 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 166.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.86 144.17 47.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.294 2.237 . . . . 0.0 108.574 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 4.8 mmpt? -143.44 162.74 34.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.67 2.388 . . . . 0.0 106.727 159.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -67.21 160.7 26.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 157.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.15 -164.5 1.13 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 168.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -113.53 142.53 27.77 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.32 -24.38 2.52 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.471 2.114 . . . . 0.0 111.528 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.39 -54.18 40.43 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -69.03 -15.6 63.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.199 0.6 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -82.35 -37.84 25.08 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.051 1.34 . . . . 0.0 110.973 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -72.23 2.21 6.36 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.016 1.327 . . . . 0.0 112.325 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -134.54 -164.52 1.52 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.734 2.414 . . . . 0.0 109.341 -163.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.531 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 5.6 ttm180 -130.26 25.1 5.19 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.931 2.092 . . . . 0.0 110.834 173.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 42.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.942 -1.098 . . . . 0.0 110.344 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.531 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 6.2 m-85 . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 119.644 -0.217 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.54 149.1 79.69 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.01 2.473 . . . . 0.0 109.27 165.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 p -139.96 170.81 15.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.29 1.836 . . . . 0.0 107.01 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.56 8.1 1.22 Allowed 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.852 -1.155 . . . . 0.0 111.468 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.9 t -129.04 111.28 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.425 1.49 . . . . 0.0 108.047 -162.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -124.38 129.44 50.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -171.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.7 t -101.0 148.81 24.61 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.404 ' HB3' ' HE3' ' A' ' 13' ' ' MET . 48.9 mt -132.62 105.52 7.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.214 1.805 . . . . 0.0 108.33 -162.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -99.56 165.52 11.59 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.411 0.624 . . . . 0.0 111.131 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.31 28.72 18.35 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 128.744 2.817 . . . . 0.0 111.423 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.404 ' HE3' ' HB3' ' A' ' 10' ' ' LEU . 2.4 ttm -84.21 -56.11 3.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.5 -0.75 . . . . 0.0 111.276 -168.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.4 157.34 27.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.128 1.771 . . . . 0.0 107.399 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -98.51 150.03 36.32 Favored Pre-proline 0 C--O 1.235 0.309 0 O-C-N 120.867 -1.146 . . . . 0.0 110.082 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -68.24 1.25 3.66 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.261 2.641 . . . . 0.0 112.912 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -127.14 12.44 7.13 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.078 1.751 . . . . 0.0 111.385 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.67 -14.58 7.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.254 0.622 . . . . 0.0 111.653 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -76.99 66.76 2.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.831 1.252 . . . . 0.0 110.707 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -130.64 -57.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.29 0.636 . . . . 0.0 109.487 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 112.48 1.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.68 1.192 . . . . 0.0 111.417 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.4 -22.24 66.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.237 1.415 . . . . 0.0 112.561 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.9 -55.62 4.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.306 1.042 . . . . 0.0 110.304 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -40.03 90.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.119 1.767 . . . . 0.0 110.473 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -49.98 -43.59 50.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.651 1.58 . . . . 0.0 112.667 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.68 -43.15 56.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.549 1.14 . . . . 0.0 109.285 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -63.74 -27.7 69.38 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.96 -0.462 . . . . 0.0 110.852 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -77.24 -24.72 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.521 1.128 . . . . 0.0 110.801 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.17 -47.32 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 120.535 -1.353 . . . . 0.0 107.718 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -72.31 -37.03 69.03 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.628 1.171 . . . . 0.0 111.988 -164.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -60.58 -42.08 95.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 111.629 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.58 -27.12 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 125.129 1.372 . . . . 0.0 110.902 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -62.0 -43.86 97.95 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.136 -0.977 . . . . 0.0 109.883 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.95 -52.52 65.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.523 0.729 . . . . 0.0 110.743 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -61.1 -35.16 76.27 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.732 0.777 . . . . 0.0 110.964 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t -76.2 -38.96 55.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.314 1.045 . . . . 0.0 109.671 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -51.9 -25.11 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.852 1.661 . . . . 0.0 111.981 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -61.28 -31.84 71.67 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.655 -1.278 . . . . 0.0 112.47 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.87 -8.29 25.94 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 112.535 -170.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.92 -178.05 19.03 Favored Glycine 0 CA--C 1.506 -0.526 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.8 tp -103.36 121.2 42.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -160.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.56 136.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.385 2.274 . . . . 0.0 108.383 172.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -98.49 -52.0 3.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.31 2.244 . . . . 0.0 109.689 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -152.01 158.4 43.02 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.118 0.567 . . . . 0.0 110.367 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.3 mt -137.33 92.21 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.73 113.11 23.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.555 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -123.79 85.64 53.54 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 125.16 1.384 . . . . 0.0 107.313 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.82 148.7 41.47 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.64 1.56 . . . . 0.0 108.323 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -137.97 160.23 65.32 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 121.004 -1.06 . . . . 0.0 110.928 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 121.964 1.776 . . . . 0.0 110.753 -178.333 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.449 -1.123 0 N-CA-C 108.451 -1.404 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.87 28.93 71.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 124.156 0.884 . . . . 0.0 111.426 169.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.5 t -69.48 153.99 42.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.153 1.781 . . . . 0.0 110.632 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.29 34.07 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.512 1.529 . . . . 0.0 114.421 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 147.74 48.49 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.567 1.683 . . . . 0.0 110.639 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.6 144.52 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -114.56 123.79 50.24 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.45 120.25 62.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -95.2 140.74 29.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.91 -168.91 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.093 1.757 . . . . 0.0 108.851 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 p -119.67 -0.65 10.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.413 1.085 . . . . 0.0 112.544 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.9 m -159.88 146.21 15.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.512 1.525 . . . . 0.0 108.873 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.31 -13.81 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.379 1.072 . . . . 0.0 111.102 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.9 -41.26 15.1 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.132 -1.605 . . . . 0.0 110.83 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.92 -37.55 87.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.969 0.907 . . . . 0.0 110.917 -173.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.5 p -68.76 -37.05 79.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.003 0.521 . . . . 0.0 110.732 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -67.02 -31.05 71.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.139 0.976 . . . . 0.0 111.232 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -62.62 -56.09 21.0 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.603 1.092 . . . . 0.0 108.773 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.17 79.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.859 0.864 . . . . 0.0 110.973 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -44.57 -58.79 2.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.849 1.66 . . . . 0.0 111.502 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -79.45 -33.25 42.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.075 0.95 . . . . 0.0 112.166 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.6 84.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.554 1.073 . . . . 0.0 112.531 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -117.53 10.57 13.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.705 1.602 . . . . 0.0 111.19 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -56.31 124.59 18.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.04 -3.63 60.79 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.289 -0.728 . . . . 0.0 112.891 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -69.48 -178.45 1.41 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.156 1.478 . . . . 0.0 109.307 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -134.11 99.64 4.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.359 1.464 . . . . 0.0 109.347 -163.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.86 13.51 4.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.118 0.967 . . . . 0.0 112.318 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.44 -73.25 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.956 2.503 . . . . 0.0 104.521 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -146.04 -30.08 0.4 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.027 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt85 -101.01 164.98 11.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.887 0.875 . . . . 0.0 111.371 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.78 111.76 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.558 1.143 . . . . 0.0 109.794 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -72.15 134.81 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 109.884 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.4 t -113.12 143.39 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 166.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 p -112.81 146.92 37.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.493 1.517 . . . . 0.0 108.224 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.1 149.74 31.56 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.649 168.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.35 118.64 17.53 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.71 -175.72 5.52 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.25 0.62 . . . . 0.0 109.727 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -101.61 144.95 29.58 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.38 -28.78 32.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.868 3.045 . . . . 0.0 111.435 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.1 -45.24 21.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.571 1.149 . . . . 0.0 110.549 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.96 14.84 27.66 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.965 0.906 . . . . 0.0 111.739 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -103.85 -39.73 6.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.86 1.264 . . . . 0.0 110.488 163.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -58.84 -15.3 11.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.698 1.599 . . . . 0.0 113.903 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -129.67 -163.85 1.34 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.616 1.967 . . . . 0.0 108.821 -168.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.41 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -104.73 38.7 1.84 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.661 1.585 . . . . 0.0 111.336 173.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -102.71 21.27 15.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.824 2.05 . . . . 0.0 114.129 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 102' ' ' ARG . 4.5 m-85 . . . . . 0 CA--C 1.533 0.315 0 O-C-N 120.8 -1.187 . . . . 0.0 110.265 -170.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.97 131.45 23.93 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.956 1.77 . . . . 0.0 108.091 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 p -123.98 179.53 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -86.33 -4.85 59.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.197 -0.906 . . . . 0.0 113.388 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.8 m -83.83 179.81 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.855 1.207 . . . . 0.0 109.098 168.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tp -155.21 163.65 39.89 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 166.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.5 t -138.61 129.37 26.46 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.783 -1.198 . . . . 0.0 109.606 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.452 HD21 HG12 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -125.6 115.02 19.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 126.217 1.807 . . . . 0.0 107.761 -164.06 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mtm -87.83 162.5 16.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 75.37 23.89 1.46 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.515 1.926 . . . . 0.0 112.968 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.572 ' HB2' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -77.84 -82.92 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.683 HG22 HD11 ' A' ' 62' ' ' ILE . 31.6 m -88.02 159.84 2.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 127.721 2.408 . . . . 0.0 109.069 -170.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.82 165.32 40.17 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.283 0.633 . . . . 0.0 109.425 155.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.2 -17.76 24.2 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.604 1.536 . . . . 0.0 112.993 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -96.17 -7.14 36.59 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.673 1.189 . . . . 0.0 111.443 -165.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.12 -38.9 17.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.312 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 14' ' ' VAL . 93.0 mt -72.03 49.44 0.19 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.516 2.326 . . . . 0.0 115.421 -155.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.43 -11.5 3.57 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 119.857 -1.777 . . . . 0.0 110.317 -167.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.85 112.69 17.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.981 0.896 . . . . 0.0 110.066 -167.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.87 -16.1 37.87 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 129.669 3.188 . . . . 0.0 113.173 -165.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.39 -51.87 7.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.45 1.5 . . . . 0.0 110.5 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.31 -44.15 72.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.527 2.331 . . . . 0.0 108.618 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.481 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 54.0 t80 -58.43 -33.63 69.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.744 0.418 . . . . 0.0 111.818 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.63 -39.9 50.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.075 . . . . 0.0 111.599 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.2 -46.11 91.81 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.33 0.652 . . . . 0.0 109.581 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.5 mt -60.49 -39.15 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.745 1.218 . . . . 0.0 110.123 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.21 -33.07 58.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 120.751 -1.218 . . . . 0.0 110.411 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.24 -42.44 25.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.192 0.597 . . . . 0.0 110.957 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.37 -40.09 93.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.577 1.18 . . . . 0.0 110.532 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.5 t -89.01 -15.41 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.209 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -72.77 -38.22 67.38 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.52 -1.363 . . . . 0.0 111.034 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.5 -52.52 64.17 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.967 0.803 . . . . 0.0 109.825 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.35 -21.15 66.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.9 t -83.15 -34.32 26.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.848 1.659 . . . . 0.0 110.592 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -17.88 19.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 113.043 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.02 -32.71 71.14 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.914 0.886 . . . . 0.0 112.627 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.3 -7.86 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.148 0.886 . . . . 0.0 112.609 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.31 -134.51 3.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -167.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.12 112.63 4.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.78 120.67 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.674 1.226 . . . . 0.0 109.209 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -60.66 3.43 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.191 2.196 . . . . 0.0 108.155 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -160.22 -178.74 7.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.779 0.718 . . . . 0.0 110.91 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.45 136.67 57.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 126.578 1.951 . . . . 0.0 106.634 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.95 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.878 1.271 . . . . 0.0 110.167 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.06 86.14 21.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.649 1.979 . . . . 0.0 106.723 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 114.82 4.14 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.537 2.825 . . . . 0.0 109.748 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 2.4 mpp_? -72.96 159.77 84.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.156 0.982 . . . . 0.0 111.696 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.352 0.741 1 C-N-CA 125.926 4.418 . . . . 0.0 112.152 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 N-CA-C 107.515 -1.764 . . . . 0.0 107.515 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.54 -8.06 6.98 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.107 1.813 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.2 t -81.94 142.68 32.23 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.226 1.513 . . . . 0.0 110.229 -164.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.84 -12.2 24.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.002 1.763 . . . . 0.0 113.477 -170.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.495 ' C ' HD12 ' A' ' 62' ' ' ILE . 6.9 mptt -86.87 146.89 26.02 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HG22 ' A' ' 14' ' ' VAL . 1.9 mp -118.84 147.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 170.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -122.53 158.54 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 HD21 ' A' ' 10' ' ' LEU . 11.9 p -144.82 153.34 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 30.9 tt0 -132.58 139.25 47.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -114.47 174.91 5.72 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.245 1.418 . . . . 0.0 110.57 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -74.37 -23.2 58.97 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.934 -0.479 . . . . 0.0 112.111 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 t -154.69 161.87 41.37 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.631 1.205 . . . . 0.0 110.111 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.2 t -52.17 -39.56 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.592 1.557 . . . . 0.0 108.173 164.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -69.36 -35.09 75.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 117.027 -1.463 . . . . 0.0 113.688 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -85.19 -20.66 29.85 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.01 1.732 . . . . 0.0 111.503 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.3 t -69.68 -49.6 51.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.517 1.527 . . . . 0.0 110.243 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -54.74 -36.82 65.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.622 0.769 . . . . 0.0 112.141 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -71.54 -45.93 60.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.08 91.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 112.036 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.7 ttm -53.69 -68.33 0.19 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.381 0.991 . . . . 0.0 109.34 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -55.64 -34.95 65.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.782 0.833 . . . . 0.0 110.617 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.9 -20.87 76.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.86 -0.967 . . . . 0.0 114.355 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.59 2.33 10.12 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.085 1.354 . . . . 0.0 112.107 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -63.2 103.01 0.44 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.614 -1.304 . . . . 0.0 109.945 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.98 0.53 30.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.079 1.323 . . . . 0.0 112.897 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -74.25 -175.53 2.31 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.333 1.066 . . . . 0.0 111.958 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -138.29 115.99 11.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -107.97 24.21 13.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.55 1.54 . . . . 0.0 111.019 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.47 -64.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.318 1.847 . . . . 0.0 108.506 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.37 -17.99 0.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 171.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -113.71 166.6 11.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 109.925 -167.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.56 118.86 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 13' ' ' MET . 77.0 t -66.91 138.23 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.14 131.37 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.7 p -106.72 147.24 29.84 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.258 1.823 . . . . 0.0 108.826 -164.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -153.95 151.05 28.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.708 1.603 . . . . 0.0 108.065 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -77.42 152.32 34.35 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 166.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -172.14 2.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.929 1.691 . . . . 0.0 107.779 168.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -111.85 143.55 28.89 Favored Pre-proline 0 C--O 1.236 0.36 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.02 -23.5 16.01 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.814 3.009 . . . . 0.0 110.997 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -51.49 -53.31 38.65 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.76 0.824 . . . . 0.0 108.985 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.32 77.87 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.788 0.835 . . . . 0.0 111.214 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -70.46 -39.85 74.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.911 2.084 . . . . 0.0 112.54 -169.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -63.78 -42.16 97.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 109.811 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -93.38 -167.33 1.69 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.847 1.259 . . . . 0.0 110.475 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 7.0 ttm180 -100.17 39.8 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.763 -0.585 . . . . 0.0 110.55 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -99.3 88.88 4.03 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.048 -1.033 . . . . 0.0 109.42 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.457 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.238 0.499 0 C-N-CA 126.491 1.916 . . . . 0.0 107.379 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -71.53 148.09 53.16 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.743 . . . . 0.0 108.444 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.9 p -136.51 -179.84 5.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.28 5.56 5.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.305 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.56 143.97 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.698 1.199 . . . . 0.0 110.464 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 mt -131.43 159.59 37.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.209 2.204 . . . . 0.0 109.526 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 t -116.77 110.88 18.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.773 1.629 . . . . 0.0 106.974 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.02 153.54 20.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.6 mtm -134.23 176.8 8.27 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 61.62 12.89 4.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.879 1.671 . . . . 0.0 113.034 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -68.33 -59.52 3.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 153.84 38.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.074 2.15 . . . . 0.0 108.227 -172.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -82.01 164.4 48.63 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.074 1.35 . . . . 0.0 109.548 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.87 5.28 2.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 124.116 3.211 . . . . 0.0 113.734 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -129.56 26.59 5.33 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.547 1.539 . . . . 0.0 110.326 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -141.05 24.64 2.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.301 1.84 . . . . 0.0 111.838 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -128.54 75.51 1.64 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.482 2.313 . . . . 0.0 107.039 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -134.35 -49.93 0.79 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.296 1.439 . . . . 0.0 108.166 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.92 105.96 3.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.904 2.481 . . . . 0.0 108.974 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.61 -19.73 41.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.117 1.367 . . . . 0.0 112.736 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.24 -65.71 0.98 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.35 -29.0 68.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.168 1.387 . . . . 0.0 111.897 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.22 -44.17 64.64 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.82 -0.55 . . . . 0.0 111.697 172.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.16 -43.77 50.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -55.88 -43.97 77.72 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.29 1.036 . . . . 0.0 111.119 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -68.31 -42.53 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.823 0.849 . . . . 0.0 109.604 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -59.07 -40.03 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.799 1.182 . . . . 0.0 109.515 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.77 -32.56 67.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.446 0.566 . . . . 0.0 112.361 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.84 -40.75 88.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.842 0.353 . . . . 0.0 110.753 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.1 t -78.47 -38.7 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 118.264 -0.874 . . . . 0.0 109.403 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -52.39 -36.23 53.48 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.07 0.85 . . . . 0.0 109.912 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.44 -38.02 88.16 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.546 0.612 . . . . 0.0 111.124 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.59 -47.65 18.85 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.686 ' SG ' HG11 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -61.74 -29.81 70.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 111.65 174.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.5 t -63.52 -9.38 12.79 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.633 1.173 . . . . 0.0 113.225 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -61.56 -41.89 98.03 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.138 -2.227 . . . . 0.0 111.111 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.67 -8.42 50.04 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.214 1.406 . . . . 0.0 113.146 -160.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.12 -159.07 27.82 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -157.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.64 120.53 36.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.419 1.109 . . . . 0.0 111.759 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.686 HG11 ' SG ' ' A' ' 36' ' ' CYS . 1.5 p -75.9 142.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.051 167.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.3 -54.67 2.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.526 1.931 . . . . 0.0 109.288 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -159.34 155.62 27.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.474 0.579 . . . . 0.0 110.621 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mt -124.34 118.57 54.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 127.143 2.177 . . . . 0.0 105.888 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 133.53 38.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.91 86.61 26.48 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -52.06 145.74 32.61 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.237 1.958 . . . . 0.0 110.128 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.67 148.14 67.19 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.33 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 C-N-CA 123.063 2.509 . . . . 0.0 111.067 178.953 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 N-CA-C 109.762 -0.899 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.46 -1.37 20.44 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.84 1.21 . . . . 0.0 113.383 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -66.45 137.45 56.84 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.509 1.654 . . . . 0.0 111.158 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.73 1.74 79.83 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.935 1.731 . . . . 0.0 113.608 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -108.87 123.23 48.74 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.59 106.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -170.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -91.11 141.94 28.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.8 135.69 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.99 148.82 41.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.033 1.733 . . . . 0.0 107.184 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -129.99 168.83 16.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.686 1.594 . . . . 0.0 109.999 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 p -70.01 -4.74 22.29 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.28 1.432 . . . . 0.0 114.088 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.2 t -171.51 165.42 6.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.256 1.822 . . . . 0.0 107.984 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.6 t -52.93 -47.82 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.251 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -61.83 -48.35 80.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.312 0.645 . . . . 0.0 110.262 -172.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.29 -40.24 93.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.227 1.011 . . . . 0.0 110.342 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -44.69 94.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.247 1.019 . . . . 0.0 109.423 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.5 -51.85 57.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.389 1.476 . . . . 0.0 110.774 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -61.05 -47.35 86.81 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.77 74.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.326 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -62.25 -65.52 0.68 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.099 0.863 . . . . 0.0 109.438 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -70.04 -24.4 63.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.968 -0.457 . . . . 0.0 111.301 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.06 -24.28 73.16 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.364 -0.687 . . . . 0.0 112.505 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -127.84 -6.24 5.63 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.217 1.008 . . . . 0.0 112.468 -171.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -59.83 142.05 54.19 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.871 1.214 . . . . 0.0 108.08 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.2 -1.32 81.1 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.206 1.384 . . . . 0.0 114.029 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -78.09 -174.74 3.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.373 2.086 . . . . 0.0 112.005 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -118.66 129.97 55.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -107.1 13.47 27.38 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.96 1.254 . . . . 0.0 110.787 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.73 -74.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.73 -12.14 0.45 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -122.4 160.91 24.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.187 0.903 . . . . 0.0 110.719 -165.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.82 128.91 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 123.159 0.287 . . . . 0.0 111.764 -165.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.56 87.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.77 146.37 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.0 p -102.11 164.36 11.74 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.491 0.717 . . . . 0.0 109.489 171.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -146.75 150.47 35.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.275 1.43 . . . . 0.0 107.582 154.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -67.43 156.28 36.96 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.358 1.036 . . . . 0.0 109.461 163.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.59 -172.38 2.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.902 1.281 . . . . 0.0 108.368 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -108.83 145.34 31.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 158.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.99 -22.24 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.541 2.828 . . . . 0.0 112.723 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -44.64 -42.11 7.21 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.867 2.067 . . . . 0.0 111.969 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 p -91.23 -27.57 18.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 112.28 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -72.79 -27.25 61.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.818 2.047 . . . . 0.0 110.637 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -65.21 -12.47 51.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -130.48 -164.18 1.4 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.75 2.02 . . . . 0.0 107.852 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 2.2 ttt180 -107.1 23.44 14.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.417 1.087 . . . . 0.0 111.252 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.68 97.83 6.71 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.72 -1.237 . . . . 0.0 110.155 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 5.6 m-85 . . . . . 0 C--O 1.235 0.29 0 C-N-CA 124.651 1.181 . . . . 0.0 108.416 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.83 149.14 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.829 1.686 . . . . 0.0 108.827 167.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.0 p -128.12 171.32 12.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 4.4 pt-20 -72.06 -10.49 59.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.773 1.229 . . . . 0.0 111.716 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -114.01 155.0 15.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 119.537 1.062 . . . . 0.0 110.056 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.1 124.82 21.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 108.63 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -80.22 129.77 34.74 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.0 122.88 42.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.323 1.449 . . . . 0.0 108.411 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -97.03 163.96 12.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 74.22 18.88 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.063 2.145 . . . . 0.0 113.649 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -73.41 0.31 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 165.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.62 174.23 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 126.183 1.793 . . . . 0.0 109.616 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -112.47 146.29 34.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 125.022 1.329 . . . . 0.0 107.654 172.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -61.37 7.37 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.808 1 C-N-CA 127.892 5.728 . . . . 0.0 116.055 -175.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.34 -0.33 1.81 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.258 1.823 . . . . 0.0 111.925 -154.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -117.42 -6.08 11.23 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 112.937 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' H ' ' A' ' 19' ' ' LEU . 2.2 mm? -68.95 -4.66 17.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.355 1.462 . . . . 0.0 113.849 -169.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.31 -25.84 60.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.978 2.111 . . . . 0.0 111.564 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.32 129.3 34.99 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.381 0.991 . . . . 0.0 109.614 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.28 -17.05 43.91 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.209 1.403 . . . . 0.0 112.393 -170.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -87.88 -61.82 1.63 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.148 0.979 . . . . 0.0 109.278 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.27 -38.03 73.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.565 0.746 . . . . 0.0 111.816 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -53.22 -39.27 63.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.258 1.023 . . . . 0.0 112.517 172.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -84.29 -31.89 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.428 0.691 . . . . 0.0 111.438 -171.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -53.95 -45.41 71.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.8 mt -67.09 -15.07 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.909 0.883 . . . . 0.0 111.724 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.0 t -86.01 -44.67 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 119.913 -1.742 . . . . 0.0 108.773 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.9 -42.54 69.84 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.684 0.793 . . . . 0.0 111.153 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -60.83 -43.6 98.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.754 1.74 . . . . 0.0 109.647 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.87 -21.78 6.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.316 -167.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -61.13 -43.34 99.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.086 -1.009 . . . . 0.0 108.826 165.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.48 -43.14 91.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.14 0.882 . . . . 0.0 111.743 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.68 -46.13 76.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.811 0.732 . . . . 0.0 110.274 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -70.89 -27.82 64.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.684 0.794 . . . . 0.0 111.276 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -55.53 -16.68 4.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.006 1.723 . . . . 0.0 113.339 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.31 -11.09 38.29 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.978 -1.701 . . . . 0.0 113.692 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.67 -15.89 10.74 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.65 -168.56 27.36 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 107.181 -2.367 . . . . 0.0 107.181 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.7 tp -99.87 119.24 37.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -162.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.58 117.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 167.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -56.23 15.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 158.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 p -160.36 170.01 21.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.504 0.593 . . . . 0.0 112.357 -166.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.64 153.1 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.14 133.21 45.37 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -137.71 85.61 20.02 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.51 148.34 92.57 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.394 1.396 . . . . 0.0 109.69 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -118.18 150.33 47.37 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 108.537 -167.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.457 -0.628 0 C-N-CA 123.079 2.519 . . . . 0.0 108.641 172.599 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.454 -0.805 0 N-CA-C 108.409 -1.419 . . . . 0.0 108.409 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.75 12.83 61.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.525 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.19 154.24 42.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.531 1.666 . . . . 0.0 110.667 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.1 -32.36 4.67 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.09 1.805 . . . . 0.0 112.89 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -72.17 172.59 9.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.11 1.455 . . . . 0.0 109.254 173.359 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.95 151.19 35.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 164.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.84 150.26 33.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 165.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.32 159.24 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.67 121.42 10.54 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -93.63 162.93 13.75 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.507 0.67 . . . . 0.0 109.361 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -72.93 -1.55 17.41 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.029 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.3 m -158.45 155.34 28.38 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 121.135 1.789 . . . . 0.0 111.627 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.7 t -59.76 -32.29 49.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.627 1.571 . . . . 0.0 109.852 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.73 -59.53 5.24 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.479 -0.763 . . . . 0.0 110.297 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.55 -39.5 57.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.335 1.454 . . . . 0.0 109.891 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 t -64.35 -50.11 69.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.973 1.309 . . . . 0.0 110.374 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.15 -30.67 62.5 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.871 1.268 . . . . 0.0 112.206 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -78.03 -50.13 12.69 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.0 0.92 . . . . 0.0 109.498 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.27 -47.35 78.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.361 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.2 ttm -48.06 -67.55 0.26 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.027 0.831 . . . . 0.0 110.752 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.49 -25.33 66.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.796 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.33 -26.75 74.09 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.649 -1.084 . . . . 0.0 112.565 174.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.494 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 94.3 mt -123.39 -5.71 8.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.608 1.204 . . . . 0.0 112.727 -167.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 m -50.59 121.08 5.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.508 1.123 . . . . 0.0 108.412 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.25 8.03 86.91 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 118.499 -1.167 . . . . 0.0 114.41 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -78.26 -169.68 1.72 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.676 1.238 . . . . 0.0 109.974 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.85 132.2 53.72 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.494 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 4.2 m-30 -110.57 19.96 18.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.698 1.199 . . . . 0.0 109.737 174.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.57 -65.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.885 1.674 . . . . 0.0 107.179 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 -29.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.076 1.351 . . . . 0.0 111.452 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -88.51 166.5 14.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.671 -0.643 . . . . 0.0 110.255 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.95 135.49 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.1 t -93.75 111.69 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.29 142.78 13.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.8 p -119.96 151.43 38.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.369 1.068 . . . . 0.0 108.128 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -150.0 144.16 25.65 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.174 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -66.48 138.17 57.34 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 120.252 1.387 . . . . 0.0 108.218 161.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 -164.37 0.94 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -116.73 143.02 30.59 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.56 -27.8 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.132 3.221 . . . . 0.0 111.991 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -46.88 72.2 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 120.902 -1.123 . . . . 0.0 111.083 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.81 55.17 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.895 1.678 . . . . 0.0 111.325 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -92.65 -51.94 4.87 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.4 1.88 . . . . 0.0 109.251 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -62.5 -30.29 71.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.858 0.463 . . . . 0.0 111.599 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -104.96 -178.25 3.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.539 1.936 . . . . 0.0 108.659 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -111.49 76.84 1.0 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.32 69.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 . . . . . 0 C--O 1.236 0.349 0 C-N-CA 123.219 0.608 . . . . 0.0 110.075 -177.952 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 120.379 0.133 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.76 148.37 52.36 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.775 2.317 . . . . 0.0 108.502 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.2 p -135.79 155.21 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.16 -3.02 3.32 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 m -93.64 -167.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.472 0.653 . . . . 0.0 110.354 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.11 160.33 43.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.467 2.307 . . . . 0.0 105.877 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 t -137.65 114.29 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 mp -125.05 153.93 42.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 110.618 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mtm -138.27 170.25 16.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 111.046 -172.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.03 13.24 5.52 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.334 2.254 . . . . 0.0 112.658 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 36.9 ttm -76.17 -75.71 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -97.24 155.9 3.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.748 1.219 . . . . 0.0 108.738 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.04 156.87 38.4 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.364 1.466 . . . . 0.0 107.065 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.91 -12.37 34.08 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.434 2.756 . . . . 0.0 113.835 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -105.1 8.65 34.3 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.013 1.725 . . . . 0.0 110.756 -168.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -124.46 -16.96 6.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.393 1.077 . . . . 0.0 111.596 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.73 56.14 3.42 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.395 1.478 . . . . 0.0 109.589 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.44 -49.06 1.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.026 0.93 . . . . 0.0 108.866 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.1 92.17 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.727 1.611 . . . . 0.0 110.327 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.69 -17.7 49.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.289 1.835 . . . . 0.0 113.097 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.21 -35.0 10.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 0.0 110.802 -172.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -74.61 -36.32 62.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.712 1.205 . . . . 0.0 111.082 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.89 -40.15 13.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.839 1.655 . . . . 0.0 111.782 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.08 -46.49 74.14 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 110.927 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.96 -46.83 79.92 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.954 1.302 . . . . 0.0 109.926 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.84 -45.29 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.889 0.875 . . . . 0.0 109.813 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 t -57.26 -47.16 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.96 -37.63 88.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.555 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -76.15 -27.7 57.1 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.963 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.4 t -76.73 -34.17 22.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.61 -28.74 69.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.045 -1.034 . . . . 0.0 111.644 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.21 -47.18 78.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.854 0.752 . . . . 0.0 110.803 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.7 -42.96 69.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.943 0.497 . . . . 0.0 110.479 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.441 ' HA ' HD11 ' A' ' 79' ' ' LEU 0.295 0.8 OUTLIER -71.96 -26.12 62.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.707 173.53 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -11.83 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 120.543 1.52 . . . . 0.0 113.04 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -63.2 -20.19 65.19 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 119.77 -1.831 . . . . 0.0 113.986 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -117.28 3.84 12.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.369 0.668 . . . . 0.0 112.524 -165.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.36 -139.4 5.99 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -168.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -137.54 133.31 34.36 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.141 1.471 . . . . 0.0 109.664 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -84.69 122.2 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.24 1.016 . . . . 0.0 108.48 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -73.02 -61.35 1.85 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.151 0.981 . . . . 0.0 108.866 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 t -151.84 166.68 30.68 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.781 0.832 . . . . 0.0 109.358 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 64' ' ' VAL . 7.2 mt -133.74 123.36 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -110.87 114.13 27.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.067 1.347 . . . . 0.0 109.808 -167.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.29 86.26 30.91 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.861 1.664 . . . . 0.0 107.94 -167.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.19 150.16 87.92 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 120.946 1.097 . . . . 0.0 109.821 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -105.39 165.43 13.16 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 109.505 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.534 0.513 0 C-N-CA 123.256 2.637 . . . . 0.0 110.883 173.859 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 N--CA 1.446 -1.279 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.57 9.68 85.39 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.805 -0.997 . . . . 0.0 113.258 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.14 154.6 37.66 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.294 1.047 . . . . 0.0 111.431 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.63 -4.56 50.69 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.671 1.605 . . . . 0.0 115.223 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -98.44 147.0 25.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.706 1.253 . . . . 0.0 107.833 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.91 139.65 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -123.12 139.17 54.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 45' ' ' ILE . 98.2 t -132.11 110.23 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -169.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 37.1 tt0 -88.62 138.96 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.522 1.129 . . . . 0.0 108.012 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.76 174.54 6.53 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.403 1.481 . . . . 0.0 110.227 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -32.41 67.51 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.696 1.199 . . . . 0.0 113.601 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.3 m -168.85 167.25 11.08 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.285 1.034 . . . . 0.0 110.324 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.406 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 2.9 t -51.73 -40.12 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 122.901 1.334 . . . . 0.0 110.328 175.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.78 -2.51 20.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.605 -1.31 . . . . 0.0 114.036 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -109.01 -33.97 6.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.237 1.015 . . . . 0.0 109.373 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 69' ' ' VAL . 29.2 p -75.82 -34.37 60.13 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.472 -0.768 . . . . 0.0 109.504 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -50.27 -35.43 27.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.883 2.073 . . . . 0.0 111.83 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.3 -46.13 12.11 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.002 0.921 . . . . 0.0 108.875 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.78 76.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.581 -1.2 . . . . 0.0 111.277 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 mtp -46.59 -64.28 0.8 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 108.907 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -68.2 -34.11 75.67 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.355 -173.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.07 -7.06 70.07 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.76 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.441 HD11 ' HA ' ' A' ' 36' ' ' CYS . 43.8 mt -131.21 -3.08 3.92 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 111.811 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -62.83 108.64 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.831 -1.168 . . . . 0.0 109.127 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.24 67.01 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.78 1.181 . . . . 0.0 113.14 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -64.57 177.36 0.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.295 1.547 . . . . 0.0 109.429 165.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -131.92 89.97 2.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -167.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -80.45 13.38 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.905 -0.497 . . . . 0.0 112.119 -168.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.08 -84.45 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.152 3.381 . . . . 0.0 103.288 156.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -147.06 18.92 1.25 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.426 -0.796 . . . . 0.0 112.022 -168.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 -132.86 171.7 13.58 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.748 -1.22 . . . . 0.0 110.338 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 t -87.3 109.56 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -73.17 124.56 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.69 163.62 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 p -132.88 163.29 29.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.186 2.194 . . . . 0.0 108.753 -168.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -164.6 158.9 18.48 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 130.127 3.371 . . . . 0.0 105.578 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.11 145.3 31.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 157.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.61 -164.3 1.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.01 1.324 . . . . 0.0 109.67 172.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -109.92 144.83 30.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 157.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.42 -19.55 10.19 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.825 3.016 . . . . 0.0 111.708 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -57.0 -59.28 5.29 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.991 -1.068 . . . . 0.0 108.611 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.4 m -70.01 -0.78 8.14 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.254 2.222 . . . . 0.0 111.9 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 65' ' ' GLU . 45.8 t80 -91.06 -48.32 7.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.412 1.485 . . . . 0.0 110.522 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -68.9 -45.6 70.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.102 0.961 . . . . 0.0 109.342 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -76.29 170.89 15.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.078 0.942 . . . . 0.0 109.222 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -101.49 68.11 1.17 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.56 74.89 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.93 1.348 . . . . 0.0 108.778 169.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 177.041 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.63 136.51 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.678 2.252 . . . . 0.0 108.705 166.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -140.82 171.28 14.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.49 -2.57 14.4 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.19 -0.944 . . . . 0.0 113.056 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.552 HG22 ' OE1' ' A' ' 65' ' ' GLU . 14.8 t -107.44 92.55 2.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.657 1.183 . . . . 0.0 108.439 -167.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.63 125.88 29.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.59 124.06 35.46 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -123.82 111.24 15.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.271 1.034 . . . . 0.0 109.585 175.075 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mtm -84.55 166.49 17.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.73 0.812 . . . . 0.0 109.778 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 70.1 14.69 7.72 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.718 2.007 . . . . 0.0 113.033 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -58.63 7.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.45 163.34 24.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.534 1.134 . . . . 0.0 111.709 -161.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -103.4 163.68 16.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.052 2.141 . . . . 0.0 109.35 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.03 4.88 4.36 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.892 2.394 . . . . 0.0 113.247 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.55 14.83 11.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.831 1.252 . . . . 0.0 111.506 -171.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.47 24.04 2.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.377 1.071 . . . . 0.0 111.123 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.7 mt -133.2 37.43 3.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.438 1.895 . . . . 0.0 109.82 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -113.58 -5.62 13.41 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.274 1.029 . . . . 0.0 111.245 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.38 127.51 53.75 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.94 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.92 -12.72 60.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.89 0.876 . . . . 0.0 111.269 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.19 -59.31 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.039 0.936 . . . . 0.0 108.728 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.67 -36.98 77.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.057 1.743 . . . . 0.0 111.136 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -52.62 -48.55 66.27 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.928 1.291 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.2 -36.47 66.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.911 0.778 . . . . 0.0 110.221 -172.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -60.39 -49.32 78.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.394 0.678 . . . . 0.0 109.415 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -63.22 -41.18 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.1 t -56.18 -48.25 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.459 1.027 . . . . 0.0 110.045 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.31 -31.39 60.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.954 1.252 . . . . 0.0 112.924 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.83 -45.52 74.44 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.603 0.716 . . . . 0.0 110.609 176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.8 t -72.55 -41.82 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -30.65 38.19 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.105 0.866 . . . . 0.0 110.349 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.67 -36.49 67.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 120.344 1.429 . . . . 0.0 113.189 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.32 -43.13 98.67 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.261 0.9 OUTLIER -79.94 -17.47 52.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.474 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -53.28 -29.57 33.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.052 1.741 . . . . 0.0 110.69 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -59.46 -20.35 54.52 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.264 -0.898 . . . . 0.0 112.44 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -125.64 51.64 1.71 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.111 1.365 . . . . 0.0 108.35 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.57 -116.12 2.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 125.269 1.414 . . . . 0.0 110.377 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 67' ' ' THR . 1.3 tm? -154.47 113.13 3.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.82 116.22 21.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.036 1.734 . . . . 0.0 107.433 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -69.31 -57.82 4.82 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.085 0.554 . . . . 0.0 109.685 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.46 166.36 25.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 0.0 109.639 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 111.58 27.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 125.748 1.619 . . . . 0.0 107.11 -169.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.24 124.81 30.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.599 0.76 . . . . 0.0 109.965 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.94 85.48 22.97 Favored Pre-proline 0 C--O 1.225 -0.234 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.1 -15.15 42.56 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.52 2.146 . . . . 0.0 114.784 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.347 0.0 OUTLIER 60.41 160.86 0.11 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 128.767 2.827 . . . . 0.0 116.438 172.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.354 0.868 0 C-N-CA 123.812 3.008 . . . . 0.0 110.33 172.117 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo . . . . . 0 N--CA 1.447 -1.237 0 N-CA-C 108.765 -1.283 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.01 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 127.055 2.264 . . . . 0.0 111.973 -175.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.28 130.57 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.296 1.548 . . . . 0.0 111.036 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.07 -13.66 66.43 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.768 1.651 . . . . 0.0 113.482 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.17 122.89 40.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.45 148.72 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 167.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.37 127.49 46.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG12 HD11 ' A' ' 10' ' ' LEU . 10.1 p -121.73 119.79 59.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -174.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.552 ' OE1' HG22 ' A' ' 7' ' ' VAL . 1.5 tp10 -88.58 150.61 22.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.674 1.59 . . . . 0.0 107.645 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -132.93 162.99 30.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.405 1.082 . . . . 0.0 110.547 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 41' ' ' LEU . 7.4 p -72.55 -6.5 44.4 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -154.28 157.3 38.48 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 120.203 1.365 . . . . 0.0 113.137 162.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.21 -16.79 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 112.107 167.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -94.24 -18.85 21.26 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.424 -1.423 . . . . 0.0 112.137 -175.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -85.03 -41.98 15.28 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.285 0.634 . . . . 0.0 110.271 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 p -62.65 -31.92 72.88 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.647 -0.658 . . . . 0.0 110.818 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -63.91 -13.91 49.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 113.206 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -95.73 -41.2 8.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 120.315 1.416 . . . . 0.0 108.488 172.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.11 45.69 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.024 0.929 . . . . 0.0 111.621 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -59.45 -31.69 69.54 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -162.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.86 -40.15 9.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.711 2.405 . . . . 0.0 110.327 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.92 -25.57 67.98 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 121.731 -0.606 . . . . 0.0 112.285 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -124.72 22.52 8.2 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.94 2.096 . . . . 0.0 110.29 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.2 m -56.87 127.47 31.89 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.277 -0.889 . . . . 0.0 109.092 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.65 5.8 64.96 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 118.628 -1.096 . . . . 0.0 112.975 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -173.65 0.17 Allowed 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.612 1.706 . . . . 0.0 110.17 176.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -124.19 121.21 34.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.8 14.06 22.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.181 0.991 . . . . 0.0 110.965 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.19 -66.45 0.09 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.67 -25.78 0.14 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.169 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -105.99 172.39 6.83 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.635 1.174 . . . . 0.0 110.452 -169.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.06 118.14 28.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.41 155.09 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.426 1.09 . . . . 0.0 109.628 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.69 147.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 158.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.71 144.43 42.97 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.543 1.937 . . . . 0.0 106.799 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -147.87 145.05 28.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.049 1.74 . . . . 0.0 107.936 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -64.79 138.13 58.2 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 164.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -165.83 1.05 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.543 1.937 . . . . 0.0 107.752 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.62 144.12 52.01 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.413 ' HA ' HG21 ' A' ' 7' ' ' VAL . 72.0 Cg_endo -78.7 -21.27 10.0 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.17 2.58 . . . . 0.0 111.644 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -49.66 -55.41 13.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -42.13 96.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.949 0.9 . . . . 0.0 109.538 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -64.54 -38.81 92.29 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.277 1.031 . . . . 0.0 112.537 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -63.33 -4.38 2.58 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.339 -0.851 . . . . 0.0 112.977 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -137.9 -173.89 3.63 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 127.675 2.39 . . . . 0.0 108.43 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.477 ' HA ' ' CE1' ' A' ' 104' ' ' PHE . 7.7 mpt_? -123.35 68.72 1.01 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -125.36 27.17 6.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.716 1.206 . . . . 0.0 112.494 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.241 0.622 0 C-N-CA 123.878 0.871 . . . . 0.0 109.547 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 119.995 -0.05 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.78 143.48 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.772 1.648 . . . . 0.0 108.751 162.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -120.32 174.37 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.962 1.305 . . . . 0.0 107.738 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.22 -5.02 55.45 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.071 0.948 . . . . 0.0 113.161 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.78 -175.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 118.856 0.753 . . . . 0.0 109.985 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.41 155.15 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.312 1.845 . . . . 0.0 106.733 164.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.3 t -113.11 136.77 52.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 169.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.1 mt -129.85 95.48 3.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.152 2.181 . . . . 0.0 107.384 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.8 mtm -87.65 157.82 19.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 66.45 30.07 8.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.69 1.596 . . . . 0.0 112.751 171.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttm -81.28 -82.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 162.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.9 m -93.73 146.38 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.822 1.649 . . . . 0.0 110.437 -162.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.74 155.04 42.13 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.253 1.021 . . . . 0.0 109.371 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.64 4.26 2.24 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.334 2.69 . . . . 0.0 113.667 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.41 6.03 8.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.986 1.714 . . . . 0.0 111.863 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -124.05 -8.56 7.7 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.907 0.883 . . . . 0.0 112.82 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.96 63.73 7.2 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.089 -1.007 . . . . 0.0 109.491 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.93 -39.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.058 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.28 100.94 0.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.373 1.069 . . . . 0.0 109.89 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.77 -2.98 0.17 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 130.219 3.408 . . . . 0.0 114.938 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.23 -54.77 1.69 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.789 2.836 . . . . 0.0 108.651 -164.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.27 -41.75 98.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.761 1.225 . . . . 0.0 111.704 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -46.98 -40.47 14.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.466 1.506 . . . . 0.0 110.854 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.91 -25.91 40.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -63.53 -52.68 60.13 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.641 1.176 . . . . 0.0 108.954 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.31 -34.97 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.405 1.082 . . . . 0.0 110.087 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.73 -47.1 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.3 0.64 . . . . 0.0 110.141 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.36 -37.69 74.64 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.688 1.131 . . . . 0.0 112.117 -172.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.18 -38.44 91.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.23 1.015 . . . . 0.0 110.505 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.36 -33.18 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 109.763 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -66.39 -32.79 74.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.95 -54.53 37.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 110.623 171.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -63.66 -37.55 87.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.812 0.815 . . . . 0.0 111.245 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.25 -22.71 57.65 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.376 1.07 . . . . 0.0 110.543 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 t -72.37 -7.51 50.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.271 1.029 . . . . 0.0 111.282 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -73.47 -9.54 58.8 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 119.351 -2.093 . . . . 0.0 112.29 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.04 1.12 9.21 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.719 1.145 . . . . 0.0 112.668 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.12 -164.93 28.61 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 106.129 -2.788 . . . . 0.0 106.129 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -108.27 108.67 19.77 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.277 1.539 . . . . 0.0 109.984 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.67 116.05 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -55.26 -74.67 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.819 2.048 . . . . 0.0 107.024 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -174.29 4.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.259 1.024 . . . . 0.0 109.123 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.86 143.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.585 1.954 . . . . 0.0 107.145 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -130.3 118.35 21.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.211 1.404 . . . . 0.0 109.301 -172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.4 mt -131.31 86.84 49.23 Favored Pre-proline 0 C--O 1.234 0.242 0 C-N-CA 125.924 1.69 . . . . 0.0 107.921 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -55.79 124.94 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 167.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.85 47.93 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.386 . . . . 0.0 108.926 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 N--CA 1.453 -0.88 0 C-N-CA 122.818 2.345 . . . . 0.0 109.792 -179.274 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 N--CA 1.448 -1.154 0 N-CA-C 107.764 -1.668 . . . . 0.0 107.764 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.6 80.09 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 121.953 -0.467 . . . . 0.0 113.168 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.25 156.99 37.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.482 0.713 . . . . 0.0 110.572 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.91 7.12 88.78 Favored Glycine 0 C--O 1.24 0.501 0 C-N-CA 123.758 0.694 . . . . 0.0 112.922 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 171.72 13.85 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 118.18 0.99 . . . . 0.0 109.589 165.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -121.83 156.03 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.99 150.1 39.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.49 155.19 28.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.89 144.97 45.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -172.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.75 168.32 10.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.941 0.877 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 -20.58 65.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.809 1.244 . . . . 0.0 112.918 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.9 t -163.19 155.82 18.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.56 1.073 . . . . 0.0 110.323 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.0 t -51.91 -40.01 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.6 1.96 . . . . 0.0 110.307 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -75.49 -12.24 60.19 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 119.435 -2.04 . . . . 0.0 114.115 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -93.16 -41.6 9.83 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.541 1.136 . . . . 0.0 109.364 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.42 -40.58 96.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -51.4 -10.48 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 130.135 3.374 . . . . 0.0 114.733 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -97.35 -41.91 8.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.966 1.257 . . . . 0.0 109.488 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.65 87.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.71 0.804 . . . . 0.0 112.625 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -43.32 63.78 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.768 2.427 . . . . 0.0 112.947 -162.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -98.66 -31.15 12.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.061 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.79 -9.18 58.78 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.921 0.782 . . . . 0.0 113.947 -170.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -123.7 3.55 8.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.203 1.401 . . . . 0.0 112.356 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -71.96 142.74 49.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.02 -3.04 82.2 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.076 -1.015 . . . . 0.0 112.731 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -63.69 175.17 1.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.284 1.542 . . . . 0.0 110.367 170.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -125.75 96.15 4.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -83.19 13.64 4.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.415 0.626 . . . . 0.0 111.631 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.0 -77.97 0.05 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.675 2.39 . . . . 0.0 104.658 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.8 -22.9 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.071 0.948 . . . . 0.0 113.368 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -92.49 166.92 12.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.548 -0.72 . . . . 0.0 110.956 -172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.94 109.79 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.0 t -82.16 146.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.204 1.402 . . . . 0.0 110.654 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -128.93 118.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 p -72.06 159.93 33.35 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.347 1.07 . . . . 0.0 110.493 170.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -156.47 159.74 38.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.989 2.516 . . . . 0.0 105.739 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -74.67 159.39 32.14 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.504 160.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.82 -164.58 1.36 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 108.527 163.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -114.47 144.52 31.95 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.67 -27.94 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.422 2.748 . . . . 0.0 112.927 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.74 -42.05 95.48 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 120.741 -1.224 . . . . 0.0 110.688 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -72.81 -19.5 61.32 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.55 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.47 -45.53 53.65 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.004 2.122 . . . . 0.0 111.444 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -63.05 -8.12 6.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.797 0.839 . . . . 0.0 111.757 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -134.41 -163.63 1.4 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.441 2.696 . . . . 0.0 106.987 -163.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.75 39.72 3.82 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.344 1.057 . . . . 0.0 109.132 -173.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.53 42.93 2.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.005 1.322 . . . . 0.0 111.331 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 CA--C 1.537 0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 109.043 174.906 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.12 146.75 52.65 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.515 2.143 . . . . 0.0 108.708 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 p -137.25 166.74 23.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.31 2.55 21.04 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.91 88.56 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.61 117.34 7.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.803 1.241 . . . . 0.0 108.429 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -84.48 143.04 29.63 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.454 ' CD2' HG22 ' A' ' 91' ' ' THR . 76.5 mt -135.45 156.13 49.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 109.388 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.56 165.47 26.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 107.752 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 60.4 26.97 16.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.606 ' HB2' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -72.31 -74.22 0.17 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 157.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.681 HG11 HD21 ' A' ' 19' ' ' LEU . 33.7 m -92.5 172.45 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 124.402 1.081 . . . . 0.0 110.733 -163.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -125.6 157.63 67.68 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.69 0.85 4.32 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 121.884 1.723 . . . . 0.0 112.824 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -123.22 12.39 9.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.851 2.06 . . . . 0.0 112.665 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -139.44 22.38 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.998 -1.064 . . . . 0.0 112.021 -169.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.681 HD21 HG11 ' A' ' 14' ' ' VAL . 90.2 mt -109.72 6.37 23.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.675 1.19 . . . . 0.0 113.004 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.29 -29.87 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.501 -0.749 . . . . 0.0 111.156 -166.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.11 110.14 3.84 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.14 1.376 . . . . 0.0 108.562 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.26 -36.09 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.691 0.797 . . . . 0.0 110.056 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.89 -64.69 0.81 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.871 0.868 . . . . 0.0 110.0 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.42 -35.21 71.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.886 0.474 . . . . 0.0 112.001 -172.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.444 ' O ' HG23 ' A' ' 29' ' ' VAL . 25.8 t80 -52.59 -44.21 65.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.515 1.126 . . . . 0.0 111.71 170.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -74.8 -34.11 62.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.375 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.35 -53.92 51.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.359 1.063 . . . . 0.0 108.631 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.38 -42.63 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.368 1.067 . . . . 0.0 110.42 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 25' ' ' TYR . 51.4 t -60.67 -32.7 52.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 124.123 0.969 . . . . 0.0 111.316 -176.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.98 -49.49 19.77 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 123.21 0.319 . . . . 0.0 110.537 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.11 -38.57 83.41 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.477 1.132 . . . . 0.0 109.588 -175.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.44 HG13 ' CE2' ' A' ' 84' ' ' PHE . 41.4 t -73.36 -36.31 48.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 121.547 -0.721 . . . . 0.0 110.12 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -59.5 -44.76 93.01 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.374 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -65.9 -42.02 90.75 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.712 0.687 . . . . 0.0 111.895 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -67.87 -34.95 77.67 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.395 -172.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.496 ' HB3' HG21 ' A' ' 42' ' ' VAL . 7.4 t -78.11 -32.75 50.65 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.339 1.056 . . . . 0.0 110.709 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -56.73 -14.66 3.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.348 1.459 . . . . 0.0 112.039 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -61.54 -19.24 61.9 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.099 -2.25 . . . . 0.0 113.269 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.58 -6.6 13.39 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.862 1.265 . . . . 0.0 112.595 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.39 -151.81 20.8 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -167.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -129.31 108.34 10.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 36' ' ' CYS . 28.6 t -72.7 115.79 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -81.8 -50.99 8.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.805 2.042 . . . . 0.0 109.39 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.0 p -153.99 169.83 22.53 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.053 0.941 . . . . 0.0 110.208 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.4 mt -141.4 116.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.57 131.6 34.33 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 110.384 170.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.93 87.02 25.38 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.932 1.693 . . . . 0.0 107.738 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.69 154.5 68.88 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.78 1.653 . . . . 0.0 109.234 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.8 155.55 62.94 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.164 0.986 . . . . 0.0 111.548 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 C-N-CA 123.967 3.112 . . . . 0.0 110.261 177.32 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.452 -0.964 0 N-CA-C 108.412 -1.418 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.82 9.19 85.78 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.767 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.54 140.66 53.89 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.036 0.918 . . . . 0.0 109.829 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.95 -32.42 6.64 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.28 1.895 . . . . 0.0 111.926 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.507 ' C ' HD12 ' A' ' 62' ' ' ILE . 6.5 mptt -85.17 152.5 23.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -174.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.606 HD13 ' HB2' ' A' ' 13' ' ' MET . 2.0 mp -123.52 146.65 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 169.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.08 120.68 25.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -118.72 106.94 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -79.23 142.74 35.97 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.404 1.481 . . . . 0.0 107.889 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -121.79 177.25 5.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.356 1.063 . . . . 0.0 111.596 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.0 p -72.05 -26.76 62.31 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.721 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.7 m -153.89 159.45 41.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.504 1.621 . . . . 0.0 112.964 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.26 -12.58 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 120.588 -1.32 . . . . 0.0 111.383 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -95.9 -21.12 18.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.313 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.59 -29.98 14.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.873 1.669 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.8 p -60.4 -35.28 75.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.172 0.511 . . . . 0.0 110.4 168.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -24.06 66.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.977 1.711 . . . . 0.0 112.413 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -86.98 -46.03 10.22 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.3 68.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.884 0.874 . . . . 0.0 110.448 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -57.13 -39.41 75.11 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.056 0.389 . . . . 0.0 111.818 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -74.91 -45.83 40.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.128 -0.358 . . . . 0.0 111.04 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.16 -21.46 61.75 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.921 -0.377 . . . . 0.0 112.41 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.14 18.66 4.95 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.865 1.266 . . . . 0.0 111.858 -163.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -70.44 23.79 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 O-C-N 120.073 -1.642 . . . . 0.0 114.017 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.09 3.33 0.03 OUTLIER Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.967 1.746 . . . . 0.0 115.068 -166.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -173.68 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.938 1.869 . . . . 0.0 111.931 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -133.64 81.57 1.93 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.393 0.677 . . . . 0.0 109.538 -168.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.44 ' CE2' HG13 ' A' ' 32' ' ' VAL . 3.6 m-30 -74.94 14.02 0.58 Allowed 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.334 -0.854 . . . . 0.0 113.165 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.35 -85.04 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.663 2.385 . . . . 0.0 105.415 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.72 -5.39 1.04 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.8 OUTLIER -97.77 176.92 5.64 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.786 1.176 . . . . 0.0 108.655 -174.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -82.51 136.9 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.42 164.39 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 124.727 1.211 . . . . 0.0 108.825 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -138.48 139.37 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 10' ' ' LEU . 34.7 p -96.61 165.55 12.1 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.181 0.9 . . . . 0.0 110.983 175.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -153.36 154.53 34.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.921 1.688 . . . . 0.0 108.247 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -80.9 141.21 34.8 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 158.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.73 -168.16 1.28 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.823 1.649 . . . . 0.0 108.847 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -121.03 145.25 41.25 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.494 1.118 . . . . 0.0 107.983 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.29 -22.41 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.626 2.884 . . . . 0.0 114.15 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.31 -47.1 76.1 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.777 1.626 . . . . 0.0 109.537 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 p -77.06 2.1 16.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.843 1.257 . . . . 0.0 111.795 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -94.11 -41.12 9.69 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.641 1.577 . . . . 0.0 109.083 165.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -64.35 -24.7 67.74 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 112.135 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -126.39 165.7 18.56 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 126.434 1.894 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -75.68 23.62 0.12 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.363 1.865 . . . . 0.0 112.566 -175.217 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -91.28 40.33 1.03 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.351 -1.468 . . . . 0.0 112.405 -160.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 7.0 m-85 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 127.213 2.205 . . . . 0.0 115.779 -165.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HA ' ' CG ' ' A' ' 93' ' ' TYR . 20.4 Cg_endo -64.29 141.17 74.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.405 2.07 . . . . 0.0 112.143 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.1 p -133.57 -178.79 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.437 1.895 . . . . 0.0 108.149 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.02 -7.3 21.53 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.374 -1.298 . . . . 0.0 113.656 171.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.33 149.57 25.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 121.036 1.743 . . . . 0.0 110.859 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD13 ' SD ' ' A' ' 76' ' ' MET . 13.2 tp -124.72 119.03 27.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.744 2.418 . . . . 0.0 107.24 -170.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.84 145.78 25.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.086 0.554 . . . . 0.0 109.762 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.9 mt -136.55 120.41 17.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.286 1.435 . . . . 0.0 109.676 -167.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -106.52 156.64 18.36 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 75.44 23.6 1.48 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.48 2.312 . . . . 0.0 113.693 170.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -81.84 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 163.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG11 HD21 ' A' ' 19' ' ' LEU . 15.0 m -87.84 172.79 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.875 1.67 . . . . 0.0 111.764 -159.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 mt -126.32 158.1 68.04 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.409 1.483 . . . . 0.0 109.762 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.11 2.59 5.94 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.141 1.894 . . . . 0.0 113.103 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -128.63 18.55 6.27 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.966 1.706 . . . . 0.0 111.297 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -137.44 33.36 2.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.568 1.147 . . . . 0.0 111.152 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD21 HG11 ' A' ' 14' ' ' VAL . 95.2 mt -130.22 39.28 3.68 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 127.202 2.201 . . . . 0.0 109.406 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.97 -33.4 6.51 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.677 0.791 . . . . 0.0 110.579 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 94.94 1.68 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.42 1.088 . . . . 0.0 110.176 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.85 -36.29 58.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.968 2.107 . . . . 0.0 111.25 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -72.66 -55.31 7.03 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.716 0.407 . . . . 0.0 110.114 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -63.35 -36.44 83.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.339 0.655 . . . . 0.0 109.732 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -45.95 -48.69 16.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.994 0.918 . . . . 0.0 111.153 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.7 -28.19 50.9 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.929 -0.482 . . . . 0.0 112.172 -167.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -64.39 -55.54 20.36 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.597 1.559 . . . . 0.0 109.59 167.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.86 -36.24 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.75 0.82 . . . . 0.0 110.554 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.1 t -59.07 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 118.768 0.713 . . . . 0.0 109.228 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.46 -38.54 74.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.771 0.714 . . . . 0.0 111.315 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -70.94 -33.82 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.046 -175.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.96 -37.65 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -57.58 -36.29 71.5 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.707 1.139 . . . . 0.0 110.24 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.31 -29.57 68.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.759 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -68.79 -45.18 71.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.468 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.603 ' HA ' HD11 ' A' ' 79' ' ' LEU 0.267 0.8 OUTLIER -69.33 -26.53 64.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 172.8 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.3 t -62.77 -14.82 49.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.95 1.3 . . . . 0.0 111.887 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -62.68 -11.12 15.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 119.556 -1.965 . . . . 0.0 114.456 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.57 -0.64 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.501 1.046 . . . . 0.0 112.985 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.4 -174.37 41.89 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -94.74 111.9 23.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.6 t -71.78 109.6 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -62.85 -52.06 64.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.982 178.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -167.87 172.23 9.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.936 1.694 . . . . 0.0 110.578 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.437 HG23 HG22 ' A' ' 64' ' ' VAL . 13.8 mt -135.58 145.89 30.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.42 125.45 47.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.517 1.927 . . . . 0.0 109.443 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.15 86.92 12.62 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.098 1.759 . . . . 0.0 107.697 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.3 140.18 30.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.774 2.316 . . . . 0.0 108.839 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mtm-85 -116.06 146.28 36.75 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.326 1.05 . . . . 0.0 108.77 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.45 -1.038 0 C-N-CA 122.244 1.962 . . . . 0.0 108.555 173.597 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 N--CA 1.449 -1.106 0 N-CA-C 108.341 -1.446 . . . . 0.0 108.341 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.54 58.82 6.13 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.5 t -72.18 154.2 41.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.82 58.38 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 124.784 1.183 . . . . 0.0 112.908 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 168.2 10.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.501 1.651 . . . . 0.0 108.276 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.81 143.54 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.32 141.86 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG22 HG23 ' A' ' 45' ' ' ILE . 96.0 t -134.12 104.52 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -167.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -83.95 135.1 34.6 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.59 173.39 6.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 126.717 2.007 . . . . 0.0 108.423 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.9 t -92.57 -9.85 39.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.562 -176.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -154.53 155.88 35.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 121.261 1.846 . . . . 0.0 111.882 166.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 t -67.02 -24.93 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.078 1.351 . . . . 0.0 109.728 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -60.56 -59.32 5.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.571 1.148 . . . . 0.0 109.502 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.79 -45.84 59.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.42 1.488 . . . . 0.0 109.632 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.1 t -62.48 -50.56 70.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.369 1.067 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -56.4 -34.87 67.14 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.059 0.943 . . . . 0.0 112.33 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.48 -42.95 33.94 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.91 0.777 . . . . 0.0 109.679 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.42 79.74 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.175 0.99 . . . . 0.0 110.51 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.559 ' SD ' HD13 ' A' ' 8' ' ' LEU . 4.3 mmm -44.76 -66.48 0.39 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.126 1.371 . . . . 0.0 110.12 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.69 -39.31 88.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.959 0.503 . . . . 0.0 111.226 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -36.45 93.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.959 0.79 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 36' ' ' CYS . 54.8 mt -104.91 3.48 30.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.417 1.087 . . . . 0.0 110.892 -168.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.2 m -61.2 110.56 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.943 0.897 . . . . 0.0 109.659 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.73 19.44 73.28 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.387 0.539 . . . . 0.0 113.05 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -66.44 -178.64 0.7 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.761 1.28 . . . . 0.0 110.701 162.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -130.43 96.15 4.06 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.07 14.01 9.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.684 0.754 . . . . 0.0 111.898 -167.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -156.42 -66.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 161.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.86 -16.65 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -121.72 168.13 12.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.143 0.977 . . . . 0.0 111.637 -167.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.59 114.44 5.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.658 0.783 . . . . 0.0 109.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.25 150.86 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.349 1.06 . . . . 0.0 109.866 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.7 t -121.7 139.25 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 162.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -115.69 130.49 56.88 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.707 2.003 . . . . 0.0 108.554 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -132.9 171.18 14.28 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 119.778 1.172 . . . . 0.0 110.579 161.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 76' ' ' MET . 86.8 m-85 -82.89 147.82 28.06 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 -163.76 1.13 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.842 1.257 . . . . 0.0 109.745 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.49 143.47 29.0 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.26 -28.18 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.709 2.272 . . . . 0.0 111.793 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.35 -50.54 73.58 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.59 -1.319 . . . . 0.0 110.166 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.4 p -70.56 -7.28 42.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.075 1.75 . . . . 0.0 111.073 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.19 -45.92 9.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.161 1.784 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -64.3 -44.52 91.37 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.515 0.674 . . . . 0.0 109.863 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -77.98 172.78 12.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 109.119 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.491 ' HG3' ' CE2' ' A' ' 104' ' ' PHE . 50.2 ttp180 -103.96 72.62 1.11 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 164.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -123.37 61.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.917 0.865 . . . . 0.0 109.66 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CE2' ' HG3' ' A' ' 102' ' ' ARG . 4.9 m-30 . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 126.254 1.821 . . . . 0.0 109.856 -171.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.39 126.33 13.43 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.072 1.848 . . . . 0.0 108.661 156.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -103.23 177.1 4.93 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HG2' HG22 ' A' ' 69' ' ' VAL . 25.8 mt-10 -81.9 3.58 25.68 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.571 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 94' ' ' CYS . 2.4 m -124.42 156.03 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.739 1.154 . . . . 0.0 108.729 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 76' ' ' MET . 23.2 tp -136.37 122.3 20.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.985 1.714 . . . . 0.0 107.713 -168.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -81.22 139.11 35.7 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.1 mt -128.62 95.25 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.863 2.465 . . . . 0.0 107.4 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mtm -92.63 155.69 17.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 75.2 23.69 1.55 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 114.265 170.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -84.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 161.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.4 163.18 3.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 111.184 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.9 158.42 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.002 1.321 . . . . 0.0 109.841 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.82 -2.66 9.0 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.929 2.419 . . . . 0.0 113.316 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.21 2.13 11.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.572 1.949 . . . . 0.0 111.187 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -104.87 -30.34 9.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 118.669 0.668 . . . . 0.0 112.199 169.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.99 49.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.011 2.124 . . . . 0.0 113.396 -161.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 -10.56 6.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.203 1.801 . . . . 0.0 111.674 -169.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.4 122.19 38.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.006 0.923 . . . . 0.0 110.297 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.18 -15.63 63.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.254 1.422 . . . . 0.0 112.705 -168.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -78.85 -63.16 1.48 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.429 1.492 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.79 -35.65 66.52 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 109.937 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -55.97 -38.43 70.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.611 0.764 . . . . 0.0 112.166 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -80.36 -36.65 33.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.647 0.779 . . . . 0.0 110.678 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -56.72 -45.14 82.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.525 0.679 . . . . 0.0 109.9 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.89 -33.31 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.387 1.075 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.33 -44.65 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.287 -0.883 . . . . 0.0 108.718 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.06 -39.52 86.91 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.809 0.732 . . . . 0.0 110.531 -173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.7 -36.29 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.993 1.378 . . . . 0.0 111.487 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.62 -28.52 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.621 1.568 . . . . 0.0 109.944 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -44.62 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.52 -0.738 . . . . 0.0 109.343 170.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.44 -44.58 92.89 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.524 0.678 . . . . 0.0 111.354 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -43.76 50.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.856 -166.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -83.36 -17.98 40.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.505 -1.278 . . . . 0.0 110.331 -167.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -65.62 -15.62 62.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 110.783 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -63.24 -12.57 29.8 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.787 -1.196 . . . . 0.0 111.212 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.649 1.579 . . . . 0.0 112.935 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.33 26.34 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 120.105 1.321 . . . . 0.0 110.784 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.0 tm? -119.77 111.58 18.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.512 1.525 . . . . 0.0 107.965 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.04 114.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -53.83 -61.36 2.36 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 109.242 166.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 t -160.23 177.35 10.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.153 0.888 . . . . 0.0 111.558 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.98 135.04 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.671 2.388 . . . . 0.0 106.087 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -125.98 106.92 9.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.231 1.013 . . . . 0.0 112.995 -167.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.31 85.93 59.84 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 127.376 2.27 . . . . 0.0 108.334 -165.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.46 138.81 61.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.553 1.502 . . . . 0.0 109.8 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 162.42 19.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 126.567 1.947 . . . . 0.0 110.471 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 C--O 1.237 0.429 0 C-N-CA 124.47 3.446 . . . . 0.0 111.977 165.463 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.454 -0.849 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.45 0.36 70.14 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -71.75 155.05 40.9 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.574 1.687 . . . . 0.0 110.049 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.59 -1.12 79.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.034 0.826 . . . . 0.0 113.203 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 170.86 7.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 120.226 2.013 . . . . 0.0 109.316 168.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.0 mt -134.82 154.37 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -119.0 166.2 13.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 158.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 p -139.07 152.7 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -132.08 139.13 48.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.14 164.32 11.9 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 108.326 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.8 t -87.15 0.95 54.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.827 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.9 p -154.68 148.38 25.41 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.548 1.067 . . . . 0.0 109.808 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 6' ' ' GLU . 1.8 t -60.13 -34.85 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.092 0.557 . . . . 0.0 109.587 176.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -76.96 -23.71 52.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.69 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.99 -49.61 49.81 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.922 1.237 . . . . 0.0 108.024 166.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.6 t -56.98 -47.0 81.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.219 1.008 . . . . 0.0 109.97 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -57.65 -27.13 62.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.341 1.056 . . . . 0.0 113.339 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -79.46 -54.27 6.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.14 -51.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.269 1.027 . . . . 0.0 110.837 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.559 ' HB2' HD13 ' A' ' 8' ' ' LEU . 2.3 ppp? -59.07 -34.54 72.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.964 0.905 . . . . 0.0 112.434 -170.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.98 -34.48 18.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.62 1.168 . . . . 0.0 110.555 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 -29.83 75.86 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.117 1.341 . . . . 0.0 112.164 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.8 mt -113.29 7.11 17.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.664 1.185 . . . . 0.0 111.619 -168.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -48.66 131.58 17.77 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.11 -2.62 80.55 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.486 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -62.99 176.71 0.67 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.221 1.511 . . . . 0.0 112.019 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -132.17 83.14 2.06 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -78.31 14.5 1.19 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.66 -0.65 . . . . 0.0 111.461 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -156.38 -80.25 0.08 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.695 -2.706 . . . . 0.0 103.695 159.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -145.12 -16.91 0.5 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.114 0.966 . . . . 0.0 113.264 -165.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -100.26 -173.5 2.44 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.591 1.087 . . . . 0.0 109.444 -175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.72 149.9 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 164.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.67 133.83 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.314 1.846 . . . . 0.0 107.391 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.82 138.46 25.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 161.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 p -102.05 151.56 22.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.597 1.559 . . . . 0.0 108.532 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -149.15 156.98 43.0 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.373 1.469 . . . . 0.0 108.408 170.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -76.18 144.63 40.39 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.695 1.589 . . . . 0.0 107.821 160.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.473 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -104.79 -163.93 1.0 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.003 0.921 . . . . 0.0 108.683 171.111 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.78 143.59 28.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 167.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.5 -27.07 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.506 2.138 . . . . 0.0 111.243 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -53.12 60.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -77.22 -10.41 59.4 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.398 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -75.69 -43.65 46.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.175 0.898 . . . . 0.0 110.874 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -62.75 -22.03 66.26 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.634 0.373 . . . . 0.0 111.659 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.4 -177.7 3.2 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.349 1.46 . . . . 0.0 109.714 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 13.4 ttt180 -91.89 30.81 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.734 0.814 . . . . 0.0 111.348 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.82 48.62 1.61 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.99 -1.069 . . . . 0.0 111.997 -162.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 10.3 m-85 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.017 -167.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -62.61 151.64 82.32 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.84 2.36 . . . . 0.0 109.312 162.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.7 p -138.95 176.96 8.25 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -75.47 7.94 3.22 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.327 -0.858 . . . . 0.0 111.988 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 t -133.17 107.08 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.121 1.769 . . . . 0.0 111.147 -169.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -100.19 129.37 46.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.735 2.414 . . . . 0.0 106.651 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 49.8 t -81.86 138.37 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.57 122.88 30.04 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.714 2.406 . . . . 0.0 107.47 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.473 ' HB2' HG23 ' A' ' 90' ' ' VAL . 35.3 mtm -135.01 73.94 1.5 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -161.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 174.52 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -51.65 30.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.625 1.17 . . . . 0.0 109.717 -172.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 165.59 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 O-C-N 125.167 1.542 . . . . 0.0 108.914 -174.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' O ' HD21 ' A' ' 19' ' ' LEU . 31.5 mt -100.66 160.68 26.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 170.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -68.46 7.66 0.65 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 126.224 4.616 . . . . 0.0 114.341 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -135.55 3.92 3.07 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.162 1.385 . . . . 0.0 112.739 -159.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.464 ' H ' HD22 ' A' ' 19' ' ' LEU . 53.2 mm-40 -126.07 5.68 7.19 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.846 -1.158 . . . . 0.0 112.051 -176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.695 HD22 ' H ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -79.12 10.36 3.62 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.879 2.072 . . . . 0.0 112.93 -176.019 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 50' ' ' PRO . 2.8 mm? -96.16 -17.89 20.51 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.789 2.035 . . . . 0.0 112.698 -168.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 88.17 2.86 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 174.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.34 -26.41 12.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.281 2.632 . . . . 0.0 112.758 -165.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.2 -28.11 69.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.307 1.843 . . . . 0.0 113.406 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -85.76 -36.67 20.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.939 0.896 . . . . 0.0 109.022 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.63 -34.26 69.12 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.82 -40.16 29.16 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.199 1.4 . . . . 0.0 112.073 -173.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -60.23 -45.79 92.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.8 mt -61.06 -31.13 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 123.735 0.814 . . . . 0.0 110.938 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.31 -55.84 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.243 0.929 . . . . 0.0 110.473 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.56 -32.98 72.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.517 1.127 . . . . 0.0 112.487 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.58 -27.3 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.474 1.11 . . . . 0.0 109.776 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -67.96 -34.25 76.21 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.176 -0.952 . . . . 0.0 109.642 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.01 -37.45 55.02 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.635 0.774 . . . . 0.0 112.483 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -50.86 61.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.437 1.017 . . . . 0.0 110.559 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.1 t -70.57 -19.39 62.87 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.783 -0.573 . . . . 0.0 110.914 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.29 3.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.351 1.86 . . . . 0.0 112.955 166.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -68.39 -9.42 48.15 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.918 -1.739 . . . . 0.0 113.863 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.4 1.51 4.58 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.741 0.816 . . . . 0.0 113.139 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.9 -139.46 5.2 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.606 HD12 HG23 ' A' ' 67' ' ' THR . 1.9 tm? -144.13 121.41 11.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.18 1.792 . . . . 0.0 106.232 176.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.1 t -74.13 120.66 23.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 170.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -76.48 -57.89 3.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.006 0.923 . . . . 0.0 109.35 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.32 172.24 18.52 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.056 1.342 . . . . 0.0 109.345 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mt -137.1 118.11 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -90.86 122.11 33.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.442 1.097 . . . . 0.0 108.344 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.66 86.31 34.27 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 126.848 2.059 . . . . 0.0 105.77 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.18 158.66 33.85 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.366 1.378 . . . . 0.0 110.447 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -123.32 165.12 23.99 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.924 0.889 . . . . 0.0 109.489 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HG2' HD11 ' A' ' 20' ' ' LEU . 60.0 Cg_endo . . . . . 0 N--CA 1.454 -0.841 0 C-N-CA 123.982 3.121 . . . . 0.0 109.011 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 N--CA 1.45 -1.03 0 N-CA-C 108.861 -1.246 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.86 2.74 88.4 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.656 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -67.75 141.76 56.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 117.753 0.776 . . . . 0.0 109.301 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.68 -25.2 27.44 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.458 1.98 . . . . 0.0 112.311 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.04 16.09 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.26 1.03 . . . . 0.0 108.981 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -123.26 145.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.15 104.53 9.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.98 153.76 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -132.34 147.02 52.38 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.22 174.67 9.37 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.529 0.604 . . . . 0.0 110.517 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.606 HG23 HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -76.03 -22.45 55.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 177.669 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.8 p -152.47 161.94 41.89 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.422 1.01 . . . . 0.0 111.168 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.68 -13.99 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 110.497 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.97 -48.44 21.12 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 120.026 -1.671 . . . . 0.0 109.894 172.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.49 -41.81 86.19 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.373 0.669 . . . . 0.0 109.554 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.4 p -68.54 -40.65 80.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.327 0.651 . . . . 0.0 109.999 -175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -56.72 -31.26 64.34 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.375 1.47 . . . . 0.0 111.032 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -83.86 -46.56 12.03 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.925 0.784 . . . . 0.0 109.7 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.63 -49.12 73.7 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.375 0.67 . . . . 0.0 109.726 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.2 tpp -44.27 -73.0 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 127.86 2.464 . . . . 0.0 110.119 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -73.11 -7.56 51.87 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.08 -35.31 61.07 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.855 -1.153 . . . . 0.0 110.678 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.413 HD23 ' HG3' ' A' ' 82' ' ' ARG . 76.5 mt -127.62 -1.13 6.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.419 1.088 . . . . 0.0 112.34 -154.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 m -50.58 122.29 6.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.753 1.221 . . . . 0.0 108.405 157.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 11.5 84.27 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.115 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.413 ' HG3' HD23 ' A' ' 79' ' ' LEU . 20.5 mmt-85 -71.2 -178.43 2.03 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.604 1.702 . . . . 0.0 112.239 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -120.92 94.98 4.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.68 43.02 1.13 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 173.63 -86.41 0.0 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.177 2.991 . . . . 0.0 105.958 166.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -149.09 -5.12 0.4 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.276 1.83 . . . . 0.0 111.622 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -118.46 -178.85 3.62 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.942 1.697 . . . . 0.0 109.797 -175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.39 165.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.1 t -130.31 132.65 64.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 125.777 1.631 . . . . 0.0 108.729 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 11' ' ' MET . 0.7 OUTLIER -106.63 143.26 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.304 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 p -113.48 156.68 23.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 127.638 2.375 . . . . 0.0 107.527 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 169.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -69.38 150.02 47.75 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -130.66 -167.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.232 1.813 . . . . 0.0 108.136 174.598 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.65 150.64 52.87 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.96 -19.97 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.508 2.805 . . . . 0.0 113.042 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.48 -49.49 61.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.127 1.331 . . . . 0.0 110.378 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.07 7.75 5.74 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.339 1.856 . . . . 0.0 111.663 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -111.79 -36.64 5.38 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -57.96 -31.7 67.13 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -123.74 168.59 12.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.251 1.42 . . . . 0.0 109.347 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -79.73 27.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.172 1.789 . . . . 0.0 111.254 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -86.74 70.59 10.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 C--O 1.235 0.33 0 C-N-CA 124.581 1.152 . . . . 0.0 108.068 -175.105 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.02 151.64 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.352 2.034 . . . . 0.0 109.331 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 p -135.33 177.04 8.12 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -78.7 -0.43 30.12 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.662 171.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -102.22 153.02 5.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 120.657 1.571 . . . . 0.0 109.86 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.65 149.76 46.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.668 1.587 . . . . 0.0 107.545 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 50.7 t -109.29 136.13 49.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.0 mt -128.43 110.03 11.95 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -170.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtm -101.66 152.96 20.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 75.11 30.41 0.89 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.691 2.797 . . . . 0.0 114.542 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.444 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -81.63 -69.12 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.521 -1.362 . . . . 0.0 109.632 169.491 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.32 148.45 29.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.727 1.611 . . . . 0.0 109.829 -155.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -95.36 158.1 35.2 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.37 3.81 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.626 2.217 . . . . 0.0 112.978 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -128.95 15.95 6.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.159 1.784 . . . . 0.0 112.268 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -142.17 31.42 1.56 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.653 1.181 . . . . 0.0 111.066 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.18 5.12 10.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.698 1.599 . . . . 0.0 111.38 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.483 ' H ' HD22 ' A' ' 20' ' ' LEU . 1.7 mm? -69.66 -23.53 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.189 0.996 . . . . 0.0 109.504 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.0 81.53 8.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.955 2.502 . . . . 0.0 109.704 -162.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.5 -4.66 0.26 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.819 2.847 . . . . 0.0 114.591 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.83 -33.47 4.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 127.889 2.476 . . . . 0.0 111.856 -166.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.86 -39.82 61.34 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.131 0.878 . . . . 0.0 109.279 162.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.426 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 67.3 t80 -45.49 -40.51 8.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.155 1.782 . . . . 0.0 113.107 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.75 -31.63 41.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.722 0.809 . . . . 0.0 113.171 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -66.55 -50.49 62.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.671 1.588 . . . . 0.0 109.17 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.33 -27.07 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.027 0.931 . . . . 0.0 109.556 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.01 -49.75 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.18 -39.24 86.37 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.52 -47.97 72.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.957 1.36 . . . . 0.0 110.161 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.648 HG13 ' CE2' ' A' ' 84' ' ' PHE . 24.8 t -78.23 -32.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.555 -173.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -66.62 -42.91 86.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.712 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.27 -56.37 21.88 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.451 0.7 . . . . 0.0 109.803 174.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HG2' ' HA ' ' A' ' 32' ' ' VAL . 5.2 pt-20 -66.53 -39.97 88.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.477 0.655 . . . . 0.0 110.582 -164.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -78.3 -20.09 52.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.832 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -73.4 -9.91 59.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.125 -0.984 . . . . 0.0 111.702 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -64.11 -15.17 59.11 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.31 -1.494 . . . . 0.0 111.44 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.615 ' CD1' HD11 ' A' ' 79' ' ' LEU . 23.9 m-85 -116.71 5.29 13.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.616 2.366 . . . . 0.0 111.101 -175.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.29 -151.71 22.82 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 120.286 1.403 . . . . 0.0 111.978 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.5 tm? -125.77 108.68 11.73 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -78.76 103.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -49.14 -56.02 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.342 1.057 . . . . 0.0 110.39 164.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.81 168.15 23.62 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.329 0.513 . . . . 0.0 111.292 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.73 138.76 43.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 127.038 2.135 . . . . 0.0 105.561 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -123.34 111.07 15.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.602 1.561 . . . . 0.0 110.019 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.47 86.16 56.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.19 1.396 . . . . 0.0 108.579 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.29 144.29 61.73 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.125 1.883 . . . . 0.0 108.582 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.426 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -123.97 155.27 67.53 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 108.594 -177.093 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 C-N-CA 122.237 1.958 . . . . 0.0 110.867 177.771 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.456 -0.706 0 N-CA-C 108.846 -1.252 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.15 27.81 47.71 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.364 0.507 . . . . 0.0 112.296 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 t -71.88 148.68 45.89 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.371 1.086 . . . . 0.0 110.474 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.07 -32.56 5.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 126.872 2.177 . . . . 0.0 111.467 -174.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 3.0 mptt -77.19 160.09 29.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mt -127.56 147.13 32.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 168.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.67 158.02 22.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.31 155.13 28.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 66.4 tt0 -133.05 134.69 44.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 0.0 107.832 -173.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.89 -177.1 3.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.766 1.626 . . . . 0.0 109.288 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.45 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.5 t -109.19 3.2 21.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.526 0.73 . . . . 0.0 112.074 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -152.01 139.37 19.45 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.085 -1.634 . . . . 0.0 109.545 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.6 t -51.98 -37.38 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.565 1.546 . . . . 0.0 109.633 168.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.31 -16.56 54.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.877 1.271 . . . . 0.0 113.104 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -115.43 -35.13 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -164.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 t -53.81 -48.48 69.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.416 1.086 . . . . 0.0 109.704 160.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -54.49 -24.34 20.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.17 1.388 . . . . 0.0 113.935 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -82.97 -53.76 5.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.871 1.214 . . . . 0.0 108.867 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -36.47 77.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.575 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -58.07 -35.67 71.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.156 0.889 . . . . 0.0 111.767 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -98.46 -44.33 6.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.616 1.166 . . . . 0.0 110.305 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.19 50.0 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 118.847 0.749 . . . . 0.0 112.836 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.615 HD11 ' CD1' ' A' ' 39' ' ' TYR . 42.6 mt -130.93 4.91 4.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.98 1.312 . . . . 0.0 111.975 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -68.36 144.07 54.91 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.926 1.694 . . . . 0.0 107.214 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.39 86.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.825 -0.986 . . . . 0.0 113.184 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -174.24 0.51 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.804 1.802 . . . . 0.0 109.526 165.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -123.94 141.32 52.14 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.648 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.7 m-30 -109.01 14.14 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.196 0.935 . . . . 0.0 110.852 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.18 -68.85 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.839 2.856 . . . . 0.0 104.946 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -153.93 -20.95 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 mtp85 -111.77 162.85 14.8 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.427 1.012 . . . . 0.0 110.471 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 t -77.95 106.37 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.004 -163.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.444 HG13 ' HE1' ' A' ' 13' ' ' MET . 75.3 t -72.38 140.56 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.432 1.093 . . . . 0.0 109.552 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.0 t -126.27 128.56 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 p -87.69 156.81 19.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 0.0 110.504 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.15 155.08 41.0 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.328 2.251 . . . . 0.0 105.878 169.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -73.89 153.44 39.84 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 119.891 1.223 . . . . 0.0 108.094 159.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -172.5 2.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 164.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.13 144.28 34.53 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.68 -22.68 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.171 1.914 . . . . 0.0 112.346 -167.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -57.54 12.59 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.061 1.301 . . . . 0.0 109.222 175.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -71.39 12.62 0.31 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.595 1.558 . . . . 0.0 111.355 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 65' ' ' GLU . 30.7 t80 -97.52 -55.68 2.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.69 1.196 . . . . 0.0 110.463 169.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -65.57 -36.6 84.25 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.098 0.959 . . . . 0.0 112.714 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -85.38 -164.55 1.02 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.149 0.98 . . . . 0.0 109.519 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -111.97 26.05 10.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.787 1.235 . . . . 0.0 112.591 172.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -77.37 33.47 0.16 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.449 2.3 . . . . 0.0 111.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--O 1.239 0.507 0 O-C-N 120.511 -1.368 . . . . 0.0 111.049 -179.917 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 119.459 -0.305 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.15 151.03 66.64 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.649 2.232 . . . . 0.0 108.639 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.9 p -126.26 176.4 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.797 0.839 . . . . 0.0 109.176 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.56 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 28.1 tt0 -72.14 -1.49 15.13 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.576 1.551 . . . . 0.0 112.876 167.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.96 114.04 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 120.503 -1.373 . . . . 0.0 108.956 -151.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 142.56 51.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 108.806 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.2 t -131.12 126.35 35.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.135 0.969 . . . . 0.0 111.648 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' CD1' HG22 ' A' ' 91' ' ' THR . 1.2 mm? -116.66 107.87 15.23 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 108.262 -159.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.6 mtm -79.1 173.45 12.56 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.389 0.675 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 65.89 18.32 11.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.809 1.644 . . . . 0.0 112.208 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.413 ' CE ' ' HB3' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -81.95 -70.68 0.53 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -165.333 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -104.33 -174.33 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 129.787 3.235 . . . . 0.0 107.051 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -127.49 153.41 77.39 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 120.142 1.337 . . . . 0.0 107.718 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -3.37 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.758 2.305 . . . . 0.0 112.5 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -115.05 11.56 16.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.675 1.19 . . . . 0.0 110.085 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -130.09 -22.57 2.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.838 1.255 . . . . 0.0 112.325 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -79.5 61.33 3.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.627 1.571 . . . . 0.0 110.385 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.03 -14.11 2.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.309 -160.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -116.6 151.75 35.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.811 1.245 . . . . 0.0 108.476 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.59 -13.42 40.04 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.59 1.556 . . . . 0.0 111.756 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.27 -60.06 1.94 Allowed 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.154 1.382 . . . . 0.0 108.445 -163.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -53.01 -36.21 60.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.513 1.525 . . . . 0.0 110.307 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -61.08 -36.82 80.67 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.44 1.896 . . . . 0.0 111.592 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.03 -40.35 53.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.392 0.996 . . . . 0.0 109.877 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.32 -34.78 72.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.433 0.693 . . . . 0.0 111.236 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.92 -24.44 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.465 0.706 . . . . 0.0 110.783 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.3 t -67.21 -47.19 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.406 -1.434 . . . . 0.0 108.322 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.86 -21.69 47.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.93 -47.62 61.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.386 1.089 . . . . 0.0 110.576 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG13 ' CE2' ' A' ' 84' ' ' PHE . 50.8 t -74.89 -30.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.974 -170.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -64.11 -31.66 72.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.202 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.81 -53.12 23.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.568 1.076 . . . . 0.0 110.624 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -62.45 -38.26 89.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.435 0.636 . . . . 0.0 110.926 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.473 ' HB3' HG11 ' A' ' 42' ' ' VAL . 8.8 t -70.54 -35.82 73.35 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.003 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -65.55 -14.33 60.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.457 1.026 . . . . 0.0 112.005 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.1 -19.77 21.57 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 119.71 -1.869 . . . . 0.0 112.791 172.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -115.42 2.53 13.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.935 1.294 . . . . 0.0 112.509 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.75 -147.16 15.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.5 120.85 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.473 HG11 ' HB3' ' A' ' 36' ' ' CYS . 2.1 p -87.92 109.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 126.34 1.856 . . . . 0.0 108.849 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -68.33 -63.96 0.96 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.466 1.906 . . . . 0.0 109.988 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -147.67 158.59 44.08 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.552 0.741 . . . . 0.0 111.691 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.7 130.89 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.399 . . . . 0.0 107.36 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -108.98 123.52 49.25 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.978 2.111 . . . . 0.0 107.845 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -129.29 85.15 60.18 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.237 1.815 . . . . 0.0 106.307 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.07 101.18 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.111 1.874 . . . . 0.0 109.825 -172.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.13 80.16 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.801 -0.562 . . . . 0.0 110.896 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 C--N 1.348 0.548 0 C-N-CA 123.572 2.848 . . . . 0.0 110.055 173.203 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 N--CA 1.453 -0.882 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.4 16.25 18.76 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.266 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.5 t -72.33 148.85 44.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.59 1.695 . . . . 0.0 110.106 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.99 -11.11 40.84 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.05 134.73 35.12 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.023 1.329 . . . . 0.0 109.657 -169.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.92 137.2 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -108.83 130.5 55.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -128.96 160.14 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.418 1.487 . . . . 0.0 107.979 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.38 143.43 39.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.596 1.958 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -110.07 -169.16 1.42 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.908 1.231 . . . . 0.0 112.249 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -93.96 -15.35 25.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 113.775 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -155.6 145.57 21.49 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.121 1.369 . . . . 0.0 108.628 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.08 -32.26 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 122.261 1.029 . . . . 0.0 110.533 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.2 -36.57 71.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.3 174.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 79.4 m-20 -64.07 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.053 1.297 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 34.4 m -76.65 -36.48 57.33 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 127.695 2.398 . . . . 0.0 109.256 -166.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.65 -40.23 82.83 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.144 1.378 . . . . 0.0 110.89 170.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.563 ' CE ' ' HA ' ' A' ' 71' ' ' ASP . 40.8 mtmt -72.34 -48.32 42.84 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.452 0.701 . . . . 0.0 109.184 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.09 -35.79 81.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.046 0.938 . . . . 0.0 112.687 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 43.1 tpp -55.1 -68.63 0.17 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.427 1.491 . . . . 0.0 109.176 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -67.81 -25.1 65.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.01 -15.46 81.1 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.341 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.74 6.71 5.15 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.668 1.187 . . . . 0.0 111.898 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.1 m -56.49 113.59 1.67 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 6.1 57.9 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.76 1.171 . . . . 0.0 113.614 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.79 179.25 0.27 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.976 1.31 . . . . 0.0 113.675 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -131.04 90.54 2.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.147 1.779 . . . . 0.0 108.35 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.431 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.7 m-30 -77.19 14.68 0.86 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.95 -1.094 . . . . 0.0 112.539 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.53 -64.45 0.06 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.002 2.521 . . . . 0.0 105.211 163.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.66 -10.43 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -109.02 148.9 30.05 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.417 -1.427 . . . . 0.0 109.949 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -64.85 131.82 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.991 -171.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -101.0 141.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.778 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 138.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 161.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.419 HG22 ' CD1' ' A' ' 10' ' ' LEU . 2.6 p -94.42 157.48 15.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.4 2.28 . . . . 0.0 108.476 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.18 157.02 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.527 1.058 . . . . 0.0 109.481 159.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 114.5 18.71 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.2 m -79.78 166.41 21.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 163.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -92.29 142.81 26.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.56 -35.73 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.427 2.752 . . . . 0.0 112.7 -172.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -54.14 -36.66 63.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.99 0.516 . . . . 0.0 111.709 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.2 p -75.41 -43.33 50.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -62.31 -30.9 71.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.373 1.469 . . . . 0.0 112.207 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -66.38 -8.48 25.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.133 0.973 . . . . 0.0 113.086 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -129.01 -174.6 3.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.495 1.918 . . . . 0.0 108.099 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -90.06 55.98 3.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -122.15 98.76 6.08 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.117 0.567 . . . . 0.0 109.785 -174.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--O 1.233 0.233 0 C-N-CA 123.553 0.741 . . . . 0.0 109.711 -172.102 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.628 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.99 -146.43 20.99 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.709 1.623 . . . . 0.0 110.154 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -58.49 150.28 56.51 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.068 0.947 . . . . 0.0 111.471 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.6 158.26 51.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.491 2.127 . . . . 0.0 109.853 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 p -139.28 -168.61 2.49 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -86.05 -2.64 58.5 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.95 -1.093 . . . . 0.0 112.704 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 94' ' ' CYS . 2.8 m -83.3 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 121.127 1.785 . . . . 0.0 109.105 175.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.86 129.6 26.24 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.227 2.211 . . . . 0.0 105.942 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -100.74 131.86 46.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mp -129.8 154.42 47.26 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.737 1.615 . . . . 0.0 109.039 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.1 mtm -136.29 161.57 35.41 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.07 21.99 1.86 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.624 1.97 . . . . 0.0 111.545 172.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.414 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -76.45 -85.22 0.06 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 163.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG22 ' H ' ' A' ' 14' ' ' VAL . 22.2 m -82.55 170.66 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 127.08 2.152 . . . . 0.0 110.748 -166.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.28 160.2 35.16 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.094 0.958 . . . . 0.0 109.79 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -0.24 5.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.363 2.042 . . . . 0.0 113.037 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.96 19.4 3.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.056 2.143 . . . . 0.0 112.797 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.23 -9.33 7.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.948 0.794 . . . . 0.0 112.556 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.7 mt -79.62 28.55 0.26 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.21 1.404 . . . . 0.0 111.774 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -100.0 -38.13 8.71 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.835 -1.166 . . . . 0.0 111.282 -170.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 127.04 31.27 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.976 0.91 . . . . 0.0 109.979 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.07 -30.95 58.54 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.956 1.303 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -92.47 16.09 12.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.068 1.347 . . . . 0.0 111.872 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -125.48 -50.24 1.64 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.488 1.515 . . . . 0.0 107.413 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -45.05 -50.29 10.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.059 1.344 . . . . 0.0 112.39 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.61 -27.57 61.35 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -66.42 -46.44 76.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.806 0.843 . . . . 0.0 108.848 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.2 mt -61.16 -28.86 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.739 1.216 . . . . 0.0 111.405 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.04 -47.33 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 120.641 -1.287 . . . . 0.0 109.3 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.51 -30.92 57.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.198 0.999 . . . . 0.0 111.569 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.5 -46.45 86.66 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.849 1.66 . . . . 0.0 110.503 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.5 t -77.94 -28.64 15.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -59.42 -48.69 80.67 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.54 -44.92 95.15 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.091 0.244 . . . . 0.0 110.772 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.75 -43.49 75.74 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.878 -0.514 . . . . 0.0 111.618 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.435 ' HG ' ' HZ ' ' A' ' 66' ' ' PHE . 1.4 t -85.24 -21.92 28.87 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.941 -168.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.9 m -60.08 -8.49 2.42 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.858 -1.151 . . . . 0.0 113.025 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -67.84 -7.58 29.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 119.527 -1.983 . . . . 0.0 113.64 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -124.73 -0.26 8.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.53 1.132 . . . . 0.0 112.623 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.3 -137.96 5.63 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 106.914 -2.475 . . . . 0.0 106.914 -170.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.47 115.31 10.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.35 107.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 108.366 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -55.97 -60.76 3.01 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.396 2.278 . . . . 0.0 108.618 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 p -158.84 175.46 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.541 0.61 . . . . 0.0 110.881 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.14 150.21 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.334 1.453 . . . . 0.0 107.779 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.99 109.18 8.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.027 1.331 . . . . 0.0 110.987 -169.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 86.46 58.67 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 127.363 2.265 . . . . 0.0 107.372 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.9 133.27 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.946 2.431 . . . . 0.0 109.232 172.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 159.71 32.66 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 124.082 0.953 . . . . 0.0 111.535 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.4 170.09 7.18 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.742 2.962 . . . . 0.0 109.926 164.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.82 91.87 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 t0 56.1 35.47 25.7 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.094 0.958 . . . . 0.0 113.033 172.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.54 -27.42 13.65 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.213 2.339 . . . . 0.0 112.095 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.82 137.63 22.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 118.791 1.296 . . . . 0.0 109.12 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.73 148.21 36.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.798 0.808 . . . . 0.0 110.591 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.9 156.71 47.8 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 126.057 1.743 . . . . 0.0 110.144 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -63.81 138.16 62.03 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.717 1.611 . . . . 0.0 108.271 168.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.4 9.98 86.52 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.765 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.3 t -67.17 154.42 41.3 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.837 0.818 . . . . 0.0 110.614 170.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.02 -5.24 80.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 125.527 1.537 . . . . 0.0 114.058 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.2 173.02 9.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.941 1.371 . . . . 0.0 107.987 170.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 mt -131.35 145.96 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 150.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -115.46 144.72 43.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 164.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -118.96 154.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.02 136.92 47.61 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HZ ' ' HG ' ' A' ' 36' ' ' CYS . 28.1 m-85 -107.86 -177.95 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.02 1.328 . . . . 0.0 109.784 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 t -112.15 7.05 19.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 110.145 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.0 p -155.97 143.42 19.34 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 120.869 -1.144 . . . . 0.0 108.368 161.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -51.39 -44.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.952 1.301 . . . . 0.0 109.207 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -71.6 -26.04 62.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.351 -167.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -76.42 -42.66 43.43 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 12.9 t -59.74 -41.01 89.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.723 0.409 . . . . 0.0 110.556 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -56.06 -27.13 52.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 113.0 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -79.88 -47.86 14.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.727 1.149 . . . . 0.0 109.456 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.86 75.97 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.682 0.793 . . . . 0.0 110.532 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -55.77 -43.51 76.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.287 0.635 . . . . 0.0 111.329 -169.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -77.41 -48.29 17.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.79 0.836 . . . . 0.0 109.461 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -19.41 63.97 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.64 1.115 . . . . 0.0 113.073 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.1 mt -124.11 14.86 9.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.798 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.4 m -60.83 118.26 6.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.48 24.23 59.16 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 120.891 -1.131 . . . . 0.0 113.45 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.49 -179.34 5.74 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.288 0.544 . . . . 0.0 110.557 154.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -129.48 99.3 5.13 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 125.164 1.386 . . . . 0.0 107.328 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -88.68 15.02 8.81 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.469 0.577 . . . . 0.0 110.639 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.23 -85.23 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.933 2.093 . . . . 0.0 106.174 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.26 -20.21 0.63 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.56 1.144 . . . . 0.0 111.983 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -90.21 -167.88 1.96 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.81 166.3 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.177 -0.952 . . . . 0.0 108.572 165.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.414 HG13 ' HE1' ' A' ' 13' ' ' MET . 55.7 t -124.68 118.03 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 p -93.04 149.9 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -117.89 168.7 10.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.692 1.197 . . . . 0.0 109.034 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.77 156.41 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.887 2.075 . . . . 0.0 106.908 -177.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -77.71 160.72 28.25 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 162.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.422 ' HB3' HG21 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -137.43 -168.47 2.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.397 0.999 . . . . 0.0 109.063 168.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.59 144.22 34.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -93.59 -20.46 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.132 1.888 . . . . 0.0 110.833 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -40.44 80.59 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.07 0.462 . . . . 0.0 110.446 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.56 -33.26 60.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.105 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -61.6 -50.27 73.27 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.499 1.52 . . . . 0.0 111.411 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.64 -14.63 63.14 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -106.11 -169.73 1.62 Allowed 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 127.544 2.337 . . . . 0.0 107.276 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -114.18 69.68 0.71 Allowed 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.31 27.02 9.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 109.812 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -74.53 154.09 38.8 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.683 0.793 . . . . 0.0 109.543 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.0 t90 . . . . . 0 C--O 1.248 0.982 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 178.123 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.441 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.61 177.77 34.01 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -67.72 152.14 96.56 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.145 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.04 126.88 16.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.401 1.401 . . . . 0.0 108.676 165.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.1 p -100.11 179.02 4.61 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.889 1.676 . . . . 0.0 108.705 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.54 8.72 13.23 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.007 0.923 . . . . 0.0 110.658 174.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.99 163.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 O-C-N 120.896 -1.127 . . . . 0.0 111.395 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -141.71 124.19 15.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -168.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.23 135.02 33.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.7 mt -128.73 131.2 47.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.5 1.52 . . . . 0.0 107.232 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mtm -125.46 163.77 21.93 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.448 -0.782 . . . . 0.0 110.177 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 74.97 16.22 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.81 2.844 . . . . 0.0 112.677 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -52.9 11.93 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.251 -0.906 . . . . 0.0 108.916 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.88 174.34 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 128.317 2.647 . . . . 0.0 108.891 -162.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.72 150.24 52.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.102 0.961 . . . . 0.0 109.319 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.62 -14.7 40.07 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.859 2.373 . . . . 0.0 113.647 -172.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -116.56 13.18 15.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.682 1.993 . . . . 0.0 110.333 -170.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -139.69 22.62 2.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.792 2.037 . . . . 0.0 109.637 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.01 65.43 0.66 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.066 2.146 . . . . 0.0 107.057 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.3 mt -135.06 -41.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -160.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.07 151.25 31.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.6 0.76 . . . . 0.0 110.149 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -95.96 -5.55 41.05 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.623 0.769 . . . . 0.0 110.675 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -113.57 -43.41 3.32 Favored 'General case' 0 C--N 1.337 0.047 0 C-N-CA 124.42 1.088 . . . . 0.0 113.049 -167.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -80.62 -37.19 31.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.734 1.214 . . . . 0.0 109.398 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.7 -35.75 61.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.218 1.007 . . . . 0.0 110.677 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.74 -37.22 70.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.491 -0.756 . . . . 0.0 111.62 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -62.32 -45.92 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.014 . . . . 0.0 109.204 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.55 -20.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.617 0.767 . . . . 0.0 111.371 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.11 -44.71 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.954 -1.092 . . . . 0.0 109.316 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.4 -35.77 63.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.908 0.776 . . . . 0.0 112.338 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.46 -51.22 60.4 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.391 1.876 . . . . 0.0 109.768 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.6 t -75.36 -29.13 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.224 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -65.54 -36.26 83.27 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.605 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.64 -40.69 40.98 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.655 0.661 . . . . 0.0 112.243 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -50.11 69.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.983 -1.073 . . . . 0.0 109.899 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.05 -25.76 61.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -167.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.91 -22.96 4.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.396 1.078 . . . . 0.0 112.969 169.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -76.24 -13.06 60.18 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.625 -1.297 . . . . 0.0 112.626 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CE1' HD21 ' A' ' 79' ' ' LEU . 87.9 m-85 -116.98 -16.52 10.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.576 1.08 . . . . 0.0 112.898 -173.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.46 -138.75 3.24 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD13 ' C ' ' A' ' 41' ' ' LEU . 2.4 tm? -140.33 123.0 16.29 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -87.04 116.32 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -66.24 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.731 1.613 . . . . 0.0 107.84 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -154.14 169.44 23.57 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.774 1.229 . . . . 0.0 110.239 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 mt -130.2 141.97 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.266 1.826 . . . . 0.0 106.179 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -126.11 120.18 29.5 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.538 1.135 . . . . 0.0 110.58 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.37 85.75 17.7 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.46 123.16 11.61 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.351 2.034 . . . . 0.0 108.257 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.99 154.07 37.5 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 123.652 0.781 . . . . 0.0 110.093 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -54.32 155.7 15.5 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.273 2.649 . . . . 0.0 111.025 167.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.86 167.32 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 128.361 2.664 . . . . 0.0 107.882 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.36 80.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.724 2.409 . . . . 0.0 109.199 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.14 -0.63 64.21 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-O 117.978 -1.457 . . . . 0.0 113.387 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.69 135.7 62.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 120.314 2.057 . . . . 0.0 108.143 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -67.45 176.9 2.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.229 1.014 . . . . 0.0 110.084 164.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.04 151.07 54.67 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 125.93 1.692 . . . . 0.0 107.443 168.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -67.85 138.08 43.53 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 N-CA-C 108.025 -1.567 . . . . 0.0 108.025 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.71 36.56 92.48 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.3 t -74.15 163.54 27.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.189 0.518 . . . . 0.0 110.166 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -39.03 2.72 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.192 1.377 . . . . 0.0 111.594 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 168.52 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.541 1.671 . . . . 0.0 109.709 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -131.86 152.48 36.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.56 157.94 28.39 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p -139.02 161.05 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -133.19 144.9 50.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.822 1.649 . . . . 0.0 107.441 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.75 -179.16 3.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.895 1.678 . . . . 0.0 111.035 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.441 ' CG2' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -86.11 -21.47 27.61 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.854 172.155 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -139.83 -179.09 5.74 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.482 1.492 . . . . 0.0 110.561 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.31 -35.14 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 158.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -76.49 -28.93 56.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.574 -1.329 . . . . 0.0 113.51 -166.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -76.49 -38.89 54.57 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.375 1.07 . . . . 0.0 109.169 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.9 t -57.1 -47.6 80.67 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.56 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -56.94 -26.89 60.4 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.449 1.499 . . . . 0.0 113.179 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -76.91 -48.13 19.08 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.17 88.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 117.155 -1.403 . . . . 0.0 111.743 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -63.89 0.89 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.719 1.145 . . . . 0.0 110.659 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -81.97 -21.13 37.33 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.529 0.732 . . . . 0.0 112.021 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.74 89.43 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.484 HD21 ' CE1' ' A' ' 39' ' ' TYR . 96.4 mt -115.01 -1.46 13.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -160.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.6 m -47.64 116.07 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.024 -1.047 . . . . 0.0 109.507 164.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.54 5.7 63.07 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.626 0.648 . . . . 0.0 114.412 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -177.85 1.26 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.853 1.327 . . . . 0.0 111.42 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -126.9 133.2 50.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.435 1.494 . . . . 0.0 107.054 163.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -108.15 15.08 24.52 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.155 0.982 . . . . 0.0 110.937 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.11 -73.31 0.06 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -150.89 -13.28 0.22 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -98.46 164.19 12.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.155 0.889 . . . . 0.0 110.017 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.41 135.99 26.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.93 139.8 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.209 1.403 . . . . 0.0 111.058 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.264 3.1 p -110.93 115.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 170.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -78.2 143.72 36.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.09 167.68 21.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.64 1.976 . . . . 0.0 106.09 162.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -71.82 164.45 25.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.91 0.777 . . . . 0.0 109.68 163.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 -164.47 1.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.469 1.108 . . . . 0.0 108.524 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -114.38 143.42 29.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.22 -25.86 5.53 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.123 2.548 . . . . 0.0 111.169 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -54.29 -59.34 4.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.036 0.922 . . . . 0.0 109.842 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -20.12 62.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.856 2.062 . . . . 0.0 110.898 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -73.14 -46.87 48.47 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 127.488 2.315 . . . . 0.0 111.006 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -60.36 -35.89 76.74 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 -97.56 -166.77 1.43 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 109.605 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -122.08 54.72 1.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.501 1.52 . . . . 0.0 107.738 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.98 38.81 3.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.713 1.244 . . . . 0.0 109.001 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -60.82 142.53 56.01 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.595 1.958 . . . . 0.0 108.822 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.9 -100.75 1.37 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -141.12 158.4 64.6 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.492 1.517 . . . . 0.0 109.066 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -66.31 133.0 31.16 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.959 2.439 . . . . 0.0 108.223 168.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.8 p -137.29 169.21 18.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.537 1.935 . . . . 0.0 106.772 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -75.39 -10.86 59.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.369 0.532 . . . . 0.0 111.798 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.87 106.78 19.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 125.469 1.508 . . . . 0.0 110.006 -170.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -91.53 113.09 25.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -85.01 134.05 34.23 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.5 139.85 52.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.276 1.031 . . . . 0.0 109.52 -173.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.5 mtm -125.18 161.13 27.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.896 0.878 . . . . 0.0 109.241 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 m120 60.87 30.68 19.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.577 2.351 . . . . 0.0 112.911 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.624 ' CE ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -77.65 -79.66 0.11 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 164.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.47 171.02 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 125.12 1.368 . . . . 0.0 109.791 -165.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.91 159.4 40.99 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 124.096 0.958 . . . . 0.0 109.445 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.69 4.87 2.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.574 2.183 . . . . 0.0 113.584 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -128.24 14.55 6.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.555 1.942 . . . . 0.0 113.415 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -132.45 -4.21 3.36 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.45 -0.781 . . . . 0.0 111.357 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -98.63 51.59 0.99 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.443 1.497 . . . . 0.0 109.885 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.41 -54.85 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.38 100.54 0.06 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.984 2.114 . . . . 0.0 109.952 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.28 -7.34 58.58 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.941 0.896 . . . . 0.0 113.088 -165.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -76.51 -59.64 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.983 1.713 . . . . 0.0 107.961 166.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.95 -34.33 77.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.668 0.787 . . . . 0.0 111.982 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -44.99 -45.56 10.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.931 1.292 . . . . 0.0 111.514 168.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.85 -23.0 42.26 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 121.573 -0.704 . . . . 0.0 112.078 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -71.42 -50.15 34.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 124.189 0.93 . . . . 0.0 109.162 169.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.31 -40.66 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.148 0.979 . . . . 0.0 111.147 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.0 t -57.87 -40.35 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.879 0.763 . . . . 0.0 109.951 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.56 -40.74 33.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.873 0.306 . . . . 0.0 111.032 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.72 -33.62 76.03 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.08 -36.68 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 O-C-N 121.545 -0.722 . . . . 0.0 109.414 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -58.28 -38.27 76.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 117.134 -1.413 . . . . 0.0 109.627 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.09 -33.37 73.24 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.588 1.54 . . . . 0.0 112.107 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -41.44 63.43 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 120.964 -1.085 . . . . 0.0 110.975 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.483 ' SG ' HG21 ' A' ' 42' ' ' VAL 0.265 0.8 OUTLIER -81.22 -27.97 35.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.287 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.04 -3.91 32.24 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.659 1.118 . . . . 0.0 112.259 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -56.81 -18.43 12.85 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.3 -1.5 . . . . 0.0 113.725 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -119.75 1.26 11.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.043 1.337 . . . . 0.0 113.003 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.13 -145.13 10.21 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -122.49 112.53 18.15 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 118.747 1.274 . . . . 0.0 110.023 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.483 HG21 ' SG ' ' A' ' 36' ' ' CYS . 75.6 t -69.81 108.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -68.71 -53.48 21.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.846 0.858 . . . . 0.0 109.884 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -161.51 163.68 30.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -135.71 108.71 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.77 119.16 31.35 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 125.91 1.684 . . . . 0.0 109.106 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mt -133.49 85.69 42.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.29 1.836 . . . . 0.0 107.838 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.72 136.4 53.5 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.682 1.588 . . . . 0.0 109.161 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -98.08 165.2 15.78 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.512 1.125 . . . . 0.0 109.616 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.37 170.96 10.0 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.56 2.173 . . . . 0.0 109.903 166.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.97 100.63 10.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t0 59.91 27.47 16.84 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.3 -15.08 36.14 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 127.188 2.328 . . . . 0.0 113.508 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -86.13 142.95 12.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.513 1.125 . . . . 0.0 110.063 -169.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -74.69 140.82 44.45 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.989 0.915 . . . . 0.0 110.044 172.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.93 153.46 78.63 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 123.651 0.78 . . . . 0.0 112.045 -175.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.56 117.32 4.64 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.225 2.617 . . . . 0.0 108.256 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.28 -15.15 15.55 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 126.735 2.112 . . . . 0.0 112.256 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.5 t -76.45 148.47 37.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.068 0.934 . . . . 0.0 111.184 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.52 -16.0 51.73 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.124 1.821 . . . . 0.0 112.622 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -92.56 157.12 16.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.761 1.781 . . . . 0.0 108.583 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.0 149.4 33.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 164.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -129.32 114.31 16.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 42' ' ' VAL . 98.5 t -101.82 111.63 32.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 148.49 29.2 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.232 1.813 . . . . 0.0 106.362 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -129.87 179.57 5.78 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.87 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -90.07 -13.3 36.17 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -164.55 155.8 15.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.553 1.069 . . . . 0.0 110.007 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG12 HE21 ' A' ' 73' ' ' GLN . 40.8 t -65.36 -23.42 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.558 0.743 . . . . 0.0 109.142 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -84.41 -18.03 37.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.5 -1.375 . . . . 0.0 113.224 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -76.52 -45.97 28.55 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.5 p -71.51 -36.43 71.07 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.665 -0.647 . . . . 0.0 110.714 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.429 HE21 HG12 ' A' ' 69' ' ' VAL . 2.0 mp0 -47.3 -36.2 8.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.928 2.091 . . . . 0.0 112.856 168.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -79.11 -48.72 13.8 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.21 73.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.67 1.188 . . . . 0.0 111.266 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.1 ttm -48.73 -70.54 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.628 1.571 . . . . 0.0 110.336 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.76 -33.29 73.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.543 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.9 -15.85 69.69 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.516 1.055 . . . . 0.0 114.027 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.54 9.05 5.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.114 1.457 . . . . 0.0 112.687 -171.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.8 m -63.77 102.11 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.16 -0.962 . . . . 0.0 110.181 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.17 1.88 51.29 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.13 1.348 . . . . 0.0 113.14 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -178.64 0.2 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.386 1.593 . . . . 0.0 111.503 173.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.35 140.08 53.29 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' A' ' 89' ' ' VAL . 3.1 m-85 -117.84 13.76 14.14 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.644 0.735 . . . . 0.0 109.854 176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.34 -70.77 0.08 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.52 2.328 . . . . 0.0 107.661 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -162.42 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.64 1.176 . . . . 0.0 111.821 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -78.18 175.26 10.34 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.489 1.04 . . . . 0.0 109.456 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.43 165.63 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.624 HG22 ' CE ' ' A' ' 13' ' ' MET . 25.6 t -114.57 125.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.0 t -105.84 129.51 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 167.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.0 p -99.2 146.86 25.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.609 1.164 . . . . 0.0 108.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -141.52 161.22 38.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.411 1.485 . . . . 0.0 107.334 160.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -69.36 157.49 36.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 158.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -176.68 2.95 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.523 1.529 . . . . 0.0 107.417 165.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -99.1 144.98 29.22 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.41 -24.17 6.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.823 2.349 . . . . 0.0 112.925 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.47 -46.93 73.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.19 0.905 . . . . 0.0 110.725 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 p -75.71 2.94 10.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.452 1.101 . . . . 0.0 111.925 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -93.16 -48.92 6.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.551 1.141 . . . . 0.0 108.932 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -60.27 -30.41 69.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.771 0.428 . . . . 0.0 111.256 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -104.63 163.46 12.46 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.524 1.13 . . . . 0.0 109.87 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 ttm-85 -73.23 21.89 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.276 2.23 . . . . 0.0 112.794 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -88.81 64.09 7.11 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.75 -1.219 . . . . 0.0 111.133 -158.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 4.4 m-85 -95.35 166.92 11.65 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.081 0.553 . . . . 0.0 109.625 -169.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.1 t90 . . . . . 0 C--O 1.246 0.878 0 C-N-CA 126.206 1.803 . . . . 0.0 109.291 -179.593 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.48 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -167.84 -168.68 30.33 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -173.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -55.78 151.33 23.47 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.966 1.306 . . . . 0.0 111.799 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.0 142.97 48.26 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.897 2.398 . . . . 0.0 108.868 166.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 p -121.33 -179.28 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.587 1.955 . . . . 0.0 107.983 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -82.74 9.68 9.19 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.437 HG12 ' HG3' ' A' ' 65' ' ' GLU . 2.9 m -130.92 157.4 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 121.083 1.765 . . . . 0.0 110.332 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 93' ' ' TYR . 5.6 tp -133.4 170.72 15.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.931 0.872 . . . . 0.0 109.268 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.86 140.4 31.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.911 1.284 . . . . 0.0 109.362 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.29 122.9 27.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.593 1.557 . . . . 0.0 107.646 -167.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.1 mtm -103.94 165.98 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.213 0.605 . . . . 0.0 110.632 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 75.22 7.36 4.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 129.334 3.054 . . . . 0.0 115.12 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -65.16 0.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.148 1.34 . . . . 0.0 109.305 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.21 144.46 35.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.784 1.634 . . . . 0.0 109.077 -158.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.45 163.78 32.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 126.197 1.799 . . . . 0.0 110.762 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.84 -1.03 7.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.08 2.52 . . . . 0.0 114.606 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.83 -0.57 3.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.565 1.146 . . . . 0.0 112.598 -163.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -115.08 -12.26 11.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.636 0.774 . . . . 0.0 112.784 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.442 ' C ' HD22 ' A' ' 20' ' ' LEU . 91.8 mt -75.06 47.97 0.38 Allowed 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.455 1.902 . . . . 0.0 112.396 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD22 ' C ' ' A' ' 19' ' ' LEU . 3.6 mm? -132.73 -13.6 2.88 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -165.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.94 179.42 1.48 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.664 1.12 . . . . 0.0 109.59 159.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -122.89 -4.09 8.61 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.129 -0.982 . . . . 0.0 111.382 165.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -90.19 -72.79 0.55 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.793 2.037 . . . . 0.0 108.928 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -57.52 -33.37 68.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.561 1.944 . . . . 0.0 110.607 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -47.46 -46.97 27.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.364 1.466 . . . . 0.0 112.138 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -75.74 -34.11 60.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -60.3 -44.36 95.48 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.96 -34.81 70.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -61.02 -54.27 37.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 O-C-N 120.749 -1.219 . . . . 0.0 108.753 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -70.87 -33.2 70.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.932 0.787 . . . . 0.0 112.031 -169.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.93 -35.32 79.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.239 1.019 . . . . 0.0 111.93 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.38 -25.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 108.966 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -69.18 -21.63 63.96 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.941 -1.099 . . . . 0.0 111.723 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.25 -62.24 1.52 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.849 1.204 . . . . 0.0 108.11 159.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HB2' HH21 ' A' ' 82' ' ' ARG . 5.0 pt-20 -61.08 -40.29 93.14 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -158.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -77.66 -28.65 51.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.0 t -65.86 -12.95 58.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.414 1.085 . . . . 0.0 111.473 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.57 -12.38 52.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 119.644 -1.91 . . . . 0.0 111.693 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -112.13 -7.13 14.08 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.073 1.349 . . . . 0.0 113.732 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.48 -167.3 31.4 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.52 104.1 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.987 0.898 . . . . 0.0 109.874 -175.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.28 106.49 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 125.406 1.482 . . . . 0.0 107.052 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -66.51 -67.57 0.44 Allowed 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 166.63 32.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.34 0.656 . . . . 0.0 111.341 -168.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -138.98 145.36 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 126.217 1.807 . . . . 0.0 108.85 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -132.84 121.97 23.72 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.93 1.292 . . . . 0.0 109.433 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.9 mt -127.85 86.1 59.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.89 2.076 . . . . 0.0 107.414 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.63 148.8 86.04 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.721 1.614 . . . . 0.0 109.861 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.07 152.57 46.76 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.862 0.865 . . . . 0.0 110.116 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -65.58 169.95 11.95 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 111.243 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 t -130.0 118.15 43.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 t70 57.5 24.9 10.82 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.332 1.853 . . . . 0.0 115.075 174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.59 -8.78 74.33 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.217 1.389 . . . . 0.0 112.751 -174.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.7 t -93.64 138.96 19.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 126.228 1.811 . . . . 0.0 109.243 -172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -59.38 152.77 20.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.297 1.839 . . . . 0.0 111.85 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.581 HG22 ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -114.57 149.59 42.51 Favored Pre-proline 0 C--N 1.326 -0.418 0 C-N-CA 126.664 1.986 . . . . 0.0 111.772 172.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -66.55 102.1 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 N-CA-C 106.706 -2.075 . . . . 0.0 106.706 164.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.54 -11.03 11.32 Favored Glycine 0 C--O 1.229 -0.205 0 C-N-CA 125.733 1.635 . . . . 0.0 111.451 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.581 ' HB2' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -70.4 144.88 51.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.995 0.897 . . . . 0.0 109.806 -177.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.18 -35.85 4.6 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 127.456 2.455 . . . . 0.0 110.512 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -85.4 167.88 15.12 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.185 -1.185 . . . . 0.0 110.389 -172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 mt -136.32 128.17 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -99.59 155.17 17.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -144.71 145.15 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 7' ' ' VAL . 10.9 tt0 -121.91 146.86 46.71 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.887 1.275 . . . . 0.0 108.901 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.07 167.03 16.51 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.492 1.117 . . . . 0.0 110.529 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.0 p -74.2 -18.1 60.8 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -159.62 159.28 32.94 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.906 1.23 . . . . 0.0 111.406 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.31 -38.97 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.923 1.289 . . . . 0.0 109.134 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -52.02 -52.49 50.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.297 1.039 . . . . 0.0 111.986 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.14 -43.92 81.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 10.7 t -58.11 -41.84 84.46 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.003 0.521 . . . . 0.0 111.005 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.86 -20.93 65.58 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.668 1.187 . . . . 0.0 112.734 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -90.42 -46.39 8.39 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.785 1.175 . . . . 0.0 108.664 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.32 -15.99 64.0 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.593 1.157 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.436 ' CE ' HD11 ' A' ' 8' ' ' LEU . 25.4 tpp -60.37 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.906 1.682 . . . . 0.0 108.226 168.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -70.76 -22.71 62.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.718 -164.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.35 -27.9 71.46 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.574 0.624 . . . . 0.0 112.426 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.442 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 96.1 mt -113.56 -4.1 13.56 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.06 1.344 . . . . 0.0 111.732 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.0 m -57.37 106.63 0.35 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.935 -1.103 . . . . 0.0 109.025 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.69 -0.17 59.38 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.182 -0.788 . . . . 0.0 113.884 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.444 HH21 ' HB2' ' A' ' 35' ' ' GLU . 9.2 mmm180 -63.67 178.76 0.55 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.944 1.372 . . . . 0.0 110.665 167.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 85' ' ' ALA . 89.6 mttt -133.96 84.47 2.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.373 1.469 . . . . 0.0 107.469 -167.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 3.0 m-30 -78.1 37.73 0.26 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.492 1.117 . . . . 0.0 109.54 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' LYS . . . 174.51 -69.32 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 1 C-N-CA 132.738 4.415 . . . . 0.0 105.895 167.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.14 -29.54 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.294 1.838 . . . . 0.0 111.456 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -89.52 162.63 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.942 -1.099 . . . . 0.0 109.78 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.37 139.9 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.69 133.73 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.9 122.86 65.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -85.6 155.54 21.1 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 129.182 2.993 . . . . 0.0 109.278 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -153.13 138.62 17.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.662 1.985 . . . . 0.0 108.541 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HA ' HD12 ' A' ' 8' ' ' LEU . 56.0 m-85 -67.22 127.53 32.99 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 162.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.67 169.7 9.51 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.823 1.249 . . . . 0.0 108.435 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -92.13 143.65 27.89 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.64 -27.51 6.1 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.507 2.804 . . . . 0.0 111.918 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -57.18 13.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.634 1.107 . . . . 0.0 111.194 -170.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 m -65.98 -33.47 75.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.187 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -65.68 -30.74 71.47 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.482 1.113 . . . . 0.0 112.588 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -64.78 -2.8 2.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.081 0.953 . . . . 0.0 112.673 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -138.46 179.49 6.43 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.974 2.11 . . . . 0.0 108.711 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.442 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -81.0 21.31 0.71 Allowed 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.195 -0.94 . . . . 0.0 112.324 174.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.73 45.41 1.07 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.44 -1.412 . . . . 0.0 112.68 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 102' ' ' ARG . 10.8 m-85 -79.1 134.27 36.74 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.302 1.441 . . . . 0.0 107.429 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.51 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.97 178.6 36.01 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -66.66 156.49 86.34 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.506 1.122 . . . . 0.0 109.53 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.65 141.13 49.1 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.054 1.836 . . . . 0.0 108.666 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -123.48 172.97 8.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.53 1.132 . . . . 0.0 110.261 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.48 -9.11 55.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.356 0.662 . . . . 0.0 112.165 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.6 m -102.16 -176.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 120.02 1.282 . . . . 0.0 111.658 -172.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 tp -145.48 155.27 43.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.122 1.369 . . . . 0.0 109.199 161.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.41 143.13 48.69 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.505 1.122 . . . . 0.0 109.645 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.25 152.8 49.28 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.604 1.962 . . . . 0.0 109.694 -170.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 39.7 mtm -132.56 165.12 25.11 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.751 1.22 . . . . 0.0 110.238 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 75.44 -8.59 1.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 130.085 3.354 . . . . 0.0 114.571 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.439 ' HE3' HG22 ' A' ' 89' ' ' VAL . 10.0 tpp -71.17 -36.9 72.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.743 1.156 . . . . 0.0 112.472 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.06 152.62 36.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 0.0 109.855 -170.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -110.12 156.13 40.61 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.49 -1.06 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.06 2.507 . . . . 0.0 113.023 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -116.61 4.52 13.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.05 1.74 . . . . 0.0 111.817 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -133.81 33.88 3.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.358 1.463 . . . . 0.0 110.817 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt -131.75 58.75 1.72 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.426 1.89 . . . . 0.0 108.57 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.25 -45.32 1.98 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.238 1.415 . . . . 0.0 110.029 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.71 105.74 7.95 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.02 -32.43 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.914 1.686 . . . . 0.0 111.778 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.33 -63.21 1.11 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.501 0.72 . . . . 0.0 109.56 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -53.83 -42.81 68.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.221 1.008 . . . . 0.0 110.143 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -53.25 -40.51 64.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.98 1.312 . . . . 0.0 111.617 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -81.98 -38.4 25.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.866 1.212 . . . . 0.0 111.029 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -59.55 -51.1 71.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -54.72 -45.57 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.558 0.743 . . . . 0.0 109.426 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.92 -26.32 39.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 118.064 -0.969 . . . . 0.0 112.708 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.41 -28.41 23.58 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.673 1.124 . . . . 0.0 112.538 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.04 -41.53 64.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.118 0.961 . . . . 0.0 110.04 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG13 ' CE2' ' A' ' 84' ' ' PHE . 42.8 t -71.96 -28.25 29.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 125.027 1.331 . . . . 0.0 109.15 -177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -56.42 -57.42 12.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.55 -40.77 97.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.217 0.948 . . . . 0.0 110.079 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.5 -39.94 85.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.458 -169.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.83 -27.1 49.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.2 t -64.47 -21.66 66.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.829 0.852 . . . . 0.0 110.815 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -56.59 -21.66 28.42 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.118 -1.614 . . . . 0.0 111.976 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.469 ' CE1' HD21 ' A' ' 79' ' ' LEU . 42.2 m-85 -110.53 2.46 18.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.928 1.691 . . . . 0.0 112.224 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.59 -156.14 26.91 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 120.164 1.347 . . . . 0.0 112.258 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.1 tm? -112.2 110.08 20.14 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.09 113.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -61.51 -61.03 2.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.874 1.27 . . . . 0.0 109.243 167.066 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 175.46 12.01 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.314 -0.866 . . . . 0.0 110.903 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 64' ' ' VAL . 57.4 mt -138.89 145.11 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.31 125.1 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.167 1.787 . . . . 0.0 109.541 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.6 mt -138.46 82.42 22.75 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.71 138.88 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.084 1.856 . . . . 0.0 109.752 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -90.81 155.75 45.16 Favored Pre-proline 0 N--CA 1.474 0.735 0 O-C-N 120.485 -1.384 . . . . 0.0 111.877 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.16 172.33 3.26 Favored 'Trans proline' 0 C--N 1.352 0.746 1 C-N-CA 126.094 4.529 . . . . 0.0 112.648 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.9 t -128.25 98.08 4.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 t70 52.28 53.7 11.97 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.905 1.682 . . . . 0.0 112.11 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.89 -10.66 59.61 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.288 -1.285 . . . . 0.0 113.356 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 t -96.24 142.36 13.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 119.801 1.801 . . . . 0.0 109.543 -172.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.91 150.91 27.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.386 -1.734 . . . . 0.0 111.249 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' H ' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -114.75 155.54 46.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 124.908 1.283 . . . . 0.0 111.381 173.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.17 99.5 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.353 2.035 . . . . 0.0 107.707 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.32 16.74 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.438 1.971 . . . . 0.0 112.758 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.448 ' HB2' ' H ' ' A' ' 56' ' ' VAL . 17.8 t -71.99 132.54 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.687 1.243 . . . . 0.0 109.352 -170.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.44 1.51 80.97 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.734 1.635 . . . . 0.0 113.815 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -108.72 161.08 15.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -126.63 148.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.09 142.75 50.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 45' ' ' ILE . 53.7 t -134.64 150.95 30.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 23.6 tt0 -129.08 142.49 50.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.09 169.84 8.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.114 1.766 . . . . 0.0 108.441 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.3 t -98.97 8.4 45.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.957 0.903 . . . . 0.0 110.419 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.1 p -155.5 147.98 23.94 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 120.261 -1.525 . . . . 0.0 111.393 156.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -49.73 -41.3 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.121 0.968 . . . . 0.0 109.032 163.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -62.92 -22.8 67.02 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.446 1.498 . . . . 0.0 114.187 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -101.34 -37.04 8.66 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -31.78 73.03 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.294 -0.879 . . . . 0.0 111.012 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -58.72 -20.35 48.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.08 1.752 . . . . 0.0 112.987 170.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -88.26 -51.84 5.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.63 1.105 . . . . 0.0 108.613 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.5 -43.52 65.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.131 0.973 . . . . 0.0 111.118 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.0 tpp -44.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.423 2.289 . . . . 0.0 110.404 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.7 -18.62 56.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.31 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.9 -25.2 72.27 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.264 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.524 HD23 ' HG3' ' A' ' 82' ' ' ARG . 90.9 mt -115.63 4.36 14.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.1 m -55.13 107.58 0.32 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.791 1.237 . . . . 0.0 109.899 168.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.0 8.2 72.77 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.765 -0.584 . . . . 0.0 113.935 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.524 ' HG3' HD23 ' A' ' 79' ' ' LEU . 64.3 mmt-85 -72.69 -174.8 1.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.901 1.351 . . . . 0.0 111.281 169.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -134.02 98.41 4.13 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.641 0.776 . . . . 0.0 109.984 -170.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.458 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.0 m-85 -83.1 19.49 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.721 2.008 . . . . 0.0 112.534 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.2 -85.49 0.0 OUTLIER 'General case' 0 C--O 1.231 0.126 0 C-N-CA 129.469 3.107 . . . . 0.0 104.46 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.3 -24.63 2.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.021 0.928 . . . . 0.0 110.96 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 87' ' ' ARG . 18.8 mtp85 -93.12 173.59 7.65 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.736 0.698 . . . . 0.0 110.287 -166.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.93 165.5 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG22 ' HE3' ' A' ' 13' ' ' MET . 71.6 t -132.84 145.39 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.49 -173.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.4 117.23 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 168.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 154.23 27.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.476 2.31 . . . . 0.0 110.007 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.92 150.43 28.35 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.157 2.983 . . . . 0.0 106.27 173.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -69.09 160.19 31.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.638 1.108 . . . . 0.0 108.891 160.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.39 -164.47 1.3 Allowed 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.773 1.229 . . . . 0.0 109.459 168.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.85 143.88 28.47 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.08 -32.88 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.367 2.712 . . . . 0.0 110.449 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -57.33 -54.31 48.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.1 m -66.89 -29.47 69.38 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.85 1.26 . . . . 0.0 110.794 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -64.05 -40.48 96.38 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.843 1.657 . . . . 0.0 111.09 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -70.97 -9.75 58.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.264 1.026 . . . . 0.0 112.349 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 20.8 mtp85 -106.45 -168.8 1.47 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.33 1.452 . . . . 0.0 109.482 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.3 tpt180 -108.82 73.12 0.85 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.68 92.44 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 2.8 m-85 -133.78 152.59 51.92 Favored 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -170.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.443 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.72 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.0 -78.29 1.24 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 172.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -137.85 160.89 62.88 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.605 1.562 . . . . 0.0 109.209 -169.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.15 146.49 41.03 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.608 2.872 . . . . 0.0 109.61 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -131.7 170.35 14.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -78.9 8.38 5.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -98.14 119.7 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.62 143.62 32.52 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -108.1 142.17 38.7 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt -138.59 128.37 25.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.843 1.257 . . . . 0.0 107.613 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -133.73 156.91 47.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.154 0.582 . . . . 0.0 109.764 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 65.34 72.01 0.43 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.125 2.17 . . . . 0.0 109.771 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.439 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -132.44 -77.14 0.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.472 1.509 . . . . 0.0 107.786 -177.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.35 146.31 19.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.555 1.542 . . . . 0.0 109.371 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 17' ' ' GLU . 50.9 mt -109.78 151.57 42.41 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.752 0.821 . . . . 0.0 109.082 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.95 4.91 0.55 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.61 2.873 . . . . 0.0 113.515 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 15' ' ' LEU . 19.0 pt-20 -131.14 2.94 4.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.334 2.654 . . . . 0.0 112.093 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -127.17 -18.06 4.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.541 -0.725 . . . . 0.0 112.587 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.843 HD11 ' HA ' ' A' ' 49' ' ' ARG 0.254 0.2 OUTLIER -90.69 16.25 9.53 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.967 -1.083 . . . . 0.0 110.927 -162.482 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.43 -22.55 16.52 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.556 -1.34 . . . . 0.0 113.36 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.22 134.39 34.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -168.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.97 -18.82 64.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.443 0.697 . . . . 0.0 112.159 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.34 -68.81 0.6 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.122 1.769 . . . . 0.0 108.968 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -58.48 -36.21 73.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.573 1.549 . . . . 0.0 112.844 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' VAL . 71.4 t80 -52.05 -47.89 64.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.281 1.432 . . . . 0.0 112.395 170.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.28 -38.93 71.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.7 0.8 . . . . 0.0 111.067 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -52.08 -48.34 64.74 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.632 1.173 . . . . 0.0 109.243 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.5 mt -63.97 -44.49 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.52 1.528 . . . . 0.0 109.899 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 25' ' ' TYR . 57.2 t -58.57 -46.37 90.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -78.36 -31.48 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -170.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.22 -42.17 99.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 123.223 1.487 . . . . 0.0 109.414 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.66 -31.78 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.403 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -66.42 -24.36 66.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 120.962 -1.086 . . . . 0.0 111.395 175.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.58 -59.71 3.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 119.884 1.22 . . . . 0.0 108.309 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -62.3 -37.58 86.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -167.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.1 t -72.7 -25.89 61.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.571 0.749 . . . . 0.0 109.881 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -61.66 -23.33 66.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.54 1.136 . . . . 0.0 111.296 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 84.3 mttt -65.52 -10.75 37.45 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.454 -1.404 . . . . 0.0 112.95 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CE1' HD21 ' A' ' 79' ' ' LEU . 71.6 m-85 -123.47 4.11 9.03 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.856 1.263 . . . . 0.0 113.424 -170.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.11 -131.26 3.26 Favored Glycine 0 CA--C 1.504 -0.594 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.17 116.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.5 104.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.109 1.363 . . . . 0.0 108.693 166.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.06 -55.91 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.92 2.488 . . . . 0.0 110.337 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -148.37 163.43 37.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.399 1.479 . . . . 0.0 110.209 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mt -138.81 133.82 41.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.01 110.46 12.99 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.963 0.905 . . . . 0.0 109.58 -170.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.493 HD12 HG22 ' A' ' 29' ' ' VAL . 13.9 mt -128.16 86.62 57.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.668 1.587 . . . . 0.0 107.516 -170.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.93 125.5 16.67 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.787 1.658 . . . . 0.0 108.232 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.843 ' HA ' HD11 ' A' ' 19' ' ' LEU . 17.7 mtp180 -90.6 151.36 43.91 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 0.0 110.117 -174.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' CD ' ' HG ' ' A' ' 19' ' ' LEU . 61.0 Cg_endo -68.6 138.62 42.27 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.83 1.687 . . . . 0.0 109.543 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.53 104.28 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 t0 52.06 39.55 26.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.537 1.535 . . . . 0.0 113.565 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.01 12.37 71.37 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.706 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.7 t -91.76 159.32 2.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 119.086 1.443 . . . . 0.0 108.772 170.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -66.24 148.78 51.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.389 1.09 . . . . 0.0 112.471 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.72 161.05 63.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.265 2.226 . . . . 0.0 110.219 170.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.96 127.7 19.12 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.648 2.899 . . . . 0.0 110.259 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.03 66.1 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 126.33 1.919 . . . . 0.0 111.583 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.14 147.95 44.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 122.042 -0.681 . . . . 0.0 109.454 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.71 65.17 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.035 1.778 . . . . 0.0 112.76 -171.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -108.42 160.81 15.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -129.36 129.97 67.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 162.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -99.83 130.66 46.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 171.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -124.73 145.76 31.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.87 139.1 51.59 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -118.71 168.02 11.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.413 1.102 . . . . 0.0 111.062 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -38.06 87.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.067 1.347 . . . . 0.0 113.273 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.5 m -160.42 156.82 26.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.596 1.089 . . . . 0.0 111.367 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.479 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 10.7 t -63.83 -28.73 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.467 1.107 . . . . 0.0 110.666 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -68.85 -24.88 64.41 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 120.724 -1.235 . . . . 0.0 112.49 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.91 -52.96 5.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.34 1.456 . . . . 0.0 108.012 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.479 ' SG ' ' HA ' ' A' ' 69' ' ' VAL . 8.5 p -62.53 -29.96 70.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.144 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.66 -38.58 67.1 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.451 0.7 . . . . 0.0 112.273 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -73.65 -46.9 43.79 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.281 1.032 . . . . 0.0 108.602 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.04 -41.22 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.88 0.472 . . . . 0.0 111.556 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -66.48 0.38 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.173 1.789 . . . . 0.0 110.123 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -38.57 89.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.416 1.087 . . . . 0.0 110.508 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.13 -29.68 75.41 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 118.954 0.797 . . . . 0.0 112.332 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.558 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 96.1 mt -112.56 -0.99 15.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.263 1.025 . . . . 0.0 111.436 -173.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -55.45 122.86 12.17 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 166.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.56 78.15 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.708 -1.051 . . . . 0.0 112.721 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -173.03 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.767 1.284 . . . . 0.0 109.051 162.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -129.47 120.36 25.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.714 1.606 . . . . 0.0 107.537 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.558 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 4.2 m-30 -101.59 28.28 5.69 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.058 . . . . 0.0 109.196 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.97 -60.81 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.485 1.514 . . . . 0.0 108.842 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t30 177.46 -28.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 127.944 2.498 . . . . 0.0 109.037 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -103.03 167.37 9.88 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.319 0.648 . . . . 0.0 111.019 -173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.43 107.59 13.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.381 -160.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 13' ' ' MET . 64.5 t -66.84 108.6 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.872 0.869 . . . . 0.0 110.294 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.73 123.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 163.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.98 142.15 27.82 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 126.289 1.835 . . . . 0.0 106.892 170.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -149.05 154.96 40.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.392 1.077 . . . . 0.0 109.373 168.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -74.34 158.21 34.38 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 169.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.84 -176.74 5.1 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.078 2.551 . . . . 0.0 108.646 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -128.52 143.7 49.31 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 119.069 0.85 . . . . 0.0 109.355 -171.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.56 -30.44 12.11 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.794 2.329 . . . . 0.0 112.357 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.83 -41.73 74.7 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.287 0.948 . . . . 0.0 110.451 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -43.77 88.76 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.33 0.652 . . . . 0.0 110.167 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -70.71 -35.81 72.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.764 1.626 . . . . 0.0 112.593 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -64.35 -10.63 25.62 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.537 1.135 . . . . 0.0 112.618 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -134.8 -164.79 1.57 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.444 1.898 . . . . 0.0 107.411 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -110.02 29.26 7.8 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.687 1.195 . . . . 0.0 110.87 -178.301 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -79.54 72.48 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.533 1.159 . . . . 0.0 109.884 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 22.0 m-30 -100.92 -5.26 26.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -165.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.34 1.456 . . . . 0.0 109.682 -177.677 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.501 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.31 -143.54 7.47 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -53.45 150.2 12.92 Favored Pre-proline 0 C--O 1.239 0.536 0 C-N-CA 123.526 0.73 . . . . 0.0 112.486 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.83 136.16 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 N-CA-C 107.619 -1.723 . . . . 0.0 107.619 165.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.4 p -104.81 168.06 9.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -88.31 16.81 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.637 -0.664 . . . . 0.0 112.418 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.54 150.65 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tp -122.52 162.46 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.481 1.113 . . . . 0.0 108.104 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -135.67 130.57 34.49 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.628 1.571 . . . . 0.0 108.866 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.47 132.12 46.86 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.601 1.16 . . . . 0.0 110.767 -164.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -120.15 162.91 18.53 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.142 0.977 . . . . 0.0 110.242 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 68.68 3.2 3.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.978 2.911 . . . . 0.0 114.222 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.501 ' HB3' HD13 ' A' ' 62' ' ' ILE . 32.6 ttm -72.59 -39.59 67.25 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 110.805 -170.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.27 167.21 25.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 127.009 2.124 . . . . 0.0 109.129 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.85 153.95 55.0 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.894 0.878 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.78 0.79 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.536 2.157 . . . . 0.0 112.624 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.64 9.88 10.91 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.108 1.763 . . . . 0.0 111.684 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -137.42 26.57 2.86 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.48 1.112 . . . . 0.0 111.493 -169.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.83 37.15 4.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.629 1.172 . . . . 0.0 110.39 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -92.92 -59.6 2.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -68.52 112.14 5.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.841 1.256 . . . . 0.0 111.67 -170.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.52 -34.86 74.71 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.146 1.378 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.55 -64.15 0.99 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.126 1.37 . . . . 0.0 110.345 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -63.86 -37.17 86.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 0.0 110.828 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -54.37 -37.71 65.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.377 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.85 -32.44 52.05 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.381 0.672 . . . . 0.0 111.078 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.06 -54.32 35.93 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.923 1.289 . . . . 0.0 109.384 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.83 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 -171.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.16 -39.85 81.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 118.245 0.475 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -78.54 -33.3 47.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.638 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.86 -43.8 98.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.324 1.059 . . . . 0.0 109.749 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 50.9 t -68.1 -30.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.826 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -64.47 -35.18 80.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 116.63 -1.653 . . . . 0.0 111.084 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.88 -52.43 59.98 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 120.24 1.382 . . . . 0.0 109.39 169.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 32' ' ' VAL . 6.3 pt-20 -63.44 -46.71 85.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.237 -162.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.66 -9.9 59.01 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.656 -1.278 . . . . 0.0 111.895 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -20.38 66.17 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.879 -1.138 . . . . 0.0 110.066 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -65.93 -3.87 5.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.204 1.402 . . . . 0.0 112.858 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -132.83 -10.99 3.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.907 1.231 . . . . 0.0 113.071 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.26 -165.22 38.72 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 119.675 1.125 . . . . 0.0 110.847 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -98.19 104.53 16.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.76 110.0 2.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.11 -62.77 1.41 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -163.36 -172.02 2.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.563 0.345 . . . . 0.0 110.326 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.76 139.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 128.27 2.628 . . . . 0.0 104.597 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -133.2 113.27 12.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.509 0.724 . . . . 0.0 110.699 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mt -126.58 86.79 57.75 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.927 2.891 . . . . 0.0 109.62 -162.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 114.16 3.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.435 2.756 . . . . 0.0 108.989 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 165.4 53.63 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 172.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -61.99 175.81 1.71 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.115 3.21 . . . . 0.0 110.218 164.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.4 t -132.98 116.2 25.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t0 58.02 31.64 20.91 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.949 1.3 . . . . 0.0 112.811 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.88 -3.22 76.8 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.859 1.695 . . . . 0.0 113.044 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.36 143.08 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.4 154.65 5.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.95 1.3 . . . . 0.0 110.331 165.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.31 153.78 80.74 Favored Pre-proline 0 C--O 1.239 0.516 0 C-N-CA 125.445 1.498 . . . . 0.0 109.18 165.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -63.51 135.17 48.11 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.251 1.967 . . . . 0.0 107.93 165.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.81 -10.08 62.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.147 1.356 . . . . 0.0 113.011 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.08 156.68 35.83 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.434 1.117 . . . . 0.0 112.281 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 0.1 83.05 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.179 1.371 . . . . 0.0 113.075 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' C ' HD12 ' A' ' 62' ' ' ILE . 1.7 mppt? -117.29 167.67 11.02 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.048 1.424 . . . . 0.0 108.966 -174.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.501 HD13 ' HB3' ' A' ' 13' ' ' MET . 3.0 mp -126.7 145.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 161.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -111.79 157.77 20.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 160.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.69 153.55 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.6 146.42 49.57 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.03 0.932 . . . . 0.0 109.113 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.53 177.91 6.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.157 1.383 . . . . 0.0 110.892 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -89.71 -15.38 32.67 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 85.0 p -150.6 152.92 34.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.194 0.906 . . . . 0.0 111.163 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.08 -27.51 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.481 1.513 . . . . 0.0 110.126 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.64 -54.65 40.05 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.317 1.047 . . . . 0.0 109.446 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.58 -33.0 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.07 -51.23 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 110.075 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -53.66 -35.78 61.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.389 1.076 . . . . 0.0 111.666 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -71.82 -52.17 18.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.346 0.976 . . . . 0.0 110.395 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.46 -51.03 68.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.405 1.482 . . . . 0.0 110.222 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.4 ttt -44.78 -68.86 0.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.174 1.79 . . . . 0.0 111.598 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -66.53 -29.0 69.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.393 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.58 -24.35 65.97 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.447 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.3 mt -129.07 0.88 5.25 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.068 1.434 . . . . 0.0 114.187 -166.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.3 m -58.01 120.63 8.89 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.87 66.14 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.449 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.84 179.2 0.53 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.585 1.692 . . . . 0.0 111.881 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.24 137.22 53.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 159.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.414 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.2 m-30 -110.8 14.43 22.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.639 0.776 . . . . 0.0 110.21 173.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.92 -85.38 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.176 2.59 . . . . 0.0 104.902 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -140.64 -10.46 1.05 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -112.73 161.58 16.71 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.024 1.738 . . . . 0.0 110.244 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.4 109.99 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.43 0.634 . . . . 0.0 109.374 -173.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.9 t -64.52 144.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.615 1.166 . . . . 0.0 108.092 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.8 150.07 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 166.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.86 144.17 47.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.294 2.237 . . . . 0.0 108.574 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 4.8 mmpt? -143.44 162.74 34.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.67 2.388 . . . . 0.0 106.727 159.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -67.21 160.7 26.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 157.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.15 -164.5 1.13 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 168.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -113.53 142.53 27.77 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.32 -24.38 2.52 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.471 2.114 . . . . 0.0 111.528 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.39 -54.18 40.43 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -69.03 -15.6 63.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.199 0.6 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -82.35 -37.84 25.08 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.051 1.34 . . . . 0.0 110.973 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -72.23 2.21 6.36 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.016 1.327 . . . . 0.0 112.325 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -134.54 -164.52 1.52 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.734 2.414 . . . . 0.0 109.341 -163.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.531 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 5.6 ttm180 -130.26 25.1 5.19 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.931 2.092 . . . . 0.0 110.834 173.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 42.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.942 -1.098 . . . . 0.0 110.344 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.531 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 6.2 m-85 -74.95 129.29 37.4 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.818 0 C-N-CA 125.22 1.408 . . . . 0.0 108.144 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.475 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.81 172.95 52.65 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.335 0.969 . . . . 0.0 111.728 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -87.49 161.13 46.36 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.773 1.629 . . . . 0.0 110.74 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.54 149.1 79.69 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.01 2.473 . . . . 0.0 109.27 165.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 p -139.96 170.81 15.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.29 1.836 . . . . 0.0 107.01 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.56 8.1 1.22 Allowed 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.852 -1.155 . . . . 0.0 111.468 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.9 t -129.04 111.28 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.425 1.49 . . . . 0.0 108.047 -162.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -124.38 129.44 50.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -171.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.7 t -101.0 148.81 24.61 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.404 ' HB3' ' HE3' ' A' ' 13' ' ' MET . 48.9 mt -132.62 105.52 7.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.214 1.805 . . . . 0.0 108.33 -162.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -99.56 165.52 11.59 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.411 0.624 . . . . 0.0 111.131 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.31 28.72 18.35 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 128.744 2.817 . . . . 0.0 111.423 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.404 ' HE3' ' HB3' ' A' ' 10' ' ' LEU . 2.4 ttm -84.21 -56.11 3.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.5 -0.75 . . . . 0.0 111.276 -168.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.4 157.34 27.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.128 1.771 . . . . 0.0 107.399 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -98.51 150.03 36.32 Favored Pre-proline 0 C--O 1.235 0.309 0 O-C-N 120.867 -1.146 . . . . 0.0 110.082 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -68.24 1.25 3.66 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.261 2.641 . . . . 0.0 112.912 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -127.14 12.44 7.13 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.078 1.751 . . . . 0.0 111.385 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.67 -14.58 7.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.254 0.622 . . . . 0.0 111.653 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -76.99 66.76 2.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.831 1.252 . . . . 0.0 110.707 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -130.64 -57.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.29 0.636 . . . . 0.0 109.487 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 112.48 1.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.68 1.192 . . . . 0.0 111.417 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.4 -22.24 66.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.237 1.415 . . . . 0.0 112.561 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.9 -55.62 4.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.306 1.042 . . . . 0.0 110.304 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -40.03 90.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.119 1.767 . . . . 0.0 110.473 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -49.98 -43.59 50.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.651 1.58 . . . . 0.0 112.667 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.68 -43.15 56.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.549 1.14 . . . . 0.0 109.285 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -63.74 -27.7 69.38 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.96 -0.462 . . . . 0.0 110.852 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -77.24 -24.72 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.521 1.128 . . . . 0.0 110.801 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.17 -47.32 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 120.535 -1.353 . . . . 0.0 107.718 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -72.31 -37.03 69.03 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.628 1.171 . . . . 0.0 111.988 -164.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -60.58 -42.08 95.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 111.629 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.58 -27.12 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 125.129 1.372 . . . . 0.0 110.902 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -62.0 -43.86 97.95 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.136 -0.977 . . . . 0.0 109.883 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.95 -52.52 65.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.523 0.729 . . . . 0.0 110.743 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -61.1 -35.16 76.27 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.732 0.777 . . . . 0.0 110.964 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t -76.2 -38.96 55.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.314 1.045 . . . . 0.0 109.671 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -51.9 -25.11 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.852 1.661 . . . . 0.0 111.981 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -61.28 -31.84 71.67 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.655 -1.278 . . . . 0.0 112.47 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.87 -8.29 25.94 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 112.535 -170.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.92 -178.05 19.03 Favored Glycine 0 CA--C 1.506 -0.526 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.8 tp -103.36 121.2 42.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -160.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.56 136.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.385 2.274 . . . . 0.0 108.383 172.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -98.49 -52.0 3.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.31 2.244 . . . . 0.0 109.689 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -152.01 158.4 43.02 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.118 0.567 . . . . 0.0 110.367 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.3 mt -137.33 92.21 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.73 113.11 23.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.555 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -123.79 85.64 53.54 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 125.16 1.384 . . . . 0.0 107.313 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.82 148.7 41.47 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.64 1.56 . . . . 0.0 108.323 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -137.97 160.23 65.32 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 121.004 -1.06 . . . . 0.0 110.928 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.98 158.12 55.8 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.964 1.776 . . . . 0.0 110.753 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.11 166.56 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.191 1.796 . . . . 0.0 107.708 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.01 86.17 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 130.335 3.454 . . . . 0.0 106.279 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.76 32.64 74.36 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.039 -1.437 . . . . 0.0 111.663 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.14 128.24 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 119.279 1.54 . . . . 0.0 107.129 162.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.69 171.7 8.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.53 1.157 . . . . 0.0 109.351 166.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -128.24 143.87 49.66 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 126.139 1.776 . . . . 0.0 108.085 167.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.61 137.3 38.63 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.493 1.462 . . . . 0.0 108.451 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.87 28.93 71.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 124.156 0.884 . . . . 0.0 111.426 169.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.406 ' HB2' HG23 ' A' ' 56' ' ' VAL . 9.5 t -69.48 153.99 42.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.153 1.781 . . . . 0.0 110.632 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.29 34.07 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.512 1.529 . . . . 0.0 114.421 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 147.74 48.49 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.567 1.683 . . . . 0.0 110.639 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.6 144.52 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -114.56 123.79 50.24 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.45 120.25 62.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -95.2 140.74 29.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.91 -168.91 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.093 1.757 . . . . 0.0 108.851 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 p -119.67 -0.65 10.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.413 1.085 . . . . 0.0 112.544 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.9 m -159.88 146.21 15.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.512 1.525 . . . . 0.0 108.873 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.31 -13.81 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.379 1.072 . . . . 0.0 111.102 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.9 -41.26 15.1 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.132 -1.605 . . . . 0.0 110.83 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.92 -37.55 87.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.969 0.907 . . . . 0.0 110.917 -173.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.5 p -68.76 -37.05 79.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.003 0.521 . . . . 0.0 110.732 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -67.02 -31.05 71.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.139 0.976 . . . . 0.0 111.232 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -62.62 -56.09 21.0 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.603 1.092 . . . . 0.0 108.773 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.17 79.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.859 0.864 . . . . 0.0 110.973 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -44.57 -58.79 2.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.849 1.66 . . . . 0.0 111.502 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -79.45 -33.25 42.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.075 0.95 . . . . 0.0 112.166 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.6 84.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.554 1.073 . . . . 0.0 112.531 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -117.53 10.57 13.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.705 1.602 . . . . 0.0 111.19 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -56.31 124.59 18.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.04 -3.63 60.79 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.289 -0.728 . . . . 0.0 112.891 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -69.48 -178.45 1.41 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.156 1.478 . . . . 0.0 109.307 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -134.11 99.64 4.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.359 1.464 . . . . 0.0 109.347 -163.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.86 13.51 4.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.118 0.967 . . . . 0.0 112.318 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.44 -73.25 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.956 2.503 . . . . 0.0 104.521 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -146.04 -30.08 0.4 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.027 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt85 -101.01 164.98 11.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.887 0.875 . . . . 0.0 111.371 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.78 111.76 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.558 1.143 . . . . 0.0 109.794 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -72.15 134.81 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 109.884 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.4 t -113.12 143.39 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 166.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 p -112.81 146.92 37.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.493 1.517 . . . . 0.0 108.224 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.1 149.74 31.56 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.649 168.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.35 118.64 17.53 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.71 -175.72 5.52 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.25 0.62 . . . . 0.0 109.727 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -101.61 144.95 29.58 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.38 -28.78 32.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.868 3.045 . . . . 0.0 111.435 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.1 -45.24 21.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.571 1.149 . . . . 0.0 110.549 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.96 14.84 27.66 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.965 0.906 . . . . 0.0 111.739 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -103.85 -39.73 6.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.86 1.264 . . . . 0.0 110.488 163.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -58.84 -15.3 11.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.698 1.599 . . . . 0.0 113.903 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -129.67 -163.85 1.34 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.616 1.967 . . . . 0.0 108.821 -168.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.41 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -104.73 38.7 1.84 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.661 1.585 . . . . 0.0 111.336 173.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -102.71 21.27 15.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.824 2.05 . . . . 0.0 114.129 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 102' ' ' ARG . 4.5 m-85 -59.92 112.79 1.99 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.8 -1.187 . . . . 0.0 110.265 -170.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 3.8 m0 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 171.632 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.537 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.96 -172.23 44.61 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 128.461 2.934 . . . . 0.0 106.677 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -134.2 158.27 75.66 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 118.428 1.114 . . . . 0.0 110.284 -171.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.97 131.45 23.93 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.956 1.77 . . . . 0.0 108.091 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 p -123.98 179.53 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -86.33 -4.85 59.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.197 -0.906 . . . . 0.0 113.388 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.8 m -83.83 179.81 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.855 1.207 . . . . 0.0 109.098 168.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tp -155.21 163.65 39.89 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 166.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.5 t -138.61 129.37 26.46 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.783 -1.198 . . . . 0.0 109.606 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.452 HD21 HG12 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -125.6 115.02 19.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 126.217 1.807 . . . . 0.0 107.761 -164.06 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mtm -87.83 162.5 16.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 75.37 23.89 1.46 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.515 1.926 . . . . 0.0 112.968 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.572 ' HB2' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -77.84 -82.92 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.683 HG22 HD11 ' A' ' 62' ' ' ILE . 31.6 m -88.02 159.84 2.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 127.721 2.408 . . . . 0.0 109.069 -170.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.82 165.32 40.17 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.283 0.633 . . . . 0.0 109.425 155.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.2 -17.76 24.2 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.604 1.536 . . . . 0.0 112.993 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -96.17 -7.14 36.59 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.673 1.189 . . . . 0.0 111.443 -165.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.12 -38.9 17.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.312 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 14' ' ' VAL . 93.0 mt -72.03 49.44 0.19 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.516 2.326 . . . . 0.0 115.421 -155.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.43 -11.5 3.57 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 119.857 -1.777 . . . . 0.0 110.317 -167.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.85 112.69 17.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.981 0.896 . . . . 0.0 110.066 -167.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.87 -16.1 37.87 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 129.669 3.188 . . . . 0.0 113.173 -165.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.39 -51.87 7.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.45 1.5 . . . . 0.0 110.5 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.31 -44.15 72.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.527 2.331 . . . . 0.0 108.618 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.481 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 54.0 t80 -58.43 -33.63 69.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.744 0.418 . . . . 0.0 111.818 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.63 -39.9 50.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.075 . . . . 0.0 111.599 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.2 -46.11 91.81 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.33 0.652 . . . . 0.0 109.581 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.5 mt -60.49 -39.15 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.745 1.218 . . . . 0.0 110.123 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.21 -33.07 58.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 120.751 -1.218 . . . . 0.0 110.411 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.24 -42.44 25.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.192 0.597 . . . . 0.0 110.957 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.37 -40.09 93.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.577 1.18 . . . . 0.0 110.532 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.5 t -89.01 -15.41 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.209 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -72.77 -38.22 67.38 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.52 -1.363 . . . . 0.0 111.034 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.5 -52.52 64.17 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.967 0.803 . . . . 0.0 109.825 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.35 -21.15 66.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.9 t -83.15 -34.32 26.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.848 1.659 . . . . 0.0 110.592 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -17.88 19.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 113.043 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.02 -32.71 71.14 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.914 0.886 . . . . 0.0 112.627 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.3 -7.86 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.148 0.886 . . . . 0.0 112.609 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.31 -134.51 3.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -167.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.12 112.63 4.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.78 120.67 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.674 1.226 . . . . 0.0 109.209 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -60.66 3.43 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.191 2.196 . . . . 0.0 108.155 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -160.22 -178.74 7.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.779 0.718 . . . . 0.0 110.91 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.45 136.67 57.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 126.578 1.951 . . . . 0.0 106.634 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.95 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.878 1.271 . . . . 0.0 110.167 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.06 86.14 21.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.649 1.979 . . . . 0.0 106.723 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 114.82 4.14 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.537 2.825 . . . . 0.0 109.748 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 2.4 mpp_? -72.96 159.77 84.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.156 0.982 . . . . 0.0 111.696 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.423 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 72.0 Cg_endo -64.97 178.29 1.95 Allowed 'Trans proline' 0 C--N 1.352 0.741 1 C-N-CA 125.926 4.418 . . . . 0.0 112.152 177.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.15 106.21 15.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 t70 53.71 28.44 8.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.566 1.146 . . . . 0.0 113.656 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.42 -2.13 88.17 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.278 1.418 . . . . 0.0 115.398 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.0 t -78.76 139.02 19.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 126.472 1.909 . . . . 0.0 107.548 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.91 144.72 55.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.533 0.682 . . . . 0.0 111.417 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 59' ' ' CYS . 1.1 m -107.32 147.19 34.75 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 125.043 1.337 . . . . 0.0 111.603 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.82 98.13 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.002 2.468 . . . . 0.0 107.515 163.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.54 -8.06 6.98 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.107 1.813 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.476 ' HB2' HG22 ' A' ' 56' ' ' VAL . 3.2 t -81.94 142.68 32.23 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.226 1.513 . . . . 0.0 110.229 -164.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.84 -12.2 24.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.002 1.763 . . . . 0.0 113.477 -170.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.495 ' C ' HD12 ' A' ' 62' ' ' ILE . 6.9 mptt -86.87 146.89 26.02 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HG22 ' A' ' 14' ' ' VAL . 1.9 mp -118.84 147.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 170.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -122.53 158.54 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 HD21 ' A' ' 10' ' ' LEU . 11.9 p -144.82 153.34 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 30.9 tt0 -132.58 139.25 47.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -114.47 174.91 5.72 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.245 1.418 . . . . 0.0 110.57 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -74.37 -23.2 58.97 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.934 -0.479 . . . . 0.0 112.111 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 t -154.69 161.87 41.37 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.631 1.205 . . . . 0.0 110.111 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.2 t -52.17 -39.56 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.592 1.557 . . . . 0.0 108.173 164.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -69.36 -35.09 75.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 117.027 -1.463 . . . . 0.0 113.688 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -85.19 -20.66 29.85 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.01 1.732 . . . . 0.0 111.503 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.3 t -69.68 -49.6 51.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.517 1.527 . . . . 0.0 110.243 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -54.74 -36.82 65.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.622 0.769 . . . . 0.0 112.141 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -71.54 -45.93 60.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.08 91.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 112.036 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.7 ttm -53.69 -68.33 0.19 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.381 0.991 . . . . 0.0 109.34 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -55.64 -34.95 65.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.782 0.833 . . . . 0.0 110.617 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.9 -20.87 76.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.86 -0.967 . . . . 0.0 114.355 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.59 2.33 10.12 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.085 1.354 . . . . 0.0 112.107 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -63.2 103.01 0.44 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.614 -1.304 . . . . 0.0 109.945 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.98 0.53 30.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.079 1.323 . . . . 0.0 112.897 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -74.25 -175.53 2.31 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.333 1.066 . . . . 0.0 111.958 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -138.29 115.99 11.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -107.97 24.21 13.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.55 1.54 . . . . 0.0 111.019 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.47 -64.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.318 1.847 . . . . 0.0 108.506 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.37 -17.99 0.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 171.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -113.71 166.6 11.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 109.925 -167.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.56 118.86 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 13' ' ' MET . 77.0 t -66.91 138.23 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.14 131.37 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.7 p -106.72 147.24 29.84 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.258 1.823 . . . . 0.0 108.826 -164.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -153.95 151.05 28.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.708 1.603 . . . . 0.0 108.065 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -77.42 152.32 34.35 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 166.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -172.14 2.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.929 1.691 . . . . 0.0 107.779 168.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -111.85 143.55 28.89 Favored Pre-proline 0 C--O 1.236 0.36 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.02 -23.5 16.01 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.814 3.009 . . . . 0.0 110.997 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -51.49 -53.31 38.65 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.76 0.824 . . . . 0.0 108.985 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.32 77.87 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.788 0.835 . . . . 0.0 111.214 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -70.46 -39.85 74.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.911 2.084 . . . . 0.0 112.54 -169.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -63.78 -42.16 97.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 109.811 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -93.38 -167.33 1.69 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.847 1.259 . . . . 0.0 110.475 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 7.0 ttm180 -100.17 39.8 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.763 -0.585 . . . . 0.0 110.55 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -99.3 88.88 4.03 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.048 -1.033 . . . . 0.0 109.42 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.457 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER -136.08 165.03 26.64 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.491 1.916 . . . . 0.0 107.379 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 11.3 t90 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 126.344 1.857 . . . . 0.0 106.743 179.625 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.569 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.66 174.26 28.22 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -171.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -115.68 160.08 36.25 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 124.832 1.253 . . . . 0.0 109.644 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -71.53 148.09 53.16 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.743 . . . . 0.0 108.444 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.9 p -136.51 -179.84 5.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.28 5.56 5.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.305 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.56 143.97 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.698 1.199 . . . . 0.0 110.464 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 mt -131.43 159.59 37.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.209 2.204 . . . . 0.0 109.526 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 t -116.77 110.88 18.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.773 1.629 . . . . 0.0 106.974 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.02 153.54 20.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.6 mtm -134.23 176.8 8.27 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 61.62 12.89 4.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.879 1.671 . . . . 0.0 113.034 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -68.33 -59.52 3.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 153.84 38.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.074 2.15 . . . . 0.0 108.227 -172.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -82.01 164.4 48.63 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.074 1.35 . . . . 0.0 109.548 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.87 5.28 2.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 124.116 3.211 . . . . 0.0 113.734 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -129.56 26.59 5.33 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.547 1.539 . . . . 0.0 110.326 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -141.05 24.64 2.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.301 1.84 . . . . 0.0 111.838 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -128.54 75.51 1.64 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.482 2.313 . . . . 0.0 107.039 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -134.35 -49.93 0.79 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.296 1.439 . . . . 0.0 108.166 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.92 105.96 3.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.904 2.481 . . . . 0.0 108.974 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.61 -19.73 41.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.117 1.367 . . . . 0.0 112.736 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.24 -65.71 0.98 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.35 -29.0 68.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.168 1.387 . . . . 0.0 111.897 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.22 -44.17 64.64 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.82 -0.55 . . . . 0.0 111.697 172.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.16 -43.77 50.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -55.88 -43.97 77.72 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.29 1.036 . . . . 0.0 111.119 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -68.31 -42.53 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.823 0.849 . . . . 0.0 109.604 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -59.07 -40.03 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.799 1.182 . . . . 0.0 109.515 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.77 -32.56 67.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.446 0.566 . . . . 0.0 112.361 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.84 -40.75 88.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.842 0.353 . . . . 0.0 110.753 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.1 t -78.47 -38.7 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 118.264 -0.874 . . . . 0.0 109.403 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -52.39 -36.23 53.48 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.07 0.85 . . . . 0.0 109.912 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.44 -38.02 88.16 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.546 0.612 . . . . 0.0 111.124 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.59 -47.65 18.85 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.686 ' SG ' HG11 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -61.74 -29.81 70.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 111.65 174.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.5 t -63.52 -9.38 12.79 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.633 1.173 . . . . 0.0 113.225 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -61.56 -41.89 98.03 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.138 -2.227 . . . . 0.0 111.111 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.67 -8.42 50.04 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.214 1.406 . . . . 0.0 113.146 -160.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.12 -159.07 27.82 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -157.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.64 120.53 36.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.419 1.109 . . . . 0.0 111.759 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.686 HG11 ' SG ' ' A' ' 36' ' ' CYS . 1.5 p -75.9 142.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.051 167.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.3 -54.67 2.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.526 1.931 . . . . 0.0 109.288 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -159.34 155.62 27.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.474 0.579 . . . . 0.0 110.621 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mt -124.34 118.57 54.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 127.143 2.177 . . . . 0.0 105.888 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 133.53 38.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.91 86.61 26.48 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -52.06 145.74 32.61 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.237 1.958 . . . . 0.0 110.128 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.67 148.14 67.19 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.33 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -61.56 161.65 23.65 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.063 2.509 . . . . 0.0 111.067 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.63 104.21 16.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 62.87 24.24 14.44 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.427 1.491 . . . . 0.0 114.496 169.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.7 -4.09 53.42 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.591 2.043 . . . . 0.0 112.873 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.4 t -94.65 140.15 17.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.946 1.299 . . . . 0.0 109.197 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.44 151.96 35.69 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.969 1.308 . . . . 0.0 112.125 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.83 143.87 34.53 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.676 1.99 . . . . 0.0 110.048 165.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.37 111.62 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.45 2.767 . . . . 0.0 109.762 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.46 -1.37 20.44 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.84 1.21 . . . . 0.0 113.383 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -66.45 137.45 56.84 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.509 1.654 . . . . 0.0 111.158 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.73 1.74 79.83 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.935 1.731 . . . . 0.0 113.608 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -108.87 123.23 48.74 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.59 106.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -170.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -91.11 141.94 28.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.8 135.69 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.99 148.82 41.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.033 1.733 . . . . 0.0 107.184 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -129.99 168.83 16.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.686 1.594 . . . . 0.0 109.999 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 p -70.01 -4.74 22.29 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.28 1.432 . . . . 0.0 114.088 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.2 t -171.51 165.42 6.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.256 1.822 . . . . 0.0 107.984 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.6 t -52.93 -47.82 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.251 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -61.83 -48.35 80.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.312 0.645 . . . . 0.0 110.262 -172.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.29 -40.24 93.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.227 1.011 . . . . 0.0 110.342 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -44.69 94.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.247 1.019 . . . . 0.0 109.423 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.5 -51.85 57.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.389 1.476 . . . . 0.0 110.774 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -61.05 -47.35 86.81 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.77 74.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.326 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -62.25 -65.52 0.68 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.099 0.863 . . . . 0.0 109.438 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -70.04 -24.4 63.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.968 -0.457 . . . . 0.0 111.301 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.06 -24.28 73.16 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.364 -0.687 . . . . 0.0 112.505 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -127.84 -6.24 5.63 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.217 1.008 . . . . 0.0 112.468 -171.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -59.83 142.05 54.19 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.871 1.214 . . . . 0.0 108.08 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.2 -1.32 81.1 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.206 1.384 . . . . 0.0 114.029 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -78.09 -174.74 3.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.373 2.086 . . . . 0.0 112.005 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -118.66 129.97 55.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -107.1 13.47 27.38 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.96 1.254 . . . . 0.0 110.787 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.73 -74.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.73 -12.14 0.45 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -122.4 160.91 24.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.187 0.903 . . . . 0.0 110.719 -165.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.82 128.91 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 123.159 0.287 . . . . 0.0 111.764 -165.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.56 87.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.77 146.37 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.0 p -102.11 164.36 11.74 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.491 0.717 . . . . 0.0 109.489 171.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -146.75 150.47 35.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.275 1.43 . . . . 0.0 107.582 154.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -67.43 156.28 36.96 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.358 1.036 . . . . 0.0 109.461 163.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.59 -172.38 2.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.902 1.281 . . . . 0.0 108.368 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -108.83 145.34 31.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 158.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.99 -22.24 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.541 2.828 . . . . 0.0 112.723 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -44.64 -42.11 7.21 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.867 2.067 . . . . 0.0 111.969 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 p -91.23 -27.57 18.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 112.28 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -72.79 -27.25 61.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.818 2.047 . . . . 0.0 110.637 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -65.21 -12.47 51.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -130.48 -164.18 1.4 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.75 2.02 . . . . 0.0 107.852 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 2.2 ttt180 -107.1 23.44 14.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.417 1.087 . . . . 0.0 111.252 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.68 97.83 6.71 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.72 -1.237 . . . . 0.0 110.155 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 5.6 m-85 -140.06 165.26 27.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.651 1.181 . . . . 0.0 108.416 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 14.3 t90 . . . . . 0 C--O 1.248 0.993 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.108 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 CA-C-O 118.159 -1.356 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.52 -174.04 17.51 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 118.408 1.104 . . . . 0.0 110.725 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -65.61 157.63 77.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.216 0.606 . . . . 0.0 110.558 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.83 149.14 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.829 1.686 . . . . 0.0 108.827 167.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.0 p -128.12 171.32 12.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 4.4 pt-20 -72.06 -10.49 59.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.773 1.229 . . . . 0.0 111.716 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -114.01 155.0 15.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 119.537 1.062 . . . . 0.0 110.056 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.1 124.82 21.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 108.63 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -80.22 129.77 34.74 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.0 122.88 42.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.323 1.449 . . . . 0.0 108.411 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -97.03 163.96 12.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 74.22 18.88 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.063 2.145 . . . . 0.0 113.649 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -73.41 0.31 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 165.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.62 174.23 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 126.183 1.793 . . . . 0.0 109.616 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -112.47 146.29 34.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 125.022 1.329 . . . . 0.0 107.654 172.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -61.37 7.37 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.808 1 C-N-CA 127.892 5.728 . . . . 0.0 116.055 -175.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.34 -0.33 1.81 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.258 1.823 . . . . 0.0 111.925 -154.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -117.42 -6.08 11.23 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 112.937 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' H ' ' A' ' 19' ' ' LEU . 2.2 mm? -68.95 -4.66 17.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.355 1.462 . . . . 0.0 113.849 -169.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.31 -25.84 60.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.978 2.111 . . . . 0.0 111.564 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.32 129.3 34.99 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.381 0.991 . . . . 0.0 109.614 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.28 -17.05 43.91 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.209 1.403 . . . . 0.0 112.393 -170.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -87.88 -61.82 1.63 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.148 0.979 . . . . 0.0 109.278 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.27 -38.03 73.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.565 0.746 . . . . 0.0 111.816 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -53.22 -39.27 63.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.258 1.023 . . . . 0.0 112.517 172.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -84.29 -31.89 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.428 0.691 . . . . 0.0 111.438 -171.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -53.95 -45.41 71.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.8 mt -67.09 -15.07 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.909 0.883 . . . . 0.0 111.724 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.0 t -86.01 -44.67 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 119.913 -1.742 . . . . 0.0 108.773 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.9 -42.54 69.84 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.684 0.793 . . . . 0.0 111.153 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -60.83 -43.6 98.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.754 1.74 . . . . 0.0 109.647 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.87 -21.78 6.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.316 -167.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -61.13 -43.34 99.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.086 -1.009 . . . . 0.0 108.826 165.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.48 -43.14 91.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.14 0.882 . . . . 0.0 111.743 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.68 -46.13 76.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.811 0.732 . . . . 0.0 110.274 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -70.89 -27.82 64.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.684 0.794 . . . . 0.0 111.276 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -55.53 -16.68 4.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.006 1.723 . . . . 0.0 113.339 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.31 -11.09 38.29 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.978 -1.701 . . . . 0.0 113.692 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.67 -15.89 10.74 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.65 -168.56 27.36 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 107.181 -2.367 . . . . 0.0 107.181 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.7 tp -99.87 119.24 37.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -162.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.58 117.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 167.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -56.23 15.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 158.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 p -160.36 170.01 21.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.504 0.593 . . . . 0.0 112.357 -166.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.64 153.1 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.14 133.21 45.37 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -137.71 85.61 20.02 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.51 148.34 92.57 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.394 1.396 . . . . 0.0 109.69 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -118.18 150.33 47.37 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 108.537 -167.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.55 124.76 11.94 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.079 2.519 . . . . 0.0 108.641 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.99 105.38 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t70 55.64 24.38 7.03 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.18 5.52 70.14 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.966 2.222 . . . . 0.0 115.06 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.83 158.48 3.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 118.591 1.196 . . . . 0.0 111.862 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.14 127.76 33.94 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 123.096 1.427 . . . . 0.0 109.105 159.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.55 143.22 29.5 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 124.992 1.317 . . . . 0.0 110.453 168.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -67.7 125.03 12.65 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.504 2.802 . . . . 0.0 108.409 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.75 12.83 61.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.525 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.19 154.24 42.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.531 1.666 . . . . 0.0 110.667 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.1 -32.36 4.67 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.09 1.805 . . . . 0.0 112.89 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -72.17 172.59 9.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.11 1.455 . . . . 0.0 109.254 173.359 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.95 151.19 35.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 164.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.84 150.26 33.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 165.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.32 159.24 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.67 121.42 10.54 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -93.63 162.93 13.75 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.507 0.67 . . . . 0.0 109.361 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -72.93 -1.55 17.41 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.029 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.3 m -158.45 155.34 28.38 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 121.135 1.789 . . . . 0.0 111.627 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.7 t -59.76 -32.29 49.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.627 1.571 . . . . 0.0 109.852 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.73 -59.53 5.24 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.479 -0.763 . . . . 0.0 110.297 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.55 -39.5 57.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.335 1.454 . . . . 0.0 109.891 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 t -64.35 -50.11 69.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.973 1.309 . . . . 0.0 110.374 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.15 -30.67 62.5 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.871 1.268 . . . . 0.0 112.206 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -78.03 -50.13 12.69 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.0 0.92 . . . . 0.0 109.498 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.27 -47.35 78.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.361 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.2 ttm -48.06 -67.55 0.26 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.027 0.831 . . . . 0.0 110.752 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.49 -25.33 66.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.796 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.33 -26.75 74.09 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.649 -1.084 . . . . 0.0 112.565 174.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.494 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 94.3 mt -123.39 -5.71 8.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.608 1.204 . . . . 0.0 112.727 -167.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 m -50.59 121.08 5.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.508 1.123 . . . . 0.0 108.412 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.25 8.03 86.91 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 118.499 -1.167 . . . . 0.0 114.41 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -78.26 -169.68 1.72 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.676 1.238 . . . . 0.0 109.974 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.85 132.2 53.72 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.494 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 4.2 m-30 -110.57 19.96 18.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.698 1.199 . . . . 0.0 109.737 174.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.57 -65.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.885 1.674 . . . . 0.0 107.179 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 -29.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.076 1.351 . . . . 0.0 111.452 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -88.51 166.5 14.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.671 -0.643 . . . . 0.0 110.255 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.95 135.49 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.1 t -93.75 111.69 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.29 142.78 13.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.8 p -119.96 151.43 38.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.369 1.068 . . . . 0.0 108.128 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -150.0 144.16 25.65 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.174 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -66.48 138.17 57.34 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 120.252 1.387 . . . . 0.0 108.218 161.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 -164.37 0.94 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -116.73 143.02 30.59 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.56 -27.8 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.132 3.221 . . . . 0.0 111.991 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -46.88 72.2 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 120.902 -1.123 . . . . 0.0 111.083 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.81 55.17 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.895 1.678 . . . . 0.0 111.325 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -92.65 -51.94 4.87 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.4 1.88 . . . . 0.0 109.251 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -62.5 -30.29 71.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.858 0.463 . . . . 0.0 111.599 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -104.96 -178.25 3.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.539 1.936 . . . . 0.0 108.659 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -111.49 76.84 1.0 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.32 69.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -97.7 153.26 18.36 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.219 0.608 . . . . 0.0 110.075 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 C-N-CA 127.35 2.26 . . . . 0.0 106.548 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.478 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.34 -143.13 4.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -59.93 156.99 32.85 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.048 0.924 . . . . 0.0 110.984 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.76 148.37 52.36 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.775 2.317 . . . . 0.0 108.502 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.2 p -135.79 155.21 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.16 -3.02 3.32 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 m -93.64 -167.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.472 0.653 . . . . 0.0 110.354 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.11 160.33 43.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.467 2.307 . . . . 0.0 105.877 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 t -137.65 114.29 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 mp -125.05 153.93 42.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 110.618 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mtm -138.27 170.25 16.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 111.046 -172.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.03 13.24 5.52 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.334 2.254 . . . . 0.0 112.658 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 36.9 ttm -76.17 -75.71 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -97.24 155.9 3.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.748 1.219 . . . . 0.0 108.738 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.04 156.87 38.4 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.364 1.466 . . . . 0.0 107.065 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.91 -12.37 34.08 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.434 2.756 . . . . 0.0 113.835 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -105.1 8.65 34.3 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.013 1.725 . . . . 0.0 110.756 -168.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -124.46 -16.96 6.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.393 1.077 . . . . 0.0 111.596 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.73 56.14 3.42 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.395 1.478 . . . . 0.0 109.589 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.44 -49.06 1.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.026 0.93 . . . . 0.0 108.866 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.1 92.17 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.727 1.611 . . . . 0.0 110.327 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.69 -17.7 49.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.289 1.835 . . . . 0.0 113.097 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.21 -35.0 10.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 0.0 110.802 -172.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -74.61 -36.32 62.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.712 1.205 . . . . 0.0 111.082 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.89 -40.15 13.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.839 1.655 . . . . 0.0 111.782 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.08 -46.49 74.14 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 110.927 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.96 -46.83 79.92 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.954 1.302 . . . . 0.0 109.926 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.84 -45.29 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.889 0.875 . . . . 0.0 109.813 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 t -57.26 -47.16 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.96 -37.63 88.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.555 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -76.15 -27.7 57.1 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.963 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.4 t -76.73 -34.17 22.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.61 -28.74 69.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.045 -1.034 . . . . 0.0 111.644 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.21 -47.18 78.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.854 0.752 . . . . 0.0 110.803 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.7 -42.96 69.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.943 0.497 . . . . 0.0 110.479 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.441 ' HA ' HD11 ' A' ' 79' ' ' LEU 0.295 0.8 OUTLIER -71.96 -26.12 62.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.707 173.53 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -11.83 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 120.543 1.52 . . . . 0.0 113.04 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -63.2 -20.19 65.19 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 119.77 -1.831 . . . . 0.0 113.986 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -117.28 3.84 12.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.369 0.668 . . . . 0.0 112.524 -165.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.36 -139.4 5.99 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -168.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -137.54 133.31 34.36 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.141 1.471 . . . . 0.0 109.664 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -84.69 122.2 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.24 1.016 . . . . 0.0 108.48 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -73.02 -61.35 1.85 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.151 0.981 . . . . 0.0 108.866 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 t -151.84 166.68 30.68 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.781 0.832 . . . . 0.0 109.358 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 64' ' ' VAL . 7.2 mt -133.74 123.36 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -110.87 114.13 27.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.067 1.347 . . . . 0.0 109.808 -167.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.29 86.26 30.91 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.861 1.664 . . . . 0.0 107.94 -167.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.19 150.16 87.92 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 120.946 1.097 . . . . 0.0 109.821 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -105.39 165.43 13.16 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 109.505 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.38 173.74 6.01 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.256 2.637 . . . . 0.0 110.883 173.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.19 91.78 2.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 170.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 53.46 33.51 16.2 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.45 1.1 . . . . 0.0 113.313 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.01 -16.64 39.0 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.563 2.03 . . . . 0.0 113.084 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.4 t -82.51 143.1 12.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 O-C-N 120.82 -1.4 . . . . 0.0 109.962 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -68.23 146.11 53.66 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.952 0.882 . . . . 0.0 111.004 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.55 156.69 79.8 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 125.877 1.671 . . . . 0.0 109.343 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -62.27 138.61 72.86 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.633 1.556 . . . . 0.0 108.796 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.57 9.68 85.39 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.805 -0.997 . . . . 0.0 113.258 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.14 154.6 37.66 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.294 1.047 . . . . 0.0 111.431 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.63 -4.56 50.69 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.671 1.605 . . . . 0.0 115.223 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -98.44 147.0 25.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.706 1.253 . . . . 0.0 107.833 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.91 139.65 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -123.12 139.17 54.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 45' ' ' ILE . 98.2 t -132.11 110.23 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -169.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 37.1 tt0 -88.62 138.96 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.522 1.129 . . . . 0.0 108.012 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.76 174.54 6.53 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.403 1.481 . . . . 0.0 110.227 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -32.41 67.51 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.696 1.199 . . . . 0.0 113.601 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.3 m -168.85 167.25 11.08 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.285 1.034 . . . . 0.0 110.324 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.406 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 2.9 t -51.73 -40.12 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 122.901 1.334 . . . . 0.0 110.328 175.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.78 -2.51 20.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.605 -1.31 . . . . 0.0 114.036 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -109.01 -33.97 6.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.237 1.015 . . . . 0.0 109.373 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 69' ' ' VAL . 29.2 p -75.82 -34.37 60.13 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.472 -0.768 . . . . 0.0 109.504 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -50.27 -35.43 27.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.883 2.073 . . . . 0.0 111.83 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.3 -46.13 12.11 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.002 0.921 . . . . 0.0 108.875 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.78 76.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.581 -1.2 . . . . 0.0 111.277 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 mtp -46.59 -64.28 0.8 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 108.907 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -68.2 -34.11 75.67 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.355 -173.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.07 -7.06 70.07 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.76 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.441 HD11 ' HA ' ' A' ' 36' ' ' CYS . 43.8 mt -131.21 -3.08 3.92 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 111.811 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -62.83 108.64 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.831 -1.168 . . . . 0.0 109.127 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.24 67.01 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.78 1.181 . . . . 0.0 113.14 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -64.57 177.36 0.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.295 1.547 . . . . 0.0 109.429 165.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -131.92 89.97 2.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -167.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -80.45 13.38 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.905 -0.497 . . . . 0.0 112.119 -168.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.08 -84.45 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.152 3.381 . . . . 0.0 103.288 156.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -147.06 18.92 1.25 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.426 -0.796 . . . . 0.0 112.022 -168.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 -132.86 171.7 13.58 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.748 -1.22 . . . . 0.0 110.338 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 t -87.3 109.56 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -73.17 124.56 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.69 163.62 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 p -132.88 163.29 29.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.186 2.194 . . . . 0.0 108.753 -168.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -164.6 158.9 18.48 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 130.127 3.371 . . . . 0.0 105.578 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.11 145.3 31.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 157.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.61 -164.3 1.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.01 1.324 . . . . 0.0 109.67 172.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -109.92 144.83 30.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 157.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.42 -19.55 10.19 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.825 3.016 . . . . 0.0 111.708 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -57.0 -59.28 5.29 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.991 -1.068 . . . . 0.0 108.611 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.4 m -70.01 -0.78 8.14 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.254 2.222 . . . . 0.0 111.9 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 65' ' ' GLU . 45.8 t80 -91.06 -48.32 7.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.412 1.485 . . . . 0.0 110.522 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -68.9 -45.6 70.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.102 0.961 . . . . 0.0 109.342 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -76.29 170.89 15.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.078 0.942 . . . . 0.0 109.222 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -101.49 68.11 1.17 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.56 74.89 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.93 1.348 . . . . 0.0 108.778 169.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -98.64 110.62 23.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.7 t90 . . . . . 0 C--O 1.257 1.457 0 C-N-CA 127.472 2.309 . . . . 0.0 105.626 174.065 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.859 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.61 -96.94 1.75 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 151.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -144.33 165.44 23.47 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.795 1.638 . . . . 0.0 109.944 -172.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.63 136.51 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.678 2.252 . . . . 0.0 108.705 166.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -140.82 171.28 14.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.49 -2.57 14.4 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.19 -0.944 . . . . 0.0 113.056 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.552 HG22 ' OE1' ' A' ' 65' ' ' GLU . 14.8 t -107.44 92.55 2.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.657 1.183 . . . . 0.0 108.439 -167.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.63 125.88 29.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.59 124.06 35.46 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -123.82 111.24 15.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.271 1.034 . . . . 0.0 109.585 175.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mtm -84.55 166.49 17.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.73 0.812 . . . . 0.0 109.778 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 70.1 14.69 7.72 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.718 2.007 . . . . 0.0 113.033 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -58.63 7.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.45 163.34 24.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.534 1.134 . . . . 0.0 111.709 -161.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -103.4 163.68 16.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.052 2.141 . . . . 0.0 109.35 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.03 4.88 4.36 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.892 2.394 . . . . 0.0 113.247 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.55 14.83 11.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.831 1.252 . . . . 0.0 111.506 -171.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.47 24.04 2.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.377 1.071 . . . . 0.0 111.123 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.7 mt -133.2 37.43 3.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.438 1.895 . . . . 0.0 109.82 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -113.58 -5.62 13.41 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.274 1.029 . . . . 0.0 111.245 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.38 127.51 53.75 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.94 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.92 -12.72 60.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.89 0.876 . . . . 0.0 111.269 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.19 -59.31 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.039 0.936 . . . . 0.0 108.728 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.67 -36.98 77.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.057 1.743 . . . . 0.0 111.136 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -52.62 -48.55 66.27 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.928 1.291 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.2 -36.47 66.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.911 0.778 . . . . 0.0 110.221 -172.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -60.39 -49.32 78.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.394 0.678 . . . . 0.0 109.415 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -63.22 -41.18 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.1 t -56.18 -48.25 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.459 1.027 . . . . 0.0 110.045 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.31 -31.39 60.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.954 1.252 . . . . 0.0 112.924 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.83 -45.52 74.44 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.603 0.716 . . . . 0.0 110.609 176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.8 t -72.55 -41.82 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -30.65 38.19 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.105 0.866 . . . . 0.0 110.349 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.67 -36.49 67.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 120.344 1.429 . . . . 0.0 113.189 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.32 -43.13 98.67 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.261 0.9 OUTLIER -79.94 -17.47 52.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -53.28 -29.57 33.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.052 1.741 . . . . 0.0 110.69 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -59.46 -20.35 54.52 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.264 -0.898 . . . . 0.0 112.44 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -125.64 51.64 1.71 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.111 1.365 . . . . 0.0 108.35 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.57 -116.12 2.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 125.269 1.414 . . . . 0.0 110.377 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 67' ' ' THR . 1.3 tm? -154.47 113.13 3.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.82 116.22 21.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.036 1.734 . . . . 0.0 107.433 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -69.31 -57.82 4.82 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.085 0.554 . . . . 0.0 109.685 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.46 166.36 25.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 0.0 109.639 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 111.58 27.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 125.748 1.619 . . . . 0.0 107.11 -169.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.24 124.81 30.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.599 0.76 . . . . 0.0 109.965 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.94 85.48 22.97 Favored Pre-proline 0 C--O 1.225 -0.234 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.1 -15.15 42.56 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.52 2.146 . . . . 0.0 114.784 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.347 0.0 OUTLIER 60.41 160.86 0.11 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 128.767 2.827 . . . . 0.0 116.438 172.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.14 177.8 2.3 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.812 3.008 . . . . 0.0 110.33 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 t -129.5 115.13 33.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 168.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.5 t70 54.72 28.91 10.79 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.777 2.431 . . . . 0.0 114.582 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.18 -8.45 67.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.783 1.659 . . . . 0.0 113.291 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.84 146.56 6.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 125.031 1.333 . . . . 0.0 108.949 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.9 145.79 55.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.525 1.13 . . . . 0.0 111.842 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.51 156.19 79.02 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.145 1.778 . . . . 0.0 109.801 172.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.7 128.58 17.24 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.048 1.832 . . . . 0.0 108.765 169.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.01 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 127.055 2.264 . . . . 0.0 111.973 -175.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.28 130.57 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.296 1.548 . . . . 0.0 111.036 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.07 -13.66 66.43 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.768 1.651 . . . . 0.0 113.482 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.17 122.89 40.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.45 148.72 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 167.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.37 127.49 46.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG12 HD11 ' A' ' 10' ' ' LEU . 10.1 p -121.73 119.79 59.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -174.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.552 ' OE1' HG22 ' A' ' 7' ' ' VAL . 1.5 tp10 -88.58 150.61 22.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.674 1.59 . . . . 0.0 107.645 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -132.93 162.99 30.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.405 1.082 . . . . 0.0 110.547 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 41' ' ' LEU . 7.4 p -72.55 -6.5 44.4 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -154.28 157.3 38.48 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 120.203 1.365 . . . . 0.0 113.137 162.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.21 -16.79 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 112.107 167.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -94.24 -18.85 21.26 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.424 -1.423 . . . . 0.0 112.137 -175.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -85.03 -41.98 15.28 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.285 0.634 . . . . 0.0 110.271 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 p -62.65 -31.92 72.88 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.647 -0.658 . . . . 0.0 110.818 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -63.91 -13.91 49.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 113.206 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -95.73 -41.2 8.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 120.315 1.416 . . . . 0.0 108.488 172.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.11 45.69 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.024 0.929 . . . . 0.0 111.621 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -59.45 -31.69 69.54 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -162.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.86 -40.15 9.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.711 2.405 . . . . 0.0 110.327 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.92 -25.57 67.98 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 121.731 -0.606 . . . . 0.0 112.285 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -124.72 22.52 8.2 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.94 2.096 . . . . 0.0 110.29 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.2 m -56.87 127.47 31.89 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.277 -0.889 . . . . 0.0 109.092 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.65 5.8 64.96 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 118.628 -1.096 . . . . 0.0 112.975 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -173.65 0.17 Allowed 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.612 1.706 . . . . 0.0 110.17 176.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -124.19 121.21 34.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.8 14.06 22.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.181 0.991 . . . . 0.0 110.965 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.19 -66.45 0.09 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.67 -25.78 0.14 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.169 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -105.99 172.39 6.83 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.635 1.174 . . . . 0.0 110.452 -169.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.06 118.14 28.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.41 155.09 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.426 1.09 . . . . 0.0 109.628 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.69 147.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 158.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.71 144.43 42.97 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.543 1.937 . . . . 0.0 106.799 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -147.87 145.05 28.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.049 1.74 . . . . 0.0 107.936 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -64.79 138.13 58.2 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 164.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -165.83 1.05 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.543 1.937 . . . . 0.0 107.752 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.62 144.12 52.01 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.413 ' HA ' HG21 ' A' ' 7' ' ' VAL . 72.0 Cg_endo -78.7 -21.27 10.0 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.17 2.58 . . . . 0.0 111.644 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -49.66 -55.41 13.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -42.13 96.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.949 0.9 . . . . 0.0 109.538 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -64.54 -38.81 92.29 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.277 1.031 . . . . 0.0 112.537 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -63.33 -4.38 2.58 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.339 -0.851 . . . . 0.0 112.977 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -137.9 -173.89 3.63 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 127.675 2.39 . . . . 0.0 108.43 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.477 ' HA ' ' CE1' ' A' ' 104' ' ' PHE . 7.7 mpt_? -123.35 68.72 1.01 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -125.36 27.17 6.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.716 1.206 . . . . 0.0 112.494 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -62.38 162.47 9.99 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.878 0.871 . . . . 0.0 109.547 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.7 t90 . . . . . 0 C--O 1.249 1.041 0 C-N-CA 124.248 1.019 . . . . 0.0 109.212 172.606 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.435 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.81 -168.62 23.87 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -172.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -60.65 158.07 33.71 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.192 0.597 . . . . 0.0 111.026 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.78 143.48 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.772 1.648 . . . . 0.0 108.751 162.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -120.32 174.37 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.962 1.305 . . . . 0.0 107.738 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.22 -5.02 55.45 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.071 0.948 . . . . 0.0 113.161 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.78 -175.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 118.856 0.753 . . . . 0.0 109.985 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.41 155.15 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.312 1.845 . . . . 0.0 106.733 164.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.3 t -113.11 136.77 52.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 169.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.1 mt -129.85 95.48 3.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.152 2.181 . . . . 0.0 107.384 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.8 mtm -87.65 157.82 19.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 66.45 30.07 8.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.69 1.596 . . . . 0.0 112.751 171.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttm -81.28 -82.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 162.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.9 m -93.73 146.38 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.822 1.649 . . . . 0.0 110.437 -162.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.74 155.04 42.13 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.253 1.021 . . . . 0.0 109.371 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.64 4.26 2.24 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.334 2.69 . . . . 0.0 113.667 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.41 6.03 8.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.986 1.714 . . . . 0.0 111.863 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -124.05 -8.56 7.7 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.907 0.883 . . . . 0.0 112.82 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.96 63.73 7.2 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.089 -1.007 . . . . 0.0 109.491 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.93 -39.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.058 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.28 100.94 0.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.373 1.069 . . . . 0.0 109.89 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.77 -2.98 0.17 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 130.219 3.408 . . . . 0.0 114.938 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.23 -54.77 1.69 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.789 2.836 . . . . 0.0 108.651 -164.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.27 -41.75 98.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.761 1.225 . . . . 0.0 111.704 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -46.98 -40.47 14.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.466 1.506 . . . . 0.0 110.854 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.91 -25.91 40.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -63.53 -52.68 60.13 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.641 1.176 . . . . 0.0 108.954 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.31 -34.97 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.405 1.082 . . . . 0.0 110.087 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.73 -47.1 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.3 0.64 . . . . 0.0 110.141 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.36 -37.69 74.64 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.688 1.131 . . . . 0.0 112.117 -172.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.18 -38.44 91.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.23 1.015 . . . . 0.0 110.505 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.36 -33.18 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 109.763 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -66.39 -32.79 74.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.95 -54.53 37.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 110.623 171.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -63.66 -37.55 87.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.812 0.815 . . . . 0.0 111.245 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.25 -22.71 57.65 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.376 1.07 . . . . 0.0 110.543 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 t -72.37 -7.51 50.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.271 1.029 . . . . 0.0 111.282 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -73.47 -9.54 58.8 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 119.351 -2.093 . . . . 0.0 112.29 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.04 1.12 9.21 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.719 1.145 . . . . 0.0 112.668 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.12 -164.93 28.61 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 106.129 -2.788 . . . . 0.0 106.129 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -108.27 108.67 19.77 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.277 1.539 . . . . 0.0 109.984 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.67 116.05 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -55.26 -74.67 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.819 2.048 . . . . 0.0 107.024 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -174.29 4.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.259 1.024 . . . . 0.0 109.123 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.86 143.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.585 1.954 . . . . 0.0 107.145 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -130.3 118.35 21.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.211 1.404 . . . . 0.0 109.301 -172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.4 mt -131.31 86.84 49.23 Favored Pre-proline 0 C--O 1.234 0.242 0 C-N-CA 125.924 1.69 . . . . 0.0 107.921 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -55.79 124.94 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 167.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.85 47.93 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.386 . . . . 0.0 108.926 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -67.58 148.18 77.91 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.818 2.345 . . . . 0.0 109.792 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.72 167.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.656 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.08 86.87 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 128.144 2.578 . . . . 0.0 106.69 171.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.4 7.24 79.78 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-O 117.478 -1.734 . . . . 0.0 113.193 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.06 132.16 70.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 120.577 2.188 . . . . 0.0 108.724 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.95 170.39 6.79 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 122.101 0.953 . . . . 0.0 108.83 170.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.06 145.99 43.09 Favored Pre-proline 0 N--CA 1.446 -0.645 0 C-N-CA 125.32 1.448 . . . . 0.0 107.76 164.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.71 143.15 50.16 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 N-CA-C 107.764 -1.668 . . . . 0.0 107.764 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.6 80.09 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 121.953 -0.467 . . . . 0.0 113.168 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.25 156.99 37.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.482 0.713 . . . . 0.0 110.572 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.91 7.12 88.78 Favored Glycine 0 C--O 1.24 0.501 0 C-N-CA 123.758 0.694 . . . . 0.0 112.922 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 171.72 13.85 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 118.18 0.99 . . . . 0.0 109.589 165.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -121.83 156.03 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.99 150.1 39.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.49 155.19 28.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.89 144.97 45.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -172.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.75 168.32 10.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.941 0.877 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 -20.58 65.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.809 1.244 . . . . 0.0 112.918 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.9 t -163.19 155.82 18.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.56 1.073 . . . . 0.0 110.323 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.0 t -51.91 -40.01 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.6 1.96 . . . . 0.0 110.307 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -75.49 -12.24 60.19 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 119.435 -2.04 . . . . 0.0 114.115 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -93.16 -41.6 9.83 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.541 1.136 . . . . 0.0 109.364 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.42 -40.58 96.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -51.4 -10.48 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 130.135 3.374 . . . . 0.0 114.733 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -97.35 -41.91 8.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.966 1.257 . . . . 0.0 109.488 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.65 87.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.71 0.804 . . . . 0.0 112.625 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -43.32 63.78 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.768 2.427 . . . . 0.0 112.947 -162.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -98.66 -31.15 12.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.061 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.79 -9.18 58.78 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.921 0.782 . . . . 0.0 113.947 -170.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -123.7 3.55 8.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.203 1.401 . . . . 0.0 112.356 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -71.96 142.74 49.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.02 -3.04 82.2 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.076 -1.015 . . . . 0.0 112.731 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -63.69 175.17 1.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.284 1.542 . . . . 0.0 110.367 170.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -125.75 96.15 4.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -83.19 13.64 4.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.415 0.626 . . . . 0.0 111.631 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.0 -77.97 0.05 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.675 2.39 . . . . 0.0 104.658 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.8 -22.9 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.071 0.948 . . . . 0.0 113.368 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -92.49 166.92 12.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.548 -0.72 . . . . 0.0 110.956 -172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.94 109.79 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.0 t -82.16 146.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.204 1.402 . . . . 0.0 110.654 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -128.93 118.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 p -72.06 159.93 33.35 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.347 1.07 . . . . 0.0 110.493 170.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -156.47 159.74 38.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.989 2.516 . . . . 0.0 105.739 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -74.67 159.39 32.14 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.504 160.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.82 -164.58 1.36 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 108.527 163.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -114.47 144.52 31.95 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.67 -27.94 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.422 2.748 . . . . 0.0 112.927 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.74 -42.05 95.48 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 120.741 -1.224 . . . . 0.0 110.688 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -72.81 -19.5 61.32 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.55 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.47 -45.53 53.65 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.004 2.122 . . . . 0.0 111.444 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -63.05 -8.12 6.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.797 0.839 . . . . 0.0 111.757 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -134.41 -163.63 1.4 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.441 2.696 . . . . 0.0 106.987 -163.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.75 39.72 3.82 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.344 1.057 . . . . 0.0 109.132 -173.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.53 42.93 2.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.005 1.322 . . . . 0.0 111.331 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -67.84 173.06 4.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 109.043 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.3 t90 . . . . . 0 C--O 1.248 0.999 0 O-C-N 121.012 -1.055 . . . . 0.0 109.265 169.948 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.711 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.66 131.4 2.26 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -172.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -68.97 152.44 96.81 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 164.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.12 146.75 52.65 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.515 2.143 . . . . 0.0 108.708 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 p -137.25 166.74 23.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.31 2.55 21.04 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.91 88.56 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.61 117.34 7.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.803 1.241 . . . . 0.0 108.429 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -84.48 143.04 29.63 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.454 ' CD2' HG22 ' A' ' 91' ' ' THR . 76.5 mt -135.45 156.13 49.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 109.388 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.56 165.47 26.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 107.752 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 60.4 26.97 16.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.606 ' HB2' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -72.31 -74.22 0.17 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 157.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.681 HG11 HD21 ' A' ' 19' ' ' LEU . 33.7 m -92.5 172.45 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 124.402 1.081 . . . . 0.0 110.733 -163.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -125.6 157.63 67.68 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.69 0.85 4.32 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 121.884 1.723 . . . . 0.0 112.824 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -123.22 12.39 9.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.851 2.06 . . . . 0.0 112.665 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -139.44 22.38 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.998 -1.064 . . . . 0.0 112.021 -169.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.681 HD21 HG11 ' A' ' 14' ' ' VAL . 90.2 mt -109.72 6.37 23.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.675 1.19 . . . . 0.0 113.004 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.29 -29.87 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.501 -0.749 . . . . 0.0 111.156 -166.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.11 110.14 3.84 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.14 1.376 . . . . 0.0 108.562 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.26 -36.09 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.691 0.797 . . . . 0.0 110.056 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.89 -64.69 0.81 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.871 0.868 . . . . 0.0 110.0 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.42 -35.21 71.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.886 0.474 . . . . 0.0 112.001 -172.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' O ' HG23 ' A' ' 29' ' ' VAL . 25.8 t80 -52.59 -44.21 65.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.515 1.126 . . . . 0.0 111.71 170.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -74.8 -34.11 62.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.375 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.35 -53.92 51.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.359 1.063 . . . . 0.0 108.631 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.38 -42.63 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.368 1.067 . . . . 0.0 110.42 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 25' ' ' TYR . 51.4 t -60.67 -32.7 52.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 124.123 0.969 . . . . 0.0 111.316 -176.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.98 -49.49 19.77 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 123.21 0.319 . . . . 0.0 110.537 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.11 -38.57 83.41 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.477 1.132 . . . . 0.0 109.588 -175.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.44 HG13 ' CE2' ' A' ' 84' ' ' PHE . 41.4 t -73.36 -36.31 48.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 121.547 -0.721 . . . . 0.0 110.12 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -59.5 -44.76 93.01 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.374 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -65.9 -42.02 90.75 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.712 0.687 . . . . 0.0 111.895 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -67.87 -34.95 77.67 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.395 -172.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.496 ' HB3' HG21 ' A' ' 42' ' ' VAL . 7.4 t -78.11 -32.75 50.65 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.339 1.056 . . . . 0.0 110.709 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -56.73 -14.66 3.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.348 1.459 . . . . 0.0 112.039 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -61.54 -19.24 61.9 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.099 -2.25 . . . . 0.0 113.269 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.58 -6.6 13.39 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.862 1.265 . . . . 0.0 112.595 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.39 -151.81 20.8 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -167.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -129.31 108.34 10.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 36' ' ' CYS . 28.6 t -72.7 115.79 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -81.8 -50.99 8.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.805 2.042 . . . . 0.0 109.39 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.0 p -153.99 169.83 22.53 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.053 0.941 . . . . 0.0 110.208 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.4 mt -141.4 116.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.57 131.6 34.33 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 110.384 170.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.93 87.02 25.38 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.932 1.693 . . . . 0.0 107.738 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.69 154.5 68.88 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.78 1.653 . . . . 0.0 109.234 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.8 155.55 62.94 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.164 0.986 . . . . 0.0 111.548 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.43 132.24 37.43 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.967 3.112 . . . . 0.0 110.261 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.3 t -81.34 104.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t0 57.97 24.28 10.86 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 170.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.04 60.97 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 128.18 2.8 . . . . 0.0 115.306 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 p -66.77 158.64 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.056 1.428 . . . . 0.0 111.601 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -71.78 132.58 44.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.143 159.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.15 161.26 32.09 Favored Pre-proline 0 C--O 1.241 0.637 0 C-N-CA 124.947 1.299 . . . . 0.0 111.305 167.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.14 137.68 34.9 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.635 2.224 . . . . 0.0 108.412 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.82 9.19 85.78 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.767 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.54 140.66 53.89 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.036 0.918 . . . . 0.0 109.829 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.95 -32.42 6.64 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.28 1.895 . . . . 0.0 111.926 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' C ' HD12 ' A' ' 62' ' ' ILE . 6.5 mptt -85.17 152.5 23.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -174.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.606 HD13 ' HB2' ' A' ' 13' ' ' MET . 2.0 mp -123.52 146.65 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 169.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.08 120.68 25.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -118.72 106.94 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -79.23 142.74 35.97 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.404 1.481 . . . . 0.0 107.889 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -121.79 177.25 5.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.356 1.063 . . . . 0.0 111.596 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.0 p -72.05 -26.76 62.31 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.721 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.7 m -153.89 159.45 41.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.504 1.621 . . . . 0.0 112.964 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.26 -12.58 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 120.588 -1.32 . . . . 0.0 111.383 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -95.9 -21.12 18.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.313 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.59 -29.98 14.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.873 1.669 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.8 p -60.4 -35.28 75.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.172 0.511 . . . . 0.0 110.4 168.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -24.06 66.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.977 1.711 . . . . 0.0 112.413 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -86.98 -46.03 10.22 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.3 68.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.884 0.874 . . . . 0.0 110.448 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -57.13 -39.41 75.11 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.056 0.389 . . . . 0.0 111.818 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -74.91 -45.83 40.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.128 -0.358 . . . . 0.0 111.04 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.16 -21.46 61.75 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.921 -0.377 . . . . 0.0 112.41 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.14 18.66 4.95 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.865 1.266 . . . . 0.0 111.858 -163.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -70.44 23.79 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 O-C-N 120.073 -1.642 . . . . 0.0 114.017 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.09 3.33 0.03 OUTLIER Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.967 1.746 . . . . 0.0 115.068 -166.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -173.68 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.938 1.869 . . . . 0.0 111.931 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -133.64 81.57 1.93 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.393 0.677 . . . . 0.0 109.538 -168.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.44 ' CE2' HG13 ' A' ' 32' ' ' VAL . 3.6 m-30 -74.94 14.02 0.58 Allowed 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.334 -0.854 . . . . 0.0 113.165 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.35 -85.04 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.663 2.385 . . . . 0.0 105.415 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.72 -5.39 1.04 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.8 OUTLIER -97.77 176.92 5.64 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.786 1.176 . . . . 0.0 108.655 -174.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -82.51 136.9 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.42 164.39 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 124.727 1.211 . . . . 0.0 108.825 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -138.48 139.37 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 10' ' ' LEU . 34.7 p -96.61 165.55 12.1 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.181 0.9 . . . . 0.0 110.983 175.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -153.36 154.53 34.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.921 1.688 . . . . 0.0 108.247 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -80.9 141.21 34.8 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 158.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.73 -168.16 1.28 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.823 1.649 . . . . 0.0 108.847 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -121.03 145.25 41.25 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.494 1.118 . . . . 0.0 107.983 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.29 -22.41 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.626 2.884 . . . . 0.0 114.15 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.31 -47.1 76.1 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.777 1.626 . . . . 0.0 109.537 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 p -77.06 2.1 16.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.843 1.257 . . . . 0.0 111.795 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -94.11 -41.12 9.69 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.641 1.577 . . . . 0.0 109.083 165.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -64.35 -24.7 67.74 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 112.135 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -126.39 165.7 18.56 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 126.434 1.894 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -75.68 23.62 0.12 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.363 1.865 . . . . 0.0 112.566 -175.217 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -91.28 40.33 1.03 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.351 -1.468 . . . . 0.0 112.405 -160.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 7.0 m-85 -73.53 12.3 0.65 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.213 2.205 . . . . 0.0 115.779 -165.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 . . . . . 0 C--O 1.241 0.652 0 C-N-CA 126.044 1.737 . . . . 0.0 110.983 -166.895 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.573 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.97 -177.86 44.36 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 122.089 0.827 . . . . 0.0 112.945 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -159.08 161.12 28.55 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 129.379 3.071 . . . . 0.0 107.08 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HA ' ' CG ' ' A' ' 93' ' ' TYR . 20.4 Cg_endo -64.29 141.17 74.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.405 2.07 . . . . 0.0 112.143 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.1 p -133.57 -178.79 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.437 1.895 . . . . 0.0 108.149 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.02 -7.3 21.53 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.374 -1.298 . . . . 0.0 113.656 171.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.33 149.57 25.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 121.036 1.743 . . . . 0.0 110.859 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD13 ' SD ' ' A' ' 76' ' ' MET . 13.2 tp -124.72 119.03 27.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.744 2.418 . . . . 0.0 107.24 -170.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.84 145.78 25.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.086 0.554 . . . . 0.0 109.762 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.9 mt -136.55 120.41 17.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.286 1.435 . . . . 0.0 109.676 -167.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -106.52 156.64 18.36 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 75.44 23.6 1.48 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.48 2.312 . . . . 0.0 113.693 170.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -81.84 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 163.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG11 HD21 ' A' ' 19' ' ' LEU . 15.0 m -87.84 172.79 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.875 1.67 . . . . 0.0 111.764 -159.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 mt -126.32 158.1 68.04 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.409 1.483 . . . . 0.0 109.762 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.11 2.59 5.94 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.141 1.894 . . . . 0.0 113.103 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -128.63 18.55 6.27 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.966 1.706 . . . . 0.0 111.297 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -137.44 33.36 2.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.568 1.147 . . . . 0.0 111.152 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD21 HG11 ' A' ' 14' ' ' VAL . 95.2 mt -130.22 39.28 3.68 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 127.202 2.201 . . . . 0.0 109.406 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.97 -33.4 6.51 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.677 0.791 . . . . 0.0 110.579 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 94.94 1.68 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.42 1.088 . . . . 0.0 110.176 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.85 -36.29 58.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.968 2.107 . . . . 0.0 111.25 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -72.66 -55.31 7.03 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.716 0.407 . . . . 0.0 110.114 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -63.35 -36.44 83.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.339 0.655 . . . . 0.0 109.732 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -45.95 -48.69 16.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.994 0.918 . . . . 0.0 111.153 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.7 -28.19 50.9 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.929 -0.482 . . . . 0.0 112.172 -167.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -64.39 -55.54 20.36 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.597 1.559 . . . . 0.0 109.59 167.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.86 -36.24 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.75 0.82 . . . . 0.0 110.554 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.1 t -59.07 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 118.768 0.713 . . . . 0.0 109.228 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.46 -38.54 74.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.771 0.714 . . . . 0.0 111.315 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -70.94 -33.82 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.046 -175.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.96 -37.65 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -57.58 -36.29 71.5 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.707 1.139 . . . . 0.0 110.24 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.31 -29.57 68.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.759 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -68.79 -45.18 71.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.468 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.603 ' HA ' HD11 ' A' ' 79' ' ' LEU 0.267 0.8 OUTLIER -69.33 -26.53 64.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 172.8 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.3 t -62.77 -14.82 49.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.95 1.3 . . . . 0.0 111.887 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -62.68 -11.12 15.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 119.556 -1.965 . . . . 0.0 114.456 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.57 -0.64 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.501 1.046 . . . . 0.0 112.985 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.4 -174.37 41.89 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -94.74 111.9 23.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.6 t -71.78 109.6 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -62.85 -52.06 64.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.982 178.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -167.87 172.23 9.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.936 1.694 . . . . 0.0 110.578 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.437 HG23 HG22 ' A' ' 64' ' ' VAL . 13.8 mt -135.58 145.89 30.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.42 125.45 47.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.517 1.927 . . . . 0.0 109.443 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.15 86.92 12.62 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.098 1.759 . . . . 0.0 107.697 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.3 140.18 30.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.774 2.316 . . . . 0.0 108.839 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mtm-85 -116.06 146.28 36.75 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.326 1.05 . . . . 0.0 108.77 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.38 131.48 23.36 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.244 1.962 . . . . 0.0 108.555 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.717 HG12 ' HB ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -69.64 167.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.134 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 85.05 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 128.933 2.893 . . . . 0.0 108.138 173.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.22 -16.33 22.47 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 126.514 2.007 . . . . 0.0 112.74 173.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.717 ' HB ' HG12 ' A' ' 51' ' ' VAL . 2.2 t -122.88 129.6 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.81 1.305 . . . . 0.0 111.276 -174.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -66.02 169.42 6.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.095 0.95 . . . . 0.0 110.832 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.18 154.37 42.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 126.22 1.808 . . . . 0.0 110.013 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.94 111.28 3.23 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.845 2.363 . . . . 0.0 108.341 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.54 58.82 6.13 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.5 t -72.18 154.2 41.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.82 58.38 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 124.784 1.183 . . . . 0.0 112.908 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 168.2 10.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.501 1.651 . . . . 0.0 108.276 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.81 143.54 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.32 141.86 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG22 HG23 ' A' ' 45' ' ' ILE . 96.0 t -134.12 104.52 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -167.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -83.95 135.1 34.6 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.59 173.39 6.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 126.717 2.007 . . . . 0.0 108.423 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.9 t -92.57 -9.85 39.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.562 -176.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -154.53 155.88 35.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 121.261 1.846 . . . . 0.0 111.882 166.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 t -67.02 -24.93 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.078 1.351 . . . . 0.0 109.728 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -60.56 -59.32 5.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.571 1.148 . . . . 0.0 109.502 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.79 -45.84 59.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.42 1.488 . . . . 0.0 109.632 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.1 t -62.48 -50.56 70.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.369 1.067 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -56.4 -34.87 67.14 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.059 0.943 . . . . 0.0 112.33 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.48 -42.95 33.94 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.91 0.777 . . . . 0.0 109.679 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.42 79.74 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.175 0.99 . . . . 0.0 110.51 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.559 ' SD ' HD13 ' A' ' 8' ' ' LEU . 4.3 mmm -44.76 -66.48 0.39 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.126 1.371 . . . . 0.0 110.12 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.69 -39.31 88.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.959 0.503 . . . . 0.0 111.226 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -36.45 93.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.959 0.79 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 36' ' ' CYS . 54.8 mt -104.91 3.48 30.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.417 1.087 . . . . 0.0 110.892 -168.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.2 m -61.2 110.56 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.943 0.897 . . . . 0.0 109.659 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.73 19.44 73.28 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.387 0.539 . . . . 0.0 113.05 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -66.44 -178.64 0.7 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.761 1.28 . . . . 0.0 110.701 162.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -130.43 96.15 4.06 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.07 14.01 9.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.684 0.754 . . . . 0.0 111.898 -167.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -156.42 -66.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 161.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.86 -16.65 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -121.72 168.13 12.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.143 0.977 . . . . 0.0 111.637 -167.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.59 114.44 5.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.658 0.783 . . . . 0.0 109.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.25 150.86 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.349 1.06 . . . . 0.0 109.866 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.7 t -121.7 139.25 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 162.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -115.69 130.49 56.88 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.707 2.003 . . . . 0.0 108.554 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -132.9 171.18 14.28 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 119.778 1.172 . . . . 0.0 110.579 161.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 76' ' ' MET . 86.8 m-85 -82.89 147.82 28.06 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 -163.76 1.13 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.842 1.257 . . . . 0.0 109.745 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.49 143.47 29.0 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.26 -28.18 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.709 2.272 . . . . 0.0 111.793 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.35 -50.54 73.58 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.59 -1.319 . . . . 0.0 110.166 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.4 p -70.56 -7.28 42.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.075 1.75 . . . . 0.0 111.073 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.19 -45.92 9.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.161 1.784 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -64.3 -44.52 91.37 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.515 0.674 . . . . 0.0 109.863 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -77.98 172.78 12.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 109.119 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.491 ' HG3' ' CE2' ' A' ' 104' ' ' PHE . 50.2 ttp180 -103.96 72.62 1.11 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 164.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -123.37 61.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.917 0.865 . . . . 0.0 109.66 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CE2' ' HG3' ' A' ' 102' ' ' ARG . 4.9 m-30 -86.84 -162.28 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.254 1.821 . . . . 0.0 109.856 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 130.191 3.396 . . . . 0.0 109.112 -171.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.512 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -82.49 -123.16 0.75 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 171.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -63.2 165.04 11.73 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.277 1.431 . . . . 0.0 112.19 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.39 126.33 13.43 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.072 1.848 . . . . 0.0 108.661 156.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -103.23 177.1 4.93 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HG2' HG22 ' A' ' 69' ' ' VAL . 25.8 mt-10 -81.9 3.58 25.68 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.571 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 94' ' ' CYS . 2.4 m -124.42 156.03 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.739 1.154 . . . . 0.0 108.729 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 76' ' ' MET . 23.2 tp -136.37 122.3 20.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.985 1.714 . . . . 0.0 107.713 -168.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -81.22 139.11 35.7 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.1 mt -128.62 95.25 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.863 2.465 . . . . 0.0 107.4 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mtm -92.63 155.69 17.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 75.2 23.69 1.55 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 114.265 170.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -84.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 161.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.4 163.18 3.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 111.184 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.9 158.42 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.002 1.321 . . . . 0.0 109.841 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.82 -2.66 9.0 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.929 2.419 . . . . 0.0 113.316 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.21 2.13 11.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.572 1.949 . . . . 0.0 111.187 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -104.87 -30.34 9.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 118.669 0.668 . . . . 0.0 112.199 169.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.99 49.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.011 2.124 . . . . 0.0 113.396 -161.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 -10.56 6.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.203 1.801 . . . . 0.0 111.674 -169.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.4 122.19 38.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.006 0.923 . . . . 0.0 110.297 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.18 -15.63 63.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.254 1.422 . . . . 0.0 112.705 -168.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -78.85 -63.16 1.48 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.429 1.492 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.79 -35.65 66.52 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 109.937 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -55.97 -38.43 70.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.611 0.764 . . . . 0.0 112.166 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -80.36 -36.65 33.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.647 0.779 . . . . 0.0 110.678 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -56.72 -45.14 82.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.525 0.679 . . . . 0.0 109.9 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.89 -33.31 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.387 1.075 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.33 -44.65 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.287 -0.883 . . . . 0.0 108.718 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.06 -39.52 86.91 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.809 0.732 . . . . 0.0 110.531 -173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.7 -36.29 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.993 1.378 . . . . 0.0 111.487 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.62 -28.52 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.621 1.568 . . . . 0.0 109.944 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -44.62 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.52 -0.738 . . . . 0.0 109.343 170.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.44 -44.58 92.89 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.524 0.678 . . . . 0.0 111.354 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -43.76 50.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.856 -166.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -83.36 -17.98 40.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.505 -1.278 . . . . 0.0 110.331 -167.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -65.62 -15.62 62.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 110.783 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -63.24 -12.57 29.8 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.787 -1.196 . . . . 0.0 111.212 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.649 1.579 . . . . 0.0 112.935 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.33 26.34 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 120.105 1.321 . . . . 0.0 110.784 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.0 tm? -119.77 111.58 18.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.512 1.525 . . . . 0.0 107.965 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.04 114.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -53.83 -61.36 2.36 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 109.242 166.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 t -160.23 177.35 10.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.153 0.888 . . . . 0.0 111.558 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.98 135.04 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.671 2.388 . . . . 0.0 106.087 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -125.98 106.92 9.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.231 1.013 . . . . 0.0 112.995 -167.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.31 85.93 59.84 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 127.376 2.27 . . . . 0.0 108.334 -165.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.46 138.81 61.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.553 1.502 . . . . 0.0 109.8 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 162.42 19.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 126.567 1.947 . . . . 0.0 110.471 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.05 169.77 1.83 Allowed 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 124.47 3.446 . . . . 0.0 111.977 165.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.452 ' H ' HG12 ' A' ' 54' ' ' VAL . 26.2 t -133.17 107.04 10.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t0 52.46 33.03 12.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.284 1.034 . . . . 0.0 112.232 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.49 6.78 88.87 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.987 2.232 . . . . 0.0 115.585 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 51' ' ' VAL . 1.4 p -58.15 157.47 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 118.402 1.101 . . . . 0.0 111.353 174.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.29 113.05 20.43 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 156.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.81 145.64 29.95 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.529 1.132 . . . . 0.0 110.011 167.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.06 133.36 33.01 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.972 2.448 . . . . 0.0 108.593 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.45 0.36 70.14 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -71.75 155.05 40.9 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.574 1.687 . . . . 0.0 110.049 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.59 -1.12 79.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.034 0.826 . . . . 0.0 113.203 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 170.86 7.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 120.226 2.013 . . . . 0.0 109.316 168.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.0 mt -134.82 154.37 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -119.0 166.2 13.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 158.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 p -139.07 152.7 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -132.08 139.13 48.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.14 164.32 11.9 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 108.326 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.8 t -87.15 0.95 54.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.827 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.9 p -154.68 148.38 25.41 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.548 1.067 . . . . 0.0 109.808 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 6' ' ' GLU . 1.8 t -60.13 -34.85 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.092 0.557 . . . . 0.0 109.587 176.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -76.96 -23.71 52.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.69 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.99 -49.61 49.81 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.922 1.237 . . . . 0.0 108.024 166.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.6 t -56.98 -47.0 81.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.219 1.008 . . . . 0.0 109.97 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -57.65 -27.13 62.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.341 1.056 . . . . 0.0 113.339 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -79.46 -54.27 6.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.14 -51.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.269 1.027 . . . . 0.0 110.837 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.559 ' HB2' HD13 ' A' ' 8' ' ' LEU . 2.3 ppp? -59.07 -34.54 72.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.964 0.905 . . . . 0.0 112.434 -170.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.98 -34.48 18.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.62 1.168 . . . . 0.0 110.555 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 -29.83 75.86 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.117 1.341 . . . . 0.0 112.164 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.8 mt -113.29 7.11 17.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.664 1.185 . . . . 0.0 111.619 -168.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -48.66 131.58 17.77 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.11 -2.62 80.55 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.486 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -62.99 176.71 0.67 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.221 1.511 . . . . 0.0 112.019 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -132.17 83.14 2.06 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -78.31 14.5 1.19 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.66 -0.65 . . . . 0.0 111.461 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -156.38 -80.25 0.08 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.695 -2.706 . . . . 0.0 103.695 159.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -145.12 -16.91 0.5 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.114 0.966 . . . . 0.0 113.264 -165.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -100.26 -173.5 2.44 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.591 1.087 . . . . 0.0 109.444 -175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.72 149.9 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 164.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.67 133.83 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.314 1.846 . . . . 0.0 107.391 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.82 138.46 25.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 161.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 p -102.05 151.56 22.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.597 1.559 . . . . 0.0 108.532 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -149.15 156.98 43.0 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.373 1.469 . . . . 0.0 108.408 170.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -76.18 144.63 40.39 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.695 1.589 . . . . 0.0 107.821 160.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.473 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -104.79 -163.93 1.0 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.003 0.921 . . . . 0.0 108.683 171.111 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.78 143.59 28.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 167.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.5 -27.07 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.506 2.138 . . . . 0.0 111.243 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -53.12 60.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -77.22 -10.41 59.4 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.398 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -75.69 -43.65 46.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.175 0.898 . . . . 0.0 110.874 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -62.75 -22.03 66.26 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.634 0.373 . . . . 0.0 111.659 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.4 -177.7 3.2 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.349 1.46 . . . . 0.0 109.714 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 13.4 ttt180 -91.89 30.81 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.734 0.814 . . . . 0.0 111.348 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.82 48.62 1.61 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.99 -1.069 . . . . 0.0 111.997 -162.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 10.3 m-85 -84.82 135.31 34.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.017 -167.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 164.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.625 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.22 -164.42 13.28 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 166.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -58.56 153.85 37.77 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.902 0.881 . . . . 0.0 113.251 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -62.61 151.64 82.32 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.84 2.36 . . . . 0.0 109.312 162.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.7 p -138.95 176.96 8.25 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -75.47 7.94 3.22 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.327 -0.858 . . . . 0.0 111.988 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 t -133.17 107.08 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.121 1.769 . . . . 0.0 111.147 -169.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -100.19 129.37 46.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.735 2.414 . . . . 0.0 106.651 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 49.8 t -81.86 138.37 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.57 122.88 30.04 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.714 2.406 . . . . 0.0 107.47 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.473 ' HB2' HG23 ' A' ' 90' ' ' VAL . 35.3 mtm -135.01 73.94 1.5 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -161.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 174.52 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -51.65 30.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.625 1.17 . . . . 0.0 109.717 -172.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 165.59 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 O-C-N 125.167 1.542 . . . . 0.0 108.914 -174.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' O ' HD21 ' A' ' 19' ' ' LEU . 31.5 mt -100.66 160.68 26.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 170.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -68.46 7.66 0.65 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 126.224 4.616 . . . . 0.0 114.341 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -135.55 3.92 3.07 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.162 1.385 . . . . 0.0 112.739 -159.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' H ' HD22 ' A' ' 19' ' ' LEU . 53.2 mm-40 -126.07 5.68 7.19 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.846 -1.158 . . . . 0.0 112.051 -176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.695 HD22 ' H ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -79.12 10.36 3.62 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.879 2.072 . . . . 0.0 112.93 -176.019 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 50' ' ' PRO . 2.8 mm? -96.16 -17.89 20.51 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.789 2.035 . . . . 0.0 112.698 -168.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 88.17 2.86 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 174.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.34 -26.41 12.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.281 2.632 . . . . 0.0 112.758 -165.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.2 -28.11 69.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.307 1.843 . . . . 0.0 113.406 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -85.76 -36.67 20.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.939 0.896 . . . . 0.0 109.022 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.63 -34.26 69.12 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.82 -40.16 29.16 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.199 1.4 . . . . 0.0 112.073 -173.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -60.23 -45.79 92.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.8 mt -61.06 -31.13 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 123.735 0.814 . . . . 0.0 110.938 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.31 -55.84 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.243 0.929 . . . . 0.0 110.473 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.56 -32.98 72.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.517 1.127 . . . . 0.0 112.487 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.58 -27.3 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.474 1.11 . . . . 0.0 109.776 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -67.96 -34.25 76.21 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.176 -0.952 . . . . 0.0 109.642 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.01 -37.45 55.02 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.635 0.774 . . . . 0.0 112.483 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -50.86 61.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.437 1.017 . . . . 0.0 110.559 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.1 t -70.57 -19.39 62.87 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.783 -0.573 . . . . 0.0 110.914 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.29 3.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.351 1.86 . . . . 0.0 112.955 166.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -68.39 -9.42 48.15 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.918 -1.739 . . . . 0.0 113.863 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.4 1.51 4.58 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.741 0.816 . . . . 0.0 113.139 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.9 -139.46 5.2 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.606 HD12 HG23 ' A' ' 67' ' ' THR . 1.9 tm? -144.13 121.41 11.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.18 1.792 . . . . 0.0 106.232 176.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.1 t -74.13 120.66 23.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 170.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -76.48 -57.89 3.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.006 0.923 . . . . 0.0 109.35 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.32 172.24 18.52 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.056 1.342 . . . . 0.0 109.345 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mt -137.1 118.11 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -90.86 122.11 33.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.442 1.097 . . . . 0.0 108.344 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.66 86.31 34.27 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 126.848 2.059 . . . . 0.0 105.77 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.18 158.66 33.85 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.366 1.378 . . . . 0.0 110.447 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -123.32 165.12 23.99 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.924 0.889 . . . . 0.0 109.489 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HG2' HD11 ' A' ' 20' ' ' LEU . 60.0 Cg_endo -78.67 124.72 6.43 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.982 3.121 . . . . 0.0 109.011 172.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.4 106.86 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 t70 53.96 24.95 4.98 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.83 13.15 70.2 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.214 1.387 . . . . 0.0 114.291 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.89 161.07 4.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 118.579 1.189 . . . . 0.0 111.094 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -81.05 129.33 34.5 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.892 0.853 . . . . 0.0 109.701 157.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.49 156.41 53.32 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 125.629 1.571 . . . . 0.0 109.668 171.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.2 136.83 35.55 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.023 1.815 . . . . 0.0 108.861 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.86 2.74 88.4 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.656 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -67.75 141.76 56.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 117.753 0.776 . . . . 0.0 109.301 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.68 -25.2 27.44 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.458 1.98 . . . . 0.0 112.311 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.04 16.09 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.26 1.03 . . . . 0.0 108.981 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -123.26 145.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.15 104.53 9.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.98 153.76 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -132.34 147.02 52.38 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.22 174.67 9.37 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.529 0.604 . . . . 0.0 110.517 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.606 HG23 HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -76.03 -22.45 55.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 177.669 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.8 p -152.47 161.94 41.89 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.422 1.01 . . . . 0.0 111.168 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.68 -13.99 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 110.497 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.97 -48.44 21.12 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 120.026 -1.671 . . . . 0.0 109.894 172.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.49 -41.81 86.19 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.373 0.669 . . . . 0.0 109.554 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.4 p -68.54 -40.65 80.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.327 0.651 . . . . 0.0 109.999 -175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -56.72 -31.26 64.34 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.375 1.47 . . . . 0.0 111.032 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -83.86 -46.56 12.03 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.925 0.784 . . . . 0.0 109.7 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.63 -49.12 73.7 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.375 0.67 . . . . 0.0 109.726 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.2 tpp -44.27 -73.0 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 127.86 2.464 . . . . 0.0 110.119 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -73.11 -7.56 51.87 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.08 -35.31 61.07 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.855 -1.153 . . . . 0.0 110.678 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.413 HD23 ' HG3' ' A' ' 82' ' ' ARG . 76.5 mt -127.62 -1.13 6.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.419 1.088 . . . . 0.0 112.34 -154.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 m -50.58 122.29 6.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.753 1.221 . . . . 0.0 108.405 157.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 11.5 84.27 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.115 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.413 ' HG3' HD23 ' A' ' 79' ' ' LEU . 20.5 mmt-85 -71.2 -178.43 2.03 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.604 1.702 . . . . 0.0 112.239 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -120.92 94.98 4.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.68 43.02 1.13 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 173.63 -86.41 0.0 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.177 2.991 . . . . 0.0 105.958 166.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -149.09 -5.12 0.4 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.276 1.83 . . . . 0.0 111.622 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -118.46 -178.85 3.62 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.942 1.697 . . . . 0.0 109.797 -175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.39 165.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.1 t -130.31 132.65 64.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 125.777 1.631 . . . . 0.0 108.729 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 11' ' ' MET . 0.7 OUTLIER -106.63 143.26 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.304 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 p -113.48 156.68 23.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 127.638 2.375 . . . . 0.0 107.527 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 169.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -69.38 150.02 47.75 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -130.66 -167.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.232 1.813 . . . . 0.0 108.136 174.598 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.65 150.64 52.87 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.96 -19.97 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.508 2.805 . . . . 0.0 113.042 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.48 -49.49 61.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.127 1.331 . . . . 0.0 110.378 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.07 7.75 5.74 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.339 1.856 . . . . 0.0 111.663 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -111.79 -36.64 5.38 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -57.96 -31.7 67.13 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -123.74 168.59 12.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.251 1.42 . . . . 0.0 109.347 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -79.73 27.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.172 1.789 . . . . 0.0 111.254 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -86.74 70.59 10.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -101.31 149.88 23.57 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.581 1.152 . . . . 0.0 108.068 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.403 -1.284 . . . . 0.0 110.095 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.974 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.04 -110.78 0.42 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -140.73 157.12 68.46 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.099 1.759 . . . . 0.0 108.831 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.02 151.64 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.352 2.034 . . . . 0.0 109.331 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 p -135.33 177.04 8.12 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -78.7 -0.43 30.12 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.662 171.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -102.22 153.02 5.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 120.657 1.571 . . . . 0.0 109.86 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.65 149.76 46.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.668 1.587 . . . . 0.0 107.545 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 50.7 t -109.29 136.13 49.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.0 mt -128.43 110.03 11.95 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -170.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtm -101.66 152.96 20.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 75.11 30.41 0.89 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.691 2.797 . . . . 0.0 114.542 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.444 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -81.63 -69.12 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.521 -1.362 . . . . 0.0 109.632 169.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.32 148.45 29.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.727 1.611 . . . . 0.0 109.829 -155.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -95.36 158.1 35.2 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.37 3.81 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.626 2.217 . . . . 0.0 112.978 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -128.95 15.95 6.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.159 1.784 . . . . 0.0 112.268 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -142.17 31.42 1.56 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.653 1.181 . . . . 0.0 111.066 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.18 5.12 10.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.698 1.599 . . . . 0.0 111.38 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' H ' HD22 ' A' ' 20' ' ' LEU . 1.7 mm? -69.66 -23.53 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.189 0.996 . . . . 0.0 109.504 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.0 81.53 8.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.955 2.502 . . . . 0.0 109.704 -162.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.5 -4.66 0.26 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.819 2.847 . . . . 0.0 114.591 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.83 -33.47 4.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 127.889 2.476 . . . . 0.0 111.856 -166.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.86 -39.82 61.34 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.131 0.878 . . . . 0.0 109.279 162.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.426 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 67.3 t80 -45.49 -40.51 8.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.155 1.782 . . . . 0.0 113.107 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.75 -31.63 41.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.722 0.809 . . . . 0.0 113.171 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -66.55 -50.49 62.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.671 1.588 . . . . 0.0 109.17 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.33 -27.07 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.027 0.931 . . . . 0.0 109.556 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.01 -49.75 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.18 -39.24 86.37 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.52 -47.97 72.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.957 1.36 . . . . 0.0 110.161 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.648 HG13 ' CE2' ' A' ' 84' ' ' PHE . 24.8 t -78.23 -32.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.555 -173.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -66.62 -42.91 86.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.712 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.27 -56.37 21.88 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.451 0.7 . . . . 0.0 109.803 174.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HG2' ' HA ' ' A' ' 32' ' ' VAL . 5.2 pt-20 -66.53 -39.97 88.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.477 0.655 . . . . 0.0 110.582 -164.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -78.3 -20.09 52.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.832 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -73.4 -9.91 59.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.125 -0.984 . . . . 0.0 111.702 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -64.11 -15.17 59.11 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.31 -1.494 . . . . 0.0 111.44 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.615 ' CD1' HD11 ' A' ' 79' ' ' LEU . 23.9 m-85 -116.71 5.29 13.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.616 2.366 . . . . 0.0 111.101 -175.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.29 -151.71 22.82 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 120.286 1.403 . . . . 0.0 111.978 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.5 tm? -125.77 108.68 11.73 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -78.76 103.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -49.14 -56.02 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.342 1.057 . . . . 0.0 110.39 164.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.81 168.15 23.62 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.329 0.513 . . . . 0.0 111.292 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.73 138.76 43.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 127.038 2.135 . . . . 0.0 105.561 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -123.34 111.07 15.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.602 1.561 . . . . 0.0 110.019 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.47 86.16 56.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.19 1.396 . . . . 0.0 108.579 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.29 144.29 61.73 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.125 1.883 . . . . 0.0 108.582 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.426 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -123.97 155.27 67.53 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 108.594 -177.093 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.73 147.98 89.98 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.237 1.958 . . . . 0.0 110.867 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.56 166.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 127.469 2.308 . . . . 0.0 107.677 171.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -64.27 78.01 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 128.117 2.567 . . . . 0.0 109.138 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.44 2.61 57.68 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 117.889 -1.506 . . . . 0.0 113.612 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 t -129.89 144.83 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 120.262 2.031 . . . . 0.0 108.877 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -82.14 172.96 12.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.161 0.981 . . . . 0.0 112.415 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.07 142.38 36.44 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.311 1.845 . . . . 0.0 108.372 174.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.22 130.4 21.24 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.586 2.191 . . . . 0.0 108.846 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.15 27.81 47.71 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.364 0.507 . . . . 0.0 112.296 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 t -71.88 148.68 45.89 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.371 1.086 . . . . 0.0 110.474 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.07 -32.56 5.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 126.872 2.177 . . . . 0.0 111.467 -174.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 3.0 mptt -77.19 160.09 29.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mt -127.56 147.13 32.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 168.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.67 158.02 22.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.31 155.13 28.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 66.4 tt0 -133.05 134.69 44.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 0.0 107.832 -173.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.89 -177.1 3.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.766 1.626 . . . . 0.0 109.288 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.45 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.5 t -109.19 3.2 21.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.526 0.73 . . . . 0.0 112.074 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -152.01 139.37 19.45 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.085 -1.634 . . . . 0.0 109.545 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.6 t -51.98 -37.38 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.565 1.546 . . . . 0.0 109.633 168.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.31 -16.56 54.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.877 1.271 . . . . 0.0 113.104 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -115.43 -35.13 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -164.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 t -53.81 -48.48 69.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.416 1.086 . . . . 0.0 109.704 160.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -54.49 -24.34 20.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.17 1.388 . . . . 0.0 113.935 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -82.97 -53.76 5.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.871 1.214 . . . . 0.0 108.867 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -36.47 77.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.575 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -58.07 -35.67 71.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.156 0.889 . . . . 0.0 111.767 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -98.46 -44.33 6.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.616 1.166 . . . . 0.0 110.305 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.19 50.0 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 118.847 0.749 . . . . 0.0 112.836 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.615 HD11 ' CD1' ' A' ' 39' ' ' TYR . 42.6 mt -130.93 4.91 4.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.98 1.312 . . . . 0.0 111.975 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -68.36 144.07 54.91 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.926 1.694 . . . . 0.0 107.214 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.39 86.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.825 -0.986 . . . . 0.0 113.184 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -174.24 0.51 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.804 1.802 . . . . 0.0 109.526 165.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -123.94 141.32 52.14 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.648 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.7 m-30 -109.01 14.14 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.196 0.935 . . . . 0.0 110.852 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.18 -68.85 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.839 2.856 . . . . 0.0 104.946 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -153.93 -20.95 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 mtp85 -111.77 162.85 14.8 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.427 1.012 . . . . 0.0 110.471 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 t -77.95 106.37 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.004 -163.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.444 HG13 ' HE1' ' A' ' 13' ' ' MET . 75.3 t -72.38 140.56 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.432 1.093 . . . . 0.0 109.552 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.0 t -126.27 128.56 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 p -87.69 156.81 19.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 0.0 110.504 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.15 155.08 41.0 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.328 2.251 . . . . 0.0 105.878 169.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -73.89 153.44 39.84 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 119.891 1.223 . . . . 0.0 108.094 159.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -172.5 2.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 164.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.13 144.28 34.53 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.68 -22.68 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.171 1.914 . . . . 0.0 112.346 -167.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -57.54 12.59 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.061 1.301 . . . . 0.0 109.222 175.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -71.39 12.62 0.31 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.595 1.558 . . . . 0.0 111.355 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 65' ' ' GLU . 30.7 t80 -97.52 -55.68 2.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.69 1.196 . . . . 0.0 110.463 169.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -65.57 -36.6 84.25 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.098 0.959 . . . . 0.0 112.714 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -85.38 -164.55 1.02 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.149 0.98 . . . . 0.0 109.519 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -111.97 26.05 10.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.787 1.235 . . . . 0.0 112.591 172.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -77.37 33.47 0.16 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.449 2.3 . . . . 0.0 111.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.03 166.13 22.02 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 120.511 -1.368 . . . . 0.0 111.049 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.035 0 C-N-CA 125.321 1.449 . . . . 0.0 108.926 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.364 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.44 -175.9 23.47 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.69 1.138 . . . . 0.0 112.775 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 -67.36 156.11 89.19 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.556 1.142 . . . . 0.0 111.509 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.15 151.03 66.64 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.649 2.232 . . . . 0.0 108.639 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.9 p -126.26 176.4 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.797 0.839 . . . . 0.0 109.176 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.56 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 28.1 tt0 -72.14 -1.49 15.13 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.576 1.551 . . . . 0.0 112.876 167.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.96 114.04 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 120.503 -1.373 . . . . 0.0 108.956 -151.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 142.56 51.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 108.806 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.2 t -131.12 126.35 35.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.135 0.969 . . . . 0.0 111.648 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' CD1' HG22 ' A' ' 91' ' ' THR . 1.2 mm? -116.66 107.87 15.23 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 108.262 -159.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.6 mtm -79.1 173.45 12.56 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.389 0.675 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 65.89 18.32 11.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.809 1.644 . . . . 0.0 112.208 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.413 ' CE ' ' HB3' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -81.95 -70.68 0.53 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -165.333 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -104.33 -174.33 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 129.787 3.235 . . . . 0.0 107.051 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -127.49 153.41 77.39 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 120.142 1.337 . . . . 0.0 107.718 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -3.37 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.758 2.305 . . . . 0.0 112.5 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -115.05 11.56 16.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.675 1.19 . . . . 0.0 110.085 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -130.09 -22.57 2.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.838 1.255 . . . . 0.0 112.325 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -79.5 61.33 3.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.627 1.571 . . . . 0.0 110.385 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.03 -14.11 2.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.309 -160.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -116.6 151.75 35.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.811 1.245 . . . . 0.0 108.476 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.59 -13.42 40.04 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.59 1.556 . . . . 0.0 111.756 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.27 -60.06 1.94 Allowed 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.154 1.382 . . . . 0.0 108.445 -163.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -53.01 -36.21 60.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.513 1.525 . . . . 0.0 110.307 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -61.08 -36.82 80.67 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.44 1.896 . . . . 0.0 111.592 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.03 -40.35 53.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.392 0.996 . . . . 0.0 109.877 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.32 -34.78 72.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.433 0.693 . . . . 0.0 111.236 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.92 -24.44 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.465 0.706 . . . . 0.0 110.783 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.3 t -67.21 -47.19 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.406 -1.434 . . . . 0.0 108.322 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.86 -21.69 47.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.93 -47.62 61.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.386 1.089 . . . . 0.0 110.576 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG13 ' CE2' ' A' ' 84' ' ' PHE . 50.8 t -74.89 -30.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.974 -170.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -64.11 -31.66 72.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.202 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.81 -53.12 23.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.568 1.076 . . . . 0.0 110.624 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -62.45 -38.26 89.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.435 0.636 . . . . 0.0 110.926 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.473 ' HB3' HG11 ' A' ' 42' ' ' VAL . 8.8 t -70.54 -35.82 73.35 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.003 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -65.55 -14.33 60.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.457 1.026 . . . . 0.0 112.005 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.1 -19.77 21.57 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 119.71 -1.869 . . . . 0.0 112.791 172.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -115.42 2.53 13.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.935 1.294 . . . . 0.0 112.509 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.75 -147.16 15.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.5 120.85 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.473 HG11 ' HB3' ' A' ' 36' ' ' CYS . 2.1 p -87.92 109.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 126.34 1.856 . . . . 0.0 108.849 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -68.33 -63.96 0.96 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.466 1.906 . . . . 0.0 109.988 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -147.67 158.59 44.08 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.552 0.741 . . . . 0.0 111.691 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.7 130.89 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.399 . . . . 0.0 107.36 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -108.98 123.52 49.25 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.978 2.111 . . . . 0.0 107.845 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -129.29 85.15 60.18 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.237 1.815 . . . . 0.0 106.307 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HB2' HG21 ' A' ' 56' ' ' VAL . 64.4 Cg_endo -77.07 101.18 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.111 1.874 . . . . 0.0 109.825 -172.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.13 80.16 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.801 -0.562 . . . . 0.0 110.896 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -62.87 170.44 7.33 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.572 2.848 . . . . 0.0 110.055 173.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t -126.7 100.88 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 t0 48.67 43.66 20.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.115 1.766 . . . . 0.0 112.209 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.83 -11.43 71.02 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.96 1.743 . . . . 0.0 114.132 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.09 140.88 15.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 120.428 2.114 . . . . 0.0 109.841 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -71.0 129.03 37.94 Favored 'General case' 0 N--CA 1.416 -2.128 0 C-N-CA 128.855 2.862 . . . . 0.0 109.59 171.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.632 HG21 ' HB2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -69.68 145.21 94.68 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.566 164.595 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -61.77 99.21 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 165.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.4 16.25 18.76 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.266 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.501 ' HB2' HG22 ' A' ' 56' ' ' VAL . 11.5 t -72.33 148.85 44.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.59 1.695 . . . . 0.0 110.106 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.99 -11.11 40.84 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.05 134.73 35.12 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.023 1.329 . . . . 0.0 109.657 -169.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.92 137.2 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -108.83 130.5 55.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -128.96 160.14 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.418 1.487 . . . . 0.0 107.979 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.38 143.43 39.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.596 1.958 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -110.07 -169.16 1.42 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.908 1.231 . . . . 0.0 112.249 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -93.96 -15.35 25.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 113.775 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -155.6 145.57 21.49 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.121 1.369 . . . . 0.0 108.628 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.08 -32.26 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 122.261 1.029 . . . . 0.0 110.533 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.2 -36.57 71.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.3 174.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 79.4 m-20 -64.07 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.053 1.297 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 34.4 m -76.65 -36.48 57.33 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 127.695 2.398 . . . . 0.0 109.256 -166.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.65 -40.23 82.83 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.144 1.378 . . . . 0.0 110.89 170.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.563 ' CE ' ' HA ' ' A' ' 71' ' ' ASP . 40.8 mtmt -72.34 -48.32 42.84 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.452 0.701 . . . . 0.0 109.184 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.09 -35.79 81.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.046 0.938 . . . . 0.0 112.687 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 43.1 tpp -55.1 -68.63 0.17 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.427 1.491 . . . . 0.0 109.176 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -67.81 -25.1 65.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.01 -15.46 81.1 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.341 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.74 6.71 5.15 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.668 1.187 . . . . 0.0 111.898 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.1 m -56.49 113.59 1.67 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 6.1 57.9 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.76 1.171 . . . . 0.0 113.614 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.79 179.25 0.27 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.976 1.31 . . . . 0.0 113.675 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -131.04 90.54 2.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.147 1.779 . . . . 0.0 108.35 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.431 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.7 m-30 -77.19 14.68 0.86 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.95 -1.094 . . . . 0.0 112.539 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.53 -64.45 0.06 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.002 2.521 . . . . 0.0 105.211 163.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.66 -10.43 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -109.02 148.9 30.05 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.417 -1.427 . . . . 0.0 109.949 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -64.85 131.82 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.991 -171.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -101.0 141.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.778 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 138.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 161.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.419 HG22 ' CD1' ' A' ' 10' ' ' LEU . 2.6 p -94.42 157.48 15.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.4 2.28 . . . . 0.0 108.476 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.18 157.02 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.527 1.058 . . . . 0.0 109.481 159.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 114.5 18.71 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.2 m -79.78 166.41 21.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 163.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -92.29 142.81 26.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.56 -35.73 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.427 2.752 . . . . 0.0 112.7 -172.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -54.14 -36.66 63.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.99 0.516 . . . . 0.0 111.709 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.2 p -75.41 -43.33 50.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -62.31 -30.9 71.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.373 1.469 . . . . 0.0 112.207 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -66.38 -8.48 25.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.133 0.973 . . . . 0.0 113.086 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -129.01 -174.6 3.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.495 1.918 . . . . 0.0 108.099 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -90.06 55.98 3.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -122.15 98.76 6.08 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.117 0.567 . . . . 0.0 109.785 -174.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.56 163.91 31.31 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.553 0.741 . . . . 0.0 109.711 -172.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.322 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.6 158.26 51.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.491 2.127 . . . . 0.0 109.853 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 p -139.28 -168.61 2.49 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -86.05 -2.64 58.5 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.95 -1.093 . . . . 0.0 112.704 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 94' ' ' CYS . 2.8 m -83.3 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 121.127 1.785 . . . . 0.0 109.105 175.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.86 129.6 26.24 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.227 2.211 . . . . 0.0 105.942 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -100.74 131.86 46.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mp -129.8 154.42 47.26 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.737 1.615 . . . . 0.0 109.039 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.1 mtm -136.29 161.57 35.41 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.07 21.99 1.86 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.624 1.97 . . . . 0.0 111.545 172.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.414 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -76.45 -85.22 0.06 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 163.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.435 HG22 ' H ' ' A' ' 14' ' ' VAL . 22.2 m -82.55 170.66 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 127.08 2.152 . . . . 0.0 110.748 -166.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.28 160.2 35.16 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.094 0.958 . . . . 0.0 109.79 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -0.24 5.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.363 2.042 . . . . 0.0 113.037 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.96 19.4 3.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.056 2.143 . . . . 0.0 112.797 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.23 -9.33 7.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.948 0.794 . . . . 0.0 112.556 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.7 mt -79.62 28.55 0.26 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.21 1.404 . . . . 0.0 111.774 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -100.0 -38.13 8.71 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.835 -1.166 . . . . 0.0 111.282 -170.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 127.04 31.27 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.976 0.91 . . . . 0.0 109.979 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.07 -30.95 58.54 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.956 1.303 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -92.47 16.09 12.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.068 1.347 . . . . 0.0 111.872 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -125.48 -50.24 1.64 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.488 1.515 . . . . 0.0 107.413 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -45.05 -50.29 10.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.059 1.344 . . . . 0.0 112.39 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.61 -27.57 61.35 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -66.42 -46.44 76.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.806 0.843 . . . . 0.0 108.848 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.2 mt -61.16 -28.86 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.739 1.216 . . . . 0.0 111.405 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.04 -47.33 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 120.641 -1.287 . . . . 0.0 109.3 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.51 -30.92 57.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.198 0.999 . . . . 0.0 111.569 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.5 -46.45 86.66 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.849 1.66 . . . . 0.0 110.503 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.5 t -77.94 -28.64 15.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -59.42 -48.69 80.67 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.54 -44.92 95.15 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.091 0.244 . . . . 0.0 110.772 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.75 -43.49 75.74 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.878 -0.514 . . . . 0.0 111.618 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.435 ' HG ' ' HZ ' ' A' ' 66' ' ' PHE . 1.4 t -85.24 -21.92 28.87 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.941 -168.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.9 m -60.08 -8.49 2.42 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.858 -1.151 . . . . 0.0 113.025 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -67.84 -7.58 29.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 119.527 -1.983 . . . . 0.0 113.64 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -124.73 -0.26 8.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.53 1.132 . . . . 0.0 112.623 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.3 -137.96 5.63 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 106.914 -2.475 . . . . 0.0 106.914 -170.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.47 115.31 10.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.35 107.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 108.366 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -55.97 -60.76 3.01 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.396 2.278 . . . . 0.0 108.618 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 p -158.84 175.46 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.541 0.61 . . . . 0.0 110.881 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.14 150.21 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.334 1.453 . . . . 0.0 107.779 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.99 109.18 8.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.027 1.331 . . . . 0.0 110.987 -169.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 86.46 58.67 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 127.363 2.265 . . . . 0.0 107.372 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.9 133.27 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.946 2.431 . . . . 0.0 109.232 172.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 159.71 32.66 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 124.082 0.953 . . . . 0.0 111.535 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.458 -0.601 0 C-N-CA 123.742 2.962 . . . . 0.0 109.926 164.692 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo . . . . . 0 N--CA 1.45 -1.084 0 N-CA-C 108.271 -1.473 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.4 9.98 86.52 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.765 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.3 t -67.17 154.42 41.3 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.837 0.818 . . . . 0.0 110.614 170.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.02 -5.24 80.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 125.527 1.537 . . . . 0.0 114.058 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.2 173.02 9.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.941 1.371 . . . . 0.0 107.987 170.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 mt -131.35 145.96 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 150.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -115.46 144.72 43.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 164.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -118.96 154.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.02 136.92 47.61 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HZ ' ' HG ' ' A' ' 36' ' ' CYS . 28.1 m-85 -107.86 -177.95 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.02 1.328 . . . . 0.0 109.784 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 t -112.15 7.05 19.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 110.145 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.0 p -155.97 143.42 19.34 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 120.869 -1.144 . . . . 0.0 108.368 161.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -51.39 -44.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.952 1.301 . . . . 0.0 109.207 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -71.6 -26.04 62.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.351 -167.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -76.42 -42.66 43.43 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 12.9 t -59.74 -41.01 89.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.723 0.409 . . . . 0.0 110.556 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -56.06 -27.13 52.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 113.0 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -79.88 -47.86 14.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.727 1.149 . . . . 0.0 109.456 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.86 75.97 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.682 0.793 . . . . 0.0 110.532 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -55.77 -43.51 76.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.287 0.635 . . . . 0.0 111.329 -169.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -77.41 -48.29 17.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.79 0.836 . . . . 0.0 109.461 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -19.41 63.97 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.64 1.115 . . . . 0.0 113.073 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.1 mt -124.11 14.86 9.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.798 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.4 m -60.83 118.26 6.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.48 24.23 59.16 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 120.891 -1.131 . . . . 0.0 113.45 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.49 -179.34 5.74 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.288 0.544 . . . . 0.0 110.557 154.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -129.48 99.3 5.13 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 125.164 1.386 . . . . 0.0 107.328 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -88.68 15.02 8.81 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.469 0.577 . . . . 0.0 110.639 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.23 -85.23 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.933 2.093 . . . . 0.0 106.174 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.26 -20.21 0.63 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.56 1.144 . . . . 0.0 111.983 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -90.21 -167.88 1.96 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.81 166.3 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.177 -0.952 . . . . 0.0 108.572 165.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.414 HG13 ' HE1' ' A' ' 13' ' ' MET . 55.7 t -124.68 118.03 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 p -93.04 149.9 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -117.89 168.7 10.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.692 1.197 . . . . 0.0 109.034 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.77 156.41 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.887 2.075 . . . . 0.0 106.908 -177.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -77.71 160.72 28.25 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 162.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.422 ' HB3' HG21 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -137.43 -168.47 2.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.397 0.999 . . . . 0.0 109.063 168.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.59 144.22 34.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -93.59 -20.46 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.132 1.888 . . . . 0.0 110.833 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -40.44 80.59 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.07 0.462 . . . . 0.0 110.446 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.56 -33.26 60.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.105 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -61.6 -50.27 73.27 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.499 1.52 . . . . 0.0 111.411 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.64 -14.63 63.14 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -106.11 -169.73 1.62 Allowed 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 127.544 2.337 . . . . 0.0 107.276 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -114.18 69.68 0.71 Allowed 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.31 27.02 9.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 109.812 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 C--O 1.235 0.313 0 C-N-CA 123.683 0.793 . . . . 0.0 109.543 -172.404 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.04 126.88 16.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.401 1.401 . . . . 0.0 108.676 165.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.1 p -100.11 179.02 4.61 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.889 1.676 . . . . 0.0 108.705 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.54 8.72 13.23 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.007 0.923 . . . . 0.0 110.658 174.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.99 163.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 O-C-N 120.896 -1.127 . . . . 0.0 111.395 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -141.71 124.19 15.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -168.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.23 135.02 33.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.7 mt -128.73 131.2 47.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.5 1.52 . . . . 0.0 107.232 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mtm -125.46 163.77 21.93 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.448 -0.782 . . . . 0.0 110.177 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 74.97 16.22 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.81 2.844 . . . . 0.0 112.677 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -52.9 11.93 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.251 -0.906 . . . . 0.0 108.916 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.88 174.34 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 128.317 2.647 . . . . 0.0 108.891 -162.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.72 150.24 52.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.102 0.961 . . . . 0.0 109.319 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.62 -14.7 40.07 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.859 2.373 . . . . 0.0 113.647 -172.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -116.56 13.18 15.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.682 1.993 . . . . 0.0 110.333 -170.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -139.69 22.62 2.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.792 2.037 . . . . 0.0 109.637 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.01 65.43 0.66 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.066 2.146 . . . . 0.0 107.057 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.3 mt -135.06 -41.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -160.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.07 151.25 31.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.6 0.76 . . . . 0.0 110.149 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -95.96 -5.55 41.05 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.623 0.769 . . . . 0.0 110.675 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -113.57 -43.41 3.32 Favored 'General case' 0 C--N 1.337 0.047 0 C-N-CA 124.42 1.088 . . . . 0.0 113.049 -167.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -80.62 -37.19 31.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.734 1.214 . . . . 0.0 109.398 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.7 -35.75 61.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.218 1.007 . . . . 0.0 110.677 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.74 -37.22 70.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.491 -0.756 . . . . 0.0 111.62 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -62.32 -45.92 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.014 . . . . 0.0 109.204 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.55 -20.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.617 0.767 . . . . 0.0 111.371 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.11 -44.71 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.954 -1.092 . . . . 0.0 109.316 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.4 -35.77 63.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.908 0.776 . . . . 0.0 112.338 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.46 -51.22 60.4 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.391 1.876 . . . . 0.0 109.768 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.6 t -75.36 -29.13 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.224 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -65.54 -36.26 83.27 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.605 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.64 -40.69 40.98 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.655 0.661 . . . . 0.0 112.243 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -50.11 69.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.983 -1.073 . . . . 0.0 109.899 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.05 -25.76 61.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -167.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.91 -22.96 4.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.396 1.078 . . . . 0.0 112.969 169.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -76.24 -13.06 60.18 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.625 -1.297 . . . . 0.0 112.626 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CE1' HD21 ' A' ' 79' ' ' LEU . 87.9 m-85 -116.98 -16.52 10.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.576 1.08 . . . . 0.0 112.898 -173.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.46 -138.75 3.24 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD13 ' C ' ' A' ' 41' ' ' LEU . 2.4 tm? -140.33 123.0 16.29 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -87.04 116.32 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -66.24 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.731 1.613 . . . . 0.0 107.84 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -154.14 169.44 23.57 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.774 1.229 . . . . 0.0 110.239 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 mt -130.2 141.97 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.266 1.826 . . . . 0.0 106.179 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -126.11 120.18 29.5 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.538 1.135 . . . . 0.0 110.58 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.37 85.75 17.7 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.46 123.16 11.61 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.351 2.034 . . . . 0.0 108.257 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.99 154.07 37.5 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 123.652 0.781 . . . . 0.0 110.093 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.456 -0.698 0 C-N-CA 123.273 2.649 . . . . 0.0 111.025 167.459 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo . . . . . 0 N--CA 1.451 -1.019 0 N-CA-C 108.025 -1.567 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.71 36.56 92.48 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.3 t -74.15 163.54 27.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.189 0.518 . . . . 0.0 110.166 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -39.03 2.72 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.192 1.377 . . . . 0.0 111.594 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 168.52 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.541 1.671 . . . . 0.0 109.709 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -131.86 152.48 36.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.56 157.94 28.39 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p -139.02 161.05 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -133.19 144.9 50.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.822 1.649 . . . . 0.0 107.441 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.75 -179.16 3.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.895 1.678 . . . . 0.0 111.035 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.441 ' CG2' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -86.11 -21.47 27.61 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.854 172.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -139.83 -179.09 5.74 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.482 1.492 . . . . 0.0 110.561 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.31 -35.14 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 158.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -76.49 -28.93 56.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.574 -1.329 . . . . 0.0 113.51 -166.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -76.49 -38.89 54.57 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.375 1.07 . . . . 0.0 109.169 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.9 t -57.1 -47.6 80.67 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.56 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -56.94 -26.89 60.4 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.449 1.499 . . . . 0.0 113.179 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -76.91 -48.13 19.08 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.17 88.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 117.155 -1.403 . . . . 0.0 111.743 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -63.89 0.89 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.719 1.145 . . . . 0.0 110.659 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -81.97 -21.13 37.33 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.529 0.732 . . . . 0.0 112.021 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.74 89.43 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.484 HD21 ' CE1' ' A' ' 39' ' ' TYR . 96.4 mt -115.01 -1.46 13.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -160.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.6 m -47.64 116.07 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.024 -1.047 . . . . 0.0 109.507 164.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.54 5.7 63.07 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.626 0.648 . . . . 0.0 114.412 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -177.85 1.26 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.853 1.327 . . . . 0.0 111.42 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -126.9 133.2 50.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.435 1.494 . . . . 0.0 107.054 163.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -108.15 15.08 24.52 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.155 0.982 . . . . 0.0 110.937 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.11 -73.31 0.06 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -150.89 -13.28 0.22 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -98.46 164.19 12.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.155 0.889 . . . . 0.0 110.017 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.41 135.99 26.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.93 139.8 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.209 1.403 . . . . 0.0 111.058 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.264 3.1 p -110.93 115.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 170.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -78.2 143.72 36.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.09 167.68 21.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.64 1.976 . . . . 0.0 106.09 162.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -71.82 164.45 25.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.91 0.777 . . . . 0.0 109.68 163.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 -164.47 1.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.469 1.108 . . . . 0.0 108.524 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -114.38 143.42 29.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.22 -25.86 5.53 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.123 2.548 . . . . 0.0 111.169 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -54.29 -59.34 4.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.036 0.922 . . . . 0.0 109.842 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -20.12 62.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.856 2.062 . . . . 0.0 110.898 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -73.14 -46.87 48.47 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 127.488 2.315 . . . . 0.0 111.006 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -60.36 -35.89 76.74 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 -97.56 -166.77 1.43 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 109.605 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -122.08 54.72 1.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.501 1.52 . . . . 0.0 107.738 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.98 38.81 3.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.713 1.244 . . . . 0.0 109.001 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--O 1.239 0.52 0 C-N-CA 126.595 1.958 . . . . 0.0 108.822 176.183 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -66.31 133.0 31.16 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.959 2.439 . . . . 0.0 108.223 168.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.8 p -137.29 169.21 18.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.537 1.935 . . . . 0.0 106.772 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -75.39 -10.86 59.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.369 0.532 . . . . 0.0 111.798 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.87 106.78 19.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 125.469 1.508 . . . . 0.0 110.006 -170.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -91.53 113.09 25.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -85.01 134.05 34.23 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.5 139.85 52.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.276 1.031 . . . . 0.0 109.52 -173.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.5 mtm -125.18 161.13 27.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.896 0.878 . . . . 0.0 109.241 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 60.87 30.68 19.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.577 2.351 . . . . 0.0 112.911 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.624 ' CE ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -77.65 -79.66 0.11 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 164.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.47 171.02 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 125.12 1.368 . . . . 0.0 109.791 -165.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.91 159.4 40.99 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 124.096 0.958 . . . . 0.0 109.445 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.69 4.87 2.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.574 2.183 . . . . 0.0 113.584 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -128.24 14.55 6.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.555 1.942 . . . . 0.0 113.415 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -132.45 -4.21 3.36 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.45 -0.781 . . . . 0.0 111.357 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -98.63 51.59 0.99 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.443 1.497 . . . . 0.0 109.885 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.41 -54.85 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.38 100.54 0.06 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.984 2.114 . . . . 0.0 109.952 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.28 -7.34 58.58 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.941 0.896 . . . . 0.0 113.088 -165.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -76.51 -59.64 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.983 1.713 . . . . 0.0 107.961 166.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.95 -34.33 77.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.668 0.787 . . . . 0.0 111.982 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -44.99 -45.56 10.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.931 1.292 . . . . 0.0 111.514 168.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.85 -23.0 42.26 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 121.573 -0.704 . . . . 0.0 112.078 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -71.42 -50.15 34.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 124.189 0.93 . . . . 0.0 109.162 169.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.31 -40.66 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.148 0.979 . . . . 0.0 111.147 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.0 t -57.87 -40.35 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.879 0.763 . . . . 0.0 109.951 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.56 -40.74 33.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.873 0.306 . . . . 0.0 111.032 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.72 -33.62 76.03 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.08 -36.68 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 O-C-N 121.545 -0.722 . . . . 0.0 109.414 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -58.28 -38.27 76.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 117.134 -1.413 . . . . 0.0 109.627 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.09 -33.37 73.24 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.588 1.54 . . . . 0.0 112.107 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -41.44 63.43 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 120.964 -1.085 . . . . 0.0 110.975 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.483 ' SG ' HG21 ' A' ' 42' ' ' VAL 0.265 0.8 OUTLIER -81.22 -27.97 35.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.287 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.04 -3.91 32.24 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.659 1.118 . . . . 0.0 112.259 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -56.81 -18.43 12.85 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.3 -1.5 . . . . 0.0 113.725 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -119.75 1.26 11.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.043 1.337 . . . . 0.0 113.003 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.13 -145.13 10.21 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -122.49 112.53 18.15 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 118.747 1.274 . . . . 0.0 110.023 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.483 HG21 ' SG ' ' A' ' 36' ' ' CYS . 75.6 t -69.81 108.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -68.71 -53.48 21.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.846 0.858 . . . . 0.0 109.884 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -161.51 163.68 30.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -135.71 108.71 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.77 119.16 31.35 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 125.91 1.684 . . . . 0.0 109.106 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mt -133.49 85.69 42.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.29 1.836 . . . . 0.0 107.838 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.72 136.4 53.5 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.682 1.588 . . . . 0.0 109.161 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -98.08 165.2 15.78 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.512 1.125 . . . . 0.0 109.616 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.239 0.531 0 C-N-CA 122.56 2.173 . . . . 0.0 109.903 166.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.454 -0.839 0 N-CA-C 108.256 -1.478 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.28 -15.15 15.55 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 126.735 2.112 . . . . 0.0 112.256 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.5 t -76.45 148.47 37.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.068 0.934 . . . . 0.0 111.184 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.52 -16.0 51.73 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.124 1.821 . . . . 0.0 112.622 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -92.56 157.12 16.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.761 1.781 . . . . 0.0 108.583 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.0 149.4 33.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 164.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -129.32 114.31 16.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 42' ' ' VAL . 98.5 t -101.82 111.63 32.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 148.49 29.2 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.232 1.813 . . . . 0.0 106.362 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -129.87 179.57 5.78 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.87 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -90.07 -13.3 36.17 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -164.55 155.8 15.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.553 1.069 . . . . 0.0 110.007 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.429 HG12 HE21 ' A' ' 73' ' ' GLN . 40.8 t -65.36 -23.42 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.558 0.743 . . . . 0.0 109.142 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -84.41 -18.03 37.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.5 -1.375 . . . . 0.0 113.224 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -76.52 -45.97 28.55 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.5 p -71.51 -36.43 71.07 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.665 -0.647 . . . . 0.0 110.714 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.429 HE21 HG12 ' A' ' 69' ' ' VAL . 2.0 mp0 -47.3 -36.2 8.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.928 2.091 . . . . 0.0 112.856 168.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -79.11 -48.72 13.8 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.21 73.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.67 1.188 . . . . 0.0 111.266 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.1 ttm -48.73 -70.54 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.628 1.571 . . . . 0.0 110.336 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.76 -33.29 73.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.543 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.9 -15.85 69.69 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.516 1.055 . . . . 0.0 114.027 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.54 9.05 5.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.114 1.457 . . . . 0.0 112.687 -171.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.8 m -63.77 102.11 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.16 -0.962 . . . . 0.0 110.181 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.17 1.88 51.29 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.13 1.348 . . . . 0.0 113.14 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -178.64 0.2 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.386 1.593 . . . . 0.0 111.503 173.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.35 140.08 53.29 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' A' ' 89' ' ' VAL . 3.1 m-85 -117.84 13.76 14.14 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.644 0.735 . . . . 0.0 109.854 176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.34 -70.77 0.08 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.52 2.328 . . . . 0.0 107.661 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -162.42 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.64 1.176 . . . . 0.0 111.821 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -78.18 175.26 10.34 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.489 1.04 . . . . 0.0 109.456 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.43 165.63 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.624 HG22 ' CE ' ' A' ' 13' ' ' MET . 25.6 t -114.57 125.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.0 t -105.84 129.51 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 167.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.0 p -99.2 146.86 25.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.609 1.164 . . . . 0.0 108.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -141.52 161.22 38.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.411 1.485 . . . . 0.0 107.334 160.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -69.36 157.49 36.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 158.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -176.68 2.95 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.523 1.529 . . . . 0.0 107.417 165.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -99.1 144.98 29.22 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.41 -24.17 6.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.823 2.349 . . . . 0.0 112.925 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.47 -46.93 73.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.19 0.905 . . . . 0.0 110.725 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 p -75.71 2.94 10.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.452 1.101 . . . . 0.0 111.925 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -93.16 -48.92 6.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.551 1.141 . . . . 0.0 108.932 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -60.27 -30.41 69.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.771 0.428 . . . . 0.0 111.256 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -104.63 163.46 12.46 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.524 1.13 . . . . 0.0 109.87 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 ttm-85 -73.23 21.89 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.276 2.23 . . . . 0.0 112.794 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -88.81 64.09 7.11 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.75 -1.219 . . . . 0.0 111.133 -158.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 4.4 m-85 . . . . . 0 C--O 1.237 0.428 0 C-N-CA 123.081 0.553 . . . . 0.0 109.625 -169.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.0 142.97 48.26 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.897 2.398 . . . . 0.0 108.868 166.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 p -121.33 -179.28 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.587 1.955 . . . . 0.0 107.983 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -82.74 9.68 9.19 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.437 HG12 ' HG3' ' A' ' 65' ' ' GLU . 2.9 m -130.92 157.4 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 121.083 1.765 . . . . 0.0 110.332 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 93' ' ' TYR . 5.6 tp -133.4 170.72 15.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.931 0.872 . . . . 0.0 109.268 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.86 140.4 31.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.911 1.284 . . . . 0.0 109.362 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.29 122.9 27.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.593 1.557 . . . . 0.0 107.646 -167.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.1 mtm -103.94 165.98 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.213 0.605 . . . . 0.0 110.632 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 75.22 7.36 4.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 129.334 3.054 . . . . 0.0 115.12 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -65.16 0.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.148 1.34 . . . . 0.0 109.305 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.21 144.46 35.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.784 1.634 . . . . 0.0 109.077 -158.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.45 163.78 32.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 126.197 1.799 . . . . 0.0 110.762 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.84 -1.03 7.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.08 2.52 . . . . 0.0 114.606 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.83 -0.57 3.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.565 1.146 . . . . 0.0 112.598 -163.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -115.08 -12.26 11.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.636 0.774 . . . . 0.0 112.784 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.442 ' C ' HD22 ' A' ' 20' ' ' LEU . 91.8 mt -75.06 47.97 0.38 Allowed 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.455 1.902 . . . . 0.0 112.396 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD22 ' C ' ' A' ' 19' ' ' LEU . 3.6 mm? -132.73 -13.6 2.88 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -165.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.94 179.42 1.48 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.664 1.12 . . . . 0.0 109.59 159.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -122.89 -4.09 8.61 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.129 -0.982 . . . . 0.0 111.382 165.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -90.19 -72.79 0.55 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.793 2.037 . . . . 0.0 108.928 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -57.52 -33.37 68.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.561 1.944 . . . . 0.0 110.607 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -47.46 -46.97 27.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.364 1.466 . . . . 0.0 112.138 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -75.74 -34.11 60.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -60.3 -44.36 95.48 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.96 -34.81 70.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -61.02 -54.27 37.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 O-C-N 120.749 -1.219 . . . . 0.0 108.753 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -70.87 -33.2 70.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.932 0.787 . . . . 0.0 112.031 -169.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.93 -35.32 79.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.239 1.019 . . . . 0.0 111.93 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.38 -25.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 108.966 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -69.18 -21.63 63.96 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.941 -1.099 . . . . 0.0 111.723 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.25 -62.24 1.52 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.849 1.204 . . . . 0.0 108.11 159.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HB2' HH21 ' A' ' 82' ' ' ARG . 5.0 pt-20 -61.08 -40.29 93.14 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -158.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -77.66 -28.65 51.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.0 t -65.86 -12.95 58.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.414 1.085 . . . . 0.0 111.473 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.57 -12.38 52.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 119.644 -1.91 . . . . 0.0 111.693 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -112.13 -7.13 14.08 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.073 1.349 . . . . 0.0 113.732 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.48 -167.3 31.4 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.52 104.1 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.987 0.898 . . . . 0.0 109.874 -175.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.28 106.49 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 125.406 1.482 . . . . 0.0 107.052 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -66.51 -67.57 0.44 Allowed 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 166.63 32.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.34 0.656 . . . . 0.0 111.341 -168.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -138.98 145.36 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 126.217 1.807 . . . . 0.0 108.85 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -132.84 121.97 23.72 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.93 1.292 . . . . 0.0 109.433 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.9 mt -127.85 86.1 59.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.89 2.076 . . . . 0.0 107.414 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.63 148.8 86.04 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.721 1.614 . . . . 0.0 109.861 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.07 152.57 46.76 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.862 0.865 . . . . 0.0 110.116 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 C--O 1.236 0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 111.243 176.459 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 N--CA 1.451 -0.979 0 N-CA-C 106.706 -2.075 . . . . 0.0 106.706 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.54 -11.03 11.32 Favored Glycine 0 C--O 1.229 -0.205 0 C-N-CA 125.733 1.635 . . . . 0.0 111.451 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.4 144.88 51.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.995 0.897 . . . . 0.0 109.806 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.18 -35.85 4.6 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 127.456 2.455 . . . . 0.0 110.512 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -85.4 167.88 15.12 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.185 -1.185 . . . . 0.0 110.389 -172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 mt -136.32 128.17 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -99.59 155.17 17.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -144.71 145.15 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 7' ' ' VAL . 10.9 tt0 -121.91 146.86 46.71 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.887 1.275 . . . . 0.0 108.901 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.07 167.03 16.51 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.492 1.117 . . . . 0.0 110.529 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.0 p -74.2 -18.1 60.8 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -159.62 159.28 32.94 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.906 1.23 . . . . 0.0 111.406 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.532 HG12 HE21 ' A' ' 73' ' ' GLN . 24.3 t -53.31 -38.97 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.923 1.289 . . . . 0.0 109.134 171.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -52.02 -52.49 50.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.297 1.039 . . . . 0.0 111.986 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.14 -43.92 81.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 10.7 t -58.11 -41.84 84.46 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.003 0.521 . . . . 0.0 111.005 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.532 HE21 HG12 ' A' ' 69' ' ' VAL . 26.2 mt-30 -62.86 -20.93 65.58 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.668 1.187 . . . . 0.0 112.734 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -90.42 -46.39 8.39 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.785 1.175 . . . . 0.0 108.664 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.32 -15.99 64.0 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.593 1.157 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.436 ' CE ' HD11 ' A' ' 8' ' ' LEU . 25.4 tpp -60.37 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.906 1.682 . . . . 0.0 108.226 168.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -70.76 -22.71 62.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.718 -164.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.35 -27.9 71.46 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.574 0.624 . . . . 0.0 112.426 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.442 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 96.1 mt -113.56 -4.1 13.56 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.06 1.344 . . . . 0.0 111.732 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.0 m -57.37 106.63 0.35 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.935 -1.103 . . . . 0.0 109.025 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.69 -0.17 59.38 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.182 -0.788 . . . . 0.0 113.884 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.444 HH21 ' HB2' ' A' ' 35' ' ' GLU . 9.2 mmm180 -63.67 178.76 0.55 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.944 1.372 . . . . 0.0 110.665 167.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 85' ' ' ALA . 89.6 mttt -133.96 84.47 2.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.373 1.469 . . . . 0.0 107.469 -167.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 3.0 m-30 -78.1 37.73 0.26 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.492 1.117 . . . . 0.0 109.54 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' LYS . . . 174.51 -69.32 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 1 C-N-CA 132.738 4.415 . . . . 0.0 105.895 167.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.14 -29.54 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.294 1.838 . . . . 0.0 111.456 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -89.52 162.63 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.942 -1.099 . . . . 0.0 109.78 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.37 139.9 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.69 133.73 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.9 122.86 65.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -85.6 155.54 21.1 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 129.182 2.993 . . . . 0.0 109.278 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -153.13 138.62 17.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.662 1.985 . . . . 0.0 108.541 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HA ' HD12 ' A' ' 8' ' ' LEU . 56.0 m-85 -67.22 127.53 32.99 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 162.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.67 169.7 9.51 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.823 1.249 . . . . 0.0 108.435 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -92.13 143.65 27.89 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.64 -27.51 6.1 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.507 2.804 . . . . 0.0 111.918 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -57.18 13.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.634 1.107 . . . . 0.0 111.194 -170.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 m -65.98 -33.47 75.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.187 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -65.68 -30.74 71.47 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.482 1.113 . . . . 0.0 112.588 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -64.78 -2.8 2.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.081 0.953 . . . . 0.0 112.673 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -138.46 179.49 6.43 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.974 2.11 . . . . 0.0 108.711 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.442 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -81.0 21.31 0.71 Allowed 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.195 -0.94 . . . . 0.0 112.324 174.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.73 45.41 1.07 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.44 -1.412 . . . . 0.0 112.68 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 102' ' ' ARG . 10.8 m-85 . . . . . 0 C--O 1.233 0.222 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.65 141.13 49.1 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.054 1.836 . . . . 0.0 108.666 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -123.48 172.97 8.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.53 1.132 . . . . 0.0 110.261 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.48 -9.11 55.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.356 0.662 . . . . 0.0 112.165 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.6 m -102.16 -176.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 120.02 1.282 . . . . 0.0 111.658 -172.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 tp -145.48 155.27 43.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.122 1.369 . . . . 0.0 109.199 161.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.41 143.13 48.69 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.505 1.122 . . . . 0.0 109.645 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.25 152.8 49.28 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.604 1.962 . . . . 0.0 109.694 -170.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 39.7 mtm -132.56 165.12 25.11 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.751 1.22 . . . . 0.0 110.238 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 75.44 -8.59 1.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 130.085 3.354 . . . . 0.0 114.571 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.439 ' HE3' HG22 ' A' ' 89' ' ' VAL . 10.0 tpp -71.17 -36.9 72.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.743 1.156 . . . . 0.0 112.472 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.06 152.62 36.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 0.0 109.855 -170.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -110.12 156.13 40.61 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.49 -1.06 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.06 2.507 . . . . 0.0 113.023 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -116.61 4.52 13.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.05 1.74 . . . . 0.0 111.817 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -133.81 33.88 3.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.358 1.463 . . . . 0.0 110.817 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt -131.75 58.75 1.72 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.426 1.89 . . . . 0.0 108.57 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.25 -45.32 1.98 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.238 1.415 . . . . 0.0 110.029 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.71 105.74 7.95 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.02 -32.43 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.914 1.686 . . . . 0.0 111.778 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.33 -63.21 1.11 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.501 0.72 . . . . 0.0 109.56 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -53.83 -42.81 68.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.221 1.008 . . . . 0.0 110.143 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -53.25 -40.51 64.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.98 1.312 . . . . 0.0 111.617 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -81.98 -38.4 25.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.866 1.212 . . . . 0.0 111.029 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -59.55 -51.1 71.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -54.72 -45.57 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.558 0.743 . . . . 0.0 109.426 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.92 -26.32 39.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 118.064 -0.969 . . . . 0.0 112.708 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.41 -28.41 23.58 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.673 1.124 . . . . 0.0 112.538 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.04 -41.53 64.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.118 0.961 . . . . 0.0 110.04 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG13 ' CE2' ' A' ' 84' ' ' PHE . 42.8 t -71.96 -28.25 29.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 125.027 1.331 . . . . 0.0 109.15 -177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -56.42 -57.42 12.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.55 -40.77 97.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.217 0.948 . . . . 0.0 110.079 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.5 -39.94 85.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.458 -169.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.83 -27.1 49.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.2 t -64.47 -21.66 66.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.829 0.852 . . . . 0.0 110.815 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -56.59 -21.66 28.42 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.118 -1.614 . . . . 0.0 111.976 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.469 ' CE1' HD21 ' A' ' 79' ' ' LEU . 42.2 m-85 -110.53 2.46 18.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.928 1.691 . . . . 0.0 112.224 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.59 -156.14 26.91 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 120.164 1.347 . . . . 0.0 112.258 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.1 tm? -112.2 110.08 20.14 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.09 113.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -61.51 -61.03 2.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.874 1.27 . . . . 0.0 109.243 167.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 175.46 12.01 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.314 -0.866 . . . . 0.0 110.903 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 64' ' ' VAL . 57.4 mt -138.89 145.11 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.31 125.1 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.167 1.787 . . . . 0.0 109.541 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.6 mt -138.46 82.42 22.75 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.71 138.88 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.084 1.856 . . . . 0.0 109.752 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -90.81 155.75 45.16 Favored Pre-proline 0 N--CA 1.474 0.735 0 O-C-N 120.485 -1.384 . . . . 0.0 111.877 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 C--N 1.352 0.746 1 C-N-CA 126.094 4.529 . . . . 0.0 112.648 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo . . . . . 0 N--CA 1.451 -1.0 0 N-CA-C 107.707 -1.69 . . . . 0.0 107.707 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.32 16.74 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.438 1.971 . . . . 0.0 112.758 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.8 t -71.99 132.54 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.687 1.243 . . . . 0.0 109.352 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.44 1.51 80.97 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.734 1.635 . . . . 0.0 113.815 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -108.72 161.08 15.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -126.63 148.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.09 142.75 50.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 45' ' ' ILE . 53.7 t -134.64 150.95 30.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 23.6 tt0 -129.08 142.49 50.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.09 169.84 8.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.114 1.766 . . . . 0.0 108.441 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.3 t -98.97 8.4 45.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.957 0.903 . . . . 0.0 110.419 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.1 p -155.5 147.98 23.94 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 120.261 -1.525 . . . . 0.0 111.393 156.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.725 HG12 HE21 ' A' ' 73' ' ' GLN . 1.9 t -49.73 -41.3 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.121 0.968 . . . . 0.0 109.032 163.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -62.92 -22.8 67.02 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.446 1.498 . . . . 0.0 114.187 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -101.34 -37.04 8.66 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -31.78 73.03 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.294 -0.879 . . . . 0.0 111.012 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.725 HE21 HG12 ' A' ' 69' ' ' VAL . 35.3 mt-30 -58.72 -20.35 48.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.08 1.752 . . . . 0.0 112.987 170.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -88.26 -51.84 5.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.63 1.105 . . . . 0.0 108.613 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.5 -43.52 65.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.131 0.973 . . . . 0.0 111.118 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.0 tpp -44.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.423 2.289 . . . . 0.0 110.404 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.7 -18.62 56.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.31 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.9 -25.2 72.27 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.264 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.524 HD23 ' HG3' ' A' ' 82' ' ' ARG . 90.9 mt -115.63 4.36 14.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.1 m -55.13 107.58 0.32 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.791 1.237 . . . . 0.0 109.899 168.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.0 8.2 72.77 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.765 -0.584 . . . . 0.0 113.935 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.524 ' HG3' HD23 ' A' ' 79' ' ' LEU . 64.3 mmt-85 -72.69 -174.8 1.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.901 1.351 . . . . 0.0 111.281 169.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -134.02 98.41 4.13 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.641 0.776 . . . . 0.0 109.984 -170.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.458 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.0 m-85 -83.1 19.49 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.721 2.008 . . . . 0.0 112.534 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.2 -85.49 0.0 OUTLIER 'General case' 0 C--O 1.231 0.126 0 C-N-CA 129.469 3.107 . . . . 0.0 104.46 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.3 -24.63 2.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.021 0.928 . . . . 0.0 110.96 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 87' ' ' ARG . 18.8 mtp85 -93.12 173.59 7.65 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.736 0.698 . . . . 0.0 110.287 -166.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.93 165.5 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG22 ' HE3' ' A' ' 13' ' ' MET . 71.6 t -132.84 145.39 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.49 -173.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.4 117.23 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 168.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 154.23 27.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.476 2.31 . . . . 0.0 110.007 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.92 150.43 28.35 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.157 2.983 . . . . 0.0 106.27 173.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -69.09 160.19 31.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.638 1.108 . . . . 0.0 108.891 160.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.39 -164.47 1.3 Allowed 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.773 1.229 . . . . 0.0 109.459 168.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.85 143.88 28.47 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.08 -32.88 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.367 2.712 . . . . 0.0 110.449 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -57.33 -54.31 48.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.1 m -66.89 -29.47 69.38 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.85 1.26 . . . . 0.0 110.794 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -64.05 -40.48 96.38 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.843 1.657 . . . . 0.0 111.09 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -70.97 -9.75 58.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.264 1.026 . . . . 0.0 112.349 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 20.8 mtp85 -106.45 -168.8 1.47 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.33 1.452 . . . . 0.0 109.482 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.3 tpt180 -108.82 73.12 0.85 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.68 92.44 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 2.8 m-85 . . . . . 0 C--O 1.227 -0.106 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -170.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.15 146.49 41.03 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.608 2.872 . . . . 0.0 109.61 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -131.7 170.35 14.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -78.9 8.38 5.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -98.14 119.7 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.62 143.62 32.52 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -108.1 142.17 38.7 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt -138.59 128.37 25.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.843 1.257 . . . . 0.0 107.613 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -133.73 156.91 47.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.154 0.582 . . . . 0.0 109.764 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 65.34 72.01 0.43 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.125 2.17 . . . . 0.0 109.771 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.439 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -132.44 -77.14 0.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.472 1.509 . . . . 0.0 107.786 -177.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.35 146.31 19.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.555 1.542 . . . . 0.0 109.371 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 17' ' ' GLU . 50.9 mt -109.78 151.57 42.41 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.752 0.821 . . . . 0.0 109.082 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.95 4.91 0.55 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.61 2.873 . . . . 0.0 113.515 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 15' ' ' LEU . 19.0 pt-20 -131.14 2.94 4.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.334 2.654 . . . . 0.0 112.093 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -127.17 -18.06 4.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.541 -0.725 . . . . 0.0 112.587 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.843 HD11 ' HA ' ' A' ' 49' ' ' ARG 0.254 0.2 OUTLIER -90.69 16.25 9.53 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.967 -1.083 . . . . 0.0 110.927 -162.482 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.43 -22.55 16.52 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.556 -1.34 . . . . 0.0 113.36 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.22 134.39 34.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -168.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.97 -18.82 64.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.443 0.697 . . . . 0.0 112.159 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.34 -68.81 0.6 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.122 1.769 . . . . 0.0 108.968 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -58.48 -36.21 73.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.573 1.549 . . . . 0.0 112.844 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' VAL . 71.4 t80 -52.05 -47.89 64.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.281 1.432 . . . . 0.0 112.395 170.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.28 -38.93 71.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.7 0.8 . . . . 0.0 111.067 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -52.08 -48.34 64.74 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.632 1.173 . . . . 0.0 109.243 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.5 mt -63.97 -44.49 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.52 1.528 . . . . 0.0 109.899 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 25' ' ' TYR . 57.2 t -58.57 -46.37 90.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -78.36 -31.48 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -170.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.22 -42.17 99.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 123.223 1.487 . . . . 0.0 109.414 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.66 -31.78 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.403 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -66.42 -24.36 66.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 120.962 -1.086 . . . . 0.0 111.395 175.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.58 -59.71 3.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 119.884 1.22 . . . . 0.0 108.309 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -62.3 -37.58 86.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -167.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.1 t -72.7 -25.89 61.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.571 0.749 . . . . 0.0 109.881 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -61.66 -23.33 66.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.54 1.136 . . . . 0.0 111.296 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 84.3 mttt -65.52 -10.75 37.45 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.454 -1.404 . . . . 0.0 112.95 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CE1' HD21 ' A' ' 79' ' ' LEU . 71.6 m-85 -123.47 4.11 9.03 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.856 1.263 . . . . 0.0 113.424 -170.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.11 -131.26 3.26 Favored Glycine 0 CA--C 1.504 -0.594 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.17 116.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.5 104.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.109 1.363 . . . . 0.0 108.693 166.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.06 -55.91 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.92 2.488 . . . . 0.0 110.337 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -148.37 163.43 37.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.399 1.479 . . . . 0.0 110.209 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mt -138.81 133.82 41.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.01 110.46 12.99 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.963 0.905 . . . . 0.0 109.58 -170.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.493 HD12 HG22 ' A' ' 29' ' ' VAL . 13.9 mt -128.16 86.62 57.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.668 1.587 . . . . 0.0 107.516 -170.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.93 125.5 16.67 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.787 1.658 . . . . 0.0 108.232 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.843 ' HA ' HD11 ' A' ' 19' ' ' LEU . 17.7 mtp180 -90.6 151.36 43.91 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 0.0 110.117 -174.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' CD ' ' HG ' ' A' ' 19' ' ' LEU . 61.0 Cg_endo . . . . . 0 N--CA 1.457 -0.633 0 C-N-CA 121.83 1.687 . . . . 0.0 109.543 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.453 -0.854 0 N-CA-C 110.259 -0.708 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.03 66.1 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 126.33 1.919 . . . . 0.0 111.583 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.14 147.95 44.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 122.042 -0.681 . . . . 0.0 109.454 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.71 65.17 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.035 1.778 . . . . 0.0 112.76 -171.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -108.42 160.81 15.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -129.36 129.97 67.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 162.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -99.83 130.66 46.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 171.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -124.73 145.76 31.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.87 139.1 51.59 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -118.71 168.02 11.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.413 1.102 . . . . 0.0 111.062 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -38.06 87.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.067 1.347 . . . . 0.0 113.273 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.5 m -160.42 156.82 26.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.596 1.089 . . . . 0.0 111.367 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.479 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 10.7 t -63.83 -28.73 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.467 1.107 . . . . 0.0 110.666 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -68.85 -24.88 64.41 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 120.724 -1.235 . . . . 0.0 112.49 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.91 -52.96 5.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.34 1.456 . . . . 0.0 108.012 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.479 ' SG ' ' HA ' ' A' ' 69' ' ' VAL . 8.5 p -62.53 -29.96 70.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.144 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.66 -38.58 67.1 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.451 0.7 . . . . 0.0 112.273 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -73.65 -46.9 43.79 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.281 1.032 . . . . 0.0 108.602 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.04 -41.22 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.88 0.472 . . . . 0.0 111.556 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -66.48 0.38 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.173 1.789 . . . . 0.0 110.123 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -38.57 89.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.416 1.087 . . . . 0.0 110.508 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.13 -29.68 75.41 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 118.954 0.797 . . . . 0.0 112.332 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.558 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 96.1 mt -112.56 -0.99 15.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.263 1.025 . . . . 0.0 111.436 -173.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -55.45 122.86 12.17 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 166.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.56 78.15 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.708 -1.051 . . . . 0.0 112.721 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -173.03 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.767 1.284 . . . . 0.0 109.051 162.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -129.47 120.36 25.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.714 1.606 . . . . 0.0 107.537 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.558 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 4.2 m-30 -101.59 28.28 5.69 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.058 . . . . 0.0 109.196 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.97 -60.81 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.485 1.514 . . . . 0.0 108.842 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t30 177.46 -28.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 127.944 2.498 . . . . 0.0 109.037 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -103.03 167.37 9.88 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.319 0.648 . . . . 0.0 111.019 -173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.43 107.59 13.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.381 -160.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 13' ' ' MET . 64.5 t -66.84 108.6 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.872 0.869 . . . . 0.0 110.294 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.73 123.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 163.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.98 142.15 27.82 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 126.289 1.835 . . . . 0.0 106.892 170.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -149.05 154.96 40.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.392 1.077 . . . . 0.0 109.373 168.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -74.34 158.21 34.38 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 169.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.84 -176.74 5.1 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.078 2.551 . . . . 0.0 108.646 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -128.52 143.7 49.31 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 119.069 0.85 . . . . 0.0 109.355 -171.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.56 -30.44 12.11 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.794 2.329 . . . . 0.0 112.357 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.83 -41.73 74.7 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.287 0.948 . . . . 0.0 110.451 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -43.77 88.76 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.33 0.652 . . . . 0.0 110.167 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -70.71 -35.81 72.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.764 1.626 . . . . 0.0 112.593 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -64.35 -10.63 25.62 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.537 1.135 . . . . 0.0 112.618 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -134.8 -164.79 1.57 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.444 1.898 . . . . 0.0 107.411 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -110.02 29.26 7.8 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.687 1.195 . . . . 0.0 110.87 -178.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -79.54 72.48 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.533 1.159 . . . . 0.0 109.884 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 22.0 m-30 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -165.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 . . . . . 0 C--O 1.239 0.536 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.83 136.16 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 N-CA-C 107.619 -1.723 . . . . 0.0 107.619 165.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.4 p -104.81 168.06 9.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -88.31 16.81 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.637 -0.664 . . . . 0.0 112.418 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.54 150.65 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tp -122.52 162.46 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.481 1.113 . . . . 0.0 108.104 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -135.67 130.57 34.49 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.628 1.571 . . . . 0.0 108.866 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.47 132.12 46.86 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.601 1.16 . . . . 0.0 110.767 -164.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -120.15 162.91 18.53 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.142 0.977 . . . . 0.0 110.242 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 68.68 3.2 3.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.978 2.911 . . . . 0.0 114.222 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.501 ' HB3' HD13 ' A' ' 62' ' ' ILE . 32.6 ttm -72.59 -39.59 67.25 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 110.805 -170.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.27 167.21 25.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 127.009 2.124 . . . . 0.0 109.129 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.85 153.95 55.0 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.894 0.878 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.78 0.79 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.536 2.157 . . . . 0.0 112.624 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.64 9.88 10.91 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.108 1.763 . . . . 0.0 111.684 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -137.42 26.57 2.86 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.48 1.112 . . . . 0.0 111.493 -169.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.83 37.15 4.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.629 1.172 . . . . 0.0 110.39 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -92.92 -59.6 2.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -68.52 112.14 5.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.841 1.256 . . . . 0.0 111.67 -170.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.52 -34.86 74.71 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.146 1.378 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.55 -64.15 0.99 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.126 1.37 . . . . 0.0 110.345 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -63.86 -37.17 86.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 0.0 110.828 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -54.37 -37.71 65.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.377 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.85 -32.44 52.05 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.381 0.672 . . . . 0.0 111.078 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.06 -54.32 35.93 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.923 1.289 . . . . 0.0 109.384 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.83 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 -171.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.16 -39.85 81.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 118.245 0.475 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -78.54 -33.3 47.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.638 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.86 -43.8 98.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.324 1.059 . . . . 0.0 109.749 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 50.9 t -68.1 -30.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.826 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -64.47 -35.18 80.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 116.63 -1.653 . . . . 0.0 111.084 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.88 -52.43 59.98 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 120.24 1.382 . . . . 0.0 109.39 169.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 32' ' ' VAL . 6.3 pt-20 -63.44 -46.71 85.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.237 -162.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.66 -9.9 59.01 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.656 -1.278 . . . . 0.0 111.895 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -20.38 66.17 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.879 -1.138 . . . . 0.0 110.066 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -65.93 -3.87 5.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.204 1.402 . . . . 0.0 112.858 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -132.83 -10.99 3.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.907 1.231 . . . . 0.0 113.071 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.26 -165.22 38.72 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 119.675 1.125 . . . . 0.0 110.847 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -98.19 104.53 16.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.76 110.0 2.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.11 -62.77 1.41 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -163.36 -172.02 2.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.563 0.345 . . . . 0.0 110.326 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.76 139.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 128.27 2.628 . . . . 0.0 104.597 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -133.2 113.27 12.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.509 0.724 . . . . 0.0 110.699 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mt -126.58 86.79 57.75 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.927 2.891 . . . . 0.0 109.62 -162.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 114.16 3.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.435 2.756 . . . . 0.0 108.989 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 165.4 53.63 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 172.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 C--N 1.353 0.777 0 C-N-CA 124.115 3.21 . . . . 0.0 110.218 164.484 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 0 N--CA 1.449 -1.106 0 N-CA-C 107.93 -1.604 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.81 -10.08 62.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.147 1.356 . . . . 0.0 113.011 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.08 156.68 35.83 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.434 1.117 . . . . 0.0 112.281 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 0.1 83.05 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.179 1.371 . . . . 0.0 113.075 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' C ' HD12 ' A' ' 62' ' ' ILE . 1.7 mppt? -117.29 167.67 11.02 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.048 1.424 . . . . 0.0 108.966 -174.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.501 HD13 ' HB3' ' A' ' 13' ' ' MET . 3.0 mp -126.7 145.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 161.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -111.79 157.77 20.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 160.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.69 153.55 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.6 146.42 49.57 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.03 0.932 . . . . 0.0 109.113 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.53 177.91 6.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.157 1.383 . . . . 0.0 110.892 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -89.71 -15.38 32.67 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 85.0 p -150.6 152.92 34.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.194 0.906 . . . . 0.0 111.163 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.08 -27.51 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.481 1.513 . . . . 0.0 110.126 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.64 -54.65 40.05 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.317 1.047 . . . . 0.0 109.446 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.58 -33.0 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.07 -51.23 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 110.075 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -53.66 -35.78 61.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.389 1.076 . . . . 0.0 111.666 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -71.82 -52.17 18.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.346 0.976 . . . . 0.0 110.395 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.46 -51.03 68.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.405 1.482 . . . . 0.0 110.222 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.4 ttt -44.78 -68.86 0.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.174 1.79 . . . . 0.0 111.598 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -66.53 -29.0 69.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.393 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.58 -24.35 65.97 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.447 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.3 mt -129.07 0.88 5.25 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.068 1.434 . . . . 0.0 114.187 -166.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.3 m -58.01 120.63 8.89 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.87 66.14 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.449 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.84 179.2 0.53 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.585 1.692 . . . . 0.0 111.881 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.24 137.22 53.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 159.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.414 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.2 m-30 -110.8 14.43 22.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.639 0.776 . . . . 0.0 110.21 173.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.92 -85.38 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.176 2.59 . . . . 0.0 104.902 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -140.64 -10.46 1.05 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -112.73 161.58 16.71 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.024 1.738 . . . . 0.0 110.244 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.4 109.99 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.43 0.634 . . . . 0.0 109.374 -173.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.9 t -64.52 144.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.615 1.166 . . . . 0.0 108.092 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.8 150.07 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 166.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.86 144.17 47.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.294 2.237 . . . . 0.0 108.574 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 4.8 mmpt? -143.44 162.74 34.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.67 2.388 . . . . 0.0 106.727 159.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -67.21 160.7 26.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 157.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.15 -164.5 1.13 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 168.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -113.53 142.53 27.77 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.32 -24.38 2.52 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.471 2.114 . . . . 0.0 111.528 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.39 -54.18 40.43 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -69.03 -15.6 63.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.199 0.6 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -82.35 -37.84 25.08 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.051 1.34 . . . . 0.0 110.973 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -72.23 2.21 6.36 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.016 1.327 . . . . 0.0 112.325 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -134.54 -164.52 1.52 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.734 2.414 . . . . 0.0 109.341 -163.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.531 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 5.6 ttm180 -130.26 25.1 5.19 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.931 2.092 . . . . 0.0 110.834 173.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 42.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.942 -1.098 . . . . 0.0 110.344 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.531 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 6.2 m-85 . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 119.644 -0.217 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.54 149.1 79.69 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.01 2.473 . . . . 0.0 109.27 165.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 p -139.96 170.81 15.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.29 1.836 . . . . 0.0 107.01 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.56 8.1 1.22 Allowed 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.852 -1.155 . . . . 0.0 111.468 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.9 t -129.04 111.28 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.425 1.49 . . . . 0.0 108.047 -162.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -124.38 129.44 50.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -171.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.7 t -101.0 148.81 24.61 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.404 ' HB3' ' HE3' ' A' ' 13' ' ' MET . 48.9 mt -132.62 105.52 7.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.214 1.805 . . . . 0.0 108.33 -162.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -99.56 165.52 11.59 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.411 0.624 . . . . 0.0 111.131 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.31 28.72 18.35 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 128.744 2.817 . . . . 0.0 111.423 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.404 ' HE3' ' HB3' ' A' ' 10' ' ' LEU . 2.4 ttm -84.21 -56.11 3.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.5 -0.75 . . . . 0.0 111.276 -168.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.4 157.34 27.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.128 1.771 . . . . 0.0 107.399 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -98.51 150.03 36.32 Favored Pre-proline 0 C--O 1.235 0.309 0 O-C-N 120.867 -1.146 . . . . 0.0 110.082 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -68.24 1.25 3.66 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.261 2.641 . . . . 0.0 112.912 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -127.14 12.44 7.13 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.078 1.751 . . . . 0.0 111.385 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.67 -14.58 7.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.254 0.622 . . . . 0.0 111.653 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -76.99 66.76 2.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.831 1.252 . . . . 0.0 110.707 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -130.64 -57.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.29 0.636 . . . . 0.0 109.487 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 112.48 1.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.68 1.192 . . . . 0.0 111.417 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.4 -22.24 66.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.237 1.415 . . . . 0.0 112.561 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.9 -55.62 4.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.306 1.042 . . . . 0.0 110.304 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -40.03 90.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.119 1.767 . . . . 0.0 110.473 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -49.98 -43.59 50.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.651 1.58 . . . . 0.0 112.667 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.68 -43.15 56.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.549 1.14 . . . . 0.0 109.285 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -63.74 -27.7 69.38 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.96 -0.462 . . . . 0.0 110.852 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -77.24 -24.72 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.521 1.128 . . . . 0.0 110.801 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.17 -47.32 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 120.535 -1.353 . . . . 0.0 107.718 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -72.31 -37.03 69.03 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.628 1.171 . . . . 0.0 111.988 -164.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -60.58 -42.08 95.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 111.629 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.58 -27.12 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 125.129 1.372 . . . . 0.0 110.902 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -62.0 -43.86 97.95 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.136 -0.977 . . . . 0.0 109.883 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.95 -52.52 65.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.523 0.729 . . . . 0.0 110.743 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -61.1 -35.16 76.27 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.732 0.777 . . . . 0.0 110.964 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t -76.2 -38.96 55.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.314 1.045 . . . . 0.0 109.671 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -51.9 -25.11 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.852 1.661 . . . . 0.0 111.981 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -61.28 -31.84 71.67 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.655 -1.278 . . . . 0.0 112.47 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.87 -8.29 25.94 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 112.535 -170.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.92 -178.05 19.03 Favored Glycine 0 CA--C 1.506 -0.526 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.8 tp -103.36 121.2 42.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -160.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.56 136.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.385 2.274 . . . . 0.0 108.383 172.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -98.49 -52.0 3.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.31 2.244 . . . . 0.0 109.689 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -152.01 158.4 43.02 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.118 0.567 . . . . 0.0 110.367 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.3 mt -137.33 92.21 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.73 113.11 23.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.555 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -123.79 85.64 53.54 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 125.16 1.384 . . . . 0.0 107.313 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.82 148.7 41.47 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.64 1.56 . . . . 0.0 108.323 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -137.97 160.23 65.32 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 121.004 -1.06 . . . . 0.0 110.928 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 121.964 1.776 . . . . 0.0 110.753 -178.333 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.449 -1.123 0 N-CA-C 108.451 -1.404 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.87 28.93 71.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 124.156 0.884 . . . . 0.0 111.426 169.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.5 t -69.48 153.99 42.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.153 1.781 . . . . 0.0 110.632 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.29 34.07 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.512 1.529 . . . . 0.0 114.421 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 147.74 48.49 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.567 1.683 . . . . 0.0 110.639 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.6 144.52 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -114.56 123.79 50.24 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.45 120.25 62.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -95.2 140.74 29.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.91 -168.91 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.093 1.757 . . . . 0.0 108.851 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 p -119.67 -0.65 10.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.413 1.085 . . . . 0.0 112.544 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.9 m -159.88 146.21 15.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.512 1.525 . . . . 0.0 108.873 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.31 -13.81 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.379 1.072 . . . . 0.0 111.102 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.9 -41.26 15.1 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.132 -1.605 . . . . 0.0 110.83 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.92 -37.55 87.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.969 0.907 . . . . 0.0 110.917 -173.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.5 p -68.76 -37.05 79.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.003 0.521 . . . . 0.0 110.732 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -67.02 -31.05 71.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.139 0.976 . . . . 0.0 111.232 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -62.62 -56.09 21.0 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.603 1.092 . . . . 0.0 108.773 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.17 79.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.859 0.864 . . . . 0.0 110.973 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -44.57 -58.79 2.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.849 1.66 . . . . 0.0 111.502 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -79.45 -33.25 42.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.075 0.95 . . . . 0.0 112.166 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.6 84.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.554 1.073 . . . . 0.0 112.531 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -117.53 10.57 13.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.705 1.602 . . . . 0.0 111.19 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -56.31 124.59 18.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.04 -3.63 60.79 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.289 -0.728 . . . . 0.0 112.891 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -69.48 -178.45 1.41 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.156 1.478 . . . . 0.0 109.307 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -134.11 99.64 4.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.359 1.464 . . . . 0.0 109.347 -163.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.86 13.51 4.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.118 0.967 . . . . 0.0 112.318 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.44 -73.25 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.956 2.503 . . . . 0.0 104.521 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -146.04 -30.08 0.4 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.027 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt85 -101.01 164.98 11.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.887 0.875 . . . . 0.0 111.371 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.78 111.76 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.558 1.143 . . . . 0.0 109.794 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -72.15 134.81 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 109.884 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.4 t -113.12 143.39 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 166.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 p -112.81 146.92 37.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.493 1.517 . . . . 0.0 108.224 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.1 149.74 31.56 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.649 168.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.35 118.64 17.53 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.71 -175.72 5.52 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.25 0.62 . . . . 0.0 109.727 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -101.61 144.95 29.58 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.38 -28.78 32.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.868 3.045 . . . . 0.0 111.435 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.1 -45.24 21.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.571 1.149 . . . . 0.0 110.549 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.96 14.84 27.66 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.965 0.906 . . . . 0.0 111.739 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -103.85 -39.73 6.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.86 1.264 . . . . 0.0 110.488 163.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -58.84 -15.3 11.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.698 1.599 . . . . 0.0 113.903 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -129.67 -163.85 1.34 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.616 1.967 . . . . 0.0 108.821 -168.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.41 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -104.73 38.7 1.84 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.661 1.585 . . . . 0.0 111.336 173.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -102.71 21.27 15.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.824 2.05 . . . . 0.0 114.129 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 102' ' ' ARG . 4.5 m-85 . . . . . 0 CA--C 1.533 0.315 0 O-C-N 120.8 -1.187 . . . . 0.0 110.265 -170.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.97 131.45 23.93 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.956 1.77 . . . . 0.0 108.091 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 p -123.98 179.53 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -86.33 -4.85 59.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.197 -0.906 . . . . 0.0 113.388 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.8 m -83.83 179.81 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.855 1.207 . . . . 0.0 109.098 168.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tp -155.21 163.65 39.89 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 166.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.5 t -138.61 129.37 26.46 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.783 -1.198 . . . . 0.0 109.606 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.452 HD21 HG12 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -125.6 115.02 19.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 126.217 1.807 . . . . 0.0 107.761 -164.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mtm -87.83 162.5 16.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 75.37 23.89 1.46 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.515 1.926 . . . . 0.0 112.968 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.572 ' HB2' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -77.84 -82.92 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.683 HG22 HD11 ' A' ' 62' ' ' ILE . 31.6 m -88.02 159.84 2.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 127.721 2.408 . . . . 0.0 109.069 -170.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.82 165.32 40.17 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.283 0.633 . . . . 0.0 109.425 155.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.2 -17.76 24.2 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.604 1.536 . . . . 0.0 112.993 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -96.17 -7.14 36.59 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.673 1.189 . . . . 0.0 111.443 -165.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.12 -38.9 17.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.312 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 14' ' ' VAL . 93.0 mt -72.03 49.44 0.19 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.516 2.326 . . . . 0.0 115.421 -155.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.43 -11.5 3.57 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 119.857 -1.777 . . . . 0.0 110.317 -167.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.85 112.69 17.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.981 0.896 . . . . 0.0 110.066 -167.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.87 -16.1 37.87 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 129.669 3.188 . . . . 0.0 113.173 -165.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.39 -51.87 7.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.45 1.5 . . . . 0.0 110.5 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.31 -44.15 72.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.527 2.331 . . . . 0.0 108.618 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.481 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 54.0 t80 -58.43 -33.63 69.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.744 0.418 . . . . 0.0 111.818 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.63 -39.9 50.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.075 . . . . 0.0 111.599 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.2 -46.11 91.81 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.33 0.652 . . . . 0.0 109.581 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.5 mt -60.49 -39.15 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.745 1.218 . . . . 0.0 110.123 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.21 -33.07 58.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 120.751 -1.218 . . . . 0.0 110.411 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.24 -42.44 25.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.192 0.597 . . . . 0.0 110.957 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.37 -40.09 93.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.577 1.18 . . . . 0.0 110.532 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.5 t -89.01 -15.41 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.209 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -72.77 -38.22 67.38 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.52 -1.363 . . . . 0.0 111.034 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.5 -52.52 64.17 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.967 0.803 . . . . 0.0 109.825 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.35 -21.15 66.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.9 t -83.15 -34.32 26.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.848 1.659 . . . . 0.0 110.592 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -17.88 19.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 113.043 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.02 -32.71 71.14 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.914 0.886 . . . . 0.0 112.627 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.3 -7.86 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.148 0.886 . . . . 0.0 112.609 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.31 -134.51 3.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -167.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.12 112.63 4.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.78 120.67 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.674 1.226 . . . . 0.0 109.209 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -60.66 3.43 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.191 2.196 . . . . 0.0 108.155 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -160.22 -178.74 7.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.779 0.718 . . . . 0.0 110.91 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.45 136.67 57.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 126.578 1.951 . . . . 0.0 106.634 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.95 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.878 1.271 . . . . 0.0 110.167 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.06 86.14 21.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.649 1.979 . . . . 0.0 106.723 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 114.82 4.14 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.537 2.825 . . . . 0.0 109.748 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 2.4 mpp_? -72.96 159.77 84.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.156 0.982 . . . . 0.0 111.696 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.352 0.741 1 C-N-CA 125.926 4.418 . . . . 0.0 112.152 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 N-CA-C 107.515 -1.764 . . . . 0.0 107.515 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.54 -8.06 6.98 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.107 1.813 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.2 t -81.94 142.68 32.23 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.226 1.513 . . . . 0.0 110.229 -164.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.84 -12.2 24.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.002 1.763 . . . . 0.0 113.477 -170.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.495 ' C ' HD12 ' A' ' 62' ' ' ILE . 6.9 mptt -86.87 146.89 26.02 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HG22 ' A' ' 14' ' ' VAL . 1.9 mp -118.84 147.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 170.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -122.53 158.54 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 HD21 ' A' ' 10' ' ' LEU . 11.9 p -144.82 153.34 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 30.9 tt0 -132.58 139.25 47.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -114.47 174.91 5.72 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.245 1.418 . . . . 0.0 110.57 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -74.37 -23.2 58.97 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.934 -0.479 . . . . 0.0 112.111 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 t -154.69 161.87 41.37 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.631 1.205 . . . . 0.0 110.111 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.2 t -52.17 -39.56 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.592 1.557 . . . . 0.0 108.173 164.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -69.36 -35.09 75.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 117.027 -1.463 . . . . 0.0 113.688 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -85.19 -20.66 29.85 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.01 1.732 . . . . 0.0 111.503 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.3 t -69.68 -49.6 51.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.517 1.527 . . . . 0.0 110.243 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -54.74 -36.82 65.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.622 0.769 . . . . 0.0 112.141 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -71.54 -45.93 60.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.08 91.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 112.036 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.7 ttm -53.69 -68.33 0.19 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.381 0.991 . . . . 0.0 109.34 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -55.64 -34.95 65.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.782 0.833 . . . . 0.0 110.617 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.9 -20.87 76.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.86 -0.967 . . . . 0.0 114.355 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.59 2.33 10.12 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.085 1.354 . . . . 0.0 112.107 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -63.2 103.01 0.44 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.614 -1.304 . . . . 0.0 109.945 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.98 0.53 30.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.079 1.323 . . . . 0.0 112.897 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -74.25 -175.53 2.31 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.333 1.066 . . . . 0.0 111.958 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -138.29 115.99 11.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -107.97 24.21 13.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.55 1.54 . . . . 0.0 111.019 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.47 -64.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.318 1.847 . . . . 0.0 108.506 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.37 -17.99 0.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 171.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -113.71 166.6 11.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 109.925 -167.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.56 118.86 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 13' ' ' MET . 77.0 t -66.91 138.23 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.14 131.37 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.7 p -106.72 147.24 29.84 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.258 1.823 . . . . 0.0 108.826 -164.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -153.95 151.05 28.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.708 1.603 . . . . 0.0 108.065 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -77.42 152.32 34.35 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 166.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -172.14 2.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.929 1.691 . . . . 0.0 107.779 168.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -111.85 143.55 28.89 Favored Pre-proline 0 C--O 1.236 0.36 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.02 -23.5 16.01 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.814 3.009 . . . . 0.0 110.997 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -51.49 -53.31 38.65 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.76 0.824 . . . . 0.0 108.985 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.32 77.87 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.788 0.835 . . . . 0.0 111.214 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -70.46 -39.85 74.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.911 2.084 . . . . 0.0 112.54 -169.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -63.78 -42.16 97.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 109.811 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -93.38 -167.33 1.69 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.847 1.259 . . . . 0.0 110.475 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 7.0 ttm180 -100.17 39.8 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.763 -0.585 . . . . 0.0 110.55 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -99.3 88.88 4.03 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.048 -1.033 . . . . 0.0 109.42 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.457 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.238 0.499 0 C-N-CA 126.491 1.916 . . . . 0.0 107.379 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -71.53 148.09 53.16 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.743 . . . . 0.0 108.444 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.9 p -136.51 -179.84 5.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.28 5.56 5.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.305 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.56 143.97 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.698 1.199 . . . . 0.0 110.464 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 mt -131.43 159.59 37.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.209 2.204 . . . . 0.0 109.526 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 t -116.77 110.88 18.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.773 1.629 . . . . 0.0 106.974 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.02 153.54 20.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.6 mtm -134.23 176.8 8.27 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 61.62 12.89 4.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.879 1.671 . . . . 0.0 113.034 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -68.33 -59.52 3.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 153.84 38.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.074 2.15 . . . . 0.0 108.227 -172.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -82.01 164.4 48.63 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.074 1.35 . . . . 0.0 109.548 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.87 5.28 2.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 124.116 3.211 . . . . 0.0 113.734 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -129.56 26.59 5.33 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.547 1.539 . . . . 0.0 110.326 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -141.05 24.64 2.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.301 1.84 . . . . 0.0 111.838 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -128.54 75.51 1.64 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.482 2.313 . . . . 0.0 107.039 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -134.35 -49.93 0.79 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.296 1.439 . . . . 0.0 108.166 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.92 105.96 3.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.904 2.481 . . . . 0.0 108.974 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.61 -19.73 41.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.117 1.367 . . . . 0.0 112.736 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.24 -65.71 0.98 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.35 -29.0 68.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.168 1.387 . . . . 0.0 111.897 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.22 -44.17 64.64 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.82 -0.55 . . . . 0.0 111.697 172.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.16 -43.77 50.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -55.88 -43.97 77.72 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.29 1.036 . . . . 0.0 111.119 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -68.31 -42.53 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.823 0.849 . . . . 0.0 109.604 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -59.07 -40.03 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.799 1.182 . . . . 0.0 109.515 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.77 -32.56 67.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.446 0.566 . . . . 0.0 112.361 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.84 -40.75 88.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.842 0.353 . . . . 0.0 110.753 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.1 t -78.47 -38.7 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 118.264 -0.874 . . . . 0.0 109.403 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -52.39 -36.23 53.48 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.07 0.85 . . . . 0.0 109.912 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.44 -38.02 88.16 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.546 0.612 . . . . 0.0 111.124 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.59 -47.65 18.85 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.686 ' SG ' HG11 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -61.74 -29.81 70.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 111.65 174.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.5 t -63.52 -9.38 12.79 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.633 1.173 . . . . 0.0 113.225 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -61.56 -41.89 98.03 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.138 -2.227 . . . . 0.0 111.111 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.67 -8.42 50.04 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.214 1.406 . . . . 0.0 113.146 -160.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.12 -159.07 27.82 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -157.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.64 120.53 36.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.419 1.109 . . . . 0.0 111.759 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.686 HG11 ' SG ' ' A' ' 36' ' ' CYS . 1.5 p -75.9 142.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.051 167.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.3 -54.67 2.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.526 1.931 . . . . 0.0 109.288 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -159.34 155.62 27.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.474 0.579 . . . . 0.0 110.621 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mt -124.34 118.57 54.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 127.143 2.177 . . . . 0.0 105.888 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 133.53 38.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.91 86.61 26.48 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -52.06 145.74 32.61 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.237 1.958 . . . . 0.0 110.128 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.67 148.14 67.19 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.33 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 C-N-CA 123.063 2.509 . . . . 0.0 111.067 178.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 N-CA-C 109.762 -0.899 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.46 -1.37 20.44 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.84 1.21 . . . . 0.0 113.383 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -66.45 137.45 56.84 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.509 1.654 . . . . 0.0 111.158 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.73 1.74 79.83 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.935 1.731 . . . . 0.0 113.608 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -108.87 123.23 48.74 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.59 106.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -170.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -91.11 141.94 28.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.8 135.69 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.99 148.82 41.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.033 1.733 . . . . 0.0 107.184 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -129.99 168.83 16.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.686 1.594 . . . . 0.0 109.999 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 p -70.01 -4.74 22.29 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.28 1.432 . . . . 0.0 114.088 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.2 t -171.51 165.42 6.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.256 1.822 . . . . 0.0 107.984 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.6 t -52.93 -47.82 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.251 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -61.83 -48.35 80.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.312 0.645 . . . . 0.0 110.262 -172.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.29 -40.24 93.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.227 1.011 . . . . 0.0 110.342 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -44.69 94.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.247 1.019 . . . . 0.0 109.423 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.5 -51.85 57.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.389 1.476 . . . . 0.0 110.774 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -61.05 -47.35 86.81 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.77 74.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.326 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -62.25 -65.52 0.68 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.099 0.863 . . . . 0.0 109.438 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -70.04 -24.4 63.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.968 -0.457 . . . . 0.0 111.301 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.06 -24.28 73.16 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.364 -0.687 . . . . 0.0 112.505 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -127.84 -6.24 5.63 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.217 1.008 . . . . 0.0 112.468 -171.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -59.83 142.05 54.19 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.871 1.214 . . . . 0.0 108.08 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.2 -1.32 81.1 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.206 1.384 . . . . 0.0 114.029 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -78.09 -174.74 3.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.373 2.086 . . . . 0.0 112.005 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -118.66 129.97 55.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -107.1 13.47 27.38 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.96 1.254 . . . . 0.0 110.787 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.73 -74.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.73 -12.14 0.45 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -122.4 160.91 24.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.187 0.903 . . . . 0.0 110.719 -165.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.82 128.91 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 123.159 0.287 . . . . 0.0 111.764 -165.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.56 87.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.77 146.37 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.0 p -102.11 164.36 11.74 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.491 0.717 . . . . 0.0 109.489 171.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -146.75 150.47 35.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.275 1.43 . . . . 0.0 107.582 154.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -67.43 156.28 36.96 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.358 1.036 . . . . 0.0 109.461 163.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.59 -172.38 2.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.902 1.281 . . . . 0.0 108.368 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -108.83 145.34 31.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 158.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.99 -22.24 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.541 2.828 . . . . 0.0 112.723 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -44.64 -42.11 7.21 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.867 2.067 . . . . 0.0 111.969 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 p -91.23 -27.57 18.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 112.28 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -72.79 -27.25 61.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.818 2.047 . . . . 0.0 110.637 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -65.21 -12.47 51.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -130.48 -164.18 1.4 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.75 2.02 . . . . 0.0 107.852 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 2.2 ttt180 -107.1 23.44 14.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.417 1.087 . . . . 0.0 111.252 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.68 97.83 6.71 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.72 -1.237 . . . . 0.0 110.155 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 5.6 m-85 . . . . . 0 C--O 1.235 0.29 0 C-N-CA 124.651 1.181 . . . . 0.0 108.416 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.83 149.14 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.829 1.686 . . . . 0.0 108.827 167.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.0 p -128.12 171.32 12.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 4.4 pt-20 -72.06 -10.49 59.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.773 1.229 . . . . 0.0 111.716 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -114.01 155.0 15.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 119.537 1.062 . . . . 0.0 110.056 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.1 124.82 21.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 108.63 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -80.22 129.77 34.74 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.0 122.88 42.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.323 1.449 . . . . 0.0 108.411 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -97.03 163.96 12.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 74.22 18.88 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.063 2.145 . . . . 0.0 113.649 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -73.41 0.31 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 165.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.62 174.23 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 126.183 1.793 . . . . 0.0 109.616 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -112.47 146.29 34.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 125.022 1.329 . . . . 0.0 107.654 172.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -61.37 7.37 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.808 1 C-N-CA 127.892 5.728 . . . . 0.0 116.055 -175.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.34 -0.33 1.81 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.258 1.823 . . . . 0.0 111.925 -154.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -117.42 -6.08 11.23 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 112.937 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' H ' ' A' ' 19' ' ' LEU . 2.2 mm? -68.95 -4.66 17.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.355 1.462 . . . . 0.0 113.849 -169.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.31 -25.84 60.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.978 2.111 . . . . 0.0 111.564 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.32 129.3 34.99 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.381 0.991 . . . . 0.0 109.614 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.28 -17.05 43.91 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.209 1.403 . . . . 0.0 112.393 -170.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -87.88 -61.82 1.63 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.148 0.979 . . . . 0.0 109.278 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.27 -38.03 73.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.565 0.746 . . . . 0.0 111.816 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -53.22 -39.27 63.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.258 1.023 . . . . 0.0 112.517 172.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -84.29 -31.89 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.428 0.691 . . . . 0.0 111.438 -171.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -53.95 -45.41 71.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.8 mt -67.09 -15.07 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.909 0.883 . . . . 0.0 111.724 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.0 t -86.01 -44.67 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 119.913 -1.742 . . . . 0.0 108.773 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.9 -42.54 69.84 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.684 0.793 . . . . 0.0 111.153 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -60.83 -43.6 98.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.754 1.74 . . . . 0.0 109.647 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.87 -21.78 6.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.316 -167.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -61.13 -43.34 99.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.086 -1.009 . . . . 0.0 108.826 165.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.48 -43.14 91.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.14 0.882 . . . . 0.0 111.743 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.68 -46.13 76.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.811 0.732 . . . . 0.0 110.274 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -70.89 -27.82 64.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.684 0.794 . . . . 0.0 111.276 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -55.53 -16.68 4.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.006 1.723 . . . . 0.0 113.339 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.31 -11.09 38.29 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.978 -1.701 . . . . 0.0 113.692 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.67 -15.89 10.74 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.65 -168.56 27.36 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 107.181 -2.367 . . . . 0.0 107.181 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.7 tp -99.87 119.24 37.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -162.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.58 117.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 167.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -56.23 15.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 158.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 p -160.36 170.01 21.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.504 0.593 . . . . 0.0 112.357 -166.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.64 153.1 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.14 133.21 45.37 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -137.71 85.61 20.02 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.51 148.34 92.57 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.394 1.396 . . . . 0.0 109.69 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -118.18 150.33 47.37 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 108.537 -167.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.457 -0.628 0 C-N-CA 123.079 2.519 . . . . 0.0 108.641 172.599 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.454 -0.805 0 N-CA-C 108.409 -1.419 . . . . 0.0 108.409 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.75 12.83 61.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.525 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.19 154.24 42.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.531 1.666 . . . . 0.0 110.667 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.1 -32.36 4.67 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.09 1.805 . . . . 0.0 112.89 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -72.17 172.59 9.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.11 1.455 . . . . 0.0 109.254 173.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.95 151.19 35.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 164.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.84 150.26 33.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 165.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.32 159.24 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.67 121.42 10.54 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -93.63 162.93 13.75 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.507 0.67 . . . . 0.0 109.361 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -72.93 -1.55 17.41 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.029 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.3 m -158.45 155.34 28.38 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 121.135 1.789 . . . . 0.0 111.627 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.7 t -59.76 -32.29 49.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.627 1.571 . . . . 0.0 109.852 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.73 -59.53 5.24 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.479 -0.763 . . . . 0.0 110.297 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.55 -39.5 57.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.335 1.454 . . . . 0.0 109.891 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 t -64.35 -50.11 69.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.973 1.309 . . . . 0.0 110.374 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.15 -30.67 62.5 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.871 1.268 . . . . 0.0 112.206 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -78.03 -50.13 12.69 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.0 0.92 . . . . 0.0 109.498 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.27 -47.35 78.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.361 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.2 ttm -48.06 -67.55 0.26 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.027 0.831 . . . . 0.0 110.752 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.49 -25.33 66.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.796 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.33 -26.75 74.09 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.649 -1.084 . . . . 0.0 112.565 174.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.494 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 94.3 mt -123.39 -5.71 8.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.608 1.204 . . . . 0.0 112.727 -167.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 m -50.59 121.08 5.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.508 1.123 . . . . 0.0 108.412 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.25 8.03 86.91 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 118.499 -1.167 . . . . 0.0 114.41 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -78.26 -169.68 1.72 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.676 1.238 . . . . 0.0 109.974 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.85 132.2 53.72 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.494 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 4.2 m-30 -110.57 19.96 18.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.698 1.199 . . . . 0.0 109.737 174.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.57 -65.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.885 1.674 . . . . 0.0 107.179 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 -29.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.076 1.351 . . . . 0.0 111.452 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -88.51 166.5 14.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.671 -0.643 . . . . 0.0 110.255 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.95 135.49 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.1 t -93.75 111.69 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.29 142.78 13.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.8 p -119.96 151.43 38.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.369 1.068 . . . . 0.0 108.128 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -150.0 144.16 25.65 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.174 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -66.48 138.17 57.34 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 120.252 1.387 . . . . 0.0 108.218 161.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 -164.37 0.94 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -116.73 143.02 30.59 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.56 -27.8 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.132 3.221 . . . . 0.0 111.991 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -46.88 72.2 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 120.902 -1.123 . . . . 0.0 111.083 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.81 55.17 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.895 1.678 . . . . 0.0 111.325 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -92.65 -51.94 4.87 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.4 1.88 . . . . 0.0 109.251 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -62.5 -30.29 71.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.858 0.463 . . . . 0.0 111.599 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -104.96 -178.25 3.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.539 1.936 . . . . 0.0 108.659 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -111.49 76.84 1.0 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.32 69.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 . . . . . 0 C--O 1.236 0.349 0 C-N-CA 123.219 0.608 . . . . 0.0 110.075 -177.952 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 120.379 0.133 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.76 148.37 52.36 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.775 2.317 . . . . 0.0 108.502 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.2 p -135.79 155.21 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.16 -3.02 3.32 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 m -93.64 -167.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.472 0.653 . . . . 0.0 110.354 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.11 160.33 43.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.467 2.307 . . . . 0.0 105.877 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 t -137.65 114.29 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 mp -125.05 153.93 42.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 110.618 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mtm -138.27 170.25 16.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 111.046 -172.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.03 13.24 5.52 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.334 2.254 . . . . 0.0 112.658 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 36.9 ttm -76.17 -75.71 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -97.24 155.9 3.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.748 1.219 . . . . 0.0 108.738 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.04 156.87 38.4 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.364 1.466 . . . . 0.0 107.065 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.91 -12.37 34.08 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.434 2.756 . . . . 0.0 113.835 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -105.1 8.65 34.3 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.013 1.725 . . . . 0.0 110.756 -168.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -124.46 -16.96 6.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.393 1.077 . . . . 0.0 111.596 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.73 56.14 3.42 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.395 1.478 . . . . 0.0 109.589 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.44 -49.06 1.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.026 0.93 . . . . 0.0 108.866 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.1 92.17 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.727 1.611 . . . . 0.0 110.327 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.69 -17.7 49.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.289 1.835 . . . . 0.0 113.097 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.21 -35.0 10.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 0.0 110.802 -172.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -74.61 -36.32 62.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.712 1.205 . . . . 0.0 111.082 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.89 -40.15 13.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.839 1.655 . . . . 0.0 111.782 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.08 -46.49 74.14 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 110.927 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.96 -46.83 79.92 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.954 1.302 . . . . 0.0 109.926 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.84 -45.29 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.889 0.875 . . . . 0.0 109.813 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 t -57.26 -47.16 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.96 -37.63 88.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.555 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -76.15 -27.7 57.1 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.963 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.4 t -76.73 -34.17 22.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.61 -28.74 69.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.045 -1.034 . . . . 0.0 111.644 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.21 -47.18 78.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.854 0.752 . . . . 0.0 110.803 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.7 -42.96 69.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.943 0.497 . . . . 0.0 110.479 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.441 ' HA ' HD11 ' A' ' 79' ' ' LEU 0.295 0.8 OUTLIER -71.96 -26.12 62.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.707 173.53 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -11.83 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 120.543 1.52 . . . . 0.0 113.04 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -63.2 -20.19 65.19 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 119.77 -1.831 . . . . 0.0 113.986 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -117.28 3.84 12.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.369 0.668 . . . . 0.0 112.524 -165.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.36 -139.4 5.99 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -168.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -137.54 133.31 34.36 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.141 1.471 . . . . 0.0 109.664 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -84.69 122.2 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.24 1.016 . . . . 0.0 108.48 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -73.02 -61.35 1.85 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.151 0.981 . . . . 0.0 108.866 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 t -151.84 166.68 30.68 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.781 0.832 . . . . 0.0 109.358 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 64' ' ' VAL . 7.2 mt -133.74 123.36 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -110.87 114.13 27.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.067 1.347 . . . . 0.0 109.808 -167.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.29 86.26 30.91 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.861 1.664 . . . . 0.0 107.94 -167.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.19 150.16 87.92 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 120.946 1.097 . . . . 0.0 109.821 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -105.39 165.43 13.16 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 109.505 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.534 0.513 0 C-N-CA 123.256 2.637 . . . . 0.0 110.883 173.859 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 N--CA 1.446 -1.279 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.57 9.68 85.39 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.805 -0.997 . . . . 0.0 113.258 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.14 154.6 37.66 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.294 1.047 . . . . 0.0 111.431 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.63 -4.56 50.69 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.671 1.605 . . . . 0.0 115.223 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -98.44 147.0 25.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.706 1.253 . . . . 0.0 107.833 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.91 139.65 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -123.12 139.17 54.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 45' ' ' ILE . 98.2 t -132.11 110.23 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -169.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 37.1 tt0 -88.62 138.96 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.522 1.129 . . . . 0.0 108.012 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.76 174.54 6.53 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.403 1.481 . . . . 0.0 110.227 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -32.41 67.51 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.696 1.199 . . . . 0.0 113.601 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.3 m -168.85 167.25 11.08 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.285 1.034 . . . . 0.0 110.324 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.406 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 2.9 t -51.73 -40.12 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 122.901 1.334 . . . . 0.0 110.328 175.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.78 -2.51 20.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.605 -1.31 . . . . 0.0 114.036 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -109.01 -33.97 6.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.237 1.015 . . . . 0.0 109.373 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 69' ' ' VAL . 29.2 p -75.82 -34.37 60.13 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.472 -0.768 . . . . 0.0 109.504 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -50.27 -35.43 27.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.883 2.073 . . . . 0.0 111.83 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.3 -46.13 12.11 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.002 0.921 . . . . 0.0 108.875 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.78 76.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.581 -1.2 . . . . 0.0 111.277 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 mtp -46.59 -64.28 0.8 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 108.907 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -68.2 -34.11 75.67 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.355 -173.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.07 -7.06 70.07 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.76 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.441 HD11 ' HA ' ' A' ' 36' ' ' CYS . 43.8 mt -131.21 -3.08 3.92 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 111.811 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -62.83 108.64 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.831 -1.168 . . . . 0.0 109.127 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.24 67.01 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.78 1.181 . . . . 0.0 113.14 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -64.57 177.36 0.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.295 1.547 . . . . 0.0 109.429 165.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -131.92 89.97 2.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -167.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -80.45 13.38 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.905 -0.497 . . . . 0.0 112.119 -168.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.08 -84.45 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.152 3.381 . . . . 0.0 103.288 156.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -147.06 18.92 1.25 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.426 -0.796 . . . . 0.0 112.022 -168.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 -132.86 171.7 13.58 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.748 -1.22 . . . . 0.0 110.338 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 t -87.3 109.56 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -73.17 124.56 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.69 163.62 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 p -132.88 163.29 29.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.186 2.194 . . . . 0.0 108.753 -168.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -164.6 158.9 18.48 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 130.127 3.371 . . . . 0.0 105.578 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.11 145.3 31.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 157.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.61 -164.3 1.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.01 1.324 . . . . 0.0 109.67 172.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -109.92 144.83 30.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 157.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.42 -19.55 10.19 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.825 3.016 . . . . 0.0 111.708 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -57.0 -59.28 5.29 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.991 -1.068 . . . . 0.0 108.611 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.4 m -70.01 -0.78 8.14 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.254 2.222 . . . . 0.0 111.9 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 65' ' ' GLU . 45.8 t80 -91.06 -48.32 7.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.412 1.485 . . . . 0.0 110.522 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -68.9 -45.6 70.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.102 0.961 . . . . 0.0 109.342 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -76.29 170.89 15.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.078 0.942 . . . . 0.0 109.222 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -101.49 68.11 1.17 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.56 74.89 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.93 1.348 . . . . 0.0 108.778 169.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 177.041 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.63 136.51 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.678 2.252 . . . . 0.0 108.705 166.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -140.82 171.28 14.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.49 -2.57 14.4 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.19 -0.944 . . . . 0.0 113.056 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.552 HG22 ' OE1' ' A' ' 65' ' ' GLU . 14.8 t -107.44 92.55 2.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.657 1.183 . . . . 0.0 108.439 -167.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.63 125.88 29.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.59 124.06 35.46 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -123.82 111.24 15.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.271 1.034 . . . . 0.0 109.585 175.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mtm -84.55 166.49 17.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.73 0.812 . . . . 0.0 109.778 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 70.1 14.69 7.72 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.718 2.007 . . . . 0.0 113.033 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -58.63 7.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.45 163.34 24.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.534 1.134 . . . . 0.0 111.709 -161.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -103.4 163.68 16.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.052 2.141 . . . . 0.0 109.35 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.03 4.88 4.36 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.892 2.394 . . . . 0.0 113.247 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.55 14.83 11.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.831 1.252 . . . . 0.0 111.506 -171.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.47 24.04 2.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.377 1.071 . . . . 0.0 111.123 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.7 mt -133.2 37.43 3.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.438 1.895 . . . . 0.0 109.82 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -113.58 -5.62 13.41 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.274 1.029 . . . . 0.0 111.245 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.38 127.51 53.75 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.94 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.92 -12.72 60.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.89 0.876 . . . . 0.0 111.269 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.19 -59.31 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.039 0.936 . . . . 0.0 108.728 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.67 -36.98 77.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.057 1.743 . . . . 0.0 111.136 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -52.62 -48.55 66.27 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.928 1.291 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.2 -36.47 66.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.911 0.778 . . . . 0.0 110.221 -172.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -60.39 -49.32 78.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.394 0.678 . . . . 0.0 109.415 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -63.22 -41.18 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.1 t -56.18 -48.25 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.459 1.027 . . . . 0.0 110.045 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.31 -31.39 60.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.954 1.252 . . . . 0.0 112.924 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.83 -45.52 74.44 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.603 0.716 . . . . 0.0 110.609 176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.8 t -72.55 -41.82 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -30.65 38.19 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.105 0.866 . . . . 0.0 110.349 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.67 -36.49 67.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 120.344 1.429 . . . . 0.0 113.189 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.32 -43.13 98.67 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.261 0.9 OUTLIER -79.94 -17.47 52.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -53.28 -29.57 33.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.052 1.741 . . . . 0.0 110.69 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -59.46 -20.35 54.52 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.264 -0.898 . . . . 0.0 112.44 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -125.64 51.64 1.71 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.111 1.365 . . . . 0.0 108.35 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.57 -116.12 2.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 125.269 1.414 . . . . 0.0 110.377 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 67' ' ' THR . 1.3 tm? -154.47 113.13 3.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.82 116.22 21.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.036 1.734 . . . . 0.0 107.433 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -69.31 -57.82 4.82 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.085 0.554 . . . . 0.0 109.685 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.46 166.36 25.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 0.0 109.639 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 111.58 27.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 125.748 1.619 . . . . 0.0 107.11 -169.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.24 124.81 30.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.599 0.76 . . . . 0.0 109.965 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.94 85.48 22.97 Favored Pre-proline 0 C--O 1.225 -0.234 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.1 -15.15 42.56 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.52 2.146 . . . . 0.0 114.784 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.347 0.0 OUTLIER 60.41 160.86 0.11 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 128.767 2.827 . . . . 0.0 116.438 172.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.354 0.868 0 C-N-CA 123.812 3.008 . . . . 0.0 110.33 172.117 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo . . . . . 0 N--CA 1.447 -1.237 0 N-CA-C 108.765 -1.283 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.01 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 127.055 2.264 . . . . 0.0 111.973 -175.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.28 130.57 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.296 1.548 . . . . 0.0 111.036 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.07 -13.66 66.43 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.768 1.651 . . . . 0.0 113.482 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.17 122.89 40.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.45 148.72 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 167.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.37 127.49 46.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG12 HD11 ' A' ' 10' ' ' LEU . 10.1 p -121.73 119.79 59.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -174.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.552 ' OE1' HG22 ' A' ' 7' ' ' VAL . 1.5 tp10 -88.58 150.61 22.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.674 1.59 . . . . 0.0 107.645 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -132.93 162.99 30.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.405 1.082 . . . . 0.0 110.547 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 41' ' ' LEU . 7.4 p -72.55 -6.5 44.4 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -154.28 157.3 38.48 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 120.203 1.365 . . . . 0.0 113.137 162.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.21 -16.79 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 112.107 167.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -94.24 -18.85 21.26 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.424 -1.423 . . . . 0.0 112.137 -175.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -85.03 -41.98 15.28 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.285 0.634 . . . . 0.0 110.271 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 p -62.65 -31.92 72.88 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.647 -0.658 . . . . 0.0 110.818 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -63.91 -13.91 49.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 113.206 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -95.73 -41.2 8.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 120.315 1.416 . . . . 0.0 108.488 172.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.11 45.69 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.024 0.929 . . . . 0.0 111.621 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -59.45 -31.69 69.54 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -162.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.86 -40.15 9.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.711 2.405 . . . . 0.0 110.327 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.92 -25.57 67.98 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 121.731 -0.606 . . . . 0.0 112.285 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -124.72 22.52 8.2 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.94 2.096 . . . . 0.0 110.29 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.2 m -56.87 127.47 31.89 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.277 -0.889 . . . . 0.0 109.092 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.65 5.8 64.96 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 118.628 -1.096 . . . . 0.0 112.975 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -173.65 0.17 Allowed 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.612 1.706 . . . . 0.0 110.17 176.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -124.19 121.21 34.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.8 14.06 22.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.181 0.991 . . . . 0.0 110.965 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.19 -66.45 0.09 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.67 -25.78 0.14 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.169 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -105.99 172.39 6.83 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.635 1.174 . . . . 0.0 110.452 -169.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.06 118.14 28.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.41 155.09 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.426 1.09 . . . . 0.0 109.628 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.69 147.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 158.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.71 144.43 42.97 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.543 1.937 . . . . 0.0 106.799 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -147.87 145.05 28.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.049 1.74 . . . . 0.0 107.936 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -64.79 138.13 58.2 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 164.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -165.83 1.05 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.543 1.937 . . . . 0.0 107.752 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.62 144.12 52.01 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.413 ' HA ' HG21 ' A' ' 7' ' ' VAL . 72.0 Cg_endo -78.7 -21.27 10.0 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.17 2.58 . . . . 0.0 111.644 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -49.66 -55.41 13.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -42.13 96.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.949 0.9 . . . . 0.0 109.538 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -64.54 -38.81 92.29 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.277 1.031 . . . . 0.0 112.537 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -63.33 -4.38 2.58 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.339 -0.851 . . . . 0.0 112.977 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -137.9 -173.89 3.63 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 127.675 2.39 . . . . 0.0 108.43 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.477 ' HA ' ' CE1' ' A' ' 104' ' ' PHE . 7.7 mpt_? -123.35 68.72 1.01 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -125.36 27.17 6.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.716 1.206 . . . . 0.0 112.494 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.241 0.622 0 C-N-CA 123.878 0.871 . . . . 0.0 109.547 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 119.995 -0.05 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.78 143.48 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.772 1.648 . . . . 0.0 108.751 162.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -120.32 174.37 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.962 1.305 . . . . 0.0 107.738 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.22 -5.02 55.45 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.071 0.948 . . . . 0.0 113.161 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.78 -175.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 118.856 0.753 . . . . 0.0 109.985 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.41 155.15 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.312 1.845 . . . . 0.0 106.733 164.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.3 t -113.11 136.77 52.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 169.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.1 mt -129.85 95.48 3.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.152 2.181 . . . . 0.0 107.384 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.8 mtm -87.65 157.82 19.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 66.45 30.07 8.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.69 1.596 . . . . 0.0 112.751 171.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttm -81.28 -82.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 162.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.9 m -93.73 146.38 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.822 1.649 . . . . 0.0 110.437 -162.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.74 155.04 42.13 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.253 1.021 . . . . 0.0 109.371 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.64 4.26 2.24 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.334 2.69 . . . . 0.0 113.667 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.41 6.03 8.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.986 1.714 . . . . 0.0 111.863 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -124.05 -8.56 7.7 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.907 0.883 . . . . 0.0 112.82 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.96 63.73 7.2 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.089 -1.007 . . . . 0.0 109.491 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.93 -39.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.058 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.28 100.94 0.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.373 1.069 . . . . 0.0 109.89 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.77 -2.98 0.17 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 130.219 3.408 . . . . 0.0 114.938 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.23 -54.77 1.69 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.789 2.836 . . . . 0.0 108.651 -164.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.27 -41.75 98.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.761 1.225 . . . . 0.0 111.704 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -46.98 -40.47 14.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.466 1.506 . . . . 0.0 110.854 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.91 -25.91 40.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -63.53 -52.68 60.13 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.641 1.176 . . . . 0.0 108.954 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.31 -34.97 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.405 1.082 . . . . 0.0 110.087 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.73 -47.1 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.3 0.64 . . . . 0.0 110.141 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.36 -37.69 74.64 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.688 1.131 . . . . 0.0 112.117 -172.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.18 -38.44 91.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.23 1.015 . . . . 0.0 110.505 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.36 -33.18 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 109.763 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -66.39 -32.79 74.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.95 -54.53 37.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 110.623 171.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -63.66 -37.55 87.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.812 0.815 . . . . 0.0 111.245 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.25 -22.71 57.65 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.376 1.07 . . . . 0.0 110.543 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 t -72.37 -7.51 50.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.271 1.029 . . . . 0.0 111.282 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -73.47 -9.54 58.8 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 119.351 -2.093 . . . . 0.0 112.29 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.04 1.12 9.21 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.719 1.145 . . . . 0.0 112.668 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.12 -164.93 28.61 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 106.129 -2.788 . . . . 0.0 106.129 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -108.27 108.67 19.77 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.277 1.539 . . . . 0.0 109.984 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.67 116.05 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -55.26 -74.67 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.819 2.048 . . . . 0.0 107.024 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -174.29 4.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.259 1.024 . . . . 0.0 109.123 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.86 143.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.585 1.954 . . . . 0.0 107.145 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -130.3 118.35 21.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.211 1.404 . . . . 0.0 109.301 -172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.4 mt -131.31 86.84 49.23 Favored Pre-proline 0 C--O 1.234 0.242 0 C-N-CA 125.924 1.69 . . . . 0.0 107.921 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -55.79 124.94 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 167.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.85 47.93 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.386 . . . . 0.0 108.926 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 N--CA 1.453 -0.88 0 C-N-CA 122.818 2.345 . . . . 0.0 109.792 -179.274 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 N--CA 1.448 -1.154 0 N-CA-C 107.764 -1.668 . . . . 0.0 107.764 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.6 80.09 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 121.953 -0.467 . . . . 0.0 113.168 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.25 156.99 37.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.482 0.713 . . . . 0.0 110.572 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.91 7.12 88.78 Favored Glycine 0 C--O 1.24 0.501 0 C-N-CA 123.758 0.694 . . . . 0.0 112.922 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 171.72 13.85 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 118.18 0.99 . . . . 0.0 109.589 165.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -121.83 156.03 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.99 150.1 39.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.49 155.19 28.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.89 144.97 45.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -172.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.75 168.32 10.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.941 0.877 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 -20.58 65.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.809 1.244 . . . . 0.0 112.918 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.9 t -163.19 155.82 18.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.56 1.073 . . . . 0.0 110.323 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.0 t -51.91 -40.01 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.6 1.96 . . . . 0.0 110.307 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -75.49 -12.24 60.19 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 119.435 -2.04 . . . . 0.0 114.115 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -93.16 -41.6 9.83 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.541 1.136 . . . . 0.0 109.364 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.42 -40.58 96.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -51.4 -10.48 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 130.135 3.374 . . . . 0.0 114.733 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -97.35 -41.91 8.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.966 1.257 . . . . 0.0 109.488 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.65 87.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.71 0.804 . . . . 0.0 112.625 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -43.32 63.78 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.768 2.427 . . . . 0.0 112.947 -162.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -98.66 -31.15 12.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.061 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.79 -9.18 58.78 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.921 0.782 . . . . 0.0 113.947 -170.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -123.7 3.55 8.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.203 1.401 . . . . 0.0 112.356 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -71.96 142.74 49.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.02 -3.04 82.2 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.076 -1.015 . . . . 0.0 112.731 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -63.69 175.17 1.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.284 1.542 . . . . 0.0 110.367 170.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -125.75 96.15 4.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -83.19 13.64 4.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.415 0.626 . . . . 0.0 111.631 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.0 -77.97 0.05 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.675 2.39 . . . . 0.0 104.658 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.8 -22.9 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.071 0.948 . . . . 0.0 113.368 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -92.49 166.92 12.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.548 -0.72 . . . . 0.0 110.956 -172.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.94 109.79 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.0 t -82.16 146.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.204 1.402 . . . . 0.0 110.654 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -128.93 118.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 p -72.06 159.93 33.35 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.347 1.07 . . . . 0.0 110.493 170.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -156.47 159.74 38.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.989 2.516 . . . . 0.0 105.739 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -74.67 159.39 32.14 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.504 160.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.82 -164.58 1.36 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 108.527 163.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -114.47 144.52 31.95 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.67 -27.94 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.422 2.748 . . . . 0.0 112.927 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.74 -42.05 95.48 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 120.741 -1.224 . . . . 0.0 110.688 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -72.81 -19.5 61.32 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.55 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.47 -45.53 53.65 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.004 2.122 . . . . 0.0 111.444 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -63.05 -8.12 6.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.797 0.839 . . . . 0.0 111.757 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -134.41 -163.63 1.4 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.441 2.696 . . . . 0.0 106.987 -163.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.75 39.72 3.82 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.344 1.057 . . . . 0.0 109.132 -173.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.53 42.93 2.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.005 1.322 . . . . 0.0 111.331 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 CA--C 1.537 0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 109.043 174.906 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.12 146.75 52.65 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.515 2.143 . . . . 0.0 108.708 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 p -137.25 166.74 23.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.31 2.55 21.04 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.91 88.56 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.61 117.34 7.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.803 1.241 . . . . 0.0 108.429 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -84.48 143.04 29.63 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.454 ' CD2' HG22 ' A' ' 91' ' ' THR . 76.5 mt -135.45 156.13 49.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 109.388 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.56 165.47 26.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 107.752 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 60.4 26.97 16.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.606 ' HB2' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -72.31 -74.22 0.17 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 157.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.681 HG11 HD21 ' A' ' 19' ' ' LEU . 33.7 m -92.5 172.45 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 124.402 1.081 . . . . 0.0 110.733 -163.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -125.6 157.63 67.68 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.69 0.85 4.32 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 121.884 1.723 . . . . 0.0 112.824 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -123.22 12.39 9.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.851 2.06 . . . . 0.0 112.665 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -139.44 22.38 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.998 -1.064 . . . . 0.0 112.021 -169.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.681 HD21 HG11 ' A' ' 14' ' ' VAL . 90.2 mt -109.72 6.37 23.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.675 1.19 . . . . 0.0 113.004 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.29 -29.87 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.501 -0.749 . . . . 0.0 111.156 -166.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.11 110.14 3.84 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.14 1.376 . . . . 0.0 108.562 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.26 -36.09 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.691 0.797 . . . . 0.0 110.056 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.89 -64.69 0.81 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.871 0.868 . . . . 0.0 110.0 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.42 -35.21 71.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.886 0.474 . . . . 0.0 112.001 -172.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.444 ' O ' HG23 ' A' ' 29' ' ' VAL . 25.8 t80 -52.59 -44.21 65.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.515 1.126 . . . . 0.0 111.71 170.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -74.8 -34.11 62.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.375 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.35 -53.92 51.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.359 1.063 . . . . 0.0 108.631 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.38 -42.63 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.368 1.067 . . . . 0.0 110.42 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 25' ' ' TYR . 51.4 t -60.67 -32.7 52.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 124.123 0.969 . . . . 0.0 111.316 -176.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.98 -49.49 19.77 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 123.21 0.319 . . . . 0.0 110.537 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.11 -38.57 83.41 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.477 1.132 . . . . 0.0 109.588 -175.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.44 HG13 ' CE2' ' A' ' 84' ' ' PHE . 41.4 t -73.36 -36.31 48.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 121.547 -0.721 . . . . 0.0 110.12 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -59.5 -44.76 93.01 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.374 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -65.9 -42.02 90.75 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.712 0.687 . . . . 0.0 111.895 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -67.87 -34.95 77.67 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.395 -172.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.496 ' HB3' HG21 ' A' ' 42' ' ' VAL . 7.4 t -78.11 -32.75 50.65 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.339 1.056 . . . . 0.0 110.709 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -56.73 -14.66 3.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.348 1.459 . . . . 0.0 112.039 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -61.54 -19.24 61.9 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.099 -2.25 . . . . 0.0 113.269 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.58 -6.6 13.39 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.862 1.265 . . . . 0.0 112.595 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.39 -151.81 20.8 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -167.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -129.31 108.34 10.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 36' ' ' CYS . 28.6 t -72.7 115.79 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -81.8 -50.99 8.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.805 2.042 . . . . 0.0 109.39 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.0 p -153.99 169.83 22.53 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.053 0.941 . . . . 0.0 110.208 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.4 mt -141.4 116.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.57 131.6 34.33 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 110.384 170.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.93 87.02 25.38 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.932 1.693 . . . . 0.0 107.738 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.69 154.5 68.88 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.78 1.653 . . . . 0.0 109.234 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.8 155.55 62.94 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.164 0.986 . . . . 0.0 111.548 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 C-N-CA 123.967 3.112 . . . . 0.0 110.261 177.32 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.452 -0.964 0 N-CA-C 108.412 -1.418 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.82 9.19 85.78 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.767 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.54 140.66 53.89 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.036 0.918 . . . . 0.0 109.829 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.95 -32.42 6.64 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.28 1.895 . . . . 0.0 111.926 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.507 ' C ' HD12 ' A' ' 62' ' ' ILE . 6.5 mptt -85.17 152.5 23.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -174.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.606 HD13 ' HB2' ' A' ' 13' ' ' MET . 2.0 mp -123.52 146.65 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 169.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.08 120.68 25.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -118.72 106.94 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -79.23 142.74 35.97 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.404 1.481 . . . . 0.0 107.889 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -121.79 177.25 5.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.356 1.063 . . . . 0.0 111.596 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.0 p -72.05 -26.76 62.31 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.721 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.7 m -153.89 159.45 41.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.504 1.621 . . . . 0.0 112.964 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.26 -12.58 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 120.588 -1.32 . . . . 0.0 111.383 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -95.9 -21.12 18.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.313 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.59 -29.98 14.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.873 1.669 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.8 p -60.4 -35.28 75.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.172 0.511 . . . . 0.0 110.4 168.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -24.06 66.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.977 1.711 . . . . 0.0 112.413 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -86.98 -46.03 10.22 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.3 68.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.884 0.874 . . . . 0.0 110.448 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -57.13 -39.41 75.11 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.056 0.389 . . . . 0.0 111.818 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -74.91 -45.83 40.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.128 -0.358 . . . . 0.0 111.04 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.16 -21.46 61.75 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.921 -0.377 . . . . 0.0 112.41 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.14 18.66 4.95 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.865 1.266 . . . . 0.0 111.858 -163.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -70.44 23.79 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 O-C-N 120.073 -1.642 . . . . 0.0 114.017 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.09 3.33 0.03 OUTLIER Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.967 1.746 . . . . 0.0 115.068 -166.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -173.68 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.938 1.869 . . . . 0.0 111.931 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -133.64 81.57 1.93 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.393 0.677 . . . . 0.0 109.538 -168.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.44 ' CE2' HG13 ' A' ' 32' ' ' VAL . 3.6 m-30 -74.94 14.02 0.58 Allowed 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.334 -0.854 . . . . 0.0 113.165 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.35 -85.04 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.663 2.385 . . . . 0.0 105.415 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.72 -5.39 1.04 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.8 OUTLIER -97.77 176.92 5.64 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.786 1.176 . . . . 0.0 108.655 -174.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -82.51 136.9 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.42 164.39 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 124.727 1.211 . . . . 0.0 108.825 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -138.48 139.37 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 10' ' ' LEU . 34.7 p -96.61 165.55 12.1 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.181 0.9 . . . . 0.0 110.983 175.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -153.36 154.53 34.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.921 1.688 . . . . 0.0 108.247 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -80.9 141.21 34.8 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 158.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.73 -168.16 1.28 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.823 1.649 . . . . 0.0 108.847 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -121.03 145.25 41.25 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.494 1.118 . . . . 0.0 107.983 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.29 -22.41 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.626 2.884 . . . . 0.0 114.15 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.31 -47.1 76.1 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.777 1.626 . . . . 0.0 109.537 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 p -77.06 2.1 16.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.843 1.257 . . . . 0.0 111.795 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -94.11 -41.12 9.69 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.641 1.577 . . . . 0.0 109.083 165.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -64.35 -24.7 67.74 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 112.135 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -126.39 165.7 18.56 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 126.434 1.894 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -75.68 23.62 0.12 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.363 1.865 . . . . 0.0 112.566 -175.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -91.28 40.33 1.03 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.351 -1.468 . . . . 0.0 112.405 -160.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 7.0 m-85 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 127.213 2.205 . . . . 0.0 115.779 -165.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HA ' ' CG ' ' A' ' 93' ' ' TYR . 20.4 Cg_endo -64.29 141.17 74.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.405 2.07 . . . . 0.0 112.143 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.1 p -133.57 -178.79 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.437 1.895 . . . . 0.0 108.149 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.02 -7.3 21.53 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.374 -1.298 . . . . 0.0 113.656 171.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.33 149.57 25.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 121.036 1.743 . . . . 0.0 110.859 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD13 ' SD ' ' A' ' 76' ' ' MET . 13.2 tp -124.72 119.03 27.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.744 2.418 . . . . 0.0 107.24 -170.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.84 145.78 25.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.086 0.554 . . . . 0.0 109.762 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.9 mt -136.55 120.41 17.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.286 1.435 . . . . 0.0 109.676 -167.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -106.52 156.64 18.36 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 75.44 23.6 1.48 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.48 2.312 . . . . 0.0 113.693 170.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -81.84 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 163.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG11 HD21 ' A' ' 19' ' ' LEU . 15.0 m -87.84 172.79 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.875 1.67 . . . . 0.0 111.764 -159.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 mt -126.32 158.1 68.04 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.409 1.483 . . . . 0.0 109.762 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.11 2.59 5.94 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.141 1.894 . . . . 0.0 113.103 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -128.63 18.55 6.27 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.966 1.706 . . . . 0.0 111.297 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -137.44 33.36 2.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.568 1.147 . . . . 0.0 111.152 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD21 HG11 ' A' ' 14' ' ' VAL . 95.2 mt -130.22 39.28 3.68 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 127.202 2.201 . . . . 0.0 109.406 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.97 -33.4 6.51 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.677 0.791 . . . . 0.0 110.579 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 94.94 1.68 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.42 1.088 . . . . 0.0 110.176 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.85 -36.29 58.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.968 2.107 . . . . 0.0 111.25 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -72.66 -55.31 7.03 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.716 0.407 . . . . 0.0 110.114 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -63.35 -36.44 83.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.339 0.655 . . . . 0.0 109.732 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -45.95 -48.69 16.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.994 0.918 . . . . 0.0 111.153 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.7 -28.19 50.9 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.929 -0.482 . . . . 0.0 112.172 -167.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -64.39 -55.54 20.36 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.597 1.559 . . . . 0.0 109.59 167.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.86 -36.24 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.75 0.82 . . . . 0.0 110.554 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.1 t -59.07 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 118.768 0.713 . . . . 0.0 109.228 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.46 -38.54 74.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.771 0.714 . . . . 0.0 111.315 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -70.94 -33.82 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.046 -175.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.96 -37.65 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -57.58 -36.29 71.5 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.707 1.139 . . . . 0.0 110.24 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.31 -29.57 68.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.759 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -68.79 -45.18 71.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.468 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.603 ' HA ' HD11 ' A' ' 79' ' ' LEU 0.267 0.8 OUTLIER -69.33 -26.53 64.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 172.8 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.3 t -62.77 -14.82 49.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.95 1.3 . . . . 0.0 111.887 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -62.68 -11.12 15.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 119.556 -1.965 . . . . 0.0 114.456 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.57 -0.64 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.501 1.046 . . . . 0.0 112.985 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.4 -174.37 41.89 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -94.74 111.9 23.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.6 t -71.78 109.6 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -62.85 -52.06 64.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.982 178.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -167.87 172.23 9.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.936 1.694 . . . . 0.0 110.578 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.437 HG23 HG22 ' A' ' 64' ' ' VAL . 13.8 mt -135.58 145.89 30.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.42 125.45 47.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.517 1.927 . . . . 0.0 109.443 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.15 86.92 12.62 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.098 1.759 . . . . 0.0 107.697 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.3 140.18 30.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.774 2.316 . . . . 0.0 108.839 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mtm-85 -116.06 146.28 36.75 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.326 1.05 . . . . 0.0 108.77 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.45 -1.038 0 C-N-CA 122.244 1.962 . . . . 0.0 108.555 173.597 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 N--CA 1.449 -1.106 0 N-CA-C 108.341 -1.446 . . . . 0.0 108.341 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.54 58.82 6.13 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.5 t -72.18 154.2 41.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.82 58.38 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 124.784 1.183 . . . . 0.0 112.908 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 168.2 10.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.501 1.651 . . . . 0.0 108.276 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.81 143.54 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.32 141.86 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG22 HG23 ' A' ' 45' ' ' ILE . 96.0 t -134.12 104.52 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -167.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -83.95 135.1 34.6 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.59 173.39 6.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 126.717 2.007 . . . . 0.0 108.423 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.9 t -92.57 -9.85 39.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.562 -176.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -154.53 155.88 35.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 121.261 1.846 . . . . 0.0 111.882 166.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 t -67.02 -24.93 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.078 1.351 . . . . 0.0 109.728 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -60.56 -59.32 5.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.571 1.148 . . . . 0.0 109.502 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.79 -45.84 59.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.42 1.488 . . . . 0.0 109.632 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.1 t -62.48 -50.56 70.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.369 1.067 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -56.4 -34.87 67.14 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.059 0.943 . . . . 0.0 112.33 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.48 -42.95 33.94 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.91 0.777 . . . . 0.0 109.679 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.42 79.74 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.175 0.99 . . . . 0.0 110.51 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.559 ' SD ' HD13 ' A' ' 8' ' ' LEU . 4.3 mmm -44.76 -66.48 0.39 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.126 1.371 . . . . 0.0 110.12 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.69 -39.31 88.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.959 0.503 . . . . 0.0 111.226 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -36.45 93.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.959 0.79 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 36' ' ' CYS . 54.8 mt -104.91 3.48 30.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.417 1.087 . . . . 0.0 110.892 -168.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.2 m -61.2 110.56 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.943 0.897 . . . . 0.0 109.659 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.73 19.44 73.28 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.387 0.539 . . . . 0.0 113.05 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -66.44 -178.64 0.7 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.761 1.28 . . . . 0.0 110.701 162.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -130.43 96.15 4.06 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.07 14.01 9.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.684 0.754 . . . . 0.0 111.898 -167.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -156.42 -66.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 161.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -147.86 -16.65 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -121.72 168.13 12.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.143 0.977 . . . . 0.0 111.637 -167.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.59 114.44 5.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.658 0.783 . . . . 0.0 109.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.25 150.86 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.349 1.06 . . . . 0.0 109.866 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.7 t -121.7 139.25 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 162.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -115.69 130.49 56.88 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.707 2.003 . . . . 0.0 108.554 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -132.9 171.18 14.28 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 119.778 1.172 . . . . 0.0 110.579 161.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 76' ' ' MET . 86.8 m-85 -82.89 147.82 28.06 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 -163.76 1.13 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.842 1.257 . . . . 0.0 109.745 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.49 143.47 29.0 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.26 -28.18 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.709 2.272 . . . . 0.0 111.793 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.35 -50.54 73.58 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.59 -1.319 . . . . 0.0 110.166 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.4 p -70.56 -7.28 42.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.075 1.75 . . . . 0.0 111.073 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.19 -45.92 9.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.161 1.784 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -64.3 -44.52 91.37 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.515 0.674 . . . . 0.0 109.863 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -77.98 172.78 12.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 109.119 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.491 ' HG3' ' CE2' ' A' ' 104' ' ' PHE . 50.2 ttp180 -103.96 72.62 1.11 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 164.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -123.37 61.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.917 0.865 . . . . 0.0 109.66 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CE2' ' HG3' ' A' ' 102' ' ' ARG . 4.9 m-30 . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 126.254 1.821 . . . . 0.0 109.856 -171.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.39 126.33 13.43 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.072 1.848 . . . . 0.0 108.661 156.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -103.23 177.1 4.93 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HG2' HG22 ' A' ' 69' ' ' VAL . 25.8 mt-10 -81.9 3.58 25.68 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.571 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 94' ' ' CYS . 2.4 m -124.42 156.03 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.739 1.154 . . . . 0.0 108.729 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 76' ' ' MET . 23.2 tp -136.37 122.3 20.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.985 1.714 . . . . 0.0 107.713 -168.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -81.22 139.11 35.7 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.1 mt -128.62 95.25 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.863 2.465 . . . . 0.0 107.4 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mtm -92.63 155.69 17.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 75.2 23.69 1.55 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 114.265 170.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -84.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 161.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.4 163.18 3.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 111.184 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.9 158.42 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.002 1.321 . . . . 0.0 109.841 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.82 -2.66 9.0 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.929 2.419 . . . . 0.0 113.316 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.21 2.13 11.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.572 1.949 . . . . 0.0 111.187 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -104.87 -30.34 9.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 118.669 0.668 . . . . 0.0 112.199 169.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.99 49.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.011 2.124 . . . . 0.0 113.396 -161.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 -10.56 6.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.203 1.801 . . . . 0.0 111.674 -169.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.4 122.19 38.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.006 0.923 . . . . 0.0 110.297 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.18 -15.63 63.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.254 1.422 . . . . 0.0 112.705 -168.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -78.85 -63.16 1.48 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.429 1.492 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.79 -35.65 66.52 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 109.937 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -55.97 -38.43 70.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.611 0.764 . . . . 0.0 112.166 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -80.36 -36.65 33.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.647 0.779 . . . . 0.0 110.678 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -56.72 -45.14 82.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.525 0.679 . . . . 0.0 109.9 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.89 -33.31 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.387 1.075 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.33 -44.65 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.287 -0.883 . . . . 0.0 108.718 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.06 -39.52 86.91 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.809 0.732 . . . . 0.0 110.531 -173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.7 -36.29 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.993 1.378 . . . . 0.0 111.487 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.62 -28.52 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.621 1.568 . . . . 0.0 109.944 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -44.62 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.52 -0.738 . . . . 0.0 109.343 170.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.44 -44.58 92.89 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.524 0.678 . . . . 0.0 111.354 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -43.76 50.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.856 -166.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -83.36 -17.98 40.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.505 -1.278 . . . . 0.0 110.331 -167.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -65.62 -15.62 62.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 110.783 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -63.24 -12.57 29.8 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.787 -1.196 . . . . 0.0 111.212 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.649 1.579 . . . . 0.0 112.935 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.33 26.34 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 120.105 1.321 . . . . 0.0 110.784 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.0 tm? -119.77 111.58 18.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.512 1.525 . . . . 0.0 107.965 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.04 114.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -53.83 -61.36 2.36 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 109.242 166.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 t -160.23 177.35 10.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.153 0.888 . . . . 0.0 111.558 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.98 135.04 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.671 2.388 . . . . 0.0 106.087 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -125.98 106.92 9.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.231 1.013 . . . . 0.0 112.995 -167.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.31 85.93 59.84 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 127.376 2.27 . . . . 0.0 108.334 -165.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.46 138.81 61.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.553 1.502 . . . . 0.0 109.8 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 162.42 19.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 126.567 1.947 . . . . 0.0 110.471 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 C--O 1.237 0.429 0 C-N-CA 124.47 3.446 . . . . 0.0 111.977 165.463 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.454 -0.849 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.45 0.36 70.14 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -71.75 155.05 40.9 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.574 1.687 . . . . 0.0 110.049 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.59 -1.12 79.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.034 0.826 . . . . 0.0 113.203 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 170.86 7.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 120.226 2.013 . . . . 0.0 109.316 168.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.0 mt -134.82 154.37 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -119.0 166.2 13.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 158.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 p -139.07 152.7 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -132.08 139.13 48.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.14 164.32 11.9 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 108.326 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.8 t -87.15 0.95 54.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.827 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.9 p -154.68 148.38 25.41 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.548 1.067 . . . . 0.0 109.808 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 6' ' ' GLU . 1.8 t -60.13 -34.85 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.092 0.557 . . . . 0.0 109.587 176.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -76.96 -23.71 52.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.69 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.99 -49.61 49.81 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.922 1.237 . . . . 0.0 108.024 166.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.6 t -56.98 -47.0 81.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.219 1.008 . . . . 0.0 109.97 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -57.65 -27.13 62.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.341 1.056 . . . . 0.0 113.339 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -79.46 -54.27 6.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.14 -51.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.269 1.027 . . . . 0.0 110.837 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.559 ' HB2' HD13 ' A' ' 8' ' ' LEU . 2.3 ppp? -59.07 -34.54 72.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.964 0.905 . . . . 0.0 112.434 -170.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.98 -34.48 18.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.62 1.168 . . . . 0.0 110.555 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 -29.83 75.86 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.117 1.341 . . . . 0.0 112.164 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.8 mt -113.29 7.11 17.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.664 1.185 . . . . 0.0 111.619 -168.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -48.66 131.58 17.77 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.11 -2.62 80.55 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.486 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -62.99 176.71 0.67 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.221 1.511 . . . . 0.0 112.019 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -132.17 83.14 2.06 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -78.31 14.5 1.19 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.66 -0.65 . . . . 0.0 111.461 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -156.38 -80.25 0.08 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.695 -2.706 . . . . 0.0 103.695 159.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -145.12 -16.91 0.5 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.114 0.966 . . . . 0.0 113.264 -165.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -100.26 -173.5 2.44 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.591 1.087 . . . . 0.0 109.444 -175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.72 149.9 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 164.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.67 133.83 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.314 1.846 . . . . 0.0 107.391 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.82 138.46 25.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 161.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 p -102.05 151.56 22.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.597 1.559 . . . . 0.0 108.532 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -149.15 156.98 43.0 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.373 1.469 . . . . 0.0 108.408 170.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -76.18 144.63 40.39 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.695 1.589 . . . . 0.0 107.821 160.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.473 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -104.79 -163.93 1.0 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.003 0.921 . . . . 0.0 108.683 171.111 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.78 143.59 28.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 167.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.5 -27.07 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.506 2.138 . . . . 0.0 111.243 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -53.12 60.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -77.22 -10.41 59.4 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.398 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -75.69 -43.65 46.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.175 0.898 . . . . 0.0 110.874 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -62.75 -22.03 66.26 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.634 0.373 . . . . 0.0 111.659 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.4 -177.7 3.2 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.349 1.46 . . . . 0.0 109.714 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 13.4 ttt180 -91.89 30.81 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.734 0.814 . . . . 0.0 111.348 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.82 48.62 1.61 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.99 -1.069 . . . . 0.0 111.997 -162.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 10.3 m-85 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.017 -167.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -62.61 151.64 82.32 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.84 2.36 . . . . 0.0 109.312 162.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.7 p -138.95 176.96 8.25 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -75.47 7.94 3.22 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.327 -0.858 . . . . 0.0 111.988 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 t -133.17 107.08 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.121 1.769 . . . . 0.0 111.147 -169.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -100.19 129.37 46.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.735 2.414 . . . . 0.0 106.651 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 49.8 t -81.86 138.37 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.57 122.88 30.04 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.714 2.406 . . . . 0.0 107.47 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.473 ' HB2' HG23 ' A' ' 90' ' ' VAL . 35.3 mtm -135.01 73.94 1.5 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -161.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 174.52 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -51.65 30.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.625 1.17 . . . . 0.0 109.717 -172.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 165.59 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 O-C-N 125.167 1.542 . . . . 0.0 108.914 -174.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' O ' HD21 ' A' ' 19' ' ' LEU . 31.5 mt -100.66 160.68 26.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 170.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -68.46 7.66 0.65 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 126.224 4.616 . . . . 0.0 114.341 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -135.55 3.92 3.07 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.162 1.385 . . . . 0.0 112.739 -159.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.464 ' H ' HD22 ' A' ' 19' ' ' LEU . 53.2 mm-40 -126.07 5.68 7.19 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.846 -1.158 . . . . 0.0 112.051 -176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.695 HD22 ' H ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -79.12 10.36 3.62 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.879 2.072 . . . . 0.0 112.93 -176.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 50' ' ' PRO . 2.8 mm? -96.16 -17.89 20.51 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.789 2.035 . . . . 0.0 112.698 -168.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 88.17 2.86 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 174.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.34 -26.41 12.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.281 2.632 . . . . 0.0 112.758 -165.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.2 -28.11 69.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.307 1.843 . . . . 0.0 113.406 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -85.76 -36.67 20.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.939 0.896 . . . . 0.0 109.022 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.63 -34.26 69.12 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.82 -40.16 29.16 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.199 1.4 . . . . 0.0 112.073 -173.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -60.23 -45.79 92.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.8 mt -61.06 -31.13 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 123.735 0.814 . . . . 0.0 110.938 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.31 -55.84 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.243 0.929 . . . . 0.0 110.473 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.56 -32.98 72.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.517 1.127 . . . . 0.0 112.487 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.58 -27.3 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.474 1.11 . . . . 0.0 109.776 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -67.96 -34.25 76.21 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.176 -0.952 . . . . 0.0 109.642 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.01 -37.45 55.02 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.635 0.774 . . . . 0.0 112.483 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -50.86 61.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.437 1.017 . . . . 0.0 110.559 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.1 t -70.57 -19.39 62.87 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.783 -0.573 . . . . 0.0 110.914 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.29 3.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.351 1.86 . . . . 0.0 112.955 166.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -68.39 -9.42 48.15 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.918 -1.739 . . . . 0.0 113.863 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.4 1.51 4.58 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.741 0.816 . . . . 0.0 113.139 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.9 -139.46 5.2 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.606 HD12 HG23 ' A' ' 67' ' ' THR . 1.9 tm? -144.13 121.41 11.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.18 1.792 . . . . 0.0 106.232 176.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.1 t -74.13 120.66 23.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 170.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -76.48 -57.89 3.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.006 0.923 . . . . 0.0 109.35 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.32 172.24 18.52 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.056 1.342 . . . . 0.0 109.345 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mt -137.1 118.11 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -90.86 122.11 33.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.442 1.097 . . . . 0.0 108.344 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.66 86.31 34.27 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 126.848 2.059 . . . . 0.0 105.77 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.18 158.66 33.85 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.366 1.378 . . . . 0.0 110.447 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -123.32 165.12 23.99 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.924 0.889 . . . . 0.0 109.489 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HG2' HD11 ' A' ' 20' ' ' LEU . 60.0 Cg_endo . . . . . 0 N--CA 1.454 -0.841 0 C-N-CA 123.982 3.121 . . . . 0.0 109.011 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 N--CA 1.45 -1.03 0 N-CA-C 108.861 -1.246 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.86 2.74 88.4 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.656 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -67.75 141.76 56.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 117.753 0.776 . . . . 0.0 109.301 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.68 -25.2 27.44 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.458 1.98 . . . . 0.0 112.311 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.04 16.09 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.26 1.03 . . . . 0.0 108.981 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -123.26 145.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.15 104.53 9.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.98 153.76 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -132.34 147.02 52.38 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.22 174.67 9.37 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.529 0.604 . . . . 0.0 110.517 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.606 HG23 HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -76.03 -22.45 55.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 177.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.8 p -152.47 161.94 41.89 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.422 1.01 . . . . 0.0 111.168 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.68 -13.99 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 110.497 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.97 -48.44 21.12 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 120.026 -1.671 . . . . 0.0 109.894 172.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.49 -41.81 86.19 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.373 0.669 . . . . 0.0 109.554 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.4 p -68.54 -40.65 80.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.327 0.651 . . . . 0.0 109.999 -175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -56.72 -31.26 64.34 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.375 1.47 . . . . 0.0 111.032 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -83.86 -46.56 12.03 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.925 0.784 . . . . 0.0 109.7 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.63 -49.12 73.7 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.375 0.67 . . . . 0.0 109.726 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.2 tpp -44.27 -73.0 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 127.86 2.464 . . . . 0.0 110.119 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -73.11 -7.56 51.87 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.08 -35.31 61.07 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.855 -1.153 . . . . 0.0 110.678 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.413 HD23 ' HG3' ' A' ' 82' ' ' ARG . 76.5 mt -127.62 -1.13 6.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.419 1.088 . . . . 0.0 112.34 -154.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 m -50.58 122.29 6.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.753 1.221 . . . . 0.0 108.405 157.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 11.5 84.27 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.115 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.413 ' HG3' HD23 ' A' ' 79' ' ' LEU . 20.5 mmt-85 -71.2 -178.43 2.03 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.604 1.702 . . . . 0.0 112.239 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -120.92 94.98 4.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.68 43.02 1.13 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 173.63 -86.41 0.0 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.177 2.991 . . . . 0.0 105.958 166.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -149.09 -5.12 0.4 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.276 1.83 . . . . 0.0 111.622 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -118.46 -178.85 3.62 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.942 1.697 . . . . 0.0 109.797 -175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.39 165.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.1 t -130.31 132.65 64.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 125.777 1.631 . . . . 0.0 108.729 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 11' ' ' MET . 0.7 OUTLIER -106.63 143.26 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 p -113.48 156.68 23.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 127.638 2.375 . . . . 0.0 107.527 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 169.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -69.38 150.02 47.75 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -130.66 -167.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.232 1.813 . . . . 0.0 108.136 174.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.65 150.64 52.87 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.96 -19.97 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.508 2.805 . . . . 0.0 113.042 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.48 -49.49 61.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.127 1.331 . . . . 0.0 110.378 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.07 7.75 5.74 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.339 1.856 . . . . 0.0 111.663 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -111.79 -36.64 5.38 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -57.96 -31.7 67.13 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -123.74 168.59 12.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.251 1.42 . . . . 0.0 109.347 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -79.73 27.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.172 1.789 . . . . 0.0 111.254 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -86.74 70.59 10.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 C--O 1.235 0.33 0 C-N-CA 124.581 1.152 . . . . 0.0 108.068 -175.105 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.02 151.64 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.352 2.034 . . . . 0.0 109.331 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 p -135.33 177.04 8.12 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -78.7 -0.43 30.12 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.662 171.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -102.22 153.02 5.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 120.657 1.571 . . . . 0.0 109.86 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.65 149.76 46.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.668 1.587 . . . . 0.0 107.545 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 50.7 t -109.29 136.13 49.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.0 mt -128.43 110.03 11.95 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -170.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtm -101.66 152.96 20.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 75.11 30.41 0.89 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.691 2.797 . . . . 0.0 114.542 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.444 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -81.63 -69.12 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.521 -1.362 . . . . 0.0 109.632 169.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.32 148.45 29.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.727 1.611 . . . . 0.0 109.829 -155.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -95.36 158.1 35.2 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.37 3.81 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.626 2.217 . . . . 0.0 112.978 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -128.95 15.95 6.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.159 1.784 . . . . 0.0 112.268 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -142.17 31.42 1.56 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.653 1.181 . . . . 0.0 111.066 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.18 5.12 10.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.698 1.599 . . . . 0.0 111.38 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.483 ' H ' HD22 ' A' ' 20' ' ' LEU . 1.7 mm? -69.66 -23.53 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.189 0.996 . . . . 0.0 109.504 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.0 81.53 8.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.955 2.502 . . . . 0.0 109.704 -162.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.5 -4.66 0.26 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.819 2.847 . . . . 0.0 114.591 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.83 -33.47 4.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 127.889 2.476 . . . . 0.0 111.856 -166.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.86 -39.82 61.34 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.131 0.878 . . . . 0.0 109.279 162.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.426 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 67.3 t80 -45.49 -40.51 8.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.155 1.782 . . . . 0.0 113.107 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.75 -31.63 41.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.722 0.809 . . . . 0.0 113.171 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -66.55 -50.49 62.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.671 1.588 . . . . 0.0 109.17 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.33 -27.07 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.027 0.931 . . . . 0.0 109.556 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.01 -49.75 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.18 -39.24 86.37 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.52 -47.97 72.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.957 1.36 . . . . 0.0 110.161 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.648 HG13 ' CE2' ' A' ' 84' ' ' PHE . 24.8 t -78.23 -32.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.555 -173.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -66.62 -42.91 86.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.712 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.27 -56.37 21.88 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.451 0.7 . . . . 0.0 109.803 174.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HG2' ' HA ' ' A' ' 32' ' ' VAL . 5.2 pt-20 -66.53 -39.97 88.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.477 0.655 . . . . 0.0 110.582 -164.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -78.3 -20.09 52.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.832 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -73.4 -9.91 59.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.125 -0.984 . . . . 0.0 111.702 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -64.11 -15.17 59.11 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.31 -1.494 . . . . 0.0 111.44 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.615 ' CD1' HD11 ' A' ' 79' ' ' LEU . 23.9 m-85 -116.71 5.29 13.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.616 2.366 . . . . 0.0 111.101 -175.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.29 -151.71 22.82 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 120.286 1.403 . . . . 0.0 111.978 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.5 tm? -125.77 108.68 11.73 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -78.76 103.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -49.14 -56.02 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.342 1.057 . . . . 0.0 110.39 164.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.81 168.15 23.62 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.329 0.513 . . . . 0.0 111.292 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.73 138.76 43.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 127.038 2.135 . . . . 0.0 105.561 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -123.34 111.07 15.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.602 1.561 . . . . 0.0 110.019 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.47 86.16 56.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.19 1.396 . . . . 0.0 108.579 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.29 144.29 61.73 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.125 1.883 . . . . 0.0 108.582 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.426 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -123.97 155.27 67.53 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 108.594 -177.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 C-N-CA 122.237 1.958 . . . . 0.0 110.867 177.771 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.456 -0.706 0 N-CA-C 108.846 -1.252 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.15 27.81 47.71 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.364 0.507 . . . . 0.0 112.296 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 t -71.88 148.68 45.89 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.371 1.086 . . . . 0.0 110.474 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.07 -32.56 5.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 126.872 2.177 . . . . 0.0 111.467 -174.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 3.0 mptt -77.19 160.09 29.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mt -127.56 147.13 32.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 168.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.67 158.02 22.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.31 155.13 28.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 66.4 tt0 -133.05 134.69 44.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 0.0 107.832 -173.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.89 -177.1 3.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.766 1.626 . . . . 0.0 109.288 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.45 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.5 t -109.19 3.2 21.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.526 0.73 . . . . 0.0 112.074 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -152.01 139.37 19.45 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.085 -1.634 . . . . 0.0 109.545 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.681 HG12 HE21 ' A' ' 73' ' ' GLN . 4.6 t -51.98 -37.38 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.565 1.546 . . . . 0.0 109.633 168.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.31 -16.56 54.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.877 1.271 . . . . 0.0 113.104 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -115.43 -35.13 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -164.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 t -53.81 -48.48 69.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.416 1.086 . . . . 0.0 109.704 160.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.681 HE21 HG12 ' A' ' 69' ' ' VAL . 41.3 mt-30 -54.49 -24.34 20.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.17 1.388 . . . . 0.0 113.935 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -82.97 -53.76 5.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.871 1.214 . . . . 0.0 108.867 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -36.47 77.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.575 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -58.07 -35.67 71.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.156 0.889 . . . . 0.0 111.767 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -98.46 -44.33 6.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.616 1.166 . . . . 0.0 110.305 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.19 50.0 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 118.847 0.749 . . . . 0.0 112.836 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.615 HD11 ' CD1' ' A' ' 39' ' ' TYR . 42.6 mt -130.93 4.91 4.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.98 1.312 . . . . 0.0 111.975 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -68.36 144.07 54.91 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.926 1.694 . . . . 0.0 107.214 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.39 86.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.825 -0.986 . . . . 0.0 113.184 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -174.24 0.51 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.804 1.802 . . . . 0.0 109.526 165.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -123.94 141.32 52.14 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.648 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.7 m-30 -109.01 14.14 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.196 0.935 . . . . 0.0 110.852 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.18 -68.85 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.839 2.856 . . . . 0.0 104.946 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -153.93 -20.95 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 mtp85 -111.77 162.85 14.8 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.427 1.012 . . . . 0.0 110.471 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 t -77.95 106.37 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.004 -163.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.444 HG13 ' HE1' ' A' ' 13' ' ' MET . 75.3 t -72.38 140.56 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.432 1.093 . . . . 0.0 109.552 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.0 t -126.27 128.56 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 p -87.69 156.81 19.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 0.0 110.504 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.15 155.08 41.0 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.328 2.251 . . . . 0.0 105.878 169.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -73.89 153.44 39.84 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 119.891 1.223 . . . . 0.0 108.094 159.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -172.5 2.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 164.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.13 144.28 34.53 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.68 -22.68 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.171 1.914 . . . . 0.0 112.346 -167.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -57.54 12.59 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.061 1.301 . . . . 0.0 109.222 175.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -71.39 12.62 0.31 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.595 1.558 . . . . 0.0 111.355 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 65' ' ' GLU . 30.7 t80 -97.52 -55.68 2.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.69 1.196 . . . . 0.0 110.463 169.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -65.57 -36.6 84.25 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.098 0.959 . . . . 0.0 112.714 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -85.38 -164.55 1.02 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.149 0.98 . . . . 0.0 109.519 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -111.97 26.05 10.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.787 1.235 . . . . 0.0 112.591 172.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -77.37 33.47 0.16 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.449 2.3 . . . . 0.0 111.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--O 1.239 0.507 0 O-C-N 120.511 -1.368 . . . . 0.0 111.049 -179.917 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 119.459 -0.305 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.15 151.03 66.64 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.649 2.232 . . . . 0.0 108.639 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.9 p -126.26 176.4 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.797 0.839 . . . . 0.0 109.176 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.56 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 28.1 tt0 -72.14 -1.49 15.13 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.576 1.551 . . . . 0.0 112.876 167.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.96 114.04 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 120.503 -1.373 . . . . 0.0 108.956 -151.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 142.56 51.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 108.806 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.2 t -131.12 126.35 35.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.135 0.969 . . . . 0.0 111.648 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' CD1' HG22 ' A' ' 91' ' ' THR . 1.2 mm? -116.66 107.87 15.23 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 108.262 -159.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.6 mtm -79.1 173.45 12.56 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.389 0.675 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 65.89 18.32 11.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.809 1.644 . . . . 0.0 112.208 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.413 ' CE ' ' HB3' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -81.95 -70.68 0.53 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -165.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -104.33 -174.33 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 129.787 3.235 . . . . 0.0 107.051 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -127.49 153.41 77.39 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 120.142 1.337 . . . . 0.0 107.718 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -3.37 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.758 2.305 . . . . 0.0 112.5 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -115.05 11.56 16.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.675 1.19 . . . . 0.0 110.085 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -130.09 -22.57 2.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.838 1.255 . . . . 0.0 112.325 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -79.5 61.33 3.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.627 1.571 . . . . 0.0 110.385 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.03 -14.11 2.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.309 -160.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -116.6 151.75 35.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.811 1.245 . . . . 0.0 108.476 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.59 -13.42 40.04 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.59 1.556 . . . . 0.0 111.756 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.27 -60.06 1.94 Allowed 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.154 1.382 . . . . 0.0 108.445 -163.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -53.01 -36.21 60.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.513 1.525 . . . . 0.0 110.307 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -61.08 -36.82 80.67 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.44 1.896 . . . . 0.0 111.592 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.03 -40.35 53.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.392 0.996 . . . . 0.0 109.877 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.32 -34.78 72.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.433 0.693 . . . . 0.0 111.236 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.92 -24.44 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.465 0.706 . . . . 0.0 110.783 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.3 t -67.21 -47.19 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.406 -1.434 . . . . 0.0 108.322 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.86 -21.69 47.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.93 -47.62 61.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.386 1.089 . . . . 0.0 110.576 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG13 ' CE2' ' A' ' 84' ' ' PHE . 50.8 t -74.89 -30.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.974 -170.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -64.11 -31.66 72.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.202 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.81 -53.12 23.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.568 1.076 . . . . 0.0 110.624 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -62.45 -38.26 89.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.435 0.636 . . . . 0.0 110.926 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.473 ' HB3' HG11 ' A' ' 42' ' ' VAL . 8.8 t -70.54 -35.82 73.35 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.003 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -65.55 -14.33 60.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.457 1.026 . . . . 0.0 112.005 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.1 -19.77 21.57 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 119.71 -1.869 . . . . 0.0 112.791 172.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -115.42 2.53 13.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.935 1.294 . . . . 0.0 112.509 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.75 -147.16 15.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.5 120.85 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.473 HG11 ' HB3' ' A' ' 36' ' ' CYS . 2.1 p -87.92 109.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 126.34 1.856 . . . . 0.0 108.849 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -68.33 -63.96 0.96 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.466 1.906 . . . . 0.0 109.988 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -147.67 158.59 44.08 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.552 0.741 . . . . 0.0 111.691 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.7 130.89 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.399 . . . . 0.0 107.36 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -108.98 123.52 49.25 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.978 2.111 . . . . 0.0 107.845 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -129.29 85.15 60.18 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.237 1.815 . . . . 0.0 106.307 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.07 101.18 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.111 1.874 . . . . 0.0 109.825 -172.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.13 80.16 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.801 -0.562 . . . . 0.0 110.896 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 C--N 1.348 0.548 0 C-N-CA 123.572 2.848 . . . . 0.0 110.055 173.203 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 N--CA 1.453 -0.882 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.4 16.25 18.76 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.266 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.5 t -72.33 148.85 44.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.59 1.695 . . . . 0.0 110.106 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.99 -11.11 40.84 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.05 134.73 35.12 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.023 1.329 . . . . 0.0 109.657 -169.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.92 137.2 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -108.83 130.5 55.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -128.96 160.14 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.418 1.487 . . . . 0.0 107.979 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.38 143.43 39.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.596 1.958 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -110.07 -169.16 1.42 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.908 1.231 . . . . 0.0 112.249 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -93.96 -15.35 25.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 113.775 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -155.6 145.57 21.49 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.121 1.369 . . . . 0.0 108.628 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.08 -32.26 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 122.261 1.029 . . . . 0.0 110.533 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.2 -36.57 71.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.3 174.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 79.4 m-20 -64.07 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.053 1.297 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 34.4 m -76.65 -36.48 57.33 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 127.695 2.398 . . . . 0.0 109.256 -166.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.65 -40.23 82.83 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.144 1.378 . . . . 0.0 110.89 170.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.563 ' CE ' ' HA ' ' A' ' 71' ' ' ASP . 40.8 mtmt -72.34 -48.32 42.84 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.452 0.701 . . . . 0.0 109.184 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.09 -35.79 81.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.046 0.938 . . . . 0.0 112.687 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 43.1 tpp -55.1 -68.63 0.17 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.427 1.491 . . . . 0.0 109.176 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -67.81 -25.1 65.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.01 -15.46 81.1 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.341 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.74 6.71 5.15 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.668 1.187 . . . . 0.0 111.898 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.1 m -56.49 113.59 1.67 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 6.1 57.9 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.76 1.171 . . . . 0.0 113.614 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.79 179.25 0.27 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.976 1.31 . . . . 0.0 113.675 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -131.04 90.54 2.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.147 1.779 . . . . 0.0 108.35 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.431 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.7 m-30 -77.19 14.68 0.86 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.95 -1.094 . . . . 0.0 112.539 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.53 -64.45 0.06 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.002 2.521 . . . . 0.0 105.211 163.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.66 -10.43 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -109.02 148.9 30.05 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.417 -1.427 . . . . 0.0 109.949 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -64.85 131.82 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.991 -171.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -101.0 141.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.778 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 138.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 161.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.419 HG22 ' CD1' ' A' ' 10' ' ' LEU . 2.6 p -94.42 157.48 15.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.4 2.28 . . . . 0.0 108.476 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.18 157.02 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.527 1.058 . . . . 0.0 109.481 159.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 114.5 18.71 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.2 m -79.78 166.41 21.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 163.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -92.29 142.81 26.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.56 -35.73 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.427 2.752 . . . . 0.0 112.7 -172.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -54.14 -36.66 63.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.99 0.516 . . . . 0.0 111.709 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.2 p -75.41 -43.33 50.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -62.31 -30.9 71.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.373 1.469 . . . . 0.0 112.207 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -66.38 -8.48 25.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.133 0.973 . . . . 0.0 113.086 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -129.01 -174.6 3.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.495 1.918 . . . . 0.0 108.099 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -90.06 55.98 3.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -122.15 98.76 6.08 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.117 0.567 . . . . 0.0 109.785 -174.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--O 1.233 0.233 0 C-N-CA 123.553 0.741 . . . . 0.0 109.711 -172.102 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.628 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.99 -146.43 20.99 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.709 1.623 . . . . 0.0 110.154 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -58.49 150.28 56.51 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.068 0.947 . . . . 0.0 111.471 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.6 158.26 51.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.491 2.127 . . . . 0.0 109.853 169.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 p -139.28 -168.61 2.49 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -86.05 -2.64 58.5 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.95 -1.093 . . . . 0.0 112.704 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 94' ' ' CYS . 2.8 m -83.3 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 121.127 1.785 . . . . 0.0 109.105 175.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.86 129.6 26.24 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.227 2.211 . . . . 0.0 105.942 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -100.74 131.86 46.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mp -129.8 154.42 47.26 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.737 1.615 . . . . 0.0 109.039 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.1 mtm -136.29 161.57 35.41 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.07 21.99 1.86 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.624 1.97 . . . . 0.0 111.545 172.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.414 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -76.45 -85.22 0.06 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 163.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG22 ' H ' ' A' ' 14' ' ' VAL . 22.2 m -82.55 170.66 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 127.08 2.152 . . . . 0.0 110.748 -166.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.28 160.2 35.16 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.094 0.958 . . . . 0.0 109.79 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -0.24 5.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.363 2.042 . . . . 0.0 113.037 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.96 19.4 3.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.056 2.143 . . . . 0.0 112.797 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.23 -9.33 7.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.948 0.794 . . . . 0.0 112.556 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.7 mt -79.62 28.55 0.26 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.21 1.404 . . . . 0.0 111.774 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -100.0 -38.13 8.71 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.835 -1.166 . . . . 0.0 111.282 -170.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 127.04 31.27 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.976 0.91 . . . . 0.0 109.979 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.07 -30.95 58.54 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.956 1.303 . . . . 0.0 110.568 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -92.47 16.09 12.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.068 1.347 . . . . 0.0 111.872 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -125.48 -50.24 1.64 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.488 1.515 . . . . 0.0 107.413 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -45.05 -50.29 10.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.059 1.344 . . . . 0.0 112.39 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.61 -27.57 61.35 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -66.42 -46.44 76.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.806 0.843 . . . . 0.0 108.848 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.2 mt -61.16 -28.86 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.739 1.216 . . . . 0.0 111.405 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.04 -47.33 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 120.641 -1.287 . . . . 0.0 109.3 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.51 -30.92 57.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.198 0.999 . . . . 0.0 111.569 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.5 -46.45 86.66 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.849 1.66 . . . . 0.0 110.503 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.5 t -77.94 -28.64 15.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -59.42 -48.69 80.67 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.54 -44.92 95.15 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.091 0.244 . . . . 0.0 110.772 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.75 -43.49 75.74 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.878 -0.514 . . . . 0.0 111.618 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.435 ' HG ' ' HZ ' ' A' ' 66' ' ' PHE . 1.4 t -85.24 -21.92 28.87 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.941 -168.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.9 m -60.08 -8.49 2.42 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.858 -1.151 . . . . 0.0 113.025 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -67.84 -7.58 29.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 119.527 -1.983 . . . . 0.0 113.64 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -124.73 -0.26 8.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.53 1.132 . . . . 0.0 112.623 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.3 -137.96 5.63 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 106.914 -2.475 . . . . 0.0 106.914 -170.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.47 115.31 10.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.35 107.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 108.366 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -55.97 -60.76 3.01 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.396 2.278 . . . . 0.0 108.618 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 p -158.84 175.46 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.541 0.61 . . . . 0.0 110.881 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.14 150.21 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.334 1.453 . . . . 0.0 107.779 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.99 109.18 8.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.027 1.331 . . . . 0.0 110.987 -169.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 86.46 58.67 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 127.363 2.265 . . . . 0.0 107.372 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.9 133.27 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.946 2.431 . . . . 0.0 109.232 172.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 159.71 32.66 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 124.082 0.953 . . . . 0.0 111.535 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.4 170.09 7.18 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.742 2.962 . . . . 0.0 109.926 164.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.82 91.87 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 t0 56.1 35.47 25.7 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.094 0.958 . . . . 0.0 113.033 172.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.54 -27.42 13.65 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.213 2.339 . . . . 0.0 112.095 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.82 137.63 22.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 118.791 1.296 . . . . 0.0 109.12 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.73 148.21 36.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.798 0.808 . . . . 0.0 110.591 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.9 156.71 47.8 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 126.057 1.743 . . . . 0.0 110.144 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -63.81 138.16 62.03 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.717 1.611 . . . . 0.0 108.271 168.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.4 9.98 86.52 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.765 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.3 t -67.17 154.42 41.3 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.837 0.818 . . . . 0.0 110.614 170.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.02 -5.24 80.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 125.527 1.537 . . . . 0.0 114.058 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.2 173.02 9.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.941 1.371 . . . . 0.0 107.987 170.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 mt -131.35 145.96 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 150.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -115.46 144.72 43.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 164.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -118.96 154.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.02 136.92 47.61 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.435 ' HZ ' ' HG ' ' A' ' 36' ' ' CYS . 28.1 m-85 -107.86 -177.95 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.02 1.328 . . . . 0.0 109.784 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 t -112.15 7.05 19.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 110.145 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.0 p -155.97 143.42 19.34 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 120.869 -1.144 . . . . 0.0 108.368 161.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -51.39 -44.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.952 1.301 . . . . 0.0 109.207 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -71.6 -26.04 62.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.351 -167.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -76.42 -42.66 43.43 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 12.9 t -59.74 -41.01 89.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.723 0.409 . . . . 0.0 110.556 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -56.06 -27.13 52.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 113.0 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -79.88 -47.86 14.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.727 1.149 . . . . 0.0 109.456 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.86 75.97 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.682 0.793 . . . . 0.0 110.532 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -55.77 -43.51 76.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.287 0.635 . . . . 0.0 111.329 -169.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -77.41 -48.29 17.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.79 0.836 . . . . 0.0 109.461 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.21 -19.41 63.97 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.64 1.115 . . . . 0.0 113.073 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.1 mt -124.11 14.86 9.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.61 1.964 . . . . 0.0 110.798 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.4 m -60.83 118.26 6.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.48 24.23 59.16 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 120.891 -1.131 . . . . 0.0 113.45 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.49 -179.34 5.74 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.288 0.544 . . . . 0.0 110.557 154.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -129.48 99.3 5.13 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 125.164 1.386 . . . . 0.0 107.328 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -88.68 15.02 8.81 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.469 0.577 . . . . 0.0 110.639 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.23 -85.23 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.933 2.093 . . . . 0.0 106.174 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.26 -20.21 0.63 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.56 1.144 . . . . 0.0 111.983 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -90.21 -167.88 1.96 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.81 166.3 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.177 -0.952 . . . . 0.0 108.572 165.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.414 HG13 ' HE1' ' A' ' 13' ' ' MET . 55.7 t -124.68 118.03 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 p -93.04 149.9 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.7 p -117.89 168.7 10.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.692 1.197 . . . . 0.0 109.034 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.77 156.41 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.887 2.075 . . . . 0.0 106.908 -177.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -77.71 160.72 28.25 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 162.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.422 ' HB3' HG21 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -137.43 -168.47 2.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.397 0.999 . . . . 0.0 109.063 168.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.59 144.22 34.94 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -93.59 -20.46 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.132 1.888 . . . . 0.0 110.833 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -40.44 80.59 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.07 0.462 . . . . 0.0 110.446 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.56 -33.26 60.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.105 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -61.6 -50.27 73.27 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.499 1.52 . . . . 0.0 111.411 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.64 -14.63 63.14 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -106.11 -169.73 1.62 Allowed 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 127.544 2.337 . . . . 0.0 107.276 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -114.18 69.68 0.71 Allowed 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 166.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.31 27.02 9.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 109.812 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -74.53 154.09 38.8 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.683 0.793 . . . . 0.0 109.543 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.0 t90 . . . . . 0 C--O 1.248 0.982 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 178.123 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.441 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.61 177.77 34.01 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -67.72 152.14 96.56 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.145 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.04 126.88 16.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.401 1.401 . . . . 0.0 108.676 165.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.1 p -100.11 179.02 4.61 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.889 1.676 . . . . 0.0 108.705 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.54 8.72 13.23 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.007 0.923 . . . . 0.0 110.658 174.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.99 163.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 O-C-N 120.896 -1.127 . . . . 0.0 111.395 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -141.71 124.19 15.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -168.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.23 135.02 33.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.7 mt -128.73 131.2 47.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.5 1.52 . . . . 0.0 107.232 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mtm -125.46 163.77 21.93 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.448 -0.782 . . . . 0.0 110.177 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 74.97 16.22 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.81 2.844 . . . . 0.0 112.677 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -52.9 11.93 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.251 -0.906 . . . . 0.0 108.916 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.88 174.34 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 128.317 2.647 . . . . 0.0 108.891 -162.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.72 150.24 52.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.102 0.961 . . . . 0.0 109.319 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.62 -14.7 40.07 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.859 2.373 . . . . 0.0 113.647 -172.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -116.56 13.18 15.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.682 1.993 . . . . 0.0 110.333 -170.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -139.69 22.62 2.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.792 2.037 . . . . 0.0 109.637 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.01 65.43 0.66 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.066 2.146 . . . . 0.0 107.057 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.3 mt -135.06 -41.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -160.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.07 151.25 31.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.6 0.76 . . . . 0.0 110.149 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -95.96 -5.55 41.05 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.623 0.769 . . . . 0.0 110.675 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -113.57 -43.41 3.32 Favored 'General case' 0 C--N 1.337 0.047 0 C-N-CA 124.42 1.088 . . . . 0.0 113.049 -167.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -80.62 -37.19 31.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.734 1.214 . . . . 0.0 109.398 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.7 -35.75 61.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.218 1.007 . . . . 0.0 110.677 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.74 -37.22 70.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.491 -0.756 . . . . 0.0 111.62 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -62.32 -45.92 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.014 . . . . 0.0 109.204 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.55 -20.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.617 0.767 . . . . 0.0 111.371 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.11 -44.71 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.954 -1.092 . . . . 0.0 109.316 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.4 -35.77 63.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.908 0.776 . . . . 0.0 112.338 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.46 -51.22 60.4 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.391 1.876 . . . . 0.0 109.768 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.6 t -75.36 -29.13 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.224 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -65.54 -36.26 83.27 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.605 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.64 -40.69 40.98 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.655 0.661 . . . . 0.0 112.243 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -50.11 69.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.983 -1.073 . . . . 0.0 109.899 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.05 -25.76 61.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -167.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.91 -22.96 4.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.396 1.078 . . . . 0.0 112.969 169.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -76.24 -13.06 60.18 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.625 -1.297 . . . . 0.0 112.626 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CE1' HD21 ' A' ' 79' ' ' LEU . 87.9 m-85 -116.98 -16.52 10.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.576 1.08 . . . . 0.0 112.898 -173.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.46 -138.75 3.24 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD13 ' C ' ' A' ' 41' ' ' LEU . 2.4 tm? -140.33 123.0 16.29 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -87.04 116.32 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -66.24 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.731 1.613 . . . . 0.0 107.84 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.6 m -154.14 169.44 23.57 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.774 1.229 . . . . 0.0 110.239 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 mt -130.2 141.97 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.266 1.826 . . . . 0.0 106.179 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -126.11 120.18 29.5 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.538 1.135 . . . . 0.0 110.58 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.37 85.75 17.7 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.46 123.16 11.61 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.351 2.034 . . . . 0.0 108.257 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.99 154.07 37.5 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 123.652 0.781 . . . . 0.0 110.093 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -54.32 155.7 15.5 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.273 2.649 . . . . 0.0 111.025 167.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.86 167.32 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 128.361 2.664 . . . . 0.0 107.882 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.36 80.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.724 2.409 . . . . 0.0 109.199 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.14 -0.63 64.21 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-O 117.978 -1.457 . . . . 0.0 113.387 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.69 135.7 62.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 120.314 2.057 . . . . 0.0 108.143 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -67.45 176.9 2.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.229 1.014 . . . . 0.0 110.084 164.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.04 151.07 54.67 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 125.93 1.692 . . . . 0.0 107.443 168.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -67.85 138.08 43.53 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 N-CA-C 108.025 -1.567 . . . . 0.0 108.025 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.71 36.56 92.48 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.3 t -74.15 163.54 27.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.189 0.518 . . . . 0.0 110.166 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -39.03 2.72 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.192 1.377 . . . . 0.0 111.594 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 168.52 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.541 1.671 . . . . 0.0 109.709 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -131.86 152.48 36.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.56 157.94 28.39 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 p -139.02 161.05 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -133.19 144.9 50.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.822 1.649 . . . . 0.0 107.441 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -110.75 -179.16 3.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.895 1.678 . . . . 0.0 111.035 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.441 ' CG2' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -86.11 -21.47 27.61 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.854 172.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -139.83 -179.09 5.74 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.482 1.492 . . . . 0.0 110.561 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.31 -35.14 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 158.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -76.49 -28.93 56.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.574 -1.329 . . . . 0.0 113.51 -166.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -76.49 -38.89 54.57 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.375 1.07 . . . . 0.0 109.169 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.9 t -57.1 -47.6 80.67 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 110.56 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -56.94 -26.89 60.4 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.449 1.499 . . . . 0.0 113.179 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -76.91 -48.13 19.08 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.17 88.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 117.155 -1.403 . . . . 0.0 111.743 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -63.89 0.89 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.719 1.145 . . . . 0.0 110.659 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -81.97 -21.13 37.33 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.529 0.732 . . . . 0.0 112.021 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.74 89.43 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.484 HD21 ' CE1' ' A' ' 39' ' ' TYR . 96.4 mt -115.01 -1.46 13.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -160.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.6 m -47.64 116.07 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.024 -1.047 . . . . 0.0 109.507 164.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.54 5.7 63.07 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.626 0.648 . . . . 0.0 114.412 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -177.85 1.26 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.853 1.327 . . . . 0.0 111.42 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -126.9 133.2 50.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.435 1.494 . . . . 0.0 107.054 163.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -108.15 15.08 24.52 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.155 0.982 . . . . 0.0 110.937 172.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.11 -73.31 0.06 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -150.89 -13.28 0.22 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -98.46 164.19 12.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.155 0.889 . . . . 0.0 110.017 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.41 135.99 26.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.93 139.8 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.209 1.403 . . . . 0.0 111.058 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.264 3.1 p -110.93 115.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 170.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -78.2 143.72 36.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.09 167.68 21.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.64 1.976 . . . . 0.0 106.09 162.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -71.82 164.45 25.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.91 0.777 . . . . 0.0 109.68 163.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 -164.47 1.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.469 1.108 . . . . 0.0 108.524 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -114.38 143.42 29.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.22 -25.86 5.53 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.123 2.548 . . . . 0.0 111.169 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -54.29 -59.34 4.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 122.036 0.922 . . . . 0.0 109.842 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -20.12 62.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.856 2.062 . . . . 0.0 110.898 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -73.14 -46.87 48.47 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 127.488 2.315 . . . . 0.0 111.006 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -60.36 -35.89 76.74 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 -97.56 -166.77 1.43 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 109.605 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -122.08 54.72 1.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.501 1.52 . . . . 0.0 107.738 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.98 38.81 3.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.713 1.244 . . . . 0.0 109.001 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -60.82 142.53 56.01 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.595 1.958 . . . . 0.0 108.822 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.9 -100.75 1.37 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -141.12 158.4 64.6 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.492 1.517 . . . . 0.0 109.066 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -66.31 133.0 31.16 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.959 2.439 . . . . 0.0 108.223 168.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.8 p -137.29 169.21 18.17 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.537 1.935 . . . . 0.0 106.772 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -75.39 -10.86 59.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.369 0.532 . . . . 0.0 111.798 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.87 106.78 19.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 125.469 1.508 . . . . 0.0 110.006 -170.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -91.53 113.09 25.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -85.01 134.05 34.23 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.5 139.85 52.52 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.276 1.031 . . . . 0.0 109.52 -173.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.5 mtm -125.18 161.13 27.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.896 0.878 . . . . 0.0 109.241 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 60.87 30.68 19.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.577 2.351 . . . . 0.0 112.911 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.624 ' CE ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -77.65 -79.66 0.11 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 164.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.47 171.02 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 125.12 1.368 . . . . 0.0 109.791 -165.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.91 159.4 40.99 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 124.096 0.958 . . . . 0.0 109.445 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.69 4.87 2.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.574 2.183 . . . . 0.0 113.584 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -128.24 14.55 6.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.555 1.942 . . . . 0.0 113.415 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -132.45 -4.21 3.36 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.45 -0.781 . . . . 0.0 111.357 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -98.63 51.59 0.99 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.443 1.497 . . . . 0.0 109.885 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.41 -54.85 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.38 100.54 0.06 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.984 2.114 . . . . 0.0 109.952 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.28 -7.34 58.58 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.941 0.896 . . . . 0.0 113.088 -165.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -76.51 -59.64 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.983 1.713 . . . . 0.0 107.961 166.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -63.95 -34.33 77.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.668 0.787 . . . . 0.0 111.982 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -44.99 -45.56 10.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.931 1.292 . . . . 0.0 111.514 168.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.85 -23.0 42.26 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 121.573 -0.704 . . . . 0.0 112.078 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -71.42 -50.15 34.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 124.189 0.93 . . . . 0.0 109.162 169.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.31 -40.66 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.148 0.979 . . . . 0.0 111.147 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.0 t -57.87 -40.35 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 118.879 0.763 . . . . 0.0 109.951 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.56 -40.74 33.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.873 0.306 . . . . 0.0 111.032 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.72 -33.62 76.03 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.08 -36.68 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 O-C-N 121.545 -0.722 . . . . 0.0 109.414 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -58.28 -38.27 76.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 117.134 -1.413 . . . . 0.0 109.627 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.09 -33.37 73.24 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.588 1.54 . . . . 0.0 112.107 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.36 -41.44 63.43 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 120.964 -1.085 . . . . 0.0 110.975 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.483 ' SG ' HG21 ' A' ' 42' ' ' VAL 0.265 0.8 OUTLIER -81.22 -27.97 35.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.287 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.04 -3.91 32.24 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.659 1.118 . . . . 0.0 112.259 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -56.81 -18.43 12.85 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.3 -1.5 . . . . 0.0 113.725 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -119.75 1.26 11.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.043 1.337 . . . . 0.0 113.003 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.13 -145.13 10.21 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -122.49 112.53 18.15 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 118.747 1.274 . . . . 0.0 110.023 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.483 HG21 ' SG ' ' A' ' 36' ' ' CYS . 75.6 t -69.81 108.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -68.71 -53.48 21.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.846 0.858 . . . . 0.0 109.884 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -161.51 163.68 30.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -135.71 108.71 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.77 119.16 31.35 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 125.91 1.684 . . . . 0.0 109.106 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mt -133.49 85.69 42.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.29 1.836 . . . . 0.0 107.838 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.72 136.4 53.5 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.682 1.588 . . . . 0.0 109.161 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -98.08 165.2 15.78 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.512 1.125 . . . . 0.0 109.616 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.37 170.96 10.0 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.56 2.173 . . . . 0.0 109.903 166.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.97 100.63 10.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t0 59.91 27.47 16.84 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.3 -15.08 36.14 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 127.188 2.328 . . . . 0.0 113.508 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -86.13 142.95 12.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.513 1.125 . . . . 0.0 110.063 -169.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -74.69 140.82 44.45 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.989 0.915 . . . . 0.0 110.044 172.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.93 153.46 78.63 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 123.651 0.78 . . . . 0.0 112.045 -175.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.56 117.32 4.64 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.225 2.617 . . . . 0.0 108.256 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.28 -15.15 15.55 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 126.735 2.112 . . . . 0.0 112.256 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.5 t -76.45 148.47 37.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.068 0.934 . . . . 0.0 111.184 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.52 -16.0 51.73 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.124 1.821 . . . . 0.0 112.622 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -92.56 157.12 16.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.761 1.781 . . . . 0.0 108.583 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.0 149.4 33.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 164.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -129.32 114.31 16.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 42' ' ' VAL . 98.5 t -101.82 111.63 32.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 148.49 29.2 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.232 1.813 . . . . 0.0 106.362 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -129.87 179.57 5.78 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.746 1.219 . . . . 0.0 109.87 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -90.07 -13.3 36.17 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -164.55 155.8 15.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.553 1.069 . . . . 0.0 110.007 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG12 HE21 ' A' ' 73' ' ' GLN . 40.8 t -65.36 -23.42 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.558 0.743 . . . . 0.0 109.142 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -84.41 -18.03 37.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.5 -1.375 . . . . 0.0 113.224 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -76.52 -45.97 28.55 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.5 p -71.51 -36.43 71.07 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.665 -0.647 . . . . 0.0 110.714 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.429 HE21 HG12 ' A' ' 69' ' ' VAL . 2.0 mp0 -47.3 -36.2 8.94 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.928 2.091 . . . . 0.0 112.856 168.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -79.11 -48.72 13.8 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.21 73.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.67 1.188 . . . . 0.0 111.266 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.1 ttm -48.73 -70.54 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.628 1.571 . . . . 0.0 110.336 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.76 -33.29 73.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.543 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.9 -15.85 69.69 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.516 1.055 . . . . 0.0 114.027 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.54 9.05 5.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.114 1.457 . . . . 0.0 112.687 -171.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.8 m -63.77 102.11 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.16 -0.962 . . . . 0.0 110.181 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.17 1.88 51.29 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.13 1.348 . . . . 0.0 113.14 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -178.64 0.2 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.386 1.593 . . . . 0.0 111.503 173.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.35 140.08 53.29 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' A' ' 89' ' ' VAL . 3.1 m-85 -117.84 13.76 14.14 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.644 0.735 . . . . 0.0 109.854 176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.34 -70.77 0.08 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.52 2.328 . . . . 0.0 107.661 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -162.42 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.64 1.176 . . . . 0.0 111.821 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -78.18 175.26 10.34 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.489 1.04 . . . . 0.0 109.456 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.43 165.63 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.624 HG22 ' CE ' ' A' ' 13' ' ' MET . 25.6 t -114.57 125.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.0 t -105.84 129.51 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 167.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.0 p -99.2 146.86 25.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.609 1.164 . . . . 0.0 108.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -141.52 161.22 38.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.411 1.485 . . . . 0.0 107.334 160.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -69.36 157.49 36.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 158.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -176.68 2.95 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.523 1.529 . . . . 0.0 107.417 165.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -99.1 144.98 29.22 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 156.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.41 -24.17 6.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.823 2.349 . . . . 0.0 112.925 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.47 -46.93 73.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.19 0.905 . . . . 0.0 110.725 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 p -75.71 2.94 10.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.452 1.101 . . . . 0.0 111.925 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -93.16 -48.92 6.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.551 1.141 . . . . 0.0 108.932 165.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -60.27 -30.41 69.42 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.771 0.428 . . . . 0.0 111.256 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -104.63 163.46 12.46 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.524 1.13 . . . . 0.0 109.87 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 ttm-85 -73.23 21.89 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.276 2.23 . . . . 0.0 112.794 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -88.81 64.09 7.11 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.75 -1.219 . . . . 0.0 111.133 -158.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 4.4 m-85 -95.35 166.92 11.65 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.081 0.553 . . . . 0.0 109.625 -169.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.1 t90 . . . . . 0 C--O 1.246 0.878 0 C-N-CA 126.206 1.803 . . . . 0.0 109.291 -179.593 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.48 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -167.84 -168.68 30.33 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -173.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -55.78 151.33 23.47 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.966 1.306 . . . . 0.0 111.799 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.0 142.97 48.26 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.897 2.398 . . . . 0.0 108.868 166.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 p -121.33 -179.28 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.587 1.955 . . . . 0.0 107.983 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -82.74 9.68 9.19 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.437 HG12 ' HG3' ' A' ' 65' ' ' GLU . 2.9 m -130.92 157.4 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 121.083 1.765 . . . . 0.0 110.332 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 93' ' ' TYR . 5.6 tp -133.4 170.72 15.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.931 0.872 . . . . 0.0 109.268 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.86 140.4 31.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.911 1.284 . . . . 0.0 109.362 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.29 122.9 27.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.593 1.557 . . . . 0.0 107.646 -167.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.1 mtm -103.94 165.98 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.213 0.605 . . . . 0.0 110.632 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 75.22 7.36 4.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 129.334 3.054 . . . . 0.0 115.12 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -65.16 0.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.148 1.34 . . . . 0.0 109.305 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.21 144.46 35.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.784 1.634 . . . . 0.0 109.077 -158.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.45 163.78 32.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 126.197 1.799 . . . . 0.0 110.762 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.84 -1.03 7.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.08 2.52 . . . . 0.0 114.606 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.83 -0.57 3.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.565 1.146 . . . . 0.0 112.598 -163.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -115.08 -12.26 11.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.636 0.774 . . . . 0.0 112.784 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.442 ' C ' HD22 ' A' ' 20' ' ' LEU . 91.8 mt -75.06 47.97 0.38 Allowed 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.455 1.902 . . . . 0.0 112.396 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD22 ' C ' ' A' ' 19' ' ' LEU . 3.6 mm? -132.73 -13.6 2.88 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -165.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.94 179.42 1.48 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.664 1.12 . . . . 0.0 109.59 159.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -122.89 -4.09 8.61 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.129 -0.982 . . . . 0.0 111.382 165.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -90.19 -72.79 0.55 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.793 2.037 . . . . 0.0 108.928 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -57.52 -33.37 68.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.561 1.944 . . . . 0.0 110.607 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -47.46 -46.97 27.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.364 1.466 . . . . 0.0 112.138 171.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -75.74 -34.11 60.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -60.3 -44.36 95.48 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.96 -34.81 70.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -61.02 -54.27 37.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 O-C-N 120.749 -1.219 . . . . 0.0 108.753 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -70.87 -33.2 70.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.932 0.787 . . . . 0.0 112.031 -169.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.93 -35.32 79.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.239 1.019 . . . . 0.0 111.93 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.38 -25.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 108.966 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -69.18 -21.63 63.96 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.941 -1.099 . . . . 0.0 111.723 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.25 -62.24 1.52 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.849 1.204 . . . . 0.0 108.11 159.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HB2' HH21 ' A' ' 82' ' ' ARG . 5.0 pt-20 -61.08 -40.29 93.14 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -158.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -77.66 -28.65 51.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.0 t -65.86 -12.95 58.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.414 1.085 . . . . 0.0 111.473 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.57 -12.38 52.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 119.644 -1.91 . . . . 0.0 111.693 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -112.13 -7.13 14.08 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.073 1.349 . . . . 0.0 113.732 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.48 -167.3 31.4 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.52 104.1 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.987 0.898 . . . . 0.0 109.874 -175.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.28 106.49 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 125.406 1.482 . . . . 0.0 107.052 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -66.51 -67.57 0.44 Allowed 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 166.63 32.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.34 0.656 . . . . 0.0 111.341 -168.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -138.98 145.36 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 126.217 1.807 . . . . 0.0 108.85 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -132.84 121.97 23.72 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.93 1.292 . . . . 0.0 109.433 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.9 mt -127.85 86.1 59.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.89 2.076 . . . . 0.0 107.414 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.63 148.8 86.04 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.721 1.614 . . . . 0.0 109.861 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -115.07 152.57 46.76 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.862 0.865 . . . . 0.0 110.116 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -65.58 169.95 11.95 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 111.243 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 t -130.0 118.15 43.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 t70 57.5 24.9 10.82 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.332 1.853 . . . . 0.0 115.075 174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.59 -8.78 74.33 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.217 1.389 . . . . 0.0 112.751 -174.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.7 t -93.64 138.96 19.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 126.228 1.811 . . . . 0.0 109.243 -172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -59.38 152.77 20.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.297 1.839 . . . . 0.0 111.85 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.581 HG22 ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -114.57 149.59 42.51 Favored Pre-proline 0 C--N 1.326 -0.418 0 C-N-CA 126.664 1.986 . . . . 0.0 111.772 172.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -66.55 102.1 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 N-CA-C 106.706 -2.075 . . . . 0.0 106.706 164.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.54 -11.03 11.32 Favored Glycine 0 C--O 1.229 -0.205 0 C-N-CA 125.733 1.635 . . . . 0.0 111.451 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.581 ' HB2' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -70.4 144.88 51.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.995 0.897 . . . . 0.0 109.806 -177.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.18 -35.85 4.6 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 127.456 2.455 . . . . 0.0 110.512 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -85.4 167.88 15.12 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.185 -1.185 . . . . 0.0 110.389 -172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 mt -136.32 128.17 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -99.59 155.17 17.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -144.71 145.15 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 7' ' ' VAL . 10.9 tt0 -121.91 146.86 46.71 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.887 1.275 . . . . 0.0 108.901 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.07 167.03 16.51 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.492 1.117 . . . . 0.0 110.529 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.0 p -74.2 -18.1 60.8 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -159.62 159.28 32.94 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.906 1.23 . . . . 0.0 111.406 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.532 HG12 HE21 ' A' ' 73' ' ' GLN . 24.3 t -53.31 -38.97 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.923 1.289 . . . . 0.0 109.134 171.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -52.02 -52.49 50.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.297 1.039 . . . . 0.0 111.986 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.14 -43.92 81.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 10.7 t -58.11 -41.84 84.46 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.003 0.521 . . . . 0.0 111.005 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.532 HE21 HG12 ' A' ' 69' ' ' VAL . 26.2 mt-30 -62.86 -20.93 65.58 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.668 1.187 . . . . 0.0 112.734 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -90.42 -46.39 8.39 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.785 1.175 . . . . 0.0 108.664 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.32 -15.99 64.0 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.593 1.157 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.436 ' CE ' HD11 ' A' ' 8' ' ' LEU . 25.4 tpp -60.37 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.906 1.682 . . . . 0.0 108.226 168.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -70.76 -22.71 62.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.718 -164.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.35 -27.9 71.46 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.574 0.624 . . . . 0.0 112.426 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.442 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 96.1 mt -113.56 -4.1 13.56 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.06 1.344 . . . . 0.0 111.732 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.0 m -57.37 106.63 0.35 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.935 -1.103 . . . . 0.0 109.025 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.69 -0.17 59.38 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.182 -0.788 . . . . 0.0 113.884 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.444 HH21 ' HB2' ' A' ' 35' ' ' GLU . 9.2 mmm180 -63.67 178.76 0.55 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.944 1.372 . . . . 0.0 110.665 167.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 85' ' ' ALA . 89.6 mttt -133.96 84.47 2.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.373 1.469 . . . . 0.0 107.469 -167.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 3.0 m-30 -78.1 37.73 0.26 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.492 1.117 . . . . 0.0 109.54 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' LYS . . . 174.51 -69.32 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 1 C-N-CA 132.738 4.415 . . . . 0.0 105.895 167.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.14 -29.54 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.294 1.838 . . . . 0.0 111.456 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -89.52 162.63 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 120.942 -1.099 . . . . 0.0 109.78 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.37 139.9 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.69 133.73 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.9 122.86 65.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -85.6 155.54 21.1 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 129.182 2.993 . . . . 0.0 109.278 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -153.13 138.62 17.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.662 1.985 . . . . 0.0 108.541 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HA ' HD12 ' A' ' 8' ' ' LEU . 56.0 m-85 -67.22 127.53 32.99 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 162.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.67 169.7 9.51 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.823 1.249 . . . . 0.0 108.435 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -92.13 143.65 27.89 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.64 -27.51 6.1 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.507 2.804 . . . . 0.0 111.918 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -57.18 13.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.634 1.107 . . . . 0.0 111.194 -170.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 m -65.98 -33.47 75.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.187 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -65.68 -30.74 71.47 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.482 1.113 . . . . 0.0 112.588 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -64.78 -2.8 2.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.081 0.953 . . . . 0.0 112.673 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -138.46 179.49 6.43 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.974 2.11 . . . . 0.0 108.711 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.442 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -81.0 21.31 0.71 Allowed 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.195 -0.94 . . . . 0.0 112.324 174.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.73 45.41 1.07 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.44 -1.412 . . . . 0.0 112.68 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 102' ' ' ARG . 10.8 m-85 -79.1 134.27 36.74 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.302 1.441 . . . . 0.0 107.429 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.51 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.97 178.6 36.01 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -66.66 156.49 86.34 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.506 1.122 . . . . 0.0 109.53 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.65 141.13 49.1 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.054 1.836 . . . . 0.0 108.666 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -123.48 172.97 8.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.53 1.132 . . . . 0.0 110.261 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.48 -9.11 55.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.356 0.662 . . . . 0.0 112.165 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.6 m -102.16 -176.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 120.02 1.282 . . . . 0.0 111.658 -172.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 tp -145.48 155.27 43.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.122 1.369 . . . . 0.0 109.199 161.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.41 143.13 48.69 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.505 1.122 . . . . 0.0 109.645 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.25 152.8 49.28 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.604 1.962 . . . . 0.0 109.694 -170.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 39.7 mtm -132.56 165.12 25.11 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.751 1.22 . . . . 0.0 110.238 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 75.44 -8.59 1.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 130.085 3.354 . . . . 0.0 114.571 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.439 ' HE3' HG22 ' A' ' 89' ' ' VAL . 10.0 tpp -71.17 -36.9 72.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.743 1.156 . . . . 0.0 112.472 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.06 152.62 36.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 0.0 109.855 -170.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -110.12 156.13 40.61 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.49 -1.06 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.06 2.507 . . . . 0.0 113.023 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -116.61 4.52 13.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.05 1.74 . . . . 0.0 111.817 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -133.81 33.88 3.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.358 1.463 . . . . 0.0 110.817 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt -131.75 58.75 1.72 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.426 1.89 . . . . 0.0 108.57 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.25 -45.32 1.98 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.238 1.415 . . . . 0.0 110.029 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.71 105.74 7.95 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.02 -32.43 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.914 1.686 . . . . 0.0 111.778 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.33 -63.21 1.11 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.501 0.72 . . . . 0.0 109.56 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -53.83 -42.81 68.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.221 1.008 . . . . 0.0 110.143 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -53.25 -40.51 64.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.98 1.312 . . . . 0.0 111.617 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -81.98 -38.4 25.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.866 1.212 . . . . 0.0 111.029 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -59.55 -51.1 71.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -54.72 -45.57 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.558 0.743 . . . . 0.0 109.426 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.92 -26.32 39.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 118.064 -0.969 . . . . 0.0 112.708 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.41 -28.41 23.58 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.673 1.124 . . . . 0.0 112.538 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.04 -41.53 64.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.118 0.961 . . . . 0.0 110.04 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG13 ' CE2' ' A' ' 84' ' ' PHE . 42.8 t -71.96 -28.25 29.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 125.027 1.331 . . . . 0.0 109.15 -177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -56.42 -57.42 12.39 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.55 -40.77 97.86 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.217 0.948 . . . . 0.0 110.079 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.5 -39.94 85.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.458 -169.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.83 -27.1 49.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.2 t -64.47 -21.66 66.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.829 0.852 . . . . 0.0 110.815 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -56.59 -21.66 28.42 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.118 -1.614 . . . . 0.0 111.976 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.469 ' CE1' HD21 ' A' ' 79' ' ' LEU . 42.2 m-85 -110.53 2.46 18.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.928 1.691 . . . . 0.0 112.224 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.59 -156.14 26.91 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 120.164 1.347 . . . . 0.0 112.258 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.1 tm? -112.2 110.08 20.14 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.09 113.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -61.51 -61.03 2.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.874 1.27 . . . . 0.0 109.243 167.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 175.46 12.01 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.314 -0.866 . . . . 0.0 110.903 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 64' ' ' VAL . 57.4 mt -138.89 145.11 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.31 125.1 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.167 1.787 . . . . 0.0 109.541 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.6 mt -138.46 82.42 22.75 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.71 138.88 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.084 1.856 . . . . 0.0 109.752 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -90.81 155.75 45.16 Favored Pre-proline 0 N--CA 1.474 0.735 0 O-C-N 120.485 -1.384 . . . . 0.0 111.877 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.16 172.33 3.26 Favored 'Trans proline' 0 C--N 1.352 0.746 1 C-N-CA 126.094 4.529 . . . . 0.0 112.648 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.9 t -128.25 98.08 4.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 t70 52.28 53.7 11.97 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.905 1.682 . . . . 0.0 112.11 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.89 -10.66 59.61 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.288 -1.285 . . . . 0.0 113.356 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 t -96.24 142.36 13.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 119.801 1.801 . . . . 0.0 109.543 -172.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.91 150.91 27.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.386 -1.734 . . . . 0.0 111.249 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' H ' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -114.75 155.54 46.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 124.908 1.283 . . . . 0.0 111.381 173.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.17 99.5 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.353 2.035 . . . . 0.0 107.707 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.32 16.74 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 126.438 1.971 . . . . 0.0 112.758 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.448 ' HB2' ' H ' ' A' ' 56' ' ' VAL . 17.8 t -71.99 132.54 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.687 1.243 . . . . 0.0 109.352 -170.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.44 1.51 80.97 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.734 1.635 . . . . 0.0 113.815 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -108.72 161.08 15.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -126.63 148.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.09 142.75 50.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 45' ' ' ILE . 53.7 t -134.64 150.95 30.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 23.6 tt0 -129.08 142.49 50.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.09 169.84 8.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.114 1.766 . . . . 0.0 108.441 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.3 t -98.97 8.4 45.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.957 0.903 . . . . 0.0 110.419 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.1 p -155.5 147.98 23.94 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 120.261 -1.525 . . . . 0.0 111.393 156.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.725 HG12 HE21 ' A' ' 73' ' ' GLN . 1.9 t -49.73 -41.3 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.121 0.968 . . . . 0.0 109.032 163.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -62.92 -22.8 67.02 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.446 1.498 . . . . 0.0 114.187 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -101.34 -37.04 8.66 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -31.78 73.03 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.294 -0.879 . . . . 0.0 111.012 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.725 HE21 HG12 ' A' ' 69' ' ' VAL . 35.3 mt-30 -58.72 -20.35 48.1 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.08 1.752 . . . . 0.0 112.987 170.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -88.26 -51.84 5.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.63 1.105 . . . . 0.0 108.613 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.5 -43.52 65.12 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.131 0.973 . . . . 0.0 111.118 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.0 tpp -44.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.423 2.289 . . . . 0.0 110.404 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.7 -18.62 56.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.31 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.9 -25.2 72.27 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.264 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.524 HD23 ' HG3' ' A' ' 82' ' ' ARG . 90.9 mt -115.63 4.36 14.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.138 0.975 . . . . 0.0 111.893 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.1 m -55.13 107.58 0.32 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.791 1.237 . . . . 0.0 109.899 168.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.0 8.2 72.77 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.765 -0.584 . . . . 0.0 113.935 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.524 ' HG3' HD23 ' A' ' 79' ' ' LEU . 64.3 mmt-85 -72.69 -174.8 1.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.901 1.351 . . . . 0.0 111.281 169.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -134.02 98.41 4.13 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.641 0.776 . . . . 0.0 109.984 -170.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.458 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.0 m-85 -83.1 19.49 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.721 2.008 . . . . 0.0 112.534 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.2 -85.49 0.0 OUTLIER 'General case' 0 C--O 1.231 0.126 0 C-N-CA 129.469 3.107 . . . . 0.0 104.46 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.3 -24.63 2.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.021 0.928 . . . . 0.0 110.96 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 87' ' ' ARG . 18.8 mtp85 -93.12 173.59 7.65 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.736 0.698 . . . . 0.0 110.287 -166.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.93 165.5 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG22 ' HE3' ' A' ' 13' ' ' MET . 71.6 t -132.84 145.39 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.49 -173.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.4 117.23 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 168.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.69 154.23 27.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.476 2.31 . . . . 0.0 110.007 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.92 150.43 28.35 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.157 2.983 . . . . 0.0 106.27 173.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -69.09 160.19 31.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.638 1.108 . . . . 0.0 108.891 160.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.39 -164.47 1.3 Allowed 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.773 1.229 . . . . 0.0 109.459 168.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.85 143.88 28.47 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.08 -32.88 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.367 2.712 . . . . 0.0 110.449 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -57.33 -54.31 48.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.1 m -66.89 -29.47 69.38 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.85 1.26 . . . . 0.0 110.794 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -64.05 -40.48 96.38 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.843 1.657 . . . . 0.0 111.09 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -70.97 -9.75 58.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.264 1.026 . . . . 0.0 112.349 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 20.8 mtp85 -106.45 -168.8 1.47 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.33 1.452 . . . . 0.0 109.482 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 4.3 tpt180 -108.82 73.12 0.85 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.68 92.44 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 2.8 m-85 -133.78 152.59 51.92 Favored 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -170.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.443 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.72 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.0 -78.29 1.24 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 172.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -137.85 160.89 62.88 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.605 1.562 . . . . 0.0 109.209 -169.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.15 146.49 41.03 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.608 2.872 . . . . 0.0 109.61 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -131.7 170.35 14.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -78.9 8.38 5.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -98.14 119.7 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.62 143.62 32.52 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -108.1 142.17 38.7 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt -138.59 128.37 25.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.843 1.257 . . . . 0.0 107.613 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -133.73 156.91 47.1 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.154 0.582 . . . . 0.0 109.764 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 65.34 72.01 0.43 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.125 2.17 . . . . 0.0 109.771 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.439 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -132.44 -77.14 0.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.472 1.509 . . . . 0.0 107.786 -177.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.35 146.31 19.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.555 1.542 . . . . 0.0 109.371 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 17' ' ' GLU . 50.9 mt -109.78 151.57 42.41 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.752 0.821 . . . . 0.0 109.082 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.95 4.91 0.55 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.61 2.873 . . . . 0.0 113.515 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 15' ' ' LEU . 19.0 pt-20 -131.14 2.94 4.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.334 2.654 . . . . 0.0 112.093 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -127.17 -18.06 4.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.541 -0.725 . . . . 0.0 112.587 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.843 HD11 ' HA ' ' A' ' 49' ' ' ARG 0.254 0.2 OUTLIER -90.69 16.25 9.53 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.967 -1.083 . . . . 0.0 110.927 -162.482 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -97.43 -22.55 16.52 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.556 -1.34 . . . . 0.0 113.36 -162.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.22 134.39 34.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -168.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.97 -18.82 64.85 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.443 0.697 . . . . 0.0 112.159 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.34 -68.81 0.6 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.122 1.769 . . . . 0.0 108.968 166.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -58.48 -36.21 73.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.573 1.549 . . . . 0.0 112.844 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' VAL . 71.4 t80 -52.05 -47.89 64.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.281 1.432 . . . . 0.0 112.395 170.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.28 -38.93 71.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.7 0.8 . . . . 0.0 111.067 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -52.08 -48.34 64.74 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.632 1.173 . . . . 0.0 109.243 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.5 mt -63.97 -44.49 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.52 1.528 . . . . 0.0 109.899 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 25' ' ' TYR . 57.2 t -58.57 -46.37 90.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -78.36 -31.48 48.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -170.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.22 -42.17 99.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 123.223 1.487 . . . . 0.0 109.414 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.66 -31.78 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.403 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -66.42 -24.36 66.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 120.962 -1.086 . . . . 0.0 111.395 175.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.58 -59.71 3.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 119.884 1.22 . . . . 0.0 108.309 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -62.3 -37.58 86.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -167.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.1 t -72.7 -25.89 61.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.571 0.749 . . . . 0.0 109.881 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -61.66 -23.33 66.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.54 1.136 . . . . 0.0 111.296 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 84.3 mttt -65.52 -10.75 37.45 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.454 -1.404 . . . . 0.0 112.95 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CE1' HD21 ' A' ' 79' ' ' LEU . 71.6 m-85 -123.47 4.11 9.03 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.856 1.263 . . . . 0.0 113.424 -170.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.11 -131.26 3.26 Favored Glycine 0 CA--C 1.504 -0.594 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.17 116.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.5 104.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.109 1.363 . . . . 0.0 108.693 166.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.06 -55.91 12.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.92 2.488 . . . . 0.0 110.337 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -148.37 163.43 37.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.399 1.479 . . . . 0.0 110.209 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mt -138.81 133.82 41.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.01 110.46 12.99 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.963 0.905 . . . . 0.0 109.58 -170.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.493 HD12 HG22 ' A' ' 29' ' ' VAL . 13.9 mt -128.16 86.62 57.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.668 1.587 . . . . 0.0 107.516 -170.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.93 125.5 16.67 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.787 1.658 . . . . 0.0 108.232 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.843 ' HA ' HD11 ' A' ' 19' ' ' LEU . 17.7 mtp180 -90.6 151.36 43.91 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 0.0 110.117 -174.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' CD ' ' HG ' ' A' ' 19' ' ' LEU . 61.0 Cg_endo -68.6 138.62 42.27 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.83 1.687 . . . . 0.0 109.543 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.53 104.28 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 t0 52.06 39.55 26.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.537 1.535 . . . . 0.0 113.565 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.01 12.37 71.37 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.706 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.7 t -91.76 159.32 2.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 119.086 1.443 . . . . 0.0 108.772 170.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -66.24 148.78 51.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.389 1.09 . . . . 0.0 112.471 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.72 161.05 63.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.265 2.226 . . . . 0.0 110.219 170.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.96 127.7 19.12 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.648 2.899 . . . . 0.0 110.259 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.03 66.1 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 126.33 1.919 . . . . 0.0 111.583 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.14 147.95 44.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 122.042 -0.681 . . . . 0.0 109.454 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.71 65.17 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.035 1.778 . . . . 0.0 112.76 -171.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -108.42 160.81 15.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -129.36 129.97 67.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 162.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -99.83 130.66 46.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 171.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -124.73 145.76 31.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.87 139.1 51.59 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -174.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -118.71 168.02 11.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.413 1.102 . . . . 0.0 111.062 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -38.06 87.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.067 1.347 . . . . 0.0 113.273 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.5 m -160.42 156.82 26.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.596 1.089 . . . . 0.0 111.367 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.479 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 10.7 t -63.83 -28.73 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.467 1.107 . . . . 0.0 110.666 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -68.85 -24.88 64.41 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 120.724 -1.235 . . . . 0.0 112.49 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.91 -52.96 5.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 125.34 1.456 . . . . 0.0 108.012 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.479 ' SG ' ' HA ' ' A' ' 69' ' ' VAL . 8.5 p -62.53 -29.96 70.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.144 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.66 -38.58 67.1 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.451 0.7 . . . . 0.0 112.273 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -73.65 -46.9 43.79 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.281 1.032 . . . . 0.0 108.602 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.04 -41.22 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.88 0.472 . . . . 0.0 111.556 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -66.48 0.38 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.173 1.789 . . . . 0.0 110.123 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -38.57 89.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.416 1.087 . . . . 0.0 110.508 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.13 -29.68 75.41 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 118.954 0.797 . . . . 0.0 112.332 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.558 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 96.1 mt -112.56 -0.99 15.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.263 1.025 . . . . 0.0 111.436 -173.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -55.45 122.86 12.17 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 166.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.56 78.15 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.708 -1.051 . . . . 0.0 112.721 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -173.03 4.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.767 1.284 . . . . 0.0 109.051 162.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -129.47 120.36 25.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.714 1.606 . . . . 0.0 107.537 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.558 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 4.2 m-30 -101.59 28.28 5.69 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.344 1.058 . . . . 0.0 109.196 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -177.97 -60.81 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.485 1.514 . . . . 0.0 108.842 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.3 t30 177.46 -28.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 127.944 2.498 . . . . 0.0 109.037 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -103.03 167.37 9.88 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.319 0.648 . . . . 0.0 111.019 -173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 p -81.43 107.59 13.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.381 -160.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 13' ' ' MET . 64.5 t -66.84 108.6 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.872 0.869 . . . . 0.0 110.294 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.73 123.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 163.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.98 142.15 27.82 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 126.289 1.835 . . . . 0.0 106.892 170.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -149.05 154.96 40.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.392 1.077 . . . . 0.0 109.373 168.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -74.34 158.21 34.38 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 169.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.84 -176.74 5.1 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.078 2.551 . . . . 0.0 108.646 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -128.52 143.7 49.31 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 119.069 0.85 . . . . 0.0 109.355 -171.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.56 -30.44 12.11 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.794 2.329 . . . . 0.0 112.357 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.83 -41.73 74.7 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.287 0.948 . . . . 0.0 110.451 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.57 -43.77 88.76 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.33 0.652 . . . . 0.0 110.167 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -70.71 -35.81 72.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.764 1.626 . . . . 0.0 112.593 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -64.35 -10.63 25.62 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.537 1.135 . . . . 0.0 112.618 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -134.8 -164.79 1.57 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.444 1.898 . . . . 0.0 107.411 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -110.02 29.26 7.8 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.687 1.195 . . . . 0.0 110.87 -178.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -79.54 72.48 6.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.533 1.159 . . . . 0.0 109.884 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 22.0 m-30 -100.92 -5.26 26.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -165.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.34 1.456 . . . . 0.0 109.682 -177.677 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.501 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.31 -143.54 7.47 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -53.45 150.2 12.92 Favored Pre-proline 0 C--O 1.239 0.536 0 C-N-CA 123.526 0.73 . . . . 0.0 112.486 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.83 136.16 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 N-CA-C 107.619 -1.723 . . . . 0.0 107.619 165.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.4 p -104.81 168.06 9.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -88.31 16.81 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.637 -0.664 . . . . 0.0 112.418 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.54 150.65 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tp -122.52 162.46 21.73 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.481 1.113 . . . . 0.0 108.104 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -135.67 130.57 34.49 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.628 1.571 . . . . 0.0 108.866 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.47 132.12 46.86 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.601 1.16 . . . . 0.0 110.767 -164.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -120.15 162.91 18.53 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.142 0.977 . . . . 0.0 110.242 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 68.68 3.2 3.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.978 2.911 . . . . 0.0 114.222 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.501 ' HB3' HD13 ' A' ' 62' ' ' ILE . 32.6 ttm -72.59 -39.59 67.25 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 110.805 -170.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.27 167.21 25.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 127.009 2.124 . . . . 0.0 109.129 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.85 153.95 55.0 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.894 0.878 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.78 0.79 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.536 2.157 . . . . 0.0 112.624 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.64 9.88 10.91 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.108 1.763 . . . . 0.0 111.684 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -137.42 26.57 2.86 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.48 1.112 . . . . 0.0 111.493 -169.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.83 37.15 4.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.629 1.172 . . . . 0.0 110.39 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -92.92 -59.6 2.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -68.52 112.14 5.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.841 1.256 . . . . 0.0 111.67 -170.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.52 -34.86 74.71 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.146 1.378 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.55 -64.15 0.99 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.126 1.37 . . . . 0.0 110.345 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -63.86 -37.17 86.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 0.0 110.828 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -54.37 -37.71 65.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 111.377 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.85 -32.44 52.05 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.381 0.672 . . . . 0.0 111.078 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.06 -54.32 35.93 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.923 1.289 . . . . 0.0 109.384 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.83 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 -171.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.16 -39.85 81.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 118.245 0.475 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -78.54 -33.3 47.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.638 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.86 -43.8 98.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.324 1.059 . . . . 0.0 109.749 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 50.9 t -68.1 -30.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.826 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -64.47 -35.18 80.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 116.63 -1.653 . . . . 0.0 111.084 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.88 -52.43 59.98 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 120.24 1.382 . . . . 0.0 109.39 169.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 32' ' ' VAL . 6.3 pt-20 -63.44 -46.71 85.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.237 -162.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.66 -9.9 59.01 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.656 -1.278 . . . . 0.0 111.895 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -20.38 66.17 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.879 -1.138 . . . . 0.0 110.066 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -65.93 -3.87 5.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.204 1.402 . . . . 0.0 112.858 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -132.83 -10.99 3.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.907 1.231 . . . . 0.0 113.071 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.26 -165.22 38.72 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 119.675 1.125 . . . . 0.0 110.847 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -98.19 104.53 16.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.76 110.0 2.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.11 -62.77 1.41 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -163.36 -172.02 2.8 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.563 0.345 . . . . 0.0 110.326 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.76 139.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 128.27 2.628 . . . . 0.0 104.597 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -133.2 113.27 12.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.509 0.724 . . . . 0.0 110.699 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mt -126.58 86.79 57.75 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.927 2.891 . . . . 0.0 109.62 -162.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 114.16 3.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.435 2.756 . . . . 0.0 108.989 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 165.4 53.63 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 172.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -61.99 175.81 1.71 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.115 3.21 . . . . 0.0 110.218 164.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.4 t -132.98 116.2 25.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t0 58.02 31.64 20.91 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.949 1.3 . . . . 0.0 112.811 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.88 -3.22 76.8 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.859 1.695 . . . . 0.0 113.044 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.36 143.08 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.4 154.65 5.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.95 1.3 . . . . 0.0 110.331 165.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.31 153.78 80.74 Favored Pre-proline 0 C--O 1.239 0.516 0 C-N-CA 125.445 1.498 . . . . 0.0 109.18 165.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -63.51 135.17 48.11 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.251 1.967 . . . . 0.0 107.93 165.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.81 -10.08 62.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.147 1.356 . . . . 0.0 113.011 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.08 156.68 35.83 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.434 1.117 . . . . 0.0 112.281 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 0.1 83.05 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.179 1.371 . . . . 0.0 113.075 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' C ' HD12 ' A' ' 62' ' ' ILE . 1.7 mppt? -117.29 167.67 11.02 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.048 1.424 . . . . 0.0 108.966 -174.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.501 HD13 ' HB3' ' A' ' 13' ' ' MET . 3.0 mp -126.7 145.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 161.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -111.79 157.77 20.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 160.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.69 153.55 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -134.6 146.42 49.57 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.03 0.932 . . . . 0.0 109.113 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.53 177.91 6.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.157 1.383 . . . . 0.0 110.892 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -89.71 -15.38 32.67 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 85.0 p -150.6 152.92 34.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.194 0.906 . . . . 0.0 111.163 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 t -65.08 -27.51 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.481 1.513 . . . . 0.0 110.126 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.64 -54.65 40.05 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.317 1.047 . . . . 0.0 109.446 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.58 -33.0 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.07 -51.23 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 110.075 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -53.66 -35.78 61.39 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.389 1.076 . . . . 0.0 111.666 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -71.82 -52.17 18.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.346 0.976 . . . . 0.0 110.395 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.46 -51.03 68.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.405 1.482 . . . . 0.0 110.222 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.4 ttt -44.78 -68.86 0.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.174 1.79 . . . . 0.0 111.598 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -66.53 -29.0 69.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.393 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.58 -24.35 65.97 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.447 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.3 mt -129.07 0.88 5.25 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.068 1.434 . . . . 0.0 114.187 -166.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.3 m -58.01 120.63 8.89 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.87 66.14 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.449 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.84 179.2 0.53 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.585 1.692 . . . . 0.0 111.881 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.24 137.22 53.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 159.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.414 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.2 m-30 -110.8 14.43 22.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.639 0.776 . . . . 0.0 110.21 173.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.92 -85.38 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.176 2.59 . . . . 0.0 104.902 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -140.64 -10.46 1.05 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -112.73 161.58 16.71 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.024 1.738 . . . . 0.0 110.244 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.4 109.99 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.43 0.634 . . . . 0.0 109.374 -173.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.9 t -64.52 144.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.615 1.166 . . . . 0.0 108.092 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.8 150.07 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 166.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.86 144.17 47.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.294 2.237 . . . . 0.0 108.574 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 4.8 mmpt? -143.44 162.74 34.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.67 2.388 . . . . 0.0 106.727 159.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -67.21 160.7 26.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 157.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.15 -164.5 1.13 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 168.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -113.53 142.53 27.77 Favored Pre-proline 0 C--O 1.233 0.226 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.32 -24.38 2.52 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.471 2.114 . . . . 0.0 111.528 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.39 -54.18 40.43 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -69.03 -15.6 63.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.199 0.6 . . . . 0.0 112.226 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -82.35 -37.84 25.08 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.051 1.34 . . . . 0.0 110.973 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -72.23 2.21 6.36 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.016 1.327 . . . . 0.0 112.325 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -134.54 -164.52 1.52 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.734 2.414 . . . . 0.0 109.341 -163.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.531 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 5.6 ttm180 -130.26 25.1 5.19 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.931 2.092 . . . . 0.0 110.834 173.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 42.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.942 -1.098 . . . . 0.0 110.344 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.531 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 6.2 m-85 -74.95 129.29 37.4 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.818 0 C-N-CA 125.22 1.408 . . . . 0.0 108.144 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.475 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.81 172.95 52.65 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.335 0.969 . . . . 0.0 111.728 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -87.49 161.13 46.36 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.773 1.629 . . . . 0.0 110.74 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.54 149.1 79.69 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.01 2.473 . . . . 0.0 109.27 165.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 p -139.96 170.81 15.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.29 1.836 . . . . 0.0 107.01 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.56 8.1 1.22 Allowed 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.852 -1.155 . . . . 0.0 111.468 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.9 t -129.04 111.28 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.425 1.49 . . . . 0.0 108.047 -162.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -124.38 129.44 50.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -171.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.7 t -101.0 148.81 24.61 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.404 ' HB3' ' HE3' ' A' ' 13' ' ' MET . 48.9 mt -132.62 105.52 7.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.214 1.805 . . . . 0.0 108.33 -162.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -99.56 165.52 11.59 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.411 0.624 . . . . 0.0 111.131 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.31 28.72 18.35 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 128.744 2.817 . . . . 0.0 111.423 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.404 ' HE3' ' HB3' ' A' ' 10' ' ' LEU . 2.4 ttm -84.21 -56.11 3.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.5 -0.75 . . . . 0.0 111.276 -168.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.4 157.34 27.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.128 1.771 . . . . 0.0 107.399 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -98.51 150.03 36.32 Favored Pre-proline 0 C--O 1.235 0.309 0 O-C-N 120.867 -1.146 . . . . 0.0 110.082 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -68.24 1.25 3.66 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.261 2.641 . . . . 0.0 112.912 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -127.14 12.44 7.13 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.078 1.751 . . . . 0.0 111.385 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.67 -14.58 7.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.254 0.622 . . . . 0.0 111.653 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -76.99 66.76 2.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.831 1.252 . . . . 0.0 110.707 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -130.64 -57.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.29 0.636 . . . . 0.0 109.487 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 112.48 1.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.68 1.192 . . . . 0.0 111.417 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.4 -22.24 66.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.237 1.415 . . . . 0.0 112.561 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.9 -55.62 4.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.306 1.042 . . . . 0.0 110.304 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -40.03 90.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.119 1.767 . . . . 0.0 110.473 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -49.98 -43.59 50.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.651 1.58 . . . . 0.0 112.667 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.68 -43.15 56.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.549 1.14 . . . . 0.0 109.285 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -63.74 -27.7 69.38 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.96 -0.462 . . . . 0.0 110.852 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -77.24 -24.72 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.521 1.128 . . . . 0.0 110.801 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.17 -47.32 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 120.535 -1.353 . . . . 0.0 107.718 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -72.31 -37.03 69.03 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.628 1.171 . . . . 0.0 111.988 -164.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -60.58 -42.08 95.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 111.629 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.58 -27.12 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 125.129 1.372 . . . . 0.0 110.902 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -62.0 -43.86 97.95 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.136 -0.977 . . . . 0.0 109.883 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.95 -52.52 65.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.523 0.729 . . . . 0.0 110.743 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -61.1 -35.16 76.27 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.732 0.777 . . . . 0.0 110.964 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t -76.2 -38.96 55.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.314 1.045 . . . . 0.0 109.671 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -51.9 -25.11 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.852 1.661 . . . . 0.0 111.981 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -61.28 -31.84 71.67 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.655 -1.278 . . . . 0.0 112.47 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.87 -8.29 25.94 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 112.535 -170.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.92 -178.05 19.03 Favored Glycine 0 CA--C 1.506 -0.526 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.8 tp -103.36 121.2 42.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -160.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.56 136.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.385 2.274 . . . . 0.0 108.383 172.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -98.49 -52.0 3.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.31 2.244 . . . . 0.0 109.689 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -152.01 158.4 43.02 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.118 0.567 . . . . 0.0 110.367 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.3 mt -137.33 92.21 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.73 113.11 23.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.555 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -123.79 85.64 53.54 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 125.16 1.384 . . . . 0.0 107.313 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.82 148.7 41.47 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.64 1.56 . . . . 0.0 108.323 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -137.97 160.23 65.32 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 121.004 -1.06 . . . . 0.0 110.928 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.98 158.12 55.8 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.964 1.776 . . . . 0.0 110.753 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.11 166.56 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.191 1.796 . . . . 0.0 107.708 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.01 86.17 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 130.335 3.454 . . . . 0.0 106.279 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.76 32.64 74.36 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.039 -1.437 . . . . 0.0 111.663 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.14 128.24 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 119.279 1.54 . . . . 0.0 107.129 162.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.69 171.7 8.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.53 1.157 . . . . 0.0 109.351 166.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -128.24 143.87 49.66 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 126.139 1.776 . . . . 0.0 108.085 167.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.61 137.3 38.63 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.493 1.462 . . . . 0.0 108.451 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.87 28.93 71.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 124.156 0.884 . . . . 0.0 111.426 169.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.406 ' HB2' HG23 ' A' ' 56' ' ' VAL . 9.5 t -69.48 153.99 42.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.153 1.781 . . . . 0.0 110.632 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.29 34.07 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.512 1.529 . . . . 0.0 114.421 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 147.74 48.49 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.567 1.683 . . . . 0.0 110.639 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.6 144.52 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -114.56 123.79 50.24 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.45 120.25 62.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -95.2 140.74 29.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.91 -168.91 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.093 1.757 . . . . 0.0 108.851 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 p -119.67 -0.65 10.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.413 1.085 . . . . 0.0 112.544 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.9 m -159.88 146.21 15.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.512 1.525 . . . . 0.0 108.873 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.31 -13.81 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.379 1.072 . . . . 0.0 111.102 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.9 -41.26 15.1 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 120.132 -1.605 . . . . 0.0 110.83 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.92 -37.55 87.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.969 0.907 . . . . 0.0 110.917 -173.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.5 p -68.76 -37.05 79.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.003 0.521 . . . . 0.0 110.732 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -67.02 -31.05 71.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.139 0.976 . . . . 0.0 111.232 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -62.62 -56.09 21.0 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.603 1.092 . . . . 0.0 108.773 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.17 79.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.859 0.864 . . . . 0.0 110.973 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -44.57 -58.79 2.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.849 1.66 . . . . 0.0 111.502 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -79.45 -33.25 42.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.075 0.95 . . . . 0.0 112.166 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.6 84.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.554 1.073 . . . . 0.0 112.531 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -117.53 10.57 13.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.705 1.602 . . . . 0.0 111.19 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -56.31 124.59 18.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.04 -3.63 60.79 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.289 -0.728 . . . . 0.0 112.891 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -69.48 -178.45 1.41 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.156 1.478 . . . . 0.0 109.307 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -134.11 99.64 4.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.359 1.464 . . . . 0.0 109.347 -163.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.86 13.51 4.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.118 0.967 . . . . 0.0 112.318 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.44 -73.25 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.956 2.503 . . . . 0.0 104.521 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -146.04 -30.08 0.4 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.027 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt85 -101.01 164.98 11.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.887 0.875 . . . . 0.0 111.371 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.78 111.76 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.558 1.143 . . . . 0.0 109.794 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -72.15 134.81 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 109.884 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.4 t -113.12 143.39 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 166.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 p -112.81 146.92 37.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.493 1.517 . . . . 0.0 108.224 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.1 149.74 31.56 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.649 168.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.35 118.64 17.53 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.71 -175.72 5.52 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.25 0.62 . . . . 0.0 109.727 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -101.61 144.95 29.58 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.38 -28.78 32.51 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.868 3.045 . . . . 0.0 111.435 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.1 -45.24 21.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.571 1.149 . . . . 0.0 110.549 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.96 14.84 27.66 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.965 0.906 . . . . 0.0 111.739 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -103.85 -39.73 6.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.86 1.264 . . . . 0.0 110.488 163.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -58.84 -15.3 11.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.698 1.599 . . . . 0.0 113.903 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -129.67 -163.85 1.34 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.616 1.967 . . . . 0.0 108.821 -168.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.41 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -104.73 38.7 1.84 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.661 1.585 . . . . 0.0 111.336 173.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -102.71 21.27 15.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.824 2.05 . . . . 0.0 114.129 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 102' ' ' ARG . 4.5 m-85 -59.92 112.79 1.99 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.8 -1.187 . . . . 0.0 110.265 -170.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 3.8 m0 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 171.632 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.537 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.96 -172.23 44.61 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 128.461 2.934 . . . . 0.0 106.677 -168.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -134.2 158.27 75.66 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 118.428 1.114 . . . . 0.0 110.284 -171.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.97 131.45 23.93 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.956 1.77 . . . . 0.0 108.091 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 p -123.98 179.53 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -86.33 -4.85 59.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.197 -0.906 . . . . 0.0 113.388 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' GLU . 3.8 m -83.83 179.81 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.855 1.207 . . . . 0.0 109.098 168.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tp -155.21 163.65 39.89 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 166.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.5 t -138.61 129.37 26.46 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.783 -1.198 . . . . 0.0 109.606 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.452 HD21 HG12 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -125.6 115.02 19.5 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 126.217 1.807 . . . . 0.0 107.761 -164.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 mtm -87.83 162.5 16.94 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 75.37 23.89 1.46 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.515 1.926 . . . . 0.0 112.968 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.572 ' HB2' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -77.84 -82.92 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.683 HG22 HD11 ' A' ' 62' ' ' ILE . 31.6 m -88.02 159.84 2.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 127.721 2.408 . . . . 0.0 109.069 -170.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.82 165.32 40.17 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.283 0.633 . . . . 0.0 109.425 155.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.2 -17.76 24.2 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.604 1.536 . . . . 0.0 112.993 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -96.17 -7.14 36.59 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.673 1.189 . . . . 0.0 111.443 -165.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.12 -38.9 17.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.312 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 14' ' ' VAL . 93.0 mt -72.03 49.44 0.19 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.516 2.326 . . . . 0.0 115.421 -155.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.43 -11.5 3.57 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 119.857 -1.777 . . . . 0.0 110.317 -167.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.85 112.69 17.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.981 0.896 . . . . 0.0 110.066 -167.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.87 -16.1 37.87 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 129.669 3.188 . . . . 0.0 113.173 -165.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.39 -51.87 7.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.45 1.5 . . . . 0.0 110.5 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.31 -44.15 72.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.527 2.331 . . . . 0.0 108.618 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.481 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 54.0 t80 -58.43 -33.63 69.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.744 0.418 . . . . 0.0 111.818 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.63 -39.9 50.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.075 . . . . 0.0 111.599 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.2 -46.11 91.81 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.33 0.652 . . . . 0.0 109.581 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.5 mt -60.49 -39.15 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.745 1.218 . . . . 0.0 110.123 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.21 -33.07 58.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 120.751 -1.218 . . . . 0.0 110.411 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.24 -42.44 25.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.192 0.597 . . . . 0.0 110.957 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.37 -40.09 93.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.577 1.18 . . . . 0.0 110.532 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.5 t -89.01 -15.41 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.209 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -72.77 -38.22 67.38 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.52 -1.363 . . . . 0.0 111.034 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.5 -52.52 64.17 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.967 0.803 . . . . 0.0 109.825 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.35 -21.15 66.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.9 t -83.15 -34.32 26.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.848 1.659 . . . . 0.0 110.592 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -17.88 19.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 113.043 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.02 -32.71 71.14 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.914 0.886 . . . . 0.0 112.627 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.3 -7.86 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.148 0.886 . . . . 0.0 112.609 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.31 -134.51 3.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -167.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.12 112.63 4.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.78 120.67 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.674 1.226 . . . . 0.0 109.209 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -60.66 3.43 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.191 2.196 . . . . 0.0 108.155 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -160.22 -178.74 7.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.779 0.718 . . . . 0.0 110.91 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.45 136.67 57.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 126.578 1.951 . . . . 0.0 106.634 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.95 119.59 38.47 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.878 1.271 . . . . 0.0 110.167 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -137.06 86.14 21.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.649 1.979 . . . . 0.0 106.723 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 114.82 4.14 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.537 2.825 . . . . 0.0 109.748 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 2.4 mpp_? -72.96 159.77 84.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.156 0.982 . . . . 0.0 111.696 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.423 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 72.0 Cg_endo -64.97 178.29 1.95 Allowed 'Trans proline' 0 C--N 1.352 0.741 1 C-N-CA 125.926 4.418 . . . . 0.0 112.152 177.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.15 106.21 15.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 t70 53.71 28.44 8.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.566 1.146 . . . . 0.0 113.656 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.42 -2.13 88.17 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.278 1.418 . . . . 0.0 115.398 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.0 t -78.76 139.02 19.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 126.472 1.909 . . . . 0.0 107.548 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.91 144.72 55.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.533 0.682 . . . . 0.0 111.417 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 59' ' ' CYS . 1.1 m -107.32 147.19 34.75 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 125.043 1.337 . . . . 0.0 111.603 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.82 98.13 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.002 2.468 . . . . 0.0 107.515 163.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.54 -8.06 6.98 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.107 1.813 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.476 ' HB2' HG22 ' A' ' 56' ' ' VAL . 3.2 t -81.94 142.68 32.23 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.226 1.513 . . . . 0.0 110.229 -164.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.84 -12.2 24.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.002 1.763 . . . . 0.0 113.477 -170.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.495 ' C ' HD12 ' A' ' 62' ' ' ILE . 6.9 mptt -86.87 146.89 26.02 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HG22 ' A' ' 14' ' ' VAL . 1.9 mp -118.84 147.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 170.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -122.53 158.54 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 HD21 ' A' ' 10' ' ' LEU . 11.9 p -144.82 153.34 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 30.9 tt0 -132.58 139.25 47.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -114.47 174.91 5.72 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.245 1.418 . . . . 0.0 110.57 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -74.37 -23.2 58.97 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.934 -0.479 . . . . 0.0 112.111 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 t -154.69 161.87 41.37 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.631 1.205 . . . . 0.0 110.111 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.2 t -52.17 -39.56 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.592 1.557 . . . . 0.0 108.173 164.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -69.36 -35.09 75.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 117.027 -1.463 . . . . 0.0 113.688 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -85.19 -20.66 29.85 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.01 1.732 . . . . 0.0 111.503 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.3 t -69.68 -49.6 51.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.517 1.527 . . . . 0.0 110.243 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -54.74 -36.82 65.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.622 0.769 . . . . 0.0 112.141 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -71.54 -45.93 60.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.08 91.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 112.036 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.7 ttm -53.69 -68.33 0.19 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.381 0.991 . . . . 0.0 109.34 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -55.64 -34.95 65.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.782 0.833 . . . . 0.0 110.617 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.9 -20.87 76.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.86 -0.967 . . . . 0.0 114.355 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.59 2.33 10.12 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.085 1.354 . . . . 0.0 112.107 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -63.2 103.01 0.44 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.614 -1.304 . . . . 0.0 109.945 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.98 0.53 30.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.079 1.323 . . . . 0.0 112.897 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -74.25 -175.53 2.31 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.333 1.066 . . . . 0.0 111.958 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -138.29 115.99 11.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -107.97 24.21 13.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.55 1.54 . . . . 0.0 111.019 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -178.47 -64.03 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.318 1.847 . . . . 0.0 108.506 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.37 -17.99 0.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 171.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -113.71 166.6 11.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 109.925 -167.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.56 118.86 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 13' ' ' MET . 77.0 t -66.91 138.23 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -125.14 131.37 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.7 p -106.72 147.24 29.84 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.258 1.823 . . . . 0.0 108.826 -164.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -153.95 151.05 28.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.708 1.603 . . . . 0.0 108.065 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -77.42 152.32 34.35 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 166.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -172.14 2.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.929 1.691 . . . . 0.0 107.779 168.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -111.85 143.55 28.89 Favored Pre-proline 0 C--O 1.236 0.36 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.02 -23.5 16.01 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.814 3.009 . . . . 0.0 110.997 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -51.49 -53.31 38.65 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.76 0.824 . . . . 0.0 108.985 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.32 77.87 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.788 0.835 . . . . 0.0 111.214 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -70.46 -39.85 74.04 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.911 2.084 . . . . 0.0 112.54 -169.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -63.78 -42.16 97.81 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 109.811 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -93.38 -167.33 1.69 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.847 1.259 . . . . 0.0 110.475 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' A' ' 104' ' ' PHE . 7.0 ttm180 -100.17 39.8 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.763 -0.585 . . . . 0.0 110.55 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -99.3 88.88 4.03 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.048 -1.033 . . . . 0.0 109.42 -172.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.457 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 0.4 OUTLIER -136.08 165.03 26.64 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.491 1.916 . . . . 0.0 107.379 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 11.3 t90 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 126.344 1.857 . . . . 0.0 106.743 179.625 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.569 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.66 174.26 28.22 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -171.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -115.68 160.08 36.25 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 124.832 1.253 . . . . 0.0 109.644 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -71.53 148.09 53.16 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.743 . . . . 0.0 108.444 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.9 p -136.51 -179.84 5.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.28 5.56 5.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.305 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.56 143.97 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.698 1.199 . . . . 0.0 110.464 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 mt -131.43 159.59 37.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.209 2.204 . . . . 0.0 109.526 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 t -116.77 110.88 18.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.773 1.629 . . . . 0.0 106.974 170.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.02 153.54 20.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.6 mtm -134.23 176.8 8.27 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 61.62 12.89 4.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.879 1.671 . . . . 0.0 113.034 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.5 ttm -68.33 -59.52 3.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 153.84 38.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.074 2.15 . . . . 0.0 108.227 -172.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.5 mt -82.01 164.4 48.63 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.074 1.35 . . . . 0.0 109.548 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.87 5.28 2.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 124.116 3.211 . . . . 0.0 113.734 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -129.56 26.59 5.33 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.547 1.539 . . . . 0.0 110.326 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -141.05 24.64 2.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.301 1.84 . . . . 0.0 111.838 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -128.54 75.51 1.64 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.482 2.313 . . . . 0.0 107.039 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -134.35 -49.93 0.79 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.296 1.439 . . . . 0.0 108.166 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.92 105.96 3.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.904 2.481 . . . . 0.0 108.974 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.61 -19.73 41.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.117 1.367 . . . . 0.0 112.736 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.24 -65.71 0.98 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.35 -29.0 68.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.168 1.387 . . . . 0.0 111.897 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.22 -44.17 64.64 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.82 -0.55 . . . . 0.0 111.697 172.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.16 -43.77 50.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -55.88 -43.97 77.72 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.29 1.036 . . . . 0.0 111.119 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -68.31 -42.53 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.823 0.849 . . . . 0.0 109.604 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -59.07 -40.03 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.799 1.182 . . . . 0.0 109.515 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.77 -32.56 67.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.446 0.566 . . . . 0.0 112.361 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.84 -40.75 88.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.842 0.353 . . . . 0.0 110.753 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.1 t -78.47 -38.7 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 118.264 -0.874 . . . . 0.0 109.403 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -52.39 -36.23 53.48 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.07 0.85 . . . . 0.0 109.912 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.44 -38.02 88.16 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.546 0.612 . . . . 0.0 111.124 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.59 -47.65 18.85 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.686 ' SG ' HG11 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -61.74 -29.81 70.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 121.27 -0.894 . . . . 0.0 111.65 174.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.5 t -63.52 -9.38 12.79 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.633 1.173 . . . . 0.0 113.225 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -61.56 -41.89 98.03 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.138 -2.227 . . . . 0.0 111.111 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.67 -8.42 50.04 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.214 1.406 . . . . 0.0 113.146 -160.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.12 -159.07 27.82 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -157.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.64 120.53 36.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.419 1.109 . . . . 0.0 111.759 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.686 HG11 ' SG ' ' A' ' 36' ' ' CYS . 1.5 p -75.9 142.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 113.901 -1.5 . . . . 0.0 108.051 167.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.3 -54.67 2.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.526 1.931 . . . . 0.0 109.288 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 m -159.34 155.62 27.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.474 0.579 . . . . 0.0 110.621 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mt -124.34 118.57 54.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 127.143 2.177 . . . . 0.0 105.888 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.16 133.53 38.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.91 86.61 26.48 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -52.06 145.74 32.61 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.237 1.958 . . . . 0.0 110.128 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.67 148.14 67.19 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.33 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -61.56 161.65 23.65 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.063 2.509 . . . . 0.0 111.067 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.63 104.21 16.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 62.87 24.24 14.44 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.427 1.491 . . . . 0.0 114.496 169.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.7 -4.09 53.42 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.591 2.043 . . . . 0.0 112.873 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.4 t -94.65 140.15 17.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.946 1.299 . . . . 0.0 109.197 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.44 151.96 35.69 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.969 1.308 . . . . 0.0 112.125 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.83 143.87 34.53 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.676 1.99 . . . . 0.0 110.048 165.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.37 111.62 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.45 2.767 . . . . 0.0 109.762 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.46 -1.37 20.44 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.84 1.21 . . . . 0.0 113.383 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -66.45 137.45 56.84 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.509 1.654 . . . . 0.0 111.158 -173.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.73 1.74 79.83 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.935 1.731 . . . . 0.0 113.608 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -108.87 123.23 48.74 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.59 106.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -170.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -91.11 141.94 28.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.8 135.69 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.99 148.82 41.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.033 1.733 . . . . 0.0 107.184 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -129.99 168.83 16.09 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.686 1.594 . . . . 0.0 109.999 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 p -70.01 -4.74 22.29 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.28 1.432 . . . . 0.0 114.088 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.2 t -171.51 165.42 6.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.256 1.822 . . . . 0.0 107.984 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.6 t -52.93 -47.82 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.251 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -61.83 -48.35 80.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.312 0.645 . . . . 0.0 110.262 -172.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.29 -40.24 93.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.227 1.011 . . . . 0.0 110.342 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -44.69 94.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.247 1.019 . . . . 0.0 109.423 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.5 -51.85 57.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.389 1.476 . . . . 0.0 110.774 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -61.05 -47.35 86.81 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.77 74.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.326 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -62.25 -65.52 0.68 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.099 0.863 . . . . 0.0 109.438 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -70.04 -24.4 63.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.968 -0.457 . . . . 0.0 111.301 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.06 -24.28 73.16 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.364 -0.687 . . . . 0.0 112.505 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -127.84 -6.24 5.63 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.217 1.008 . . . . 0.0 112.468 -171.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -59.83 142.05 54.19 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.871 1.214 . . . . 0.0 108.08 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.2 -1.32 81.1 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.206 1.384 . . . . 0.0 114.029 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -78.09 -174.74 3.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 120.373 2.086 . . . . 0.0 112.005 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -118.66 129.97 55.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -107.1 13.47 27.38 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.96 1.254 . . . . 0.0 110.787 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.73 -74.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 172.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.73 -12.14 0.45 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -122.4 160.91 24.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.187 0.903 . . . . 0.0 110.719 -165.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.82 128.91 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 123.159 0.287 . . . . 0.0 111.764 -165.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -101.56 87.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.77 146.37 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.0 p -102.11 164.36 11.74 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.491 0.717 . . . . 0.0 109.489 171.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -146.75 150.47 35.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.275 1.43 . . . . 0.0 107.582 154.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -67.43 156.28 36.96 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 124.358 1.036 . . . . 0.0 109.461 163.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.59 -172.38 2.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.902 1.281 . . . . 0.0 108.368 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -108.83 145.34 31.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 158.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.99 -22.24 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.541 2.828 . . . . 0.0 112.723 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -44.64 -42.11 7.21 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.867 2.067 . . . . 0.0 111.969 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 p -91.23 -27.57 18.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 112.28 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -72.79 -27.25 61.87 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.818 2.047 . . . . 0.0 110.637 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -65.21 -12.47 51.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -130.48 -164.18 1.4 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.75 2.02 . . . . 0.0 107.852 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 2.2 ttt180 -107.1 23.44 14.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.417 1.087 . . . . 0.0 111.252 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.68 97.83 6.71 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.72 -1.237 . . . . 0.0 110.155 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 5.6 m-85 -140.06 165.26 27.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.651 1.181 . . . . 0.0 108.416 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 14.3 t90 . . . . . 0 C--O 1.248 0.993 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.108 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 CA-C-O 118.159 -1.356 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.52 -174.04 17.51 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 118.408 1.104 . . . . 0.0 110.725 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -65.61 157.63 77.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.216 0.606 . . . . 0.0 110.558 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.83 149.14 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.829 1.686 . . . . 0.0 108.827 167.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.0 p -128.12 171.32 12.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 4.4 pt-20 -72.06 -10.49 59.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.773 1.229 . . . . 0.0 111.716 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -114.01 155.0 15.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 119.537 1.062 . . . . 0.0 110.056 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -138.1 124.82 21.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 108.63 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -80.22 129.77 34.74 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.0 122.88 42.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.323 1.449 . . . . 0.0 108.411 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -97.03 163.96 12.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 74.22 18.88 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.063 2.145 . . . . 0.0 113.649 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -73.41 0.31 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 165.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.62 174.23 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 C-N-CA 126.183 1.793 . . . . 0.0 109.616 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -112.47 146.29 34.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 125.022 1.329 . . . . 0.0 107.654 172.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -61.37 7.37 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.808 1 C-N-CA 127.892 5.728 . . . . 0.0 116.055 -175.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.34 -0.33 1.81 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.258 1.823 . . . . 0.0 111.925 -154.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -117.42 -6.08 11.23 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 112.937 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' H ' ' A' ' 19' ' ' LEU . 2.2 mm? -68.95 -4.66 17.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.355 1.462 . . . . 0.0 113.849 -169.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.31 -25.84 60.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.978 2.111 . . . . 0.0 111.564 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.32 129.3 34.99 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.381 0.991 . . . . 0.0 109.614 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.28 -17.05 43.91 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.209 1.403 . . . . 0.0 112.393 -170.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -87.88 -61.82 1.63 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.148 0.979 . . . . 0.0 109.278 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.27 -38.03 73.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.565 0.746 . . . . 0.0 111.816 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -53.22 -39.27 63.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.258 1.023 . . . . 0.0 112.517 172.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -84.29 -31.89 24.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.428 0.691 . . . . 0.0 111.438 -171.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -53.95 -45.41 71.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.8 mt -67.09 -15.07 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.909 0.883 . . . . 0.0 111.724 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.0 t -86.01 -44.67 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 119.913 -1.742 . . . . 0.0 108.773 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.9 -42.54 69.84 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.684 0.793 . . . . 0.0 111.153 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -60.83 -43.6 98.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.754 1.74 . . . . 0.0 109.647 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.87 -21.78 6.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.316 -167.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -61.13 -43.34 99.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.086 -1.009 . . . . 0.0 108.826 165.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.48 -43.14 91.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.14 0.882 . . . . 0.0 111.743 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.68 -46.13 76.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.811 0.732 . . . . 0.0 110.274 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -70.89 -27.82 64.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.684 0.794 . . . . 0.0 111.276 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -55.53 -16.68 4.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.006 1.723 . . . . 0.0 113.339 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.31 -11.09 38.29 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.978 -1.701 . . . . 0.0 113.692 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.67 -15.89 10.74 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.65 -168.56 27.36 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 107.181 -2.367 . . . . 0.0 107.181 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.7 tp -99.87 119.24 37.89 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -162.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.58 117.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 167.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -56.23 15.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 158.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 p -160.36 170.01 21.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.504 0.593 . . . . 0.0 112.357 -166.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.64 153.1 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.14 133.21 45.37 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -137.71 85.61 20.02 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.51 148.34 92.57 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.394 1.396 . . . . 0.0 109.69 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -118.18 150.33 47.37 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.758 1.223 . . . . 0.0 108.537 -167.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.55 124.76 11.94 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.079 2.519 . . . . 0.0 108.641 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.99 105.38 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t70 55.64 24.38 7.03 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.18 5.52 70.14 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.966 2.222 . . . . 0.0 115.06 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.83 158.48 3.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 118.591 1.196 . . . . 0.0 111.862 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.14 127.76 33.94 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 123.096 1.427 . . . . 0.0 109.105 159.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.55 143.22 29.5 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 124.992 1.317 . . . . 0.0 110.453 168.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -67.7 125.03 12.65 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.504 2.802 . . . . 0.0 108.409 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.75 12.83 61.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.525 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.19 154.24 42.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.531 1.666 . . . . 0.0 110.667 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.1 -32.36 4.67 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.09 1.805 . . . . 0.0 112.89 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -72.17 172.59 9.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.11 1.455 . . . . 0.0 109.254 173.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.95 151.19 35.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 164.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.84 150.26 33.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 165.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.32 159.24 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.67 121.42 10.54 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -93.63 162.93 13.75 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.507 0.67 . . . . 0.0 109.361 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -72.93 -1.55 17.41 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.029 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.3 m -158.45 155.34 28.38 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 121.135 1.789 . . . . 0.0 111.627 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.7 t -59.76 -32.29 49.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.627 1.571 . . . . 0.0 109.852 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.73 -59.53 5.24 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.479 -0.763 . . . . 0.0 110.297 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.55 -39.5 57.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.335 1.454 . . . . 0.0 109.891 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 t -64.35 -50.11 69.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.973 1.309 . . . . 0.0 110.374 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -56.15 -30.67 62.5 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.871 1.268 . . . . 0.0 112.206 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -78.03 -50.13 12.69 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.0 0.92 . . . . 0.0 109.498 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.27 -47.35 78.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.361 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.2 ttm -48.06 -67.55 0.26 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.027 0.831 . . . . 0.0 110.752 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.49 -25.33 66.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.796 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.33 -26.75 74.09 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.649 -1.084 . . . . 0.0 112.565 174.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.494 HD13 ' HZ ' ' A' ' 84' ' ' PHE . 94.3 mt -123.39 -5.71 8.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.608 1.204 . . . . 0.0 112.727 -167.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 m -50.59 121.08 5.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.508 1.123 . . . . 0.0 108.412 167.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.25 8.03 86.91 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 118.499 -1.167 . . . . 0.0 114.41 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -78.26 -169.68 1.72 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.676 1.238 . . . . 0.0 109.974 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.85 132.2 53.72 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 173.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.494 ' HZ ' HD13 ' A' ' 79' ' ' LEU . 4.2 m-30 -110.57 19.96 18.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.698 1.199 . . . . 0.0 109.737 174.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.57 -65.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.885 1.674 . . . . 0.0 107.179 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 -29.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.076 1.351 . . . . 0.0 111.452 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -88.51 166.5 14.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.671 -0.643 . . . . 0.0 110.255 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.95 135.49 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.1 t -93.75 111.69 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.29 142.78 13.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.8 p -119.96 151.43 38.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.369 1.068 . . . . 0.0 108.128 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -150.0 144.16 25.65 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.174 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -66.48 138.17 57.34 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 120.252 1.387 . . . . 0.0 108.218 161.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.67 -164.37 0.94 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -116.73 143.02 30.59 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.56 -27.8 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.132 3.221 . . . . 0.0 111.991 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -46.88 72.2 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 120.902 -1.123 . . . . 0.0 111.083 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -1.81 55.17 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.895 1.678 . . . . 0.0 111.325 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -92.65 -51.94 4.87 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.4 1.88 . . . . 0.0 109.251 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -62.5 -30.29 71.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.858 0.463 . . . . 0.0 111.599 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -104.96 -178.25 3.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.539 1.936 . . . . 0.0 108.659 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -111.49 76.84 1.0 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.32 69.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -97.7 153.26 18.36 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.219 0.608 . . . . 0.0 110.075 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 C-N-CA 127.35 2.26 . . . . 0.0 106.548 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.478 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.34 -143.13 4.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -59.93 156.99 32.85 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.048 0.924 . . . . 0.0 110.984 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.76 148.37 52.36 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.775 2.317 . . . . 0.0 108.502 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.2 p -135.79 155.21 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.16 -3.02 3.32 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 m -93.64 -167.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.472 0.653 . . . . 0.0 110.354 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.11 160.33 43.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.467 2.307 . . . . 0.0 105.877 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 t -137.65 114.29 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 mp -125.05 153.93 42.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 110.618 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mtm -138.27 170.25 16.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 111.046 -172.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.03 13.24 5.52 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.334 2.254 . . . . 0.0 112.658 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 36.9 ttm -76.17 -75.71 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -97.24 155.9 3.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.748 1.219 . . . . 0.0 108.738 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.04 156.87 38.4 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.364 1.466 . . . . 0.0 107.065 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.91 -12.37 34.08 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.434 2.756 . . . . 0.0 113.835 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -105.1 8.65 34.3 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.013 1.725 . . . . 0.0 110.756 -168.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -124.46 -16.96 6.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.393 1.077 . . . . 0.0 111.596 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.73 56.14 3.42 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.395 1.478 . . . . 0.0 109.589 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.44 -49.06 1.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.026 0.93 . . . . 0.0 108.866 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.1 92.17 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.727 1.611 . . . . 0.0 110.327 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.69 -17.7 49.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.289 1.835 . . . . 0.0 113.097 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.21 -35.0 10.12 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 0.0 110.802 -172.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -74.61 -36.32 62.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.712 1.205 . . . . 0.0 111.082 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.89 -40.15 13.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.839 1.655 . . . . 0.0 111.782 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.08 -46.49 74.14 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 110.927 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.96 -46.83 79.92 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.954 1.302 . . . . 0.0 109.926 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.84 -45.29 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.889 0.875 . . . . 0.0 109.813 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 t -57.26 -47.16 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.96 -37.63 88.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.555 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -76.15 -27.7 57.1 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.963 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.4 t -76.73 -34.17 22.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.61 -28.74 69.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.045 -1.034 . . . . 0.0 111.644 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.21 -47.18 78.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.854 0.752 . . . . 0.0 110.803 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.7 -42.96 69.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.943 0.497 . . . . 0.0 110.479 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.441 ' HA ' HD11 ' A' ' 79' ' ' LEU 0.295 0.8 OUTLIER -71.96 -26.12 62.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.707 173.53 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -11.83 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 120.543 1.52 . . . . 0.0 113.04 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -63.2 -20.19 65.19 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 119.77 -1.831 . . . . 0.0 113.986 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -117.28 3.84 12.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.369 0.668 . . . . 0.0 112.524 -165.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.36 -139.4 5.99 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -168.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -137.54 133.31 34.36 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.141 1.471 . . . . 0.0 109.664 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 t -84.69 122.2 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.24 1.016 . . . . 0.0 108.48 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -73.02 -61.35 1.85 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.151 0.981 . . . . 0.0 108.866 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 t -151.84 166.68 30.68 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.781 0.832 . . . . 0.0 109.358 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 64' ' ' VAL . 7.2 mt -133.74 123.36 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -110.87 114.13 27.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.067 1.347 . . . . 0.0 109.808 -167.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.29 86.26 30.91 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.861 1.664 . . . . 0.0 107.94 -167.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.19 150.16 87.92 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 120.946 1.097 . . . . 0.0 109.821 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -105.39 165.43 13.16 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 109.505 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.38 173.74 6.01 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.256 2.637 . . . . 0.0 110.883 173.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.19 91.78 2.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 170.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 53.46 33.51 16.2 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.45 1.1 . . . . 0.0 113.313 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.01 -16.64 39.0 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.563 2.03 . . . . 0.0 113.084 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.4 t -82.51 143.1 12.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 O-C-N 120.82 -1.4 . . . . 0.0 109.962 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -68.23 146.11 53.66 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.952 0.882 . . . . 0.0 111.004 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.55 156.69 79.8 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 125.877 1.671 . . . . 0.0 109.343 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -62.27 138.61 72.86 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.633 1.556 . . . . 0.0 108.796 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.57 9.68 85.39 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.805 -0.997 . . . . 0.0 113.258 170.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.14 154.6 37.66 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.294 1.047 . . . . 0.0 111.431 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.63 -4.56 50.69 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.671 1.605 . . . . 0.0 115.223 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -98.44 147.0 25.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.706 1.253 . . . . 0.0 107.833 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.91 139.65 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -123.12 139.17 54.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 45' ' ' ILE . 98.2 t -132.11 110.23 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -169.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 37.1 tt0 -88.62 138.96 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.522 1.129 . . . . 0.0 108.012 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.76 174.54 6.53 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.403 1.481 . . . . 0.0 110.227 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -32.41 67.51 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.696 1.199 . . . . 0.0 113.601 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.3 m -168.85 167.25 11.08 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.285 1.034 . . . . 0.0 110.324 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.406 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 2.9 t -51.73 -40.12 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 122.901 1.334 . . . . 0.0 110.328 175.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.78 -2.51 20.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.605 -1.31 . . . . 0.0 114.036 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -109.01 -33.97 6.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.237 1.015 . . . . 0.0 109.373 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 69' ' ' VAL . 29.2 p -75.82 -34.37 60.13 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.472 -0.768 . . . . 0.0 109.504 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -50.27 -35.43 27.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.883 2.073 . . . . 0.0 111.83 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -84.3 -46.13 12.11 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.002 0.921 . . . . 0.0 108.875 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.78 76.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.581 -1.2 . . . . 0.0 111.277 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 mtp -46.59 -64.28 0.8 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 108.907 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -68.2 -34.11 75.67 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.355 -173.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.07 -7.06 70.07 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.76 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.441 HD11 ' HA ' ' A' ' 36' ' ' CYS . 43.8 mt -131.21 -3.08 3.92 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 111.811 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -62.83 108.64 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.831 -1.168 . . . . 0.0 109.127 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.24 67.01 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.78 1.181 . . . . 0.0 113.14 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -64.57 177.36 0.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.295 1.547 . . . . 0.0 109.429 165.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -131.92 89.97 2.76 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -167.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -80.45 13.38 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.905 -0.497 . . . . 0.0 112.119 -168.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.08 -84.45 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.152 3.381 . . . . 0.0 103.288 156.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -147.06 18.92 1.25 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.426 -0.796 . . . . 0.0 112.022 -168.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 mtp85 -132.86 171.7 13.58 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.748 -1.22 . . . . 0.0 110.338 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 t -87.3 109.56 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -172.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -73.17 124.56 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.69 163.62 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 p -132.88 163.29 29.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.186 2.194 . . . . 0.0 108.753 -168.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -164.6 158.9 18.48 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 130.127 3.371 . . . . 0.0 105.578 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.11 145.3 31.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 157.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.61 -164.3 1.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.01 1.324 . . . . 0.0 109.67 172.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -109.92 144.83 30.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 157.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.42 -19.55 10.19 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.825 3.016 . . . . 0.0 111.708 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -57.0 -59.28 5.29 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.991 -1.068 . . . . 0.0 108.611 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.4 m -70.01 -0.78 8.14 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.254 2.222 . . . . 0.0 111.9 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 65' ' ' GLU . 45.8 t80 -91.06 -48.32 7.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.412 1.485 . . . . 0.0 110.522 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -68.9 -45.6 70.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.102 0.961 . . . . 0.0 109.342 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -76.29 170.89 15.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.078 0.942 . . . . 0.0 109.222 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -101.49 68.11 1.17 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.56 74.89 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.93 1.348 . . . . 0.0 108.778 169.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -98.64 110.62 23.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.7 t90 . . . . . 0 C--O 1.257 1.457 0 C-N-CA 127.472 2.309 . . . . 0.0 105.626 174.065 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.859 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.61 -96.94 1.75 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 151.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -144.33 165.44 23.47 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.795 1.638 . . . . 0.0 109.944 -172.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.63 136.51 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.678 2.252 . . . . 0.0 108.705 166.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -140.82 171.28 14.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.49 -2.57 14.4 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.19 -0.944 . . . . 0.0 113.056 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.552 HG22 ' OE1' ' A' ' 65' ' ' GLU . 14.8 t -107.44 92.55 2.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.657 1.183 . . . . 0.0 108.439 -167.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.63 125.88 29.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.59 124.06 35.46 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -123.82 111.24 15.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.271 1.034 . . . . 0.0 109.585 175.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mtm -84.55 166.49 17.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.73 0.812 . . . . 0.0 109.778 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 70.1 14.69 7.72 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.718 2.007 . . . . 0.0 113.033 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -58.63 7.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.45 163.34 24.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.534 1.134 . . . . 0.0 111.709 -161.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -103.4 163.68 16.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.052 2.141 . . . . 0.0 109.35 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.03 4.88 4.36 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.892 2.394 . . . . 0.0 113.247 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.55 14.83 11.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.831 1.252 . . . . 0.0 111.506 -171.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -139.47 24.04 2.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.377 1.071 . . . . 0.0 111.123 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.7 mt -133.2 37.43 3.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.438 1.895 . . . . 0.0 109.82 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -113.58 -5.62 13.41 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.274 1.029 . . . . 0.0 111.245 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.38 127.51 53.75 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.94 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.92 -12.72 60.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.89 0.876 . . . . 0.0 111.269 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.19 -59.31 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.039 0.936 . . . . 0.0 108.728 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.67 -36.98 77.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.057 1.743 . . . . 0.0 111.136 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -52.62 -48.55 66.27 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.928 1.291 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.2 -36.47 66.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.911 0.778 . . . . 0.0 110.221 -172.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -60.39 -49.32 78.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.394 0.678 . . . . 0.0 109.415 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.5 mt -63.22 -41.18 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.1 t -56.18 -48.25 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.459 1.027 . . . . 0.0 110.045 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.31 -31.39 60.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.954 1.252 . . . . 0.0 112.924 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -67.83 -45.52 74.44 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.603 0.716 . . . . 0.0 110.609 176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.8 t -72.55 -41.82 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -30.65 38.19 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.105 0.866 . . . . 0.0 110.349 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.67 -36.49 67.94 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 120.344 1.429 . . . . 0.0 113.189 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -63.32 -43.13 98.67 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . 0.261 0.9 OUTLIER -79.94 -17.47 52.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -53.28 -29.57 33.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.052 1.741 . . . . 0.0 110.69 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -59.46 -20.35 54.52 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.264 -0.898 . . . . 0.0 112.44 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -125.64 51.64 1.71 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.111 1.365 . . . . 0.0 108.35 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.57 -116.12 2.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 125.269 1.414 . . . . 0.0 110.377 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 67' ' ' THR . 1.3 tm? -154.47 113.13 3.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.82 116.22 21.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.036 1.734 . . . . 0.0 107.433 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -69.31 -57.82 4.82 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.085 0.554 . . . . 0.0 109.685 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.46 166.36 25.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 0.0 109.639 175.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 111.58 27.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 125.748 1.619 . . . . 0.0 107.11 -169.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.24 124.81 30.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.599 0.76 . . . . 0.0 109.965 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.94 85.48 22.97 Favored Pre-proline 0 C--O 1.225 -0.234 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.1 -15.15 42.56 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.52 2.146 . . . . 0.0 114.784 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.347 0.0 OUTLIER 60.41 160.86 0.11 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 128.767 2.827 . . . . 0.0 116.438 172.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.14 177.8 2.3 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.812 3.008 . . . . 0.0 110.33 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 t -129.5 115.13 33.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 168.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.5 t70 54.72 28.91 10.79 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.777 2.431 . . . . 0.0 114.582 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.18 -8.45 67.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.783 1.659 . . . . 0.0 113.291 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.84 146.56 6.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 125.031 1.333 . . . . 0.0 108.949 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.9 145.79 55.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.525 1.13 . . . . 0.0 111.842 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.51 156.19 79.02 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.145 1.778 . . . . 0.0 109.801 172.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.7 128.58 17.24 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.048 1.832 . . . . 0.0 108.765 169.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.01 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 127.055 2.264 . . . . 0.0 111.973 -175.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.28 130.57 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.296 1.548 . . . . 0.0 111.036 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.07 -13.66 66.43 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.768 1.651 . . . . 0.0 113.482 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.17 122.89 40.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.45 148.72 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 167.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.37 127.49 46.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG12 HD11 ' A' ' 10' ' ' LEU . 10.1 p -121.73 119.79 59.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -174.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.552 ' OE1' HG22 ' A' ' 7' ' ' VAL . 1.5 tp10 -88.58 150.61 22.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.674 1.59 . . . . 0.0 107.645 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -132.93 162.99 30.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.405 1.082 . . . . 0.0 110.547 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 41' ' ' LEU . 7.4 p -72.55 -6.5 44.4 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -154.28 157.3 38.48 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 120.203 1.365 . . . . 0.0 113.137 162.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.21 -16.79 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 112.107 167.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -94.24 -18.85 21.26 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.424 -1.423 . . . . 0.0 112.137 -175.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -85.03 -41.98 15.28 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.285 0.634 . . . . 0.0 110.271 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 p -62.65 -31.92 72.88 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.647 -0.658 . . . . 0.0 110.818 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -63.91 -13.91 49.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 113.206 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -95.73 -41.2 8.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 120.315 1.416 . . . . 0.0 108.488 172.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.11 45.69 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.024 0.929 . . . . 0.0 111.621 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -59.45 -31.69 69.54 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -162.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -94.86 -40.15 9.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.711 2.405 . . . . 0.0 110.327 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.92 -25.57 67.98 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 121.731 -0.606 . . . . 0.0 112.285 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -124.72 22.52 8.2 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.94 2.096 . . . . 0.0 110.29 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.2 m -56.87 127.47 31.89 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.277 -0.889 . . . . 0.0 109.092 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.65 5.8 64.96 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 118.628 -1.096 . . . . 0.0 112.975 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -173.65 0.17 Allowed 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.612 1.706 . . . . 0.0 110.17 176.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -124.19 121.21 34.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.8 14.06 22.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.181 0.991 . . . . 0.0 110.965 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -158.19 -66.45 0.09 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.67 -25.78 0.14 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.169 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -105.99 172.39 6.83 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.635 1.174 . . . . 0.0 110.452 -169.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.06 118.14 28.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.41 155.09 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.426 1.09 . . . . 0.0 109.628 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.69 147.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 158.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.71 144.43 42.97 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.543 1.937 . . . . 0.0 106.799 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -147.87 145.05 28.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.049 1.74 . . . . 0.0 107.936 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -64.79 138.13 58.2 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 164.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -165.83 1.05 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.543 1.937 . . . . 0.0 107.752 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.62 144.12 52.01 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.413 ' HA ' HG21 ' A' ' 7' ' ' VAL . 72.0 Cg_endo -78.7 -21.27 10.0 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.17 2.58 . . . . 0.0 111.644 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -49.66 -55.41 13.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -64.38 -42.13 96.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 123.949 0.9 . . . . 0.0 109.538 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -64.54 -38.81 92.29 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.277 1.031 . . . . 0.0 112.537 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -63.33 -4.38 2.58 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.339 -0.851 . . . . 0.0 112.977 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -137.9 -173.89 3.63 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 127.675 2.39 . . . . 0.0 108.43 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.477 ' HA ' ' CE1' ' A' ' 104' ' ' PHE . 7.7 mpt_? -123.35 68.72 1.01 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -125.36 27.17 6.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.716 1.206 . . . . 0.0 112.494 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -62.38 162.47 9.99 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.878 0.871 . . . . 0.0 109.547 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.7 t90 . . . . . 0 C--O 1.249 1.041 0 C-N-CA 124.248 1.019 . . . . 0.0 109.212 172.606 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.435 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.81 -168.62 23.87 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -172.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -60.65 158.07 33.71 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.192 0.597 . . . . 0.0 111.026 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.78 143.48 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.772 1.648 . . . . 0.0 108.751 162.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -120.32 174.37 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.962 1.305 . . . . 0.0 107.738 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.22 -5.02 55.45 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.071 0.948 . . . . 0.0 113.161 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.78 -175.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 118.856 0.753 . . . . 0.0 109.985 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.41 155.15 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.312 1.845 . . . . 0.0 106.733 164.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.3 t -113.11 136.77 52.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 169.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.1 mt -129.85 95.48 3.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.152 2.181 . . . . 0.0 107.384 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.8 mtm -87.65 157.82 19.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 66.45 30.07 8.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.69 1.596 . . . . 0.0 112.751 171.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttm -81.28 -82.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 162.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.9 m -93.73 146.38 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.822 1.649 . . . . 0.0 110.437 -162.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.74 155.04 42.13 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.253 1.021 . . . . 0.0 109.371 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.64 4.26 2.24 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.334 2.69 . . . . 0.0 113.667 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.41 6.03 8.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.986 1.714 . . . . 0.0 111.863 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -124.05 -8.56 7.7 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.907 0.883 . . . . 0.0 112.82 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.8 mt -82.96 63.73 7.2 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.089 -1.007 . . . . 0.0 109.491 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.93 -39.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.058 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.28 100.94 0.86 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.373 1.069 . . . . 0.0 109.89 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.77 -2.98 0.17 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 130.219 3.408 . . . . 0.0 114.938 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.23 -54.77 1.69 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.789 2.836 . . . . 0.0 108.651 -164.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.27 -41.75 98.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.761 1.225 . . . . 0.0 111.704 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -46.98 -40.47 14.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.466 1.506 . . . . 0.0 110.854 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.91 -25.91 40.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -63.53 -52.68 60.13 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.641 1.176 . . . . 0.0 108.954 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.31 -34.97 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.405 1.082 . . . . 0.0 110.087 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.73 -47.1 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.3 0.64 . . . . 0.0 110.141 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.36 -37.69 74.64 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.688 1.131 . . . . 0.0 112.117 -172.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.18 -38.44 91.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 122.23 1.015 . . . . 0.0 110.505 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.36 -33.18 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 109.763 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -66.39 -32.79 74.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.95 -54.53 37.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 110.623 171.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -63.66 -37.55 87.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.812 0.815 . . . . 0.0 111.245 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.25 -22.71 57.65 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.376 1.07 . . . . 0.0 110.543 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 t -72.37 -7.51 50.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.271 1.029 . . . . 0.0 111.282 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -73.47 -9.54 58.8 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 119.351 -2.093 . . . . 0.0 112.29 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.04 1.12 9.21 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.719 1.145 . . . . 0.0 112.668 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.12 -164.93 28.61 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 106.129 -2.788 . . . . 0.0 106.129 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -108.27 108.67 19.77 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.277 1.539 . . . . 0.0 109.984 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.67 116.05 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -55.26 -74.67 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.819 2.048 . . . . 0.0 107.024 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -174.29 4.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.259 1.024 . . . . 0.0 109.123 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.86 143.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.585 1.954 . . . . 0.0 107.145 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -130.3 118.35 21.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.211 1.404 . . . . 0.0 109.301 -172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.4 mt -131.31 86.84 49.23 Favored Pre-proline 0 C--O 1.234 0.242 0 C-N-CA 125.924 1.69 . . . . 0.0 107.921 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -55.79 124.94 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 167.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.85 47.93 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.386 . . . . 0.0 108.926 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -67.58 148.18 77.91 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.818 2.345 . . . . 0.0 109.792 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.72 167.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.656 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.08 86.87 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 128.144 2.578 . . . . 0.0 106.69 171.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.4 7.24 79.78 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-O 117.478 -1.734 . . . . 0.0 113.193 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.06 132.16 70.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 120.577 2.188 . . . . 0.0 108.724 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.95 170.39 6.79 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 122.101 0.953 . . . . 0.0 108.83 170.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.06 145.99 43.09 Favored Pre-proline 0 N--CA 1.446 -0.645 0 C-N-CA 125.32 1.448 . . . . 0.0 107.76 164.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.71 143.15 50.16 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 N-CA-C 107.764 -1.668 . . . . 0.0 107.764 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.6 80.09 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 121.953 -0.467 . . . . 0.0 113.168 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.25 156.99 37.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.482 0.713 . . . . 0.0 110.572 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.91 7.12 88.78 Favored Glycine 0 C--O 1.24 0.501 0 C-N-CA 123.758 0.694 . . . . 0.0 112.922 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 171.72 13.85 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 118.18 0.99 . . . . 0.0 109.589 165.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -121.83 156.03 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.99 150.1 39.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.49 155.19 28.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.89 144.97 45.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -172.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.75 168.32 10.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.941 0.877 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 -20.58 65.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.809 1.244 . . . . 0.0 112.918 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.9 t -163.19 155.82 18.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.56 1.073 . . . . 0.0 110.323 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.0 t -51.91 -40.01 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.6 1.96 . . . . 0.0 110.307 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -75.49 -12.24 60.19 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 119.435 -2.04 . . . . 0.0 114.115 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -93.16 -41.6 9.83 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.541 1.136 . . . . 0.0 109.364 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.42 -40.58 96.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -51.4 -10.48 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 130.135 3.374 . . . . 0.0 114.733 170.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -97.35 -41.91 8.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.966 1.257 . . . . 0.0 109.488 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.65 87.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.71 0.804 . . . . 0.0 112.625 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -43.32 63.78 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.768 2.427 . . . . 0.0 112.947 -162.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -98.66 -31.15 12.07 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.061 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.79 -9.18 58.78 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.921 0.782 . . . . 0.0 113.947 -170.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -123.7 3.55 8.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.203 1.401 . . . . 0.0 112.356 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -71.96 142.74 49.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.02 -3.04 82.2 Favored Glycine 0 CA--C 1.528 0.877 0 O-C-N 121.076 -1.015 . . . . 0.0 112.731 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -63.69 175.17 1.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.284 1.542 . . . . 0.0 110.367 170.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -125.75 96.15 4.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -83.19 13.64 4.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.415 0.626 . . . . 0.0 111.631 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -161.0 -77.97 0.05 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.675 2.39 . . . . 0.0 104.658 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.8 -22.9 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.071 0.948 . . . . 0.0 113.368 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -92.49 166.92 12.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.548 -0.72 . . . . 0.0 110.956 -172.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.94 109.79 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.0 t -82.16 146.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.204 1.402 . . . . 0.0 110.654 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -128.93 118.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 p -72.06 159.93 33.35 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 122.347 1.07 . . . . 0.0 110.493 170.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -156.47 159.74 38.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.989 2.516 . . . . 0.0 105.739 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -74.67 159.39 32.14 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.504 160.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.82 -164.58 1.36 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 108.527 163.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -114.47 144.52 31.95 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.67 -27.94 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.422 2.748 . . . . 0.0 112.927 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.74 -42.05 95.48 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 120.741 -1.224 . . . . 0.0 110.688 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 p -72.81 -19.5 61.32 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.55 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.47 -45.53 53.65 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.004 2.122 . . . . 0.0 111.444 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -63.05 -8.12 6.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.797 0.839 . . . . 0.0 111.757 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -134.41 -163.63 1.4 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.441 2.696 . . . . 0.0 106.987 -163.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.75 39.72 3.82 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.344 1.057 . . . . 0.0 109.132 -173.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.53 42.93 2.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.005 1.322 . . . . 0.0 111.331 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -67.84 173.06 4.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.298 1.039 . . . . 0.0 109.043 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 1.3 t90 . . . . . 0 C--O 1.248 0.999 0 O-C-N 121.012 -1.055 . . . . 0.0 109.265 169.948 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.711 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.66 131.4 2.26 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -172.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -68.97 152.44 96.81 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 164.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.12 146.75 52.65 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.515 2.143 . . . . 0.0 108.708 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 p -137.25 166.74 23.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.31 2.55 21.04 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.91 88.56 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.61 117.34 7.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.803 1.241 . . . . 0.0 108.429 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -84.48 143.04 29.63 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.454 ' CD2' HG22 ' A' ' 91' ' ' THR . 76.5 mt -135.45 156.13 49.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 109.388 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.56 165.47 26.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.385 1.474 . . . . 0.0 107.752 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 60.4 26.97 16.54 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.531 2.333 . . . . 0.0 111.973 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.606 ' HB2' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -72.31 -74.22 0.17 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 157.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.681 HG11 HD21 ' A' ' 19' ' ' LEU . 33.7 m -92.5 172.45 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 124.402 1.081 . . . . 0.0 110.733 -163.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -125.6 157.63 67.68 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.69 0.85 4.32 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 121.884 1.723 . . . . 0.0 112.824 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -123.22 12.39 9.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.851 2.06 . . . . 0.0 112.665 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -139.44 22.38 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.998 -1.064 . . . . 0.0 112.021 -169.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.681 HD21 HG11 ' A' ' 14' ' ' VAL . 90.2 mt -109.72 6.37 23.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.675 1.19 . . . . 0.0 113.004 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.29 -29.87 28.02 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.501 -0.749 . . . . 0.0 111.156 -166.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.11 110.14 3.84 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.14 1.376 . . . . 0.0 108.562 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.26 -36.09 80.88 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.691 0.797 . . . . 0.0 110.056 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.89 -64.69 0.81 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.871 0.868 . . . . 0.0 110.0 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.42 -35.21 71.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.886 0.474 . . . . 0.0 112.001 -172.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' O ' HG23 ' A' ' 29' ' ' VAL . 25.8 t80 -52.59 -44.21 65.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.515 1.126 . . . . 0.0 111.71 170.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -74.8 -34.11 62.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.375 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.35 -53.92 51.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.359 1.063 . . . . 0.0 108.631 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.38 -42.63 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.368 1.067 . . . . 0.0 110.42 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 25' ' ' TYR . 51.4 t -60.67 -32.7 52.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 124.123 0.969 . . . . 0.0 111.316 -176.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.98 -49.49 19.77 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 123.21 0.319 . . . . 0.0 110.537 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -60.11 -38.57 83.41 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.477 1.132 . . . . 0.0 109.588 -175.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.44 HG13 ' CE2' ' A' ' 84' ' ' PHE . 41.4 t -73.36 -36.31 48.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 121.547 -0.721 . . . . 0.0 110.12 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -59.5 -44.76 93.01 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.374 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -65.9 -42.02 90.75 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.712 0.687 . . . . 0.0 111.895 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -67.87 -34.95 77.67 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.395 -172.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.496 ' HB3' HG21 ' A' ' 42' ' ' VAL . 7.4 t -78.11 -32.75 50.65 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.339 1.056 . . . . 0.0 110.709 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -56.73 -14.66 3.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.348 1.459 . . . . 0.0 112.039 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -61.54 -19.24 61.9 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.099 -2.25 . . . . 0.0 113.269 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -113.58 -6.6 13.39 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.862 1.265 . . . . 0.0 112.595 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.39 -151.81 20.8 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -167.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -129.31 108.34 10.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 36' ' ' CYS . 28.6 t -72.7 115.79 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -81.8 -50.99 8.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.805 2.042 . . . . 0.0 109.39 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.0 p -153.99 169.83 22.53 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.053 0.941 . . . . 0.0 110.208 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.4 mt -141.4 116.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.57 131.6 34.33 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 110.384 170.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.93 87.02 25.38 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.932 1.693 . . . . 0.0 107.738 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.69 154.5 68.88 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.78 1.653 . . . . 0.0 109.234 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.8 155.55 62.94 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.164 0.986 . . . . 0.0 111.548 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.43 132.24 37.43 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.967 3.112 . . . . 0.0 110.261 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.3 t -81.34 104.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t0 57.97 24.28 10.86 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 170.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.04 60.97 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 128.18 2.8 . . . . 0.0 115.306 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 p -66.77 158.64 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.056 1.428 . . . . 0.0 111.601 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -71.78 132.58 44.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.143 159.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.15 161.26 32.09 Favored Pre-proline 0 C--O 1.241 0.637 0 C-N-CA 124.947 1.299 . . . . 0.0 111.305 167.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.14 137.68 34.9 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.635 2.224 . . . . 0.0 108.412 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.82 9.19 85.78 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.767 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.54 140.66 53.89 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.036 0.918 . . . . 0.0 109.829 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.95 -32.42 6.64 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.28 1.895 . . . . 0.0 111.926 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' C ' HD12 ' A' ' 62' ' ' ILE . 6.5 mptt -85.17 152.5 23.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -174.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.606 HD13 ' HB2' ' A' ' 13' ' ' MET . 2.0 mp -123.52 146.65 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 169.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.08 120.68 25.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -118.72 106.94 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -79.23 142.74 35.97 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.404 1.481 . . . . 0.0 107.889 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -121.79 177.25 5.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.356 1.063 . . . . 0.0 111.596 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.0 p -72.05 -26.76 62.31 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.721 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.7 m -153.89 159.45 41.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.504 1.621 . . . . 0.0 112.964 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.26 -12.58 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 O-C-N 120.588 -1.32 . . . . 0.0 111.383 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -95.9 -21.12 18.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.313 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.59 -29.98 14.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.873 1.669 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.8 p -60.4 -35.28 75.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.172 0.511 . . . . 0.0 110.4 168.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -24.06 66.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.977 1.711 . . . . 0.0 112.413 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -86.98 -46.03 10.22 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.11 -51.3 68.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.884 0.874 . . . . 0.0 110.448 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -57.13 -39.41 75.11 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.056 0.389 . . . . 0.0 111.818 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -74.91 -45.83 40.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.128 -0.358 . . . . 0.0 111.04 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.16 -21.46 61.75 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 119.921 -0.377 . . . . 0.0 112.41 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.14 18.66 4.95 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.865 1.266 . . . . 0.0 111.858 -163.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -70.44 23.79 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 O-C-N 120.073 -1.642 . . . . 0.0 114.017 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.09 3.33 0.03 OUTLIER Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.967 1.746 . . . . 0.0 115.068 -166.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -173.68 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.938 1.869 . . . . 0.0 111.931 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -133.64 81.57 1.93 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.393 0.677 . . . . 0.0 109.538 -168.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.44 ' CE2' HG13 ' A' ' 32' ' ' VAL . 3.6 m-30 -74.94 14.02 0.58 Allowed 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.334 -0.854 . . . . 0.0 113.165 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.35 -85.04 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.663 2.385 . . . . 0.0 105.415 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.72 -5.39 1.04 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 87' ' ' ARG . 0.8 OUTLIER -97.77 176.92 5.64 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.786 1.176 . . . . 0.0 108.655 -174.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -82.51 136.9 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.42 164.39 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 124.727 1.211 . . . . 0.0 108.825 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -138.48 139.37 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 10' ' ' LEU . 34.7 p -96.61 165.55 12.1 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.181 0.9 . . . . 0.0 110.983 175.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -153.36 154.53 34.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.921 1.688 . . . . 0.0 108.247 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -80.9 141.21 34.8 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 158.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.73 -168.16 1.28 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.823 1.649 . . . . 0.0 108.847 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -121.03 145.25 41.25 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.494 1.118 . . . . 0.0 107.983 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.29 -22.41 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.626 2.884 . . . . 0.0 114.15 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.31 -47.1 76.1 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.777 1.626 . . . . 0.0 109.537 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 p -77.06 2.1 16.06 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.843 1.257 . . . . 0.0 111.795 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -94.11 -41.12 9.69 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.641 1.577 . . . . 0.0 109.083 165.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -64.35 -24.7 67.74 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 112.135 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -126.39 165.7 18.56 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 126.434 1.894 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -75.68 23.62 0.12 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.363 1.865 . . . . 0.0 112.566 -175.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -91.28 40.33 1.03 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.351 -1.468 . . . . 0.0 112.405 -160.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 7.0 m-85 -73.53 12.3 0.65 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.213 2.205 . . . . 0.0 115.779 -165.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 . . . . . 0 C--O 1.241 0.652 0 C-N-CA 126.044 1.737 . . . . 0.0 110.983 -166.895 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.573 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.97 -177.86 44.36 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 122.089 0.827 . . . . 0.0 112.945 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -159.08 161.12 28.55 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 129.379 3.071 . . . . 0.0 107.08 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HA ' ' CG ' ' A' ' 93' ' ' TYR . 20.4 Cg_endo -64.29 141.17 74.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.405 2.07 . . . . 0.0 112.143 170.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.1 p -133.57 -178.79 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.437 1.895 . . . . 0.0 108.149 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.02 -7.3 21.53 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.374 -1.298 . . . . 0.0 113.656 171.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.33 149.57 25.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 121.036 1.743 . . . . 0.0 110.859 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD13 ' SD ' ' A' ' 76' ' ' MET . 13.2 tp -124.72 119.03 27.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.744 2.418 . . . . 0.0 107.24 -170.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.84 145.78 25.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.086 0.554 . . . . 0.0 109.762 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.9 mt -136.55 120.41 17.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.286 1.435 . . . . 0.0 109.676 -167.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -106.52 156.64 18.36 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 75.44 23.6 1.48 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.48 2.312 . . . . 0.0 113.693 170.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -81.84 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 163.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG11 HD21 ' A' ' 19' ' ' LEU . 15.0 m -87.84 172.79 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.875 1.67 . . . . 0.0 111.764 -159.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 mt -126.32 158.1 68.04 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.409 1.483 . . . . 0.0 109.762 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.11 2.59 5.94 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.141 1.894 . . . . 0.0 113.103 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -128.63 18.55 6.27 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.966 1.706 . . . . 0.0 111.297 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -137.44 33.36 2.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.568 1.147 . . . . 0.0 111.152 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD21 HG11 ' A' ' 14' ' ' VAL . 95.2 mt -130.22 39.28 3.68 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 127.202 2.201 . . . . 0.0 109.406 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.97 -33.4 6.51 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.677 0.791 . . . . 0.0 110.579 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 94.94 1.68 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.42 1.088 . . . . 0.0 110.176 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.85 -36.29 58.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.968 2.107 . . . . 0.0 111.25 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -72.66 -55.31 7.03 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.716 0.407 . . . . 0.0 110.114 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -63.35 -36.44 83.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.339 0.655 . . . . 0.0 109.732 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -45.95 -48.69 16.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.994 0.918 . . . . 0.0 111.153 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.7 -28.19 50.9 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.929 -0.482 . . . . 0.0 112.172 -167.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -64.39 -55.54 20.36 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.597 1.559 . . . . 0.0 109.59 167.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.86 -36.24 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.75 0.82 . . . . 0.0 110.554 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.1 t -59.07 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 118.768 0.713 . . . . 0.0 109.228 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.46 -38.54 74.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.771 0.714 . . . . 0.0 111.315 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -70.94 -33.82 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.046 -175.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.96 -37.65 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -57.58 -36.29 71.5 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.707 1.139 . . . . 0.0 110.24 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.31 -29.57 68.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.759 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -68.79 -45.18 71.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.468 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.603 ' HA ' HD11 ' A' ' 79' ' ' LEU 0.267 0.8 OUTLIER -69.33 -26.53 64.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 172.8 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.3 t -62.77 -14.82 49.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.95 1.3 . . . . 0.0 111.887 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -62.68 -11.12 15.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 119.556 -1.965 . . . . 0.0 114.456 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.57 -0.64 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.501 1.046 . . . . 0.0 112.985 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.4 -174.37 41.89 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -94.74 111.9 23.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.6 t -71.78 109.6 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -62.85 -52.06 64.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.982 178.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -167.87 172.23 9.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.936 1.694 . . . . 0.0 110.578 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.437 HG23 HG22 ' A' ' 64' ' ' VAL . 13.8 mt -135.58 145.89 30.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.42 125.45 47.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.517 1.927 . . . . 0.0 109.443 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.15 86.92 12.62 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.098 1.759 . . . . 0.0 107.697 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.3 140.18 30.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.774 2.316 . . . . 0.0 108.839 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mtm-85 -116.06 146.28 36.75 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.326 1.05 . . . . 0.0 108.77 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.38 131.48 23.36 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.244 1.962 . . . . 0.0 108.555 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.717 HG12 ' HB ' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -69.64 167.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.134 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 85.05 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 128.933 2.893 . . . . 0.0 108.138 173.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.22 -16.33 22.47 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 126.514 2.007 . . . . 0.0 112.74 173.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.717 ' HB ' HG12 ' A' ' 51' ' ' VAL . 2.2 t -122.88 129.6 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.81 1.305 . . . . 0.0 111.276 -174.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -66.02 169.42 6.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.095 0.95 . . . . 0.0 110.832 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.18 154.37 42.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 126.22 1.808 . . . . 0.0 110.013 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.94 111.28 3.23 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.845 2.363 . . . . 0.0 108.341 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.54 58.82 6.13 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 23.5 t -72.18 154.2 41.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.82 58.38 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 124.784 1.183 . . . . 0.0 112.908 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 168.2 10.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.501 1.651 . . . . 0.0 108.276 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.81 143.54 34.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.32 141.86 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG22 HG23 ' A' ' 45' ' ' ILE . 96.0 t -134.12 104.52 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -167.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -83.95 135.1 34.6 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.59 173.39 6.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 126.717 2.007 . . . . 0.0 108.423 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.9 t -92.57 -9.85 39.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.562 -176.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -154.53 155.88 35.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 121.261 1.846 . . . . 0.0 111.882 166.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 t -67.02 -24.93 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.078 1.351 . . . . 0.0 109.728 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -60.56 -59.32 5.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.571 1.148 . . . . 0.0 109.502 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.79 -45.84 59.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.42 1.488 . . . . 0.0 109.632 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.1 t -62.48 -50.56 70.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.369 1.067 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -56.4 -34.87 67.14 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.059 0.943 . . . . 0.0 112.33 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.48 -42.95 33.94 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.91 0.777 . . . . 0.0 109.679 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.42 79.74 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.175 0.99 . . . . 0.0 110.51 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.559 ' SD ' HD13 ' A' ' 8' ' ' LEU . 4.3 mmm -44.76 -66.48 0.39 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.126 1.371 . . . . 0.0 110.12 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.69 -39.31 88.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.959 0.503 . . . . 0.0 111.226 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -36.45 93.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.959 0.79 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 36' ' ' CYS . 54.8 mt -104.91 3.48 30.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.417 1.087 . . . . 0.0 110.892 -168.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.2 m -61.2 110.56 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.943 0.897 . . . . 0.0 109.659 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.73 19.44 73.28 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.387 0.539 . . . . 0.0 113.05 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -66.44 -178.64 0.7 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.761 1.28 . . . . 0.0 110.701 162.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -130.43 96.15 4.06 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.07 14.01 9.98 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.684 0.754 . . . . 0.0 111.898 -167.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -156.42 -66.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 161.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -147.86 -16.65 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -121.72 168.13 12.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.143 0.977 . . . . 0.0 111.637 -167.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.59 114.44 5.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.658 0.783 . . . . 0.0 109.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.25 150.86 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 124.349 1.06 . . . . 0.0 109.866 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.7 t -121.7 139.25 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 162.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -115.69 130.49 56.88 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.707 2.003 . . . . 0.0 108.554 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -132.9 171.18 14.28 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 119.778 1.172 . . . . 0.0 110.579 161.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 76' ' ' MET . 86.8 m-85 -82.89 147.82 28.06 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 -163.76 1.13 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.842 1.257 . . . . 0.0 109.745 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.49 143.47 29.0 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.26 -28.18 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.709 2.272 . . . . 0.0 111.793 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.35 -50.54 73.58 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.59 -1.319 . . . . 0.0 110.166 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.4 p -70.56 -7.28 42.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.075 1.75 . . . . 0.0 111.073 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.19 -45.92 9.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.161 1.784 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -64.3 -44.52 91.37 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.515 0.674 . . . . 0.0 109.863 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -77.98 172.78 12.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.035 1.734 . . . . 0.0 109.119 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.491 ' HG3' ' CE2' ' A' ' 104' ' ' PHE . 50.2 ttp180 -103.96 72.62 1.11 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 164.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -123.37 61.8 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.917 0.865 . . . . 0.0 109.66 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CE2' ' HG3' ' A' ' 102' ' ' ARG . 4.9 m-30 -86.84 -162.28 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.254 1.821 . . . . 0.0 109.856 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 130.191 3.396 . . . . 0.0 109.112 -171.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.512 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -82.49 -123.16 0.75 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 171.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -63.2 165.04 11.73 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.277 1.431 . . . . 0.0 112.19 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.39 126.33 13.43 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.072 1.848 . . . . 0.0 108.661 156.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -103.23 177.1 4.93 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HG2' HG22 ' A' ' 69' ' ' VAL . 25.8 mt-10 -81.9 3.58 25.68 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.571 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 94' ' ' CYS . 2.4 m -124.42 156.03 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 119.739 1.154 . . . . 0.0 108.729 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 76' ' ' MET . 23.2 tp -136.37 122.3 20.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.985 1.714 . . . . 0.0 107.713 -168.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -81.22 139.11 35.7 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.1 mt -128.62 95.25 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.863 2.465 . . . . 0.0 107.4 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mtm -92.63 155.69 17.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 75.2 23.69 1.55 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 114.265 170.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -84.96 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 161.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -102.4 163.18 3.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 111.184 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.9 158.42 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.002 1.321 . . . . 0.0 109.841 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.82 -2.66 9.0 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.929 2.419 . . . . 0.0 113.316 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.21 2.13 11.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.572 1.949 . . . . 0.0 111.187 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -104.87 -30.34 9.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 118.669 0.668 . . . . 0.0 112.199 169.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.99 49.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.011 2.124 . . . . 0.0 113.396 -161.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 -10.56 6.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.203 1.801 . . . . 0.0 111.674 -169.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.4 122.19 38.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.006 0.923 . . . . 0.0 110.297 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.18 -15.63 63.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.254 1.422 . . . . 0.0 112.705 -168.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -78.85 -63.16 1.48 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.429 1.492 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.79 -35.65 66.52 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 109.937 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -55.97 -38.43 70.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.611 0.764 . . . . 0.0 112.166 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -80.36 -36.65 33.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.647 0.779 . . . . 0.0 110.678 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -56.72 -45.14 82.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.525 0.679 . . . . 0.0 109.9 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.89 -33.31 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.387 1.075 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.33 -44.65 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.287 -0.883 . . . . 0.0 108.718 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.06 -39.52 86.91 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.809 0.732 . . . . 0.0 110.531 -173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -61.7 -36.29 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.993 1.378 . . . . 0.0 111.487 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.62 -28.52 5.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.621 1.568 . . . . 0.0 109.944 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -44.62 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.52 -0.738 . . . . 0.0 109.343 170.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.44 -44.58 92.89 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.524 0.678 . . . . 0.0 111.354 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -43.76 50.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.856 -166.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -83.36 -17.98 40.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.505 -1.278 . . . . 0.0 110.331 -167.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -65.62 -15.62 62.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.913 -1.117 . . . . 0.0 110.783 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -63.24 -12.57 29.8 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.787 -1.196 . . . . 0.0 111.212 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.649 1.579 . . . . 0.0 112.935 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.33 26.34 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 120.105 1.321 . . . . 0.0 110.784 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.0 tm? -119.77 111.58 18.18 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.512 1.525 . . . . 0.0 107.965 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.04 114.61 23.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -53.83 -61.36 2.36 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.749 1.62 . . . . 0.0 109.242 166.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 t -160.23 177.35 10.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.153 0.888 . . . . 0.0 111.558 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.98 135.04 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 127.671 2.388 . . . . 0.0 106.087 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -125.98 106.92 9.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.231 1.013 . . . . 0.0 112.995 -167.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.31 85.93 59.84 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 127.376 2.27 . . . . 0.0 108.334 -165.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.46 138.81 61.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.553 1.502 . . . . 0.0 109.8 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 162.42 19.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 126.567 1.947 . . . . 0.0 110.471 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.05 169.77 1.83 Allowed 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 124.47 3.446 . . . . 0.0 111.977 165.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.452 ' H ' HG12 ' A' ' 54' ' ' VAL . 26.2 t -133.17 107.04 10.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t0 52.46 33.03 12.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.284 1.034 . . . . 0.0 112.232 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.49 6.78 88.87 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.987 2.232 . . . . 0.0 115.585 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 51' ' ' VAL . 1.4 p -58.15 157.47 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 118.402 1.101 . . . . 0.0 111.353 174.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.29 113.05 20.43 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 156.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.81 145.64 29.95 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.529 1.132 . . . . 0.0 110.011 167.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.06 133.36 33.01 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.972 2.448 . . . . 0.0 108.593 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.45 0.36 70.14 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -71.75 155.05 40.9 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.574 1.687 . . . . 0.0 110.049 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.59 -1.12 79.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.034 0.826 . . . . 0.0 113.203 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 170.86 7.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 120.226 2.013 . . . . 0.0 109.316 168.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.0 mt -134.82 154.37 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 167.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -119.0 166.2 13.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 158.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 p -139.07 152.7 24.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -132.08 139.13 48.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.14 164.32 11.9 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.772 1.229 . . . . 0.0 108.326 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.8 t -87.15 0.95 54.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.827 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.9 p -154.68 148.38 25.41 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.548 1.067 . . . . 0.0 109.808 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 6' ' ' GLU . 1.8 t -60.13 -34.85 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.092 0.557 . . . . 0.0 109.587 176.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -76.96 -23.71 52.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.69 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.99 -49.61 49.81 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.922 1.237 . . . . 0.0 108.024 166.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.6 t -56.98 -47.0 81.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.219 1.008 . . . . 0.0 109.97 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -57.65 -27.13 62.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.341 1.056 . . . . 0.0 113.339 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -79.46 -54.27 6.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.14 -51.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.269 1.027 . . . . 0.0 110.837 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.559 ' HB2' HD13 ' A' ' 8' ' ' LEU . 2.3 ppp? -59.07 -34.54 72.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.964 0.905 . . . . 0.0 112.434 -170.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.98 -34.48 18.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.62 1.168 . . . . 0.0 110.555 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 -29.83 75.86 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.117 1.341 . . . . 0.0 112.164 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.8 mt -113.29 7.11 17.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.664 1.185 . . . . 0.0 111.619 -168.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -48.66 131.58 17.77 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.11 -2.62 80.55 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.486 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -62.99 176.71 0.67 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.221 1.511 . . . . 0.0 112.019 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -132.17 83.14 2.06 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -78.31 14.5 1.19 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.66 -0.65 . . . . 0.0 111.461 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -156.38 -80.25 0.08 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.695 -2.706 . . . . 0.0 103.695 159.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -145.12 -16.91 0.5 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.114 0.966 . . . . 0.0 113.264 -165.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -100.26 -173.5 2.44 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.591 1.087 . . . . 0.0 109.444 -175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.72 149.9 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 164.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.67 133.83 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.314 1.846 . . . . 0.0 107.391 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.82 138.46 25.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 161.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 p -102.05 151.56 22.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.597 1.559 . . . . 0.0 108.532 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -149.15 156.98 43.0 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.373 1.469 . . . . 0.0 108.408 170.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -76.18 144.63 40.39 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.695 1.589 . . . . 0.0 107.821 160.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.473 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -104.79 -163.93 1.0 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.003 0.921 . . . . 0.0 108.683 171.111 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.78 143.59 28.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 167.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.5 -27.07 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.506 2.138 . . . . 0.0 111.243 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -53.12 60.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -77.22 -10.41 59.4 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.398 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -75.69 -43.65 46.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.175 0.898 . . . . 0.0 110.874 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -62.75 -22.03 66.26 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.634 0.373 . . . . 0.0 111.659 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.4 -177.7 3.2 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.349 1.46 . . . . 0.0 109.714 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 104' ' ' PHE . 13.4 ttt180 -91.89 30.81 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.734 0.814 . . . . 0.0 111.348 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.82 48.62 1.61 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.99 -1.069 . . . . 0.0 111.997 -162.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 10.3 m-85 -84.82 135.31 34.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.017 -167.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 164.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.625 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.22 -164.42 13.28 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 166.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -58.56 153.85 37.77 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.902 0.881 . . . . 0.0 113.251 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -62.61 151.64 82.32 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.84 2.36 . . . . 0.0 109.312 162.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.7 p -138.95 176.96 8.25 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -75.47 7.94 3.22 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.327 -0.858 . . . . 0.0 111.988 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 t -133.17 107.08 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.121 1.769 . . . . 0.0 111.147 -169.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -100.19 129.37 46.2 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.735 2.414 . . . . 0.0 106.651 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 49.8 t -81.86 138.37 35.07 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.57 122.88 30.04 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.714 2.406 . . . . 0.0 107.47 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.473 ' HB2' HG23 ' A' ' 90' ' ' VAL . 35.3 mtm -135.01 73.94 1.5 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -161.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 174.52 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -51.65 30.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.625 1.17 . . . . 0.0 109.717 -172.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 165.59 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 O-C-N 125.167 1.542 . . . . 0.0 108.914 -174.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' O ' HD21 ' A' ' 19' ' ' LEU . 31.5 mt -100.66 160.68 26.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 170.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -68.46 7.66 0.65 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 126.224 4.616 . . . . 0.0 114.341 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -135.55 3.92 3.07 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.162 1.385 . . . . 0.0 112.739 -159.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' H ' HD22 ' A' ' 19' ' ' LEU . 53.2 mm-40 -126.07 5.68 7.19 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.846 -1.158 . . . . 0.0 112.051 -176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.695 HD22 ' H ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -79.12 10.36 3.62 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.879 2.072 . . . . 0.0 112.93 -176.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 50' ' ' PRO . 2.8 mm? -96.16 -17.89 20.51 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.789 2.035 . . . . 0.0 112.698 -168.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 88.17 2.86 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 174.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.34 -26.41 12.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.281 2.632 . . . . 0.0 112.758 -165.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.2 -28.11 69.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.307 1.843 . . . . 0.0 113.406 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -85.76 -36.67 20.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.939 0.896 . . . . 0.0 109.022 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.63 -34.26 69.12 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.82 -40.16 29.16 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.199 1.4 . . . . 0.0 112.073 -173.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -60.23 -45.79 92.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.8 mt -61.06 -31.13 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 123.735 0.814 . . . . 0.0 110.938 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.31 -55.84 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.243 0.929 . . . . 0.0 110.473 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.56 -32.98 72.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.517 1.127 . . . . 0.0 112.487 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.58 -27.3 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.474 1.11 . . . . 0.0 109.776 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -67.96 -34.25 76.21 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.176 -0.952 . . . . 0.0 109.642 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.01 -37.45 55.02 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.635 0.774 . . . . 0.0 112.483 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -50.86 61.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.437 1.017 . . . . 0.0 110.559 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.1 t -70.57 -19.39 62.87 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.783 -0.573 . . . . 0.0 110.914 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.29 3.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.351 1.86 . . . . 0.0 112.955 166.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -68.39 -9.42 48.15 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.918 -1.739 . . . . 0.0 113.863 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.4 1.51 4.58 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.741 0.816 . . . . 0.0 113.139 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.9 -139.46 5.2 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.606 HD12 HG23 ' A' ' 67' ' ' THR . 1.9 tm? -144.13 121.41 11.57 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.18 1.792 . . . . 0.0 106.232 176.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.1 t -74.13 120.66 23.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 170.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -76.48 -57.89 3.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.006 0.923 . . . . 0.0 109.35 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.32 172.24 18.52 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.056 1.342 . . . . 0.0 109.345 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mt -137.1 118.11 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -90.86 122.11 33.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.442 1.097 . . . . 0.0 108.344 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.66 86.31 34.27 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 126.848 2.059 . . . . 0.0 105.77 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.18 158.66 33.85 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.366 1.378 . . . . 0.0 110.447 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -123.32 165.12 23.99 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.924 0.889 . . . . 0.0 109.489 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HG2' HD11 ' A' ' 20' ' ' LEU . 60.0 Cg_endo -78.67 124.72 6.43 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.982 3.121 . . . . 0.0 109.011 172.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.4 106.86 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 t70 53.96 24.95 4.98 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.83 13.15 70.2 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.214 1.387 . . . . 0.0 114.291 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.89 161.07 4.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 118.579 1.189 . . . . 0.0 111.094 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -81.05 129.33 34.5 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.892 0.853 . . . . 0.0 109.701 157.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.49 156.41 53.32 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 125.629 1.571 . . . . 0.0 109.668 171.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.2 136.83 35.55 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.023 1.815 . . . . 0.0 108.861 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.86 2.74 88.4 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.656 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -67.75 141.76 56.48 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 117.753 0.776 . . . . 0.0 109.301 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.68 -25.2 27.44 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.458 1.98 . . . . 0.0 112.311 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.04 16.09 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.26 1.03 . . . . 0.0 108.981 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -123.26 145.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -122.15 104.53 9.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.98 153.76 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -132.34 147.02 52.38 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.22 174.67 9.37 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.529 0.604 . . . . 0.0 110.517 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.606 HG23 HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -76.03 -22.45 55.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 177.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.8 p -152.47 161.94 41.89 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.422 1.01 . . . . 0.0 111.168 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.68 -13.99 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 110.497 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.97 -48.44 21.12 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 120.026 -1.671 . . . . 0.0 109.894 172.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.49 -41.81 86.19 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.373 0.669 . . . . 0.0 109.554 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 28.4 p -68.54 -40.65 80.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.327 0.651 . . . . 0.0 109.999 -175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -56.72 -31.26 64.34 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.375 1.47 . . . . 0.0 111.032 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -83.86 -46.56 12.03 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.925 0.784 . . . . 0.0 109.7 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.63 -49.12 73.7 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.375 0.67 . . . . 0.0 109.726 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.2 tpp -44.27 -73.0 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 127.86 2.464 . . . . 0.0 110.119 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -73.11 -7.56 51.87 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.08 -35.31 61.07 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.855 -1.153 . . . . 0.0 110.678 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.413 HD23 ' HG3' ' A' ' 82' ' ' ARG . 76.5 mt -127.62 -1.13 6.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.419 1.088 . . . . 0.0 112.34 -154.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 m -50.58 122.29 6.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.753 1.221 . . . . 0.0 108.405 157.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 11.5 84.27 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.115 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.413 ' HG3' HD23 ' A' ' 79' ' ' LEU . 20.5 mmt-85 -71.2 -178.43 2.03 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.604 1.702 . . . . 0.0 112.239 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -120.92 94.98 4.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.68 43.02 1.13 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 173.63 -86.41 0.0 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.177 2.991 . . . . 0.0 105.958 166.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -149.09 -5.12 0.4 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.276 1.83 . . . . 0.0 111.622 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -118.46 -178.85 3.62 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.942 1.697 . . . . 0.0 109.797 -175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.39 165.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.1 t -130.31 132.65 64.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 125.777 1.631 . . . . 0.0 108.729 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 11' ' ' MET . 0.7 OUTLIER -106.63 143.26 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 p -113.48 156.68 23.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 127.638 2.375 . . . . 0.0 107.527 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 169.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -69.38 150.02 47.75 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -130.66 -167.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.232 1.813 . . . . 0.0 108.136 174.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.65 150.64 52.87 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.96 -19.97 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.508 2.805 . . . . 0.0 113.042 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.48 -49.49 61.71 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.127 1.331 . . . . 0.0 110.378 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.07 7.75 5.74 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.339 1.856 . . . . 0.0 111.663 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -111.79 -36.64 5.38 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -57.96 -31.7 67.13 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -123.74 168.59 12.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.251 1.42 . . . . 0.0 109.347 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -79.73 27.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.172 1.789 . . . . 0.0 111.254 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -86.74 70.59 10.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -101.31 149.88 23.57 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.581 1.152 . . . . 0.0 108.068 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.403 -1.284 . . . . 0.0 110.095 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.974 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.04 -110.78 0.42 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -140.73 157.12 68.46 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.099 1.759 . . . . 0.0 108.831 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.02 151.64 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.352 2.034 . . . . 0.0 109.331 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 p -135.33 177.04 8.12 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -78.7 -0.43 30.12 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.662 171.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -102.22 153.02 5.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 120.657 1.571 . . . . 0.0 109.86 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.65 149.76 46.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.668 1.587 . . . . 0.0 107.545 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 50.7 t -109.29 136.13 49.24 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.0 mt -128.43 110.03 11.95 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -170.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtm -101.66 152.96 20.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 75.11 30.41 0.89 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.691 2.797 . . . . 0.0 114.542 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.444 ' HE1' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -81.63 -69.12 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.521 -1.362 . . . . 0.0 109.632 169.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.32 148.45 29.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.727 1.611 . . . . 0.0 109.829 -155.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -95.36 158.1 35.2 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.37 3.81 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.626 2.217 . . . . 0.0 112.978 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -128.95 15.95 6.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.159 1.784 . . . . 0.0 112.268 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -142.17 31.42 1.56 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.653 1.181 . . . . 0.0 111.066 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.18 5.12 10.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.698 1.599 . . . . 0.0 111.38 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' H ' HD22 ' A' ' 20' ' ' LEU . 1.7 mm? -69.66 -23.53 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.189 0.996 . . . . 0.0 109.504 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.0 81.53 8.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.955 2.502 . . . . 0.0 109.704 -162.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.5 -4.66 0.26 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 128.819 2.847 . . . . 0.0 114.591 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.83 -33.47 4.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 127.889 2.476 . . . . 0.0 111.856 -166.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.86 -39.82 61.34 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.131 0.878 . . . . 0.0 109.279 162.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.426 ' CE1' ' HD2' ' A' ' 49' ' ' ARG . 67.3 t80 -45.49 -40.51 8.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.155 1.782 . . . . 0.0 113.107 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.75 -31.63 41.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.722 0.809 . . . . 0.0 113.171 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -66.55 -50.49 62.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.671 1.588 . . . . 0.0 109.17 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.33 -27.07 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.027 0.931 . . . . 0.0 109.556 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.01 -49.75 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.18 -39.24 86.37 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.52 -47.97 72.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 122.957 1.36 . . . . 0.0 110.161 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.648 HG13 ' CE2' ' A' ' 84' ' ' PHE . 24.8 t -78.23 -32.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.555 -173.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -66.62 -42.91 86.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.712 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.27 -56.37 21.88 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.451 0.7 . . . . 0.0 109.803 174.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HG2' ' HA ' ' A' ' 32' ' ' VAL . 5.2 pt-20 -66.53 -39.97 88.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.477 0.655 . . . . 0.0 110.582 -164.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -78.3 -20.09 52.22 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.832 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -73.4 -9.91 59.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.125 -0.984 . . . . 0.0 111.702 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -64.11 -15.17 59.11 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.31 -1.494 . . . . 0.0 111.44 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.615 ' CD1' HD11 ' A' ' 79' ' ' LEU . 23.9 m-85 -116.71 5.29 13.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.616 2.366 . . . . 0.0 111.101 -175.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.29 -151.71 22.82 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 120.286 1.403 . . . . 0.0 111.978 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.5 tm? -125.77 108.68 11.73 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -78.76 103.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -49.14 -56.02 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.342 1.057 . . . . 0.0 110.39 164.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.81 168.15 23.62 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.329 0.513 . . . . 0.0 111.292 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.73 138.76 43.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 127.038 2.135 . . . . 0.0 105.561 172.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -123.34 111.07 15.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.602 1.561 . . . . 0.0 110.019 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.47 86.16 56.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.19 1.396 . . . . 0.0 108.579 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.29 144.29 61.73 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.125 1.883 . . . . 0.0 108.582 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.426 ' HD2' ' CE1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -123.97 155.27 67.53 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 108.594 -177.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.73 147.98 89.98 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.237 1.958 . . . . 0.0 110.867 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.56 166.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 127.469 2.308 . . . . 0.0 107.677 171.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -64.27 78.01 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 128.117 2.567 . . . . 0.0 109.138 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.44 2.61 57.68 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 117.889 -1.506 . . . . 0.0 113.612 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 t -129.89 144.83 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 120.262 2.031 . . . . 0.0 108.877 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -82.14 172.96 12.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.161 0.981 . . . . 0.0 112.415 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.07 142.38 36.44 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.311 1.845 . . . . 0.0 108.372 174.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.22 130.4 21.24 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.586 2.191 . . . . 0.0 108.846 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.15 27.81 47.71 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.364 0.507 . . . . 0.0 112.296 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 t -71.88 148.68 45.89 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.371 1.086 . . . . 0.0 110.474 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.07 -32.56 5.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 126.872 2.177 . . . . 0.0 111.467 -174.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 3.0 mptt -77.19 160.09 29.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mt -127.56 147.13 32.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 168.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.67 158.02 22.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.31 155.13 28.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 66.4 tt0 -133.05 134.69 44.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 0.0 107.832 -173.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.89 -177.1 3.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.766 1.626 . . . . 0.0 109.288 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.45 HG22 ' HB3' ' A' ' 41' ' ' LEU . 3.5 t -109.19 3.2 21.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.526 0.73 . . . . 0.0 112.074 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -152.01 139.37 19.45 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.085 -1.634 . . . . 0.0 109.545 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.681 HG12 HE21 ' A' ' 73' ' ' GLN . 4.6 t -51.98 -37.38 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.565 1.546 . . . . 0.0 109.633 168.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.31 -16.56 54.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.877 1.271 . . . . 0.0 113.104 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -115.43 -35.13 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -164.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 t -53.81 -48.48 69.82 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.416 1.086 . . . . 0.0 109.704 160.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.681 HE21 HG12 ' A' ' 69' ' ' VAL . 41.3 mt-30 -54.49 -24.34 20.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.17 1.388 . . . . 0.0 113.935 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -82.97 -53.76 5.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.871 1.214 . . . . 0.0 108.867 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.06 -36.47 77.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.575 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -58.07 -35.67 71.7 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.156 0.889 . . . . 0.0 111.767 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -98.46 -44.33 6.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.616 1.166 . . . . 0.0 110.305 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.93 -10.19 50.0 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 118.847 0.749 . . . . 0.0 112.836 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.615 HD11 ' CD1' ' A' ' 39' ' ' TYR . 42.6 mt -130.93 4.91 4.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.98 1.312 . . . . 0.0 111.975 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 t -68.36 144.07 54.91 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.926 1.694 . . . . 0.0 107.214 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.39 86.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.825 -0.986 . . . . 0.0 113.184 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -174.24 0.51 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.804 1.802 . . . . 0.0 109.526 165.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -123.94 141.32 52.14 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.648 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.7 m-30 -109.01 14.14 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.196 0.935 . . . . 0.0 110.852 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.18 -68.85 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.839 2.856 . . . . 0.0 104.946 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -153.93 -20.95 0.14 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 mtp85 -111.77 162.85 14.8 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.427 1.012 . . . . 0.0 110.471 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 t -77.95 106.37 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.004 -163.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.444 HG13 ' HE1' ' A' ' 13' ' ' MET . 75.3 t -72.38 140.56 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.432 1.093 . . . . 0.0 109.552 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.0 t -126.27 128.56 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.0 p -87.69 156.81 19.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 0.0 110.504 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.15 155.08 41.0 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.328 2.251 . . . . 0.0 105.878 169.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -73.89 153.44 39.84 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 119.891 1.223 . . . . 0.0 108.094 159.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -172.5 2.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 164.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.13 144.28 34.53 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.68 -22.68 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.171 1.914 . . . . 0.0 112.346 -167.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -57.54 12.59 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.061 1.301 . . . . 0.0 109.222 175.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -71.39 12.62 0.31 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.595 1.558 . . . . 0.0 111.355 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 65' ' ' GLU . 30.7 t80 -97.52 -55.68 2.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.69 1.196 . . . . 0.0 110.463 169.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -65.57 -36.6 84.25 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.098 0.959 . . . . 0.0 112.714 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -85.38 -164.55 1.02 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.149 0.98 . . . . 0.0 109.519 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -111.97 26.05 10.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.787 1.235 . . . . 0.0 112.591 172.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -77.37 33.47 0.16 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.449 2.3 . . . . 0.0 111.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.03 166.13 22.02 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 120.511 -1.368 . . . . 0.0 111.049 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.035 0 C-N-CA 125.321 1.449 . . . . 0.0 108.926 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.364 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.44 -175.9 23.47 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.69 1.138 . . . . 0.0 112.775 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 -67.36 156.11 89.19 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.556 1.142 . . . . 0.0 111.509 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.15 151.03 66.64 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.649 2.232 . . . . 0.0 108.639 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.9 p -126.26 176.4 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.797 0.839 . . . . 0.0 109.176 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.56 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 28.1 tt0 -72.14 -1.49 15.13 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.576 1.551 . . . . 0.0 112.876 167.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.96 114.04 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 120.503 -1.373 . . . . 0.0 108.956 -151.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 142.56 51.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 108.806 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.2 t -131.12 126.35 35.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.135 0.969 . . . . 0.0 111.648 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' CD1' HG22 ' A' ' 91' ' ' THR . 1.2 mm? -116.66 107.87 15.23 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 108.262 -159.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.6 mtm -79.1 173.45 12.56 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.389 0.675 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 65.89 18.32 11.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.809 1.644 . . . . 0.0 112.208 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.413 ' CE ' ' HB3' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -81.95 -70.68 0.53 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -165.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -104.33 -174.33 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 129.787 3.235 . . . . 0.0 107.051 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -127.49 153.41 77.39 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 120.142 1.337 . . . . 0.0 107.718 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -3.37 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.758 2.305 . . . . 0.0 112.5 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -115.05 11.56 16.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.675 1.19 . . . . 0.0 110.085 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -130.09 -22.57 2.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.838 1.255 . . . . 0.0 112.325 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -79.5 61.33 3.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.627 1.571 . . . . 0.0 110.385 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.03 -14.11 2.4 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.309 -160.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -116.6 151.75 35.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.811 1.245 . . . . 0.0 108.476 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.59 -13.42 40.04 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.59 1.556 . . . . 0.0 111.756 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.27 -60.06 1.94 Allowed 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.154 1.382 . . . . 0.0 108.445 -163.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -53.01 -36.21 60.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.513 1.525 . . . . 0.0 110.307 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -61.08 -36.82 80.67 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.44 1.896 . . . . 0.0 111.592 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.03 -40.35 53.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.392 0.996 . . . . 0.0 109.877 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.32 -34.78 72.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.433 0.693 . . . . 0.0 111.236 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.92 -24.44 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.465 0.706 . . . . 0.0 110.783 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.3 t -67.21 -47.19 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.406 -1.434 . . . . 0.0 108.322 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.86 -21.69 47.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.93 -47.62 61.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.386 1.089 . . . . 0.0 110.576 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG13 ' CE2' ' A' ' 84' ' ' PHE . 50.8 t -74.89 -30.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.974 -170.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -64.11 -31.66 72.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.202 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.81 -53.12 23.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.568 1.076 . . . . 0.0 110.624 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -62.45 -38.26 89.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.435 0.636 . . . . 0.0 110.926 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.473 ' HB3' HG11 ' A' ' 42' ' ' VAL . 8.8 t -70.54 -35.82 73.35 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.003 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -65.55 -14.33 60.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.457 1.026 . . . . 0.0 112.005 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.1 -19.77 21.57 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 119.71 -1.869 . . . . 0.0 112.791 172.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -115.42 2.53 13.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.935 1.294 . . . . 0.0 112.509 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.75 -147.16 15.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.5 120.85 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.473 HG11 ' HB3' ' A' ' 36' ' ' CYS . 2.1 p -87.92 109.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 126.34 1.856 . . . . 0.0 108.849 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -68.33 -63.96 0.96 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.466 1.906 . . . . 0.0 109.988 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -147.67 158.59 44.08 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.552 0.741 . . . . 0.0 111.691 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.7 130.89 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.399 . . . . 0.0 107.36 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -108.98 123.52 49.25 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.978 2.111 . . . . 0.0 107.845 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -129.29 85.15 60.18 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.237 1.815 . . . . 0.0 106.307 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HB2' HG21 ' A' ' 56' ' ' VAL . 64.4 Cg_endo -77.07 101.18 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.111 1.874 . . . . 0.0 109.825 -172.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.13 80.16 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.801 -0.562 . . . . 0.0 110.896 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -62.87 170.44 7.33 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.572 2.848 . . . . 0.0 110.055 173.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t -126.7 100.88 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 t0 48.67 43.66 20.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.115 1.766 . . . . 0.0 112.209 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.83 -11.43 71.02 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.96 1.743 . . . . 0.0 114.132 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.09 140.88 15.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 120.428 2.114 . . . . 0.0 109.841 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -71.0 129.03 37.94 Favored 'General case' 0 N--CA 1.416 -2.128 0 C-N-CA 128.855 2.862 . . . . 0.0 109.59 171.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.632 HG21 ' HB2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -69.68 145.21 94.68 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.566 164.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -61.77 99.21 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 N-CA-C 107.03 -1.95 . . . . 0.0 107.03 165.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.4 16.25 18.76 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.266 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.501 ' HB2' HG22 ' A' ' 56' ' ' VAL . 11.5 t -72.33 148.85 44.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.59 1.695 . . . . 0.0 110.106 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.99 -11.11 40.84 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.05 134.73 35.12 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.023 1.329 . . . . 0.0 109.657 -169.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.92 137.2 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -108.83 130.5 55.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -128.96 160.14 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.418 1.487 . . . . 0.0 107.979 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.38 143.43 39.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.596 1.958 . . . . 0.0 109.875 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -110.07 -169.16 1.42 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.908 1.231 . . . . 0.0 112.249 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -93.96 -15.35 25.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 113.775 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.9 m -155.6 145.57 21.49 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.121 1.369 . . . . 0.0 108.628 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.08 -32.26 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 122.261 1.029 . . . . 0.0 110.533 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.2 -36.57 71.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 117.333 -1.317 . . . . 0.0 112.3 174.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 79.4 m-20 -64.07 -36.77 85.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.053 1.297 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 34.4 m -76.65 -36.48 57.33 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 127.695 2.398 . . . . 0.0 109.256 -166.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.65 -40.23 82.83 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.144 1.378 . . . . 0.0 110.89 170.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.563 ' CE ' ' HA ' ' A' ' 71' ' ' ASP . 40.8 mtmt -72.34 -48.32 42.84 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.452 0.701 . . . . 0.0 109.184 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.09 -35.79 81.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.046 0.938 . . . . 0.0 112.687 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 43.1 tpp -55.1 -68.63 0.17 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.427 1.491 . . . . 0.0 109.176 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -67.81 -25.1 65.41 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.01 -15.46 81.1 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.341 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.74 6.71 5.15 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.668 1.187 . . . . 0.0 111.898 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.1 m -56.49 113.59 1.67 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 6.1 57.9 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.76 1.171 . . . . 0.0 113.614 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.79 179.25 0.27 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.976 1.31 . . . . 0.0 113.675 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -131.04 90.54 2.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.147 1.779 . . . . 0.0 108.35 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.431 ' CE2' HG13 ' A' ' 32' ' ' VAL . 2.7 m-30 -77.19 14.68 0.86 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.95 -1.094 . . . . 0.0 112.539 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.53 -64.45 0.06 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.002 2.521 . . . . 0.0 105.211 163.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.66 -10.43 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -109.02 148.9 30.05 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.417 -1.427 . . . . 0.0 109.949 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -64.85 131.82 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.991 -171.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -101.0 141.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.778 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 138.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 161.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.419 HG22 ' CD1' ' A' ' 10' ' ' LEU . 2.6 p -94.42 157.48 15.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.4 2.28 . . . . 0.0 108.476 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.18 157.02 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.527 1.058 . . . . 0.0 109.481 159.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 114.5 18.71 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.2 m -79.78 166.41 21.77 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 163.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -92.29 142.81 26.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.56 -35.73 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.427 2.752 . . . . 0.0 112.7 -172.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -54.14 -36.66 63.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.99 0.516 . . . . 0.0 111.709 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.2 p -75.41 -43.33 50.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -62.31 -30.9 71.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.373 1.469 . . . . 0.0 112.207 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -66.38 -8.48 25.88 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.133 0.973 . . . . 0.0 113.086 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -129.01 -174.6 3.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.495 1.918 . . . . 0.0 108.099 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -90.06 55.98 3.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -122.15 98.76 6.08 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.117 0.567 . . . . 0.0 109.785 -174.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.56 163.91 31.31 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.553 0.741 . . . . 0.0 109.711 -172.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.322 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.699 . . . . . . . . 1 1 . 1 stop_ save_